{"article": "PMC1325254.txt", "subject": "APOE genotype", "relationship": "RELATED_TREATMENT", "object": "was related to increased risk for AD", "chunk": 1}
{"article": "PMC1325254.txt", "subject": "APOE \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk of Alzheimer's Disease", "chunk": 2}
{"article": "PMC1325254.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "Poorer cognitive outcomes", "chunk": 2}
{"article": "PMC1325254.txt", "subject": "BMI", "relationship": "RELATED_PROGNOSIS", "object": "Reduced brain volume", "chunk": 3}
{"article": "PMC1325254.txt", "subject": "BMI", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Brain atrophy", "chunk": 3}
{"article": "PMC1325254.txt", "subject": "BMI", "relationship": "PREDICT", "object": "Increased vulnerability to brain atrophy over subsequent years", "chunk": 3}
{"article": "PMC1325254.txt", "subject": "BMI", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive decline or dementia", "chunk": 3}
{"article": "PMC1325254.txt", "subject": "obesity (classification by the WHO)", "relationship": "INDICATES_PRESENCE_OF", "object": "Greater global brain atrophy", "chunk": 3}
{"article": "PMC1325254.txt", "subject": "BMI", "relationship": "RELATED_TO", "object": "Lesser brain volume", "chunk": 4}
{"article": "PMC1325254.txt", "subject": "BMI", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk of adverse consequences related to overweight individuals", "chunk": 4}
{"article": "PMC1325254.txt", "subject": "Elevated BMI", "relationship": "RELATED_PROGNOSIS", "object": "Greater rate of cerebral atrophy over time", "chunk": 4}
{"article": "PMC1325254.txt", "subject": "Elevated BMI", "relationship": "RELATED_PROGNOSIS", "object": "Increased risk of future cognitive decline and incidence of dementia", "chunk": 4}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Risk for Alzheimer's disease", "chunk": 1}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "ASSOCIATED_WITH", "object": "Metabolic brain changes several years before the onset of typical AD symptoms", "chunk": 1}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "Increased risk and reduced age of onset in people with the late-onset form of AD", "chunk": 1}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Determining risk of Alzheimer's disease and potential interventions", "chunk": 1}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Tailoring treatment plans to individual risk profiles", "chunk": 1}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_TREATMENT", "object": "Development of targeted therapies to mitigate the risk or progression of AD", "chunk": 1}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "Increased risk for Alzheimer's Disease", "chunk": 2}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "increased risk of memory impairment and AD", "chunk": 5}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "greater risk for memory impairment and AD", "chunk": 5}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "reduced hippocampal volume", "chunk": 5}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "poorer memory ability", "chunk": 5}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "PREDICT_MORATILITY", "object": "cognitive impairment over a 4-year follow-up period", "chunk": 5}
{"article": "PMC1373642.txt", "subject": "RAVLT", "relationship": "INDICATES_PRESENCE_OF", "object": "better learning ability", "chunk": 5}
{"article": "PMC1373642.txt", "subject": "reduced fMRI activation in \u03b53/4 heterozygotes", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "requires further studies to understand the conditions under which the APOE \u03b54 allele results in reduced MTL volume", "chunk": 5}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "High Risk of AD", "chunk": 6}
{"article": "PMC1373642.txt", "subject": "APOE3/3 homozygotes", "relationship": "INDICATES_PRESENCE_OF", "object": "Low Risk of AD", "chunk": 6}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Greater longitudinal decline in fMRI activation in the inferotemporal cortex", "chunk": 6}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 carriers", "relationship": "RELATED_TREATMENT", "object": "Require additional cognitive effort to achieve comparable performance", "chunk": 6}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 carriers", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Compensatory response", "chunk": 6}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "accelerate[s] with increasing age", "chunk": 7}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "reduced hippocampal volume in elderly \u03b54 carriers", "chunk": 7}
{"article": "PMC1373642.txt", "subject": "resting state cerebral metabolic rate of glucose (CMRgl)", "relationship": "RELATED_TREATMENT", "object": "reductions in resting state cerebral metabolic rate of glucose (CMRgl) in the MTL and cortical regions of AD patients", "chunk": 7}
{"article": "PMC1373642.txt", "subject": "reduced hippocampal BOLD signal", "relationship": "RELATED_TREATMENT", "object": "reduced glucose metabolism would lead to reduced neuronal activation", "chunk": 7}
{"article": "PMC1373642.txt", "subject": "Homocysteine", "relationship": "RELATED_PROGNOSIS", "object": "Measured in the study, but no specific relationship to Alzheimer's prognosis stated", "chunk": 9}
{"article": "PMC1373642.txt", "subject": "Blood Cholesterol", "relationship": "RELATED_PROGNOSIS", "object": "Measured in the study, but no specific relationship to Alzheimer's prognosis stated", "chunk": 9}
{"article": "PMC1779282.txt", "subject": "Strength training", "relationship": "ASSOCIATED_WITH_PREVENTING", "object": "Falls", "chunk": 2}
{"article": "PMC1779282.txt", "subject": "Flexibility", "relationship": "ASSOCIATED_WITH_PREVENTING", "object": "Falls", "chunk": 2}
{"article": "PMC1851724.txt", "subject": "Individuals with 2 y or more of sustained NSAID treatment", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduced relative hazard of Alzheimer's dementia", "chunk": 2}
{"article": "PMC1851724.txt", "subject": "Naproxen sodium", "relationship": "RELATED_TREATMENT", "object": "Prevention ofAlzheimer's Disease", "chunk": 2}
{"article": "PMC1851724.txt", "subject": "Celecoxib", "relationship": "RELATED_TREATMENT", "object": "Prevention ofAlzheimer's Disease", "chunk": 2}
{"article": "PMC1851724.txt", "subject": "NSAID", "relationship": "RELATED_TREATMENT", "object": "treatment of chronic conditions frequently necessitating decades of analgesic therapy", "chunk": 5}
{"article": "PMC1851724.txt", "subject": "NSAID", "relationship": "RELATED_TREATMENT", "object": "conditions such as osteoarthritis and rheumatoid arthritis, and the potential risks need to be weighed against the known immediate benefits of treatment", "chunk": 5}
{"article": "PMC1851724.txt", "subject": "Alzheimer's disease", "relationship": "RELATED_TREATMENT", "object": " NSAIDs for the prevention of Alzheimer's disease", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Cognitive impairment", "relationship": "INDICATES_PRESENCE_OF", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "SPMSQ >= 4 errors", "relationship": "INDICATES_PRESENCE_OF", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Prior nursing home use", "relationship": "PREDICTS_SURVIVAL", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Age", "relationship": "PREDICTS_SURVIVAL", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "White (vs. all other races/ethnicities)", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Married", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Owning a home", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Being female", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Diabetes", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Falls", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Cancer", "relationship": "HAS_RELATONSHIP_TO", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Stroke", "relationship": "HAS_RELATONSHIP_TO", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Arthritis", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Blood pressure", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Cardiovascular disease", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Lung disease", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Incontinence", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Number prescription drugs", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Living with others", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "ADL dependencies", "relationship": "RELATED_PROGNOSIS", "object": "Predict NH admission", "chunk": 7}
{"article": "PMC1914346.txt", "subject": "Cognitive impairment", "relationship": "RELATED_PROGNOSIS", "object": "Predict NH admission", "chunk": 7}
{"article": "PMC1914346.txt", "subject": "3 or more ADL dependencies", "relationship": "RELATED_PROGNOSIS", "object": "Predict NH admission", "chunk": 7}
{"article": "PMC1914346.txt", "subject": "Prior NH use", "relationship": "RELATED_PROGNOSIS", "object": "Predict NH admission", "chunk": 7}
{"article": "PMC1914346.txt", "subject": "Non-Caucasian race/ethnicity", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk for NH admission", "chunk": 7}
{"article": "PMC1914346.txt", "subject": "Lack of informal support or socioeconomic resources", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk for NH admission", "chunk": 7}
{"article": "PMC2194921.txt", "subject": "indomethacin", "relationship": "RELATED_TREATMENT", "object": "Slowing cognitive decline in patients with Alzheimer's disease", "chunk": 1}
{"article": "PMC2194921.txt", "subject": "indomethacin", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treating Alzheimer's disease", "chunk": 1}
{"article": "PMC2194921.txt", "subject": "indomethacin", "relationship": "PREDICTED_SURVIVAL", "object": "To retard clinical progression of AD", "chunk": 1}
{"article": "PMC2194921.txt", "subject": "ADAS-cog", "relationship": "RELATED_TREATMENT", "object": "measured the effect of indomethacin treatment on cognitive decline", "chunk": 2}
{"article": "PMC2194921.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "measured dementia severity in patients receiving indomethacin or placebo", "chunk": 2}
{"article": "PMC2194921.txt", "subject": "CIBIC+", "relationship": "RELATED_TREATMENT", "object": "assessed the change in clinical status in patients receiving indomethacin or placebo", "chunk": 2}
{"article": "PMC2194921.txt", "subject": "ADAS-noncog", "relationship": "RELATED_TREATMENT", "object": "evaluated non-cognitive functions in patients receiving indomethacin or placebo", "chunk": 2}
{"article": "PMC2194921.txt", "subject": "NPI", "relationship": "RELATED_TREATMENT", "object": "assessed neuropsychiatric symptoms in patients receiving indomethacin or placebo", "chunk": 2}
{"article": "PMC2194921.txt", "subject": "IDDD", "relationship": "RELATED_TREATMENT", "object": "measured deterioration in daily living activities in patients receiving indomethacin or placebo", "chunk": 2}
{"article": "PMC2194921.txt", "subject": "ADAS-cog", "relationship": "RELATED_PROGNOSIS", "object": "Change in score after one year of treatment", "chunk": 3}
{"article": "PMC2194921.txt", "subject": "ADAS-noncog", "relationship": "RELATED_PROGNOSIS", "object": "Change in score after one year of treatment", "chunk": 3}
{"article": "PMC2194921.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Change in score after one year of treatment", "chunk": 3}
{"article": "PMC2194921.txt", "subject": "NPI", "relationship": "RELATED_PROGNOSIS", "object": "Change in score after one year of treatment", "chunk": 3}
{"article": "PMC2194921.txt", "subject": "NPI-D", "relationship": "RELATED_PROGNOSIS", "object": "Change in score after one year of treatment", "chunk": 3}
{"article": "PMC2194921.txt", "subject": "IDDD", "relationship": "RELATED_PROGNOSIS", "object": "Change in score after one year of treatment", "chunk": 3}
{"article": "PMC2194921.txt", "subject": "CIBIC+", "relationship": "RELATED_PROGNOSIS", "object": "Change in score after one year of treatment", "chunk": 3}
{"article": "PMC2194921.txt", "subject": "creatinine", "relationship": "MONITORED_DURING_TREATMENT", "object": "Indomethacin treatment", "chunk": 4}
{"article": "PMC2194921.txt", "subject": "creatininine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Avoid indomethacin administration", "chunk": 4}
{"article": "PMC2194921.txt", "subject": "blood pressure", "relationship": "MONITORED_DURING_TREATMENT", "object": "Indomethacin treatment", "chunk": 4}
{"article": "PMC2194921.txt", "subject": "alanine aminotransferase", "relationship": "MONITORED_DURING_TREATMENT", "object": "Indomethacin treatment", "chunk": 4}
{"article": "PMC2194921.txt", "subject": "aspartate aminotransferase", "relationship": "MONITORED_DURING_TREATMENT", "object": "Indomethacin treatment", "chunk": 4}
{"article": "PMC2241592.txt", "subject": "TNF", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuroinflammation", "chunk": 1}
{"article": "PMC2241592.txt", "subject": "TNF", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Impairment in spatial memory", "chunk": 1}
{"article": "PMC2241592.txt", "subject": "TNF", "relationship": "RELATED_TO", "object": "Synaptic dysregulation", "chunk": 1}
{"article": "PMC2241592.txt", "subject": "IL-1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Impairment in LTP and related behaviors", "chunk": 1}
{"article": "PMC2241592.txt", "subject": "etanercept", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Cognitive recovery", "chunk": 1}
{"article": "PMC2241592.txt", "subject": "etanercept", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Direct-to-the-brain delivery of anti-cytokine therapies", "chunk": 1}
{"article": "PMC2241592.txt", "subject": "perispinal etanercept", "relationship": "RELATED_PROGNOSIS", "object": "Sustained improvement in cognitive function", "chunk": 1}
{"article": "PMC2291469.txt", "subject": "electronic tagging", "relationship": "INDICATES_PRESENCE_OF", "object": "Boundary transgressions", "chunk": 2}
{"article": "PMC2291469.txt", "subject": "electronic tagging", "relationship": "RELATED_TO", "object": "reduced distress and burden of family caregivers", "chunk": 2}
{"article": "PMC2291469.txt", "subject": "electronic tagging", "relationship": "RELATED_TO", "object": "improving both caregiver and elder's quality of life", "chunk": 2}
{"article": "PMC2291469.txt", "subject": "electronic tagging", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "care for the elder in the community", "chunk": 2}
{"article": "PMC2291469.txt", "subject": "Clinical dementia Rating (CDR)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC2291469.txt", "subject": "Mini Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC2291469.txt", "subject": "Cambridge Cognitive Examination \u2013 Revised (CAMCOG-R)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC2291469.txt", "subject": "Apathy Evaluation Scale, Clinical Version (AES-C)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC2291469.txt", "subject": "Clock Drawing Test \u2013 Modified and Integrated Approach (CDT-MIA)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC2291469.txt", "subject": "Neuropsychiatric Inventory (NPI)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC2291469.txt", "subject": "Trail Making Test (TMT)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC2291469.txt", "subject": "Geriatric Depression scale (GDS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression", "chunk": 7}
{"article": "PMC2500042.txt", "subject": "TNF-alpha", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC2500042.txt", "subject": "Excess TNF-alpha", "relationship": "RELATED_TO", "object": "Pathogenesis of Alzheimer's disease", "chunk": 1}
{"article": "PMC2500042.txt", "subject": "Etanercept", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC2500042.txt", "subject": "Excess TNF-alpha", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Etanercept", "chunk": 1}
{"article": "PMC2500042.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "Improvement in the main outcome measures which were the Mini-Mental State Examination (MMSE)", "chunk": 2}
{"article": "PMC2500042.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TREATMENT", "object": "Improvement in the main outcome measures which were the Mini-Mental State Examination (MMSE), the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog)", "chunk": 2}
{"article": "PMC2500042.txt", "subject": "Severe Impairment Battery", "relationship": "RELATED_TREATMENT", "object": "Improvement in the main outcome measures which were the Mini-Mental State Examination (MMSE), the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog), and the Severe Impairment Battery", "chunk": 2}
{"article": "PMC2500042.txt", "subject": "TNF-alpha", "relationship": "RELATED_PROGNOSIS", "object": "Pro-inflammatory effects may be associated with negative outcomes in Alzheimer's disease", "chunk": 5}
{"article": "PMC2702274.txt", "subject": "Firmicutes", "relationship": "RELATED_PROGNOSIS", "object": "Elevated Firmicutes/Bacteroidetes ratio also observed in obese subjects", "chunk": 1}
{"article": "PMC2702274.txt", "subject": "Bacteroidetes", "relationship": "RELATED_PROGNOSIS", "object": "Elevated Firmicutes/Bacteroidetes ratio also observed in obese subjects", "chunk": 1}
{"article": "PMC2702274.txt", "subject": "Firmicutes/Bacteroidetes ratio", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Elevated Firmicutes/Bacteroidetes ratio observed in obese subjects", "chunk": 1}
{"article": "PMC2702274.txt", "subject": "Firmicutes/Bacteroidetes ratio", "relationship": "RELATED_TREATMENT", "object": "Decreased Firmicutes/Bacteroidetes ratio associated with weight loss", "chunk": 1}
{"article": "PMC2702274.txt", "subject": "C. leptum", "relationship": "RELATED_TO_AGE", "object": "Lower levels in infants compared to adults and seniors", "chunk": 2}
{"article": "PMC2702274.txt", "subject": "C. coccoides", "relationship": "RELATED_TO_AGE", "object": "Lower levels in infants compared to adults and seniors", "chunk": 2}
{"article": "PMC2702274.txt", "subject": "E. coli", "relationship": "RELATED_TO_AGE", "object": "Dominant in infants compared to adults and seniors", "chunk": 2}
{"article": "PMC2702274.txt", "subject": "Bifidobacterium", "relationship": "RELATED_TO_AGE", "object": "Dominant in infants compared to adults and seniors", "chunk": 2}
{"article": "PMC2731764.txt", "subject": "APOE", "relationship": "RELATED_PROGNOSIS", "object": "Risk of developing Alzheimer's disease", "chunk": 1}
{"article": "PMC2731764.txt", "subject": "APOE epsilon 4 (E4) variant", "relationship": "DIAGNOSTIC_OF", "object": "Sporadic or late onset Alzheimer's disease", "chunk": 1}
{"article": "PMC2731764.txt", "subject": "APOE epsilon 4 (E4) variant", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk of developing Alzheimer's disease", "chunk": 1}
{"article": "PMC2731764.txt", "subject": "APOE epsilon 4 (E4) variant", "relationship": "RELATED_PROGNOSIS", "object": "Higher risk of developing Alzheimer's disease (dose-dependent)", "chunk": 1}
{"article": "PMC2731764.txt", "subject": "\u03b2-hydroxybutyrate (BHB)", "relationship": "RELATED_TO_TREATMENT_ELIGIBILITY", "object": "Induction of ketosis (a potential therapy for Alzheimer's disease)", "chunk": 1}
{"article": "PMC2731764.txt", "subject": "A\u03b2 peptide", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Toxic effects in cultured neurons", "chunk": 2}
{"article": "PMC2731764.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC2731764.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC2731764.txt", "subject": "apoe4 allele", "relationship": "RELATED_PROGNOSIS", "object": "Response to ketosis", "chunk": 2}
{"article": "PMC2731764.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "MONITORED_DURING_TREATMENT", "object": " Safety evaluations", "chunk": 4}
{"article": "PMC2731764.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "pre-defined additional analyses", "chunk": 4}
{"article": "PMC2731764.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "RELATED_PROGNOSIS", "object": "2 hour post-dose serum BHB levels at Day 90", "chunk": 4}
{"article": "PMC2731764.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "RELATED_PROGNOSIS", "object": "change from Baseline ADAS-Cog total score", "chunk": 4}
{"article": "PMC2731764.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "4/4 genotype", "chunk": 5}
{"article": "PMC2731764.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "3/3 genotype", "chunk": 5}
{"article": "PMC2731764.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased cognitive impairment", "chunk": 6}
{"article": "PMC2731764.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Change from baseline in ADAS-Cog scores at Day 90 and total CGIC scores at Day 90 were primary outcomes defined by the protocol", "chunk": 6}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "RELATED_TREATMENT", "object": "Cumulative dose", "chunk": 6}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "RELATED_TO_TREATMENT_ELIGIBILITY", "object": "Effects of AC-1202 administration on ADAS-Cog, MMSE and CGIC were stratified by apoe4 carriage status", "chunk": 7}
{"article": "PMC2731764.txt", "subject": "apoe4-", "relationship": "INDICATES_PRESENCE_OF", "object": "Compared to a 3.05 point decline in Placebo at Day 45", "chunk": 7}
{"article": "PMC2731764.txt", "subject": "apoe4-", "relationship": "INDICATES_PRESENCE_OF", "object": "compared to a 1.61 point decline in Placebo at Day 90", "chunk": 7}
{"article": "PMC2731764.txt", "subject": "apoe4-", "relationship": "IS_TARGET_OF_TREATMENT", "object": " AC-1202 resulted in improvement in ADAS-Cog in apoe4(-) AD patients", "chunk": 7}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Associated with significant statistical differences in ADAS-Cog scores from Baseline between AC-1202 and Placebo groups on Day 45 in dosage compliant subjects", "chunk": 9}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Associated with significant statistical differences in ADAS-Cog scores from Baseline between AC-1202 and Placebo groups at Day 45 in dosage compliant subjects", "chunk": 9}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Associated with significant statistical differences in ADAS-Cog scores from Baseline between AC-1202 and Placebo groups on Day 90 in dosage compliant subjects", "chunk": 9}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Associated with significant statistical differences in ADAS-Cog scores from Baseline between AC-1202 and Placebo groups on Day 104 in dosage compliant subjects", "chunk": 9}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "Associated with specific effects on cognitive function in the per protocol population", "chunk": 9}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Associated with significant improvement in MMSE scores on Day 104 among dosage compliant subjects", "chunk": 9}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": " Associated with worse than Placebo results for MMSE scores on Day 104 in dosage compliant subjects", "chunk": 9}
{"article": "PMC2731764.txt", "subject": "ADAS-Cog", "relationship": "MONITORED_DURING_TREATMENT", "object": "Monitoring of cognitive function", "chunk": 10}
{"article": "PMC2731764.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TREATMENT", "object": "Correlation between ADAS-Cog scores and total dose of AC-1202", "chunk": 10}
{"article": "PMC2731764.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TREATMENT", "object": "Correlation between ADAS-Cog scores and serum BHB levels", "chunk": 10}
{"article": "PMC2731764.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "Changes in MMSE scores were significantly different between AC-1202 and Placebo groups among E4(+) subjects on Day 104", "chunk": 10}
{"article": "PMC2731764.txt", "subject": "BHB", "relationship": "RELATED_TREATMENT", "object": "Serum BHB levels and change in ADAS-Cog scores were significantly correlated", "chunk": 10}
{"article": "PMC2731764.txt", "subject": "BUN", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Dehydration", "chunk": 11}
{"article": "PMC2731764.txt", "subject": "creatinine", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Dehydration", "chunk": 11}
{"article": "PMC2731764.txt", "subject": "uric acid", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Dehydration", "chunk": 11}
{"article": "PMC2731764.txt", "subject": "BUN/creatinine ratio", "relationship": "RELATED_TO", "object": "Dehydration", "chunk": 11}
{"article": "PMC2731764.txt", "subject": "BHB", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Treatment with AC-1202", "chunk": 11}
{"article": "PMC2731764.txt", "subject": "BHB", "relationship": "RELATED_PROGNOSIS", "object": "Levels of BHB (above 1 mM) have been reported to be associated with positive cognitive effects in E4(-) subjects.", "chunk": 12}
{"article": "PMC2731764.txt", "subject": "BHB", "relationship": "RELATED_TREATMENT", "object": "Induction of mild ketosis by AC-1202, increasing BHB levels.", "chunk": 12}
{"article": "PMC2731764.txt", "subject": "BHB", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Mild ketosis, induced by AC-1202, resulting in increased BHB levels, was associated with improved respiration rates in the parietal regions of the brain in an aged dog model.", "chunk": 12}
{"article": "PMC2731764.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "BHB was found to protect cultured hippocampal neurons from the toxic effects of A\u03b242.", "chunk": 12}
{"article": "PMC2731764.txt", "subject": "AC-1202", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "The effects of AC-1202 on cognitive performance were examined in AD patients, with the aim of guiding treatment selection based on an individual's APOE4 genotype.", "chunk": 12}
{"article": "PMC2731764.txt", "subject": "AD", "relationship": "RELATED_PROGNOSIS", "object": " improvement in cognition may be feasible", "chunk": 13}
{"article": "PMC2731764.txt", "subject": "ADAS-Cog", "relationship": "USED_TO_DIAGNOSE", "object": "clinically significant changes in AD trials", "chunk": 13}
{"article": "PMC2731764.txt", "subject": "BHB", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "higher levels of ketosis appear to confer greater benefit", "chunk": 13}
{"article": "PMC2731764.txt", "subject": "AC-1202", "relationship": "RESPONDED_TO", "object": "E4(-) subjects who were dosage compliant experienced a -4 point or greater improvement", "chunk": 13}
{"article": "PMC2764863.txt", "subject": "hippocampal volume", "relationship": "PREDICTS_SURVIVAL", "object": "conversion from mild cognitive impairment to probable AD", "chunk": 1}
{"article": "PMC2764863.txt", "subject": "decreased hippocampal volume", "relationship": "RELATED_PROGNOSIS", "object": "imminent conversion from mild cognitive impairment to probable AD", "chunk": 1}
{"article": "PMC2764863.txt", "subject": "hippocampal volume", "relationship": "RELATED_TREATMENT", "object": "detection of subtle changes in brain structure associated with disease progression", "chunk": 1}
{"article": "PMC2764863.txt", "subject": "Hippocampal GM density", "relationship": "RELATED_TREATMENT", "object": "Monitored during treatment", "chunk": 2}
{"article": "PMC2764863.txt", "subject": "Amygdalar volume", "relationship": "RELATED_TREATMENT", "object": "Monitored during treatment", "chunk": 2}
{"article": "PMC2764863.txt", "subject": "Entorhinal, temporal, and parietal cortical thickness", "relationship": "RELATED_TREATMENT", "object": "Monitored during treatment", "chunk": 2}
{"article": "PMC2764863.txt", "subject": "hippocampus", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC2764863.txt", "subject": "hippocampus", "relationship": "RELATED_PROGNOSIS", "object": "Reduced hippocampal GM density", "chunk": 4}
{"article": "PMC2764863.txt", "subject": "amygdala", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease symptoms", "chunk": 4}
{"article": "PMC2764863.txt", "subject": "entorhinal cortex", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC2764863.txt", "subject": "grey matter (GM)", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC2764863.txt", "subject": "Grey Matter density", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC2764863.txt", "subject": "Hippocampal volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment  -Converters", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Amygdalar volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment -Converters", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Entorhinal cortex thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment -Converters", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Bilateral hippocampal volume", "relationship": "RELATED_PROGNOSIS", "object": "Imminent conversion from mild cognitive impairment to probable AD", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Mean cortical thickness values from lateral temporal cortices", "relationship": "RELATED_PROGNOSIS", "object": "Imminent conversion from mild cognitive impairment to probable AD", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Cortical thickness values from the inferior and middle temporal gyri", "relationship": "RELATED_PROGNOSIS", "object": "Imminent conversion from mild cognitive impairment to probable AD", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Cortical thickness values from the entorhinal cortex", "relationship": "RELATED_PROGNOSIS", "object": "Imminent conversion from mild cognitive impairment to probable AD", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Amygdalar volume", "relationship": "RELATED_PROGNOSIS", "object": "Imminent conversion from mild cognitive impairment to probable AD", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Cortical thickness in bilateral inferior parietal gyrus", "relationship": "RELATED_PROGNOSIS", "object": "Imminent conversion from mild cognitive impairment to probable AD", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Cortical thickness in precuneus", "relationship": "RELATED_PROGNOSIS", "object": "Imminent conversion from mild cognitive impairment to probable AD", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "hippocampal volumes", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease ", "chunk": 6}
{"article": "PMC2764863.txt", "subject": "hippocampal GM density", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease ", "chunk": 6}
{"article": "PMC2764863.txt", "subject": "hippocampal volumes", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Conversion to AD within a year", "chunk": 6}
{"article": "PMC2764863.txt", "subject": "amygdalar volume", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Conversion to AD within a year", "chunk": 6}
{"article": "PMC2764863.txt", "subject": "cortical thickness in entorhinal cortex, inferior, middle, and superior temporal gyri, inferior parietal gyrus, and precuneus", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Conversion to AD within a year", "chunk": 6}
{"article": "PMC2764863.txt", "subject": "APOE genotype", "relationship": "RELATED_PROGNOSIS", "object": "Prediction of  disease course ", "chunk": 7}
{"article": "PMC2764863.txt", "subject": "VBM", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Clinical trials in mild cognitive impairment and AD ", "chunk": 7}
{"article": "PMC2764863.txt", "subject": "automated parcellation", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Clinical trials in mild cognitive impairment and AD ", "chunk": 7}
{"article": "PMC2764863.txt", "subject": " hippocampal GM density", "relationship": "RELATED_TREATMENT", "object": "Decreased hippocampal GM density is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": "hippocampal volume", "relationship": "RELATED_TREATMENT", "object": "Decreased hippocampal volume is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": " entorhinal cortex thickness", "relationship": "RELATED_TREATMENT", "object": "Decreased entorhinal cortex thickness is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": "inferior temporal gyrus cortical thickness", "relationship": "RELATED_TREATMENT", "object": "Decreased inferior temporal gyrus cortical thickness is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": "middle temporal gyrus cortical thickness", "relationship": "RELATED_TREATMENT", "object": "Decreased middle temporal gyrus cortical thickness is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": "superior temporal gyrus cortical thickness", "relationship": "RELATED_TREATMENT", "object": "Decreased superior temporal gyrus cortical thickness is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": "inferior parietal gyrus cortical thickness", "relationship": "RELATED_TREATMENT", "object": "Decreased inferior parietal gyrus cortical thickness is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": "precuneus cortical thickness", "relationship": "RELATED_TREATMENT", "object": "Decreased precuneus cortical thickness is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": "Amygdala Volume", "relationship": "RELATED_TREATMENT", "object": "Decreased amygdala volume is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2765081.txt", "subject": "amyloid-\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Senile plaques, histopathological hallmark of AD", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "amyloid-\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Reduction of amyloid-\u03b2 via inhibiting production, aggregation, or promoting degradation and removal", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "amyloid-\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "active or passive immunization", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "amyloid-\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Deposition of amyloid-\u03b2 in the cerebral blood vessels via down-regulation of RAR-\u03b1 in the forebrain neurons", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "amyloid precursor protein (APP)", "relationship": "RELATED_TO_THE_LEVELS_OF", "object": "amyloid-\u03b2", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "retinoids", "relationship": "RELATED_TO_THE_LEVELS_OF", "object": "amyloid-\u03b2", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "ChAT", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Loss of choline acetyltransferase (ChAT) expression", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "retinoic acid", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Activates the \u03b1-secretase", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "vitamin A", "relationship": "RELATED_TREATMENT", "object": "Dietary deficiency disrupts the retinoid signaling pathway and leads to amyloid-\u03b2 deposition", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "retinoic acid", "relationship": "RELATED_TREATMENT", "object": "Can reverse the changes caused by vitamin A deficiency", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "rheumatoid arthritis", "relationship": "RELATED_TREATMENT", "object": "Anti-inflammatory drugs can treat rheumatoid arthritis", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "IL6", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Chronic inflammation and astrocytosis are histopathological hallmarks of AD patients", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "IL6", "relationship": "RELATED_TREATMENT", "object": "Retinoids strongly suppress the production of IL6", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "IL17", "relationship": "INDICATES_PRESENCE_OF", "object": "autoimmune response in neurodegenerative diseases", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "IL17", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "central nervous system inflammation in MS lesions", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "IL17", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "neuron killing ", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "IL17", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treatment of autoimmune diseases", "chunk": 3}
{"article": "PMC2765081.txt", "subject": " IL22 receptors", "relationship": "INDICATES_PRESENCE_OF", "object": "autoimmune response in neurodegenerative diseases", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "Th17 cells", "relationship": "RELATED_TREATMENT", "object": "suppression of autoimmune response, slowing the progression of autoimmune diseases", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "Th17 cells", "relationship": "INDICATES_PRESENCE_OF", "object": "neuroinflammation", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "Treg", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "therapies for activation or proliferation of Treg for autoimmune diseases", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "Treg", "relationship": "RELATED_PROGNOSIS", "object": "immune homeostasis", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "Treg", "relationship": "RELATED_PROGNOSIS", "object": "disease-related immune mechanisms", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "Treg", "relationship": "MONITORED_DURING_TREATMENT", "object": "MTPT-treated mouse model of PD", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "Foxp3", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treg activation or proliferation therapies", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "TTR", "relationship": "RELATED_TREATMENT", "object": "Treatment of Alzheimer's disease", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "TTR", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower levels found in Alzheimer's patients", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "TTR", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "RA uptake was shown to improve memory deficits", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "ChAT", "relationship": "RELATED_PROGNOSIS", "object": "An increase seems to be beneficial", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "RA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Development of retinoids selective for individual RARs", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "RA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Retinoids are under investigation for treatment of Alzheimer's disease", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "TrkB", "relationship": "RELATED_TREATMENT", "object": "Development of retinoids for treatment of neurodegenerative diseases", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "t-PA", "relationship": "RELATED_TREATMENT", "object": "Development of retinoids for treatment of neurodegenerative diseases", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "Gap43", "relationship": "RELATED_TREATMENT", "object": "Development of retinoids for treatment of neurodegenerative diseases", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "amyloid-\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "decrease", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "IL-1b", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammatory response", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "IL-1b", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammatory response, triggered by amyloid-\u03b2", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "IL-6", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammatory response", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "TNFa", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammatory response", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "MCP1", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammatory response", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "actin", "relationship": "RELATED_TREATMENT", "object": "Differentiation", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "neurotransmission", "relationship": "RELATED_TREATMENT", "object": "influencing memory and learning", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "T cells", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "regulation of autoimmune pathways", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "Th17 cells", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Retinoid-mediated suppression in autoimmune responses", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "IL-12", "relationship": "RELATED_TREATMENT", "object": "Th1 cell differentiation", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "TGF\u03b2", "relationship": "RELATED_TREATMENT", "object": "Th2 cell differentiation.", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "IL-4", "relationship": "RELATED_TREATMENT", "object": "Th2 cell differentiation", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "Treg cells", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Immune system homeostasis and self-tolerance", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "retinoids", "relationship": "MONITORED_DURING_TREATMENT", "object": "Response", "chunk": 6}
{"article": "PMC2868024.txt", "subject": "A\u03b2 plaque pathology", "relationship": "RELATED_PROGNOSIS", "object": "Reduces plaque pathology in TgCRND8 mice.", "chunk": 1}
{"article": "PMC2868024.txt", "subject": "A\u03b2 plaque pathology", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Amloid toxicity", "chunk": 1}
{"article": "PMC2868024.txt", "subject": "anti-A\u03b2 antibodies", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Alzheimer's disease", "chunk": 1}
{"article": "PMC2868024.txt", "subject": "anti-A\u03b2 antibodies", "relationship": "RELATED_TREATMENT", "object": "Treating Alzheimer's disease.", "chunk": 1}
{"article": "PMC2868024.txt", "subject": "anti-A\u03b2 antibodies", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Drug development for Alzheimer's disease.", "chunk": 1}
{"article": "PMC2868024.txt", "subject": "anti-A\u03b2 antibodies", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Selecting appropriate treatments for Alzheimer's disease.", "chunk": 1}
{"article": "PMC2868024.txt", "subject": "anti-A\u03b2 antibodies", "relationship": "RESPONDED_TO", "object": "Targeted delivery via MRIgFUS.", "chunk": 1}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "IS_TARGET_OF_TREATMENT", "object": "A\u03b2 plaques", "chunk": 2}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "DIRECTED_AGAINST", "object": "N-terminus of A\u03b2 (residues 1\u201310)", "chunk": 2}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "SHOWS_EFFECT", "object": "Dissociating A\u03b2 aggregates and rescuing cognitive function", "chunk": 2}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "A\u03b2 clearance", "chunk": 2}
{"article": "PMC2868024.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC2868024.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid plaques", "chunk": 2}
{"article": "PMC2868024.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "determined using commercially available ELISA kits (BioSource, Invitrogen, Burlington, ON, Canada)", "chunk": 3}
{"article": "PMC2868024.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "determined using commercially available ELISA kits (BioSource, Invitrogen, Burlington, ON, Canada)", "chunk": 3}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "MRI-guided Focused Ultrasound (MRIgFUS) delivery of BAM-10 to the brain", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treatment of A\u03b2-plaque pathology", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "RELATED_TREATMENT", "object": "MRI-guided Focused Ultrasound (MRIgFUS) delivery", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "IS_TARGET_OF_TREATMENT", "object": "MRIgFUS-delivery", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "RESPONDED_TO", "object": "MRIgFUS treatment", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "A\u03b240", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with BAM-10/FUS, BAM-10, FUS", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with BAM-10/FUS, BAM-10, FUS", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "A\u03b2 plaques", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with BAM-10/FUS", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "A\u03b2 plaques", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "MRIgFUS and BAM-10 treatment", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "A\u03b2 plaque pathology", "relationship": "RELATED_TREATMENT", "object": "MRIgFUS delivery of anti-A\u03b2 antibodies", "chunk": 5}
{"article": "PMC2868024.txt", "subject": "A\u03b2 plaques", "relationship": "RELATED_TREATMENT", "object": "MRIgFUS delivery of anti-A\u03b2 antibodies", "chunk": 5}
{"article": "PMC2868024.txt", "subject": "A\u03b2-positive plaques", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "MRIgFUS immunotherapy", "chunk": 5}
{"article": "PMC2868024.txt", "subject": "A\u03b2 plaque burden", "relationship": "MONITORED_DURING_TREATMENT", "object": "MRIgFUS immunotherapy", "chunk": 5}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "MRIgFUS immunotherapy", "chunk": 5}
{"article": "PMC2868024.txt", "subject": "A\u03b2-positive plaques", "relationship": "RESPONDED_TO", "object": "MRIgFUS delivered antibodies", "chunk": 5}
{"article": "PMC2868024.txt", "subject": "BBB permeability", "relationship": "MONITORED_DURING_TREATMENT", "object": "MRIgFUS", "chunk": 5}
{"article": "PMC2871786.txt", "subject": "Proteobacteria", "relationship": "INDICATES_PRESENCE_OF", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Bacilli", "relationship": "INDICATES_PRESENCE_OF", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Clostridium cluster XIVa", "relationship": "RELATED_TO", "object": "Decreased in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Bacteroidetes", "relationship": "ASSOCIATED_WITH", "object": "Decrease in gut microbiota", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Escherichia coli et rel.", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Haemophilus", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Klebsiella pneumoniae et rel.", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Leminorella", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Proteus et rel.", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Pseudomonas", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Serratia", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Vibrio", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Yersinia et rel.", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Bacillus", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Staphylococcus", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Faecalibacterium prausnitzii et rel.", "relationship": "ASSOCIATED_WITH", "object": "Decreased in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Clostridium leptum et rel.", "relationship": "ASSOCIATED_WITH", "object": "Increased in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Bifidobacterium", "relationship": "INDICATES_PRESENCE_OF", "object": "Old age decrease", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "Archaea", "relationship": "RELATED_TO", "object": "Centenarians  harbouring Archaea more frequently than the elderly or young adults", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "Akkermansia muciniphila", "relationship": "INDICATES_PRESENCE_OF", "object": "Old age decrease", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "Fusobacteria", "relationship": "INDICATES_PRESENCE_OF", "object": "higher prevalence in centenarians and their offspring", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "Proteobacteria", "relationship": "INDICATES_PRESENCE_OF", "object": "higher prevalence in centenarians and their offspring", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "Campylobacter", "relationship": "INDICATES_PRESENCE_OF", "object": "higher prevalence in centenarians and their offspring", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "Helicobacter", "relationship": "INDICATES_PRESENCE_OF", "object": "higher prevalence in centenarians and their offspring", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "Fusobacterium", "relationship": "INDICATES_PRESENCE_OF", "object": "higher prevalence in centenarians and their offspring", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "IL-6", "relationship": "RELATED_TO", "object": "The gut microbiota", "chunk": 6}
{"article": "PMC2871786.txt", "subject": "IL-8", "relationship": "RELATED_PROGNOSIS", "object": "Gut microbiota composition", "chunk": 6}
{"article": "PMC2871786.txt", "subject": "IL-6", "relationship": "RELATED_TO", "object": "Gut microbiota composition", "chunk": 6}
{"article": "PMC2871786.txt", "subject": "Bacteroidetes", "relationship": "INDICATES_PRESENCE_OF", "object": "Healthy adults", "chunk": 6}
{"article": "PMC2871786.txt", "subject": "Firmicutes", "relationship": "INDICATES_PRESENCE_OF", "object": "Healthy adults", "chunk": 6}
{"article": "PMC2871786.txt", "subject": "Actinobacteria", "relationship": "INDICATES_PRESENCE_OF", "object": "Healthy adults", "chunk": 6}
{"article": "PMC2871786.txt", "subject": "Proteobacteria", "relationship": "INDICATES_PRESENCE_OF", "object": "Centenarians", "chunk": 6}
{"article": "PMC2871786.txt", "subject": "Clostridium cluster XIVa", "relationship": "RELATES_TO", "object": "Lower relative contribution found in centenarians", "chunk": 7}
{"article": "PMC2871786.txt", "subject": "Clostridium cluster IV", "relationship": "RELATED_PROGNOSIS", "object": "Proportion comparable in all subjects", "chunk": 7}
{"article": "PMC2871786.txt", "subject": "Bacilli", "relationship": "INDICATES_PRESENCE_OF", "object": "Higher proportions in centenarians", "chunk": 7}
{"article": "PMC2871786.txt", "subject": "Ruminococcus obeum et rel.", "relationship": "ASSOCIATED_WITH", "object": "Lower amount in centenarians", "chunk": 7}
{"article": "PMC2871786.txt", "subject": "IL-1\u03b1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "IL-1\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "IL-2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "IL-6", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "IL-8", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "IL-10", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "IL-12p70", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "IFN-\u03b3", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "TNF-\u03b1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "TGF-\u03b21", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "white blood cell count", "relationship": "RELATED_TO_TREATMENT", "object": "Inflammatory Score (IS)", "chunk": 10}
{"article": "PMC2871786.txt", "subject": "C reactive protein", "relationship": "RELATED_TO_TREATMENT", "object": "Inflammatory Score (IS)", "chunk": 10}
{"article": "PMC2871786.txt", "subject": "number of central memory helper and cytotoxic T lymphocytes (CD45RA\u2212CCR7+)", "relationship": "RELATED_TO_TREATMENT", "object": "Inflammatory Score (IS)", "chunk": 10}
{"article": "PMC2871786.txt", "subject": "number of effector helper and cytotoxic T lymphocytes (CD28\u2212)", "relationship": "RELATED_TO_TREATMENT", "object": "Inflammatory Score (IS)", "chunk": 10}
{"article": "PMC2871786.txt", "subject": "IL-6", "relationship": "RELATED_TO_TREATMENT", "object": "Inflammatory Score (IS)", "chunk": 10}
{"article": "PMC2871786.txt", "subject": "IL-8", "relationship": "RELATED_TO_TREATMENT", "object": "Inflammatory Score (IS)", "chunk": 10}
{"article": "PMC2876785.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer disease", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-40", "relationship": "RELATED_TO", "object": "most abundant isoform", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TO", "object": "most prone to aggregation", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14", "relationship": "MONITORED_DURING_TREATMENT", "object": "\u03b3-secretase inhibitor treatment", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-15", "relationship": "MONITORED_DURING_TREATMENT", "object": "\u03b3-secretase inhibitor treatment", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-16", "relationship": "MONITORED_DURING_TREATMENT", "object": "\u03b3-secretase inhibitor treatment", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14", "relationship": "Levels_Reflect_Response", "object": "\u03b3-secretase inhibitor treatment", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-15", "relationship": "Levels_Reflect_Response", "object": "\u03b3-secretase inhibitor treatment", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-16", "relationship": "Levels_Reflect_Response", "object": "\u03b3-secretase inhibitor treatment", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14, A\u03b21-15, and A\u03b21-16", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Clinical trials response to \u03b3-secretase inhibitors", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-40", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Monitoring the effect of \u03b3-secretase inhibitors", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-42", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Monitoring the effect of \u03b3-secretase inhibitors", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-16", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14", "relationship": "RESPONDED_TO", "object": "\u03b3-secretase inhibitor treatment", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-15", "relationship": "RESPONDED_TO", "object": "\u03b3-secretase inhibitor treatment", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-16", "relationship": "RESPONDED_TO", "object": "\u03b3-secretase inhibitor treatment", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14", "relationship": "RELATED_TREATMENT", "object": "LY450139 is used to monitor for efficacy", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-15", "relationship": "RELATED_TREATMENT", "object": "LY450139 is used to monitor for efficacy", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-16", "relationship": "RELATED_TREATMENT", "object": "LY450139 is used to monitor for efficacy", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "LY450139", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Therapeutic choice for AD", "chunk": 3}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14", "relationship": "RELATED_TREATMENT", "object": "Reduction observed with LY450139 treatment", "chunk": 3}
{"article": "PMC2876785.txt", "subject": "A\u03b21-15", "relationship": "RELATED_TREATMENT", "object": "Reduction observed with LY450139 treatment", "chunk": 3}
{"article": "PMC2876785.txt", "subject": "A\u03b21-16", "relationship": "RELATED_TREATMENT", "object": "Reduction observed with LY450139 treatment", "chunk": 3}
{"article": "PMC2876785.txt", "subject": "A\u03b21-34", "relationship": "RELATED_TREATMENT", "object": "Reduction observed with LY450139 treatment", "chunk": 3}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Detection of \u03b3-secretase inhibitor treatment effects", "chunk": 4}
{"article": "PMC2876785.txt", "subject": "A\u03b21-15", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Detection of \u03b3-secretase inhibitor treatment effects", "chunk": 4}
{"article": "PMC2876785.txt", "subject": "A\u03b21-16", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Detection of \u03b3-secretase inhibitor treatment effects", "chunk": 4}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14, A\u03b21-15, and A\u03b21-16", "relationship": "INDICATES_PRESENCE_OF", "object": "\u03b3-secretase inhibitor treatment", "chunk": 4}
{"article": "PMC2880123.txt", "subject": "MMSE sum score", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 1}
{"article": "PMC2880123.txt", "subject": "MMSE sum score", "relationship": "RELATED_TREATMENT", "object": "Initial cognitive screening", "chunk": 1}
{"article": "PMC2880123.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 2}
{"article": "PMC2880123.txt", "subject": "MMSE", "relationship": "USED_TO_DIAGNOSE", "object": "Dementia", "chunk": 2}
{"article": "PMC2880123.txt", "subject": "MMSE score", "relationship": "INDICATES_PRESENCE_OF", "object": "early stage AD", "chunk": 3}
{"article": "PMC2880123.txt", "subject": "MMSE sum score", "relationship": "HIGHER", "object": "Younger and more often male patients", "chunk": 3}
{"article": "PMC2880123.txt", "subject": "Cognition", "relationship": "RELATED_PROGNOSIS", "object": "Progression of dementia", "chunk": 3}
{"article": "PMC2880123.txt", "subject": "Cognitive impairment", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Disregard by both relatives and health professionals", "chunk": 3}
{"article": "PMC2880593.txt", "subject": "\u03b2-amyloid", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC2880593.txt", "subject": "\u03b2-amyloid", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment", "chunk": 1}
{"article": "PMC2880593.txt", "subject": "A\u03b240 and A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment", "chunk": 1}
{"article": "PMC2880593.txt", "subject": "chol\u00edne acetyltransferase (ChAT) levels", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function", "chunk": 1}
{"article": "PMC2880593.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Cognitive function improvement in Ts65Dn mice", "chunk": 2}
{"article": "PMC2880593.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Cognitive function improvement in Ts65Dn mice", "chunk": 2}
{"article": "PMC2880593.txt", "subject": "A\u03b2", "relationship": "RELATED_TO_TREATMENT", "object": "Controlling A\u03b2 production", "chunk": 2}
{"article": "PMC2880593.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Targeting A\u03b2 levels to improve cognitive function", "chunk": 2}
{"article": "PMC2880593.txt", "subject": "DAPT", "relationship": "RELATED_TREATMENT", "object": "Cognitive dysfunction in Ts65Dn mice", "chunk": 2}
{"article": "PMC2880593.txt", "subject": "DAPT", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Developing treatments for cognitive dysfunction in Down Syndrome", "chunk": 2}
{"article": "PMC2880593.txt", "subject": "DAPT", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Synagmatic regulation in genetically modified mice", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "BIMC", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "CAMCOG", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "MDRS", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "NTB", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "SCIP", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "SIB", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "SKT", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "ADL-PI", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "ADLQ", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "ADCS-ADL19/23", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "B-ADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "Bristol ADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "BANS-S", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "Barthel ADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "DAD", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "GERRI", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "IADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "IDDD", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "Katz ADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "PGDRS", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "RDRS", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "PSMS", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "SMAF", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "Weintraub ADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "ADCS-CGIC", "relationship": "INDICATES_PRESENCE_OF", "object": "Global Impression", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "CDR", "relationship": "INDICATES_PRESENCE_OF", "object": "Global Impression", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "CGI", "relationship": "INDICATES_PRESENCE_OF", "object": "Global Impression", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "CIBI", "relationship": "INDICATES_PRESENCE_OF", "object": "Global Impression", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "DIAGNOSITC_OF", "object": "Cognitive disturbances derived from dementia syndromes, affective or personality disorders", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "RELATED_PROGNOSIS", "object": "Disease progression and pharmacological treatment effects", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "INDICA TES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "Alzheimer's Disease Assessment Scale (ADAS)", "relationship": "RELATED_PROGNOSIS", "object": "Disease progression", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "Alzheimer's Disease Assessment Scale -Cognitive (ADAS-Cog)", "relationship": "INDICA TES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "Alzheimer's Disease Assessment Scale - Cognitive (ADAS-Cog)", "relationship": "DIAGNOSITC_OF", "object": "Symptomatic Alzheimer's Disease therapy efficacy", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "Neuropsychological Test Battery (NTB)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Treatment effects in early disease stages", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "BEHAVE-AD", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "assess behavior in patients with AD apart of cognitive symptomatology", "chunk": 4}
{"article": "PMC2949590.txt", "subject": "BEHAVE-AD", "relationship": "RELATED_TREATMENT", "object": "assess behavior in patients with AD apart of cognitive symptomatology", "chunk": 4}
{"article": "PMC2949590.txt", "subject": "BPRS", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "assess behavior in AD", "chunk": 4}
{"article": "PMC2949590.txt", "subject": "BPRS", "relationship": "RELATED_TREATMENT", "object": "assess behavior in AD", "chunk": 4}
{"article": "PMC2949590.txt", "subject": "NPI", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "compensates for shortcomings of the BEHAVE-AD", "chunk": 4}
{"article": "PMC2949590.txt", "subject": "NPI", "relationship": "RELATED_TREATMENT", "object": "compensates for shortcomings of the BEHAVE-AD", "chunk": 4}
{"article": "PMC3126705.txt", "subject": "donepezil 23 mg/d", "relationship": "INDICATES_PRESENCE_OF", "object": "typical cholinergic AEs, particularly gastrointestinal-related AEs", "chunk": 1}
{"article": "PMC3126705.txt", "subject": "donepezil 23 mg/d", "relationship": "RELATED_TREATMENT", "object": "increased cognitive benefit", "chunk": 1}
{"article": "PMC3126705.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "Baseline MMSE was 13.1 (4.99) in the 23 mg/d group and 13.0 (4.75) in the 10 mg/d group", "chunk": 2}
{"article": "PMC3126705.txt", "subject": "GI bleeding", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "GI bleeding was more common in the 23 mg/d group as compared to the 10 mg/d group", "chunk": 3}
{"article": "PMC3126705.txt", "subject": "Bradycardia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "All but 1 of the bradycardia events in the 23 mg/d group were mild or moderate in severity; none of the events in the 10 mg/d group was severe and only 4 of the 23 mg/d events were defined as serious.", "chunk": 3}
{"article": "PMC3126705.txt", "subject": "Weight loss", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Weight loss was reported as an AE more frequently in the donepezil 23 mg/d group (4.7%) than in the donepezil 10 mg/d group (2.5%). By the end of the study, 8.4% of patients in the donepezil 23 mg/d group experienced a weight decrease of \u2265 7%, compared with 4.9% of those in the 10 mg/d group.", "chunk": 3}
{"article": "PMC3126705.txt", "subject": "Donepezil 23 mg/d", "relationship": "RELATED_PROGNOSIS", "object": "higher rate of gastrointestinal side-effects", "chunk": 4}
{"article": "PMC3126705.txt", "subject": "Donepezil 23 mg/d", "relationship": "RELATED_PROGNOSIS", "object": "higher rate of adverse events", "chunk": 4}
{"article": "PMC3126705.txt", "subject": "Donepezil 10 mg/d", "relationship": "RELATED_PROGNOSIS", "object": "lower rate of adverse events", "chunk": 4}
{"article": "PMC3126705.txt", "subject": "Donepezil", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "in treating  mild to moderate AD", "chunk": 4}
{"article": "PMC3126705.txt", "subject": "donepezil", "relationship": "RELATED_TREATMENT", "object": "Treatment for Alzheimer's disease", "chunk": 5}
{"article": "PMC3126705.txt", "subject": "donepezil 23 mg/d", "relationship": "RELATED_TREATMENT", "object": "Treatment for moderate to severe Alzheimer's disease", "chunk": 5}
{"article": "PMC3126705.txt", "subject": "donepezil", "relationship": "ASSOCIATED_WITH", "object": "cholinergic-related GI AEs", "chunk": 5}
{"article": "PMC3126705.txt", "subject": "donepezil 23 mg/d", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk of bradycardia", "chunk": 5}
{"article": "PMC3126705.txt", "subject": "donepezil 23 mg/d", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased incidence of weight decrease", "chunk": 5}
{"article": "PMC3126705.txt", "subject": "donepezil 23 mg/d", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Higher incidence of fatigue, somnolence, and urinary incontinence", "chunk": 5}
{"article": "PMC3126705.txt", "subject": "donepezil", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Choice of treatment for Alzheimer's disease", "chunk": 5}
{"article": "PMC3212921.txt", "subject": "vitamin D", "relationship": "RELATED_TO_TREATMENT", "object": "Coupling an antioxidant with memantine could provide a solution to the problem of neuronal apoptosis induced by glutamatergic excitotoxicity.", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "vitamin D", "relationship": "INDICATES_PRESENCE_OF", "object": "neuroprotective properties against glutamate toxicity", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "vitamin D", "relationship": "INDICATES_PRESENCE_OF", "object": "antioxidant effects", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "vitamin D", "relationship": "PREDICT_SURVIVAL", "object": "vitamin D deficiency has been associated with cognitive decline", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "memantine", "relationship": "RELATED_TO_TREATMENT", "object": "Memantine has no immediate treatment effect, but after 3 to 6 months of use, patients report better cognitive performance and autonomy than those receiving placebo", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "memantine", "relationship": "RELATED_TREATMENT", "object": "Coupling an antioxidant with memantine could provide a solution to the problem of neuronal apoptosis induced by glutamatergic excitotoxicity.", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "memantine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "One of the most prescribed drugs to slow the progression of ADRD", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "25OHD", "relationship": "MONITORED_DURING_TREATMENT", "object": "These outcomes are assessed at baseline, 12 and 24 weeks, together with the serum concentrations of 25OHD, calcium and parathyroid hormone.", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Patients aged 60 years and older presenting with moderate ADRD (i.e., Mini-Mental State Examination (MMSE) score between 10-20)", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "serum 25-hydroxyvitamin D [25OHD]", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Patients aged 60 years and older presenting with moderate ADRD (i.e., Mini-Mental State Examination (MMSE) score between 10-20), hypovitaminosis D (i.e., serum 25-hydroxyvitamin D [25OHD] < 30 ng/mL)", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "25OHD concentration", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Dosage of vitamin D supplementation", "chunk": 3}
{"article": "PMC3212921.txt", "subject": "serum 25OHD concentration", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Inclusion criteria for the study", "chunk": 3}
{"article": "PMC3212921.txt", "subject": "serum calcium concentration", "relationship": "DIAGNOSITC_OF", "object": "Hypercalcemia in patients", "chunk": 3}
{"article": "PMC3212921.txt", "subject": "25OHD concentration", "relationship": "RELATED_TO", "object": "Hypovitaminosis D", "chunk": 3}
{"article": "PMC3212921.txt", "subject": "serum 25-hydroxyvitamin D [25OHD] concentration \u226430 ng/mL", "relationship": "INDICATES_PRESENCE_OF", "object": "Hypovitaminosis D", "chunk": 3}
{"article": "PMC3212921.txt", "subject": "25OHD concentration", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood samples collection procedures", "chunk": 4}
{"article": "PMC3212921.txt", "subject": "25OHD concentration", "relationship": "RELATED_TREATMENT", "object": "Compliance", "chunk": 4}
{"article": "PMC3212921.txt", "subject": "vitamin D", "relationship": "RELATED_TREATMENT", "object": "treating Alzheimer's disease", "chunk": 6}
{"article": "PMC3212921.txt", "subject": "vitamin D", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "improved cognitive function in AD patients", "chunk": 6}
{"article": "PMC3212921.txt", "subject": "vitamin D", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "could be added to standard Alzheimer's medication regimen", "chunk": 6}
{"article": "PMC3213220.txt", "subject": "apoe4", "relationship": "DIAGNOSITC_OF", "object": "Risk of developing Early-onset or Sporadic Alzheimer's Disease", "chunk": 1}
{"article": "PMC3213220.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Dominant, dose-dependent effect on the risk of Alzheimer's Disease", "chunk": 1}
{"article": "PMC3213220.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "Increased risk of developing Alzheimer's Disease", "chunk": 1}
{"article": "PMC3213220.txt", "subject": "apoe4", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Reduced response to induced ketosis therapy", "chunk": 1}
{"article": "PMC3213220.txt", "subject": "IDE", "relationship": "RELATED_TREATMENT", "object": "Cognitive outcomes during induced ketosis therapy", "chunk": 1}
{"article": "PMC3213220.txt", "subject": "IL1B", "relationship": "RELATED_TREATMENT", "object": "Cognitive outcomes during induced ketosis therapy", "chunk": 1}
{"article": "PMC3213220.txt", "subject": "IL1B", "relationship": "RELATED_PROGNOSIS", "object": "Progression of Alzheimer's Disease", "chunk": 1}
{"article": "PMC3213220.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "RELATED_TREATMENT", "object": "AC-1202 treatment", "chunk": 2}
{"article": "PMC3213220.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "MONITORED_DURING_TREATMENT", "object": "AC-1202 treatment", "chunk": 2}
{"article": "PMC3213220.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Change in ADAS-Cog scores", "chunk": 2}
{"article": "PMC3213220.txt", "subject": "APOE", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Genotyping", "chunk": 2}
{"article": "PMC3213220.txt", "subject": "apoe4", "relationship": "DIAGNOSTIC_OF", "object": "Prognosis of cognitive performance", "chunk": 2}
{"article": "PMC3213220.txt", "subject": "IDE rs2251101", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive improvement in Alzheimer's Disease patients", "chunk": 3}
{"article": "PMC3213220.txt", "subject": "IDE rs2251101 C/T", "relationship": "RELATED_PROGNOSIS", "object": "Significant improvement compared to Placebo at Days 45 and 90", "chunk": 3}
{"article": "PMC3213220.txt", "subject": "IDE rs2251101 C/C(-)", "relationship": "RELATED_PROGNOSIS", "object": "Significant improvement compared to Placebo at Days 45 and 90", "chunk": 3}
{"article": "PMC3213220.txt", "subject": "rs1143627 T/T", "relationship": "RELATED_PROGNOSIS", "object": "Improvement in cognitive performance", "chunk": 4}
{"article": "PMC3213220.txt", "subject": "rs16944 C/C", "relationship": "RELATED_PROGNOSIS", "object": "Improvement in cognitive performance", "chunk": 4}
{"article": "PMC3213220.txt", "subject": "APOE E3", "relationship": "RELATED_PROGNOSIS", "object": "Significant improvement in ADAS-Cog scores", "chunk": 4}
{"article": "PMC3213220.txt", "subject": "APOE E4", "relationship": "RELATED_PROGNOSIS", "object": "No significant effects on ADAS-Cog scores", "chunk": 4}
{"article": "PMC3213220.txt", "subject": "APOE E4(-)", "relationship": "RELATED_PROGNOSIS", "object": "Significant improvement in ADAS-Cog scores with AC-1202", "chunk": 4}
{"article": "PMC3213220.txt", "subject": "IDE rs2251101 heterozygous C/T", "relationship": "RELATED_PROGNOSIS", "object": "Additive improvements in cognitive performance", "chunk": 4}
{"article": "PMC3213220.txt", "subject": "IL1B rs1143627 homozygous T/T", "relationship": "RELATED_PROGNOSIS", "object": "Additive improvements in cognitive performance", "chunk": 4}
{"article": "PMC3213220.txt", "subject": "APOE4", "relationship": "INDICATES_PRESENCE_OF", "object": "Change in serum \u03b2-hydroxybutyrate levels", "chunk": 5}
{"article": "PMC3213220.txt", "subject": "apoe4", "relationship": "DIAGNOSITC_OF", "object": "late onset AD", "chunk": 7}
{"article": "PMC3213220.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "response to ketosis", "chunk": 7}
{"article": "PMC3218804.txt", "subject": "ROSA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "determining the severity of relevant symptoms in AD and to document disease progression and therapy effects over time", "chunk": 1}
{"article": "PMC3218804.txt", "subject": "memantine", "relationship": "RELATED_TREATMENT", "object": "Treatment for Alzheimer's Disease", "chunk": 2}
{"article": "PMC3218804.txt", "subject": "cholinesterase inhibitors", "relationship": "RELATED_TREATMENT", "object": "Eligible patients were on a stable dosage of this for at least 2 months prior to study enrollment", "chunk": 2}
{"article": "PMC3218804.txt", "subject": "MMSE score", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC3218804.txt", "subject": "ADAS-cog score", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC3218804.txt", "subject": "SIB score", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC3218804.txt", "subject": "DAD score", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC3218804.txt", "subject": "NPI score", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC3218804.txt", "subject": "ADAS-cog", "relationship": "RELATED_TO", "object": "ROSA used for construct validity", "chunk": 4}
{"article": "PMC3218804.txt", "subject": "SIB", "relationship": "RELATED_TO", "object": "ROSA used for construct validity", "chunk": 4}
{"article": "PMC3218804.txt", "subject": "NPI", "relationship": "RELATED_TO", "object": "ROSA used for construct validity", "chunk": 4}
{"article": "PMC3218804.txt", "subject": "DAD", "relationship": "RELATED_TO", "object": "ROSA used for construct validity", "chunk": 4}
{"article": "PMC3218804.txt", "subject": "ROSA", "relationship": "INDIVIDUAL_COMPONENT_OF", "object": "Relevant Outcome Scale for Alzheimer's Disease", "chunk": 5}
{"article": "PMC3218804.txt", "subject": "ROSA", "relationship": "RELATED_TREATMENT", "object": "Measures treatment effects in AD", "chunk": 5}
{"article": "PMC3218804.txt", "subject": "ROSA", "relationship": "RESPONDED_TO", "object": "Treatment in patients with Alzheimer's Disease", "chunk": 5}
{"article": "PMC3218804.txt", "subject": "ROSA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "assessing change in long-term clinical trials", "chunk": 7}
{"article": "PMC3218804.txt", "subject": "ROSA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "identifying particular symptoms assessed with single ROSA items that necessitate treatment and counseling", "chunk": 7}
{"article": "PMC3218804.txt", "subject": "ROSA", "relationship": "MONITORED_DURING_TREATMENT", "object": "assessing short-term longitudinal change assessments", "chunk": 7}
{"article": "PMC3226277.txt", "subject": "amyloid-beta (A\u03b2) peptides", "relationship": "RELATED_PROGNOSIS", "object": "minimising accumulation is a new therapeutic approach", "chunk": 1}
{"article": "PMC3226277.txt", "subject": "mast cells", "relationship": "INDICATES_PRESENCE_OF", "object": "neuroinflammation", "chunk": 1}
{"article": "PMC3226277.txt", "subject": "mast cells", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Masitinib targets c-Kit, platelet-derived growth factor receptors (PDGFR), and, to a lesser extent, Lyn, Fyn, and the FAK pathway, without inhibiting kinases of known toxicities", "chunk": 1}
{"article": "PMC3226277.txt", "subject": "defective blood-brain barrier (BBB)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Neuroinflammatory and Neurodegenerative Disorders, including AD", "chunk": 1}
{"article": "PMC3226277.txt", "subject": "Masitinib", "relationship": "IS_TARGET_OF_TREATMENT", "object": "to control the survival, differentiation, and degranulation of mast cells", "chunk": 1}
{"article": "PMC3226277.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "SUBJECT_OF", "object": "Baseline MMSE score", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "Clinical dementia Rating (CDR)", "relationship": "SUBJECT_OF", "object": "baseline CDR of 1 or 2", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "Alzheimer's Disease Assessment Scale - cognitive subscale (ADAS-Cog)", "relationship": "DIAGNOSITC_OF", "object": "Primary endpoint to assess cognitive function", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Response expressed as the mean difference in ADAS-Cog at week 24 relative to baseline", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory (ADCS-ADL)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "ASSESSES self-care", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "Clinician's Interview-Based Impression of Change-plus caregiver input (CIBIC-Plus)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Evaluates overall clinical response", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "MMSE", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Evaluates cognitive function", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "CDR", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Characterises cognitive and functional performance", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "ADAS-Cog", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment of Alzheimer's Disease", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "ADCS-ADL", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment of Alzheimer's Disease", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "MMSE", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment of Alzheimer's Disease", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "CIBIC-plus", "relationship": "INDICATES_PRESENCE_OF", "object": "Change in disease progression", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "CDR", "relationship": "INDICATES_PRESENCE_OF", "object": "Change in disease progression", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "Neurotoxicity in Alzheimer's Disease", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "A\u03b242", "relationship": "TARGET_OF_THERAPY_CHOICES", "object": "Therapies aimed at reducing neurotoxicity in Alzheimer's Disease", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "Neuroinflammatory response", "relationship": "TARGET_OF_THERAPY_CHOICES", "object": "Therapies aimed at reducing neuroinflammatory response in Alzheimer's Disease", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "A\u03b2 peptides", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC3226277.txt", "subject": "A\u03b2 peptides", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 5}
{"article": "PMC3226277.txt", "subject": "A\u03b2 peptides", "relationship": "RELATED_TREATMENT", "object": "Therapies to maintain or reinforce the integrity of the BBB", "chunk": 5}
{"article": "PMC3226277.txt", "subject": "A\u03b2 peptides", "relationship": "RELATED_PROGNOSIS", "object": "Plaque formation", "chunk": 5}
{"article": "PMC3226277.txt", "subject": "A\u03b2 peptides", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Neuroinflammation", "chunk": 5}
{"article": "PMC3226277.txt", "subject": "A\u03b2 peptides", "relationship": "RELATED_TREATMENT", "object": "Masitinib (as an adjunct to standard treatments)", "chunk": 5}
{"article": "PMC3226277.txt", "subject": "A\u03b2 peptides", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Masitinib", "chunk": 5}
{"article": "PMC3226277.txt", "subject": "ADAS-Cog score", "relationship": "INDICATES_PRESENCE_OF", "object": "worsening of ADAS-Cog score", "chunk": 6}
{"article": "PMC3226277.txt", "subject": "ADAS-Cog score", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline in AD", "chunk": 6}
{"article": "PMC3226311.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Moderate to Severe Alzheimer's Disease", "chunk": 1}
{"article": "PMC3226311.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "RELATED_PROGNOSIS", "object": "Prognosis of progression of AD symptoms", "chunk": 1}
{"article": "PMC3226311.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment with Donepezil", "chunk": 1}
{"article": "PMC3226311.txt", "subject": "Severe Impairment Battery-Language scale (SIB-L)", "relationship": "RELATED_PROGNOSIS", "object": "Assessment of language function in AD", "chunk": 1}
{"article": "PMC3226311.txt", "subject": "Severe Impairment Battery-Language scale (SIB-L)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Dose adjustment of Donepezil", "chunk": 1}
{"article": "PMC3226311.txt", "subject": "Severe Impairment Battery (SIB)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment strategies for patients with moderate to severe AD", "chunk": 1}
{"article": "PMC3226311.txt", "subject": "Severe Impairment Battery (SIB)", "relationship": "RELATED_PROGNOSIS", "object": "Predicting cognitive decline in AD", "chunk": 1}
{"article": "PMC3226311.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Moderate to severe AD", "chunk": 2}
{"article": "PMC3226311.txt", "subject": "CIBIC-plus", "relationship": "RELATED_PROGNOSIS", "object": "Global function", "chunk": 2}
{"article": "PMC3226311.txt", "subject": "SIB-L", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of moderate to severe AD", "chunk": 2}
{"article": "PMC3226311.txt", "subject": "SIB[lang]", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of moderate to severe AD", "chunk": 2}
{"article": "PMC3226311.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "RELATED_PROGNOSIS", "object": "Decline in language is associated with increased risk of mortality", "chunk": 3}
{"article": "PMC3226311.txt", "subject": "Severe Impairment Battery (SIB)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Therapy to slow or reduce the loss of language abilities has the potential to result in additional quality time for patients and caregivers alike.", "chunk": 3}
{"article": "PMC3226311.txt", "subject": "Severe Impairment Battery-Language scale (SIB-L)", "relationship": "RELATED_TREATMENT", "object": "Patients treated with donepezil 23 mg/day showed significant improvement in cognition, as measured by the SIB, compared with patients taking donepezil 10 mg/day", "chunk": 3}
{"article": "PMC3226311.txt", "subject": "SIB-derived language scales", "relationship": "RELATED_TREATMENT", "object": "Treatment with donepezil 23 mg/day was associated with improvement in language function in the full ITT population", "chunk": 3}
{"article": "PMC3226311.txt", "subject": "Severe Impairment Battery (SIB)", "relationship": "INDICATES_PRESENCE_OF", "object": "The already fragile relationships in the lives of patients with AD can become profoundly disrupted as patients lose the ability to communicate coherently. ", "chunk": 3}
{"article": "PMC3226311.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Cognition as measured by the MMSE is strongly related to language abilities as measured by SIB-derived language scales", "chunk": 4}
{"article": "PMC3226311.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "The findings of this post hoc language analysis have important clinical implications. One is to support the assertion that language and the ability to communicate can be reliably and easily assessed in patients with moderate to severe AD using SIB-derived language scales.", "chunk": 4}
{"article": "PMC3226311.txt", "subject": "SIB-L", "relationship": "RELATED_TREATMENT", "object": "Donepezil 23 mg/day treatment", "chunk": 5}
{"article": "PMC3226311.txt", "subject": "SIB[lang]", "relationship": "RELATED_TREATMENT", "object": "Donepezil 23 mg/day treatment", "chunk": 5}
{"article": "PMC3226311.txt", "subject": "SIB-L", "relationship": "MONITORED_DURING_TREATMENT", "object": "Donepezil 23 mg/day treatment", "chunk": 5}
{"article": "PMC3226311.txt", "subject": "SIB[lang]", "relationship": "MONITORED_DURING_TREATMENT", "object": "Donepezil 23 mg/day treatment", "chunk": 5}
{"article": "PMC3335851.txt", "subject": "DHA", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease risk reduction", "chunk": 1}
{"article": "PMC3335851.txt", "subject": "EPA", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease risk reduction", "chunk": 1}
{"article": "PMC3335851.txt", "subject": "n-3 FAs", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "Cognitive decline delay", "chunk": 1}
{"article": "PMC3335851.txt", "subject": "DHA", "relationship": "RELATED_ traitement", "object": "inflammation regulation", "chunk": 1}
{"article": "PMC3335851.txt", "subject": "DHA", "relationship": "RELATED_TO_TREATMENT", "object": "treatment with DHA and EPA supplementation", "chunk": 2}
{"article": "PMC3335851.txt", "subject": "EPA", "relationship": "RELATED_TO_TREATMENT", "object": "treatment with DHA and EPA supplementation", "chunk": 2}
{"article": "PMC3335851.txt", "subject": "NAIP", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "NAIP", "relationship": "RELATED_PROGNOSIS", "object": "Protect AD patients against tangle pathology and cognitive decline", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "DRG1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Hereditary variant of Charcot-Marie-Tooth disease (type Lom)", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "CD63", "relationship": "RELATED_TREATMENT", "object": "Regulation of inflammation", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "HSD17B11", "relationship": "RELATED_TREATMENT", "object": "Regulation of inflammation", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "RAB27A", "relationship": "RELATED_TREATMENT", "object": "Regulation of inflammation", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "CASP4", "relationship": "RELATED_TREATMENT", "object": "Apoptosis signalling in AD", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "CASP4", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "INNATE IMMUNITY", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "SORL1", "relationship": "RELATED_PROGNOSIS", "object": "The expression of SORL1 is reduced in the brain of AD patients, thus being of considerable interest for understanding of the AD pathology", "chunk": 4}
{"article": "PMC3335851.txt", "subject": "PARP1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "An over activity of PARP-1 has been shown in the AD brain", "chunk": 4}
{"article": "PMC3335851.txt", "subject": "DHA", "relationship": "RELATED_TO", "object": "Changes in the expression of ANAPC5 and RHOB genes", "chunk": 5}
{"article": "PMC3335851.txt", "subject": "EPA", "relationship": "RELATED_TO", "object": "Changes in the expression of ANAPC5 and RHOB genes", "chunk": 5}
{"article": "PMC3335851.txt", "subject": "EPA", "relationship": "RELATED_TO", "object": "Changes in the expression of the CASP4 gene", "chunk": 5}
{"article": "PMC3335851.txt", "subject": "n-3 FAs", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "The aim of the OmegAD study to investigate", "chunk": 5}
{"article": "PMC3382377.txt", "subject": "Falls", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's dementia", "chunk": 1}
{"article": "PMC3382377.txt", "subject": "Fractures", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased rate of falls in individuals with Alzheimer's dementia", "chunk": 1}
{"article": "PMC3382377.txt", "subject": "Hospitalization", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased rate of falls in individuals with Alzheimer's dementia", "chunk": 1}
{"article": "PMC3382377.txt", "subject": "Institutionalization", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased rate of falls in individuals with Alzheimer's dementia", "chunk": 1}
{"article": "PMC3481364.txt", "subject": "MMSE scores", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment: Donepezil or placebo", "chunk": 1}
{"article": "PMC3481364.txt", "subject": "MMSE scores", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function in AD", "chunk": 1}
{"article": "PMC3481364.txt", "subject": "ADAS-Cog", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment: Donepezil or placebo", "chunk": 1}
{"article": "PMC3481364.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function in AD", "chunk": 1}
{"article": "PMC3481364.txt", "subject": "Clock Drawing Test", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment: Donepezil or placebo", "chunk": 1}
{"article": "PMC3481364.txt", "subject": "Clock Drawing Test", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function in AD", "chunk": 1}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3481364.txt", "subject": "Clock Drawing Test (CDT)", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC3481364.txt", "subject": "Clock Drawing Test (CDT)", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 2}
{"article": "PMC3481364.txt", "subject": "IQ-CODE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline", "chunk": 2}
{"article": "PMC3481364.txt", "subject": "Montgomery and Aasberg Depression Rating Scale (MADRS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Depressive symptoms", "chunk": 2}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "DIAGNOSTIC_OF", "object": "Cognitive function", "chunk": 3}
{"article": "PMC3481364.txt", "subject": "ADAS-Cog", "relationship": "DIAGNOSTIC_OF", "object": "Cognitive function", "chunk": 3}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "PRIMARY_OUTCOME", "object": "Study", "chunk": 3}
{"article": "PMC3481364.txt", "subject": "ADAS-Cog", "relationship": "SECONDARY_OUTCOME", "object": "Study", "chunk": 3}
{"article": "PMC3481364.txt", "subject": "CDT", "relationship": "SECONDARY_OUTCOME", "object": "Study", "chunk": 3}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "Drug", "chunk": 4}
{"article": "PMC3481364.txt", "subject": "Clock Drawing Test", "relationship": "RELATED_TREATMENT", "object": "Drug", "chunk": 4}
{"article": "PMC3481364.txt", "subject": "ADAS-cog", "relationship": "RELATED_TREATMENT", "object": "Drug", "chunk": 4}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 5}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline in AD", "chunk": 5}
{"article": "PMC3481364.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Progression of AD", "chunk": 5}
{"article": "PMC3481364.txt", "subject": "Memantin", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Not used in this study", "chunk": 5}
{"article": "PMC3481364.txt", "subject": "ChEI", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Not used in this study", "chunk": 5}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function during the one-year follow-up", "chunk": 6}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower cognitive performance", "chunk": 6}
{"article": "PMC3481364.txt", "subject": "ADAS-cog", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Cognitive Assessment", "chunk": 6}
{"article": "PMC3481364.txt", "subject": "BI", "relationship": "RELATED_TREATMENT", "object": "Barthel Index for assessing disability", "chunk": 6}
{"article": "PMC3518146.txt", "subject": "Mini Mental Status Examination (MMSE)", "relationship": "RELATED_PROGNOSIS", "object": "MMSE severity groups", "chunk": 3}
{"article": "PMC3518146.txt", "subject": "Health Aging Brain Care (HABC) Monitor", "relationship": "MONITORED_DURING_TREATMENT", "object": "patient and caretaker", "chunk": 3}
{"article": "PMC3518146.txt", "subject": "HABC Monitor", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Individualized recommendations", "chunk": 3}
{"article": "PMC3518146.txt", "subject": "HABC Monitor", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Behavioral intervention protocols", "chunk": 3}
{"article": "PMC3518146.txt", "subject": "ADCS Group Activities of Daily Living Inventory", "relationship": "PRIMARY_OUTCOME_MEASURE", "object": "Assessment of Functional Status in Alzheimer's Disease Patient", "chunk": 4}
{"article": "PMC3518146.txt", "subject": "Neuropsychiatric Inventory (NPI)", "relationship": "SECONDARY_OUTCOME_MEASURE", "object": "Assessment of Behavioral and Psychological Symptoms in Alzheimer's Disease Patients", "chunk": 4}
{"article": "PMC3518146.txt", "subject": "Short Physical Performance Battery (SPPB)", "relationship": "SECONDARY_OUTCOME_MEASURE", "object": "Assessment of Lower Extremity Physical Performance in Older Adults", "chunk": 4}
{"article": "PMC3518146.txt", "subject": "ADL Inventory", "relationship": "RELATED_TO_OUTCOME", "object": "Efficacy Analysis of the Clinical Trial", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "Mini Mental State Examination (MMSE)", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive function", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "Word List Learning Test", "relationship": "INDICATES_PRESENCE_OF ", "object": "Cognitive function ", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "Mini Nutritional Assessment (MNA)", "relationship": "INDICATES_PRESENCE_OF", "object": "Nutritional status ", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "Patient Health Questionnaire-9 (PHQ-9)", "relationship": "INDICATES_PRESENCE_OF", "object": "Depressive symptoms", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "Generalized Anxiety Disorder-7 (GAD-7) Scale", "relationship": "INDICATES_PRESENCE_OF", "object": "Anxiety symptoms", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "Blood pressure", "relationship": "RELATED_TO_TREATMENt", "object": "Pharmacological management", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "height", "relationship": "RELATED_TO_TREATMENt", "object": "Pharmacological management", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "weight", "relationship": "RELATED_TO_TREATMENt", "object": "Pharmacological management", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "body composition (by bioelectrical impedance analysis)", "relationship": "RELATED_TO_TREATMENt", "object": "Pharmacological management", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "anti-dementia drug", "relationship": "USED_TO_TREAT", "object": " AD-related Condition", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "antipsychotic drug", "relationship": "USED_TO_TREAT", "object": "AD-related Condition", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "antidepressant", "relationship": "USED_TO_TREAT", "object": "AD-related Condition", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "sedative-hypnotic", "relationship": "USED_TO_TREAT", "object": "AD-related Condition", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "cholinesterase inhibitor and anticholinergic medications", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Pharmacological management", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "anticholinergic medication", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Pharmacological management", "chunk": 5}
{"article": "PMC3543284.txt", "subject": "Memory Impairment Screen (MIS)", "relationship": "USED_TO_DIAGNOSE", "object": "Identify individuals who need further evaluation for dementia", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "A\u03b21-40", "relationship": "RELATED_TO", "object": "levels measured in plasma", "chunk": 1}
{"article": "PMC3580400.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TO", "object": "levels measured in plasma and cerebral spinal fluid", "chunk": 1}
{"article": "PMC3580400.txt", "subject": "t-tau", "relationship": "RELATED_TO", "object": "levels measured in cerebral spinal fluid", "chunk": 1}
{"article": "PMC3580400.txt", "subject": "p-tau181", "relationship": "RELATED_TO", "object": "levels measured in cerebral spinal fluid", "chunk": 1}
{"article": "PMC3580400.txt", "subject": "F2-isoprostanes", "relationship": "RELATED_TO", "object": "levels measured in cerebral spinal fluid", "chunk": 1}
{"article": "PMC3580400.txt", "subject": "Plasma levels of curcumin", "relationship": "RELATED_TO", "object": "measured up to four hours after drug administration", "chunk": 1}
{"article": "PMC3580400.txt", "subject": "A\u03b21-40", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma levels at baseline and at the 24 week visit", "chunk": 2}
{"article": "PMC3580400.txt", "subject": "A\u03b21-42", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma levels at baseline and at the 24 week visit", "chunk": 2}
{"article": "PMC3580400.txt", "subject": "A\u03b21-42", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal fluid levels at baseline and at week 24", "chunk": 2}
{"article": "PMC3580400.txt", "subject": "Total tau (t-tau)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal fluid levels at baseline and at week 24", "chunk": 2}
{"article": "PMC3580400.txt", "subject": "Tau phosphorylated at threonine 181 (p-tau181)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal fluid levels at baseline and at week 24", "chunk": 2}
{"article": "PMC3580400.txt", "subject": "isoprostanes (F2-IsoPs)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal fluid levels ", "chunk": 2}
{"article": "PMC3580400.txt", "subject": "curcumin", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment phase", "chunk": 3}
{"article": "PMC3580400.txt", "subject": "curcumin", "relationship": "RESPONDED_TO", "object": "LC/MS/MS analysis", "chunk": 3}
{"article": "PMC3580400.txt", "subject": "curcumin", "relationship": "RELATED_TREATMENT", "object": "Curcumin was given at 2 and 4 grams daily doses", "chunk": 3}
{"article": "PMC3580400.txt", "subject": "Glucose", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "Curcumin treatment resulted in higher glucose levels.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Hematocrit", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "Curcumin treatment resulted in lower hematocrit levels.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Plasma A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels were measured in plasma during the study.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Plasma A\u03b240", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels were measured in plasma during the study.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Cerebral cerebral cerebral cerebral spinal fluid A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels were measured in cerebrospinal fluid during the study.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Cerebral cerebral cerebral cerebral spinal fluid Tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels were measured in cerebrospinal fluid during the study.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Cerebral cerebral cerebral cerebral spinal fluid Phospho-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels were measured in cerebrospinal fluid during the study.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Cerebral cerebral cerebral cerebral spinal fluid F2-IsoPs", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels were measured in cerebrospinal fluid during the study.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Native curcumin", "relationship": "IS_BASELINE_FOR_THERAPY_CHOICE", "object": "Limited bioavailability suggests the need to establish optimal dosages.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Tetrahydrocurcumin", "relationship": "IS_BASELINE_FOR_THERAPY_CHOICE", "object": "Limited bioavailability suggests the need to establish optimal dosages.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Mobilization of A\u03b240 ", "chunk": 5}
{"article": "PMC3580400.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral cerebral cerebral cerebral spinal fluid", "chunk": 5}
{"article": "PMC3580400.txt", "subject": "t-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral cerebral cerebral cerebral spinal fluid", "chunk": 5}
{"article": "PMC3580400.txt", "subject": "p-tau181", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral cerebral cerebral cerebral spinal fluid", "chunk": 5}
{"article": "PMC3580400.txt", "subject": "isoprostanes", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral cerebral cerebral cerebral spinal fluid", "chunk": 5}
{"article": "PMC3681660.txt", "subject": "MMSE score", "relationship": "RELATED_PROGNOSIS", "object": "Severity of dementia", "chunk": 3}
{"article": "PMC3681660.txt", "subject": "MMSE score", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild stage dementia (25-21 score)", "chunk": 3}
{"article": "PMC3681660.txt", "subject": "MMSE score", "relationship": "INDICATES_PRESENCE_OF", "object": "Moderate stage dementia (20-10 score)", "chunk": 3}
{"article": "PMC3681660.txt", "subject": "MMSE score", "relationship": "INDICATES_PRESENCE_OF", "object": "Severe stage dementia (Below 10 score)", "chunk": 3}
{"article": "PMC3681971.txt", "subject": "Fractional anisotropy (FA)", "relationship": "RELATED_PROGNOSIS", "object": "can differentiate between IPD and MSA/PSP, while FA and MD values within specific white matter tracts can be helpful in differentiating PSP and the parkinsonian variant of MSA (MSA-P) from both each other and from IPD", "chunk": 1}
{"article": "PMC3681971.txt", "subject": "Mean diffusivity (MD)", "relationship": "RELATED_PROGNOSIS", "object": "can differentiate between IPD and MSA/PSP, while FA and MD values within specific white matter tracts can be helpful in differentiating PSP and the parkinsonian variant of MSA (MSA-P) from both each other and from IPD", "chunk": 1}
{"article": "PMC3681971.txt", "subject": "Radial diffusivity (RD)", "relationship": "RELATED_PROGNOSIS", "object": "can differentiate between IPD and MSA/PSP, while FA and MD values within specific white matter tracts can be helpful in differentiating PSP and the parkinsonian variant of MSA (MSA-P) from both each other and from IPD", "chunk": 1}
{"article": "PMC3681971.txt", "subject": "Apparent area coefficient (AAC)", "relationship": "RELATED_PROGNOSIS", "object": "can differentiate between IPD and MSA/PSP, while FA and MD values within specific white matter tracts can be helpful in differentiating PSP and the parkinsonian variant of MSA (MSA-P) from both each other and from IPD", "chunk": 1}
{"article": "PMC3681971.txt", "subject": "FA", "relationship": "RELATED_TO", "object": "Demographic and clinical data", "chunk": 3}
{"article": "PMC3681971.txt", "subject": "MD", "relationship": "RELATED_TO", "object": "Demographic and clinical data", "chunk": 3}
{"article": "PMC3681971.txt", "subject": "RD", "relationship": "RELATED_TO", "object": "Demographic and clinical data", "chunk": 3}
{"article": "PMC3681971.txt", "subject": "AAC", "relationship": "RELATED_TO", "object": "Demographic and clinical data", "chunk": 3}
{"article": "PMC3681971.txt", "subject": "AAC in the CG", "relationship": "INDICATES_PRESENCE_OF", "object": "Progressive supranuclear palsy (PSP)", "chunk": 4}
{"article": "PMC3681971.txt", "subject": "MD in the CST", "relationship": "INDICATES_PRESENCE_OF", "object": "Progressive supranuclear palsy (PSP)", "chunk": 4}
{"article": "PMC3681971.txt", "subject": "MD in the CC", "relationship": "INDICATES_PRESENCE_OF", "object": "Progressive supranuclear palsy (PSP)", "chunk": 4}
{"article": "PMC3764973.txt", "subject": "donepezil", "relationship": "USED_TO_DIAGNOSE", "object": "Mild to moderate Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC3764973.txt", "subject": "galantamine", "relationship": "USED_TO_DIAGNOSE", "object": "Mild to moderate Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC3764973.txt", "subject": "rivastigmine", "relationship": "USED_TO_DIAGNOSE", "object": "Mild to moderate Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC3764973.txt", "subject": "CYP2D6", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Hepatic metabolism of acetylcholinesterase inhibitors", "chunk": 4}
{"article": "PMC3764973.txt", "subject": "CYP3A4", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Hepatic metabolism of acetylcholinesterase inhibitors", "chunk": 4}
{"article": "PMC3764973.txt", "subject": "CYP3A5", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Hepatic metabolism of acetylcholinesterase inhibitors", "chunk": 4}
{"article": "PMC3764973.txt", "subject": "ApoE\u03f52", "relationship": "RELATED_PROGNOSIS", "object": "Response to approved drugs", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "ApoE\u03f53", "relationship": "RELATED_PROGNOSIS", "object": "Response to approved drugs", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "ApoE\u03f54", "relationship": "RELATED_PROGNOSIS", "object": "Response to approved drugs", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "CYP450 genotypes", "relationship": "INDICATES_PRESENCE_OF", "object": "Influences on drug pharmacokinetics", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "CYP2D6", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Donepezil metabolism pathway", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "CYP3A4/5", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Galantamine metabolism pathway", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "CYP2D6 poor metabolizer", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Potential for increased side effects", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "CYP3A4/5 poor metabolizer", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Potential for increased side effects", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "CYP2D6 non-functional allele", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "CYP2D6 poor metabolizer status", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "CYP3A4/5 inhibitor", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "CYP3A4/5 poor metabolizer status", "chunk": 5}
{"article": "PMC3804449.txt", "subject": "Dementia of the Alzheimer's type", "relationship": "INDICATES_PRESENCE_OF", "object": "Functional Impairments", "chunk": 1}
{"article": "PMC3804449.txt", "subject": "Dementia of the Alzheimer's type", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairments", "chunk": 1}
{"article": "PMC3804449.txt", "subject": "Folstein Mini-Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Global cognition", "chunk": 3}
{"article": "PMC3804449.txt", "subject": "MMSE", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Determine the need for interventions", "chunk": 4}
{"article": "PMC3804449.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Predict cognitive decline", "chunk": 4}
{"article": "PMC3804449.txt", "subject": "MMSE", "relationship": "DIAGNOSTIC_OF", "object": "Mild cognitive impairment", "chunk": 4}
{"article": "PMC3804449.txt", "subject": "MMSE", "relationship": "MONITORED_DURING_TREATMENT", "object": "Evaluate the effectiveness of interventions", "chunk": 4}
{"article": "PMC3804449.txt", "subject": "MMSE score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Care Recipient Characteristics", "chunk": 5}
{"article": "PMC3804449.txt", "subject": "PSMS score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Care Recipient Characteristics", "chunk": 5}
{"article": "PMC3804449.txt", "subject": "FAQ score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Care Recipient Characteristics", "chunk": 5}
{"article": "PMC3804449.txt", "subject": "MBRC score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Care Recipient Characteristics", "chunk": 5}
{"article": "PMC3804449.txt", "subject": "MOS-SSS score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Care Recipient Characteristics", "chunk": 5}
{"article": "PMC3849204.txt", "subject": "Apolipoprotein E (ApoE)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treating late onset Alzheimer's Disease", "chunk": 1}
{"article": "PMC3849204.txt", "subject": "ApoE \u03f54 allele", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk of both familial and sporadic forms of Alzheimer's", "chunk": 1}
{"article": "PMC3849204.txt", "subject": "ApoE \u03f54 allele", "relationship": "DIAGNOSITC_OF", "object": "Late onset Alzheimer's disease", "chunk": 1}
{"article": "PMC3849204.txt", "subject": "Geriatric Depression Scale", "relationship": "RELATED_TO", "object": "Diagnosis of depression", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "DSM IV-TR", "relationship": "USED_TO_DIAGNOSE", "object": "Dementia", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "NINCDS/ADRDA criteria", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "NINDS-AIREN criteria", "relationship": "USED_TO_DIAGNOSE", "object": "Vascular dementia", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "DLB Consortium criteria", "relationship": "USED_TO_DIAGNOSE", "object": "Dementia with Lewy Bodies", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "Manchester Royal Infirmary group criteria", "relationship": "USED_TO_DIAGNOSE", "object": "Frontotemporal dementia", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "Petersen\u2019s criteria", "relationship": "USED_TO_DIAGNOSE", "object": "Mild cognitive impairment", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "CES-D scale", "relationship": "RELATED_TO", "object": "Diagnosis of depression", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "Neuropsychological tests", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Cognitive diagnosis", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "TSH", "relationship": "RELATED_TO", "object": "Thyroid Function", "chunk": 4}
{"article": "PMC3849204.txt", "subject": "Cyanocobalamin", "relationship": "RELATED_TO", "object": "Thyroid Function", "chunk": 4}
{"article": "PMC3849204.txt", "subject": "Folate", "relationship": "RELATED_TO", "object": "Thyroid Function", "chunk": 4}
{"article": "PMC3849204.txt", "subject": "Blood cell count", "relationship": "RELATED_TO", "object": "Thyroid Function", "chunk": 4}
{"article": "PMC3898226.txt", "subject": "donepezil", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of patients with Alzheimer\u2019s disease and related disorders (ADRD)", "chunk": 1}
{"article": "PMC3898226.txt", "subject": "galantamine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of patients with Alzheimer\u2019s disease and related disorders (ADRD)", "chunk": 1}
{"article": "PMC3898226.txt", "subject": "rivastigimine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of patients with Alzheimer\u2019s disease and related disorders (ADRD)", "chunk": 1}
{"article": "PMC3898226.txt", "subject": "memantine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of patients with Alzheimer\u2019s disease and related disorders (ADRD)", "chunk": 1}
{"article": "PMC3898226.txt", "subject": "donepezil", "relationship": "RELATED_TREATMENT", "object": "Effective Daily Dose", "chunk": 2}
{"article": "PMC3898226.txt", "subject": "galantamine", "relationship": "RELATED_TREATMENT", "object": "Effective Daily Dose", "chunk": 2}
{"article": "PMC3898226.txt", "subject": "rivastigmine", "relationship": "RELATED_TREATMENT", "object": "Effective Daily Dose", "chunk": 2}
{"article": "PMC3898226.txt", "subject": "memantine", "relationship": "RELATED_TREATMENT", "object": "Effective Daily Dose", "chunk": 2}
{"article": "PMC3898226.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3898226.txt", "subject": "MMSE score", "relationship": "RELATED_PROGNOSIS", "object": "MMSE score at baseline assessment\u00a0associated with a significant decrease of CoV of stride time", "chunk": 3}
{"article": "PMC3898226.txt", "subject": "Femal gender", "relationship": "RELATED_PROGNOSIS", "object": "Female gender associated with a significant decrease of CoV of stride time", "chunk": 3}
{"article": "PMC3898226.txt", "subject": "Memantine", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Memantine decreases gait variability in patients with ADRD", "chunk": 3}
{"article": "PMC3898226.txt", "subject": "Memantine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Memantine is a basis for therapy choice", "chunk": 3}
{"article": "PMC3898226.txt", "subject": "CEIs", "relationship": "RELATED_TREATMENT", "object": "CEIs showed no effect on gait variability", "chunk": 3}
{"article": "PMC3978714.txt", "subject": "Blessed Orientation-Memory-Concentration Test", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnose: Dementia", "chunk": 3}
{"article": "PMC3978714.txt", "subject": "Blessed Orientation-Memory-Concentration Test", "relationship": "USED_TO_DIAGNOSE", "object": "Determine Veteran's Eligibility for Research Interview", "chunk": 3}
{"article": "PMC3978714.txt", "subject": "cognitive impairment", "relationship": "RELATED_PROGNOSIS", "object": "Improvements in outcomes were related to cognitive impairment levels.", "chunk": 7}
{"article": "PMC3978714.txt", "subject": "personal-care dependencies", "relationship": "RELATED_PROGNOSIS", "object": "Improvements in some outcomes were related to personal-care dependencies levels.", "chunk": 7}
{"article": "PMC3978714.txt", "subject": "unmet need", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Veterans with higher unmet needs received more benefit from the PDC intervention.", "chunk": 7}
{"article": "PMC3978714.txt", "subject": "embarrassment about memory problems", "relationship": "RELATED_TREATMENT", "object": "Experiencing embarrassment about memory problems was linked to benefits from the PDC intervention.", "chunk": 7}
{"article": "PMC3978714.txt", "subject": "relationship strain", "relationship": "RELATED_TREATMENT", "object": "Veterans experiencing high relationship strain saw benefits from the PDC intervention.", "chunk": 7}
{"article": "PMC3978714.txt", "subject": "depression", "relationship": "RELATED_TREATMENT", "object": "Veterans with higher levels of depression benefitted from the PDC intervention.", "chunk": 7}
{"article": "PMC3978714.txt", "subject": "PDC intervention", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "This intervention was selected based on the needs of veterans receiving it.", "chunk": 7}
{"article": "PMC4003513.txt", "subject": "amyloid-\u03b2 (A\u03b2) pathology", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4003513.txt", "subject": "Bielschowsky silver stain", "relationship": "RELATED_TREATMENT", "object": "Confirmation of Alzheimer\u2019s disease diagnosis", "chunk": 1}
{"article": "PMC4003513.txt", "subject": "[18F]flutemetamol PET imaging", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Alzheimer\u2019s disease diagnosis and intervention", "chunk": 1}
{"article": "PMC4003513.txt", "subject": "[cerebral cerebral cerebral cerebral spinal fluid] A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Brain A\u03b2 clearance", "chunk": 1}
{"article": "PMC4003513.txt", "subject": "A\u03b2 oligomers", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 2}
{"article": "PMC4003513.txt", "subject": "A\u03b2 oligomers", "relationship": "RELATED_TREATMENT", "object": "Treatment is the surgical placement of a ventriculoperitoneal shunt", "chunk": 2}
{"article": "PMC4003513.txt", "subject": "elevated soluble A\u03b2 oligomers", "relationship": "ASSOCIATED_WITH", "object": "AD", "chunk": 2}
{"article": "PMC4003513.txt", "subject": "Biopsies from iNPH patients", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Study correlations between PET amyloid imaging and pathology in living subjects", "chunk": 2}
{"article": "PMC4003513.txt", "subject": "Concomitant AD pathology", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Response to ventriculoperitoneal shunting", "chunk": 2}
{"article": "PMC4003513.txt", "subject": "A\u03b2 plaque burden", "relationship": "RELATED_TREATMENT", "object": "Treatment is the surgical placement of a ventriculoperitoneal shunt", "chunk": 2}
{"article": "PMC4003513.txt", "subject": "[18F]flutemetamol", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Assess brain amyloid density", "chunk": 2}
{"article": "PMC4003513.txt", "subject": "A\u03b2 plaque burden", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-\u03b2 deposition in the brain", "chunk": 4}
{"article": "PMC4003513.txt", "subject": "[18F]flutemetamol", "relationship": "RELATED_PROGNOSIS", "object": "SUVR  reflects the level of amyloid in the brain", "chunk": 4}
{"article": "PMC4003513.txt", "subject": "4G8 percentage area", "relationship": "RELATED_PROGNOSIS", "object": "Dichotomise 4G8 data (normal/abnormal)", "chunk": 5}
{"article": "PMC4003513.txt", "subject": "4G8 percentage area", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis of normal/abnormal based on a threshold of 2.5%", "chunk": 5}
{"article": "PMC4003513.txt", "subject": "Bielschowsky silver plaque score", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal pathology", "chunk": 5}
{"article": "PMC4003513.txt", "subject": "Thioflavin S plaque score", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal pathology", "chunk": 5}
{"article": "PMC4003513.txt", "subject": "4G8 antibody", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Histometric analysis of 4G8 stained sections for pathology assessment", "chunk": 5}
{"article": "PMC4003513.txt", "subject": "4G8 positivity", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Dichotomization of 4G8 data into normal/abnormal categories", "chunk": 5}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-Beta Pathology in Cerebellum", "chunk": 7}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-Beta Pathology in Pons", "chunk": 7}
{"article": "PMC4003513.txt", "subject": "Bielschowsky Silver Plaque", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-Beta Pathology in Cerebellum", "chunk": 7}
{"article": "PMC4003513.txt", "subject": "Bielschowsky Silver Plaque", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-Beta Pathology in Pons", "chunk": 7}
{"article": "PMC4003513.txt", "subject": "Thioflavin S Plaque Score", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-Beta Pathology in Cerebellum", "chunk": 7}
{"article": "PMC4003513.txt", "subject": "Thioflavin S Plaque Score", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-Beta Pathology in Pons", "chunk": 7}
{"article": "PMC4003513.txt", "subject": "SUVR", "relationship": "RELATED_PROGNOSIS", "object": "diagnoses Alzheimer's Disease", "chunk": 8}
{"article": "PMC4003513.txt", "subject": "Bielschowsky silver stain", "relationship": "INDICATES_PRESENCE_OF", "object": "amyloid plaques", "chunk": 8}
{"article": "PMC4003513.txt", "subject": "SUVR", "relationship": "RELATED_TREATMENT", "object": "assists in the identification of areas in the brain deserving of investigation", "chunk": 8}
{"article": "PMC4003513.txt", "subject": "SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Sum (sensitivity + specificity) for 4G8, Bielschowsky, Thioflavin S, and Overall pathology in various regions of the brain", "chunk": 9}
{"article": "PMC4003513.txt", "subject": "BIE", "relationship": "RELATED_PROGNOSIS", "object": "Sum (sensitivity + specificity) for 4G8, Bielschowsky, Thioflavin S, and Overall pathology in various regions of the brain", "chunk": 9}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease when used as the SoT in imaging studies along with SUVR and BIE", "chunk": 9}
{"article": "PMC4003513.txt", "subject": "Bielschowsky", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease when used as the SoT in imaging studies along with SUVR and BIE", "chunk": 9}
{"article": "PMC4003513.txt", "subject": "Thioflavin S", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease when used as the SoT in imaging studies along with SUVR and BIE", "chunk": 9}
{"article": "PMC4003513.txt", "subject": "Overall pathology", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease when used as the SoT in imaging studies along with SUVR and BIE", "chunk": 9}
{"article": "PMC4003513.txt", "subject": "composite-cerebellum", "relationship": "INDICATES_PRESENCE_OF", "object": "Overall pathology (for retrospective studies)", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "composite-cerebellum", "relationship": "INDICATES_PRESENCE_OF", "object": "Bielschowsky silver (for retrospective studies)", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "composite-cerebellum", "relationship": "INDICATES_PRESENCE_OF", "object": "Overall pathology (for all studies)", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "contralateral-cerebellum", "relationship": "INDICATES_PRESENCE_OF", "object": "Overall pathology in prospective studies", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "composite-cerebellum", "relationship": "INDICATES_PRESENCE_OF", "object": "Overall pathology  (for all studies)", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "composite-cerebellum", "relationship": "RELATION_PROGNOSIS", "object": "Overall Pathology", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "RELATION_PROGNOSIS", "object": "Diagnosis: Early onset Alzheimer's disease", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "Bielschowsky silver", "relationship": "RELATION_PROGNOSIS", "object": "Diagnoses:  Overall Pathology", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "Thioflavin S", "relationship": "RELATION_PROGNOSIS", "object": "Diagnoses: Overall Pathology", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "Bielschowsky silver", "relationship": "BETTER_TOOL_FOR_PREDICTING", "object": "Bielschowsky pathology findings", "chunk": 11}
{"article": "PMC4003513.txt", "subject": "SUVR", "relationship": "RELATED_TO", "object": "cerebellum", "chunk": 11}
{"article": "PMC4003513.txt", "subject": "SUVR", "relationship": "RELATED_TO", "object": "pons", "chunk": 11}
{"article": "PMC4003513.txt", "subject": "4G8 antibody", "relationship": "DETECTING", "object": "amino acids 17-23 (or 17-24) of A\u03b2 ", "chunk": 11}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "IS_BASIS_FOR_", "object": "morphology of deposits in AD brain", "chunk": 11}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Decision to investigate molecular biology of A\u03b2", "chunk": 12}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "MONITORED_DURING_TREATMENT", "object": "Testing of drugs that exploit the molecular biology of A\u03b2", "chunk": 12}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "RELATED_PROGNOSIS", "object": "Diagnosing AD or other age-related pathologies", "chunk": 12}
{"article": "PMC4003513.txt", "subject": "Apolipoprotein E (\u03f54 allele)", "relationship": "DIAGNOSITC_OF", "object": "AD risk", "chunk": 12}
{"article": "PMC4003513.txt", "subject": "post mortem examination", "relationship": "USED_TO_DIAGNOSE", "object": "AD", "chunk": 12}
{"article": "PMC4013077.txt", "subject": "ApoE \u03b54", "relationship": "STRONGEST KNOWN GENETIC PREDICTOR", "object": "Sporadic late-onset Alzheimer\u2019s Disease", "chunk": 1}
{"article": "PMC4013077.txt", "subject": "A\u03b2 protofibrils", "relationship": "MORE NEUROTOXIC", "object": "Monomers", "chunk": 1}
{"article": "PMC4013077.txt", "subject": "Cytomegalovirus (CMV) seropositivity", "relationship": "ASSOCIATED_WITH", "object": "IFN-\u03b3 in cerebral spinal fluid and Neurofibrillary tangles density", "chunk": 1}
{"article": "PMC4013077.txt", "subject": "HIV", "relationship": "CORRELATION BETWEEN INFECTION", "object": "Systemic inflammation and risk of age-related diseases", "chunk": 1}
{"article": "PMC4013077.txt", "subject": "Infection with multiple agents in the herpes virus family", "relationship": "POSSIBLE CUMULATIVE COGNITIVE EFFECT", "object": "Including cytomegalovirus (CMV)", "chunk": 1}
{"article": "PMC4013077.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "AD", "chunk": 2}
{"article": "PMC4013077.txt", "subject": "CMV IgG", "relationship": "DIAGNOSITC_OF", "object": "CMV infection", "chunk": 2}
{"article": "PMC4013077.txt", "subject": "IFN-\u03b3", "relationship": "MONITORED_DURING_TREATMENT", "object": "antigen stimulation", "chunk": 4}
{"article": "PMC4013077.txt", "subject": "IFN-\u03b3", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "antigen stimulation", "chunk": 4}
{"article": "PMC4013077.txt", "subject": "ApoE \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 4}
{"article": "PMC4013077.txt", "subject": "ApoE \u03b54 allele", "relationship": "RELATED_TREATMENT", "object": "lower levels of CRP", "chunk": 4}
{"article": "PMC4013077.txt", "subject": "CRP", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "all-cause dementia", "chunk": 4}
{"article": "PMC4013077.txt", "subject": "Epstein-Barr virus immune response", "relationship": "RELATED_TREATMENT", "object": "viral load", "chunk": 4}
{"article": "PMC4013077.txt", "subject": "CMV serostatus", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "treatment of AD", "chunk": 4}
{"article": "PMC4021450.txt", "subject": "ADCS-ADL", "relationship": "RELATED_PROGNOSIS", "object": "Decline in ADCS-ADL score reflects progression of disease severity.", "chunk": 2}
{"article": "PMC4021450.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Decline in MMSE score reflects progression of disease severity.", "chunk": 2}
{"article": "PMC4021450.txt", "subject": "ADCS-ADL", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Items on the ADCS-ADL reflect various aspects of functional impairment and guide the selection of treatment strategies.", "chunk": 2}
{"article": "PMC4021450.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Disease severity over 2 years", "chunk": 4}
{"article": "PMC4021450.txt", "subject": "ADCS-ADL", "relationship": "RELATED_PROGNOSIS", "object": "Disease severity over 2 years", "chunk": 4}
{"article": "PMC4021450.txt", "subject": "BADL", "relationship": "RELATED_PROGNOSIS", "object": "Disease severity over 2 years", "chunk": 4}
{"article": "PMC4021450.txt", "subject": "IADL", "relationship": "RELATED_PROGNOSIS", "object": "Disease severity over 2 years", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "Box and Block Test (B & B)", "relationship": "RELATED_TREATMENT", "object": "Training intervention using MusicGlove, IsoTrainer, or control (standard therapy)", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "Box and Block Test (B & B)", "relationship": "INDICATES_PRESENCE_OF", "object": "Hand motor control", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "Fugl-Meyer score (AMFM)", "relationship": "RELATED_TREATMENT", "object": "Training intervention using MusicGlove, IsoTrainer, or control (standard therapy)", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "Action Research Arm Test (ARAT)", "relationship": "RELATED_TREATMENT", "object": "Training intervention using MusicGlove, IsoTrainer, or control (standard therapy)", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "Wolf Motor Function test (WMFT)", "relationship": "RELATED_TREATMENT", "object": "Training intervention using MusicGlove, IsoTrainer, or control (standard therapy)", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "9-hole peg test (NHPT)", "relationship": "RELATED_TREATMENT", "object": "Training intervention using MusicGlove, IsoTrainer, or control (standard therapy)", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "Intrinsic Motivation Inventory (IMI)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Assessing Motivation level to guide training intervention type", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "Dexeterity and Speed tests", "relationship": "RELATED_TREATMENT", "object": "Training intervention using MusicGlove, IsoTrainer, or control (standard therapy)", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "B & B score", "relationship": "INDICATES_PRESENCE_OF", "object": "Improved hand function related to grasping small objects", "chunk": 6}
{"article": "PMC4022276.txt", "subject": "B & B score", "relationship": "RELATED_TREATMENT", "object": "MusicGlove training", "chunk": 6}
{"article": "PMC4022276.txt", "subject": "B & B score", "relationship": "RELATED_TREATMENT", "object": "Conventional tabletop exercises", "chunk": 6}
{"article": "PMC4022276.txt", "subject": "B & B score", "relationship": "RELATED_TREATMENT", "object": "Progress in hand motor control", "chunk": 7}
{"article": "PMC4022276.txt", "subject": "Percentage of total notes hit", "relationship": "CORRELATED_WITH", "object": "B & B score", "chunk": 7}
{"article": "PMC4022276.txt", "subject": "Percentage of notes hit for each grip type", "relationship": "CORRELATED_WITH", "object": "B & B score", "chunk": 7}
{"article": "PMC4027995.txt", "subject": "florbetapir F 18", "relationship": "DIAGNOSITC_OF", "object": "Amyloid Deposition in  AD and DLB patients", "chunk": 1}
{"article": "PMC4027995.txt", "subject": "florbenazine", "relationship": "INDICATES_PRESENCE_OF", "object": "Dopaminergic Deficits in PD and DLB patients", "chunk": 1}
{"article": "PMC4027995.txt", "subject": "florbenazine", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment in DLB patients", "chunk": 1}
{"article": "PMC4027995.txt", "subject": "11C-labeled Pittsburgh compound B (11C-PiB)", "relationship": "INDICATES_PRESENCE_OF", "object": "\u03b2-amyloid visualization in living patients", "chunk": 1}
{"article": "PMC4027995.txt", "subject": "Florbetapir SUVr", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (AD)", "chunk": 3}
{"article": "PMC4027995.txt", "subject": "Florbetapir SUVr", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia  (DLB)", "chunk": 3}
{"article": "PMC4027995.txt", "subject": "Florbenazine SUVr", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia  (DLB)", "chunk": 3}
{"article": "PMC4027995.txt", "subject": "Florbetapir mean cortical SUVr values", "relationship": "RELATED_PROGNOSIS", "object": "Diagnosis of Alzheimer's Disease and Dementia  ", "chunk": 3}
{"article": "PMC4027995.txt", "subject": "Florbenazine SUVr", "relationship": "INDICATES_PRESENCE_OF", "object": "Dopamine degeneration", "chunk": 3}
{"article": "PMC4027995.txt", "subject": "Posterior putamen florbenazine SUVr value", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "differentiation of Parkinson's Disease from Alzheimer's Disease patients and healthy controls", "chunk": 3}
{"article": "PMC4027995.txt", "subject": "florbetapir", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid deposition", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "florbenazine", "relationship": "INDICATES_PRESENCE_OF", "object": "Dopamine abnormalities", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "florbetapir", "relationship": "RELATED_TREATMENT", "object": "Fluorescence imaging", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "florbenazine", "relationship": "RELATED_TREATMENT", "object": "Fluorescence imaging", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "florbetapir SUVr", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline in patients with DLB", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "VMAT2 binding", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline in patients with DLB", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "florbenazine binding", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline in patients with DLB", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive dysfunction", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "florbetapir", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid", "chunk": 5}
{"article": "PMC4027995.txt", "subject": "florbetapir", "relationship": "RELATED_TO", "object": "Diagnostic reliability studies", "chunk": 5}
{"article": "PMC4027995.txt", "subject": "florbetapir", "relationship": "RELATED_TO", "object": "Published cut-off values", "chunk": 5}
{"article": "PMC4027995.txt", "subject": "florbetapir", "relationship": "RELATED_TO", "object": "Amyloid imaging", "chunk": 5}
{"article": "PMC4027995.txt", "subject": "dopa", "relationship": "RELATED_TO", "object": "Dopamine imaging", "chunk": 5}
{"article": "PMC4051660.txt", "subject": "QT interval", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis and management of QT prolongation", "chunk": 2}
{"article": "PMC4051660.txt", "subject": "QTc interval", "relationship": "INDICATES_PRESENCE_OF", "object": "Prolonged QT syndrome", "chunk": 2}
{"article": "PMC4051660.txt", "subject": "QTc interval", "relationship": "RELATED_PROGNOSIS", "object": "Increased risk of Torsade de pointes and sudden cardiac death", "chunk": 2}
{"article": "PMC4051660.txt", "subject": "QTc interval", "relationship": "MONITORED_DURING_TREATMENT", "object": "Patients taking citalopram", "chunk": 2}
{"article": "PMC4051660.txt", "subject": "QT prolongation", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk of mortality", "chunk": 2}
{"article": "PMC4051660.txt", "subject": "QTc interval", "relationship": "MONITORED_DURING_TREATMENT", "object": "During the CitAD trial", "chunk": 3}
{"article": "PMC4051660.txt", "subject": "QTc interval", "relationship": "RELATED_TREATMENT", "object": "The CitAD Steering Committee (SC) decided to monitor QTc interval in participants following FDA warnings about citalopram and prolonged QT interval.", "chunk": 3}
{"article": "PMC4051660.txt", "subject": "QTc interval", "relationship": "INDICATES_PRESENCE_OF", "object": "A prolonged QTc interval (>450 ms for men and >470 ms for women) became an exclusion criterion for participation in the CitAD trial.", "chunk": 3}
{"article": "PMC4051660.txt", "subject": "QT interval", "relationship": "RELATED_PROGNOSIS", "object": "Prolonged QT interval during follow-up was associated with clinical events", "chunk": 5}
{"article": "PMC4051660.txt", "subject": "QT interval", "relationship": "MONITORED_DURING_TREATMENT", "object": "ECG monitoring began on 11", "chunk": 5}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease in a mouse model", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Hypocretin receptor antagonist", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Decrease in levels under the effect of a hypocretin receptor antagonist", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "hypocretin-1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Dementia with Lewy bodies", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Increase in levels during hypocretin infusion", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "In hourly cerebral spinal fluid samples", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Correlation with hypocretin-1 levels in advanced stage AD", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "hypocretin-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease/mild cognitive impairment", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's disease in a mouse model", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Increased concentration during wakefulness", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Decreased concentration during sleep", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "PREDICT_SURVIVAL", "object": "May decline later in AD", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b22", "relationship": "RELATED_PROGNOSIS", "object": "Levels found to be lower in the elderly patients with NC compared to aged controls", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "DIAGNOSITC_OF", "object": "Clinically discriminate AD from normal aging and other neurologic disorders", "chunk": 2}
{"article": "PMC4052448.txt", "subject": "total tau", "relationship": "DIAGNOSITC_OF", "object": "Clinically discriminate AD from normal aging and other neurologic disorders", "chunk": 2}
{"article": "PMC4052448.txt", "subject": "P-tau", "relationship": "DIAGNOSITC_OF", "object": "Clinically discriminate AD from normal aging and other neurologic disorders", "chunk": 2}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Calculated an Innotest\u00ae amyloid Tau Index (IATI) for each patient", "chunk": 2}
{"article": "PMC4052448.txt", "subject": "Hypocretin-1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Low cerebral cerebral cerebral cerebral spinal fluid hypocretin-1 levels (<110 pg/mL) were considered  clinically recognized as AD ", "chunk": 2}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "Tau", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "P-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "P-tau", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "IATI index", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "IATI index", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "A\u03b242 (pg/ml)", "relationship": "INDICATES_PRESENCE_OF", "object": "AD + mild cognitive impairment due to AD", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "A\u03b242 (pg/ml)", "relationship": "RELATING_PROGNOSIS", "object": "advanced AD", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "A\u03b242 (pg/ml)", "relationship": "RELATED_TREATMENT", "object": "diagnosing AD in atypical clinical forms", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "P-tau (pg/ml)", "relationship": "RELATED_TREATMENT", "object": "diagnosing AD in atypical clinical forms", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "tau (pg/ml)", "relationship": "RELATED_TREATMENT", "object": "diagnosing AD in atypical clinical forms", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "hypocretin-1 (pg/ml)", "relationship": "INDICATES_PRESENCE_OF", "object": "demented patients", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "hypocretin-1 (pg/ml)", "relationship": "GUIDE_TREATMENT_SELECTION", "object": "differentiating an AD + mild cognitive impairment due to AD diagnosis from other dementia diagnoses", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "hypocretin-1 (pg/ml)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "demented patients", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "hypocretin-1 (pg/ml)", "relationship": "RELATED_TREATMENT", "object": "diagnosing AD in atypical clinical forms", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "A\u03b242 (pg/ml)", "relationship": "PREDICTS_SURVIVAL", "object": "advanced AD", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "hypocretin-1 (pg/ml)", "relationship": "RELATED_TREATMENT", "object": "differentiating an AD + mild cognitive impairment due to AD diagnosis from other dementia diagnoses", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "hypocretin-1 (pg/ml)", "relationship": "PREDICTED_STAY_DURATION", "object": "hospice enrollment", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "hypocretin-1", "relationship": "DIAGNOSTIC_OF", "object": "Early-onset Alzheimer's Disease", "chunk": 5}
{"article": "PMC4052448.txt", "subject": "hypocretin-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimers Disease  ", "chunk": 5}
{"article": "PMC4052448.txt", "subject": "hypocretin-1", "relationship": "correlated with", "object": "A\u03b242", "chunk": 5}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Sleep quality", "chunk": 5}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid plaques", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH", "object": "A\u03b2 plaques", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "APPs", "relationship": "ASSOCIATED_WITH", "object": "Synaptic plasticity", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral spinal fluid", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "tau", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral spinal fluid", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "P-tau", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral spinal fluid", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "IATI", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral spinal fluid", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "hypocretin-1", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral spinal fluid", "chunk": 6}
{"article": "PMC4054967.txt", "subject": "amyloid-beta (A\u03b2)", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 1}
{"article": "PMC4054967.txt", "subject": "amyloid-beta (A\u03b2)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Alzheimer\u2019s disease immunotherapy", "chunk": 1}
{"article": "PMC4054967.txt", "subject": "amyloid-beta protofibrils", "relationship": "RELATED_PROGNOSIS", "object": "Early-stage Alzheimer's Disease", "chunk": 1}
{"article": "PMC4054967.txt", "subject": "A\u03b2PP E693G (Arctic mutation)", "relationship": "ASSOCIATED_WITH", "object": "increase in soluble A\u03b2 oligomers", "chunk": 1}
{"article": "PMC4054967.txt", "subject": "A\u03b2 peptide", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "\u03b3-secretase inhibitors and \u03b2-secretase inhibitors", "chunk": 1}
{"article": "PMC4054967.txt", "subject": "A\u03b2 immunotherapy", "relationship": "RELATED_TREATMENT", "object": "Bapineuzumab", "chunk": 2}
{"article": "PMC4054967.txt", "subject": "Bapineuzumab", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "requires very adequate biomarkers", "chunk": 2}
{"article": "PMC4054967.txt", "subject": "AN1792", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "active vaccination", "chunk": 2}
{"article": "PMC4054967.txt", "subject": "Bapineuzumab", "relationship": "RELATED_TREATMENT", "object": "positive effect in the clinic", "chunk": 2}
{"article": "PMC4054967.txt", "subject": "Bapineuzumab", "relationship": "MONITORED_DURING_TREATMENT", "object": "levels of A\u03b2 in cerebral cerebral cerebral cerebral spinal fluid", "chunk": 2}
{"article": "PMC4054967.txt", "subject": "Bapineuzumab", "relationship": "RELATED_TREATMENT", "object": " vasogenic edema called amyloid-related imaging abnormalities with parenchymal edema as well as intracerebral microhemorrhages", "chunk": 2}
{"article": "PMC4054967.txt", "subject": "A\u03b21-6", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4054967.txt", "subject": "Soluble A\u03b2 protofibrils", "relationship": "IS_TARGET_OF_TREATMENT", "object": "BAN2401", "chunk": 3}
{"article": "PMC4054967.txt", "subject": "Altered A\u03b2 aggregation", "relationship": "RELATED_TREATMENT", "object": "Tau deposition", "chunk": 3}
{"article": "PMC4054967.txt", "subject": "A\u03b242 protofibrils", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Inflammatory response in microglia, in vitro", "chunk": 3}
{"article": "PMC4054967.txt", "subject": "A\u03b2 protofibrils", "relationship": "RELATED_PROGNOSIS", "object": "Spatial learning impairment in transgenic mice", "chunk": 3}
{"article": "PMC4054967.txt", "subject": "A\u03b2 protofibrils", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "AD immunotherapy", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "A\u03b2 protofibrils", "relationship": "IS_TARGET_OF_TREATMENT", "object": "mAb158", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "aid in refinement of clinical diagnosis", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "tau", "relationship": "RELATED_TREATMENT", "object": "aid in refinement of clinical diagnosis", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "amyloid PET", "relationship": "RELATED_TREATMENT", "object": "aid in refinement of clinical diagnosis", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "amyloid PET", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "A\u03b2 protofibrils", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "A\u03b2", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "AD", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "BAN2401", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "AD immunotherapy", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "amyloid PET", "relationship": "USED_TO_DIAGNOSE", "object": "early patient population in the BAN2401 phase 2b trial", "chunk": 5}
{"article": "PMC4054967.txt", "subject": "A\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "A\u03b2 immunotherapy", "chunk": 5}
{"article": "PMC4054967.txt", "subject": "soluble protofibrils", "relationship": "IS_TARGET_OF_TREATMENT", "object": "immunotherapy", "chunk": 5}
{"article": "PMC4054967.txt", "subject": "A\u03b2 neurotoxicity", "relationship": "RELATED_PROGNOSIS", "object": "disease intervention in AD", "chunk": 5}
{"article": "PMC4055052.txt", "subject": "A\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "anti-amyloid therapies", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s Disease brain pathology", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "A\u03b2 Plaque", "relationship": "RELATED_PROGNOSIS", "object": "reduction of brain A\u03b2 levels", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_TREATMENT", "object": "monoclonal antibodies directed against A\u03b2", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "passive immunisation", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "GSK933776", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "immunotherapy during early clinical development", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "Gantenerumab", "relationship": "RESPONDED_TO", "object": "reduction of brain A\u03b2 levels", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "Solanezumab", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral spinal fluid  A\u03b21\u201342", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment with GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Treatment response to GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "total tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment with GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "total tau", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Treatment response to GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "phospho-tau 181", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment with GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "phospho-tau 181", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Treatment response to GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "GSK933776", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Thereapeutic intervention", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Treatment with GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "TotalTau", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Treatment with GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "phospho-tau 181", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Treatment with GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_TREATMENT", "object": "Increased decreases in total cerebral cerebral cerebral cerebral spinal fluid A\u03b21\u201342 levels after administration of GSK933776", "chunk": 4}
{"article": "PMC4055052.txt", "subject": "tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (relationship inferred by its measurement in cerebral cerebral cerebral cerebral spinal fluid and discussion of changes with treatment)", "chunk": 4}
{"article": "PMC4055052.txt", "subject": "phosphorylated tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (relationship inferred by its measurement in cerebral cerebral cerebral cerebral spinal fluid and discussion of changes with treatment)", "chunk": 4}
{"article": "PMC4055052.txt", "subject": "APOE \u03f54 allele", "relationship": "DIAGNOSITC_OF", "object": "Early-onset Alzheimer's Disease", "chunk": 4}
{"article": "PMC4055052.txt", "subject": "A\u03b218\u201335", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Alzheimer's Disease", "chunk": 5}
{"article": "PMC4055052.txt", "subject": "A\u03b24228\u201342", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Alzheimer's Disease", "chunk": 5}
{"article": "PMC4055052.txt", "subject": "tau", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Alzheimer's Disease", "chunk": 5}
{"article": "PMC4055052.txt", "subject": "phosphorylate tau", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Alzheimer's Disease", "chunk": 5}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_PROGNOSIS", "object": "Decreases in cerebral cerebral cerebral cerebral spinal fluid A\u03b21\u201342 after treatment with GSK933776", "chunk": 6}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_TREATMENT", "object": "GSK933776", "chunk": 6}
{"article": "PMC4055052.txt", "subject": "A\u03b228\u201342", "relationship": "RELATED_TREATMENT", "object": "GSK933776", "chunk": 6}
{"article": "PMC4055052.txt", "subject": "A\u03b218\u201335", "relationship": "RELATED_TREATMENT", "object": "GSK933776", "chunk": 6}
{"article": "PMC4055052.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Assessing short-term A\u03b2 changes", "chunk": 7}
{"article": "PMC4055052.txt", "subject": "A\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "GSK933776", "chunk": 7}
{"article": "PMC4055052.txt", "subject": "A\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Continuous sampling method using a catheter", "chunk": 7}
{"article": "PMC4055052.txt", "subject": "A\u03b2", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Response to single-dose administration of an anti-A\u03b2 antibody", "chunk": 7}
{"article": "PMC4055052.txt", "subject": "APOE \u03f54", "relationship": "DIAGNOSTIC_OF", "object": "Reducing A\u03b2 and increasing tau levels in cerebral spinal fluid", "chunk": 7}
{"article": "PMC4055052.txt", "subject": "tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (in conjunction with A\u03b2)", "chunk": 7}
{"article": "PMC4055052.txt", "subject": "Phosphorylated tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (in conjunction with A\u03b2)", "chunk": 7}
{"article": "PMC4058849.txt", "subject": "personal-care dependency", "relationship": "PREDICTES_SURVIVAL", "object": "inpatient hospitalization", "chunk": 3}
{"article": "PMC4058849.txt", "subject": "Personal-care dependency", "relationship": "RELATED_PROGNOSIS", "object": "inpatient hospitalization", "chunk": 3}
{"article": "PMC4058849.txt", "subject": "Personal care dependency", "relationship": "RELATED_PROGNOSIS", "object": "Inpatient admission", "chunk": 6}
{"article": "PMC4058849.txt", "subject": "Behavior problems", "relationship": "RELATED_PROGNOSIS", "object": "Inpatient admission", "chunk": 6}
{"article": "PMC4066282.txt", "subject": "dementia screening", "relationship": "INDICATES_PRESENCE_OF", "object": "Reversible causes of cognitive impairment", "chunk": 1}
{"article": "PMC4066282.txt", "subject": "dementia screening", "relationship": "INDICATES_PRESENCE_OF", "object": "Opportunity for early pharmacological and non-pharmacological interventions", "chunk": 1}
{"article": "PMC4066282.txt", "subject": "dementia screening", "relationship": "INDICATES_PRESENCE_OF", "object": "Enhance patient and caregiver education and planning about the disease and its course", "chunk": 1}
{"article": "PMC4066282.txt", "subject": "dementia screening", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Induction of depression and anxiety once diagnosed", "chunk": 1}
{"article": "PMC4066282.txt", "subject": "dementia screening", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Patient stigmatization", "chunk": 1}
{"article": "PMC4066282.txt", "subject": "MIS-T", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 3}
{"article": "PMC4066282.txt", "subject": "MIS-T", "relationship": "RELATED_TREATMENT", "object": "Referral to the ABC MedHome program for co-management of dementia.", "chunk": 3}
{"article": "PMC4066282.txt", "subject": "PHQ-9", "relationship": "INDICATES_PRESENCE_OF", "object": "Suicidal thoughts", "chunk": 4}
{"article": "PMC4066282.txt", "subject": "PHQ-9", "relationship": "USED_TO_DIAGNOSE", "object": "Major depression", "chunk": 4}
{"article": "PMC4066282.txt", "subject": "GAD-7", "relationship": "USED_TO_DIAGNOSE", "object": "General anxiety disorders", "chunk": 4}
{"article": "PMC4066282.txt", "subject": "HUI", "relationship": "RELATED_PROGNOSIS", "object": "Patient health-related quality of life", "chunk": 4}
{"article": "PMC4066282.txt", "subject": "PHQ-9", "relationship": "RELATED_TREATMENT", "object": "Testing equivalence levels in treatment of mood", "chunk": 6}
{"article": "PMC4066282.txt", "subject": "GAD-7", "relationship": "RELATED_TREATMENT", "object": "Testing equivalence levels in treatment of anxiety", "chunk": 6}
{"article": "PMC4095696.txt", "subject": "N-methyl-D-aspartate (NMDA) receptor", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Currently FDA approved drug \"Memantine\"", "chunk": 1}
{"article": "PMC4095696.txt", "subject": "cholinesterase inhibitors", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Currently FDA approved drugs Tacrine, Donepezil, Rivastigmine, Galantamine", "chunk": 1}
{"article": "PMC4095696.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4095696.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "Anti-A\u03b2 therapies", "chunk": 3}
{"article": "PMC4095696.txt", "subject": "tau-related", "relationship": "RELATED_TREATMENT", "object": "drugs", "chunk": 3}
{"article": "PMC4095696.txt", "subject": "memantine", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4095696.txt", "subject": "disease-modifying", "relationship": "RELATED_PROGNOSIS", "object": "compounds", "chunk": 3}
{"article": "PMC4107377.txt", "subject": "APOE \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4107377.txt", "subject": "APOE \u03b54 variants", "relationship": "INDICATES_PRESENCE_OF", "object": "Substantially increased risk of dementia", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "APOE \u03b54 variants", "relationship": "RELATED_PROGNOSIS", "object": "Substantially increased risk of dementia", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "rs7412", "relationship": "RELATED_TO", "object": "APOE \u03b54 variants", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "rs429358", "relationship": "RELATED_TO", "object": "APOE \u03b54 variants", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "BIN1", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "CLU", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "ABCA7", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "CR1", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "PICALM", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "MS4A6A", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "CD33", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "MS4A4E", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "CD2AP", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "RELATED_TO", "object": "Probability of dementia", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia risk", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "AD-GRS (excluding APOE)", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia risk", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia risk", "chunk": 3}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia risk (stronger association in NHW compared to NHB)", "chunk": 3}
{"article": "PMC4107377.txt", "subject": "APOE", "relationship": "IS_PART_OF", "object": "AD-GRS", "chunk": 3}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "RELATED_PROGNOSIS", "object": "Dementia probability", "chunk": 4}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "RELATED_PROGNOSIS", "object": "Memory score", "chunk": 4}
{"article": "PMC4107377.txt", "subject": "APOE-\u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Higher dementia probability", "chunk": 4}
{"article": "PMC4107377.txt", "subject": "APOE-\u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower memory score", "chunk": 4}
{"article": "PMC4107377.txt", "subject": "ABCA7 SNP rs115550680", "relationship": "NOT_ASSOCIATED_WITH", "object": "Dementia probability in NHB", "chunk": 4}
{"article": "PMC4107377.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "Dementia risk", "chunk": 5}
{"article": "PMC4107377.txt", "subject": "AD-GRS including APOE", "relationship": "PREDICTING_SURVIVAL", "object": "Dementia risk in NHW", "chunk": 5}
{"article": "PMC4107377.txt", "subject": "AD-GRS including APOE", "relationship": "PREDICTING_SURVIVAL", "object": "Dementia risk in NHB", "chunk": 5}
{"article": "PMC4107377.txt", "subject": "AD-GRS excluding APOE", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Dementia risk in NHB males", "chunk": 5}
{"article": "PMC4107377.txt", "subject": "APOE", "relationship": "RELATED_TREATMENT", "object": "Genetic and social modifiers to explain divergent effects on dementia", "chunk": 5}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "RELATED_TREATMENT", "object": "Potential modifiers of APOE effects in different populations", "chunk": 5}
{"article": "PMC4107377.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TO_MORTALITY", "object": "Associated with mortality", "chunk": 6}
{"article": "PMC4107377.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "De mentia risk", "chunk": 6}
{"article": "PMC4107377.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "Genetic determinants of chronic illnesses", "chunk": 6}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Dementia and memory", "chunk": 6}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "PREDICTS_SURVIVAL", "object": "Memory and dementia in NHW", "chunk": 6}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Genetic risk profiles by race and gender", "chunk": 6}
{"article": "PMC4109111.txt", "subject": "vitamin D receptor (VDR)", "relationship": "RELATED_TO_DISEASE", "object": "Sarcopenia", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "androgen receptor (AR)", "relationship": "RELATED_TO_DISEASE", "object": "Sarcopenia", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "ciliary neurotrophic factor (CNTF)", "relationship": "RELATED_TO_DISEASE", "object": "Sarcopenia", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "myostatin (MSTN)", "relationship": "RELATED_TO_DISEASE", "object": "Sarcopenia", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "insulin-like growth factor 1 (IGF1)", "relationship": "RELATED_TO_DISEASE", "object": "Sarcopenia", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "angiotensin I converting enzyme 1 (ACE)", "relationship": "RELATED_TO_DISEASE", "object": "Sarcopenia", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "alpha actinin 3 (ACTN3)", "relationship": "RELATED_TO_DISEASE", "object": "Sarcopenia", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "interleukin 6 (IL-6)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Muscle mass and strength", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "tumor necrosis factor (TNF)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Muscle mass and strength", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "ROS", "relationship": "INDICATES_PRESENCE_OF", "object": "Oxidative Stress", "chunk": 3}
{"article": "PMC4109111.txt", "subject": "Catalase", "relationship": "DECREASED_IN", "object": "Elderly Individuals", "chunk": 3}
{"article": "PMC4109111.txt", "subject": "Glutathione Transferase", "relationship": "DECREASED_IN", "object": "Elderly Individuals", "chunk": 3}
{"article": "PMC4109111.txt", "subject": "Superoxide Dismutase (MnSOD)", "relationship": "INCREASED_IN", "object": "Old Individuals", "chunk": 3}
{"article": "PMC4109111.txt", "subject": "Catalase", "relationship": "INCREASED_IN", "object": "Old Individuals", "chunk": 3}
{"article": "PMC4109111.txt", "subject": "TNF-\u03b1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "muscle wasting and sarcopenia", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "TNF-\u03b1", "relationship": "IS_CAUSE_OF", "object": "ROS production, mitochondrial dysfunction, and inflammation", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "NF-\u03baB", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "muscle atrophy", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "NF-\u03baB", "relationship": "INDUCED_BY", "object": "ROS and RNS", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "NF-\u03baB", "relationship": "REGULATES", "object": "Ubiquitin-proteasome pathway (UPS)", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "p38", "relationship": "REGULATES", "object": "expression of E3 ubiquitin ligases (atrogin-1)", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "MuRF-1", "relationship": "ASSOCIATED_WITH", "object": "muscle atrophy", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "atrogin-1", "relationship": "ASSOCIATED_WITH", "object": "muscle atrophy", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "Apoptosis", "relationship": "ASSOCIATED_WITH", "object": "Muscle atrophy and sarcopenia", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "p53", "relationship": "ASSOCIATED_WITH", "object": "Apoptosis", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "Bax", "relationship": "ASSOCIATED_WITH", "object": "Apoptosis", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "Caspase 3", "relationship": "ASSOCIATED_WITH", "object": "Apoptosis", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "EndoG", "relationship": "ASSOCIATED_WITH", "object": "Apoptosis", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "MAPK", "relationship": "ASSOCIATED_WITH", "object": "Cell death", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "Calpains", "relationship": "ASSOCIATED_WITH", "object": "Muscle wasting and sarcopenia", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "RyR1", "relationship": "ASSOCIATED_WITH", "object": "Proteolytic pathway and muscle wasting", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "AGEs", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower muscle strength", "chunk": 6}
{"article": "PMC4109111.txt", "subject": "8-OHdG", "relationship": "USED_TO_DIAGNOSE", "object": "DNA damage", "chunk": 6}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "RELATED_TREATMENT", "object": "Delaying or preventing muscle wasting in the elderly", "chunk": 6}
{"article": "PMC4109111.txt", "subject": "\u03b3-tocopherol", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Muscle strength", "chunk": 6}
{"article": "PMC4109111.txt", "subject": "\u03b1-tocopherol", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Muscle strength", "chunk": 6}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "REDUCED_MORTALITY", "object": " Attenuation of the early onset of muscle weakness in the elderly", "chunk": 7}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "RELATED_PROGNOSIS", "object": "improved physical performance and oxidative status", "chunk": 8}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "attenuated unfavorable elevations", "chunk": 8}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "RELATED_TREATMENT", "object": "repair of oxidative damaged proteins", "chunk": 8}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "provide a stable antioxidant supply", "chunk": 8}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "RELATED_TREATMENT", "object": "prevention and treatment for sarcopenia", "chunk": 9}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "RELATED_TREATMENT", "object": "antiaging intervention for the muscle", "chunk": 9}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Reducing oxidative stress in aging", "chunk": 9}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "MONITORED_DURING_TREATMENT", "object": "repair of cell membrane injury", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid amyloid-\u03b21\u201342", "relationship": "DIAGNOSITC_OF", "object": "Diagnosis: Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid amyloid-\u03b21\u201342", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis of Alzheimer's disease", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "amyloid-\u03b21\u201342", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis of Alzheimer's disease", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid phosphorylated tau", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Alzheimer's disease", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid phosphorylated tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis of Alzheimer's disease ", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid total tau", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Alzheimer's disease", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid total tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis of Alzheimer's disease", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "APOE4", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "cerebral spinal fluid amyloid-\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4132648.txt", "subject": "cerebral spinal fluid total tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4132648.txt", "subject": "hippocampal volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4132648.txt", "subject": "FDG-PET hypometabolism", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4132648.txt", "subject": "atrophy rate measured from structural MRI", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4132648.txt", "subject": "Biomarker evidence", "relationship": "INDICATES_PRESENCE_OF", "object": "presymptomatic Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4132648.txt", "subject": "impaired cognitive function", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4132648.txt", "subject": "amyloid-\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "phosphorylated tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "total tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "Rey Auditory Verbal Learning Test", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "Mini-Mental State Examination", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "brain", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "ventricles", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "hippocampus", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "entorhinal", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "mid temporal", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "fusiform", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "hippocampal atrophy", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "brain atrophy", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "amyloid", "relationship": "RELATED_TO", "object": "Staging of 285 subjects: 189 were amyloid+", "chunk": 4}
{"article": "PMC4132648.txt", "subject": "APOE", "relationship": "RELATED_TO", "object": "Staging of 285 subjects: 139 were APOE+", "chunk": 4}
{"article": "PMC4132648.txt", "subject": "amyloid", "relationship": "RELATED_TO", "object": "Staging of 285 subjects: 123 were amyloid+APOE+", "chunk": 4}
{"article": "PMC4132648.txt", "subject": "APOE +/\u2212", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC4132648.txt", "subject": "amyloid+ ", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC4132648.txt", "subject": "total tau", "relationship": "RELATED_TO", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC4132648.txt", "subject": "phosphorylated tau", "relationship": "RELATED_TO", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC4132648.txt", "subject": "amyloid-\u03b21\u201342", "relationship": "RELATED_TO", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC4132648.txt", "subject": "total tau", "relationship": "RELATED_TREATMENT", "object": "cerebral spinal fluid total tau assays", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "phosphorylated tau", "relationship": "RELATED_TREATMENT", "object": "cerebral spinal fluid total tau and phosphorylated tau assays", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "amyloid-\u03b21\u201342", "relationship": "RELATED_TREATMENT", "object": "cerebral cerebral cerebral cerebral spinal fluid amyloid-\u03b21\u201342 assays", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "amyloid-\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Predict abnormal amyloid levels", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "hippocampal atrophy rate", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "entorhinal volume loss", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "whole brain atrophy rate", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer\u2019s disease", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "Mini-Mental State Examination reduction", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "vascular disease", "relationship": "RELATED_TREATMENT", "object": "contribute to brain atrophy rate", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "amyloid-\u03b2", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Phosphorylated tau", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Total tau", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Hippocampal atrophy", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Measured in ml/year, abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Brain atrophy", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Measured in ml/year, abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "RAVLT", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "ADAS-Cog", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Hippocampus (% TIV)", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Entorhinal (% TIV)", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Mid temporal (% TIV)", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Whole brain (% TIV)", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Fusiform (% TIV)", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Ventricles (% TIV)", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "FDG", "relationship": "RELATED_TO_DIAGNOSTIC", "object": "Mild Cognitive Impairment subtypes", "chunk": 10}
{"article": "PMC4132648.txt", "subject": "Amyloid PET biomarkers", "relationship": "RELATED_TO_DIAGNOSTIC", "object": "Mild Cognitive Impairment subtypes", "chunk": 10}
{"article": "PMC4132648.txt", "subject": "Tau-PET", "relationship": "RELATED_TO_DIAGNOSTIC", "object": "Alzheimer's Disease", "chunk": 10}
{"article": "PMC4132648.txt", "subject": "APOE", "relationship": "RELATED_TO_DIAGNOSTIC", "object": "Alzheimer's Disease", "chunk": 10}
{"article": "PMC4150993.txt", "subject": "amyloid deposits", "relationship": "RELATED TO", "object": "neurophysiological status", "chunk": 1}
{"article": "PMC4150993.txt", "subject": "white matter pathways", "relationship": "RELATED TO", "object": "neurophysiological status", "chunk": 1}
{"article": "PMC4150993.txt", "subject": "genetic, pharmacological and other biomarkers ", "relationship": "RELATED TO", "object": "neurophysiological status", "chunk": 1}
{"article": "PMC4150993.txt", "subject": "high level of cardiovascular fitness", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "cognitive aging and protection against risk", "chunk": 5}
{"article": "PMC4150993.txt", "subject": "high level of cardiovascular fitness", "relationship": "RELATED_TO", "object": "modest enhancement of brain health directly, most likely through increased secretion of brain-derived neurotrophic factor (BDNF)", "chunk": 5}
{"article": "PMC4150993.txt", "subject": "high level of cardiovascular fitness", "relationship": "RELATED_TO", "object": "improved vasculature", "chunk": 5}
{"article": "PMC4150993.txt", "subject": "intellectual and social activities in middle and late adulthood", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "better cognitive ability in middle-aged and older adults, less age-related cognitive decline", "chunk": 5}
{"article": "PMC4150993.txt", "subject": "highly educated individuals", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "diagnosed with dementia at later ages", "chunk": 5}
{"article": "PMC4150993.txt", "subject": "APOE-4 gene", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s diagnosis", "chunk": 6}
{"article": "PMC4150993.txt", "subject": "APOE-4 gene", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Substantially increases the risk of Alzheimer\u2019s diagnosis", "chunk": 6}
{"article": "PMC4150993.txt", "subject": "amyloid and tau deposition", "relationship": "RELATED_TO", "object": "Alzheimer\u2019s disease", "chunk": 6}
{"article": "PMC4150993.txt", "subject": "amyloid and tau deposition", "relationship": "RELATED_TREATMENT", "object": "Used in amyloid imaging techniques", "chunk": 6}
{"article": "PMC4150993.txt", "subject": "amyloid", "relationship": "INDICATES_PRESENCE_OF", "object": "preclinical AD ", "chunk": 6}
{"article": "PMC4150993.txt", "subject": "high amyloid burden", "relationship": "INDICATES_PRESENCE_OF", "object": "preclinical AD", "chunk": 6}
{"article": "PMC4150993.txt", "subject": "amyloid deposition", "relationship": "INDICATES_PRESENCE_OF", "object": "Preclinical AD", "chunk": 7}
{"article": "PMC4150993.txt", "subject": "tau protein", "relationship": "INDICATES_PRESENCE_OF", "object": "Preclinical AD", "chunk": 7}
{"article": "PMC4150993.txt", "subject": "hippocampal volume", "relationship": "RELATED_PROGNOSIS", "object": "Decline in AD", "chunk": 7}
{"article": "PMC4153626.txt", "subject": "Gait Speed", "relationship": "RELATED_PROGNOSIS", "object": "Faster gait speed is predictor of Cluster Falls trajectory.", "chunk": 4}
{"article": "PMC4153626.txt", "subject": "Diabetes Mellitus (DM)", "relationship": "RELATED_PROGNOSIS", "object": "Diabetes Mellitus is a predictor of Increasing Falls trajectory.", "chunk": 4}
{"article": "PMC4153626.txt", "subject": "Cognitive Impairment", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment is a predictor of Increasing Falls trajectory.", "chunk": 4}
{"article": "PMC4153626.txt", "subject": "Comorbidities (2 or more)", "relationship": "RELATED_PROGNOSIS", "object": "2 or more comorbidities is a predictor of Chronic Recurring Falls trajectory.", "chunk": 4}
{"article": "PMC4153626.txt", "subject": "Falls in past year", "relationship": "RELATED_PROGNOSIS", "object": "Falls in the past year are predictors of Cluster Falls and Chronic Recurring Falls trajectories.", "chunk": 4}
{"article": "PMC4153626.txt", "subject": "Symptoms of Depression", "relationship": "RELATED_PROGNOSIS", "object": "Symptoms of depression are predictive of all faller trajectory groups.", "chunk": 4}
{"article": "PMC4159858.txt", "subject": "Aluminum", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer-like lesions in the brain", "chunk": 1}
{"article": "PMC4159858.txt", "subject": "Sulforaphane", "relationship": "PREDICTS_SURVIVAL", "object": "Lower aluminum levels in the brain of AD-like mice", "chunk": 1}
{"article": "PMC4159858.txt", "subject": "Sulforaphane", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Potential application in AD therapeutics", "chunk": 1}
{"article": "PMC4159858.txt", "subject": "Cholinergic neurons", "relationship": "RELATED_PROGNOSIS", "object": "Decreased numbers were observed in the medial septal (MS) and hippocampal CA1 regions of AD-like mice compared with controls and AD-like mice treated with SFN", "chunk": 2}
{"article": "PMC4159858.txt", "subject": "Cholinergic neurons", "relationship": "RELATED_TREATMENT", "object": "SFN treatment  increased the numbers in these regions", "chunk": 2}
{"article": "PMC4159858.txt", "subject": "BrdU-positive neurons", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "SFN significantly increased the numbers of BrdU-positive neurons in the SVZ and SGZ of AD-like mice", "chunk": 2}
{"article": "PMC4159858.txt", "subject": "BrdU-positive neurons", "relationship": "INDICATES_PRESENCE_OF", "object": "proliferation, a marker of neurogenesis", "chunk": 2}
{"article": "PMC4159858.txt", "subject": "Cholinergic neurons", "relationship": "INDICATES_PRESENCE_OF", "object": "The presence of cholinergic neurons was indicated by the presence of brown immunoreactive cells", "chunk": 2}
{"article": "PMC4159858.txt", "subject": "ChAT", "relationship": "INDICATES_PRESENCE_OF", "object": "Cholinergic neurons", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "ChAT", "relationship": "RELATED_TREATMENT", "object": "Treating AD-like mice with SFN could lead to the increase of cholinergic neurons", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "ChAT", "relationship": "MONITORED_DURING_TREATMENT", "object": "Changes in the cholinergic system (ACh level and ChAT and AChE activities) in the cerebral cortex", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "AChE", "relationship": "MONITORED_DURING_TREATMENT", "object": "Changes in the cholinergic system (ACh level and ChAT and AChE activities) in the cerebral cortex", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "ACh", "relationship": "MONITORED_DURING_TREATMENT", "object": "Changes in the cholinergic system (ACh level and ChAT and AChE activities) in the cerebral cortex", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "ChAT", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Cholinergic neuron loss in the MS and hippocampal CA1 regions", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "SFN", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "SFN is a promising compound with neuroprotective properties, which is expected to be useful in the prevention of AD.", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "BrdU", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "can be incorporated into DNA only during the S-phase of the mitotic process", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "Ki-67", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Another marker, such as Ki-67, which is fully positive for its whole duration", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "TUNEL", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "A Terminal-deoxynucleoitidyl Transferase Mediated Nick End Labeling (TUNEL) test", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "Aluminum", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Aluminum load reduction may be implicated in SFN-mediated neuroprotective effects in AD-like mice", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "Aluminum", "relationship": "RELATED_TREATMENT", "object": "SFN may reduce aluminum load", "chunk": 5}
{"article": "PMC4159858.txt", "subject": "AChE", "relationship": "MONITORED_DURING_TREATMENT", "object": "Activities were described in units per milligram fresh tissue protein", "chunk": 5}
{"article": "PMC4159858.txt", "subject": "ChAT", "relationship": "MONITORED_DURING_TREATMENT", "object": "Activities were described in units per milligram fresh tissue protein", "chunk": 5}
{"article": "PMC4159858.txt", "subject": "ACh", "relationship": "MONITORED_DURING_TREATMENT", "object": "Level was expressed as micrograms per milligram fresh tissue protein", "chunk": 5}
{"article": "PMC4174765.txt", "subject": "Amyloid (A\u03b2) oligomers", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurotransmission pathways dysfunction", "chunk": 1}
{"article": "PMC4174765.txt", "subject": "Amyloid (A\u03b2) oligomers", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cell dysfunction, neurotransmitters signalling imbalance and neurological signs", "chunk": 1}
{"article": "PMC4174765.txt", "subject": "Amyloid precursor protein (APP)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Amyloid hypothesis postulates that APP undergoes impairment of physiological cleavage system due to unknown trigger(s), producing oligomeric toxic species", "chunk": 1}
{"article": "PMC4174765.txt", "subject": "APP oligomers", "relationship": "RELATED_PROGNOSIS", "object": "Impairment of synaptic plasticity mechanisms, neuronal network disarrangement and cell death", "chunk": 1}
{"article": "PMC4174765.txt", "subject": "Oligomers", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alteration in stoichiometry could be responsible for cell degeneration and death", "chunk": 1}
{"article": "PMC4174765.txt", "subject": "Extrapyramidal signs", "relationship": "INDICATES_PRESENCE_OF", "object": "Dopamine (DA) containing neurons undergo degenerative changes", "chunk": 1}
{"article": "PMC4174765.txt", "subject": "Dopamine (DA) containing neurons", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive decline and non-cognitive symptoms of AD", "chunk": 1}
{"article": "PMC4174765.txt", "subject": "A\u03b2 oligomers", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurodegeneration", "chunk": 3}
{"article": "PMC4174765.txt", "subject": "A\u03b2 oligomers", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Rapid progression of cognitive decline", "chunk": 3}
{"article": "PMC4174765.txt", "subject": " \u03b17 nAChRs", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment targeting A\u03b2 oligomers", "chunk": 3}
{"article": "PMC4174765.txt", "subject": "\u03b5 -syn", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Prevention of aggregation", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "Hcy", "relationship": "RELATED_TREATMENT", "object": "n-3 PUFAs have demonstrated their ability to reduce Hcy levels", "chunk": 1}
{"article": "PMC4179179.txt", "subject": "DHA", "relationship": "RELATED_TREATMENT", "object": "daily administration of oils rich in DHA and LA to rats significantly decreased the plasma Hcy concentration", "chunk": 1}
{"article": "PMC4179179.txt", "subject": "n-3 PUFAs", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "cardiovascular diseases are risk factors for both vascular and degenerative dementia", "chunk": 1}
{"article": "PMC4179179.txt", "subject": "n-3 PUFAs", "relationship": "RELATED_PROGNOSIS", "object": "reduce the risk of cognitive decline", "chunk": 1}
{"article": "PMC4179179.txt", "subject": "n-3 PUFAs, particularly DHA", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "associated with reduced cognitive decline during aging", "chunk": 1}
{"article": "PMC4179179.txt", "subject": "n-3 PUFAs", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "an important mechanism to reduce the risk of cognitive decline", "chunk": 1}
{"article": "PMC4179179.txt", "subject": "hs-CRP", "relationship": "INDICATES_PRESENCE_OF", "object": "inflammation", "chunk": 2}
{"article": "PMC4179179.txt", "subject": "homocysteine (Hcy)", "relationship": "RELATED_TO", "object": "cardiovascular risk", "chunk": 2}
{"article": "PMC4179179.txt", "subject": "homocysteine (Hcy)", "relationship": "PREDICTED_BY", "object": "the clinical assessments of cognitive function", "chunk": 2}
{"article": "PMC4179179.txt", "subject": "Total cholesterol", "relationship": "RELATED_TO_DISEASE_STATE", "object": "Increased in the case group (with cognitive impairment) compared to the control group", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "LDL cholesterol", "relationship": "RELATED_TO_DISEASE_STATE", "object": "Increased in the case group (with cognitive impairment) compared to the control group", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "Triglycerides", "relationship": "RELATED_TO_DISEASE_STATE", "object": "Increased in the case group (with cognitive impairment) compared to the control group", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "Total cholesterol/HDL-C ratio", "relationship": "RELATED_TO_DISEASE_STATE", "object": "Increased in the case group (with cognitive impairment) compared to the control group", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "14:0", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "16:0", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "22:0", "relationship": "INDICATES_ABSENCE_OF", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "24:1n-9", "relationship": "INDICATES_ABSENCE_OF", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "16:1n-7", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "22:6n-3 (DHA)", "relationship": "RELATED_TO_DISEASE_STATE", "object": "Decreased in the case group (with cognitive impairment) compared to the control group", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "Total Polyunsaturated fatty acids", "relationship": "RELATED_TO_DISEASE_STATE", "object": "Decreased in the case group (with cognitive impairment) compared to the control group", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "Hcy", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "Hcy", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive decline (negative correlation with cognitive performance)", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "Hcy", "relationship": "RELATED_TREATMENT", "object": "Management of cognitive impairment", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "22:6n-3", "relationship": "RELATED_TREATMENT", "object": "Brain health (specifically memory formation)", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "22:6n-3", "relationship": "RELATED_TREATMENT", "object": "Neurological function", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "n-6/n-3 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk for chronic diseases", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "20:4n-6", "relationship": "RELATED_PROGNOSIS", "object": "Inflammation", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "EPA and DHA", "relationship": "INDICATES_PRESENCE_OF", "object": "Anti-inflammatory effects", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "hs-CRP", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Managing inflammation", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "n-3 PUFAs", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Better cognitive performance", "chunk": 5}
{"article": "PMC4179179.txt", "subject": "DHA", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Better cognitive performance", "chunk": 5}
{"article": "PMC4179179.txt", "subject": "DHA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": " Suppressing A\u03b2 peptide production and amyloid plaque formation", "chunk": 5}
{"article": "PMC4179179.txt", "subject": "myristic acid (14:0)", "relationship": "RELATED_TO", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC4179179.txt", "subject": "palmitic acid (16:0)", "relationship": "RELATED_TO", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC4179179.txt", "subject": "palmitoleic acid (16:1n-7)", "relationship": "RELATED_TO", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC4179179.txt", "subject": "n-6/n-3 ratio", "relationship": "RELATED_TO", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC4181752.txt", "subject": "Geriatric Depression Scale (GDS)", "relationship": "RELATED_PROGNOSIS", "object": "Assessment of progression of dementia", "chunk": 1}
{"article": "PMC4181752.txt", "subject": "Geriatric Depression Scale (GDS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression in elderly patients", "chunk": 3}
{"article": "PMC4195286.txt", "subject": "CNV amplitude", "relationship": "INDICATES_PRESENCE_OF", "object": "Modulations in the P1 and N1 components", "chunk": 5}
{"article": "PMC4195286.txt", "subject": "SC condition", "relationship": "RELATED_TO", "object": "Higher amplitude (more negative) of the CNV", "chunk": 5}
{"article": "PMC4195286.txt", "subject": "SC condition", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Stimuli presentation and targets", "chunk": 5}
{"article": "PMC4195286.txt", "subject": "N1 amplitude", "relationship": "INDICATES_PRESENCE_OF", "object": "Congruent target condition", "chunk": 7}
{"article": "PMC4195286.txt", "subject": "BA 19", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "P1 generator", "chunk": 10}
{"article": "PMC4200223.txt", "subject": "frontal structural abnormalities", "relationship": "RELATED_TO", "object": "neuropsychiatric symptoms observed in AD patients", "chunk": 2}
{"article": "PMC4200223.txt", "subject": "apathy", "relationship": "ASSOCIATED_WITH", "object": "frontal structures", "chunk": 2}
{"article": "PMC4200223.txt", "subject": "delusions", "relationship": "CORRELATED_WITH", "object": "frontal, parietal, and temporal structures", "chunk": 2}
{"article": "PMC4200223.txt", "subject": "depressive symptoms", "relationship": "ASSOCIATED_WITH", "object": "thalamus, lentiform nucleus, and medial temporal cortex", "chunk": 2}
{"article": "PMC4200223.txt", "subject": "agitation", "relationship": "ASSOCIATED_WITH", "object": "temporal and frontal structures", "chunk": 2}
{"article": "PMC4200223.txt", "subject": "amygdale atrophy", "relationship": "RELATED_TO", "object": "aberrant motor behaviour", "chunk": 2}
{"article": "PMC4200223.txt", "subject": "amygdale atrophy", "relationship": "POTENTIALLY_RELATED_TO", "object": "anxiety and irritability", "chunk": 2}
{"article": "PMC4200223.txt", "subject": "Mini-Zarit test", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Caregiver health", "chunk": 3}
{"article": "PMC4200223.txt", "subject": "Geriatric Depression Scale (GDS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression", "chunk": 3}
{"article": "PMC4200223.txt", "subject": "MINI", "relationship": "INDICATES_PRESENCE_OF", "object": "Previous instances of depression", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "F2-isoprostane levels", "relationship": "INDICATES_PRESENCE_OF", "object": "Oxidative stress", "chunk": 2}
{"article": "PMC4202787.txt", "subject": "\u03b2-OHB levels", "relationship": "INDICATES_PRESENCE_OF", "object": "Paragraph recall improvement with MCT administration", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "ADAS-cog", "relationship": "RELATED_PROGNOSIS", "object": "Treatment effect of AC-1202", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "ADAS-cog", "relationship": "MONITORED_DURING_TREATMENT", "object": "Ginkgo Biloba treatment", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "3MSE", "relationship": "MONITORED_DURING_TREATMENT", "object": "Ginkgo Biloba treatment", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "vitamin E (\u03b1-tocopherol)", "relationship": "USED_TO_DIAGNOSE", "object": "Slowing the progression of AD", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "\u03b1-tocopherol", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "AD treatment", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "\u03b1-tocopherol", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "AD progression slowing", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "\u03b1-tocopherol", "relationship": "IS_TARGET_OF_TREATMENT", "object": "AD progression slowing", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "vitamin C (ascorbic acid)", "relationship": "RELATED_PROGNOSIS", "object": "Prevention and treatment of AD", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "vitamin C (ascorbic acid)", "relationship": "INDICATES_PRESENCE_OF", "object": "Essential vitamin for human health", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "Vitamin C", "relationship": "INDICATES_PRESENCE_OF", "object": "AD and cognitive impairment", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "vitamin C", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD and cognitive impairment", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "CoQ10", "relationship": "IS_TARGET_OF_TREATMENT", "object": "reduce amyloid plaque deposition", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "CoQ10", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "antioxidant therapy", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "Latreperdine", "relationship": "is_basis_for_therapy_choice", "object": "treatment of AD", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "Omage-3 fatty acids", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "prevention or slow AD progression", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "Docosahexaenoic acid (DHA)", "relationship": "RELATED_TREATMENT", "object": " prevention or slow AD progression", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "Eicosapentaenoic acid (EPA)", "relationship": "RELATED_TREATMENT", "object": " prevention or slow AD progression", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "ApoE \u03b54", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Negating the beneficial effects of omega-3 fatty acids", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "ApoE \u03b54", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "omega-3 fatty acids", "relationship": "INDICATES_PRESENCE_OF", "object": "cognitive decline in association with AD", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "vitamin B12", "relationship": "RELATED_PROGNOSIS", "object": "increased risk of AD", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "serum homocysteine levels", "relationship": "RELATED_PROGNOSIS", "object": "increased risk of AD", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "folate", "relationship": "RELATED_TREATMENT", "object": "slowing the onset or progression of AD in cerebral gray matter", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "Cerefolin NAC", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treating vitamin deficiencies associated with memory loss", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "B complex vitamins", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "routine laboratory analysis of such vitamin levels, and repletion if found to be deficient", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "INDICATES_PRESENCE_OF", "object": "Higher ketone levels", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "RELATED_TREATMENT", "object": "Possible strategy for treatment of AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Medium chain triglycerides (MCTs)", "relationship": "RELATED_TREATMENT", "object": "Possible strategy for treatment of AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "MCTs", "relationship": "RELATED_TREATMENT", "object": "Produce higher ketone levels in the blood", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Coconut oil", "relationship": "RELATED_TREATMENT", "object": "Treatment for AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Caprylic acid", "relationship": "RELATED_TREATMENT", "object": "Restore brain function", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Axona\u00ae", "relationship": "RELATED_TREATMENT", "object": "Improve cognition", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Souvenaid\u00ae", "relationship": "RELATED_TREATMENT", "object": "Promote synaptic formation and function", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Souvenaid\u00ae", "relationship": "RELATED_TREATMENT", "object": "Cognitive improvement", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Souvenaid\u00ae", "relationship": "RELATED_TREATMENT", "object": "Enhance synaptic health and neuronal stability", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "uridine monophosphate", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "choline", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "phospholipids", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "EPA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "DHA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "vitamins E, C, B12, and B6", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "folic acid", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "selenium", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Mediterranean diet", "relationship": "RELATED_PROGNOSIS", "object": "reduced mortality in patients with AD", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "Mediterranean diet", "relationship": "RELATED_PROGNOSIS", "object": "lower risk of AD (primary prevention)", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "Mediterranean diet", "relationship": "RELATED_PROGNOSIS", "object": "slower progression of symptoms of mild cognitive decline into AD", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "Mediterranean diet", "relationship": "RELATED_TREATMENT", "object": "preventive measure for AD and cognitive impairment", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "Mediterranean diet", "relationship": "RELATED_PROGNOSIS", "object": "greater compliance and dosage being associated with greater benefits", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "olive oil", "relationship": "RELATED_TREATMENT", "object": "inhibitory properties on fibrillization of tau protein", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "monounsaturated fatty acids (MUFAs)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "promotes neuronal health", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "polyunsaturated fatty acids (PUFAs)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "promotes neuronal health", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "micronutrients", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "promotes neuronal health", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "macronutrients", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "promotes neuronal health", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "Huperzine A", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": " Treatment of AD patients", "chunk": 8}
{"article": "PMC4202787.txt", "subject": "Huperzine A", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Drug-na\u00efve populations", "chunk": 8}
{"article": "PMC4202787.txt", "subject": "Gingko biloba", "relationship": "RELATED_TREATMENT", "object": "Preventing the development of or slowing progression of mild cognitive impairment into AD", "chunk": 8}
{"article": "PMC4202787.txt", "subject": "Resveratrol", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Mild to moderate AD patients", "chunk": 8}
{"article": "PMC4202787.txt", "subject": "Curcumin", "relationship": "RELATED_TREATMENT", "object": "Treat or preventing cancer, aging and AD", "chunk": 8}
{"article": "PMC4221919.txt", "subject": "VO2max", "relationship": "RELATED_PROGNOSIS", "object": "Aerobic exercise capacity", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "HRV", "relationship": "RELATED_PROGNOSIS", "object": "Autonomic nervous system", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "SNS activity", "relationship": "RELATED_PROGNOSIS", "object": "Autonomic nervous system", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "BP", "relationship": "RELATED_PROGNOSIS", "object": "Cardiovascular", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "pulse wave velocity", "relationship": "RELATED_PROGNOSIS", "object": "Cardiovascular", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "endothelial function", "relationship": "RELATED_PROGNOSIS", "object": "Cardiovascular", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "cardiac-echocardiography", "relationship": "RELATED_PROGNOSIS", "object": "Cardiovascular", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "executive function", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "memory", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "Glucose tolerance", "relationship": "RELATED_PROGNOSIS", "object": "glucose", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "insulin sensitivity", "relationship": "RELATED_PROGNOSIS", "object": "glucose", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "superoxide production", "relationship": "RELATED_PROGNOSIS", "object": "Inflammation/oxidative stress", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "cytokines", "relationship": "RELATED_PROGNOSIS", "object": "Inflammation/oxidative stress", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "antioxidants", "relationship": "RELATED_PROGNOSIS", "object": "Inflammation/oxidative stress", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "GFR", "relationship": "RELATED_PROGNOSIS", "object": "Kidney function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "BUN", "relationship": "RELATED_PROGNOSIS", "object": "Kidney function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "urinary protein", "relationship": "RELATED_PROGNOSIS", "object": "Kidney function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "strength", "relationship": "RELATED_PROGNOSIS", "object": "Motor/physical function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "endurance", "relationship": "RELATED_PROGNOSIS", "object": "Motor/physical function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "balance", "relationship": "RELATED_PROGNOSIS", "object": "Motor/physical function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "coordination", "relationship": "RELATED_PROGNOSIS", "object": "Motor/physical function", "chunk": 4}
{"article": "PMC4227681.txt", "subject": "Amyloid peptides (A\u03b2)", "relationship": "DIAGNOSITC_OF", "object": "Senile plaques, hallmark of Alzheimer's disease", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Amyloid-related locomotor dysfunction and premature death", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "A\u03b2", "relationship": "RELATED_TO", "object": "Neuronal death and brain shrinkage", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "SmartSoup reduces A\u03b2 levels and amyloid associated pathology in AD transgenic mice", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "Tau protein", "relationship": "DIAGNOSITC_OF", "object": "Neurofibrillary tangles, a hallmark of Alzheimer's disease", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloidosis", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "Radix Polygalae (RP)", "relationship": "RELATED_TREATMENT", "object": "Reduces A\u03b2 generation", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "Rhizoma Acori Tatarinowii (AT)", "relationship": "RELATED_TREATMENT", "object": "Exerts neuroprotective effects against A\u03b2", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "Poria cum Radix Pini (PRP)", "relationship": "RELATED_TREATMENT", "object": "Exerts neuroprotective effects against A\u03b2", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATEMENT", "object": "SS was administered to assess its efficacy against AD.", "chunk": 2}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATEMENT", "object": "SS was administered to assess its efficacy against AD.", "chunk": 2}
{"article": "PMC4227681.txt", "subject": "A\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "A\u03b2 plaque deposition was monitored using immunohistochemistry.", "chunk": 2}
{"article": "PMC4227681.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The efficacy of SS was assessed relative to its effect on A\u03b2 plaque deposition.", "chunk": 2}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid fibril formation", "chunk": 3}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "Oligomeric  A\u03b2 peptides", "chunk": 3}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "Amyloid peptides", "chunk": 3}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "Fibrils", "chunk": 3}
{"article": "PMC4227681.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid fibril formation", "chunk": 3}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "USED_TO_DIAGNOSE", "object": "A\u00df42 amyloid fibril formation", "chunk": 3}
{"article": "PMC4227681.txt", "subject": "APP", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Early-onset Alzheimer's Disease", "chunk": 3}
{"article": "PMC4227681.txt", "subject": "A\u03b2 levels", "relationship": "RELATED_TO_TREATMENT", "object": "reduced by SS treatment", "chunk": 4}
{"article": "PMC4227681.txt", "subject": "A\u03b2 deposits", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebral amyloidosis", "chunk": 4}
{"article": "PMC4227681.txt", "subject": "A\u03b2 plaques", "relationship": "ASSOCIATED_WITH", "object": "amyloidosis", "chunk": 4}
{"article": "PMC4227681.txt", "subject": "amyloid plaques", "relationship": "PREDICTS_SURVIVAL", "object": "formation prevented or clearance enhanced by SS treatment", "chunk": 4}
{"article": "PMC4227681.txt", "subject": "A\u03b2 plaque burden", "relationship": "REDUCED_BY", "object": "SS treatment", "chunk": 4}
{"article": "PMC4227681.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "A\u03b240 levels in the culture medium of cells treated with SS were reduced in a dose-dependent manner", "chunk": 6}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "A\u03b242 levels in the culture medium of cells treated with SS were reduced in a dose-dependent manner.", "chunk": 6}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "A\u03b2-induced premature death", "chunk": 6}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 transgenic flies", "chunk": 6}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "Toxicity", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "TARGET_OF_TREATMENT", "object": "SS", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH", "object": "Amyloidosis", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "A\u03b240", "relationship": "TARGET_OF_TREATMENT", "object": "RP", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "AT", "relationship": "PROTECTS_AGAINST", "object": "A\u03b242 induced toxicity", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "PRP", "relationship": "PROTECTS_AGAINST", "object": "A\u03b242 induced toxicity", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "SS", "relationship": "AMELIORATED", "object": "AD-related pathological symptoms", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "SS", "relationship": "REDUCES", "object": "A\u03b2 levels", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "RP reduces the A\u03b2 generation", "chunk": 8}
{"article": "PMC4227681.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "RP reduces the A\u03b2 generation", "chunk": 8}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "Representative Western blots and Atomic Force Microscope (AFM) for A\u03b242 oligomers", "chunk": 8}
{"article": "PMC4227681.txt", "subject": "A\u03b242 oligomers", "relationship": "MONITORED_DURING_TREATMENT", "object": "Representative Western blots and Atomic Force Microscope (AFM) for A\u03b242 oligomers", "chunk": 8}
{"article": "PMC4233234.txt", "subject": "BACbche gene gene", "relationship": "IS_TARGET_OF_TREATMENT", "object": "disease-modifying treatment of Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "BACbche gene gene", "relationship": "RELATED_TREATMENT", "object": "Alzheimer\u2019s disease treatment", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Monitoring target engagement of BACbche gene gene inhibitors", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "MONITORED_DURING_TREATMENT", "object": "BACbche gene gene inhibition", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "MONITORED_DURING_TREATMENT", "object": "BACbche gene gene inhibition", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "BACbche gene gene inhibition resulted in decreased levels of", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "BACbche gene gene inhibition resulted in increased levels of", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "A\u03b25-X", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "BACbche gene gene inhibition resulted in increased levels of", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "A\u03b21-40", "relationship": "RELATED_TO_TREATMENT", "object": "LY2811376 reduced the levels of A\u03b21-40.", "chunk": 2}
{"article": "PMC4233234.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TO_TREATMENT", "object": "LY2811376 reduced the levels of A\u03b21-42.", "chunk": 2}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "RELATED_TO_TREATMENT", "object": "LY2811376 increased relative levels of A\u03b25-40 compared to vehicle-treated cells.", "chunk": 2}
{"article": "PMC4233234.txt", "subject": "\u00df-amyloid", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 concentration in cerebral spinal fluid indicates the presence of \u00df-amyloid.", "chunk": 2}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 production via a  BACE1-independent APP processing pathway", "chunk": 3}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "RELATED_PROGNOSIS", "object": "Positive effect with a BACE1 inhibitor", "chunk": 3}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "RELATED_TREATMENT", "object": "Decreased by a BACE1 inhibitor like LY2811376", "chunk": 3}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "MONITORED_DURING_TREATMENT", "object": "Effects of a BACE1 inhibitor", "chunk": 3}
{"article": "PMC4233234.txt", "subject": "LY2811376", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Monitoring changes in A\u03b21-34 levels", "chunk": 3}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Suitable for the use of a BACE1 inhibitor", "chunk": 3}
{"article": "PMC4233234.txt", "subject": "sAPP\u03b1", "relationship": "RELATED_PROGNOSIS", "object": "Increased with LY2811376", "chunk": 3}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "INDICATES_PRESENCE_OF", "object": "BACbche gene gene inhibition", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "BACbche gene gene inhibitors", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "MONITORED_DURING_TREATMENT", "object": "BACbche gene gene inhibition", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b21-40", "relationship": "PREDICTED_SURVIVAL", "object": "LY2811376 treatment", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "INDICATES_PRESENCE_OF", "object": "BACbche gene gene inhibition", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "RELATED_TO", "object": "Inhibition of BACbche gene gene", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b25-X", "relationship": "correlated_to", "object": "sAPP\u03b1", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b25-X", "relationship": "correlated_to", "object": "sAPP\u03b2", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b25-X", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "inhibition of BACbche gene gene", "chunk": 4}
{"article": "PMC4239389.txt", "subject": "Neuropsychiatric Inventory (NPI)", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuropsychiatric problems", "chunk": 2}
{"article": "PMC4239389.txt", "subject": "Neuropsychiatric Inventory (NPI)", "relationship": "RELATED_TREATMENT", "object": "Assessment of behavioral disorders", "chunk": 2}
{"article": "PMC4239389.txt", "subject": "Neuropsychiatric Inventory (NPI-Q)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment for behavioral disorders", "chunk": 2}
{"article": "PMC4239389.txt", "subject": "Mini Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Global cognitive function", "chunk": 2}
{"article": "PMC4239389.txt", "subject": "EuroQuol EQ-5D", "relationship": "RELATED_PROGNOSIS", "object": "Patients' quality of life", "chunk": 2}
{"article": "PMC4239389.txt", "subject": "Caregiver\u2019s Quality of Life (QDVA)", "relationship": "RELATED_PROGNOSIS", "object": "Caregivers' quality of life", "chunk": 2}
{"article": "PMC4239389.txt", "subject": "mini-Zarit", "relationship": "RELATED_PROGNOSIS", "object": "Caregiver\u2019s burden", "chunk": 2}
{"article": "PMC4239389.txt", "subject": "BPSD", "relationship": "INDICATES_PRESENCE_OF", "object": "Requires hospitalization in a specific unit", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "BPSD", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Negative impact on both patients\u2019 and caregivers\u2019 quality of life", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "BPSD", "relationship": "RELATED_TREATMENT", "object": "Specific pharmacological or non drug therapy ", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "BPSD", "relationship": "RELATED_TREATMENT", "object": "Management in CBUs", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Global cognitive performance", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "EQ-5D", "relationship": "RELATED_TREATMENT", "object": "Patients\u2019 and caregivers\u2019 QoL", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "NPI", "relationship": "RELATED_TREATMENT", "object": "BPSD", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "NPI-ES", "relationship": "RELATED_TREATMENT", "object": "BPSD", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "mini-Zarit", "relationship": "RELATED_TREATMENT", "object": "Caregivers\u2019 burden", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "QDVA", "relationship": "RELATED_TREATMENT", "object": "Patients\u2019 and caregivers\u2019 QoL", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "Tau", "relationship": "RELATED_PROGNOSIS", "object": "Neurodegeneration and cognitive decline", "chunk": 1}
{"article": "PMC4247762.txt", "subject": "Tau", "relationship": "RELATED_PROGNOSIS", "object": "Dementia", "chunk": 1}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Neurodegeneration", "chunk": 1}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Extracellular plaque", "chunk": 1}
{"article": "PMC4247762.txt", "subject": "Tau", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Nilotinib", "chunk": 1}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Nilotinib partially cleared", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "proteasome inhibition", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "autophagy blockade", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "MONITORIED_DURING_TREATMENT", "object": "Nilotinib treatment", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Bafilomycin-A1 blocking autophagy", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "accumulation", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TREATMENT", "object": "Ilotinib prevented accumulation", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TREATMENT", "object": "MG132 increasing levels", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TREATMENT", "object": "Bafilomycin-A1 increasing levels", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Nilotinib was used to modulate A\u03b21-42 levels", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "detected in AV10 and AV20  but not in the lysosome in WT mice expressing A\u03b21-42", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Nilotinib reduced A\u03b21-42 levels in AV10 and increased it in the lysosome,", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Nilotinib significantly reduced A\u03b21-42 in AV10 and increased it in the lysosome,", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RESPONDED_TO", "object": "Nilotinib", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TREATMENT", "object": "Nilotinib reduced p-Tau", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TREATMENT", "object": "Nilotinib reduced p-Tau ", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "p-Tau clearance was examined", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Nilotinib reduced p-Tau  ", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_PROGNOSIS", "object": "Nilotinib decreased A\u03b21-42 in AV20 and increased it in the lysosomes", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Nilotinib did not alter A\u03b21-42 levels in AVs", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RESPONDED_TO", "object": "Nilotinib", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_PROGNOSIS", "object": "Nilotinib reduced p-Tau", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TREATMENT", "object": "Parkin and Nilotinib decreased p-Tau", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Nilotinib and parkin", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RESPONDED_TO", "object": "Neilotinib", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_PROGNOSIS", "object": "Boosting autophagy leads to A\u03b21-42 clearance in WT but not Tau\u2212/\u2212 mice", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "Beclin-1", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Nilotinib and parkin", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "LC3-II", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Nilotinib and parkin", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TO", "object": "Nilotinib treatment", "chunk": 5}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzhiemer's Disease", "chunk": 5}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TO", "object": "Tau expression", "chunk": 5}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TO", "object": "Tau expression", "chunk": 5}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_PROGNOSIS", "object": "plaque deposition", "chunk": 6}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Nilotinib", "chunk": 6}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "MONITORED_DURING_TREATMENT", "object": "Autophagic intracellular clearance", "chunk": 6}
{"article": "PMC4247762.txt", "subject": "Tau", "relationship": "RELATED_TREATMENT", "object": "Treatment of neurodegeneration using Nilotinib", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "Tau", "relationship": "RELATED_TREATMENT", "object": "Management of neurodegeneration through autophagic clearance", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "Tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Determining treatment strategies based on Tau status", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Treatment of neurodegeneration by influencing A\u03b21-42 levels", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "LC3-B", "relationship": "MONITORED_DURING_TREATMENT", "object": "Monitoring of autophagy activity during treatment interventions", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "Beclin-1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Monitoring of autophagy activity during treatment interventions", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Evaluation of A\u03b21-42 dynamics in response to treatment", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RESPONDED_TO", "object": "Reduction in free unbound p-Tau in response to boosting autophagy", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "Tau", "relationship": " relacionada con", "object": "Neurodegeneration", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Nilotinib treatment", "chunk": 8}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Increased Beclin-1 and LC3-II levels", "chunk": 8}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Decreased p-Tau levels", "chunk": 8}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_PROGNOSIS", "object": "Disease severity", "chunk": 8}
{"article": "PMC4247762.txt", "subject": "Caspase-3 activity", "relationship": "INDICATES_PRESENCE_OF", "object": "Apoptosis", "chunk": 8}
{"article": "PMC4255368.txt", "subject": "tau protein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Immunotherapy targeting structural determinants on tau", "chunk": 1}
{"article": "PMC4255368.txt", "subject": "phospho-tau epitopes", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Proposed tau immunotherapeutic approaches", "chunk": 1}
{"article": "PMC4255368.txt", "subject": "phospho-Ser396/phospho-Ser404 ", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Immunotherapeutic approaches", "chunk": 1}
{"article": "PMC4255368.txt", "subject": "phospho-Thr231/phospho-Ser235", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Immunotherapeutic approaches", "chunk": 1}
{"article": "PMC4255368.txt", "subject": "phospho-Ser422", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Immunotherapeutic approaches", "chunk": 1}
{"article": "PMC4255368.txt", "subject": "AT8", "relationship": "INDICATES_PRESENCE_OF", "object": "pSer202/pThr205 phosphorylation", "chunk": 2}
{"article": "PMC4255368.txt", "subject": "DC209", "relationship": "INDICATES_PRESENCE_OF", "object": "pThr231 phosphorylation", "chunk": 2}
{"article": "PMC4255368.txt", "subject": "DC217", "relationship": "INDICATES_PRESENCE_OF", "object": "pThr217 phosphorylation", "chunk": 2}
{"article": "PMC4255368.txt", "subject": "DC179", "relationship": "INDICATES_PRESENCE_OF", "object": "pThr181 phosphorylation", "chunk": 2}
{"article": "PMC4255368.txt", "subject": "DC25", "relationship": "INDICATES_PRESENCE_OF", "object": "All forms of physiological and pathological tau protein", "chunk": 2}
{"article": "PMC4255368.txt", "subject": "tau peptide sequence 294KDNIKHVPGGGS305", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Development of immunotherapeutic approach against diseased forms of tau", "chunk": 2}
{"article": "PMC4255368.txt", "subject": "AT8", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau pathology", "chunk": 3}
{"article": "PMC4255368.txt", "subject": "pT212", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau pathology", "chunk": 3}
{"article": "PMC4255368.txt", "subject": "pS214", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau pathology", "chunk": 3}
{"article": "PMC4255368.txt", "subject": "Tau5", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau pathology", "chunk": 3}
{"article": "PMC4255368.txt", "subject": "HT7", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau pathology", "chunk": 3}
{"article": "PMC4255368.txt", "subject": "tau peptide vaccine", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of AD and related tauopathies.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "tau peptide vaccine", "relationship": "RELATED_TREATMENT", "object": "Therapeutic efficacy studies in a transgenic rat model of AD.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "DC8E8", "relationship": "INDICATES_PRESENCE_OF", "object": "Structural determinants of the tau protein important for pathological tau\u2013tau interaction", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "DC8E8", "relationship": "RELATED_PROGNOSIS", "object": "Could lead to successful treatment of AD and related tauopathies.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "tau oligomers", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of the impact of tau vaccine treatment.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "highly phosphorylated forms of truncated tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of the impact of tau vaccine treatment.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "full-length tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of the impact of tau vaccine treatment.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "pThr217", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of the impact of tau vaccine treatment.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "pThr231", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of the impact of tau vaccine treatment.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "pSer202/pThr205", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of the impact of tau vaccine treatment.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "pThr181", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of the impact of tau vaccine treatment.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "tau oligomers", "relationship": "INDICATES_PRESENCE_OF", "object": "Pathological tau", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Neurofibrillary tangles (PHFs)", "relationship": "INDICATES_PRESENCE_OF", "object": "Late forms of pathological tau", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Thr217 phosphorylated tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Hyperphosphorylated tau species", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "pThr231 tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Hyperphosphorylated tau species", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "pS202/pThr205 tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Hyperphosphorylated tau species", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "pThr181 tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Hyperphosphorylated tau species", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Neurofibrillary tangles", "relationship": "INDICATES_PRESENCE_OF", "object": "Extensive neurofibrillary degeneration", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "AT8 antibody staining", "relationship": "RELATED_PROGNOSIS", "object": "Reduced number of Neurofibrillary tangles", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "pS214 antibody staining", "relationship": "RELATED_PROGNOSIS", "object": "Reduced number of Neurofibrillary tangles", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "pT212 antibody staining", "relationship": "RELATED_PROGNOSIS", "object": "Reduced number of Neurofibrillary tangles", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Active tau peptide vaccine", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved sensorimotor functions, neurofibrillary degeneration reduction", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Reduced escape latency", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved sensorimotor functions", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Reduced hindlimb slips", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved sensorimotor functions", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Decreased NeuroScale score", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved sensorimotor functions", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurofibrillary pathology", "chunk": 6}
{"article": "PMC4255368.txt", "subject": "Tau", "relationship": "RELATED_BYOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Reduction of tau hyperphosphorylation, prevention of tau aggregation or clearance of tau oligomers", "chunk": 6}
{"article": "PMC4255368.txt", "subject": "Tau phosphorylation", "relationship": "RELATED_TREATMENT", "object": "Tau immunotherapy", "chunk": 6}
{"article": "PMC4255368.txt", "subject": "Tau oligomers", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Tau peptide vaccine", "chunk": 6}
{"article": "PMC4255368.txt", "subject": "Tau pathology", "relationship": "RELATES_TO_INDICATION_OF_TREATMENT", "object": "Tau peptide vaccine", "chunk": 6}
{"article": "PMC4255368.txt", "subject": "tau pathology", "relationship": "DIAGNOSITC_OF", "object": "Cognitive decline and Memory impairment", "chunk": 6}
{"article": "PMC4255368.txt", "subject": "Neurofibrillary tangles", "relationship": "RELATED_PROGNOSIS", "object": "Disease Duration & Cognitive Impairment in AD", "chunk": 6}
{"article": "PMC4255368.txt", "subject": "tau phosphorylation", "relationship": "RELATED_TO", "object": "Therapeutic effect of the active tau vaccine", "chunk": 7}
{"article": "PMC4255368.txt", "subject": "tau oligomers", "relationship": "RELATED_TO", "object": "Therapeutic effect of the active tau vaccine", "chunk": 7}
{"article": "PMC4255368.txt", "subject": "Neurofibrillary tangles", "relationship": "TARGETED_BY", "object": "TAU5, HT7, pT212 and pS214", "chunk": 7}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RELATED_TREATMENT", "object": "Treatment of Alzheimer's Disease", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Tau immunotherapy", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Immunotherapy for Alzheimer's Disease", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Tau immunotherapy", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RESPONDED_TO", "object": "Disease-modifying Therapy", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "phospho-Ser396/phospho-Ser404", "relationship": "RELATED_TREATMENT", "object": "Tau immunotherapy strategy", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "phospho-Thr231/phospho-Ser235", "relationship": "RELATED_TREATMENT", "object": "Tau immunotherapy strategy", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "phospho-Ser422", "relationship": "RELATED_TREATMENT", "object": "Tau immunotherapy strategy", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Crystallisation of Fab was performed", "chunk": 2}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RELATED_TREATMENT", "object": "This study", "chunk": 2}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RELATED_TO_TREATMENT", "object": "candidate therapeutic antibody", "chunk": 4}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "IS_TARGET_OF_TREATMENT", "object": "an in vitro pathological tau\u2013tau interaction assay", "chunk": 4}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RELATED_PROGNOSIS", "object": " enables the detection of early stages of pathological tau in human preclinical AD", "chunk": 4}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RELATED_PROGNOSIS", "object": "recognised both the stage of pathological tau oligomers and the stage of pathological tau polymers (tangles)", "chunk": 4}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RELATED_PROGNOSIS", "object": "recognised mainly pathological tau polymers in the form of Neurofibrillary tangles, neuritic plaques and neuropil threads", "chunk": 4}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Immunotherapy", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "MONITORED_DURING_TREATMENT", "object": "Immunotherapy", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RESPONDED_TO", "object": "Immunotherapy", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "tau protein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "DC8E8 immunotherapy", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "Neurofibrillary tangles", "relationship": "PREDICTED_SURVIVAL", "object": "Transgenic mice treated with DC8E8 reduced neurofibrillary tangles and lived longer", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "sarcosyl-insoluble tau oligomers", "relationship": "MONITORED_DURING_TREATMENT", "object": "DC8E8 immunotherapy", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "  targeting tau protein", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "tau protein", "relationship": "RELATED_PROGNOSIS", "object": "Misordered tau protein is associated with Neurofibrillary tangles and disease progression", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "truncated tau protein", "relationship": "RELATED_PROGNOSIS", "object": "DC8E8 recognizes truncated tau protein, a possible indicator of disease progression", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "full-length tau protein", "relationship": "RELATED_PROGNOSIS", "object": "DC8E8 recognizes full-length tau protein, potentially indicating disease progression", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "assembled tau protein", "relationship": "RELATED_PROGNOSIS", "object": "DC8E8 recognizes assembled tau protein, potentially indicating disease progression", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "soluble tau", "relationship": "RELATED_PROGNOSIS", "object": "DC8E8 recognizes soluble tau, potentially indicating disease progression", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "sarcosyl-insoluble tau", "relationship": "RELATED_PROGNOSIS", "object": "DC8E8 recognizes sarcosyl-insoluble tau, a marker of pathology", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "alphabeta amyloid", "relationship": "RELATED_PROGNOSIS", "object": "alphabeta amyloid is a hallmark of Alzheimer's disease", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "Neurofibrillary tangles", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "tau protein", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Targeting tau protein with DC8E8 immunotherapy", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "INDICATES_PRESENCE_OF", "object": "Mis-disordered tau", "chunk": 7}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RELATED_PROGNOSIS", "object": "Distinguishes between pathological and physiological \u2018healthy\u2019 tau", "chunk": 7}
{"article": "PMC4255369.txt", "subject": "Truncated mis-disordered tau protein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Immunotherapy targeting various tau species", "chunk": 7}
{"article": "PMC4255369.txt", "subject": "Mis-disordered truncated tau", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target vaccine development strategy", "chunk": 7}
{"article": "PMC4255369.txt", "subject": "HXPGGG", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment for AD", "chunk": 8}
{"article": "PMC4255369.txt", "subject": "HXPGGG", "relationship": "RELATED_TREATMENT", "object": "DC8E8 antibody therapy", "chunk": 8}
{"article": "PMC4255369.txt", "subject": "truncated tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "DC8E8 antibody treatment", "chunk": 8}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RESPONDED_TO", "object": "DC8E8 antibody treatment", "chunk": 8}
{"article": "PMC4255540.txt", "subject": "Mini-Mental Score Examination", "relationship": "RELATED_PROGNOSIS", "object": "defined by MMSE,  scores of 26 to 11/30 (mild to moderately severe stages of the disease)", "chunk": 2}
{"article": "PMC4283145.txt", "subject": "aerobic exercise", "relationship": "RELATED_TREATMENT", "object": "Treating cognitive impairment in Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4283145.txt", "subject": "aerobic exercise", "relationship": "RELATED_TREATMENT", "object": "Increasing gray-matter volumes in the hippocampus", "chunk": 1}
{"article": "PMC4283145.txt", "subject": "aerobic exercise", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "A potential treatment that may increase physical function and quality of life", "chunk": 1}
{"article": "PMC4283145.txt", "subject": "magnetic resonance imaging", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "An outcome measure in clinical trials", "chunk": 1}
{"article": "PMC4283145.txt", "subject": "hippocampal volume", "relationship": "RELATED_PROGNOSIS", "object": "Assess the effect of aerobic exercise on hippocampal volume over 12\u00a0months", "chunk": 1}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive Decline", "chunk": 2}
{"article": "PMC4283145.txt", "subject": "hippocampal volume", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC4283145.txt", "subject": "hippocampal volume", "relationship": "RELATED_PROGNOSIS", "object": "Progression of Alzheimer's Disease", "chunk": 2}
{"article": "PMC4283145.txt", "subject": "CDR score", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild-to-moderate AD", "chunk": 3}
{"article": "PMC4283145.txt", "subject": "MMSE score", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild-to-moderate AD", "chunk": 3}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Change from baseline after 6 months of intervention", "chunk": 3}
{"article": "PMC4283145.txt", "subject": "MMSE", "relationship": "USED_TO_DIAGNOSE", "object": "AD diagnosis", "chunk": 4}
{"article": "PMC4283145.txt", "subject": "CDR", "relationship": "USED_TO_DIAGNOSE", "object": "AD diagnosis", "chunk": 4}
{"article": "PMC4283145.txt", "subject": "CDR", "relationship": "RELATED_TO", "object": "MRI safety verification", "chunk": 4}
{"article": "PMC4283145.txt", "subject": "MMSE", "relationship": "RELATED_TO", "object": "MRI safety verification", "chunk": 4}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TREATMENT", "object": "Measures cognition", "chunk": 5}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "USED_TO_DIAGNOSE", "object": "Cognitive function in Alzheimer's Disease Drug RCTs", "chunk": 5}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "PRIMARY_OUTCOME", "object": "Global Cognition", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "CDR", "relationship": "RELATED_TREATMENT", "object": "AD stage", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "AD stage", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "CDR ", "relationship": "DIAGNOSTIC_OF", "object": "AD stage", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "MMSE", "relationship": "DIAGNOSTIC_OF", "object": "AD stage", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Wechsler Digit Span", "relationship": "USED_TO_DIAGNOSE", "object": "Attention", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Wechsler Digit Symbol", "relationship": "USED_TO_DIAGNOSE", "object": "Processing speed", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "TMT Part A", "relationship": "USED_TO_DIAGNOSE", "object": "Executive function", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "TMT Part B", "relationship": "USED_TO_DIAGNOSE", "object": "Executive function", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "EXIT-25", "relationship": "USED_TO_DIAGNOSE", "object": "Executive function", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Behavioral Dyscontrol Scale (BDS)", "relationship": "USED_TO_DIAGNOSE", "object": "Executive function", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Executive Clock Drawing Test (CLOX)", "relationship": "USED_TO_DIAGNOSE", "object": "Executive function", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Wechsler Memory Scale-Revised Logical Memory Story A and B", "relationship": "USED_TO_DIAGNOSE", "object": "Memory", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Animal and Vegetable Verbal Fluency", "relationship": "USED_TO_DIAGNOSE", "object": "Language", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Boston Naming Test", "relationship": "USED_TO_DIAGNOSE", "object": "Language", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Symptom-limited peak cycle-ergometer test, Shuttle-walk test", "relationship": "USED_TO_DIAGNOSE", "object": "Aerobic fitness", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "6-minute walk test", "relationship": "USED_TO_DIAGNOSE", "object": "Aerobic fitness", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Short Physical Performance Battery (SPPB)", "relationship": "USED_TO_DIAGNOSE", "object": "Physical function", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Disability in AD (DAD) scale", "relationship": "USED_TO_DIAGNOSE", "object": "Physical function", "chunk": 6}
{"article": "PMC4283145.txt", "subject": " Neuropsychiatric Inventory-Caregiver (NPI-Q)", "relationship": "INDICATES_PRESENCE_OF", "object": "BPSD", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Alzheimer\u2019s Mood Scale (AMS)", "relationship": "INDICATES_PRESENCE_OF", "object": "BPSD", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Cornell Scale for Depression in dementia (CSDD)", "relationship": "INDICATES_PRESENCE_OF", "object": "BPSD", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Progression of Alzheimer's disease", "chunk": 7}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline in Alzheimer's disease", "chunk": 7}
{"article": "PMC4283145.txt", "subject": "Hippocampal volume", "relationship": "ASSOCIATED_WITH", "object": "Effects of aerobic exercise in AD", "chunk": 7}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Change in ADAS-Cog scores from baseline to 6 months", "chunk": 8}
{"article": "PMC4283612.txt", "subject": "R-WAB", "relationship": "USED_TO_DIAGNOSE", "object": "Type and level of aphasia severity", "chunk": 4}
{"article": "PMC4283612.txt", "subject": "R-WAB", "relationship": "INDICATES_PRESENCE_OF", "object": "Cortical Quotient (CQ)", "chunk": 4}
{"article": "PMC4283612.txt", "subject": "CLQT", "relationship": "USED_TO_DIAGNOSE", "object": "Relate cognitive deficits to language dysfunction", "chunk": 4}
{"article": "PMC4283612.txt", "subject": "CLQT", "relationship": "USED_TO_DIAGNOSE", "object": "Rule out dementia", "chunk": 4}
{"article": "PMC4283612.txt", "subject": "Standard tests R-WAB", "relationship": "RELATED_PROGNOSIS", "object": "Language and cognitive profile ", "chunk": 5}
{"article": "PMC4294473.txt", "subject": "Tau protein", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Therapeutic strategies targeting Tau pathology", "chunk": 1}
{"article": "PMC4294473.txt", "subject": "Tau protein", "relationship": "RELATED_TREATMENT", "object": "development of treatments targeting Tau aggregation", "chunk": 1}
{"article": "PMC4294473.txt", "subject": "P301S Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau pathology; Neurodegenerative disorders", "chunk": 1}
{"article": "PMC4294473.txt", "subject": "Tau", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC4294473.txt", "subject": "Tau", "relationship": "RELATED_TREATMENT", "object": "Therapeutic avenues", "chunk": 2}
{"article": "PMC4294473.txt", "subject": "Aggregation-dependent manner", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of Alzheimer's Disease", "chunk": 2}
{"article": "PMC4294473.txt", "subject": "Sarkosyl-insoluble Tau", "relationship": "RELATED_TREATMENT", "object": "Treatment of Alzheimer's Disease", "chunk": 2}
{"article": "PMC4294473.txt", "subject": "AT8", "relationship": "INDICATES_PRESENCE_OF", "object": "Phosphorylated Tau", "chunk": 3}
{"article": "PMC4294473.txt", "subject": "TAT8", "relationship": "RELATED_TO", "object": "Level of Tau phosphorylation", "chunk": 3}
{"article": "PMC4294473.txt", "subject": "TG5", "relationship": "INDICATES_PRESENCE_OF", "object": "Phosphorylated Tau", "chunk": 3}
{"article": "PMC4294473.txt", "subject": "MC1", "relationship": "INDICATES_PRESENCE_OF", "object": "Conformationally changed Tau", "chunk": 3}
{"article": "PMC4294473.txt", "subject": "DA9", "relationship": "USED_TO_DETECT", "object": "Tau protein levels", "chunk": 3}
{"article": "PMC4294473.txt", "subject": "AT8", "relationship": "DIAGNOSTIC_OF", "object": "Tau aggregation", "chunk": 4}
{"article": "PMC4294473.txt", "subject": "AT8", "relationship": "INDICATES_PRESENCE_OF", "object": "Phosphorylated Tau (Ser(P)202/Thr(P)205)", "chunk": 4}
{"article": "PMC4294473.txt", "subject": "Sarkosyl-insoluble Tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Analyzing Tau aggregation", "chunk": 4}
{"article": "PMC4294473.txt", "subject": "DA9", "relationship": "USED_TO_DIAGNOSE", "object": "Tau aggregation", "chunk": 4}
{"article": "PMC4294473.txt", "subject": "MC1 (conformationally changed Tau)", "relationship": "INDICATES_PRESENCE_OF", "object": "Seeding in HEK 293T cells transfected with human P301S 1N4R Tau", "chunk": 5}
{"article": "PMC4294473.txt", "subject": "AT8 (Ser(P)202/Thr(P)205)", "relationship": "INDICATES_PRESENCE_OF", "object": "Seeding in HEK 293T cells transfected with human P301S 1N4R Tau", "chunk": 5}
{"article": "PMC4294473.txt", "subject": "MC1 (conformationally changed)-positive Tau", "relationship": "RELATES_TO", "object": "Sarkosyl-insoluble fraction enriched for seed-competent Tau", "chunk": 5}
{"article": "PMC4294473.txt", "subject": "AT8 (Ser(P)202/Thr(P)205)-positive Tau", "relationship": "RELATES_TO", "object": "Sarkosyl-insoluble fraction enriched for seed-competent Tau", "chunk": 5}
{"article": "PMC4294473.txt", "subject": "TgP301S Tau aggregates", "relationship": "INDICATES_PRESENCE_OF", "object": "Sarkosyl-insoluble, hyperphosphorylated Tau", "chunk": 6}
{"article": "PMC4294473.txt", "subject": "TgP301S Tau aggregates", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment aiming to reduce phosphorylated Tau accumulation in Alzheimer's disease", "chunk": 6}
{"article": "PMC4294473.txt", "subject": "Recombinant P301S Tau aggregates", "relationship": "INDICATES_PRESENCE_OF", "object": "Sarkosyl-insoluble, hyperphosphorylated Tau", "chunk": 6}
{"article": "PMC4294473.txt", "subject": "Recombinant P301S Tau aggregates", "relationship": "RELATED_PROGNOSIS", "object": "Potency for seeding hyperphosphorylated Tau formation in cells expressing soluble P301S Tau", "chunk": 6}
{"article": "PMC4294473.txt", "subject": "HT7", "relationship": "GUIDE_TREATMENT_SELECTION", "object": "Selection of therapeutic strategies targeting hyperphosphorylated Tau in Alzheimer's disease", "chunk": 6}
{"article": "PMC4294473.txt", "subject": "AT100", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Selection of therapeutic strategies targeting hyperphosphorylated Tau in Alzheimer's disease", "chunk": 6}
{"article": "PMC4294473.txt", "subject": "Sarkosyl-insoluble Tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment strategies targeting Tau pathology in Alzheimer's disease", "chunk": 6}
{"article": "PMC4294473.txt", "subject": "TgP301S Tau aggregates", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "They were used in an assay to compare seeding activity", "chunk": 8}
{"article": "PMC4294473.txt", "subject": "TgP301S Tau aggregates", "relationship": "RELATED_PROGNOSIS", "object": "Seeding ability is likely related to spreading of disease.", "chunk": 8}
{"article": "PMC4294473.txt", "subject": "Sarkosyl-insoluble Tau", "relationship": "RELATED_PROGNOSIS", "object": "Seeding activity is likely related to spreading of disease.", "chunk": 8}
{"article": "PMC4294473.txt", "subject": "P301S Tau aggregates", "relationship": "INDICATES_PRESENCE_OF", "object": "Evidence of disease.", "chunk": 8}
{"article": "PMC4294473.txt", "subject": "levels of P301S Tau aggregates", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analyzing changes helps understand treatment effect", "chunk": 8}
{"article": "PMC4294473.txt", "subject": "Hyperphosphorylated recombinant P301S Tau aggregates", "relationship": "RELATED_TREATMENT", "object": "Their formation and stability are studied in relation to treatment", "chunk": 8}
{"article": "PMC4294473.txt", "subject": "synthetic Tau aggregates", "relationship": "RELATED_TREATMENT", "object": "target for therapies like immunization, inhibition of fibril assembly, and enhanced cellular degradation", "chunk": 9}
{"article": "PMC4294473.txt", "subject": "conformation of aggregated Tau", "relationship": "RELATED_PROGNOSIS", "object": "may provide a molecular explanation for the tauopathies, which are defined by the presence of Tau inclusions in the brain but have distinct neuropathologies and rates of progression", "chunk": 9}
{"article": "PMC4294473.txt", "subject": "synthetic Tau aggregates", "relationship": "RELATED_TREATMENT", "object": "Target Therapies", "chunk": 9}
{"article": "PMC4294473.txt", "subject": "HT7 epitope", "relationship": "MONITORED_DURING_TREATMENT", "object": "exposure of the HT7 epitope was enhanced with low concentrations of guanidine hydrochloride", "chunk": 9}
{"article": "PMC4301197.txt", "subject": "Agitation", "relationship": "DIAGNOSITC_OF", "object": "A cognitive impairment or dementia syndrome", "chunk": 2}
{"article": "PMC4301197.txt", "subject": "Agitation", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Excess disability", "chunk": 2}
{"article": "PMC4301197.txt", "subject": "Agitation", "relationship": "INDICATES_PRESENCE_OF", "object": "rapid changes in mood, irritability, outbursts", "chunk": 2}
{"article": "PMC4301197.txt", "subject": "Agitation", "relationship": "INDICATES_PRESENCE_OF", "object": "Excessive motor activity", "chunk": 2}
{"article": "PMC4301197.txt", "subject": "Agitation", "relationship": "INDICATES_PRESENCE_OF", "object": "Verbal aggression (e.g. yelling, speaking in an excessively loud voice, using profanity, screaming, shouting)", "chunk": 2}
{"article": "PMC4301197.txt", "subject": "Agitation", "relationship": "INDICATES_PRESENCE_OF", "object": "Physical aggression (e.g. grabbing, shoving, pushing, resisting, hitting others, kicking objects or people, scratching, biting)", "chunk": 2}
{"article": "PMC4301197.txt", "subject": "Agitation", "relationship": "RELATED_TREATMENT", "object": "Anti-agitation agents", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "\u03b2-amyloid (A\u03b2) peptide", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4304279.txt", "subject": "\u03b2-amyloid (A\u03b2) peptide", "relationship": "RELATED_TO", "object": "etiology of Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4304279.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_PROGNOSIS", "object": "onset of dementia", "chunk": 1}
{"article": "PMC4304279.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT_ELIGIBILITY", "object": "effect of drugs targeting  \u03b2-secretase", "chunk": 1}
{"article": "PMC4304279.txt", "subject": "\u03b2-secretase inhibitors", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "intervention strategy for alzheimer's disease", "chunk": 1}
{"article": "PMC4304279.txt", "subject": "\u03b2-secretase", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "development of drugs to prevent or treat Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4304279.txt", "subject": "APP (amyloid precursor protein)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "development of therapies aimed at reducing A\u03b2 production", "chunk": 1}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Amyloid deposition and A\u03b2-associated memory impairments", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "APP mutations likely have a reduction in A\u03b2 production of only ~20% yet they are still protected against AD", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "AD and cognitive decline in the elderly", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "inhibition of \u03b2-secretase cleavage of APP should be beneficial for AD", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "BACE", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "therapeutically target for the development of small molecule inhibitor drugs for the treatment of AD", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "App", "relationship": "RELATED_TREATMENT", "object": "inhibition of \u03b2-secretase cleavage of APP should be beneficial for AD", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "BACE", "relationship": "TARGET", "object": "inhibitor drugs", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "MONITORED_DURING_TREATMENT", "object": "BACbche gene gene inhibitor drug development efforts", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Development of BACbche gene gene inhibitor drugs", "chunk": 3}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "RELATED_TREATMENT", "object": "Therapeutic inhibition of BACbche gene gene", "chunk": 3}
{"article": "PMC4304279.txt", "subject": "NRG1 EGF domain", "relationship": "RELEASED_BY", "object": "BACbche gene gene cleavage", "chunk": 3}
{"article": "PMC4304279.txt", "subject": "CHL1", "relationship": "Cleavage by", "object": "BACbche gene gene", "chunk": 3}
{"article": "PMC4304279.txt", "subject": "Jagged 1 (Jag1)", "relationship": "Cleavage by", "object": "BACbche gene gene", "chunk": 3}
{"article": "PMC4304279.txt", "subject": "APP", "relationship": "Processed by", "object": "BACbche gene gene", "chunk": 3}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene substrates", "relationship": "Processed by", "object": "BACbche gene gene", "chunk": 3}
{"article": "PMC4304279.txt", "subject": "BACE2", "relationship": "RELATED_TREATMENT", "object": "Treatment of Type 2 diabetes", "chunk": 4}
{"article": "PMC4304279.txt", "subject": "BACE2", "relationship": "RELATED_TREATMENT", "object": "Inhibition of  BACE2", "chunk": 4}
{"article": "PMC4304279.txt", "subject": "LY2886721", "relationship": "RELATED_TREATMENT", "object": "Treatment A\u03b2 levels", "chunk": 4}
{"article": "PMC4304279.txt", "subject": "LY2886721", "relationship": "USED_TO_DIAGNOSE", "object": "Safety and tolerability, pharmacokinetics, and pharmacodynamics", "chunk": 4}
{"article": "PMC4304279.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Levels decreased in cerebral cerebral cerebral cerebral spinal fluid by LY2886721", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Levels reduced in cerebral cerebral cerebral cerebral spinal fluid by LY2886721", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "sAPP\u03b2", "relationship": "RELATED_TREATMENT", "object": "Levels reduced in cerebral cerebral cerebral cerebral spinal fluid by LY2886721", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "sAPP\u03b1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels increased in cerebral cerebral cerebral cerebral spinal fluid by LY2886721", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "A\u03b240", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measuring reductions in cerebral cerebral cerebral cerebral spinal fluid to assess treatment efficacy", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "A\u03b242", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measuring reductions in cerebral cerebral cerebral cerebral spinal fluid to assess treatment efficacy", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "sAPP\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measuring reductions in cerebral cerebral cerebral cerebral spinal fluid to assess treatment efficacy", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Decreased by MK-8931 in cerebral cerebral cerebral cerebral spinal fluid", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Decreased by MK-8931 in cerebral cerebral cerebral cerebral spinal fluid", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "sAPP\u03b2", "relationship": "RELATED_TREATMENT", "object": "Decreased by MK-8931 in cerebral cerebral cerebral cerebral spinal fluid", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "sAPP\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "sAPP\u03b1", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "BACbche gene", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "APP", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "IS_TARGET_OF_TREATMENT", "object": "BACbche gene gene inhibitors", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "RELATED_TREATMENT", "object": "disease-modifying therapies", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "RELATED_TREATMENT", "object": "BACbche gene gene inhibitors", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "INDICATES_PRESENCE_OF", "object": "cerebral A\u03b2 production", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Determination of BACbche gene gene inhibitor dose", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "RELATED_PROGNOSIS", "object": "AD progression", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "A\u03b2 levels", "relationship": "RELATED_PROGNOSIS", "object": "AD progression", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increased peri-plaque A\u03b2 production", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "A673T APP mutation", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "AD protection", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene inhibition", "relationship": "RELATED_PROGNOSIS", "object": "AD progression", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "A\u03b2 accumulation", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathogenesis", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "AB deposition", "relationship": "RELATED_PROGNOSIS", "object": "cognitive deficits", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The therapy choice aims to inhibit its activity for AD", "chunk": 9}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Inhibition of activity is a therapeutic approach for AD", "chunk": 9}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "DIAGNOSITC_OF", "object": "Reduction of A\u03b2 in cerebral spinal fluid is a goal of treatment", "chunk": 9}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Reducing A\u03b2 levels is expected to improve AD prognosis", "chunk": 9}
{"article": "PMC4307639.txt", "subject": "Physical activity index", "relationship": "INDICATES_PRESENCE_OF", "object": "Interest in trial participation", "chunk": 3}
{"article": "PMC4307639.txt", "subject": "Personal computer usage", "relationship": "INDICATES_PRESENCE_OF", "object": "Interest in trial participation", "chunk": 3}
{"article": "PMC4307639.txt", "subject": "Age", "relationship": "RELATED_PROGNOSIS", "object": "Interest in trial participation (Younger participants were more likely to be interested)", "chunk": 3}
{"article": "PMC4307639.txt", "subject": "Loneliness scale", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Interest in trial participation (Higher scores were associated with higher interest)", "chunk": 3}
{"article": "PMC4307639.txt", "subject": "Self-rated health", "relationship": "RELATED_PROGNOSIS", "object": "Interest in trial participation", "chunk": 3}
{"article": "PMC4307639.txt", "subject": "internet access", "relationship": "RELATED_TO", "object": "elderly individuals' likelihood of participating in prevention studies", "chunk": 4}
{"article": "PMC4307639.txt", "subject": "current PC users", "relationship": "ASSOCIATED_WITH", "object": "greater interest in prevention studies using information communication technologies", "chunk": 4}
{"article": "PMC4307639.txt", "subject": "participants in PC-based conversational sessions", "relationship": "REQUIRED", "object": "no prior experience with PCs and internet", "chunk": 4}
{"article": "PMC4307822.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "functional impairment", "chunk": 1}
{"article": "PMC4307822.txt", "subject": "MMSE", "relationship": "RELATED_TO", "object": "VR-DOT functional index", "chunk": 4}
{"article": "PMC4307822.txt", "subject": "Bristol ADL scores", "relationship": "RELATED_TO", "object": "VR-DOT functional index", "chunk": 4}
{"article": "PMC4307822.txt", "subject": "upper extremity function psychomotor performance", "relationship": "PREDICTS_SURVIVAL", "object": "cognitive decline at year 3", "chunk": 4}
{"article": "PMC4307822.txt", "subject": "VR-DOT", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "functional independence", "chunk": 4}
{"article": "PMC4307822.txt", "subject": "MMSE", "relationship": "RELATED_TO", "object": "VR-DOT functional index", "chunk": 5}
{"article": "PMC4307822.txt", "subject": "MMSE", "relationship": "RELATED_TO", "object": "Bristol Activities of Daily Living (ADL)", "chunk": 5}
{"article": "PMC4307822.txt", "subject": "VR-DOT", "relationship": "PREDICTS_SURVIVAL", "object": "Conversion to AD", "chunk": 5}
{"article": "PMC4307822.txt", "subject": "VR-DOT REff", "relationship": "PREDICTS_SURVIVAL", "object": "Conversion to AD", "chunk": 5}
{"article": "PMC4307822.txt", "subject": "Bristol ADL", "relationship": "PREDICTS_SURVIVAL", "object": "Conversion to AD", "chunk": 5}
{"article": "PMC4307822.txt", "subject": "Blessed ADL", "relationship": "PREDICTS_SURVIVAL", "object": "Conversion to AD", "chunk": 5}
{"article": "PMC4307822.txt", "subject": "VR-DOT", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "PREDICTION for conversion to AD", "chunk": 6}
{"article": "PMC4307822.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "mild cognitive impairment  and AD", "chunk": 6}
{"article": "PMC4307822.txt", "subject": "Bristol scores ADL", "relationship": "DIAGNOSITC_OF", "object": "mild cognitive impairment  and AD", "chunk": 6}
{"article": "PMC4307822.txt", "subject": "Blessed score ADL", "relationship": "DIAGNOSITC_OF", "object": "mild cognitive impairment  and AD", "chunk": 6}
{"article": "PMC4307822.txt", "subject": "RAVLT delayed recall", "relationship": "DIAGNOSITC_OF", "object": "mild cognitive impairment  and AD", "chunk": 6}
{"article": "PMC4307822.txt", "subject": "DOT-VR", "relationship": "DIAGNOSITC_OF", "object": "mild cognitive impairment  and AD", "chunk": 6}
{"article": "PMC4307822.txt", "subject": "VR-DOT", "relationship": "RELATED_TO_PREDICTION", "object": "Functional Impairment", "chunk": 6}
{"article": "PMC4311425.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk for Alzheimer's disease", "chunk": 1}
{"article": "PMC4311425.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Changes in putative AD-prevention behaviors", "chunk": 1}
{"article": "PMC4311425.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "Advance planning", "chunk": 1}
{"article": "PMC4311425.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "Lifestyle modifications", "chunk": 1}
{"article": "PMC4311425.txt", "subject": "APOE genotype", "relationship": "INDICATES_PRESENCE_OF", "object": "Risk of Alzheimer's Disease", "chunk": 2}
{"article": "PMC4311425.txt", "subject": "APOE genotype", "relationship": "RELATED_TREATMENT", "object": "Genetic risk assessment", "chunk": 2}
{"article": "PMC4311425.txt", "subject": "APOE4", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower  reassortment to mental activities and diet at 6 weeks", "chunk": 5}
{"article": "PMC4311425.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "Changes to medications at 12 months", "chunk": 5}
{"article": "PMC4311425.txt", "subject": "APOE4", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk for AD", "chunk": 6}
{"article": "PMC4311425.txt", "subject": "APOE4", "relationship": "DIAGNOSITC_OF", "object": "Early-onset Alzheimer's Disease", "chunk": 6}
{"article": "PMC4324943.txt", "subject": "Physical function", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 1}
{"article": "PMC4324943.txt", "subject": "Cognitive function", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 1}
{"article": "PMC4324943.txt", "subject": "Quality of life", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 1}
{"article": "PMC4324943.txt", "subject": "Caregiver burden", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 1}
{"article": "PMC4324943.txt", "subject": "implicit memory", "relationship": "PROVIDES_BASIS_FOR_THERAPY_CHOICE", "object": "Develop a exercise program for dementia patients", "chunk": 2}
{"article": "PMC4324943.txt", "subject": "ADAS-cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 5}
{"article": "PMC4324943.txt", "subject": "ADAS-cog", "relationship": "RELATED_TREATMENT", "object": "Dementia drug treatment trials", "chunk": 5}
{"article": "PMC4324943.txt", "subject": "NPI", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia-related behaviors", "chunk": 5}
{"article": "PMC4324943.txt", "subject": "3MS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Cognitive function assessment", "chunk": 5}
{"article": "PMC4324943.txt", "subject": "ADCS-ADL", "relationship": "RELATED_PROGNOSIS", "object": "Functional status in dementia", "chunk": 5}
{"article": "PMC4324943.txt", "subject": "QOL-AD", "relationship": "RELATED_TREATMENT", "object": "Quality of life assessment in Alzheimer's disease", "chunk": 5}
{"article": "PMC4324943.txt", "subject": "ADAS-cog", "relationship": "RELATED_PROGNOSIS", "object": "Positive change in score suggests better cognitive function", "chunk": 7}
{"article": "PMC4324943.txt", "subject": "QOL-AD", "relationship": "RELATED_PROGNOSIS", "object": "Higher scores indicate better quality of life", "chunk": 7}
{"article": "PMC4324943.txt", "subject": "SPPB", "relationship": "RELATED_PROGNOSIS", "object": "Higher scores indicate better physical performance", "chunk": 7}
{"article": "PMC4324943.txt", "subject": "NPI-FS", "relationship": "INDICATES_PRESENCE_OF", "object": "Frequency and severity of dementia-related behaviors", "chunk": 7}
{"article": "PMC4324943.txt", "subject": "NPI-CD", "relationship": "INDICATES_PRESENCE_OF", "object": "Caregiver distress related to dementia behaviors", "chunk": 7}
{"article": "PMC4324943.txt", "subject": "CBI", "relationship": "INDICATES_PRESENCE_OF", "object": "Caregiver burden", "chunk": 7}
{"article": "PMC4324943.txt", "subject": "ADAS-cog", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function", "chunk": 8}
{"article": "PMC4324943.txt", "subject": "ADAS-cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 8}
{"article": "PMC4324943.txt", "subject": "Physical performance (SPPB)", "relationship": "RELATED_TREATMENT", "object": "PLI\u00c9 program", "chunk": 8}
{"article": "PMC4324943.txt", "subject": "Quality of Life in Alzheimer\u2019s Disease scale (QOL-AD)", "relationship": "RELATED_TREATMENT", "object": "PLI\u00c9 program", "chunk": 8}
{"article": "PMC4324943.txt", "subject": "Caregiver Burden Inventory (CBI)", "relationship": "RELATED_TREATMENT", "object": "PLI\u00c9 program", "chunk": 8}
{"article": "PMC4333880.txt", "subject": "Apolipoprotein apoe4", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4333880.txt", "subject": "APOE4", "relationship": "RELATED_TO_PREDICTOR_VARIABLE", "object": "risk of Alzheimer's disease", "chunk": 2}
{"article": "PMC4333880.txt", "subject": "brain-derived neurotrophic factor (BDNF)", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "neuroprotection", "chunk": 3}
{"article": "PMC4333880.txt", "subject": "insulin-like growth factor (IGF-1)", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "neuroprotection", "chunk": 3}
{"article": "PMC4335024.txt", "subject": "Alzheimer's Disease", "relationship": "RELATED_PROGNOSIS", "object": "This is because two thirds of dementia patients in Sweden are estimated to have Alzheimer's disease.", "chunk": 1}
{"article": "PMC4335024.txt", "subject": "Alzheimer's Disease", "relationship": "DIAGNOSITC_OF", "object": "SveDem was initiated to achieve dementia care of similar and high quality for the whole country.", "chunk": 1}
{"article": "PMC4335024.txt", "subject": "Alzheimer's Disease", "relationship": "INDICATES_PRESENCE_OF", "object": "In Sweden, it is estimated that 150,000 individuals suffer from dementia and two thirds of them have Alzheimer's disease.", "chunk": 1}
{"article": "PMC4335024.txt", "subject": "BMI", "relationship": "RELATED_PROGNOSIS", "object": "BMI provides information about the patient's weight and health status, which can be related to the prognosis.", "chunk": 2}
{"article": "PMC4335024.txt", "subject": "MMSE Score", "relationship": "INDICATES_PRESENCE_OF", "object": "A low MMSE score indicates the presence of cognitive impairment.", "chunk": 2}
{"article": "PMC4335024.txt", "subject": "MMSE Score", "relationship": "RELATED_TREATMENT", "object": "MMSE score can help guide treatment decisions for dementia patients.", "chunk": 2}
{"article": "PMC4335024.txt", "subject": "MMSE score", "relationship": "USED_TO_DIAGNOSE", "object": "diagnose dementia", "chunk": 3}
{"article": "PMC4335024.txt", "subject": "MMSE score", "relationship": "RELATED_PROGNOSIS", "object": "cognitive impairment", "chunk": 3}
{"article": "PMC4335024.txt", "subject": "MMSE score", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment is mild (20\u201330 points) or moderate (10 to <20 points)", "chunk": 3}
{"article": "PMC4335024.txt", "subject": "calcium", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "basic dementia work-up", "chunk": 3}
{"article": "PMC4335024.txt", "subject": "homocysteine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "basic dementia work-up", "chunk": 3}
{"article": "PMC4335024.txt", "subject": "thyroid function", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "basic dementia work-up", "chunk": 3}
{"article": "PMC4346122.txt", "subject": "Pittsburgh compound B", "relationship": "RELATED_TO_TREATMENT", "object": "Amyloid PET scan", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "Amyloid (Pittsburgh compound B; PIB)", "relationship": "RELATED_TO_TREATMENT", "object": "Surrogate of Alzheimer\u2019s disease neuropathology", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "PIB+", "relationship": "INDICATES_PRESENCE_OF", "object": "Underlying Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "Alzheimer\u2019s disease pathology", "relationship": "ASSOCIATED_WITH_GREATER_EPISODIC_MEMORY_LOSS", "object": "CBS-AD patients", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "Alzheimer\u2019s disease pathology", "relationship": "ASSOCIATED_WITH_GREATER_VISUOSPATIAL_DEFICITS", "object": "CBS-AD patients", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "Alzheimer\u2019s disease pathology", "relationship": "PREDICTED_BY", "object": "Temporoparietal-predominant neuroimaging patterns", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "Alzheimer\u2019s disease pathology", "relationship": "ASSOCIATED_WITH_GREATER_TEMPOROPARIETAL_INVOLVEMENT", "object": "neuroimaging", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "Amyloid deposition", "relationship": "SURROGATE_FOR", "object": "Alzheimer\u2019s disease neuropathology", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "PIB positivity", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease pathology", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "amyloid deposition", "relationship": "SURROGATE_OF", "object": "Alzheimer\u2019s disease neuropathology", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "temporoparietal-predominant neuroimaging patterns", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "sensitivity for AD", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "Pittsburgh compound B; PIB", "relationship": "RELATED_TO", "object": "PET scans showing amyloid deposition", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "frontal variant CBS (fvCBS)", "relationship": "RELATED_TO", "object": "patients with lower likelihood of underlying AD", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "temporoparietal variant CBS (tpvCBS)", "relationship": "RELATED_TO", "object": "patients with higher likelihood of underlying AD", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "PIB-PET", "relationship": "SURROGATE_MARKER_OF", "object": "AD pathology", "chunk": 2}
{"article": "PMC4346122.txt", "subject": "amyloid PET scans", "relationship": "MAY_PREDICT", "object": "AD pathology in CBS patients", "chunk": 2}
{"article": "PMC4346122.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "Neither 'CBS-PIB+' nor 'CBS-PIB-' patients showed significant differences in age at...", "chunk": 2}
{"article": "PMC4346122.txt", "subject": "Apolipoprotein E \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid burden (CBS-PIB+)", "chunk": 3}
{"article": "PMC4346122.txt", "subject": "PIB", "relationship": "INDICATES_PRESENCE_OF", "object": "Cotictobasal syndrome (CBS)", "chunk": 4}
{"article": "PMC4346122.txt", "subject": "apoe4 allele", "relationship": "RELATED_TREATMENT", "object": "100% of patients", "chunk": 4}
{"article": "PMC4346122.txt", "subject": "PIB-PET", "relationship": "USED_TO_DIAGNOSE", "object": "Determine CBS-PIB status", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "FDG-PET", "relationship": "RELATED_PROGNOSIS", "object": "Predicting PIB-PET findings", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "FDG-PET", "relationship": "RELATED_PROGNOSIS", "object": "Predicting PIB status", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "CBS-PIB+", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Showed greater lateralization of FDG uptake", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "CBS-PIB-", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Showed greater lateralization of FDG uptake", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "CBS-PIB+", "relationship": "INDICATES_PRESENCE_OF", "object": "High probability AD and CBD", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "CBS-PIB+", "relationship": "INDICATES_PRESENCE_OF", "object": "Frequent neocortical neuritic plaques (CERAD score)", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "CBS-PIB+", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurofibrillary tangles (Braak Stage VI)", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "CBS-PIB+", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau-positive glial cytoplasmic inclusions (astrocytes and oligodendroglia)", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "CBS-PIB-", "relationship": "INDICATES_PRESENCE_OF", "object": "Negative PIB-PET scans", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "PIB+ status", "relationship": "PREDICTS", "object": "visuospatial and episodic memory loss", "chunk": 6}
{"article": "PMC4346122.txt", "subject": "PIB+ status", "relationship": "PREDICTS", "object": "worse performance on the Benson figure copy", "chunk": 6}
{"article": "PMC4346122.txt", "subject": "FDG-PET", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "differentiating AD from FTLD", "chunk": 6}
{"article": "PMC4346122.txt", "subject": "temporal-parietal overlap (tpv)-predominant clinical criteria", "relationship": "RELATED_WITH", "object": "FDG-PET", "chunk": 6}
{"article": "PMC4346122.txt", "subject": "ftd", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "greater temporoparietal hypometabolism", "chunk": 6}
{"article": "PMC4346122.txt", "subject": "CBS-PIB-", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "FDG-PET scan", "chunk": 6}
{"article": "PMC4346122.txt", "subject": "frontal-predominant hypometabolism", "relationship": "USED_TO_DIAGNOSE", "object": " CBS", "chunk": 6}
{"article": "PMC4346122.txt", "subject": "amyloid beta peptides peptides (A\u03b2)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "future diagnostic algorithm", "chunk": 7}
{"article": "PMC4346122.txt", "subject": "Tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "future diagnostic algorithm", "chunk": 7}
{"article": "PMC4346122.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "predict pathology for the individual patient", "chunk": 7}
{"article": "PMC4346122.txt", "subject": "Tau", "relationship": "RELATED_TREATMENT", "object": "predict pathology for the individual patient", "chunk": 7}
{"article": "PMC4346122.txt", "subject": "amyloid PET", "relationship": "RELATED_TREATMENT", "object": "predict pathology for the individual patient", "chunk": 7}
{"article": "PMC4346122.txt", "subject": "tau PET", "relationship": "RELATED_TREATMENT", "object": "predict pathology for the individual patient", "chunk": 7}
{"article": "PMC4353453.txt", "subject": "ADAS-cog score", "relationship": "USED_TO_DIAGNOSE", "object": "Determine  improvement or lack of decline in patients with Alzheimer's Disease", "chunk": 2}
{"article": "PMC4353453.txt", "subject": "ADAS-cog score", "relationship": "RELATED_PROGNOSIS", "object": "Significant improvement on ADAS-cog score is associated with better clinical outcomes in patients with Alzheimer's Disease", "chunk": 2}
{"article": "PMC4353453.txt", "subject": "ADCS-IADL score", "relationship": "RELATED_PROGNOSIS", "object": "No decline on ADCS-IADL score is associated with better functional outcomes in patients with Alzheimer's Disease", "chunk": 2}
{"article": "PMC4353453.txt", "subject": "MMSE score", "relationship": "INDICATES_PRESENCE_OF", "object": "MMSE score of 10 to 24 is a diagnostic criterion for mild-to-moderate Alzheimer's Disease", "chunk": 2}
{"article": "PMC4353453.txt", "subject": "Mini-Mental State Examination (MMSE) score", "relationship": "RELATED_PROGNOSIS", "object": "A lower MMSE score is associated with a greater decline in cognitive function in patients with Alzheimer's Disease", "chunk": 2}
{"article": "PMC4353453.txt", "subject": "ADAS-cog", "relationship": "RELATED_PROGNOSIS", "object": "Probability of improvement", "chunk": 3}
{"article": "PMC4353453.txt", "subject": "ADAS-cog", "relationship": "INDICATES_PRESENCE_OF", "object": "More severe cognitive impairment", "chunk": 3}
{"article": "PMC4353453.txt", "subject": "ADCS-IADL", "relationship": "RELATED_PROGNOSIS", "object": "Probability of improvement", "chunk": 3}
{"article": "PMC4353453.txt", "subject": "ADCS-IADL", "relationship": "INDICATES_PRESENCE_OF", "object": "More severe functional impairment", "chunk": 3}
{"article": "PMC4353453.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "More severe cognitive impairment", "chunk": 3}
{"article": "PMC4353453.txt", "subject": "13.3\u00a0mg/24\u00a0h rivastigmine patch", "relationship": "RELATED_TREATMENT", "object": "Increased probability of improvement", "chunk": 3}
{"article": "PMC4353453.txt", "subject": "9.5\u00a0mg/24\u00a0h rivastigmine patch", "relationship": "RELATED_TREATMENT", "object": "Decreased probability of improvement", "chunk": 3}
{"article": "PMC4353453.txt", "subject": "ADAS-cog", "relationship": "USED_TO_DIAGNOSE", "object": "Deterioration from DB-BL to Week 48", "chunk": 4}
{"article": "PMC4353453.txt", "subject": "ADCS-IADL", "relationship": "USED_TO_DIAGNOSE", "object": "Deterioration from DB-BL to Week 48", "chunk": 4}
{"article": "PMC4353453.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Moderate stage of AD", "chunk": 4}
{"article": "PMC4353453.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Reduced chance of improvement after 24 weeks", "chunk": 4}
{"article": "PMC4353453.txt", "subject": "ADAS-cog", "relationship": "RELATED_PROGNOSIS", "object": "Significantly greater chance of improvement with rivastigmine after 24 weeks", "chunk": 4}
{"article": "PMC4353453.txt", "subject": "ADCS-IADL", "relationship": "RELATED_PROGNOSIS", "object": "Significantly greater chance of improvement with rivastigmine after 24 weeks", "chunk": 4}
{"article": "PMC4362220.txt", "subject": "Antidepressant medication", "relationship": "RELATED_TREATMENT", "object": "Treatment resistant depression", "chunk": 6}
{"article": "PMC4362220.txt", "subject": "tDCS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment for depression", "chunk": 6}
{"article": "PMC4362220.txt", "subject": "tDCS", "relationship": "RELATED_TREATMENT", "object": "Non pharmacotherapy resistant depression", "chunk": 6}
{"article": "PMC4362220.txt", "subject": "tDCS", "relationship": "INDICATES_PRESENCE_OF", "object": "Antidepressant effects", "chunk": 6}
{"article": "PMC4362220.txt", "subject": "Expanded Disability Status Scale (EDSS) score", "relationship": "USED_TO_DIAGNOSE", "object": "exlcude those with scores of 6.5 or greater from a remotely-supervised tDCS protocol", "chunk": 7}
{"article": "PMC4362220.txt", "subject": "Brief International Cognitive Assessment in MS (BICAMS)", "relationship": "USED_TO_DIAGNOSE", "object": "exclude those with severe cognitive deficits from a remotely-supervised tDCS protocol", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "A\u03b2 (amyloid beta)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Investigational anti-A\u03b2 treatments", "chunk": 1}
{"article": "PMC4366075.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Senile plaques, a hallmark of Alzheimer\u2019s disease brain pathology", "chunk": 1}
{"article": "PMC4366075.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Unwanted effects such as vasogenic cerebral edema (ARIA-E)", "chunk": 1}
{"article": "PMC4366075.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Amyloid-related imaging abnormalities-edema (ARIA-E)", "chunk": 1}
{"article": "PMC4366075.txt", "subject": "bapineuzumab and gantenerumab", "relationship": "INDICATES_PRESENCE_OF", "object": "Anti-A\u03b2 monoclonal antibodies targeting the N-terminus of A\u03b2", "chunk": 1}
{"article": "PMC4366075.txt", "subject": "bapineuzumab", "relationship": "RELATED_TREATMENT", "object": "Clinical trials associated with unwanted effects like ARIA-E", "chunk": 1}
{"article": "PMC4366075.txt", "subject": "gantenerumab", "relationship": "RELATED_TREATMENT", "object": "Clinical trials associated with unwanted effects like ARIA-E", "chunk": 1}
{"article": "PMC4366075.txt", "subject": "GSK933776", "relationship": "RELATED_TREATMENT", "object": "Treatment for mild AD", "chunk": 2}
{"article": "PMC4366075.txt", "subject": "GSK933776", "relationship": "RELATED_TREATMENT", "object": "Treatment for mild cognitive impairment", "chunk": 2}
{"article": "PMC4366075.txt", "subject": "A\u03b2 N-terminus (aa1\u20135)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Passive immunization strategy targeting A\u03b2", "chunk": 2}
{"article": "PMC4366075.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild AD", "chunk": 2}
{"article": "PMC4366075.txt", "subject": "total A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Cerebral spinal fluid biomarker for prodromal or mild AD", "chunk": 2}
{"article": "PMC4366075.txt", "subject": "phosphorylated tau", "relationship": "RELATED_TREATMENT", "object": "Cerebral spinal fluid biomarker for prodromal or mild AD", "chunk": 2}
{"article": "PMC4366075.txt", "subject": "total tau", "relationship": "RELATED_TREATMENT", "object": "Cerebral spinal fluid biomarker for prodromal or mild AD", "chunk": 2}
{"article": "PMC4366075.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measurement in plasma and cerebrospinal fluid", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "A\u03b2X\u201338", "relationship": "RELATED_TREATMENT", "object": " Measured using a commercially available assay", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "A\u03b2X\u201340", "relationship": "RELATED_TREATMENT", "object": " Measured using a commercially available assay", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "A\u03b2X\u201342", "relationship": "RELATED_TREATMENT", "object": " Measured using a commercially available assay", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_TREATMENT", "object": "Measured using a commercially available assay", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "ApoE", "relationship": "RELATED_TREATMENT", "object": " Measured using a commercially available assay", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "total tau", "relationship": "RELATED_TREATMENT", "object": " Measured using a commercially available assay", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "phosphorylated tau", "relationship": "RELATED_TREATMENT", "object": " Measured using a commercially available assay", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "GSK933776", "relationship": "INDIATES_PRESENCE_OF", "object": "Antibodies", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "GSK933776", "relationship": "RELATED_PROGNOSIS", "object": "Incidence of ARIA-E (amyloid-related imaging abnormalities-edema)", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Early Alzheimer's Disease", "chunk": 4}
{"article": "PMC4366075.txt", "subject": "A\u03b21\u201342", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Solanezumab-triggered changes in patients", "chunk": 6}
{"article": "PMC4366075.txt", "subject": "A\u03b21\u201340", "relationship": "RELATED_TO_A_DISEASE", "object": "Cerebrospinal fluid levels are decreased", "chunk": 6}
{"article": "PMC4366075.txt", "subject": "A\u03b2 X\u201338", "relationship": "IS_TARGET_OF_TREATMENT", "object": "GSK933776, a monoclonal antibody", "chunk": 6}
{"article": "PMC4366075.txt", "subject": "A\u03b2 X\u201342", "relationship": "IS_TARGET_OF_TREATMENT", "object": "GSK933776, a monoclonal antibody", "chunk": 6}
{"article": "PMC4366075.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "GSK933776 may need adjustments in dosage regimen depending on APOE genotype", "chunk": 6}
{"article": "PMC4366075.txt", "subject": "total A\u03b2", "relationship": "RISKS_ASSOCIATED_WITH_TREATMENT", "object": "GSK933776 may increase risk of ARIA-E in higher doses if Fc activity is high", "chunk": 6}
{"article": "PMC4366075.txt", "subject": "ARIA-E", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Selection of anti-A\u03b2 antibodies (such as GSK933776) with an inactivated Fc region", "chunk": 6}
{"article": "PMC4366075.txt", "subject": "A\u03b2X\u201342", "relationship": "CAPTURED_USING", "object": "MSD Capture (aa37\u201342)", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "A\u03b2X\u201342", "relationship": "DETECTED_USING", "object": "4G8 (aa18\u201322; Covance)", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "fragments", "relationship": "CAPTURED_USING", "object": "Meso Scale Discovery (MSD) 21F12 clone (aa37\u201342)", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "fragments", "relationship": "DETECTED_USING", "object": "3D6 clone (aa1\u20136)", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "A\u03b2", "relationship": "DETERMINED_IN_CSF", "object": "cerebral spinal fluid", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "Total A\u03b242 [aa28\u201342]", "relationship": "COMPARED_BETWEEN_DOSES", "object": "GSK933776", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "total A\u03b2 [aa18\u201335]", "relationship": "COMPARED_BETWEEN_DOSES", "object": "GSK933776", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "A\u03b2X\u201340", "relationship": "DETERMINED_IN_CSF", "object": "cerebral spinal fluid", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "pan-APOE", "relationship": "DETERMINED_IN_CSF", "object": "cerebral spinal fluid", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "total tau", "relationship": "DETERMINED_IN_CSF", "object": "cerebral spinal fluid", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "phosphorylated-tau", "relationship": "DETERMINED_IN_CSF", "object": "cerebral spinal fluid", "chunk": 7}
{"article": "PMC4374455.txt", "subject": "SRT latencies", "relationship": "RELATED_PROGNOSIS", "object": "SRT latencies  failed to correlate with age", "chunk": 5}
{"article": "PMC4374455.txt", "subject": "SRT latencies", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "SRT latencies were prolonged at the shortest SOA", "chunk": 5}
{"article": "PMC4374455.txt", "subject": "SRT latencies", "relationship": "RELATED_PROGNOSIS", "object": "SRT latencies increased at the shortest SOA", "chunk": 5}
{"article": "PMC4374455.txt", "subject": "SRT latencies", "relationship": "RELATED_TREATMENT", "object": "Comparing SRT latencies measured in the current experiment and MIT, the time needed to depress the response button", "chunk": 5}
{"article": "PMC4374455.txt", "subject": "SDT latencies", "relationship": "PREDICTED_SURVIVAL", "object": "SDT latencies did not increase with age", "chunk": 5}
{"article": "PMC4374455.txt", "subject": "MIT latencies", "relationship": "RELATED_PROGNOSIS", "object": "Comparisons of the correlations of age with MIT latency and age with SRT latency showed significantly larger correlations of age with MIT latency", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "CDR-SOB", "relationship": "INDICATES_PRESENCE_OF", "object": "More severe cognitive impairment", "chunk": 3}
{"article": "PMC4380493.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Early Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4380493.txt", "subject": "CMMSE", "relationship": "RELATED_PROGNOSIS", "object": "Better cognitive function", "chunk": 3}
{"article": "PMC4380493.txt", "subject": "CSDD", "relationship": "INDICATES_PRESENCE_OF", "object": "Severity of depression in older adults with cognitive impairment", "chunk": 3}
{"article": "PMC4380493.txt", "subject": "MIC", "relationship": "RELATED_PROGNOSIS", "object": "More cognitive complaints", "chunk": 3}
{"article": "PMC4380493.txt", "subject": "CDAD", "relationship": "RELATED_TREATMENT", "object": "Assessment for older adults with different degree of cognitive abilities", "chunk": 3}
{"article": "PMC4380493.txt", "subject": "CDR-SOB", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "CMMSE", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "Delayed Recall", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "CVFT", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "Digit Span (Forward)", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "Digit Span (Backward)", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "Trail A (in Seconds)", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "Trail B (in Seconds)", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "CSDD", "relationship": "RELATED_TO", "object": "Mood, Depression", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "CDR-SOB", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "Improvements in ADAS-Cog, delayed recall, subjective cognitive complaints (MIC) and CVFT were found with time", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "CMMSE", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "For the sdmild cognitive impairment  group, a time trend for lower CMMSE scores was observed (p = 0.04).", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "For the sdmild cognitive impairment group, integrated CP intervention were associated with better performance in ADAS-Cog (time \u00d7 group effects, \u03c72 = 10.25, p = 0.02)", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "Delayed Recall", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "For the sdmild cognitive impairment group, integrated CP intervention were associated with better performance in delayed recall (time \u00d7 group effects, \u03c72 = 9.45, p = 0.02)", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "CVFT", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "For the sdmild cognitive impairment group, integrated CP intervention were associated with better performance in CVFT (time \u00d7 group effects, \u03c72 = 12.41, p = 0.006). For the mdmild cognitive impairment participants, the CP group was associated with greater improvement in CVFT (time \u00d7 group effects, \u03c72 = 11.64, p = 0.009)", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "CDAD-IADL", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "No change in CDAD-IADL", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "CSDD (total)", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "For the sdmild cognitive impairment group, integrated CP intervention were associated with better performance in ADAS-Cog (time \u00d7 group effects, \u03c72 = 10.25, p = 0.02)", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "Subjective cognitive complaints (SCC)", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "Improvements in subjective cognitive complaints (MIC)", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TO_TREATMENT", "object": "showed significant improvements", "chunk": 6}
{"article": "PMC4380493.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TO_TREATMENT", "object": "improvements in cognitive scores", "chunk": 6}
{"article": "PMC4380493.txt", "subject": "Delayed Recall", "relationship": "RELATED_TO_TREATMENT", "object": "showed significant improvements", "chunk": 6}
{"article": "PMC4380493.txt", "subject": "CVFT", "relationship": "RELATED_TO_TREATMENT", "object": "showed significant improvements", "chunk": 6}
{"article": "PMC4380493.txt", "subject": "CMMSE", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "may be affected by ceiling effects, so subtle changes may not be detected", "chunk": 6}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "INDICATES_PRESENCE_OF", "object": "Molecular changes in response to Yogic breathing", "chunk": 1}
{"article": "PMC4383272.txt", "subject": "IGLC2", "relationship": "INDICATES_PRESENCE_OF", "object": "Molecular changes in response to Yogic breathing", "chunk": 1}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The authors chose it based on its abundance in saliva, spectral counts and level of statistical significance in MS data, and the roles of these proteins in immune regulation, epithelial differentiation, tumor suppression, and stress response", "chunk": 2}
{"article": "PMC4383272.txt", "subject": "IGLC2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The authors chose it based on its abundance in saliva, spectral counts and level of statistical significance in MS data, and the roles of these proteins in immune regulation, epithelial differentiation, tumor suppression, and stress response", "chunk": 2}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "INDICATES_PRESENCE_OF", "object": "Elevated expression in 7 out of 10 subjects from the YB group and none in the AC group", "chunk": 3}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Yogic Breathing exercises", "chunk": 3}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "RELATED_TREATMENT", "object": "Yogic Breathing exercises", "chunk": 3}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "INDICATES_PRESENCE_OF", "object": "Elevated levels in YB group compared to AC group after 10 and 15 minutes", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "RELATED_TO", "object": "Innate immune response", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "IS_TARGET_OF_TREATMENT", "object": "reduction of infectivity of HIV1 and influenza A viruses", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "IGLC2", "relationship": "INDICATES_PRESENCE_OF", "object": "Marked increase in YB group after 5 minutes", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "RELATED_TO", "object": "Epithelial cell differentiation", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "RELATED_TO", "object": "Angiogenesis at the vascular extracellular matrix", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "RELATED_TO", "object": "Binding to galectin-3", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "RELATED_PROGNOSIS", "object": "Tumor suppressor gene", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased level in saliva following Yogic Breathing", "chunk": 5}
{"article": "PMC4383272.txt", "subject": "IGLC2", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased level in saliva following Yogic Breathing", "chunk": 5}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "RESPONSED_TO", "object": "Yogic Breathing", "chunk": 5}
{"article": "PMC4383272.txt", "subject": "IGLC2", "relationship": "RESPONSED_TO", "object": "Yogic Breathing", "chunk": 5}
{"article": "PMC4396171.txt", "subject": "A\u03b240", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with AZD0530", "chunk": 3}
{"article": "PMC4396171.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with AZD0530", "chunk": 3}
{"article": "PMC4396171.txt", "subject": "Tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with AZD0530", "chunk": 3}
{"article": "PMC4396171.txt", "subject": "P231-Tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with AZD0530", "chunk": 3}
{"article": "PMC4396171.txt", "subject": "sCTX", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with AZD0530", "chunk": 3}
{"article": "PMC4396171.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "provides an assessment of cognitive function and is used to monitor disease progression in Alzheimer's disease", "chunk": 4}
{"article": "PMC4396171.txt", "subject": "AZD0530", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of Alzheimer's disease  ", "chunk": 5}
{"article": "PMC4396171.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "p-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "18F-FDG PET imaging", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of Alzheimer's disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "sCTX", "relationship": "RELATED_PROGNOSIS", "object": "Treatment Effect on Alzheimer's disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "AZD0530", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "AZD0530", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "AZD0530", "relationship": "PREDICTS_SURVIVAL", "object": "Patients with Alzheimer's Disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "AB amyloid-beta", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Developing NgR- and PrP-based therapeutics", "chunk": 7}
{"article": "PMC4396171.txt", "subject": "A\u03b2 oligomeric amyloid-beta", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Developing NgR- and PrP-based therapeutics", "chunk": 7}
{"article": "PMC4396171.txt", "subject": "cellular prion protein", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Developing NgR- and PrP-based therapeutics", "chunk": 7}
{"article": "PMC4397698.txt", "subject": "Aluminum concentration", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Aluminum chloride (AlCl3) administration resulted in a significant increase in the aluminum concentration", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "Acetylcholinesterase activity", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AlCl3 administration resulted in a significant increase in the acetylcholinesterase activity", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "Amyloid beta peptides peptides peptidesss (A\u03b2) deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AlCl3 administration resulted in a significant increase in the amyloid beta peptides peptides peptidesss (A\u03b2) deposition", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "BDNF", "relationship": "RELATED_TREATMENT", "object": "Increased levels of BDNF has great potential for the treatment of AD", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "GDNF", "relationship": "RELATED_TREATMENT", "object": "Increased levels of GDNF has great potential for the treatment of AD", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "VEGF", "relationship": "RELATED_TREATMENT", "object": "Emerging treatment strategies focus on reducing A\u03b2 plaques from the brain of AD patients", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "LIPUS", "relationship": "RELATED_TREATMENT", "object": "This study was designed to investigate the neuroprotective effect of LIPUS against AlCl3-induced cognitive dysfunction and associated cerebral damage in rats.", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "Brain-derived neurotrophic factor (BDNF)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The results suggested the enhancement of endogenous neurotrophic factors via LIPUS could be a novel treatment strategy for brain disorder.", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "LIDPUS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Recently, one study demonstrated that FUS enhanced delivery of anti-A\u03b2 antibodies rapidly reduces plaque in a model of AD with aggressive A\u03b2 pathology", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "AChE activity", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease risk", "chunk": 2}
{"article": "PMC4397698.txt", "subject": "A\u03b21-42 expression", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Brain damage", "chunk": 2}
{"article": "PMC4397698.txt", "subject": "A\u03b21-42 content", "relationship": "RELATED_PROGNOSIS", "object": "Brain damage", "chunk": 2}
{"article": "PMC4397698.txt", "subject": "Aluminum concentration", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease risk", "chunk": 2}
{"article": "PMC4397698.txt", "subject": "Karyopyknosis", "relationship": "RELATED_PROGNOSIS", "object": "Brain damage", "chunk": 2}
{"article": "PMC4397698.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Significantly improved memory retention and attenuated AChE activity levels, and A\u03b2 deposition produced by LIPUS lend support to our hypothesis that transcranial LIPUS has a neuroprotective effect against Al-induced cerebral damage", "chunk": 3}
{"article": "PMC4397698.txt", "subject": "AChE", "relationship": "RELATED_PROGNOSIS", "object": "Significantly improved memory retention and attenuated AChE activity levels, and A\u03b2 deposition produced by LIPUS lend support to our hypothesis that transcranial LIPUS has a neuroprotective effect against Al-induced cerebral damage", "chunk": 3}
{"article": "PMC4397698.txt", "subject": "VEGF", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "This might explain why the A\u03b2 content significantly decreased in AlCl3-treated rats after chronic LIPUS application", "chunk": 3}
{"article": "PMC4397698.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "The use of LIPUS could potentially increase neurotrophic factors and perhaps aid with controlling or reversing related brain disorders such as AD", "chunk": 3}
{"article": "PMC4397698.txt", "subject": "A\u03b2 protein", "relationship": "RELATED_PROGNOSIS", "object": "accumulation of A\u03b2 in cortex and hippocampus of brain", "chunk": 4}
{"article": "PMC4397698.txt", "subject": "Acetylcholinesterase activity", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "  AchE is a marker of extensive loss of cholinergic neurons in the forebrain", "chunk": 4}
{"article": "PMC4397698.txt", "subject": "BDNF", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurotrophic factor expression in the rat brain", "chunk": 5}
{"article": "PMC4397698.txt", "subject": "GDNF", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurotrophic factor expression in the rat brain", "chunk": 5}
{"article": "PMC4397698.txt", "subject": "VEGF", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurotrophic factor expression in the rat brain", "chunk": 5}
{"article": "PMC4397698.txt", "subject": "Aluminum (Al)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Aluminum levels in the brain", "chunk": 5}
{"article": "PMC4397698.txt", "subject": "Acetylcholinesterase activity", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Ammonium chloride induced neurodegeneration", "chunk": 5}
{"article": "PMC4397698.txt", "subject": "A\u03b2 content", "relationship": "associated_with_poor_outcome", "object": "Alzheimer's disease related cognitive decline", "chunk": 5}
{"article": "PMC4397698.txt", "subject": "Cognitive impairment", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid beta excess", "chunk": 5}
{"article": "PMC4401690.txt", "subject": "Alzheimer\u2019s dementia", "relationship": "INDICATES_PRESENCE_OF", "object": "MMSE: 20.6\u00b16.5 points", "chunk": 1}
{"article": "PMC4401690.txt", "subject": "Alzheimer\u2019s dementia", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "home-based PA program performed on a movement trainer", "chunk": 1}
{"article": "PMC4401690.txt", "subject": "Alzheimer\u2019s dementia", "relationship": "RELATED_TO", "object": "ADL performance", "chunk": 1}
{"article": "PMC4401690.txt", "subject": "Alzheimer\u2019s dementia", "relationship": "RELATED_TO", "object": "executive function & language ability", "chunk": 1}
{"article": "PMC4401690.txt", "subject": "Alzheimer\u2019s dementia", "relationship": "RELATED_TO", "object": "physical skill", "chunk": 1}
{"article": "PMC4401690.txt", "subject": "Alzheimer\u2019s dementia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "cognitive decline", "chunk": 1}
{"article": "PMC4401690.txt", "subject": "Alzheimer\u2019s dementia", "relationship": "RELATED_TREATMENT", "object": "physical activity training ", "chunk": 1}
{"article": "PMC4401690.txt", "subject": "acetylcholinesterase inhibitor", "relationship": "RELATED_TREATMENT", "object": "stable treatment for AD ", "chunk": 3}
{"article": "PMC4401690.txt", "subject": "memantin", "relationship": "RELATED_TREATMENT", "object": "stable treatment for AD ", "chunk": 3}
{"article": "PMC4401690.txt", "subject": "MMSE (total score)", "relationship": "RELATED_PROGNOSIS", "object": "The study demonstrates long-term effects three months after completion of the intervention on ADL and behavioural symptoms.", "chunk": 4}
{"article": "PMC4401690.txt", "subject": "brain-derived neurotrophic factor", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Potential to improve brain functionality", "chunk": 5}
{"article": "PMC4406069.txt", "subject": "Apolipoprotein-E \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "Risk factor for Alzheimer's disease", "chunk": 1}
{"article": "PMC4406069.txt", "subject": "Apolipoprotein-E \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk of Alzheimer's disease", "chunk": 1}
{"article": "PMC4406069.txt", "subject": "Hippocampal atrophy", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurodegenerative changes characteristic of Alzheimer's disease", "chunk": 1}
{"article": "PMC4406069.txt", "subject": "Amyloid plaques", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4406069.txt", "subject": "Neurofibrillary tangles", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4406069.txt", "subject": "abnormal Abeta42 or tau protein concentrations", "relationship": "INDICATES_PRESENCE_OF", "object": "Diagnosis: AD", "chunk": 3}
{"article": "PMC4406069.txt", "subject": "APOE \u03b54 allele", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Alzheimer's Disease", "chunk": 6}
{"article": "PMC4406069.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Increased within-domain IIV in HCS and amild cognitive impairment groups", "chunk": 7}
{"article": "PMC4406069.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "Population status", "chunk": 8}
{"article": "PMC4406069.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "the frontal lobe is believed to be the basis of IIV (MacDonald et al., 2009), our findings add evidence to recent studies (K\u00e4lin et al., 2014) and further support the relationship between within-domain IIV and APOE status.", "chunk": 9}
{"article": "PMC4406069.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "increased IIV in HCS \u03b54 carriers vs. non-carriers", "chunk": 9}
{"article": "PMC4406069.txt", "subject": "APOE \u03b54", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "the frontal lobe constitutes a brain region that manifests \u03b54-effects very early in the disease (Filbey et al., 2010)", "chunk": 9}
{"article": "PMC4406069.txt", "subject": "MRI", "relationship": "DIAGNOSTIC_OF", "object": "Early stage of the disease", "chunk": 10}
{"article": "PMC4410460.txt", "subject": "amyloid-\u03b2 (A\u03b2) peptide", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4410460.txt", "subject": "amyloid-\u03b2 (A\u03b2) peptide", "relationship": "IS_TARGET_OF_TREATMENT", "object": "disease-modifying immunotherapies", "chunk": 1}
{"article": "PMC4410460.txt", "subject": "A\u03b21\u20136", "relationship": "IS_TARGET_OF_TREATMENT", "object": "CAD106", "chunk": 1}
{"article": "PMC4410460.txt", "subject": "A\u03b21\u20136", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "CAD106", "chunk": 1}
{"article": "PMC4410460.txt", "subject": "A\u03b2-specific antibodies", "relationship": "RELATED_PROGNOSIS", "object": "reduced amyloid accumulation in the brain", "chunk": 1}
{"article": "PMC4410460.txt", "subject": "A\u03b2-specific antibodies", "relationship": "RELATED_PROGNOSIS", "object": "increasing with additional injections", "chunk": 1}
{"article": "PMC4410460.txt", "subject": "A\u03b21\u201340", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment choice measured using total plasma A\u03b21\u201340 (free and bound) levels", "chunk": 3}
{"article": "PMC4410460.txt", "subject": "A\u03b21\u201342", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measurement of A\u03b21-42 concentration", "chunk": 3}
{"article": "PMC4410460.txt", "subject": "total tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measurement of total tau concentration", "chunk": 3}
{"article": "PMC4410460.txt", "subject": "phospho-tau181", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measurement of phospho-tau181 concentration", "chunk": 3}
{"article": "PMC4410460.txt", "subject": "apoe4", "relationship": "DIAGNOSTIC_OF", "object": "Early-onset Alzheimer's Disease", "chunk": 5}
{"article": "PMC4410460.txt", "subject": "A\u03b2-IgG titers", "relationship": "INDICATES_PRESENCE_OF", "object": "Antibody response to CAD106", "chunk": 6}
{"article": "PMC4410460.txt", "subject": "A\u03b2-IgG titers", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment with CAD106", "chunk": 6}
{"article": "PMC4410460.txt", "subject": "A\u03b2-IgG titers", "relationship": "RELATED_PROGNOSIS", "object": "Progression of disease", "chunk": 6}
{"article": "PMC4410460.txt", "subject": "A\u03b21-40 levels", "relationship": "RELATED_TO_TREATMENT", "object": "CAD106 administration", "chunk": 6}
{"article": "PMC4410460.txt", "subject": "phospho-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "CAD106 treatment", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "phospho-tau", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "CAD106 treatment response", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "apoe4", "relationship": "RELATED_TREATMENT", "object": "CAD106 treatment", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "A\u03b2-specific IgGs", "relationship": "MONITORED_DURING_TREATMENT", "object": "CAD106 treatment", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "A\u03b2-specific IgGs", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "CAD106 treatment", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "A\u03b2-specific antibodies", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Choice of CAD106 dosing regimen", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "A\u03b21\u201340", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "Long-term CAD106 treatment", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "CAD106", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of Alzheimer's Disease", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "A\u03b21\u20136", "relationship": "IS_TARGET_OF_TREATMENT", "object": "CAD106 antibodies", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "A\u03b2 accumulation", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 8}
{"article": "PMC4410460.txt", "subject": "phospho-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with CAD106", "chunk": 8}
{"article": "PMC4410460.txt", "subject": "phospho-tau", "relationship": "RELATED_PROGNOSIS", "object": "later stages of AD", "chunk": 8}
{"article": "PMC4410460.txt", "subject": "A\u03b21\u201340", "relationship": "RELATED_TREATMENT", "object": "long-term treatment with CAD106 ", "chunk": 8}
{"article": "PMC4431827.txt", "subject": "falls", "relationship": "INDICATES_PRESENCE_OF", "object": "reduced balance", "chunk": 1}
{"article": "PMC4431827.txt", "subject": "Falls and fractures", "relationship": "ASSOCIATED_WITH", "object": "dementia residents", "chunk": 1}
{"article": "PMC4431827.txt", "subject": "dementia", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "muscle strength training", "chunk": 1}
{"article": "PMC4431827.txt", "subject": "knee extension muscle strength", "relationship": "THRESHOLD_LEVELS_PREDICT", "object": "lower extremity dysfunction", "chunk": 1}
{"article": "PMC4431827.txt", "subject": "Neuropsychiatric symptoms (NPS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 2}
{"article": "PMC4431827.txt", "subject": "Agitation", "relationship": "RELATED_PROGNOSIS", "object": "Predictor of fall for nursing home patients, causing considerable morbidity and mortality", "chunk": 2}
{"article": "PMC4431827.txt", "subject": "Apathy", "relationship": "RELATED_PROGNOSIS", "object": "Predictor of fall for nursing home patients, causing considerable morbidity and mortality", "chunk": 2}
{"article": "PMC4431827.txt", "subject": "Agitation", "relationship": "RELATED_PROGNOSIS", "object": "Can be reduced by exercise", "chunk": 2}
{"article": "PMC4431827.txt", "subject": "Exercise", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved physical function and mental health in dementia patients", "chunk": 2}
{"article": "PMC4431827.txt", "subject": "Exercise", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Selection of physical functional exercise program for dementia patients", "chunk": 2}
{"article": "PMC4431827.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4431827.txt", "subject": "CDR", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 3}
{"article": "PMC4431827.txt", "subject": "CDR", "relationship": "DIAGNOSITC_OF", "object": "Dementia", "chunk": 3}
{"article": "PMC4431827.txt", "subject": "Cornell Scale for Depression in dementia", "relationship": "DIAGNOSITC_OF", "object": "Depression", "chunk": 3}
{"article": "PMC4431827.txt", "subject": "Cornell Scale for Depression in Dementia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower score on Cornell Scale for Depression in Dementia at baseline was associated with poorer BI score (p<0.01).", "chunk": 5}
{"article": "PMC4431827.txt", "subject": "Berg Balance Scale", "relationship": "RELATED_PROGNOSIS", "object": "Higher score on Berg Balance Scale at baseline", "chunk": 5}
{"article": "PMC4431827.txt", "subject": "Berg Balance Scale", "relationship": "USED_TO_DIAGNOSE", "object": "Lower score on BBS at baseline was associated with poorer BI score (p<0.01).", "chunk": 5}
{"article": "PMC4431827.txt", "subject": "Barthel Index", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower score on BBS at baseline increased to be associated with poorer BI score (p<0.01).", "chunk": 5}
{"article": "PMC4431827.txt", "subject": "Walking speed", "relationship": "RELATED_PROGNOSIS", "object": "Walking speed is given in meters/ second; all other variables are given in points.", "chunk": 5}
{"article": "PMC4431827.txt", "subject": "Neurological Disease", "relationship": "RELATED_PROGNOSIS", "object": "The participants with neurological disease scored significantly poorer on BBS at baseline (p<0.01) than those with no neurological disease.", "chunk": 5}
{"article": "PMC4431827.txt", "subject": "BBS", "relationship": "RELATED_PROGNOSIS", "object": "Balance, which was the predetermined primary outcome", "chunk": 6}
{"article": "PMC4431827.txt", "subject": "BBS", "relationship": "PREDICTED_SURVIVAL", "object": "Higher scores on sit to stand test after intervention", "chunk": 6}
{"article": "PMC4431827.txt", "subject": "BI score", "relationship": "RELATED_TREATMENT", "object": "correlated with the baseline score of BBS", "chunk": 6}
{"article": "PMC4431827.txt", "subject": "BI score", "relationship": "RELATED_TREATMENT", "object": "correlations between the scores on the BI and the CST at baseline", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "H2DCF-DA", "relationship": "USED_TO_DIAGNOSE", "object": "intracellular ROS level", "chunk": 2}
{"article": "PMC4436517.txt", "subject": "H2DCF-DA", "relationship": "MONITORED_DURING_TREATMENT", "object": "thermal stress", "chunk": 2}
{"article": "PMC4436517.txt", "subject": "SYTOX Green Nucleic Acid Stain", "relationship": "MONITORED_DURING_TREATMENT", "object": "Thermal stress to determine cellular damage and viability of nematodes", "chunk": 3}
{"article": "PMC4436517.txt", "subject": "SYTOX Green Nucleic Acid Stain", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Cellular damage caused by thermal stress", "chunk": 3}
{"article": "PMC4436517.txt", "subject": "quercetin", "relationship": "INDICATES_PRESENCE_OF", "object": "Antioxidative effects", "chunk": 4}
{"article": "PMC4436517.txt", "subject": "quercetin", "relationship": "RELATED_TO", "object": "superior antioxidative capacity", "chunk": 4}
{"article": "PMC4436517.txt", "subject": "quercetin", "relationship": "ASSOCIATED_WITH", "object": " reduction of DCF fluorescence", "chunk": 4}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Reduced induction of SOD-3 expression", "chunk": 4}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Reduced induction of SOD-3 expression", "chunk": 4}
{"article": "PMC4436517.txt", "subject": "quercetin", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Significantly diminished the induction of GST-4", "chunk": 4}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "to understand its potential to protect against stress conditions", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "RELATED_TREATMENT", "object": "has been reported to be beneficial in cases of ageing-related cardiovascular and neurodegenerative disorders", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "RELATED_TREATMENT", "object": "was reported to be beneficial in cases of ageing-related cardiovascular and neurodegenerative disorders", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "RELATED_TREATMENT", "object": "reported an increase of life span after treatment with resveratrol (100\u2009\u03bcM).  ", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "RELATED_TREATMENT", "object": "reported that resveratrol significantly extends C. elegans life span already at a concentration of 5\u2009\u03bcM by 3.6% (mean life span) and 3.4% (maximum life span).", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Resveratrol showed a slightly weaker decrease in lipofuscin fluorescence (846.8\u2009rfu), while quercetin again showed the strongest reduction in this parameter. ", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "MONITORED_DURING_TREATMENT", "object": "since it is known that a reduction of lipofuscin mostly correlates with an increase in life span of C. elegans,  ", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "to verify the antioxidative effects of the compounds in the nematode and (ii) to estimate effects of these compounds on the ageing process in C. elegans.", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "RESPONDED_TO", "object": "TSG strongly increases the resistance against thermal stress: 50\u2009\u03bcM TSG induces a 22% increase in the mean survival time.", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "INDICATES_PRESENCE_OF", "object": "It is known that a reduction of lipofuscin mostly correlates with an increase in life span of C. elegans", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "quercetin", "relationship": "RESPONDED_TO", "object": "Incubation with 100\u2009\u03bcM quercetin reduces the lipofuscin fluorescence by 27.85% (686.9 \u00b1 14\u2009rfu). ", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "quercetin", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Incubation with 100\u2009\u03bcM quercetin reduces the lipofuscin fluorescence by 27.85% (686.9 \u00b1 14\u2009rfu). These results show that TSG is capable of decreasing lipofuscin accumulation in C. elegans ", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": " reported that resveratrol significantly extends C. elegans life span already at a concentration of 5\u2009\u03bcM by 3.6% (mean life span) and 3.4% (maximum life span).", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "reported an increase of life span after treatment with resveratrol (100\u2009\u03bcM).", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "The mean life span of DMSO-treated nematodes was 17.4 \u00b1 0.56 days; in case of TSG, resveratrol, and quercetin, the mean life span was 21.1 \u00b1 0.58\u2009d, 20.7 \u00b1 0.67\u2009d, and 21.3 \u00b1 0.5\u2009d, respectively.", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "The median life span of DMSO-treated nematodes was 18.0 \u00b1 0.61 days; in case of TSG, resveratrol, and quercetin, the median life span was 22.0 \u00b1 0.81\u2009d, 22.0 \u00b1 0.71\u2009d, and 23.0 \u00b1 1.01\u2009d, respectively.", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treat as anti-ageing drug", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "RELATED_TREATMENT", "object": "Alleviates lipofuscin accumulation", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "RELATED_TREATMENT", "object": "Prolongevity effect during adult life", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "RELATED_TREATMENT", "object": "Increased resistance against heat stress", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Acts as an active component in Polygonum multiflorum extract for anti-ageing", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Modulation of SOD-3 and GST-4", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Modulation of ROS accumulation", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Increased lifespans in C. elegans", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "RESPONDED_TO", "object": "Increased stress resistance", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "MONITORED_DURING_TREATMENT", "object": "Antioxidative effects in C. elegans", "chunk": 6}
{"article": "PMC4461930.txt", "subject": "amyloid-\u03b2 peptide 42 (A\u03b242)", "relationship": "RELATED_TREATMENT", "object": "Semagacestat", "chunk": 1}
{"article": "PMC4461930.txt", "subject": "A\u03b242", "relationship": "IN_TREATMENT_WITH", "object": "Semagacestat alters levels", "chunk": 1}
{"article": "PMC4461930.txt", "subject": "phosphorylated tau (p-tau)", "relationship": "RELATED_TREATMENT", "object": "Semagacestat", "chunk": 1}
{"article": "PMC4461930.txt", "subject": "amino-\u03b2 peptide 42 (A\u03b242)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "cognitive and other adverse effects", "chunk": 1}
{"article": "PMC4461930.txt", "subject": "ventricular volume", "relationship": "RELATED_TREATMENT", "object": "Semagacestat", "chunk": 1}
{"article": "PMC4461930.txt", "subject": "\u03b3-secretase", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "inhibition", "chunk": 1}
{"article": "PMC4461930.txt", "subject": "amyloid precursor protein (APP)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "\u03b3-secretase inhibitors", "chunk": 1}
{"article": "PMC4461930.txt", "subject": "Apolipoprotein E polymorphisms", "relationship": "RELATED_TREATMENT", "object": "Genotyped at baseline and end point of the trial.", "chunk": 2}
{"article": "PMC4461930.txt", "subject": " plasma A\u03b2 peptides", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (dose-related reduction through treatment)", "chunk": 2}
{"article": "PMC4461930.txt", "subject": "plasma A\u03b2 peptides", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma A\u03b2 was assessed at baseline and weeks 6, 12 and 52 or early termination.", "chunk": 2}
{"article": "PMC4461930.txt", "subject": "A\u03b2 peptides", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Optional cerebral cerebral cerebral cerebral spinal fluid analysis for A\u03b2 peptides and tau and phosphorylated tau (p-tau) proteins was conducted in willing subjects.", "chunk": 2}
{"article": "PMC4461930.txt", "subject": "tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Optional cerebral cerebral cerebral cerebral spinal fluid analysis for A\u03b2 peptides and tau and phosphorylated tau (p-tau) proteins was conducted in willing subjects.", "chunk": 2}
{"article": "PMC4461930.txt", "subject": "phosphorylated tau (p-tau)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Optional cerebral cerebral cerebral cerebral spinal fluid analysis for A\u03b2 peptides and tau and phosphorylated tau (p-tau) proteins was conducted in willing subjects.", "chunk": 2}
{"article": "PMC4461930.txt", "subject": "p-tau", "relationship": "RELATED_PROGNOSIS", "object": "cognitive decline", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "amloid-\u03b2 peptide 40", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "ADAScog11", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "Ventricular volume", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Reduced plasma levels of A\u03b2 peptides", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Consistent with \u03b3-secretase inhibition in the periphery", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduction in cerebral cerebral cerebral cerebral spinal fluid A\u03b2 peptide levels", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "A\u03b242", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Stable isotope labeling kinetic technique", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "p-tau", "relationship": "PREDICTOR_OF", "object": "Early termination of the trial", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "p-tau", "relationship": "RELATED_PROGNOSIS", "object": "A possible beneficial effect on disease pathology", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "p-tau", "relationship": "RELATED_PROGNOSIS", "object": "An increase in neurodegeneration due to accelerated disease", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "ventricular volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Brain atrophy", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "A\u03b240", "relationship": "RELATED_TO", "object": "Gastrointestinal symptoms", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "A\u03b240", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Pharmacological effect on the disease process", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "p-tau", "relationship": "RELATED_PROGNOSIS", "object": "worsening cognition", "chunk": 5}
{"article": "PMC4461930.txt", "subject": "clearance of amyloid beta", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "design of studies targeting secretases", "chunk": 5}
{"article": "PMC4461930.txt", "subject": "A\u03b2 peptides", "relationship": "MONITORED_DURING_TREATMENT", "object": "exposure to drug", "chunk": 5}
{"article": "PMC4461930.txt", "subject": "clearance of APP ", "relationship": "ASSOSIATED_WITH_POOR_OUTCOME", "object": " gastrointestinal symptoms", "chunk": 5}
{"article": "PMC4465490.txt", "subject": "C-TMT completion times", "relationship": "INDICATES_PRESENCE_OF", "object": "Malingering", "chunk": 10}
{"article": "PMC4465490.txt", "subject": "C-TMT-A completion times", "relationship": "RELATED_TO", "object": "Detection of malingering", "chunk": 10}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "RELATED_TO", "object": "Detection of malingering", "chunk": 10}
{"article": "PMC4465490.txt", "subject": "Velocity", "relationship": "RELATED_TO", "object": "Detection of malingering", "chunk": 10}
{"article": "PMC4465490.txt", "subject": "dwell-time/total-time ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Malingering", "chunk": 10}
{"article": "PMC4465490.txt", "subject": "Differences in z-scores on the C-TMT-B and C-TMT-A", "relationship": "INDICATES_PRESENCE_OF", "object": "Malingering", "chunk": 10}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "INDICATES_PRESENCE_OF", "object": "TBI", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "RELATED_PROGNOSIS", "object": "functional outcome", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "PREDICTS_SURVIVAL", "object": "Eventual functional outcome", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-A  completion times", "relationship": "RELATED_PROGNOSIS", "object": "functional outcome", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B/C-TMT-A ratios", "relationship": "RELATED_PROGNOSIS", "object": "Functional outcome", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "movement velocities", "relationship": "RELATED_PROGNOSIS", "object": "Functional outcome", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT completion times", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Mild TBI", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "Movement velocities", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Mild TBI", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-A abnormalities", "relationship": "associated with", "object": "sTBI", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B abnormalities", "relationship": "associated with", "object": "sTBI", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-A completion times", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "TBI patients", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "TBI patients", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "TBI patients", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-A completion times", "relationship": "MONITORED_DURING_TREATMENT", "object": "TBI patients", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "MONITORED_DURING_TREATMENT", "object": "TBI patients", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "dwell-time/total-time ratios", "relationship": "MONITORED_DURING_TREATMENT", "object": "TBI patients", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "TBI treatment", "chunk": 11}
{"article": "PMC4468784.txt", "subject": "PSS-14", "relationship": "PREDICT_SURVIVAL", "object": "Predict caregivers' stress levels at 3 months", "chunk": 2}
{"article": "PMC4468784.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Baseline Alzheimer's disease", "chunk": 3}
{"article": "PMC4468784.txt", "subject": "Instrumental Activities of Daily Living (IADL)", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's disease progression", "chunk": 3}
{"article": "PMC4468784.txt", "subject": "BDI-II", "relationship": "RELATED_TO", "object": "Beck Depression Inventory-second version", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "BPSD", "relationship": "RELATED_TO", "object": "behavioral and psychological symptoms of dementia", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "IADL", "relationship": "RELATED_TO", "object": "Instrumental Activities of Daily Living", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "MMS", "relationship": "RELATED_TO", "object": "Mini-Mental State Examination", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "NHP", "relationship": "RELATED_TO", "object": "Nottingham Health Profile", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "PSS-14", "relationship": "RELATED_TO", "object": "Perceived Stress Scale", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "PWAD", "relationship": "RELATED_TO", "object": "Persons with Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "RCT", "relationship": "RELATED_TO", "object": "Randomized controlled trial", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "RMBP", "relationship": "RELATED_TO", "object": "Revised Memory and Behavior Problems Checklist", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "RSCS", "relationship": "RELATED_TO", "object": "Revised Scale for Caregiving Self-Efficacy", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "VAS", "relationship": "RELATED_TO", "object": "Visual analog scales", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "ZBIZ", "relationship": "RELATED_TO", "object": "Zarit Burden Interview", "chunk": 7}
{"article": "PMC4481070.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_RISK_FACTOR", "object": "Alzheimer's Disease", "chunk": 1}
{"article": "PMC4481070.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "INDICATES_PRESENCE_OF", "object": "AD dementia", "chunk": 2}
{"article": "PMC4481070.txt", "subject": "Clinical dementia Rating scored by the sum of boxes method (CDR-SB)", "relationship": "RELATED_PROGNOSIS", "object": "Disease progression", "chunk": 2}
{"article": "PMC4481070.txt", "subject": "Alzheimer\u2019s Disease Assessment Scale \u2013 cognitive subscale (ADAS-cog11)", "relationship": "USED_TO_DIAGNOSE", "object": "Disease progression", "chunk": 2}
{"article": "PMC4481070.txt", "subject": "Alzheimer\u2019s Disease Cooperative Study \u2013 Activities of Daily Living Scale (ADCS-ADL)", "relationship": "USED_TO_DIAGNOSE", "object": "Disease progression", "chunk": 2}
{"article": "PMC4481070.txt", "subject": "Neuropsychiatric Inventory (NPI)", "relationship": "RELATED_PROGNOSIS", "object": "Disease progression", "chunk": 2}
{"article": "PMC4481070.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Most common in Western Europe/Israel and North America and least common in Asia", "chunk": 3}
{"article": "PMC4481070.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "more rapid clinical disease progression", "chunk": 5}
{"article": "PMC4481070.txt", "subject": "ADAS-cog11", "relationship": "INDICATES_PRESENCE_OF", "object": "AD progression", "chunk": 6}
{"article": "PMC4481070.txt", "subject": "ADAS-cog11", "relationship": "RELATED_PROGNOSIS", "object": "Response to treatment", "chunk": 6}
{"article": "PMC4481070.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "AD progression", "chunk": 6}
{"article": "PMC4481070.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Response to treatment", "chunk": 6}
{"article": "PMC4481070.txt", "subject": "ADCS-ADL", "relationship": "RELATED_PROGNOSIS", "object": "Response to treatment", "chunk": 6}
{"article": "PMC4481070.txt", "subject": "CDR-SB", "relationship": "RELATED_PROGNOSIS", "object": "Response to treatment", "chunk": 6}
{"article": "PMC4481906.txt", "subject": "activities of daily living (ADL)", "relationship": "RELATED_PROGNOSIS", "object": "quality of life", "chunk": 1}
{"article": "PMC4481906.txt", "subject": "activities of daily living (ADL)", "relationship": "RELATED_TREATMENT", "object": "medicinal product-related improvements in everyday function", "chunk": 1}
{"article": "PMC4481906.txt", "subject": "ADL", "relationship": "PREDICTOR", "object": "quality of life", "chunk": 1}
{"article": "PMC4481906.txt", "subject": "ECG", "relationship": "USED_TO_DIAGNOSE", "object": "ADL events", "chunk": 2}
{"article": "PMC4481906.txt", "subject": "Wearable devices", "relationship": "RELATED_TREATMENT", "object": "assess older peoples\u2019 motor function performance", "chunk": 2}
{"article": "PMC4481906.txt", "subject": "Wearable devices", "relationship": "RELATED_TREATMENT", "object": "to identify disturbances in gait patterns that could be associated with disease progression", "chunk": 2}
{"article": "PMC4481906.txt", "subject": "Wearable devices", "relationship": "RELATED_TREATMENT", "object": "to personalize patient care", "chunk": 2}
{"article": "PMC4481906.txt", "subject": "Wearable devices", "relationship": "RELATED_TREATMENT", "object": "to assess the independent living associated risks", "chunk": 2}
{"article": "PMC4481906.txt", "subject": "Wearable devices", "relationship": "RELATED_TREATMENT", "object": "to decide on institutionalization", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Oxidative stress and mitochondrial dysfunction", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Accelerated oxidative stress and mitochondrial dysfunction", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "Oxidative stress", "relationship": "RELATED_PROGNOSIS", "object": "Considered as a primary factor of Neurofibrillary tangles formation in AD", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "Mitochondrial SOD2 deficiency", "relationship": "RELATED_PROGNOSIS", "object": "Increases the levels of Ser396 phosphorylated tau in the Tg2576 mouse model of AD", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "tau protein", "relationship": "RELATED_PROGNOSIS", "object": "Outgrowth of neuronal processes and the development of neuronal polarity", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "tau protein", "relationship": "RELATED_PROGNOSIS", "object": "Promote microtubule assembly, stabilize microtubules, affect the dynamics of microtubules in neurons", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "tau protein", "relationship": "RELATED_PROGNOSIS", "object": "Inhibit apoptosis, particularly in axons", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "hyperphosphorylated tau", "relationship": "RELATED_PROGNOSIS", "object": "Destabilizes microtubules by decreasing the binding affinity of tau, affecting its axonal transport and resulting in its aggregation in Neurofibrillary tangless", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "hyperphosphorylated tau", "relationship": "RELATED_PROGNOSIS", "object": "Proposed as the likely pathological processes that induce the loss of function or gain of tau toxicity, which caused neurodegeneration", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "GSK3\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Plays a key role in the pathogenesis of AD, contributing to A\u03b2 production and A\u03b2-mediated neuronal death by phosphorylating tau in most serine and threonine residues and inducing hyperphosphorylation in Neurofibrillary tangles", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "CDK5", "relationship": "RELATED_PROGNOSIS", "object": "May be a key candidate target for therapeutic gene silencing", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "p38 MAPK", "relationship": "RELATED_PROGNOSIS", "object": "Likely to play a role in the hyperphosphorylation of tau under pathological conditions", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "PP2A", "relationship": "IS_RELATED_TO", "object": "Abnormally hyperphosphorylated tau protein and is the most efficient phosphatase", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "PP2A", "relationship": "REDUCED_ACTIVTY_IN", "object": "AD brain", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "PP2A", "relationship": "INHIBITED_BY", "object": "I2PP2A", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "I2PP2A", "relationship": "PHYSICAL_INTERACTION_WITH", "object": "PP2A", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "I2PP2A", "relationship": "ACTIVATED_BY", "object": "Oxidative stress", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "GSK-3\u03b2", "relationship": "INCREASED_ACTIVITY_IN", "object": "Oxidative stress", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "GSK-3\u03b2", "relationship": "INHIBITS", "object": "PP2A", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Oxidative stress", "relationship": "CONTRIBUTES_TO", "object": "Tau phosphorylation", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Okadaic acid", "relationship": "INHIBITS", "object": "PP2A", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "HSP70", "relationship": "UPREGULATED_BY", "object": "Antioxidants", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Melatonin", "relationship": "REDUCES", "object": "GSK-3\u03b2 activity", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Melatonin", "relationship": "BLOCKS", "object": "Tau hyperphosphorylation", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Vitamins E and C", "relationship": "HAS_A_PROTECTIVE_EFFECT", "object": "Against neurotoxicity", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Gossypin", "relationship": "HAS_A_PROTECTIVE_EFFECT", "object": "Against neurotoxicity", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Curcumin", "relationship": "HAS_A_PROTECTIVE_EFFECT", "object": "Against neurotoxicity", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Beta-carotene", "relationship": "HAS_A_PROTECTIVE_EFFECT", "object": "Against neurotoxicity", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Ginkgo biloba", "relationship": "HAS_A_PROTECTIVE_EFFECT", "object": "Against neurotoxicity", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "tau hyperphosphorylation", "relationship": "RELATED_TO", "object": "autophagic dysfunction", "chunk": 5}
{"article": "PMC4485995.txt", "subject": "tau hyperphosphorylation", "relationship": "ASSOCIATED_WITH", "object": "destabilization of neuronal microtubules", "chunk": 5}
{"article": "PMC4485995.txt", "subject": "tau hyperphosphorylation", "relationship": "ASSOCIATED_WITH", "object": "Neurofibrillary tangles formation", "chunk": 5}
{"article": "PMC4485995.txt", "subject": "tau hyperphosphorylation", "relationship": "INDICATES_PRESENCE_OF", "object": "neuronal dysfunction and death", "chunk": 5}
{"article": "PMC4485995.txt", "subject": "PP2A downregulation", "relationship": "ASSOCIATED_WITH", "object": "autophagy disruption", "chunk": 5}
{"article": "PMC4485995.txt", "subject": "Atg7 conditional knockout", "relationship": "RELATED_TO", "object": "accumulation of phosphorylated tau and GSK3\u03b2", "chunk": 5}
{"article": "PMC4485995.txt", "subject": "genetic reduction of mammalian target of rapamycin", "relationship": "RELATED_TO", "object": "increase in autophagy induction and amelioration of Alzheimer's disease-like cognitive and pathological deficits", "chunk": 5}
{"article": "PMC4485995.txt", "subject": "Induction autophagy adaptor protein NDP52", "relationship": "RELATED_TO", "object": "reduction of tau protein phosphorylation in neurons", "chunk": 5}
{"article": "PMC4487699.txt", "subject": "N-methyl-D-aspartate (NMDA) receptor activity", "relationship": "INDICATES_PRESENCE_OF", "object": "HF rTMS", "chunk": 2}
{"article": "PMC4487699.txt", "subject": "gamma-aminobutyric acid (GABA) mediated inhibition", "relationship": "INDICATES_PRESENCE_OF", "object": "HF rTMS", "chunk": 2}
{"article": "PMC4487699.txt", "subject": "Brain derived neurotrophic factor (BDNF)", "relationship": "RELATED_TREATMENT", "object": "synaptic plasticity", "chunk": 2}
{"article": "PMC4487699.txt", "subject": "total tau (t-Tau)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "stronger inhibition of MEPs, suggesting that also t-Tau modulates excitatory activity and may alter mechanisms of cortical plasticity", "chunk": 5}
{"article": "PMC4487699.txt", "subject": "total tau (t-Tau)", "relationship": "INDICATES_PRESENCE_OF", "object": "higher cerebral spinal fluid t-Tau levels", "chunk": 5}
{"article": "PMC4487699.txt", "subject": "MoCA Test", "relationship": "USED_TO_DIAGNOSE", "object": "Screening for mild cognitive impairment", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "CDR", "relationship": "USED_TO_DIAGNOSE", "object": "Screening for mild cognitive impairment", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "GDS-15", "relationship": "USED_TO_DIAGNOSE", "object": "Screening for depression", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "HAMD-17", "relationship": "USED_TO_DIAGNOSE", "object": "Screening for depression", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "HAMA-14", "relationship": "USED_TO_DIAGNOSE", "object": "Screening for anxiety", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "IQCODE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Decline in the Elderly", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "B-ADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Functional Impairment", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "RBMT", "relationship": "EVALUATES", "object": "Behavioral Memory", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "WMS", "relationship": "EVALUATES", "object": "Memory Function", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "WAIS", "relationship": "EVALUATES", "object": "Cognitive Abilities", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "RAVLT", "relationship": "EVALUATES", "object": "Auditory Verbal Learning and Memory", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "Stroop", "relationship": "EVALUATES", "object": "Executive Function", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "Trail Making Test", "relationship": "EVALUATES", "object": "Executive Function and Visuomotor Skills", "chunk": 6}
{"article": "PMC4489713.txt", "subject": "TDP-43", "relationship": "RELATED_TO", "object": "Ubiquitinated inclusion bodies", "chunk": 1}
{"article": "PMC4489713.txt", "subject": "LC3-I/II", "relationship": "RELATED_TO_DISEASE", "object": "VCPR155H/+ disease pathology", "chunk": 2}
{"article": "PMC4489713.txt", "subject": "p62/SQSTM1", "relationship": "RELATED_TO_DISEASE", "object": "VCPR155H/+ disease pathology", "chunk": 2}
{"article": "PMC4489713.txt", "subject": "TDP-43", "relationship": "RELATED_TO_DISEASE", "object": "VCPR155H/+ disease pathology", "chunk": 2}
{"article": "PMC4489713.txt", "subject": "Ubiquitin", "relationship": "RELATED_TO_DISEASE", "object": "VCPR155H/+ disease pathology", "chunk": 2}
{"article": "PMC4489713.txt", "subject": "Optineurin", "relationship": "RELATED_TO_DISEASE", "object": "VCPR155H/+ disease pathology", "chunk": 2}
{"article": "PMC4489713.txt", "subject": "LC3-I/II", "relationship": "RELATED_TREATMENT", "object": "Increased LED levels display comparable levels of ubiquitin, however, decreased levels of LC3-I and LC3-II protein expressions", "chunk": 3}
{"article": "PMC4489713.txt", "subject": "p62/SQSTM1", "relationship": "RELATED_TREATMENT", "object": "Increased LED levels display comparable levels of ubiquitin, however, decreased levels of LC3-I and LC3-II protein expressions, as well as reduced levels in p62/SQSTM1 protein", "chunk": 3}
{"article": "PMC4489713.txt", "subject": "p62/SQSTM1", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "increased levels in mice fed LED", "chunk": 4}
{"article": "PMC4489713.txt", "subject": "TDP-43", "relationship": "RELATED_PROGNOSIS", "object": "nuclear TDP-43 expression suggests reduced pathological phenotype", "chunk": 4}
{"article": "PMC4489713.txt", "subject": "acid phosphatase", "relationship": "RELATED_TREATMENT", "object": "decreased levels potentially associated with VCP disease", "chunk": 4}
{"article": "PMC4489713.txt", "subject": "lysosomal acid lipase (LAL)", "relationship": "RELATED_TREATMENT", "object": "unchanged expression levels in response to LEDs", "chunk": 4}
{"article": "PMC4489713.txt", "subject": "lipid-enriched diets (LED)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "different percentages investigated for effects on VCP pathology", "chunk": 4}
{"article": "PMC4489713.txt", "subject": "TRPML1", "relationship": "RELATED_TREATMENT", "object": "TRPML1 upregulation potentially for membrane repair in skeletal muscle to prevent muscle dystrophy", "chunk": 5}
{"article": "PMC4489713.txt", "subject": "TRPML1", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Decreased expression associated with lipid accumulation leading to a block in lysosomal trafficking", "chunk": 5}
{"article": "PMC4489713.txt", "subject": "p62/SQSTM1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Decreased expression levels observed in VCPR155H/+ animals on increasing LED in comparison to those on a normal diet", "chunk": 5}
{"article": "PMC4489713.txt", "subject": "LC3", "relationship": "MONITORED_DURING_TREATMENT", "object": "Decreased expression levels of LC3 autophagy intermediates observed in VCPR155H/+ animals on increasing LED compared to those on a normal diet", "chunk": 5}
{"article": "PMC4489713.txt", "subject": "acid phosphatase", "relationship": "MONITORED_DURING_TREATMENT", "object": "Increased levels observed, suggesting the functionality of the autophagy-lysosomal cascade in VCP disease", "chunk": 5}
{"article": "PMC4489713.txt", "subject": "LAL", "relationship": "MONITORED_DURING_TREATMENT", "object": "Increased levels observed, suggesting the functionality of the autophagy-lysosomal cascade in VCP disease", "chunk": 5}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "RELATED_PROGNOSIS", "object": "slower longitundinal cognitive decline", "chunk": 1}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "PREDICT_SURVIVAL", "object": "increased cognitive gains", "chunk": 1}
{"article": "PMC4497726.txt", "subject": "VO2 peak", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measuring cardiorespiratory fitness to personalize exercise prescriptions", "chunk": 2}
{"article": "PMC4497726.txt", "subject": "CDR", "relationship": "USED_TO_DIAGNOSE", "object": "Presence of dementia", "chunk": 2}
{"article": "PMC4497726.txt", "subject": "VO2 peak", "relationship": "RELATED_PROGNOSIS", "object": "VO2 peak was greater in higher dose exercise groups", "chunk": 3}
{"article": "PMC4497726.txt", "subject": "VO2 peak", "relationship": "RELATED_PROGNOSIS", "object": "improved VO2 peak associated with gains in Visuospatial Processing", "chunk": 4}
{"article": "PMC4497726.txt", "subject": "VO2 peak", "relationship": "RELATED_TREATMENT", "object": "Improved VO2 peak mediated the exercise duration effect on improvements in Visuospatial Processing", "chunk": 4}
{"article": "PMC4497726.txt", "subject": "Visuospatial Processing", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Visuospatial Processing improved with 6-months of any exercise", "chunk": 4}
{"article": "PMC4497726.txt", "subject": "Visuospatial Processing", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "improved Visuospatial Processing associated with gains in VO2 peak", "chunk": 4}
{"article": "PMC4497726.txt", "subject": "Simple Attention", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "improved Simple Attention in all exercise groups equivalently indicating an intervention effect", "chunk": 4}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "INDICATES_PRESENCE_OF", "object": "mortality", "chunk": 5}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "RELATED_PROGNOSIS", "object": "cognitive decline", "chunk": 5}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "RELATED_PROGNOSIS", "object": "cardiovascular disease risk", "chunk": 5}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "RELATED_PROGNOSIS", "object": "functional health", "chunk": 5}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "IS_TARGET_OF_TREATMENT", "object": "achieving cognitive benefits", "chunk": 5}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "exercise prescription", "chunk": 5}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "individualized exercise", "chunk": 5}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Risk for Alzheimer's Disease", "chunk": 1}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54 carriers", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "understanding the development of AD", "chunk": 1}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54 carriers", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "for better understanding the development of AD", "chunk": 1}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54 carriers", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "good candidates for learning the development of AD", "chunk": 1}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive performance", "chunk": 2}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "functional changes between cerebellar tonsils and retrosplenial", "chunk": 3}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "increased functional connectivity between left parahippocampal gyrus and right superior frontal cortex", "chunk": 3}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "increased  functional connectivity between left parahippocampal gyrus and medial prefrontal cortex (ventral)", "chunk": 3}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "DIAGNOSTIC_OF", "object": "Risk for Alzheimer's Disease", "chunk": 4}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "Understanding genetic influence on  DMN and cognitive performance in clinical practice", "chunk": 4}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased amyloid-\u03b2 deposition", "chunk": 4}
{"article": "PMC4503593.txt", "subject": "APOE \u03b53\u03b54 allele", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Myelin breakdown and disrupted functional connectivity", "chunk": 4}
{"article": "PMC4511231.txt", "subject": "genetic testing", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "clinical trials for ADAD", "chunk": 1}
{"article": "PMC4511231.txt", "subject": "mutation status", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "participation in clinical trials", "chunk": 1}
{"article": "PMC4511231.txt", "subject": "genetic status", "relationship": "RELATED_PROGNOSIS", "object": "future dementia", "chunk": 1}
{"article": "PMC4511231.txt", "subject": "mutation carriers", "relationship": "RELATED_TREATMENT", "object": "experimental preventative therapies for AD", "chunk": 1}
{"article": "PMC4511231.txt", "subject": "PSEN1", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis: Familial Alzheimer's disease", "chunk": 2}
{"article": "PMC4511231.txt", "subject": "PSEN2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis: Familial Alzheimer's disease", "chunk": 2}
{"article": "PMC4511231.txt", "subject": "APP", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis: Familial Alzheimer's disease", "chunk": 2}
{"article": "PMC4511231.txt", "subject": "APP", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treatment for Alzheimer\u2019s disease", "chunk": 6}
{"article": "PMC4511231.txt", "subject": "amyloid precursor protein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "drugs to treat Alzheimer\u2019s disease", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "amyloid-\u03b2 (A\u03b2)", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal brain amyloid-\u03b2 level", "chunk": 1}
{"article": "PMC4519341.txt", "subject": "apical brain amyloid deposition", "relationship": "ASSOCIATED_WITH", "object": "Faster decline in executive/speed cognitive function", "chunk": 1}
{"article": "PMC4519341.txt", "subject": "apical brain amyloid deposition", "relationship": "ASSOCIATED_WITH", "object": "Faster decline in mean cognition", "chunk": 1}
{"article": "PMC4519341.txt", "subject": "apical brain amyloid deposition", "relationship": "ASSOCIATED_WITH", "object": "Faster decline in language cognitive function", "chunk": 1}
{"article": "PMC4519341.txt", "subject": "apical brain amyloid deposition", "relationship": "ASSOCIATED_WITH", "object": "Faster decline in executive/speed cognitive function in African-Americans", "chunk": 1}
{"article": "PMC4519341.txt", "subject": "apical brain amyloid deposition", "relationship": "ASSOCIATED_WITH", "object": "Faster memory decline in APOE \u03b54 carriers", "chunk": 1}
{"article": "PMC4519341.txt", "subject": "amyloid-\u03b2 (A\u03b2)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "PET imaging is used to detect A\u03b2 plaques in the brain", "chunk": 2}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_PROGNOSIS", "object": "Faster cognitive decline in later years", "chunk": 2}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_PROGNOSIS", "object": "Underlying subtle cognitive deficit", "chunk": 2}
{"article": "PMC4519341.txt", "subject": "apoE4 (APOE)", "relationship": "USED_TO_DIAGNOSE", "object": "Early-onset Alzheimer's Disease", "chunk": 2}
{"article": "PMC4519341.txt", "subject": "18F-Florbetaben", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Visual rating of brain A\u03b2 deposition", "chunk": 3}
{"article": "PMC4519341.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "Participants with one or two APOE \u03b54 alleles had significantly higher SUVR than those without \u03b54 allele globally and in each region", "chunk": 4}
{"article": "PMC4519341.txt", "subject": "APOE \u03b54 allele", "relationship": "DIAGNOSTIC_OF", "object": "Diagnose: Prospective", "chunk": 4}
{"article": "PMC4519341.txt", "subject": "vA\u03b2 positive", "relationship": "INDICATES_PRESENCE_OF", "object": "higher global SUVR values, higher A\u03b2 SUVR values in each of the ROIs", "chunk": 4}
{"article": "PMC4519341.txt", "subject": "AGE", "relationship": "INDICATES_PRESENCE_OF", "object": "Trending to increase  A\u03b2 SUVR, although not significantly", "chunk": 4}
{"article": "PMC4519341.txt", "subject": "vA\u03b2 positive", "relationship": "RELATED_TREATMENT", "object": "Participants with positive vA\u03b2 declined in executive/speed at a rate that was 0.034 points/year greater than that of subjects with negative vA\u03b2", "chunk": 4}
{"article": "PMC4519341.txt", "subject": "higher A\u03b2 burden in the temporal region", "relationship": "RELATED_TREATMENT", "object": "associated with faster decline in speed (one unit increase in SUVR values was associated with 0.080 points/year faster decline)", "chunk": 4}
{"article": "PMC4519341.txt", "subject": "PET A\u03b2", "relationship": "RELATED_TREATMENT", "object": "associated with a larger amount of annual decline on mean cognition, language, and executive/speed scores in African-Americans but not in Whites", "chunk": 5}
{"article": "PMC4519341.txt", "subject": "PET A\u03b2", "relationship": "RELATED_TREATMENT", "object": "associated with a faster decline in memory in APOE \u03b54 carriers, but not in APOE \u03b54 negative subjects", "chunk": 5}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO_PROGNOSIS", "object": "faster decline in executive/speed", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO_PROGNOSIS", "object": "faster decline in language, speed, and mean cognitive scores", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO_PROGNOSIS", "object": "faster decline in verbal memory", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO_PROGNOSIS", "object": "faster decline in visual memory", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO_PROGNOSIS", "object": "steeper trajectories of semantic fluency", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO_PROGNOSIS", "object": "steeper trajectories of working memory", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO_PROGNOSIS", "object": "steeper trajectories of visuospatial ability", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "faster decline in executive/speed", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "faster decline in language, speed, and mean cognitive scores", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "faster decline in verbal memory", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "faster decline in visual memory", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "steeper trajectories of semantic fluency", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "steeper trajectories of working memory", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "steeper trajectories of visuospatial ability", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 SUVR", "relationship": "RELATED_TO_PROGNOSIS", "object": "faster decline in executive/speed scores", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 SUVR", "relationship": "RELATED_TO_PROGNOSIS", "object": "faster decline in mean cognition", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "APOE \u03b54 allele", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Genetic risk factor for Alzheimer's Disease", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "APOE \u03b54 allele", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Risk factor for Alzheimer's Disease", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline", "chunk": 7}
{"article": "PMC4519341.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH", "object": "Accelerated decline in executive/speed function", "chunk": 7}
{"article": "PMC4519341.txt", "subject": "APOE genotype", "relationship": "RELATED_TO", "object": "Cognitive decline", "chunk": 7}
{"article": "PMC4526582.txt", "subject": "[18F]flutemetamol", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Treatment with flutemetamol (18F) injection", "chunk": 3}
{"article": "PMC4526582.txt", "subject": "[18F]flutemetamol", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4526582.txt", "subject": "[18F]flutemetamol", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "mild cognitive impairment", "chunk": 1}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "RELATED_PROGNOSIS", "object": "progression of AD", "chunk": 1}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "assessing the effectiveness of purported AD treatments", "chunk": 1}
{"article": "PMC4529274.txt", "subject": "retinal thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 2}
{"article": "PMC4529274.txt", "subject": "reduced retinal thickness", "relationship": "RELATED_PROGNOSIS", "object": "age-related processes, such as for instance supranuclear cataract and opacities of ocular lens", "chunk": 2}
{"article": "PMC4529274.txt", "subject": "reduced retinal thickness", "relationship": "RELATED_PROGNOSIS", "object": "pathological neural degeneration undoubtedly associated with mild cognitive impairment  and AD", "chunk": 2}
{"article": "PMC4529274.txt", "subject": "retinal thickness", "relationship": "MONITORED_DURING_TREATMENT", "object": "Progression from normal and abnormal age-related processes", "chunk": 2}
{"article": "PMC4529274.txt", "subject": "RNFL (retinal nerve fiber layer)", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "RELATED_PROGNOSIS", "object": "AD diagnosis", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "RELATED_PROGNOSIS", "object": "MMSE score", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Reduced RNFL in AD patients", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Significant association between RNFL thickness in superior and nasal quadrants, and MMSE score", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "Retinal involvement", "relationship": "INDICATES_PRESENCE_OF", "object": "Early event in the course of Alzheimer's disease", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "Enlarged optic cup to disc ratio", "relationship": "RELATED_TO", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "PERG (pattern electroretinography)", "relationship": "RELATED_TO", "object": "NFL overall values", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "RELATED_TO", "object": "Severity of AD", "chunk": 4}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "DIAGNOSTIC_OF", "object": "Differentiating AD from normal ageing", "chunk": 5}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "Degeneration of retinal ganglion cells", "chunk": 5}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "RELATED_PROGNOSIS", "object": "Annual incidence of conversion to AD", "chunk": 5}
{"article": "PMC4529274.txt", "subject": "MRI measurements of the brain", "relationship": "RELATED_TO", "object": "Potential correlation", "chunk": 5}
{"article": "PMC4545875.txt", "subject": "Mini Mental State Examination (MMSE)", "relationship": "RELATED_PROGNOSIS", "object": "Disease Severity Classification (Mild, Moderate, Severe)", "chunk": 1}
{"article": "PMC4545875.txt", "subject": "PLI", "relationship": "RELATED_PROGNOSIS", "object": "decrease in functional connectivity is associated with increasing disease severity", "chunk": 3}
{"article": "PMC4545875.txt", "subject": "BC", "relationship": "RELATED_PROGNOSIS", "object": " increasing BC values in the global and anterior regions in the lower alpha band, in the global, anterior, and central regions in the upper alpha band, and in the anterior region in the beta band", "chunk": 3}
{"article": "PMC4545875.txt", "subject": "BC", "relationship": "RELATED_PROGNOSIS", "object": "decreasing BC values in the beta band in the posterior region", "chunk": 3}
{"article": "PMC4545875.txt", "subject": "center of mass of the BC values", "relationship": "RELATED_PROGNOSIS", "object": " back-to-front shifting of the center of mass from the posterior to the central regions, as indicated by the y-values, increased with increasing disease severity", "chunk": 3}
{"article": "PMC4545875.txt", "subject": "center of mass of the BC values", "relationship": "RELATED_PROGNOSIS", "object": "left-to-right shifting of the center of mass was significant only in the beta band indicating a shift to the right side of the brain in the most severely affected AD patients", "chunk": 3}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Early cognitive impairment (includes mild cognitive impairment and Alzheimer's disease)", "chunk": 1}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Staging of Alzheimer's disease", "chunk": 1}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "RELATED_PROGNOSIS", "object": "Provides better sensitivity for detecting mild cognitive impairment and Alzheimer's disease compared to MMSE", "chunk": 1}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "RELATED_PROGNOSIS", "object": "Captures wide range of mild cognitive impairment cases with less ceiling effect compared to MMSE", "chunk": 1}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Can aid in the earlier diagnosis and management of Alzheimer's disease", "chunk": 1}
{"article": "PMC4562190.txt", "subject": "MoCA \u226517", "relationship": "DIAGNOSITC_OF", "object": "Mild cognitive impairment cases", "chunk": 1}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild Cognitive Impairment", "chunk": 2}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "DIAGNOSTIC_OF", "object": "AD dementia", "chunk": 2}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "DIAGNOSTIC_OF", "object": "Mild Cognitive Impairment", "chunk": 2}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Distinguishing Mild Cognitive Impairment cases from HC and AD Dementia", "chunk": 2}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "RELATED_TREATMENT", "object": "Functional scale evaluation", "chunk": 2}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "Functional scale evaluation", "chunk": 2}
{"article": "PMC4562190.txt", "subject": "MoCA domain subscores", "relationship": "RELATED_TREATMENT", "object": "Functional scale evaluation", "chunk": 2}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "Dementia", "chunk": 3}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "DIAGNOSITC_OF", "object": "Dementia", "chunk": 3}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Impairment level", "chunk": 3}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "RELATED_PROGNOSIS", "object": "Impairment level", "chunk": 3}
{"article": "PMC4562190.txt", "subject": "FAQ", "relationship": "INDICATES_PRESENCE_OF", "object": "Impaired function consistent with dementia", "chunk": 3}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 4}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 4}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "DIAGNOSITC_OF", "object": "Mild cognitive impairment", "chunk": 4}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "RELATED_PROGNOSIS", "object": "Earlier detection of mild cognitive impairment", "chunk": 4}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Helps clinicians select appropriate treatment options", "chunk": 4}
{"article": "PMC4562190.txt", "subject": "MoCA score (\u226430)", "relationship": "INDICATES_PRESENCE_OF", "object": "Range of severity of mild cognitive impairment   patients", "chunk": 5}
{"article": "PMC4562190.txt", "subject": "MoCA cutoff value (\u226517 to 19)", "relationship": "INDICATES_PRESENCE_OF", "object": "mild cognitive impairment   cases", "chunk": 5}
{"article": "PMC4562190.txt", "subject": "MoCA score (<24)", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia cases", "chunk": 5}
{"article": "PMC4562190.txt", "subject": "MoCA score (\u226517)", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia cases", "chunk": 5}
{"article": "PMC4563885.txt", "subject": "Western diet", "relationship": "ASSOCIATED_WITH", "object": "smaller left hippocampal volume", "chunk": 1}
{"article": "PMC4563885.txt", "subject": "healthy 'prudent' dietary pattern", "relationship": "ASSOCIATED_WITH", "object": "larger left hippocampal volume", "chunk": 1}
{"article": "PMC4563885.txt", "subject": "high fat/refined sugar (cafeteria) diets", "relationship": "RELATED_TO", "object": "reduced BDNF levels", "chunk": 1}
{"article": "PMC4563885.txt", "subject": "omega-3 fatty acids", "relationship": "STIMULATES", "object": "neurogenesis", "chunk": 1}
{"article": "PMC4563885.txt", "subject": "flavonoids", "relationship": "STIMULATES", "object": "neurogenesis", "chunk": 1}
{"article": "PMC4563885.txt", "subject": "antioxidant-rich berries", "relationship": "STIMULATES", "object": "neurogenesis", "chunk": 1}
{"article": "PMC4563885.txt", "subject": "resveratrol", "relationship": "STIMULATES", "object": "neurogenesis", "chunk": 1}
{"article": "PMC4563885.txt", "subject": "high fat and high sugar foods", "relationship": "REDUCES", "object": "neuronal proliferation", "chunk": 1}
{"article": "PMC4563885.txt", "subject": "high fat and high sugar foods", "relationship": "INCREASES", "object": "production of reactive oxygen species", "chunk": 1}
{"article": "PMC4563885.txt", "subject": "high fat and high sugar foods", "relationship": "INCREASES", "object": "up-regulation of pro-inflammatory processes", "chunk": 1}
{"article": "PMC4563885.txt", "subject": "Prudent dietary pattern", "relationship": "RELATED_PROGNOSIS", "object": "Larger left hippocampal volume", "chunk": 3}
{"article": "PMC4563885.txt", "subject": "Western dietary pattern", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Smaller left hippocampal volume", "chunk": 3}
{"article": "PMC4563885.txt", "subject": "Western dietary factor", "relationship": "INDICATES_PRESENCE_OF", "object": "Unhealthy Diet", "chunk": 4}
{"article": "PMC4563885.txt", "subject": "Prudent dietary factor", "relationship": "INDICATES_PRESENCE_OF", "object": "Healthy Diet", "chunk": 4}
{"article": "PMC4563885.txt", "subject": "Western dietary factor", "relationship": "ASSOCIATED_WITH", "object": "Smaller left hippocampal volumes", "chunk": 4}
{"article": "PMC4563885.txt", "subject": "Prudent dietary factor", "relationship": "ASSOCIATED_WITH", "object": "Larger left hippocampal volumes in older adults", "chunk": 4}
{"article": "PMC4563885.txt", "subject": "BDNF", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function", "chunk": 4}
{"article": "PMC4563885.txt", "subject": "High-fat and sucrose diet", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Impairments in neuronal plasticity, learning and behaviour", "chunk": 4}
{"article": "PMC4563885.txt", "subject": "High-fat and sucrose diet", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive deficits", "chunk": 4}
{"article": "PMC4563885.txt", "subject": "High-fat and sucrose diet", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Decreases in BDNF", "chunk": 4}
{"article": "PMC4563885.txt", "subject": "Polyphenols", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Dietary interventions for targeting hippocampal health", "chunk": 4}
{"article": "PMC4563885.txt", "subject": "Polyphenols", "relationship": "RELATED_TREATMENT", "object": "Dietary interventions", "chunk": 4}
{"article": "PMC4563885.txt", "subject": "Flavonoids", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Increased BDNF", "chunk": 4}
{"article": "PMC4563885.txt", "subject": "Omega-3 fatty acids", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Promote neurogenesis", "chunk": 4}
{"article": "PMC4563885.txt", "subject": "Vitamin E", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Reversible hippocampal-associated cognitive impairments", "chunk": 4}
{"article": "PMC4568340.txt", "subject": "amyloid beta peptides (A\u03b2)", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4568340.txt", "subject": "Apolipoprotein E (ApoE) \u03b54 allele", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "earlier age of onset of dementia", "chunk": 1}
{"article": "PMC4568340.txt", "subject": "Apolipoprotein E (ApoE) \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "greater accumulation of A\u03b2 plaques in the brains of adults with DS", "chunk": 1}
{"article": "PMC4568340.txt", "subject": "hippocampal atrophy", "relationship": "RELATED_PROGNOSIS", "object": "onset of dementia in older adults with DS", "chunk": 1}
{"article": "PMC4568340.txt", "subject": "plasma A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "increasing levels", "chunk": 1}
{"article": "PMC4568340.txt", "subject": "ApoE", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Not mentioned in text.", "chunk": 2}
{"article": "PMC4568340.txt", "subject": "tau PET", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC4568340.txt", "subject": "Amyvid PET", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC4568340.txt", "subject": "FDG PET", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC4568340.txt", "subject": "vMRI", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC4568340.txt", "subject": "Retinal amyloid imaging", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC4568340.txt", "subject": "Plasma, Serum", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Not mentioned in text.", "chunk": 2}
{"article": "PMC4568340.txt", "subject": "A\u03b2 38", "relationship": "ASSAYED_QUANTIFIED", "object": "using the MesoScale Validated A\u03b2 triplex", "chunk": 3}
{"article": "PMC4568340.txt", "subject": "A\u03b2 40", "relationship": "ASSAYED_QUANTIFIED", "object": "using the MesoScale Validated A\u03b2 triplex", "chunk": 3}
{"article": "PMC4568340.txt", "subject": "A\u03b2 42", "relationship": "ASSAYED_QUANTIFIED", "object": "using the MesoScale Validated A\u03b2 triplex", "chunk": 3}
{"article": "PMC4568340.txt", "subject": "Apolipoprotein E (ApoE)", "relationship": "GENOTYPED", "object": "using real time PCR Restriction Fragment Length Polymorphism analysis", "chunk": 3}
{"article": "PMC4568340.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "comparison of cognitive and functional performance", "chunk": 4}
{"article": "PMC4568340.txt", "subject": "apoe4", "relationship": "RELATED_TREATMENT", "object": "compared ApoE\u03b54 carriers and non-carriers", "chunk": 4}
{"article": "PMC4568340.txt", "subject": "Amyloid PET", "relationship": "RELATED_PROGNOSIS", "object": "Gray matter amyloid PET signal", "chunk": 5}
{"article": "PMC4568340.txt", "subject": "amyloid PET", "relationship": "INDICATES_PRESENCE_OF", "object": "Fibrillar amyloid plaque deposition", "chunk": 5}
{"article": "PMC4568340.txt", "subject": "Plasma A\u03b21\u201342", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Elevated levels", "chunk": 5}
{"article": "PMC4568340.txt", "subject": "Plasma A\u03b21\u201342:A\u03b21\u201340 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "preclinical AD in adults with DS ", "chunk": 5}
{"article": "PMC4568340.txt", "subject": "Florbetapir (AV45) uptake", "relationship": "RELATED_TREATMENT", "object": "A\u03b2 amyloid deposition", "chunk": 5}
{"article": "PMC4568340.txt", "subject": "Florbetapir (AV45) uptake", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid plaques in the retina", "chunk": 5}
{"article": "PMC4568340.txt", "subject": "FDG Uptake", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Staging of Alzheimer's disease", "chunk": 5}
{"article": "PMC4568340.txt", "subject": "Retinal amyloid", "relationship": "MONITORED_DURING_TREATMENT", "object": "Progress of Alzheimer's disease", "chunk": 5}
{"article": "PMC4568340.txt", "subject": "A\u03b2 plaque", "relationship": "RELATED_TO", "object": "Structural and functional abnormalities", "chunk": 6}
{"article": "PMC4568340.txt", "subject": "A\u03b2 plaques", "relationship": "INDICATES_PRESENCE_OF", "object": "Preclinical AD", "chunk": 6}
{"article": "PMC4568340.txt", "subject": "A\u03b21\u201342", "relationship": "ASSOCIATED_WITH", "object": "Plasma biomarker findings consistent with", "chunk": 6}
{"article": "PMC4568340.txt", "subject": "A\u03b2 PET", "relationship": "RELATED_TO", "object": "Biomarker changes", "chunk": 6}
{"article": "PMC4568340.txt", "subject": "Tau PET", "relationship": "RELATED_TO", "object": "Biomarker changes", "chunk": 6}
{"article": "PMC4568340.txt", "subject": "A\u03b2 PET imaging", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Anti-A\u03b2 therapy", "chunk": 6}
{"article": "PMC4585277.txt", "subject": "oxytocin", "relationship": "RELATED_PROGNOSIS", "object": "social and health benefits of music", "chunk": 1}
{"article": "PMC4585277.txt", "subject": "oxytocin", "relationship": "RELATED_TREATMENT", "object": "suppressive effects on the HPA axis, including ACTH", "chunk": 1}
{"article": "PMC4585277.txt", "subject": "ACTH", "relationship": "RELATED_TREATMENT", "object": "stimulates the synthesis and release of glucocorticoids, such as cortisol, from the adrenal gland", "chunk": 1}
{"article": "PMC4585277.txt", "subject": "ACTH", "relationship": "RELATED_PROGNOSIS", "object": "engagement and arousal effects of music", "chunk": 1}
{"article": "PMC4585277.txt", "subject": "oxytocin", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "maternal behaviors such as mother-infant bonding, breast-feeding, and uterine contractions", "chunk": 1}
{"article": "PMC4585277.txt", "subject": "ACTH", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment conditions: pre-composed singing performance and improvised performance", "chunk": 3}
{"article": "PMC4585277.txt", "subject": "oxytocin", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment conditions: pre-composed singing performance and improvised performance", "chunk": 3}
{"article": "PMC4585277.txt", "subject": "Oxytocin", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Whether or not subjects would undergo a blood draw", "chunk": 4}
{"article": "PMC4585277.txt", "subject": "ACTH", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Whether or not subjects would undergo a blood draw", "chunk": 4}
{"article": "PMC4585277.txt", "subject": "Oxytocin", "relationship": "MONITORED_DURING_TREATMENT", "object": "A blood draw after the standard performance", "chunk": 4}
{"article": "PMC4585277.txt", "subject": "ACTH", "relationship": "MONITORED_DURING_TREATMENT", "object": "A blood draw after the standard performance", "chunk": 4}
{"article": "PMC4585277.txt", "subject": "Oxytocin", "relationship": "MONITORED_DURING_TREATMENT", "object": "A blood draw after the improvised performance", "chunk": 4}
{"article": "PMC4585277.txt", "subject": "ACTH", "relationship": "MONITORED_DURING_TREATMENT", "object": "A blood draw after the improvised performance", "chunk": 4}
{"article": "PMC4585277.txt", "subject": "ACTH", "relationship": "MONITORED_DURING_TREATMENT", "object": "Group singing intervention", "chunk": 5}
{"article": "PMC4585277.txt", "subject": "Oxytocin", "relationship": "MONITORED_DURING_TREATMENT", "object": "Group singing intervention", "chunk": 5}
{"article": "PMC4585277.txt", "subject": "ACTH", "relationship": "RELATED_PROGNOSIS", "object": "Inverse relationship with oxytocin levels suggests a possible link to social flow experience", "chunk": 5}
{"article": "PMC4585277.txt", "subject": "ACTH", "relationship": "RELATED_TREATMENT", "object": "Stress and Arousal", "chunk": 6}
{"article": "PMC4585277.txt", "subject": "ACTH", "relationship": "MONITORED_DURING_TREATMENT", "object": "During active music production", "chunk": 6}
{"article": "PMC4585277.txt", "subject": "Oxytocin", "relationship": "RELATED_TREATMENT", "object": "Social bonding", "chunk": 6}
{"article": "PMC4585277.txt", "subject": "Oxytocin", "relationship": "MONITORED_DURING_TREATMENT", "object": "During active music production", "chunk": 6}
{"article": "PMC4606063.txt", "subject": "A\u03b242", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Early detection of Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4606063.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 deposition in plaques", "chunk": 2}
{"article": "PMC4606063.txt", "subject": "Total tau (T-tau)", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuroaxonal degeneration", "chunk": 2}
{"article": "PMC4606063.txt", "subject": "Phosphorylated tau (P-tau)", "relationship": "INDICATES_PRESENCE_OF", "object": "Brain tangle pathology", "chunk": 2}
{"article": "PMC4606063.txt", "subject": "\u03b1-synuclein", "relationship": "USED_TO_DIAGNOSE", "object": "Dementia with Lewy bodies (DLB)", "chunk": 2}
{"article": "PMC4606063.txt", "subject": "amyloid PET", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The virtual biobank provides an estimation of the number of samples", "chunk": 3}
{"article": "PMC4606063.txt", "subject": "amyloid PET", "relationship": "RELATED_TREATMENT", "object": "The virtual biobank provides an estimation of the number of samples", "chunk": 3}
{"article": "PMC4606063.txt", "subject": "MRI data", "relationship": "RELATED_TREATMENT", "object": "The virtual biobank provides an estimation of the number of samples", "chunk": 3}
{"article": "PMC4606063.txt", "subject": "MRI data", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The virtual biobank provides an estimation of the number of samples", "chunk": 3}
{"article": "PMC4606063.txt", "subject": "MMSE", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer\u2019s disease", "chunk": 4}
{"article": "PMC4606063.txt", "subject": "CDR overall", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 4}
{"article": "PMC4606063.txt", "subject": "Word list immediate recall", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 4}
{"article": "PMC4606063.txt", "subject": "Word list delayed recall", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 4}
{"article": "PMC4606063.txt", "subject": "Story immediate recall", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 4}
{"article": "PMC4606063.txt", "subject": "Story delayed recall", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 4}
{"article": "PMC4606063.txt", "subject": "Fluency", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 4}
{"article": "PMC4606063.txt", "subject": "Copy figures", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 4}
{"article": "PMC4606063.txt", "subject": "TMTA", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 4}
{"article": "PMC4606063.txt", "subject": "TMTB", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 4}
{"article": "PMC4606063.txt", "subject": "Erythrocyte count >500/\u03bcL", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 4}
{"article": "PMC4606063.txt", "subject": "cerebral spinal fluid", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "BIOMARKAPD project aims to standardize the assessment of existing assays and to validate novel fluid biomarkers for AD and PD", "chunk": 5}
{"article": "PMC4606063.txt", "subject": "plasma", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "BIOMARKAPD project aims to standardize the assessment of existing assays and to validate novel fluid biomarkers for AD and PD", "chunk": 5}
{"article": "PMC4606063.txt", "subject": "serum", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "BIOMARKAPD project aims to standardize the assessment of existing assays and to validate novel fluid biomarkers for AD and PD", "chunk": 5}
{"article": "PMC4606063.txt", "subject": "biomarkers", "relationship": "RELATED_TO", "object": "Diagnosis and prognosis of neurodegenerative disorderssss", "chunk": 5}
{"article": "PMC4611062.txt", "subject": "N200", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline", "chunk": 2}
{"article": "PMC4611062.txt", "subject": "N200", "relationship": "ARE_RELATED_TO", "object": "Cognitive processes of stimulus evaluation, selective attention, and conscious discrimination", "chunk": 2}
{"article": "PMC4611062.txt", "subject": "P300", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline", "chunk": 2}
{"article": "PMC4611062.txt", "subject": "P300", "relationship": "RELATED_TO", "object": "Endogenous brain response that occurs as a positive deflection, roughly, 300 ms after the onset of stimulus whenever the subject detects a meaningful task-relevant stimulus", "chunk": 2}
{"article": "PMC4611062.txt", "subject": "N100", "relationship": "RELATED_PROGNOSIS", "object": "General attention", "chunk": 4}
{"article": "PMC4611062.txt", "subject": "N200", "relationship": "RELATED_PROGNOSIS", "object": "Pre-attentive detection", "chunk": 4}
{"article": "PMC4611062.txt", "subject": "N200", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive process of stimulus evaluation, selective attention, and conscious discrimination", "chunk": 4}
{"article": "PMC4611062.txt", "subject": "P300", "relationship": "RELATED_PROGNOSIS", "object": "Selective attention or cognitive ability", "chunk": 4}
{"article": "PMC4611062.txt", "subject": "P300", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Brain functioning", "chunk": 4}
{"article": "PMC4611062.txt", "subject": "PAC measurements", "relationship": "RELATED_PROGNOSIS", "object": "Detecting amild cognitive impairment", "chunk": 6}
{"article": "PMC4611062.txt", "subject": "\u03b31 rhythm", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Higher Wscores, indicating better discriminability", "chunk": 6}
{"article": "PMC4611062.txt", "subject": "SW component", "relationship": "RELATED_TREATMENT", "object": "Related to discriminability of \u03b11/\u03b12 rhythm", "chunk": 6}
{"article": "PMC4611062.txt", "subject": "TVPAC measurements", "relationship": "INDICATES_PRESENCE_OF", "object": "amild cognitive impairment", "chunk": 7}
{"article": "PMC4611062.txt", "subject": "increased CFC", "relationship": "ASSOCIATED_WITH", "object": "cognitive responses", "chunk": 7}
{"article": "PMC4611062.txt", "subject": "Relative-difference in CFC", "relationship": "RELATED_TO", "object": "deviation from normal behavior", "chunk": 7}
{"article": "PMC4611062.txt", "subject": "TVPAC-measurements", "relationship": "IS_BASIS_FOR", "object": "amild cognitive impairment detection biomarker", "chunk": 7}
{"article": "PMC4611062.txt", "subject": "TVPAC", "relationship": "RELATED_TREATMENT", "object": "detect mild cognitive impairment", "chunk": 9}
{"article": "PMC4611062.txt", "subject": "phase-to-amplitude coupling (PAC)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "the proposed biomarker", "chunk": 9}
{"article": "PMC4611062.txt", "subject": "CFC", "relationship": "RELATED_PROGNOSIS", "object": "relationship to early cognitive decline", "chunk": 9}
{"article": "PMC4611062.txt", "subject": "\u03b4 amplitude", "relationship": "RELATED_PROGNOSIS", "object": "decreased amplitude related to mild cognitive impairment", "chunk": 10}
{"article": "PMC4611062.txt", "subject": "\u03b4 phase coupling", "relationship": "INDICATES_PRESENCE_OF", "object": "increased attention in patients with mild cognitive impairment", "chunk": 10}
{"article": "PMC4611062.txt", "subject": "\u03b8 oscillations", "relationship": "RELATED_TO", "object": "attention focusing and memory processes", "chunk": 10}
{"article": "PMC4611062.txt", "subject": "\u03b8 phase coupling", "relationship": "RELATED_TO", "object": "cognitive processes related to memory", "chunk": 10}
{"article": "PMC4611062.txt", "subject": "PAC value (\u03b4\u2212\u03b12, \u03b8\u2212\u03b12, \u03b8\u2212\u03b21, \u03b8\u2212\u03b3, \u03b21\u2212\u03b3 and \u03b22\u2212\u03b3)", "relationship": "INDICATES_PRESENCE_OF", "object": "higher demands for synchronization between memory and attention state in patients with mild cognitive impairment", "chunk": 10}
{"article": "PMC4611062.txt", "subject": "\u03b8:\u03b3 phase-amplitude CFC in the hippocampus", "relationship": "RELATED_TO", "object": "simultaneous maintenance of multiple items in working memory", "chunk": 10}
{"article": "PMC4611062.txt", "subject": "phase of \u03b2 sub-bands", "relationship": "RELATED_TO", "object": "higher PAC synchronization with \u03b3 in patients with mild cognitive impairment, indicating high demands to shift the system to an attention state", "chunk": 10}
{"article": "PMC4611062.txt", "subject": "PAC in cognitive responses", "relationship": "MAY_BE_LISTED_AMONG", "object": "known functional changes due to mild cognitive impairment", "chunk": 11}
{"article": "PMC4611062.txt", "subject": "PAC", "relationship": "CAN_LEAD_TO", "object": "reliable biomarkers", "chunk": 11}
{"article": "PMC4611062.txt", "subject": "PAC", "relationship": "CAN_SERVE_AS_THE_BASIS_OF", "object": "diagnostic and prognostic tools", "chunk": 11}
{"article": "PMC4611852.txt", "subject": "Speech tempo", "relationship": "INDICATES_PRESENCE_OF", "object": "Early stage of Alzheimer's Disease", "chunk": 1}
{"article": "PMC4611852.txt", "subject": "Hesitation ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Early stage of Alzheimer's Disease", "chunk": 1}
{"article": "PMC4611852.txt", "subject": "Articulation tempo", "relationship": "INDICATES_PRESENCE_OF", "object": "Moderate Alzheimer's Disease", "chunk": 1}
{"article": "PMC4611852.txt", "subject": "Semantic verbal fluency", "relationship": "RELATED_TO", "object": "Diagnosis of Early Alzheimer's Disease", "chunk": 1}
{"article": "PMC4611852.txt", "subject": "Phonological verbal fluency", "relationship": "RELATED_TO", "object": "Diagnosis of Early Alzheimer's Disease", "chunk": 1}
{"article": "PMC4611852.txt", "subject": "Shortened text production", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease", "chunk": 1}
{"article": "PMC4611852.txt", "subject": "Less relevant information in texts", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease", "chunk": 1}
{"article": "PMC4611852.txt", "subject": "Multiple error types in texts", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease", "chunk": 1}
{"article": "PMC4611852.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment in AD", "chunk": 2}
{"article": "PMC4611852.txt", "subject": "CDR", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment in AD", "chunk": 2}
{"article": "PMC4611852.txt", "subject": "verbal fluency", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "amnestic mild cognitive impairment", "chunk": 2}
{"article": "PMC4611852.txt", "subject": "Semantic memory", "relationship": "RELATED_PROGNOSIS", "object": "Overall cognitive ability", "chunk": 2}
{"article": "PMC4611852.txt", "subject": "Episodic memory", "relationship": "RELATED_PROGNOSIS", "object": "Overall cognitive ability", "chunk": 2}
{"article": "PMC4611852.txt", "subject": "mPRC damage", "relationship": "PREDICTS_SURVIVAL", "object": "Early AD detection with semantic memory tests", "chunk": 2}
{"article": "PMC4611852.txt", "subject": "fMRI", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Diagnosis and investigation of language impairments in AD", "chunk": 2}
{"article": "PMC4611852.txt", "subject": "DTI", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Diagnosis and investigation of language impairments in AD", "chunk": 2}
{"article": "PMC4611852.txt", "subject": "PET", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Diagnosis and investigation of language impairments in AD", "chunk": 2}
{"article": "PMC4611852.txt", "subject": "articulatory and syntactic domains of language", "relationship": "RELATED_TREATMENT", "object": "Impairment typically present in late stages of AD", "chunk": 2}
{"article": "PMC4611852.txt", "subject": "articulation rate", "relationship": "RELATED_TO", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4611852.txt", "subject": "speech tempo", "relationship": "RELATED_TO", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4611852.txt", "subject": "hesitation ratio", "relationship": "RELATED_TO", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4611852.txt", "subject": "grammatical error ratio", "relationship": "RELATED_TO", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4611852.txt", "subject": "speech rate", "relationship": "RELATED_TO", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4611852.txt", "subject": "break analysis", "relationship": "RELATED_TO", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4611852.txt", "subject": "hesitation number and time", "relationship": "RELATED_TO", "object": "Moderate or Severe Alzheimer's Disease", "chunk": 3}
{"article": "PMC4611852.txt", "subject": "accessing the mental lexicon", "relationship": "RELATED_TO", "object": "Moderate or Severe Alzheimer's Disease", "chunk": 3}
{"article": "PMC4611852.txt", "subject": "semantic processing", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The identification and understanding of the extent of semantic processing deficits are crucial for developing tailored language therapies", "chunk": 4}
{"article": "PMC4611852.txt", "subject": "lexical decision", "relationship": "RELATED_TO", "object": "Speech parameters", "chunk": 4}
{"article": "PMC4615808.txt", "subject": "ApoE", "relationship": "INDICATES_PRESENCE_OF", "object": "Senile plaques in patients with AD", "chunk": 1}
{"article": "PMC4615808.txt", "subject": "ApoE\u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Senile plaques in patients with AD", "chunk": 1}
{"article": "PMC4615808.txt", "subject": "ApoE", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Brain function through lipid transport", "chunk": 1}
{"article": "PMC4615808.txt", "subject": "Diabetes", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk of developing AD", "chunk": 1}
{"article": "PMC4615808.txt", "subject": "Apolipoprotein E", "relationship": "RELATED_TREATMENT", "object": "Statins", "chunk": 1}
{"article": "PMC4615808.txt", "subject": "ApoE\u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurofibrillary tangles formation", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "ApoE\u03b54", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Neurofibrillary tangles formation", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "high levels of low-density lipoprotein cholesterol", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "higher amyloid-PET indices", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "low levels of high-density lipoprotein cholesterol", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "higher amyloid-PET indices", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "deleteion of ABCA7", "relationship": "CAUSES", "object": "increased A\u03b2 accumulation in amyloid precursor protein transgenic (APP Tg) mice through reduced phagocytic clearance of A\u03b2", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "statins", "relationship": "RELATED_TREATMENT", "object": "reduces A\u03b2 levels in the brain", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "statins", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "preventing AD in late life", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "statins", "relationship": "RELATED_PROGNOSIS", "object": "preventingAD", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "statins", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Individual", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "statins", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "modify the genetic and non-genetic risk factors for AD", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "LRP1", "relationship": "IS_TARGET_OF_TREATMENT", "object": "increased by statins", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "ApoE\u03b53", "relationship": "RELATED_PROGNOSIS", "object": "Associated with lower risk of Neurofibrillary tangles formation", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "bin1", "relationship": "RELATED_PROGNOSIS", "object": "May correlate with Neurofibrillary tangles in AD", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "statin", "relationship": "RELATED_PROGNOSIS", "object": "reduce Neurofibrillary tangles", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "cholesterol metabolism impairment", "relationship": "RELATED_PROGNOSIS", "object": "CAUSES neurodegeneration", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "impaired cholesterol metabolism", "relationship": "RELATED_PROGNOSIS", "object": "assocciated with neurodegenerative disorders", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "phosphatidylinositol-binding clathrin assembly protein (PICALM)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Statins administered in midlife", "chunk": 2}
{"article": "PMC4615808.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "neurodegeneration resulting in marked cognitive deficits", "chunk": 3}
{"article": "PMC4615808.txt", "subject": "high-fat diet", "relationship": "PREDICTS_SURVIVAL", "object": "cause A\u03b2 accumulation", "chunk": 3}
{"article": "PMC4615808.txt", "subject": "acute hyperglycemia", "relationship": "PREDICTS_SURVIVAL", "object": "increases A\u03b2 production", "chunk": 3}
{"article": "PMC4615808.txt", "subject": "insulin-degrading enzymes", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "change A\u03b2 levels in the brain through proteolysis", "chunk": 3}
{"article": "PMC4615808.txt", "subject": "A\u03b2 clearance from the brain", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "change A\u03b2 levels in the brain", "chunk": 3}
{"article": "PMC4615808.txt", "subject": "GSK3", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "controls APP processing and A\u03b2 levels in brain", "chunk": 3}
{"article": "PMC4615808.txt", "subject": "pioglitazone", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "stimulated A\u03b2 degradation by both microglia and astrocytes", "chunk": 3}
{"article": "PMC4615808.txt", "subject": "metformin", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "induces protein phosphatase 2A activity and reduces tau phosphorylation", "chunk": 3}
{"article": "PMC4615808.txt", "subject": "O-GlcNAcylation of proteins", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "protective roles of O-GlcNAc in neurons", "chunk": 3}
{"article": "PMC4615808.txt", "subject": "AMPK", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "energy-sensor, and AMPK over-activation is sufficient to cause dendritic spine loss", "chunk": 3}
{"article": "PMC4615808.txt", "subject": "mTOR signaling", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "affected by glucose-energy metabolism also causes neurodegeneration through mitochondrial dysfunction and autophagy", "chunk": 3}
{"article": "PMC4615808.txt", "subject": "pioglitazone treatment", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "associated with a reduced dementia risk in diabetes patients", "chunk": 3}
{"article": "PMC4617238.txt", "subject": "APOE \u01904 allele", "relationship": "RELATED_PROGNOSIS", "object": "Earlier onset of Alzheimer's disease", "chunk": 1}
{"article": "PMC4617238.txt", "subject": "CCL11", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "10-year delay in the age at onset of Alzheimer's disease", "chunk": 1}
{"article": "PMC4617238.txt", "subject": "APOE", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Potential for manipulating the amyloid pathway to reduce Alzheimer's disease", "chunk": 1}
{"article": "PMC4617238.txt", "subject": "APOE4", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Age at onset of AD", "chunk": 2}
{"article": "PMC4617238.txt", "subject": "APP p.A673T", "relationship": "PROTECTIVE_EFFECT_IDENTIFIED", "object": "Risk of Alzheimer's Disease", "chunk": 2}
{"article": "PMC4617238.txt", "subject": "eotaxin", "relationship": "ASSOCIATED_WITH", "object": "Delerious cognitive function and neurogenesis in aging ", "chunk": 2}
{"article": "PMC4632531.txt", "subject": "PI20", "relationship": "INDICATES_PRESENCE_OF", "object": "Prosopagnosia", "chunk": 3}
{"article": "PMC4632531.txt", "subject": "PI20 score", "relationship": "RELATED_PROGNOSIS", "object": "Prosopagnosics and controls", "chunk": 3}
{"article": "PMC4632531.txt", "subject": "PI20", "relationship": "RELATED_TO", "object": "Face and object recognition ability", "chunk": 3}
{"article": "PMC4632531.txt", "subject": "PI20 scores", "relationship": "INDICATES_PRESENCE_OF", "object": "Prosopagnosic traits", "chunk": 4}
{"article": "PMC4632531.txt", "subject": "PI20 scores", "relationship": "RELATED_TO", "object": "Familiar face recognition ability", "chunk": 4}
{"article": "PMC4632531.txt", "subject": "PI20 scores", "relationship": "CORRELATES_WITH", "object": "Unfamiliar face recognition ability", "chunk": 4}
{"article": "PMC4632531.txt", "subject": "PI20 scores", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Self-report measure of prosopagnosic traits (PI20)", "chunk": 4}
{"article": "PMC4637414.txt", "subject": "Simple reaction time (SRT)", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurological disorders, including traumatic brain injury (TBI)", "chunk": 1}
{"article": "PMC4637414.txt", "subject": "SRT latency", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Simulating mild TBI ", "chunk": 5}
{"article": "PMC4637414.txt", "subject": "SRT latency", "relationship": "RELATED_TREATMENT", "object": "Performance-validity metric ", "chunk": 5}
{"article": "PMC4637414.txt", "subject": "log-SRT z-scores", "relationship": "DIAGNOSITC_OF", "object": "Presence of malingering", "chunk": 6}
{"article": "PMC4637414.txt", "subject": "SRT latencies", "relationship": "INDICATES_PRESENCE_OF", "object": "Malingering", "chunk": 6}
{"article": "PMC4637414.txt", "subject": "SRT latencies", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Malingering detection", "chunk": 6}
{"article": "PMC4637414.txt", "subject": "log-SRT z-score cutoff (z-score > 3.0)", "relationship": "USED_TO_DIAGNOSE", "object": "Simulated malingerers", "chunk": 6}
{"article": "PMC4637414.txt", "subject": "SRT latencies", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Malingering detection", "chunk": 6}
{"article": "PMC4637414.txt", "subject": "SRT latencies", "relationship": "INDICATES_PRESENCE_OF", "object": "TBI", "chunk": 7}
{"article": "PMC4637414.txt", "subject": "SRT latencies", "relationship": "RELATED_PROGNOSIS", "object": "long-term effects of TBI", "chunk": 7}
{"article": "PMC4637414.txt", "subject": "Increased trial-to-trial SRT variance", "relationship": "RELATED_PROGNOSIS", "object": "TBI", "chunk": 7}
{"article": "PMC4637414.txt", "subject": "Log-SRT z-scores", "relationship": "INDICATES_PRESENCE_OF", "object": "malingering", "chunk": 7}
{"article": "PMC4637414.txt", "subject": "SRT performance", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Distinguishes between TBI severity types", "chunk": 7}
{"article": "PMC4650298.txt", "subject": "Alzheimer\u2019s disease", "relationship": "DIAGNOSITC_OF", "object": "CBT-based, multicomponent treatment programme", "chunk": 3}
{"article": "PMC4650298.txt", "subject": "Alzheimer\u2019s disease", "relationship": "INDICATES_PRESENCE_OF", "object": "dementia", "chunk": 3}
{"article": "PMC4650298.txt", "subject": "Alzheimer\u2019s disease", "relationship": "RELATED_TREATMENT", "object": "CBT-based, multicomponent treatment programme", "chunk": 3}
{"article": "PMC4650298.txt", "subject": "Alzheimer\u2019s disease", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "couples counselling", "chunk": 3}
{"article": "PMC4650298.txt", "subject": "Clinical dementia Rating Scale", "relationship": "RELATED_TO", "object": "Mild severity of dementia", "chunk": 4}
{"article": "PMC4650298.txt", "subject": "Mini Mental State Examination", "relationship": "RELATED_TO", "object": "Mild severity of dementia", "chunk": 4}
{"article": "PMC4650298.txt", "subject": "Geriatric Depression Scale", "relationship": "USED_TO_DIAGNOSE", "object": "Depression in patients with Alzheimer's disease", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Cornell Scale for Depression in dementia", "relationship": "USED_TO_DIAGNOSE", "object": "Depression in patients with Alzheimer's disease", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Structured Clinical Interview for DSM-IV Axis I Disorders", "relationship": "USED_TO_DIAGNOSE", "object": "Depression in patients with Alzheimer's disease", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Neuropsychiatric Inventory", "relationship": "MONITORED_DURING_TREATMENT", "object": "Behavioral and affective domains common in dementia", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Apathy Evaluation Scale", "relationship": "MONITORED_DURING_TREATMENT", "object": "Apathy in patients with Alzheimer's disease", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Quality of Life (Alzheimer\u2019s Disease) Instrument", "relationship": "MONITORED_DURING_TREATMENT", "object": "Quality of life in patients with Alzheimer's disease", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Stress Coping Inventory", "relationship": "MONITORED_DURING_TREATMENT", "object": "Preferred coping strategies of the patient", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Zarit Burden Interview", "relationship": "MONITORED_DURING_TREATMENT", "object": "Caregiver burden", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Centre for Epidemiologic Studies Depression Scale", "relationship": "MONITORED_DURING_TREATMENT", "object": "Depression in caregivers", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "trait scale of the State Trait Anxiety Inventory", "relationship": "MONITORED_DURING_TREATMENT", "object": "Trait anxiety in caregivers", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "anger-in and anger-out scales of the State Trait Anger Expression Inventory", "relationship": "MONITORED_DURING_TREATMENT", "object": "Anger expression in caregivers", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Satisfaction With Life Scale", "relationship": "MONITORED_DURING_TREATMENT", "object": "Satisfaction with life in caregivers", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "12-item Short-Form Health Survey", "relationship": "MONITORED_DURING_TREATMENT", "object": "Health status in caregivers", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD) Neuropsychological Assessment Battery", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Cognitive function assessment", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Mini Mental State Examination", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cognitive function", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "CERAD Word List Memory Test", "relationship": "MONITORED_DURING_TREATMENT", "object": "Memory function", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Auditory Verbal Learning Test", "relationship": "MONITORED_DURING_TREATMENT", "object": "Learning ability", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Corsi Block Task", "relationship": "MONITORED_DURING_TREATMENT", "object": "Working memory", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "CERAD Animal Naming Task", "relationship": "MONITORED_DURING_TREATMENT", "object": "Language function", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Boston Naming Test", "relationship": "MONITORED_DURING_TREATMENT", "object": "Naming ability", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Controlled Oral Word Association Test", "relationship": "MONITORED_DURING_TREATMENT", "object": "Verbal fluency", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "CERAD Constructional Praxis", "relationship": "MONITORED_DURING_TREATMENT", "object": "Constructional ability", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Rey\u2013Osterrieth Complex Figure Test", "relationship": "MONITORED_DURING_TREATMENT", "object": "Visuospatial learning and copying abilities", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Picture Completion subtest of the Wechsler Adult Intelligence Scale-III", "relationship": "MONITORED_DURING_TREATMENT", "object": "Visual comprehension", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Trail Making Test, Part B", "relationship": "MONITORED_DURING_TREATMENT", "object": "Task switching", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Stroop Color-Word Test", "relationship": "MONITORED_DURING_TREATMENT", "object": "Inhibition of prepotent responses", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Digit Span Backward from the Wechsler Adult Intelligence Scale-III", "relationship": "MONITORED_DURING_TREATMENT", "object": "Working memory updating", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Trail Making Test, Part A", "relationship": "MONITORED_DURING_TREATMENT", "object": "Sustained attention", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Digit Symbol Substitution Test from the Wechsler Adult Intelligence Scale-III", "relationship": "MONITORED_DURING_TREATMENT", "object": "Processing speed", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Barthel Index", "relationship": "MONITORED_DURING_TREATMENT", "object": "Activities of daily living", "chunk": 6}
{"article": "PMC4650298.txt", "subject": "Bayer Activities of Daily Living Scale", "relationship": "MONITORED_DURING_TREATMENT", "object": "Instrumental activities of daily living", "chunk": 6}
{"article": "PMC4656817.txt", "subject": "CRT z-scores", "relationship": "RELATED_PROGNOSIS", "object": "were virtually identical to those predicted by the age-regression functions from Woods et al. (2015c) ", "chunk": 4}
{"article": "PMC4656817.txt", "subject": "CRT z-scores", "relationship": "RELATED_TREATMENT", "object": "The Experiment 1 data were well-fit by the regression functions derived from the normative population: CRT z-scores, log-mSOA z-scores, CentPT z-scores, and omnibus z-scores did not differ significantly between the participants in the first test session of Experiment 1 and the normative control group", "chunk": 4}
{"article": "PMC4656817.txt", "subject": "CentPT z-scores", "relationship": "RELATED_PROGNOSIS", "object": "were virtually identical to those predicted by the age-regression functions from Woods et al. (2015c)", "chunk": 4}
{"article": "PMC4656817.txt", "subject": "CentPT z-scores", "relationship": "RELATED_TREATMENT", "object": "The Experiment 1 data were well-fit by the regression functions derived from the normative population: CRT z-scores, log-mSOA z-scores, CentPT z-scores, and omnibus z-scores did not differ significantly between the participants in the first test session of Experiment 1 and the normative control group", "chunk": 4}
{"article": "PMC4656817.txt", "subject": "omnibus z-scores", "relationship": "RELATED_PROGNOSIS", "object": "did not differ significantly between the participants in the first test session of Experiment 1 and the normative control group", "chunk": 4}
{"article": "PMC4656817.txt", "subject": "log-mSOA z-scores", "relationship": "RELATED_PROGNOSIS", "object": "did not differ significantly between the participants in the first test session of Experiment 1 and the normative control group", "chunk": 4}
{"article": "PMC4656817.txt", "subject": "CRT latencies", "relationship": "RELATED_TREATMENT", "object": "repeated testing resulted in improvements in performance for CRT z-scores, CentPT z-scores, log-mSOA z-scores, and omnibus z-scores. Omnibus z-scores fell significantly with repeated testing, CRT latencies decreased, and there was a trend toward reduced log-mSOAs", "chunk": 4}
{"article": "PMC4656817.txt", "subject": "log-mSOA z-scores", "relationship": "RELATED_TREATMENT", "object": "repeated testing resulted in improvements in performance for CRT z-scores, CentPT z-scores, log-mSOA z-scores, and omnibus z-scores. Omnibus z-scores fell significantly with repeated testing, CRT latencies decreased, and there was a trend toward reduced log-mSOAs", "chunk": 4}
{"article": "PMC4656817.txt", "subject": "CRT latencies", "relationship": "INDICATES_PRESENCE_OF", "object": "Simulated malingering", "chunk": 6}
{"article": "PMC4656817.txt", "subject": "log-mSOAs", "relationship": "INDICATES_PRESENCE_OF", "object": "Simulated malingering", "chunk": 6}
{"article": "PMC4656817.txt", "subject": "latency-consistency z-scores", "relationship": "RELATED_TO", "object": "Simulated malingering", "chunk": 6}
{"article": "PMC4656817.txt", "subject": "CentPT", "relationship": "PREDICTS_SURVIVAL", "object": "Greater functional outcome", "chunk": 6}
{"article": "PMC4656817.txt", "subject": "latency-consistency z-score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "in differentiating between TBI and simulated malingering", "chunk": 8}
{"article": "PMC4659639.txt", "subject": "beta-amyloid1-42 peptide", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4659639.txt", "subject": "amyloid precursor protein-presenilin (APP-PSN)", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC4659639.txt", "subject": "A\u03b2 deposits", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC4659639.txt", "subject": "Mo/HuAPP695swe", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC4659639.txt", "subject": "PS1-dE9", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC4659639.txt", "subject": "DHA+EPA (5:1)", "relationship": "RELATED_TREATMENT", "object": "Cognitive Deficits Related to Alzheimer's Disease", "chunk": 2}
{"article": "PMC4659639.txt", "subject": "phosphatidylserine", "relationship": "RELATED_TREATMENT", "object": "Cognitive Deficits Related to Alzheimer's Disease", "chunk": 2}
{"article": "PMC4659639.txt", "subject": "blueberry extracts", "relationship": "RELATED_TREATMENT", "object": "Cognitive Deficits Related to Alzheimer's Disease", "chunk": 2}
{"article": "PMC4659639.txt", "subject": "selenium", "relationship": "RELATED_TREATMENT", "object": "Oxidative Stress in Alzheimer's Disease", "chunk": 2}
{"article": "PMC4659639.txt", "subject": "zinc", "relationship": "RELATED_TREATMENT", "object": "Oxidative Stress in Alzheimer's Disease", "chunk": 2}
{"article": "PMC4659639.txt", "subject": "vitamins E, B12, and B6", "relationship": "RELATED_TREATMENT", "object": "Oxidative Stress in Alzheimer's Disease", "chunk": 2}
{"article": "PMC4659639.txt", "subject": "folic acid", "relationship": "RELATED_TREATMENT", "object": "Oxidative Stress in Alzheimer's Disease", "chunk": 2}
{"article": "PMC4659639.txt", "subject": "lutein", "relationship": "RELATED_TREATMENT", "object": "Oxidative Stress in Alzheimer's Disease", "chunk": 2}
{"article": "PMC4659639.txt", "subject": "superoxide dismutase (SOD)", "relationship": "MONITORED_DURING_TREATMENT", "object": "measured in the brain and serum", "chunk": 3}
{"article": "PMC4659639.txt", "subject": "glutathione peroxidase (GSH-Px)", "relationship": "MONITORED_DURING_TREATMENT", "object": "measured in the brain", "chunk": 3}
{"article": "PMC4659639.txt", "subject": "malondialdehyde (MDA)", "relationship": "MONITORED_DURING_TREATMENT", "object": "measured in the blood and brain", "chunk": 3}
{"article": "PMC4659639.txt", "subject": "total cholinesterase (TChE)", "relationship": "MONITORED_DURING_TREATMENT", "object": "measured in the blood and brain", "chunk": 3}
{"article": "PMC4659639.txt", "subject": "acetylcholine (ACh)", "relationship": "MONITORED_DURING_TREATMENT", "object": "measured in the blood serum ", "chunk": 3}
{"article": "PMC4659639.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_TO", "object": "Immunohistochemistry of brain", "chunk": 3}
{"article": "PMC4659639.txt", "subject": "ACh (in brain)", "relationship": "RELATED_TO_TREATMENT", "object": "Study focused on treatment interventions", "chunk": 4}
{"article": "PMC4659639.txt", "subject": "TChE (in brain)", "relationship": "RELATED_TO_TREATMENT", "object": "Study focused on treatment interventions", "chunk": 4}
{"article": "PMC4659639.txt", "subject": "MDA (in brain)", "relationship": "RELATED_TO_TREATMENT", "object": "Study focused on treatment interventions", "chunk": 4}
{"article": "PMC4659639.txt", "subject": "SOD (in brain)", "relationship": "RELATED_TO_TREATMENT", "object": "Study focused on treatment interventions", "chunk": 4}
{"article": "PMC4659639.txt", "subject": "GSH-PX (in brain)", "relationship": "RELATED_TO_TREATMENT", "object": "Study focused on treatment interventions", "chunk": 4}
{"article": "PMC4659639.txt", "subject": "ACh (in serum)", "relationship": "RELATED_TO_TREATMENT", "object": "Study focused on treatment interventions", "chunk": 4}
{"article": "PMC4659639.txt", "subject": "TChE (in serum)", "relationship": "RELATED_TO_TREATMENT", "object": "Study focused on treatment interventions", "chunk": 4}
{"article": "PMC4659639.txt", "subject": "MDA (in serum)", "relationship": "RELATED_TO_TREATMENT", "object": "Study focused on treatment interventions", "chunk": 4}
{"article": "PMC4659639.txt", "subject": "SOD (in serum)", "relationship": "RELATED_TO_TREATMENT", "object": "Study focused on treatment interventions", "chunk": 4}
{"article": "PMC4659639.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 4}
{"article": "PMC4659639.txt", "subject": "A\u03b21\u201342", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Strategies targeting A\u03b21\u201342 deposition may be beneficial for treating AD", "chunk": 5}
{"article": "PMC4659639.txt", "subject": "A\u03b2", "relationship": "PREDICTS_SURVIVAL", "object": "Progression of A\u03b2 deposition is associated with decreased survival", "chunk": 5}
{"article": "PMC4659639.txt", "subject": "MDA, SOD, and GSH-PX", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels of these oxidative stress markers were monitored during dietary intervention", "chunk": 5}
{"article": "PMC4659639.txt", "subject": "TChE", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Modulating TChE activity and signaling pathways is a potential therapeutic strategy for AD", "chunk": 5}
{"article": "PMC4659639.txt", "subject": "ACh", "relationship": "RELATED_TREATMENT", "object": "Increasing ACh levels in the brain may be beneficial for AD treatment", "chunk": 5}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "INDICATES_PRESENCE_OF", "object": "Synapses in the human hippocampus", "chunk": 1}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_TO", "object": "Synaptic adhesion and synaptic plasticity", "chunk": 1}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "ASSOCIATED_WITH", "object": "Down syndrome", "chunk": 1}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "INDICATES_PRESENCE_OF", "object": "Risk factor related to the progression of AD", "chunk": 1}
{"article": "PMC4674770.txt", "subject": "NCAM2 ED", "relationship": "PRODUCED_BY", "object": "Cleavage of membrane proximal external region of NCAM2 ", "chunk": 1}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_TREATMENT", "object": "Developing a better understanding of AD pathology", "chunk": 1}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Synaptic loss observed in AD", "chunk": 2}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_PROGNOSIS", "object": "Levels of soluble NCAM2 fragments in AD hippocampus", "chunk": 2}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels of soluble NCAM2 fragments in AD hippocampus", "chunk": 2}
{"article": "PMC4674770.txt", "subject": "NCAM2aa682-701", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Cleavage", "chunk": 2}
{"article": "PMC4674770.txt", "subject": "NCAM2-ED", "relationship": "RESPONDED_TO", "object": "A\u03b21-42", "chunk": 2}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_TREATMENT", "object": "Removal of NCAM2 from the cell surface of cultured hippocampal neurons", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_TREATMENT", "object": "Incubation with A\u03b21-42 did not increase levels of soluble NCAM2 in the culture medium from cortical neurons", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_TREATMENT", "object": "Synaptic localisation of NCAM2 in neurons", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_TREATMENT", "object": "A\u03b21-42 oligomers form complexes with NCAM2", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_TREATMENT", "object": "Appearence of NCAM2 in synapses of mouse hippocampal neurons", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_TREATMENT", "object": "Compensatory reaction in hippocampal and cortical neurons to A\u03b2-dependent loss of NCAM2", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "RELATED_PROGNOSIS", "object": "Significantly reduced levels of NCAM2 in synaptosomes isolated from neurons ", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "RELATED_PROGNOSIS", "object": "Increases in NCAM2/A\u03b21-42 PL signal", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "RELATED_PROGNOSIS", "object": "Levels of soluble NCAM2 with the molecular weight of \u223c100\u2009kDa", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "RELATED_PROGNOSIS", "object": " Levels of soluble proteolytic products of NCAM2", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Removal of NCAM2 from the neuronal cell surface", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased levels of soluble NCAM2 in culture medium from hippocampal neurons", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Dissociation of NCAM2/A\u03b21-42 complexes from synaptic sites into the medium", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Intracellular accumulations of A\u03b2", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b21-42 oligomers", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Intereaction of A\u03b21-42 with NCAM2", "chunk": 3}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_PROGNOSIS", "object": "Increased levels of NCAM2 were found in the synapse in early-aged wild-type mice, but significantly declined in APP23 mice.", "chunk": 4}
{"article": "PMC4674770.txt", "subject": "A\u03b2", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "A\u03b2 was found to bind to NCAM2 and its presence was associated with degradation of NCAM2.", "chunk": 4}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "A\u03b21-42 oligomers were shown to disrupt the function of NCAM2, leading to synapse disassembly. ", "chunk": 4}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Synapse loss", "chunk": 5}
{"article": "PMC4674770.txt", "subject": "GluR1", "relationship": "RELATED_TO_SYMPTOM", "object": "Synapse loss in hippocampus", "chunk": 5}
{"article": "PMC4674770.txt", "subject": "A\u03b2", "relationship": "CAUSES", "object": "Synapse loss", "chunk": 5}
{"article": "PMC4674770.txt", "subject": "NCAM2-ED", "relationship": "CAUSES", "object": "Reduction in GluR1-containing synapses", "chunk": 5}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_TREATMENT", "object": "Treatment for Alzheimer's Disease", "chunk": 5}
{"article": "PMC4674770.txt", "subject": "NCAM2D693A", "relationship": "PROTECTIVE_EFFECT", "object": "Synapse loss", "chunk": 5}
{"article": "PMC4674770.txt", "subject": "APP23 mice", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduced synaptic NCAM2 levels", "chunk": 5}
{"article": "PMC4674770.txt", "subject": "Hippocampus", "relationship": "HIGHLY_SUSCEPTIBLE_TO", "object": "A\u03b2-dependent effects on NCAM2 synaptic targeting", "chunk": 5}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4674770.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Synaptic loss", "chunk": 6}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Incubation with A\u03b2", "chunk": 6}
{"article": "PMC4674770.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treating synaptic loss in Alzheimer's ", "chunk": 6}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "A\u03b2 administration", "chunk": 6}
{"article": "PMC4674770.txt", "subject": "A\u03b2", "relationship": "PREDICTS_SURVIVAL", "object": "Healthy synaptic function", "chunk": 6}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RESPONDED_TO", "object": "Proteolytic cleavage", "chunk": 6}
{"article": "PMC4674770.txt", "subject": "A\u03b2", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Selection of treatments targeting synaptic connectivity", "chunk": 6}
{"article": "PMC4674770.txt", "subject": "A\u03b21\u201342 peptide", "relationship": "RELATED_TREATMENT", "object": "Neurons were treated for 24\u2009h with 0.5\u2009\u03bcM of A\u03b21\u201342 peptide", "chunk": 7}
{"article": "PMC4674770.txt", "subject": "A\u03b21\u201342 peptide", "relationship": "RELATED_TREATMENT", "object": "in the form of A\u03b2-derived diffusible ligand", "chunk": 7}
{"article": "PMC4674770.txt", "subject": "N-cadherin", "relationship": "RELATED_TREATMENT", "object": "With 2.5\u2009\u03bcg\u2009ml\u22121 monoclonal antibodies against the extracellular domain of NCAM2 (2.5\u2009\u03bcg\u2009ml\u22121; R&D systems), or recombinant extracellular domains of NCAM2 (2.5\u2009\u03bcg\u2009ml\u22121) applied in the cell culture medium", "chunk": 7}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "NCAM2 biomarker detected with ELISA", "chunk": 8}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Detected and quantitated with DLS; suggests NCAM2 as a target for therapy", "chunk": 8}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_PROGNOSIS", "object": "Synaptic accumulation of NCAM2 is reduced in the hippocampus of AD-affected individuals", "chunk": 9}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 9}
{"article": "PMC4674770.txt", "subject": "NCAM2aa682-701", "relationship": "RELATED_PROGNOSIS", "object": "The efficiency of the peptide cleavage is higher in AD cases and particularly in synaptosomes", "chunk": 9}
{"article": "PMC4674770.txt", "subject": "NCAM2aa682-701", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "The efficiency of the peptide cleavage is higher in AD cases and particularly in synaptosomes", "chunk": 9}
{"article": "PMC4674770.txt", "subject": "NCAM2aa666-685", "relationship": "RELATED_PROGNOSIS", "object": "Assay showing the efficiency of the peptide cleavage of NCAM2aa666-685 and NCAM2aa682-701 in controls and AD patients", "chunk": 9}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_TO_TREATMENT", "object": "treatment with A\u03b21-42 oligomers", "chunk": 10}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_TREATMENT", "object": "A\u03b21-42 oligomers", "chunk": 10}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_TREATMENT", "object": "binding to A\u03b21-42 oligomers", "chunk": 10}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 10}
{"article": "PMC4674770.txt", "subject": "NCAM2", "relationship": "RELATED_TREATMENT", "object": "Dissembly of glutamatergic synapses", "chunk": 11}
{"article": "PMC4674770.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Dissembly of glutamatergic synapses", "chunk": 11}
{"article": "PMC4674770.txt", "subject": "NCAM2-ED", "relationship": "RELATED_TREATMENT", "object": "Dissembly of glutamatergic synapses", "chunk": 11}
{"article": "PMC4674770.txt", "subject": "NCAM2mAb", "relationship": "RELATED_TREATMENT", "object": "Dissembly of glutamatergic synapses", "chunk": 11}
{"article": "PMC4675859.txt", "subject": "EGCG", "relationship": "RELATED_TO_TREATMENT", "object": "Treatment of improving cognitive decline", "chunk": 1}
{"article": "PMC4675859.txt", "subject": "amyloid-\u00df (A\u03b2)", "relationship": "DIAGNOSITC_OF", "object": "AD neuropathology", "chunk": 1}
{"article": "PMC4675859.txt", "subject": "Hyperphosphorylated tau", "relationship": "DIAGNOSITC_OF", "object": "AD neuropathology later in life", "chunk": 1}
{"article": "PMC4675859.txt", "subject": "EGCG", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improvement in cognitive function in DS mouse models", "chunk": 1}
{"article": "PMC4675859.txt", "subject": "EGCG", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved cognitive performance in young adults with DS", "chunk": 1}
{"article": "PMC4675859.txt", "subject": "Environmental enrichment (EE)", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improvement in cognitive function in mouse models with DS and AD", "chunk": 1}
{"article": "PMC4675859.txt", "subject": "EGCG", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Anti-amyloidogenic effects and influence on DYRK1A activity", "chunk": 1}
{"article": "PMC4675859.txt", "subject": "Environmental enrichment (EE)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Promotive effects on neuroplasticity, antioxidant activity and neuroprotection", "chunk": 1}
{"article": "PMC4675859.txt", "subject": "EGCG", "relationship": "RELATED_PROGNOSIS", "object": "Positive influence on cognitive decline in DS", "chunk": 1}
{"article": "PMC4675859.txt", "subject": "DYRK1A", "relationship": "RELATED_PROGNOSIS", "object": "Increased expression levels are associated with DS neurocognitive symptoms and neurodegenerative phenotypes", "chunk": 1}
{"article": "PMC4675859.txt", "subject": "APP", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Ts65Dn mouse model developed for DS and AD research", "chunk": 2}
{"article": "PMC4675859.txt", "subject": "DYRK1A", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Ts65Dn mouse model developed for DS and AD research", "chunk": 2}
{"article": "PMC4675859.txt", "subject": "\u03b2-amyloid", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Extracellular \u03b2-amyloid-containing plaques associated with AD pathology", "chunk": 2}
{"article": "PMC4675859.txt", "subject": "Neurofibrillary tangles", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Neurofibrillary tangles are associated with AD pathology", "chunk": 2}
{"article": "PMC4675859.txt", "subject": "Endosomes", "relationship": "RELATED_PROGNOSIS", "object": "Abnormal neuronal process associated with A\u03b2 production and potentially influencing AD progression", "chunk": 2}
{"article": "PMC4675859.txt", "subject": "Latency to reach the escape platform", "relationship": "RELATED_PROGNOSIS", "object": "Hippocampal-dependent learning", "chunk": 5}
{"article": "PMC4675859.txt", "subject": "Latency to reach the escape platform", "relationship": "RELATED_TREATMENT", "object": "Enriched environment (EE) and EE-EGCG treatment", "chunk": 5}
{"article": "PMC4675859.txt", "subject": "Gallager Index", "relationship": "RELATED_PROGNOSIS", "object": "Reference memory", "chunk": 5}
{"article": "PMC4675859.txt", "subject": "Thigmotactic behavior", "relationship": "RELATED_PROGNOSIS", "object": "Learning ability", "chunk": 5}
{"article": "PMC4675859.txt", "subject": "Swimming speed", "relationship": "RELATED_TREATMENT", "object": "EGCG treatment", "chunk": 5}
{"article": "PMC4675859.txt", "subject": "EGCG", "relationship": "RELATED_TREATMENT", "object": "Amelioration of hippocampal-dependent spatial learning and memory deficits", "chunk": 7}
{"article": "PMC4675859.txt", "subject": "EGCG", "relationship": "RELATED_TREATMENT", "object": "Potential treatment for cognitive decline in Ts65Dn mice", "chunk": 7}
{"article": "PMC4675859.txt", "subject": "EE", "relationship": "RELATED_TREATMENT", "object": "Combined treatment with EGCG for cognitive decline in Ts65Dn mice", "chunk": 7}
{"article": "PMC4675859.txt", "subject": "EE-EGCG", "relationship": "RELATED_TREATMENT", "object": "Potential treatment for cognitive decline in Ts65Dn mice", "chunk": 7}
{"article": "PMC4675859.txt", "subject": "A\u03b2 plaques", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 9}
{"article": "PMC4675859.txt", "subject": "EGCG", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 9}
{"article": "PMC4675859.txt", "subject": "EE", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 9}
{"article": "PMC4675859.txt", "subject": "EE-EGCG", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 9}
{"article": "PMC4675859.txt", "subject": "BDNF", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 9}
{"article": "PMC4675859.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 9}
{"article": "PMC4675859.txt", "subject": "EY", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 9}
{"article": "PMC4675859.txt", "subject": "Dyrk1A kinase activity", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 9}
{"article": "PMC4683859.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "A\u03b242 is a strong predictor of amyloid PET positivity.", "chunk": 1}
{"article": "PMC4683859.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "brain amyloidosis", "chunk": 1}
{"article": "PMC4683859.txt", "subject": "A\u03b242/A\u03b238", "relationship": "DIAGNOSITC_OF", "object": "Preclinical Alzheimer's Disease", "chunk": 1}
{"article": "PMC4683859.txt", "subject": "A\u03b242/A\u03b240", "relationship": "DIAGNOSITC_OF", "object": "Preclinical Alzheimer's Disease", "chunk": 1}
{"article": "PMC4683859.txt", "subject": "A\u03b242/ttau", "relationship": "RELATED_PROGNOSIS", "object": "A\u03b242/ttau ratios had a higher accuracy to identify amyloid-positive subjects.", "chunk": 1}
{"article": "PMC4683859.txt", "subject": "A\u03b242/ttau", "relationship": "DIAGNOSITC_OF", "object": "Preclinical Alzheimer's Disease", "chunk": 1}
{"article": "PMC4683859.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "A\u03b242 levels decline as the disease progresses.", "chunk": 1}
{"article": "PMC4683859.txt", "subject": "A\u03b242", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 1}
{"article": "PMC4683859.txt", "subject": "total tau (ttau)", "relationship": "RELATED_PROGNOSIS", "object": "Changes in total tau levels can indicate disease progression.", "chunk": 1}
{"article": "PMC4683859.txt", "subject": "cerebral spinal fluid", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Cerebrospinal fluid analysis can guide treatment decisions in preclinical AD.", "chunk": 1}
{"article": "PMC4683859.txt", "subject": "APOE\u03b54", "relationship": "RELATED_TO_PROGNOSIS", "object": "interaction between brain-derived neurotrophic factor (BDNF) and apolipoprotein E (APOE) genetic polymorphisms on amyloid deposition and functional reorganization", "chunk": 2}
{"article": "PMC4683859.txt", "subject": "BDNF", "relationship": "RELATED_TO_PROGNOSIS", "object": "interaction between brain-derived neurotrophic factor (BDNF) and apolipoprotein E (APOE) genetic polymorphisms on amyloid deposition and functional reorganization", "chunk": 2}
{"article": "PMC4683859.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "amyloid deposition", "chunk": 2}
{"article": "PMC4683859.txt", "subject": " amyloid+\u2009", "relationship": "DIAGNOSITC_OF", "object": "amyloid positivity", "chunk": 2}
{"article": "PMC4683859.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-positive older individuals", "chunk": 3}
{"article": "PMC4683859.txt", "subject": "A\u03b21\u201340", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-positive older individuals", "chunk": 3}
{"article": "PMC4683859.txt", "subject": "A\u03b21\u201338", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-positive older individuals", "chunk": 3}
{"article": "PMC4683859.txt", "subject": "ttau", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-positive older individuals", "chunk": 3}
{"article": "PMC4683859.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Diagnose: Alzheimer's Disease", "chunk": 4}
{"article": "PMC4683859.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "18F-flutemetamol-positive", "chunk": 4}
{"article": "PMC4683859.txt", "subject": "A\u03b242", "relationship": "PREDICTS_SURVIVAL", "object": "Amyloid PET-positive cases", "chunk": 4}
{"article": "PMC4683859.txt", "subject": "A\u03b242/A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "18F-flutemetamol-positive", "chunk": 4}
{"article": "PMC4683859.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4683859.txt", "subject": "A\u03b242/ttau", "relationship": "INDICATES_PRESENCE_OF", "object": "18F-flutemetamol-positive", "chunk": 4}
{"article": "PMC4683859.txt", "subject": "A\u03b242/ttau", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4683859.txt", "subject": "A\u03b242/ttau", "relationship": "PREDICTS_SURVIVAL", "object": "Amyloid PET-positive cases", "chunk": 4}
{"article": "PMC4683859.txt", "subject": "A\u03b242/A\u03b238", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4683859.txt", "subject": "A\u03b242/A\u03b238", "relationship": "INDICATES_PRESENCE_OF", "object": "18F-flutemetamol-positive", "chunk": 4}
{"article": "PMC4683859.txt", "subject": "A\u03b238", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4683859.txt", "subject": "A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4683859.txt", "subject": "ttau", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4683859.txt", "subject": "A\u03b242/ttau", "relationship": "DIAGNOSITC_OF", "object": "Diagnose: Alzheimer's Disease", "chunk": 5}
{"article": "PMC4683859.txt", "subject": "A\u03b242/A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Preclinical Alzheimer's Disease ", "chunk": 5}
{"article": "PMC4683859.txt", "subject": "A\u03b242/A\u03b238", "relationship": "INDICATES_PRESENCE_OF", "object": "Preclinical Alzheimer's Disease ", "chunk": 5}
{"article": "PMC4683859.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Preclinical Alzheimer's Disease ", "chunk": 5}
{"article": "PMC4683859.txt", "subject": "A\u03b242/ttau", "relationship": "RELATED_PROGNOSIS", "object": "Progression to Alzheimer's Disease", "chunk": 5}
{"article": "PMC4683859.txt", "subject": "A\u03b242/A\u03b240", "relationship": "PREDICTS_SURVIVAL", "object": "Survival Time in Preclinical Alzheimer's Disease", "chunk": 5}
{"article": "PMC4683859.txt", "subject": "A\u03b242/A\u03b238", "relationship": "PREDICTS_SURVIVAL", "object": "Survival Time in Preclinical Alzheimer's Disease", "chunk": 5}
{"article": "PMC4683859.txt", "subject": "A\u03b242", "relationship": "PREDICTS_SURVIVAL", "object": "Survival Time in Preclinical Alzheimer's Disease", "chunk": 5}
{"article": "PMC4683859.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Define preclinical AD", "chunk": 6}
{"article": "PMC4683859.txt", "subject": "A\u03b242", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Selection of subjects with increased PET amyloid load", "chunk": 6}
{"article": "PMC4683859.txt", "subject": "A\u03b242", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Selecting a marker, cerebral spinal fluid versus amyloid PET", "chunk": 6}
{"article": "PMC4683859.txt", "subject": "ttau", "relationship": "RELATED_PROGNOSIS", "object": "Reflect neuronal loss", "chunk": 6}
{"article": "PMC4683859.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "18F-flutemetamol", "chunk": 7}
{"article": "PMC4683859.txt", "subject": "ptau181", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment", "chunk": 7}
{"article": "PMC4683859.txt", "subject": "ttau", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment", "chunk": 7}
{"article": "PMC4683859.txt", "subject": "AICAkeike information criterion", "relationship": "RELATED_PROGNOSIS", "object": "Prognosis of Alzheimer's disease.", "chunk": 7}
{"article": "PMC4690296.txt", "subject": "neurogranin", "relationship": "INDICATES_PRESENCE_OF", "object": "Synaptic damage", "chunk": 1}
{"article": "PMC4690296.txt", "subject": "YKL-40", "relationship": "INDICATES_PRESENCE_OF", "object": "microglial activation", "chunk": 1}
{"article": "PMC4690296.txt", "subject": "neurogranin", "relationship": "RELATED_TO", "object": "loss of dendrites in AD", "chunk": 1}
{"article": "PMC4690296.txt", "subject": "neurogranin", "relationship": "MONITORED_DURING_TREATMENT", "object": "A potential AD treatment target", "chunk": 1}
{"article": "PMC4690296.txt", "subject": "YKL-40", "relationship": "INDICATES_PRESENCE_OF", "object": "several infectious and noninfectious disorders of the central nervous system", "chunk": 2}
{"article": "PMC4690296.txt", "subject": "YKL-40", "relationship": "INDICATES_PRESENCE_OF", "object": "AD (Alzheimer's disease)", "chunk": 2}
{"article": "PMC4690296.txt", "subject": "neurogranin", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4690296.txt", "subject": "A\u03b21-42", "relationship": "LOW_RELATED_TO", "object": "Mild cognitive impairment due to Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4690296.txt", "subject": "A\u03b21-40", "relationship": "HIGH_RELATED_TO", "object": "Subjects without Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4690296.txt", "subject": "t-tau", "relationship": "HIGH_RELATED_TO", "object": "Mild cognitive impairment due to Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4690296.txt", "subject": "p-tau", "relationship": "HIGH_RELATED_TO", "object": "Mild cognitive impairment due to Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4690296.txt", "subject": "neurogranin", "relationship": "INDICATES_PRESENCE_OF", "object": "Synaptic destruction", "chunk": 4}
{"article": "PMC4690296.txt", "subject": "neurogranin", "relationship": "RELATED_PROGNOSIS", "object": "Rapid decline in cognition", "chunk": 4}
{"article": "PMC4690296.txt", "subject": "YKL-40", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuroinflammatin", "chunk": 4}
{"article": "PMC4690296.txt", "subject": "YKL-40", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive decline", "chunk": 4}
{"article": "PMC4690296.txt", "subject": "YKL-40", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Drugs targeting microglial activation", "chunk": 4}
{"article": "PMC4690296.txt", "subject": "neurogranin", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4690296.txt", "subject": "YKL-40", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4690296.txt", "subject": "neurogranin", "relationship": "RELATED_PROGNOSIS", "object": "Aspects of AD pathophysiology", "chunk": 5}
{"article": "PMC4690296.txt", "subject": "YKL-40", "relationship": "RELATED_PROGNOSIS", "object": "Aspects of AD pathophysiology", "chunk": 5}
{"article": "PMC4694064.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "developed to treat the age and AD-associated phenotypes of SAMP8 mice", "chunk": 1}
{"article": "PMC4694064.txt", "subject": "J147", "relationship": "RESPONSED_TO", "object": "reducing cognitive deficits in old SAMP8 mice", "chunk": 1}
{"article": "PMC4694064.txt", "subject": "J147", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "used to identify some of the molecular contributions of aging to AD", "chunk": 1}
{"article": "PMC4694064.txt", "subject": "J147", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "an integrative multi-omics approach was carried out to investigate J147's interaction between aging and the AD drug candidate on brain function", "chunk": 1}
{"article": "PMC4694064.txt", "subject": "J147", "relationship": "MONITORED_DURING_TREATMENT", "object": "levels of metabolites", "chunk": 1}
{"article": "PMC4694064.txt", "subject": "eIF2\u03b1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased phosphorylation of eIF2\u03b1 is reported in AD patients", "chunk": 2}
{"article": "PMC4694064.txt", "subject": "HSP60", "relationship": "RELATED_TREATMENT", "object": "J147 treatment restores HSP60 levels in old SAMP8 mice", "chunk": 2}
{"article": "PMC4694064.txt", "subject": "HSP90", "relationship": "RELATED_TREATMENT", "object": "J147 treatment restores HSP90 levels in old SAMP8 mice", "chunk": 2}
{"article": "PMC4694064.txt", "subject": "A\u03b21-40", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased levels of A\u03b21-40 in the hippocampus of old SAMP8 mice", "chunk": 2}
{"article": "PMC4694064.txt", "subject": "tau", "relationship": "RELATED_TREATMENT", "object": "J147 prevented the increase in tau protein levels in the hippocampus of old SAMP8 mice", "chunk": 2}
{"article": "PMC4694064.txt", "subject": "pTau Ser396", "relationship": "RELATED_TREATMENT", "object": "J147 prevented the increase in phosphorylation of tau at Ser396 in the hippocampus of old SAMP8 mice", "chunk": 2}
{"article": "PMC4694064.txt", "subject": "VCAM-1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased levels of VCAM-1 indicate vascular endothelial inflammation, which is often associated with AD", "chunk": 2}
{"article": "PMC4694064.txt", "subject": "IgG", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased levels of IgG indicate disrupted blood-brain barrier (BBB) permeability, which is a feature of AD", "chunk": 2}
{"article": "PMC4694064.txt", "subject": "GFAP", "relationship": "INDICATES_PRESENCE_OF", "object": "Astrocytes in the hippocampus", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "SAPK/JNK", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Abnormal tau phosphorylation", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "SAPK/JNK", "relationship": "RELATED_TO", "object": "Stress-associated inflammation in the hippocampus", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "Map3k7", "relationship": "RELATED_TO", "object": "Activation of  SAPK/JNK", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "Map2k4", "relationship": "RELATED_TO", "object": "Activation of SAPK/JNK", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "C1qa", "relationship": "INDICATES_PRESENCE_OF", "object": "Complement system", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "C1qb", "relationship": "INDICATES_PRESENCE_OF", "object": "Complement system", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "C3", "relationship": "INDICATES_PRESENCE_OF", "object": "Complement system", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "C4a", "relationship": "INDICATES_PRESENCE_OF", "object": "Complement system", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "Flt1", "relationship": "RELATED_TO", "object": "Brain vasculature", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "DHA", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "J147 treatment", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "Adrenic acid", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "J147 treatment", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "9-HETE", "relationship": "RESPONDED_TO", "object": "J147 treatment", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "8-iso-15-keto PGF2\u03b2", "relationship": "RESPONDED_TO", "object": "J147 treatment", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "TXB2", "relationship": "RESPONDED_TO", "object": "J147 treatment", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "11- and 13-HDoHEs", "relationship": "RESPONDED_TO", "object": "J147 treatment", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "9-HODE", "relationship": "RESPONDED_TO", "object": "J147 treatment", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "13-HODE", "relationship": "RESPONDED_TO", "object": "J147 treatment", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "19-HETE", "relationship": "RESPONDED_TO", "object": "J147 treatment", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "20-HETE", "relationship": "RESPONDED_TO", "object": "J147 treatment", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "9,10-DiHOME", "relationship": "RESPONDED_TO", "object": "J147 treatment", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "19(20)-EpDPE", "relationship": "RESPONDED_TO", "object": "J147 treatment", "chunk": 3}
{"article": "PMC4694064.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "Treatment that rescues changes in metabolites in aging SAMP8 mice", "chunk": 4}
{"article": "PMC4694064.txt", "subject": "J147", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "J147 treatment reverses age-related changes in gene expression", "chunk": 4}
{"article": "PMC4694064.txt", "subject": "\u03b3-glutamyl amino acids", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "downregulation with age", "chunk": 4}
{"article": "PMC4694064.txt", "subject": "Branched-chain amino acids (BCAAs)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "downregulation with age", "chunk": 4}
{"article": "PMC4694064.txt", "subject": "Acylcarnitines", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "highly elevated in old SAMP8 mice", "chunk": 4}
{"article": "PMC4694064.txt", "subject": "PUFAs", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "highly elevated in old SAMP8 mice", "chunk": 4}
{"article": "PMC4694064.txt", "subject": "cAMP", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "elevated in old SAMP8 mice", "chunk": 4}
{"article": "PMC4694064.txt", "subject": "Glutamate", "relationship": "RELATED_PROGNOSIS", "object": "preserved levels by J147", "chunk": 4}
{"article": "PMC4694064.txt", "subject": "J147", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "J147 treatment alters gene expression associated with aging pathways", "chunk": 4}
{"article": "PMC4694064.txt", "subject": "\u03b1-ketoglutarate", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels rescued by J147", "chunk": 4}
{"article": "PMC4694064.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "May act as a preventative measure against age-related stress and its associated metabolic changes", "chunk": 5}
{"article": "PMC4694064.txt", "subject": "HSP40, 60 and 90", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Changes in their levels are indicative of stress and may be a target for therapeutic interventions", "chunk": 5}
{"article": "PMC4694064.txt", "subject": "eIF2\u03b1", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Involvement in protein homeostasis and potential role in AD suggest it could be a target for therapy", "chunk": 5}
{"article": "PMC4694064.txt", "subject": "VCAM-1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Reduction indicates potential preservation of BBB homeostasis by J147", "chunk": 5}
{"article": "PMC4694064.txt", "subject": "Glutamate", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4694064.txt", "subject": "Glutamate", "relationship": "RELATED_PROGNOSIS", "object": "Found decrease in brain glutamate levels with aging", "chunk": 6}
{"article": "PMC4694064.txt", "subject": "\u03b1-ketoglutarate", "relationship": "RELATED_PROGNOSIS", "object": "Restored by J147", "chunk": 6}
{"article": "PMC4694064.txt", "subject": "cAMP", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased cAMP-PKA signaling in the aging brain is associated with impaired cognition and increased vulnerability to neurodegeneration", "chunk": 6}
{"article": "PMC4694064.txt", "subject": "PKA", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Dysregulation of PKA might be partially responsible for AD-related abnormal tau phosphorylation", "chunk": 6}
{"article": "PMC4694064.txt", "subject": "J147", "relationship": "RESPONDED_TO", "object": "Acycarnitines", "chunk": 6}
{"article": "PMC4694064.txt", "subject": "A\u03b21-40", "relationship": "MEASURED_DURING_TREATMENT", "object": "Levels analyzed using A\u03b21\u221240 ELISA", "chunk": 7}
{"article": "PMC4694064.txt", "subject": "A\u03b21-42", "relationship": "MEASURED_DURING_TREATMENT", "object": "Levels analyzed using A\u03b21-42 ELISA", "chunk": 7}
{"article": "PMC4694064.txt", "subject": "RO1 AG046153", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC4694064.txt", "subject": "RO1 AG035055", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC4700270.txt", "subject": "MnS", "relationship": "INDICATES_PRESENCE_OF", "object": "Deficit in spatial working memory (in patients with diseases like dementia, schizophrenia, Parkinson\u2019s disease, stroke, PTSD, and ADHD)", "chunk": 1}
{"article": "PMC4700270.txt", "subject": "MnS", "relationship": "RELATED_PROGNOSIS", "object": "MnS scores correlate negatively with response times (ReTs)", "chunk": 1}
{"article": "PMC4700270.txt", "subject": "Response times (ReTs)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Measured as part of the C-SST for assessing the reliability and sensitivity of spatial span testing", "chunk": 1}
{"article": "PMC4700270.txt", "subject": "C-SST", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "C-SST performance used to detect malingering, distinguish normal and abnormal spans", "chunk": 1}
{"article": "PMC4700270.txt", "subject": "MnS scores", "relationship": "RELATED_TO", "object": "Malingering", "chunk": 4}
{"article": "PMC4700270.txt", "subject": "MnS z-scores", "relationship": "RELATED_TO", "object": "Processing speed", "chunk": 4}
{"article": "PMC4700270.txt", "subject": "ReT z-scores", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Malingering", "chunk": 4}
{"article": "PMC4700270.txt", "subject": "Digit span scores", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Being able to accurately identify malingerers", "chunk": 4}
{"article": "PMC4700270.txt", "subject": "MnS z-score", "relationship": "DIAGNOSITC_OF", "object": "Malingering", "chunk": 5}
{"article": "PMC4700270.txt", "subject": "MnS z-score", "relationship": "INDICATES_PRESENCE_OF", "object": "Malingering", "chunk": 5}
{"article": "PMC4700270.txt", "subject": "MnS z-score", "relationship": "RELATED_PROGNOSIS", "object": "Malingering", "chunk": 5}
{"article": "PMC4700270.txt", "subject": "Substitution errors", "relationship": "RELATED_PROGNOSIS", "object": "Malingering", "chunk": 5}
{"article": "PMC4706154.txt", "subject": "White matter hyperintensities (WMH)", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebral small vessel disease (SVD)", "chunk": 1}
{"article": "PMC4706154.txt", "subject": "Lacunes", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebral small vessel disease (SVD)", "chunk": 1}
{"article": "PMC4706154.txt", "subject": "Microbleeds", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebral small vessel disease (SVD)", "chunk": 1}
{"article": "PMC4706154.txt", "subject": "Perivascular spaces", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebral small vessel disease (SVD)", "chunk": 1}
{"article": "PMC4706154.txt", "subject": "Lacunes", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive dysfunction", "chunk": 1}
{"article": "PMC4706154.txt", "subject": "White matter hyperintensities (WMH)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive dysfunction", "chunk": 1}
{"article": "PMC4706154.txt", "subject": "Microbleeds", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive dysfunction", "chunk": 1}
{"article": "PMC4706154.txt", "subject": "Perivascular spaces", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive dysfunction", "chunk": 1}
{"article": "PMC4706154.txt", "subject": "Fazekas score", "relationship": "INDICATES_PRESENCE_OF", "object": "Confluent deep WMH (Fazekas score 2 or 3) and/or irregular periventricular WMH extending into the deep white matter (Fazekas score 3)", "chunk": 2}
{"article": "PMC4706154.txt", "subject": "lacunes", "relationship": "INDICATES_PRESENCE_OF", "object": "1 point on the SVD scale", "chunk": 2}
{"article": "PMC4706154.txt", "subject": "Microbleeds", "relationship": "INDICATES_PRESENCE_OF", "object": "1 point on the SVD scale", "chunk": 2}
{"article": "PMC4706154.txt", "subject": "moderate to severe (grade 2\u20134) basal ganglia perivascular spaces", "relationship": "INDICATES_PRESENCE_OF", "object": "1 point on the SVD scale", "chunk": 2}
{"article": "PMC4706154.txt", "subject": "SVD score", "relationship": "RELATED_PROGNOSIS", "object": "lower general cognitive ability (g)", "chunk": 3}
{"article": "PMC4706154.txt", "subject": "SVD score", "relationship": "RELATED_PROGNOSIS", "object": "lower processing speed", "chunk": 3}
{"article": "PMC4706154.txt", "subject": "SVD score", "relationship": "RELATED_PROGNOSIS", "object": "lower memory", "chunk": 3}
{"article": "PMC4706154.txt", "subject": "higher SVD score", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "lower g", "chunk": 3}
{"article": "PMC4706154.txt", "subject": "SVD score", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive ability", "chunk": 5}
{"article": "PMC4706154.txt", "subject": "SVD scale", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC4706154.txt", "subject": "SVD scale", "relationship": "RELATED_PROGNOSIS", "object": "Processing speed", "chunk": 5}
{"article": "PMC4706154.txt", "subject": "SVD scale", "relationship": "RELATED_PROGNOSIS", "object": "Memory", "chunk": 5}
{"article": "PMC4706154.txt", "subject": "Latent SVD", "relationship": "RELATED_PROGNOSIS", "object": "Processing speed", "chunk": 5}
{"article": "PMC4706154.txt", "subject": "Latent SVD", "relationship": "RELATED_PROGNOSIS", "object": "Memory", "chunk": 5}
{"article": "PMC4707222.txt", "subject": "\u03b2-amyloid plaques", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4707222.txt", "subject": "Neurofibrillary tangles", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4707222.txt", "subject": "\u03b2-amyloid peptide", "relationship": "ASSOCIATED_WITH", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4707222.txt", "subject": "hyperphosphorylated tau protein", "relationship": "ASSOCIATED_WITH", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4707222.txt", "subject": "\u03b2-amyloid", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease pathogenesis", "chunk": 2}
{"article": "PMC4707222.txt", "subject": "\u03b2-amyloid plaques", "relationship": "RELATED_TO", "object": "Reductions in \u03b2-amyloid plaques", "chunk": 3}
{"article": "PMC4707222.txt", "subject": "Neurofibrillary tangles of hyperphosphorylated tau protein", "relationship": "RELATED_TO", "object": "Reductions in Neurofibrillary tangles of hyperphosphorylated tau protein", "chunk": 3}
{"article": "PMC4707222.txt", "subject": "inflammation", "relationship": "RELATED_TO", "object": "Reductions in inflammation", "chunk": 3}
{"article": "PMC4707222.txt", "subject": "oxidative stress", "relationship": "RELATED_TO", "object": "Reductions in oxidative stress", "chunk": 3}
{"article": "PMC4707222.txt", "subject": "ATP levels", "relationship": "RELATED_TO", "object": "Increases in ATP levels", "chunk": 3}
{"article": "PMC4707222.txt", "subject": "mitochondrial function", "relationship": "RELATED_TO", "object": "Improved overall mitochondrial function", "chunk": 3}
{"article": "PMC4707222.txt", "subject": "\u03b2-amyloid aggregates", "relationship": "RELATED_TO", "object": "Reductions in \u03b2-amyloid aggregates", "chunk": 3}
{"article": "PMC4707222.txt", "subject": "cell number", "relationship": "RELATED_TO", "object": "Increases in overall cell number", "chunk": 3}
{"article": "PMC4707222.txt", "subject": "Mitochondrial dysfunction", "relationship": "ASSOCIATED_WITH", "object": "Vascular conditions including atherosclerosis and hypertension", "chunk": 6}
{"article": "PMC4707222.txt", "subject": "Mitochondrial dysfunction", "relationship": "RELATED_TO", "object": "Breakdown of the integrity of small cerebral vessels and the blood-brain barrier", "chunk": 6}
{"article": "PMC4731943.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "Increases the risk of developing Alzheimer's disease", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "Decreases the age of onset of Alzheimer's disease", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "Associated with greater amyloid burden", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "Associated with greater cortical and vascular amyloid deposition", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": " Alzheimer's disease (AD)", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "Serum amyloid-\u03b2 (A\u03b2) peptide sequences A\u03b21\u201340 and A\u03b21\u201342 measurements", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Bexarotene treatment for AD", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "RXR agonists", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treating AD", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_TREATMENT", "object": "Reduced by bexarotene treatment", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_TREATMENT", "object": "Removal from the brain by ApoE, increased by RXR agonists", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "Amyloid-\u03b2 (A\u03b2) protein", "relationship": "ASSOCIATED_WITH", "object": "Peptide aggregation, neurotoxicity, and formation of neuritic plaques", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "Apolipoprotein E \u03b54 (apoe4)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk of developing Alzheimer's disease", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "Apolipoprotein E \u03b54 (apoe4)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Decreased age of onset of Alzheimer's disease", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "apoe4", "relationship": "RELATIONSHIP_TO_THERAPY", "object": "RXR agonists", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "BBXAROTENE", "relationship": "RELATED_TO", "object": "Potential Treatment for AD", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "Bexarotene", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4731943.txt", "subject": "florbetapir PET", "relationship": "INDICATES_PRESENCE_OF", "object": "Positive amyloid PET", "chunk": 2}
{"article": "PMC4731943.txt", "subject": "ApoE genotype", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The effect of ApoE genotype was hypothesized to be influential", "chunk": 2}
{"article": "PMC4731943.txt", "subject": "A\u03b21\u201340", "relationship": "MONITORED_DURING_TREATMENT", "object": "Change in A\u03b21\u201340 and A\u03b21\u201342 serum levels from baseline to week 4", "chunk": 2}
{"article": "PMC4731943.txt", "subject": "A\u03b21\u201342", "relationship": "MONITORED_DURING_TREATMENT", "object": "Change in A\u03b21\u201340 and A\u03b21\u201342 serum levels from baseline to week 4", "chunk": 2}
{"article": "PMC4731943.txt", "subject": "A\u03b21\u201340", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Alzheimer's Disease", "chunk": 3}
{"article": "PMC4731943.txt", "subject": "A\u03b21\u201342", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Alzheimer's Disease", "chunk": 3}
{"article": "PMC4731943.txt", "subject": "Composite SUVr", "relationship": "RELATED_PROGNOSIS", "object": "Change in amyloid burden over treatment period", "chunk": 3}
{"article": "PMC4731943.txt", "subject": "SUVr values", "relationship": "MONITORED_DURING_TREATMENT", "object": "Amyloid burden response to Bexarotene treatment", "chunk": 3}
{"article": "PMC4731943.txt", "subject": "apoe4 genotype", "relationship": "INDICATES_PRESENCE_OF", "object": "Genetic predisposition to Alzheimer's Disease", "chunk": 3}
{"article": "PMC4731943.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Reduction of A\u03b2 in anterior cingulate cortex, parietal cortex, posterior cingulate cortex, precuneus, and temporal cortex in apoe4 noncarriers", "chunk": 4}
{"article": "PMC4731943.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "Analysis showed a significant increase in serum A\u03b21\u201342 was seen at week 4 in the bexarotene group compared with those on placebo when all subjects were included.", "chunk": 4}
{"article": "PMC4731943.txt", "subject": "A\u03b2", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Increases in serum A\u03b21\u201342 correlated with decreased cortical amyloid in treated apoe4 noncarriers", "chunk": 4}
{"article": "PMC4731943.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "Apolipoprotein E \u03b54 allele is a known genetic risk factor for AD", "chunk": 6}
{"article": "PMC4731943.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": " Targeting amyloid-beta with amyloid imaging agents is part of a therapeutic strategy", "chunk": 6}
{"article": "PMC4743597.txt", "subject": "Pseudobulbar affect (PBA)", "relationship": "RELATED_TO", "object": "a range of neurological disorders and injury affecting the brain", "chunk": 1}
{"article": "PMC4743597.txt", "subject": "Pseudobulbar affect (PBA)", "relationship": "CHARACTERIZED_BY", "object": "frequent, uncontrollable episodes of crying and/or laughing that are exaggerated or unrelated to the patient\u2019s emotional state", "chunk": 1}
{"article": "PMC4743597.txt", "subject": "Alzheimer\u2019s Disease", "relationship": "ASSOCIATED_WITH", "object": "PBA (at least 5%)", "chunk": 1}
{"article": "PMC4743597.txt", "subject": "Amyotrophic lateral sclerosis (ALS)", "relationship": "ASSOCIATED_WITH", "object": "PBA (up to 50%)", "chunk": 1}
{"article": "PMC4743597.txt", "subject": "Parkinson\u2019s disease (PD)", "relationship": "ASSOCIATED_WITH", "object": "PBA (at least 5%)", "chunk": 1}
{"article": "PMC4743597.txt", "subject": "Multiple sclerosis (MS)", "relationship": "ASSOCIATED_WITH", "object": "PBA (10%)", "chunk": 1}
{"article": "PMC4743597.txt", "subject": "Stroke", "relationship": "ASSOCIATED_WITH", "object": "PBA", "chunk": 1}
{"article": "PMC4743597.txt", "subject": "Traumatic brain injury (TBI)", "relationship": "ASSOCIATED_WITH", "object": "PBA", "chunk": 1}
{"article": "PMC4743597.txt", "subject": "Progressive supranuclear palsy", "relationship": "ASSOCIATED_WITH", "object": "PBA (20%)", "chunk": 1}
{"article": "PMC4743597.txt", "subject": "AD", "relationship": "RELATED_TO", "object": "Primary neurological conditions", "chunk": 2}
{"article": "PMC4743597.txt", "subject": "donepezil", "relationship": "USED_TO_DIAGNOSE", "object": "AD/dementia", "chunk": 4}
{"article": "PMC4743597.txt", "subject": "memantine", "relationship": "USED_TO_DIAGNOSE", "object": "AD/dementia", "chunk": 4}
{"article": "PMC4743597.txt", "subject": "riluzole", "relationship": "USED_TO_DIAGNOSE", "object": "ALS/MND", "chunk": 4}
{"article": "PMC4743597.txt", "subject": "Respiratory failure", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "31 of the 39 ALS deaths", "chunk": 6}
{"article": "PMC4743597.txt", "subject": "ALZHEIMER\u2019S DISEASE", "relationship": "ASSOCIATES_WITH", "object": "Stroke ", "chunk": 6}
{"article": "PMC4746584.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease pathology", "chunk": 1}
{"article": "PMC4746584.txt", "subject": "A\u03b238", "relationship": "ASSOCIATED_WITH", "object": "Lower levels in cerebral cerebral cerebral cerebral spinal fluid", "chunk": 1}
{"article": "PMC4746584.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH", "object": "Lower levels in cerebral cerebral cerebral cerebral spinal fluid", "chunk": 1}
{"article": "PMC4746584.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH", "object": "Temporal white matter lesions", "chunk": 1}
{"article": "PMC4746584.txt", "subject": "A\u03b238", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebral amyloid angiopathy (CAA)", "chunk": 2}
{"article": "PMC4746584.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebral amyloid angiopathy (CAA)", "chunk": 2}
{"article": "PMC4746584.txt", "subject": "A\u03b242", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Severe WML", "chunk": 2}
{"article": "PMC4746584.txt", "subject": "A\u03b238", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased WML volume", "chunk": 2}
{"article": "PMC4746584.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased WML volume", "chunk": 2}
{"article": "PMC4746584.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "WMH in subjects with mild cognitive impairment, AD and CAA", "chunk": 3}
{"article": "PMC4746584.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "microvascular dysfunction", "chunk": 3}
{"article": "PMC4746584.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "plaque pathology that might be associated with SVD in individuals with dementia due to AD", "chunk": 3}
{"article": "PMC4746584.txt", "subject": "A\u03b238", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "WML", "chunk": 3}
{"article": "PMC4746584.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "WML", "chunk": 3}
{"article": "PMC4746584.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "AD development risk", "chunk": 3}
{"article": "PMC4746584.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "Treatment for vascular risk factors", "chunk": 3}
{"article": "PMC4746584.txt", "subject": "18F-flutemetamol PET imaging", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "AD diagnosis", "chunk": 3}
{"article": "PMC4746584.txt", "subject": "WVML", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 3}
{"article": "PMC4746584.txt", "subject": "18F-flutemetamol PET", "relationship": "USED_TO_DIAGNOSE", "object": "PD and AD cases", "chunk": 4}
{"article": "PMC4746584.txt", "subject": "quantitative WML analysis", "relationship": "USED_TO_DIAGNOSE", "object": "AD cases", "chunk": 4}
{"article": "PMC4746584.txt", "subject": "Data on cerebral microbleeds", "relationship": "INDICATES_PRESENCE_OF", "object": "cerebral amyloid angiopathy", "chunk": 4}
{"article": "PMC4746584.txt", "subject": "Fazekas score", "relationship": "RELATED_PROGNOSIS", "object": "cognitive decline", "chunk": 4}
{"article": "PMC4746584.txt", "subject": "ARWMC scales", "relationship": "RELATED_PROGNOSIS", "object": "cognitive decline", "chunk": 4}
{"article": "PMC4746584.txt", "subject": "WML volume", "relationship": "MONITORED_DURING_TREATMENT", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4746584.txt", "subject": "Lacunes", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "cerebral cerebral cerebral cerebral spinal fluid A\u03b238 and cerebral cerebral cerebral cerebral spinal fluid A\u03b240 levels", "chunk": 4}
{"article": "PMC4746584.txt", "subject": "WML", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "lower cerebral cerebral cerebral cerebral spinal fluid A\u03b238 and A\u03b240 levels", "chunk": 4}
{"article": "PMC4746584.txt", "subject": "WML", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Alzheimer's Disease treatment", "chunk": 4}
{"article": "PMC4746584.txt", "subject": "WML", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Alzheimer's Disease treatment", "chunk": 4}
{"article": "PMC4746584.txt", "subject": "A\u03b238", "relationship": "MEASURED_IN", "object": "cerebral cerebrospinal fluid", "chunk": 5}
{"article": "PMC4746584.txt", "subject": "A\u03b240", "relationship": "MEASURED_IN", "object": "cerebral cerebrospinal fluid", "chunk": 5}
{"article": "PMC4746584.txt", "subject": "A\u03b242", "relationship": "MEASURED_IN", "object": "cerebral cerebrospinal fluid", "chunk": 5}
{"article": "PMC4746584.txt", "subject": "P-tau", "relationship": "MEASURED_IN", "object": "cerebral cerebrospinal fluid", "chunk": 5}
{"article": "PMC4746584.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Indicates prognosis for Cognitive Decline", "chunk": 6}
{"article": "PMC4746584.txt", "subject": "cerebral cerebral cerebral  spinal fluid A\u03b238", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4746584.txt", "subject": "cerebral cerebral cerebral  spinal fluid A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4746584.txt", "subject": "cerebral cerebral cerebral  spinal fluid A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4746584.txt", "subject": "WML volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4746584.txt", "subject": "Fazekas total score", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4746584.txt", "subject": "Composite SUVR", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4746584.txt", "subject": "A\u03b238", "relationship": "RELATED_PROGNOSIS", "object": "Cerebrovascular disease", "chunk": 7}
{"article": "PMC4746584.txt", "subject": "A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Cerebrovascular disease", "chunk": 7}
{"article": "PMC4746584.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Cerebrovascular disease", "chunk": 7}
{"article": "PMC4747225.txt", "subject": "LIPUS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Drug delivery", "chunk": 3}
{"article": "PMC4747225.txt", "subject": "LIPUS", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of brain injuries after BBBD", "chunk": 3}
{"article": "PMC4747225.txt", "subject": "LIPUS", "relationship": "MONITORED_DURING_TREATMENT", "object": "BBBD duration", "chunk": 3}
{"article": "PMC4747225.txt", "subject": "FUS/MB", "relationship": "INDICATES_PRESENCE_OF", "object": "BBBD", "chunk": 3}
{"article": "PMC4747225.txt", "subject": "FUS/MB", "relationship": "RELATED_TO", "object": "Cerebral edema", "chunk": 3}
{"article": "PMC4747225.txt", "subject": "FUS/MB", "relationship": "RELATED_TO", "object": "Brain injuries", "chunk": 3}
{"article": "PMC4772335.txt", "subject": "amyloid \u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4772335.txt", "subject": "appoprotein (APO)\u03b54", "relationship": "RELATED_TREATMENT", "object": "Treatment-related differences in biomarkers", "chunk": 1}
{"article": "PMC4772335.txt", "subject": "A\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "immunotherapy", "chunk": 1}
{"article": "PMC4772335.txt", "subject": "amyloid-\u03b2 (A\u03b2)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "ARIA-E (vasogenic edema) and microhemorrhage", "chunk": 1}
{"article": "PMC4772335.txt", "subject": "AAB-003", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "dose escalation", "chunk": 1}
{"article": "PMC4772335.txt", "subject": "bapineuzumab", "relationship": "RELATED_TREATMENT", "object": "treatment related differences in biomarkers", "chunk": 1}
{"article": "PMC4772335.txt", "subject": "ARIA-E", "relationship": "INDICATES_PRESENCE_OF", "object": "brain abnormalities (MRI)", "chunk": 2}
{"article": "PMC4772335.txt", "subject": "ARIA-E", "relationship": "RELATED_TO", "object": "Safety", "chunk": 2}
{"article": "PMC4772335.txt", "subject": "ARIA-H", "relationship": "RELATED_TO", "object": "Safety", "chunk": 2}
{"article": "PMC4772335.txt", "subject": "Mini-Mental State Exam (MMSE)", "relationship": "RELATED_TO", "object": "Diagnosis of probable AD", "chunk": 2}
{"article": "PMC4772335.txt", "subject": "Rosen Modified Hachinski Ischemic score", "relationship": "RELATED_TO", "object": "Diagnosis of probable AD", "chunk": 2}
{"article": "PMC4772335.txt", "subject": "ARIA-E", "relationship": "RELATED_TREATMENT", "object": "Dose reduction algorithm", "chunk": 2}
{"article": "PMC4772335.txt", "subject": "ARIA-E", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "ARIA-E showed progressive resolution on MRI at weeks 16 and 19, with complete resolution reported on MRI at week 39", "chunk": 4}
{"article": "PMC4772335.txt", "subject": "ARIA-E", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Thereafter, ARIA-E showed progressive resolution on MRI at weeks 16 and 19, with complete resolution reported on MRI at week 39", "chunk": 4}
{"article": "PMC4772335.txt", "subject": "ARIA-E", "relationship": "RELATED_TO_ADVERSE_EVENT", "object": "Asymptomatic ARIA-E was identified in 2 (8.3 %) of the 24 patients who received 8 mg/kg", "chunk": 4}
{"article": "PMC4772335.txt", "subject": "apoe4 negative", "relationship": "RELATED_PROGNOSIS", "object": "The subject was apoe4 negative (\u03b53/\u03b53)", "chunk": 4}
{"article": "PMC4772335.txt", "subject": "apoe4 positive", "relationship": "RELATED_PROGNOSIS", "object": "The subject was apoe4 positive (\u03b53/\u03b54)", "chunk": 4}
{"article": "PMC4772335.txt", "subject": "AAB-003", "relationship": "RELATED_PROGNOSIS", "object": "The study did not find evidence of clinically significant changes in laboratory tests, vital sign measurements, physical examination, neurologic examination, or ECG results", "chunk": 5}
{"article": "PMC4772335.txt", "subject": "AAB-003", "relationship": "RELATED_TREATMENT", "object": "Dose-dependent increase in plasma A\u03b2x-40 was observed across the entire dose range", "chunk": 5}
{"article": "PMC4772335.txt", "subject": "AAB-003", "relationship": "RELATED_TREATMENT", "object": "The median time to maximum plasma A\u03b2x-40 increased from approximately 24 hours at lower doses (0.5\u20132 mg/kg) to approximately 164 hours at higher doses (4\u20138 mg/kg)", "chunk": 5}
{"article": "PMC4772335.txt", "subject": "AAB-003", "relationship": "RELATED_TREATMENT", "object": "The t1/2 for plasma A\u03b2x-40, when estimated, was approximately 30 days.", "chunk": 5}
{"article": "PMC4772335.txt", "subject": "A\u03b2x-40", "relationship": "RELATED_TREATMENT", "object": "Dose-dependent increase in plasma A\u03b2x-40 was observed across the entire dose range", "chunk": 5}
{"article": "PMC4772335.txt", "subject": "A\u03b2x-40", "relationship": "RELATED_TREATMENT", "object": "The median time to maximum plasma A\u03b2x-40 increased from approximately 24 hours at lower doses (0.5\u20132 mg/kg) to approximately 164 hours at higher doses (4\u20138 mg/kg)", "chunk": 5}
{"article": "PMC4772335.txt", "subject": "A\u03b2x-40", "relationship": "RELATED_PROGNOSIS", "object": "Lack of significant change in cerebral spinal fluid levels", "chunk": 6}
{"article": "PMC4772335.txt", "subject": "A\u03b2x-42", "relationship": "RELATED_PROGNOSIS", "object": "Lack of significant change in cerebral spinal fluid levels", "chunk": 6}
{"article": "PMC4772335.txt", "subject": "tau", "relationship": "RELATED_PROGNOSIS", "object": "Lack of significant change in cerebral spinal fluid levels", "chunk": 6}
{"article": "PMC4772335.txt", "subject": "p-tau", "relationship": "RELATED_PROGNOSIS", "object": "Lack of significant change in cerebral spinal fluid levels", "chunk": 6}
{"article": "PMC4772335.txt", "subject": "ARIA-E", "relationship": "RELATED_TREATMENT", "object": "The safety profile of AAB-003 in patients who experienced ARIA-E and continued to receive AAB-003 is unknown", "chunk": 7}
{"article": "PMC4780148.txt", "subject": "amyloid beta peptides", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Neuronal degeneration, memory loss, and cognitive decline", "chunk": 1}
{"article": "PMC4780148.txt", "subject": "amyloid beta peptides", "relationship": "PRODUCED_BY", "object": "Enzymatic cleavage of the amyloid precursor protein (APP) by \u03b2-secretase (BACE) and \u03b3-secretase", "chunk": 1}
{"article": "PMC4780148.txt", "subject": "A\u03b242", "relationship": "PREDICTS_SURVIVAL", "object": "The driving force in the disease", "chunk": 1}
{"article": "PMC4780148.txt", "subject": "semagacestat", "relationship": "USED_TO_DIAGNOSE", "object": " Decrease the production of potentially toxic amyloid beta peptides species", "chunk": 1}
{"article": "PMC4780148.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "A maximum A\u03b2 inhibitory effect was seen between 9 and 12\u00a0h", "chunk": 2}
{"article": "PMC4780148.txt", "subject": "EDVGSNK", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 production ", "chunk": 3}
{"article": "PMC4780148.txt", "subject": "EDVGSNK", "relationship": "RELATED_TO", "object": "APP (amyloid precursor protein)", "chunk": 3}
{"article": "PMC4780148.txt", "subject": "DELAPAGTGVSREAVSG", "relationship": "INDICATES_PRESENCE_OF", "object": "gamma secretase cleavage", "chunk": 3}
{"article": "PMC4780148.txt", "subject": "DELAPAGTGVSREAVSG", "relationship": "RELATED_TO", "object": "APLP1 (amyloid-like protein 1)", "chunk": 3}
{"article": "PMC4798753.txt", "subject": "MMSE", "relationship": "USED_TO_DIAGNOSE", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC4798753.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment level", "chunk": 3}
{"article": "PMC4798753.txt", "subject": "CDR-SOB", "relationship": "RELATED_PROGNOSIS", "object": "Severity of dementia", "chunk": 3}
{"article": "PMC4798753.txt", "subject": "Apathy Inventory", "relationship": "RELATED_PROGNOSIS", "object": "Severity of apathy", "chunk": 3}
{"article": "PMC4798753.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "significantly lower MMSE scores in dementia group compared to mild cognitive impairment group", "chunk": 4}
{"article": "PMC4798753.txt", "subject": "CDR-SOB", "relationship": "RELATED_PROGNOSIS", "object": "significantly higher CDR-SOB scores in dementia group compared to mild cognitive impairment group", "chunk": 4}
{"article": "PMC4798753.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Significant level of cognitive impairment", "chunk": 4}
{"article": "PMC4798753.txt", "subject": "CDR-SOB", "relationship": "INDICATES_PRESENCE_OF", "object": "Significant impairment in activities of daily living", "chunk": 4}
{"article": "PMC4804486.txt", "subject": "Mini Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4804486.txt", "subject": "MMSE", "relationship": "USED_TO_DIAGNOSE", "object": "Screening tool for cognitive impairment", "chunk": 2}
{"article": "PMC4804486.txt", "subject": "CVLT-II", "relationship": "USED_TO_DIAGNOSE", "object": "Assess patients with Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4804486.txt", "subject": "Cornell Scale for Depression in dementia", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression", "chunk": 2}
{"article": "PMC4804486.txt", "subject": "IQCODE", "relationship": "MONITORED_DURING_TREATMENT", "object": "Progressive decline", "chunk": 2}
{"article": "PMC4804486.txt", "subject": "Confusion Assessment Method", "relationship": "MONITORED_DURING_TREATMENT", "object": "Potential confusion during neuropsychological testing", "chunk": 2}
{"article": "PMC4810525.txt", "subject": "Chinese herbs", "relationship": "MAY_PROTECT", "object": "brain cells against AD", "chunk": 1}
{"article": "PMC4810525.txt", "subject": "herbal products", "relationship": "USED_TO", "object": "relieve AD-related symptoms", "chunk": 1}
{"article": "PMC4810525.txt", "subject": "Chinese medicine (CM)", "relationship": "MAY_PROTECT", "object": "brain cells against AD", "chunk": 1}
{"article": "PMC4810525.txt", "subject": "Bu-Zhong-Yi-Qi-Tang", "relationship": "USED_TO_TREAT", "object": "Mental disorders, diseases of the nervous system and sense organs", "chunk": 3}
{"article": "PMC4810525.txt", "subject": "Ginseng Radix(Ren-Shen)", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4810525.txt", "subject": "Angelicae Sinensis Radix Integra(Dang-Gui)", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4810525.txt", "subject": "Ma-Zi-Ren-Wan", "relationship": "RELATED_TREATMENT", "object": "Treatment of constipation", "chunk": 5}
{"article": "PMC4810525.txt", "subject": "Emodin", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Treating AD", "chunk": 5}
{"article": "PMC4810525.txt", "subject": "\u03b2-amyloid", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 5}
{"article": "PMC4810525.txt", "subject": "Ginseng Radix", "relationship": "RELATED_TREATMENT", "object": "AD related factors", "chunk": 5}
{"article": "PMC4810525.txt", "subject": "Ginseng Radix", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Syndrome pattern identification", "chunk": 5}
{"article": "PMC4810525.txt", "subject": "Dang-Gui", "relationship": "RELATED_TREATMENT", "object": "AD", "chunk": 5}
{"article": "PMC4810525.txt", "subject": "Emodin", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treating AD", "chunk": 5}
{"article": "PMC4811920.txt", "subject": "amygdala", "relationship": "RELATED_PROGNOSIS", "object": "Memory performance in the amnestic mild cognitive impairment group and in the entire sample correlated with", "chunk": 1}
{"article": "PMC4811920.txt", "subject": "entorhinal cortex", "relationship": "RELATED_PROGNOSIS", "object": "Memory performance in the amnestic mild cognitive impairment group and in the entire sample correlated with the thickness of the entorhinal cortex and with the volume of the amygdala", "chunk": 1}
{"article": "PMC4811920.txt", "subject": "ACE Total Score", "relationship": "DIAGNOSITC_OF", "object": "mMCI", "chunk": 2}
{"article": "PMC4811920.txt", "subject": "ACE VL/OM-ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC4811920.txt", "subject": "ACE VL/OM-ratio", "relationship": "RELATED_PROGNOSIS", "object": "frontotemporal dementia", "chunk": 2}
{"article": "PMC4811920.txt", "subject": "Rey Auditory Verbal Learning Test (RAVLT)", "relationship": "USED_TO_DIAGNOSE", "object": "amild cognitive impairment", "chunk": 2}
{"article": "PMC4811920.txt", "subject": "RAVLT delayed recall subscore", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "amild cognitive impairment  group", "chunk": 2}
{"article": "PMC4811920.txt", "subject": "RAVLT total score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "amild cognitive impairment  group", "chunk": 2}
{"article": "PMC4811920.txt", "subject": "amild cognitive impairment ", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Neuropsychological test battery", "chunk": 2}
{"article": "PMC4811920.txt", "subject": "Mini Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Dementia", "chunk": 3}
{"article": "PMC4811920.txt", "subject": "Mini Mental State Examination (MMSE)", "relationship": "RELATED_PROGNOSIS", "object": "Differentiating between subjects with dementia and healthy controls", "chunk": 3}
{"article": "PMC4811920.txt", "subject": "hippocampus volume", "relationship": "DIAGNOSITC_OF", "object": "amild cognitive impairment", "chunk": 4}
{"article": "PMC4811920.txt", "subject": "entorhinal cortex volume", "relationship": "DIAGNOSITC_OF", "object": "amild cognitive impairment", "chunk": 4}
{"article": "PMC4811920.txt", "subject": "ENTORHINAL CORTEX THICKN...", "relationship": "RELATED_PROGNOSIS", "object": "Anterograde memory,  Retrograde memory, Categorical fluency, Letter fluency", "chunk": 5}
{"article": "PMC4811920.txt", "subject": "FUSIFORM GYRUS THICKNE...", "relationship": "RELATED_PROGNOSIS", "object": "Anterograde memory,  Retrograde memory, Categorical fluency, Letter fluency", "chunk": 5}
{"article": "PMC4811920.txt", "subject": "ISTHMUS OF CINGULATE G...", "relationship": "RELATED_PROGNOSIS", "object": "Anterograde memory,  Retrograde memory, Categorical fluency, Letter fluency", "chunk": 5}
{"article": "PMC4811920.txt", "subject": "PRECUNEUS THICKNESS", "relationship": "RELATED_PROGNOSIS", "object": "Anterograde memory,  Retrograde memory, Categorical fluency, Letter fluency", "chunk": 5}
{"article": "PMC4811920.txt", "subject": "Entorhinal cortex thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "Amnestic mild cognitive impairment", "chunk": 6}
{"article": "PMC4811920.txt", "subject": "Fusiform gyrus thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "Amnestic mild cognitive impairment", "chunk": 6}
{"article": "PMC4811920.txt", "subject": "Isthmus of cingulate gyrus thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "Amnestic mild cognitive impairment", "chunk": 6}
{"article": "PMC4811920.txt", "subject": "Precuneus thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "Amnestic mild cognitive impairment", "chunk": 6}
{"article": "PMC4811920.txt", "subject": "Amygdala volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Amnestic mild cognitive impairment", "chunk": 6}
{"article": "PMC4811920.txt", "subject": "Hippocampus volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Amnestic mild cognitive impairment", "chunk": 6}
{"article": "PMC4811920.txt", "subject": "Entorhinal cortex volume", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's disease", "chunk": 6}
{"article": "PMC4811920.txt", "subject": "Entorhinal cortex volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Amnestic mild cognitive impairment", "chunk": 6}
{"article": "PMC4811920.txt", "subject": "Fusiform gyrus volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Amnestic mild cognitive impairment", "chunk": 6}
{"article": "PMC4811920.txt", "subject": "Fusiform gyrus thickness", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Retrograde memory", "chunk": 6}
{"article": "PMC4822297.txt", "subject": "amyloid \u03b2 (A\u03b2) protofibrils", "relationship": "RELATED_TO_TREATMENT", "object": "Selective targeting of A\u03b2 protofibrils with BAN2401", "chunk": 1}
{"article": "PMC4822297.txt", "subject": "A\u03b2 protofibrils", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "The selection of BAN2401 for treatment", "chunk": 1}
{"article": "PMC4822297.txt", "subject": "A\u03b2 protofibrils", "relationship": "IS_TARGET_OF_TREATMENT", "object": "BAN2401", "chunk": 1}
{"article": "PMC4822297.txt", "subject": "A\u03b2 protofibrils", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Targeting A\u03b2 protofibrils for potential treatment of AD", "chunk": 1}
{"article": "PMC4822297.txt", "subject": "A\u03b2(1-40)", "relationship": "TARGET_ENGAGEMENT_AND_PHARMACODYNAMICS", "object": "Plasma concentrations were measured", "chunk": 2}
{"article": "PMC4822297.txt", "subject": "A\u03b2(1-42)", "relationship": "RELATED_TREATMENT", "object": "Brain spinal fluid A\u03b2(1-42), t-tau, and p-tau concentrations were measured", "chunk": 2}
{"article": "PMC4822297.txt", "subject": "t-tau", "relationship": "RELATED_TREATMENT", "object": "Brain spinal fluid A\u03b2(1-42), t-tau, and p-tau concentrations were measured", "chunk": 2}
{"article": "PMC4822297.txt", "subject": "p-tau", "relationship": "RELATED_TREATMENT", "object": "Brain spinal fluid A\u03b2(1-42), t-tau, and p-tau concentrations were measured", "chunk": 2}
{"article": "PMC4822297.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 3}
{"article": "PMC4822297.txt", "subject": "ARIA-H", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of Alzheimer's disease", "chunk": 3}
{"article": "PMC4822297.txt", "subject": "BAN2401", "relationship": "RELATED_TREATMENT", "object": "treatment with increasing BAN2401 doses", "chunk": 4}
{"article": "PMC4822297.txt", "subject": "BAN2401", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "treatment with BAN2401 at 0.3\u20133\u00a0mg/kg every 28\u00a0days (4 doses), or 10\u00a0mg/kg biweekly (7 doses)", "chunk": 4}
{"article": "PMC4822297.txt", "subject": "BAN2401", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "selection of different BAN2401 dosing regimens", "chunk": 4}
{"article": "PMC4822297.txt", "subject": "BAN2401", "relationship": "IS_TARGET_OF_TREATMENT", "object": "pharmacokinetic and pharmacodynamic studies", "chunk": 4}
{"article": "PMC4822297.txt", "subject": "A\u03b2(1-40)", "relationship": "RESPONDED_TO", "object": "treatment with BAN2401", "chunk": 4}
{"article": "PMC4822297.txt", "subject": "A\u03b2(1-40)", "relationship": "RELATED_PROGNOSIS", "object": "plasma A\u03b2(1-40) levels", "chunk": 4}
{"article": "PMC4822297.txt", "subject": "A\u03b2(1-40)", "relationship": "MONITORED_DURING_TREATMENT", "object": "BAN2401 treatment", "chunk": 5}
{"article": "PMC4822297.txt", "subject": "A\u03b2(1-40)", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Response to BAN2401 treatment", "chunk": 5}
{"article": "PMC4822297.txt", "subject": "A\u03b2(1-42)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "BAN2401", "chunk": 5}
{"article": "PMC4822297.txt", "subject": "t-tau", "relationship": "IS_TARGET_OF_TREATMENT", "object": "BAN2401", "chunk": 5}
{"article": "PMC4822297.txt", "subject": "p-tau", "relationship": "IS_TARGET_OF_TREATMENT", "object": "BAN2401", "chunk": 5}
{"article": "PMC4822297.txt", "subject": "A\u03b2(1-42)", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "BAN2401 treatment", "chunk": 5}
{"article": "PMC4835514.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4835514.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "The development of AD or the conversion from mild cognitive impairment  (mild cognitive impairment  ) to AD", "chunk": 1}
{"article": "PMC4835514.txt", "subject": "A\u03b2 amyloid angiopathy", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease", "chunk": 1}
{"article": "PMC4835514.txt", "subject": "arthorelosclerotic small vessel disease (SVD)", "relationship": "RELATED_WITH_NEUROPATHOLOGY", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4835514.txt", "subject": "Cerebral infarcts or foci of haemorrhage", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4835514.txt", "subject": "APOE \u03f54", "relationship": "RELATED_TREATMENT", "object": "increases the risk of A\u03b2 amyloid angiopathy-associated lobar haemorrhage", "chunk": 3}
{"article": "PMC4835514.txt", "subject": "APOE \u03f54", "relationship": "USED_TO_DIAGNOSE", "object": "may increase the risk of A\u03b2 amyloid angiopathy-associated lobar haemorrhage", "chunk": 3}
{"article": "PMC4835514.txt", "subject": "A\u03b2 amyloid angiopathy", "relationship": "INDICATES_PRESENCE_OF", "object": "neuritis, vascular deposition of A\u03b2, and cerebral hypoperfusion", "chunk": 3}
{"article": "PMC4835514.txt", "subject": "A\u03b2 amyloid angiopathy", "relationship": "RELATED_PROGNOSIS", "object": "increased risk of cerebral haemorrhage ", "chunk": 3}
{"article": "PMC4835514.txt", "subject": "regional oxygen extraction fraction (rOEF)", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "tissue oxygenation index (TOI)", "relationship": "INDICATES_PRESENCE_OF", "object": "amnestic mild cognitive impairment", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "Myelin-associated glycoprotein (MAG)", "relationship": "RELATED_TO", "object": "hypoperfusion and occurs in the adaxonal loop of myelin", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "proteolipid protein-1 (PLP1)", "relationship": "RELATED_TO", "object": "spread throughout the myelin sheath ", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "MAG:PLP1 ratio", "relationship": "RELATED_PROGNOSIS", "object": "severity of SVD ", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "MAG:PLP1 ratio", "relationship": "RELATED_PROGNOSIS", "object": "concentration of the vasoconstrictor endothelin-1 (EDN1)", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "MAG:PLP1 ratio", "relationship": "RELATED_PROGNOSIS", "object": "concentration of vascular endothelial growth factor (VEGF)", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "vasoconstriction", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "reduced cerebral perfusion", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "elevated A\u03b2 ", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "vasoconstriction, reduce cerebral perfusion", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "elevated A\u03b2 ", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "prevent functional hyperaemia and autoregulation", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "elevated A\u03b2 ", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increase expression of endothelin-converting enzyme-1 and -2 (ECbche gene gene and ECE2)", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "elevated A\u03b2 ", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "inhibit endothelial nitric oxide synthase activity", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "elevated A\u03b2 ", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increase the neuronal expression and activity of angiotensin-converting enzyme (ACE)", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "endothelin-1 (EDN1)", "relationship": "RELATED_TO", "object": "vasoconstriction", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "endothelin-1 (EDN1)", "relationship": "RELATED_TO", "object": "reduced tissue oxygenation", "chunk": 4}
{"article": "PMC4835514.txt", "subject": "MAG:PLP1", "relationship": "RELATED_TREATMENT", "object": "Protective vasodilatory response to reduced oxygenation", "chunk": 5}
{"article": "PMC4835514.txt", "subject": "MAG:PLP1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased EDN1 in overlying cortex", "chunk": 5}
{"article": "PMC4835514.txt", "subject": "EDN1", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduced oxygenation of the precuneus in early AD", "chunk": 5}
{"article": "PMC4835514.txt", "subject": "EDN1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Vasoconstriction of perforating arterioles", "chunk": 5}
{"article": "PMC4835514.txt", "subject": "A\u03b242", "relationship": "PREDICTS_SURVIVAL", "object": "Upregulation of neuronal ECE2", "chunk": 5}
{"article": "PMC4835514.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Elevated cardiovascular activity and inflammatory response", "chunk": 5}
{"article": "PMC4835514.txt", "subject": "Bradykinin", "relationship": "RELATED_TREATMENT", "object": "Dilatation and increased permeability of venules and arterioles", "chunk": 5}
{"article": "PMC4835514.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Progression of Alzheimer\u2019s disease", "chunk": 5}
{"article": "PMC4835514.txt", "subject": "A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Upregulation of endothelial ECE2", "chunk": 5}
{"article": "PMC4835514.txt", "subject": "Ischaemia", "relationship": "RELATED_PROGNOSIS", "object": "Increases production of A\u03b242", "chunk": 5}
{"article": "PMC4835514.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Diffuse Traumatic Brain Injury", "chunk": 6}
{"article": "PMC4835514.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment involving endothelin receptor antagonists in AD", "chunk": 6}
{"article": "PMC4835514.txt", "subject": "Endothelin System", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Pharmacotherapy targeting to slow the progression of dementia in AD", "chunk": 6}
{"article": "PMC4835514.txt", "subject": "EDN1", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral blood flow in AD", "chunk": 6}
{"article": "PMC4835514.txt", "subject": "EDNRA receptor antagonists (e.g., zibotentan)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of AD", "chunk": 6}
{"article": "PMC4835514.txt", "subject": "Renin-angiotensin system", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Therapeutic strategies for AD", "chunk": 6}
{"article": "PMC4846650.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO", "object": "Appearance of  Pre-AD symptoms", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "Cognitive reserve (CR)", "relationship": "RELATED_TREATMENT", "object": "Relationship with brain imaging", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "ApoE-E4 genotype", "relationship": "INDICATES_PRESENCE_OF", "object": "Predict cognitive degeneration symptom earlier", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "ApoE-E4 genotype", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis of  Pre-AD via sMRI", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "Left amydala atrophy rate", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Earlier emergence of clinical symptom", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "Prefrontal cortex", "relationship": "USED_TO_DIAGNOSE", "object": "Pre-AD symptom", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "Precuneus deactivation", "relationship": "RESPONDED_TO", "object": "Increasing frequency of words", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "Left dorsolateral prefrontal cortex activation", "relationship": "RESPONDED_TO", "object": "Decreasing frequency of words", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "Functional connectivity between precuneus and hippocampus", "relationship": "DIAGNOSTIC_OF", "object": "Pre-AD", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "Altered functional connectivity of hippocampus", "relationship": "INDICATES_PRESENCE_OF", "object": "Pre-AD", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "Clustering coefficient", "relationship": "PREDICTS_SURVIVAL", "object": "Cognitive decline", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "Modularity measure", "relationship": "PREDICTS_SURVIVAL", "object": "Cognitive decline", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "Medial prefrontal corticies and anterior cingulate", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Diagnosis of Pre-AD", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "Clusterin genotype", "relationship": "IS_TARGET_OF_TREATMENT", "object": "BOLD signals during an executive attention task", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "Clusterin genotype", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Coupling strength between hippocampus and prefrontal cortex during memory retrieval tasks", "chunk": 2}
{"article": "PMC4846650.txt", "subject": "ApoE-E4 gene", "relationship": "INDICATES_PRESENCE_OF", "object": "Pre-AD", "chunk": 3}
{"article": "PMC4846650.txt", "subject": "ApoE-E4 gene", "relationship": "RELATED_PROGNOSIS", "object": "Increased risk of suffering from Pre-AD", "chunk": 3}
{"article": "PMC4846650.txt", "subject": "Reduced functional connectivity between brain regions", "relationship": "RELATED_PROGNOSIS", "object": "Pre-AD", "chunk": 3}
{"article": "PMC4846650.txt", "subject": "Functional connectivity", "relationship": "SUBJECT_IS_A_BIOMARKER_FOR", "object": "Pre-AD", "chunk": 3}
{"article": "PMC4847010.txt", "subject": "A\u03b240", "relationship": "RELATED_TO_TREATMENT", "object": "Fingolimod decreased A\u03b240 plaque load", "chunk": 2}
{"article": "PMC4847010.txt", "subject": "A\u03b242", "relationship": "RELATED_TO_TREATMENT", "object": "Fingolimod decreased A\u03b242 plaque deposition", "chunk": 2}
{"article": "PMC4847010.txt", "subject": "A\u03b242", "relationship": "PREDICTS_SURVIVAL", "object": "Reduced A\u03b242 plaque density was associated with increased survival", "chunk": 2}
{"article": "PMC4847010.txt", "subject": "GFAP", "relationship": "RELATED_TREATMENT", "object": "Fingolimod treatment resulted in a decreased GFAP staining", "chunk": 2}
{"article": "PMC4847010.txt", "subject": "Iba1", "relationship": "RELATED_TREATMENT", "object": "Fingolimod treatment reduced the number of Iba1-positive activated microglia", "chunk": 2}
{"article": "PMC4847010.txt", "subject": "Taurine", "relationship": "RELATED_TREATMENT", "object": "Fingolimod treatment protected against taurine decrease", "chunk": 2}
{"article": "PMC4847010.txt", "subject": "NAA", "relationship": "MONITORED_DURING_TREATMENT", "object": "NAA levels were monitored during fingolimod treatment", "chunk": 2}
{"article": "PMC4847010.txt", "subject": "Glutamate", "relationship": "MONITORED_DURING_TREATMENT", "object": "Glutamate levels were monitored during fingolimod treatment", "chunk": 2}
{"article": "PMC4847010.txt", "subject": "GABA", "relationship": "MONITORED_DURING_TREATMENT", "object": "GABA levels were monitored during fingolimod treatment", "chunk": 2}
{"article": "PMC4847010.txt", "subject": "Glutamine", "relationship": "MONITORED_DURING_TREATMENT", "object": "Glutamine levels were monitored during fingolimod treatment", "chunk": 2}
{"article": "PMC4847010.txt", "subject": "Myo-inositol", "relationship": "MONITORED_DURING_TREATMENT", "object": "Myo-inositol levels were monitored during fingolimod treatment", "chunk": 2}
{"article": "PMC4847010.txt", "subject": "A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Significant decrease observed in levels correlate with fingolimod treatment", "chunk": 3}
{"article": "PMC4847010.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Significant decrease observed in levels and plaques correlate with fingolimod treatment", "chunk": 3}
{"article": "PMC4847010.txt", "subject": "A\u03b242", "relationship": "PREDICTS_SURVIVAL", "object": "Decrease in levels and plaques correlate with enhanced survival, cognitive function, and lower microglial activation", "chunk": 3}
{"article": "PMC4847010.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Elevated A\u03b2 levels correlated with worse cognitive function and higher amyloid accumulation ", "chunk": 3}
{"article": "PMC4847010.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Elevated A\u03b2 levels correlated with worse cognitive function and higher amyloid accumulation", "chunk": 3}
{"article": "PMC4847010.txt", "subject": "Taurine", "relationship": "MONITORED_DURING_TREATMENT", "object": "Changes in taurine levels monitored as a potential indicator of treatment response ", "chunk": 3}
{"article": "PMC4847010.txt", "subject": "GFAP staining", "relationship": "RELATED_PROGNOSIS", "object": "Increase in GFAP staining with age indicates increased astrocytic activation and possible neuroinflammatory response", "chunk": 4}
{"article": "PMC4847010.txt", "subject": "Taurine levels", "relationship": "RESPONDED_TO", "object": "Fingolimod treatment", "chunk": 4}
{"article": "PMC4847010.txt", "subject": "Taurine levels", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Neuroprotection observed in models of traumatic brain injury", "chunk": 4}
{"article": "PMC4847010.txt", "subject": "Taurine levels", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Taurine levels may provide a non-invasive marker for modulation of neuroinflammation in the brain", "chunk": 4}
{"article": "PMC4847010.txt", "subject": "Taurine levels", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Inverse correlation between taurine levels and GFAP staining may reflect protective effects of taurine", "chunk": 4}
{"article": "PMC4847010.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Fingolimod treatment decreased levels of A\u03b240", "chunk": 5}
{"article": "PMC4847010.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Fingolimod treatment decreased levels of A\u03b242", "chunk": 5}
{"article": "PMC4847010.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased A\u03b242 plaque burden", "chunk": 5}
{"article": "PMC4847010.txt", "subject": "GFAP-positive astrocytes", "relationship": "RELATED_TREATMENT", "object": "Fingolimod treatment decreased the presence of reactive astrocytes", "chunk": 5}
{"article": "PMC4849800.txt", "subject": "BodyMedia (SenseWear)", "relationship": "RELATED_TO", "object": "AD/mild cognitive impairment ", "chunk": 6}
{"article": "PMC4849800.txt", "subject": "Shimmer sensor", "relationship": "RELATED_TO", "object": "AD", "chunk": 6}
{"article": "PMC4849800.txt", "subject": "Shimmer sensor", "relationship": "RELATED_TO", "object": "dementia diagnosis", "chunk": 6}
{"article": "PMC4849800.txt", "subject": "step count", "relationship": "INDICATES_PRESENCE_OF", "object": "mild cognitive impairment", "chunk": 10}
{"article": "PMC4849800.txt", "subject": "step count", "relationship": "USED_TO_DIAGNOSE", "object": "early Alzheimer\u2019s disease", "chunk": 10}
{"article": "PMC4849800.txt", "subject": "physical activity", "relationship": "RELATED_PROGNOSIS", "object": "shorter disease duration and lower disability scores", "chunk": 10}
{"article": "PMC4849800.txt", "subject": "physical activity level", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "apathy and more daytime napping", "chunk": 10}
{"article": "PMC4849800.txt", "subject": "Physical activity monitoring", "relationship": "RELATED_TREATMENT", "object": "Neurological care and neurorehabilitation", "chunk": 12}
{"article": "PMC4849800.txt", "subject": "Commercial wearable devices", "relationship": "RELATED_TREATMENT", "object": "Neurological care and neurorehabilitation", "chunk": 12}
{"article": "PMC4849800.txt", "subject": "Smartphones", "relationship": "RELATED_TREATMENT", "object": "Neurological care and neurorehabilitation", "chunk": 12}
{"article": "PMC4866415.txt", "subject": "Phosphorylated tau (p-tau) protein", "relationship": "RELATED_TO", "object": "Cerebral spinal fluid", "chunk": 1}
{"article": "PMC4866415.txt", "subject": "Bapineuzumab", "relationship": "DESIGNED_TO", "object": "Decrease plaque formation and promote clearance of A\u03b2", "chunk": 1}
{"article": "PMC4866415.txt", "subject": "Bapineuzumab", "relationship": "REDUCED", "object": "Phosphorylated tau (p-tau) protein", "chunk": 1}
{"article": "PMC4866415.txt", "subject": "Bapineuzumab", "relationship": "REDUCED", "object": "11C-Pittsburgh compound B (PiB) average uptake", "chunk": 1}
{"article": "PMC4866415.txt", "subject": "Bapineuzumab", "relationship": "ASSOCIATED_WITH", "object": "Amyloid-related imaging abnormalities with edema or effusion (ARIA-E)", "chunk": 1}
{"article": "PMC4866415.txt", "subject": "ADAS-Cog/11 total score", "relationship": "RELATED_PROGNOSIS", "object": "Change from baseline to week 78", "chunk": 2}
{"article": "PMC4866415.txt", "subject": "DAD total score", "relationship": "RELATED_PROGNOSIS", "object": "Change from baseline to week 78", "chunk": 2}
{"article": "PMC4866415.txt", "subject": "PiB-PET global cortical average (GCA) standardized uptake value ratio (SUVr)", "relationship": "RELATED_TREATMENT", "object": "Evaluated", "chunk": 2}
{"article": "PMC4866415.txt", "subject": "p-tau", "relationship": "RELATED_TREATMENT", "object": "Measured in cerebral spinal fluid", "chunk": 2}
{"article": "PMC4866415.txt", "subject": "Human plasma A\u03b2x\u201340 peptide levels", "relationship": "RELATED_TREATMENT", "object": "Measured using an electrochemiluminescence immunoassay method", "chunk": 2}
{"article": "PMC4866415.txt", "subject": "181phospho-tau concentrations", "relationship": "RELATED_TREATMENT", "object": "Measured using an enzyme-linked immunosorbent assay (ELISA)", "chunk": 2}
{"article": "PMC4866415.txt", "subject": "MMSE score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Stratification included for randomization", "chunk": 2}
{"article": "PMC4866415.txt", "subject": "ApoE \u03b54 allele", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Stratification included for randomization, particularly in carrier study", "chunk": 2}
{"article": "PMC4866415.txt", "subject": "Clinical dementia Rating\u2013Sum of Boxes (CDR-SOB)", "relationship": "RELATED_PROGNOSIS", "object": "Change from baseline to week 78 was an additional endpoint", "chunk": 2}
{"article": "PMC4866415.txt", "subject": "Neuropsychological Test Battery (NTB) total Z-scores", "relationship": "RELATED_PROGNOSIS", "object": "Change from baseline to week 78 was an additional endpoint", "chunk": 2}
{"article": "PMC4866415.txt", "subject": "brain volume assessed by brain boundary shift integral (BBSI)", "relationship": "RELATED_PROGNOSIS", "object": "Change from baseline to week 71 was a prespecified secondary biomarker endpoint", "chunk": 2}
{"article": "PMC4866415.txt", "subject": "PiB-PET", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Patients had to have a baseline SUVr \u22651.35 (amyloid positivity) to be included in the PiB-PET analyzed population", "chunk": 2}
{"article": "PMC4866415.txt", "subject": "ApoE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 3}
{"article": "PMC4866415.txt", "subject": "ApoE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4866415.txt", "subject": "cholinesterase inhibitors and/or memantine", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4866415.txt", "subject": "ADAS-Cog/11", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 4}
{"article": "PMC4866415.txt", "subject": "DAD", "relationship": "INDICATES_PRESENCE_OF", "object": "Decreased function", "chunk": 4}
{"article": "PMC4866415.txt", "subject": "CDR-SOB total score", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment severity", "chunk": 4}
{"article": "PMC4866415.txt", "subject": "DS total score", "relationship": "RELATED_PROGNOSIS", "object": "Deterioration in functional ability", "chunk": 4}
{"article": "PMC4866415.txt", "subject": "NTB total Z-score", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 4}
{"article": "PMC4866415.txt", "subject": "PiB-PET GCA SUVr", "relationship": "RELATED_PROGNOSIS", "object": "Amyloid plaque deposition", "chunk": 4}
{"article": "PMC4866415.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuronal damage", "chunk": 4}
{"article": "PMC4866415.txt", "subject": "BBSI on vMRI", "relationship": "PREDICTS_SURVIVAL", "object": "Alzheimer's Disease progression", "chunk": 4}
{"article": "PMC4866415.txt", "subject": "A\u03b2 levels", "relationship": "INCREASED_BY", "object": "Bapineuzumab treatment", "chunk": 5}
{"article": "PMC4866415.txt", "subject": "ARIA-E", "relationship": "ASSOCIATED_WITH", "object": "Bapineuzumab treatment", "chunk": 5}
{"article": "PMC4866415.txt", "subject": "Cerebral microhemorrhage", "relationship": "ASSOCIATED_WITH", "object": "Bapineuzumab treatment", "chunk": 5}
{"article": "PMC4866415.txt", "subject": "ApoE \u03b54 carriers", "relationship": "RELATED_PROGNOSIS", "object": "Higher incidence of ARIA-E with bapineuzumab treatment", "chunk": 5}
{"article": "PMC4866415.txt", "subject": "ApoE \u03b54 carriers", "relationship": "RELATED_PROGNOSIS", "object": "Higher incidence of TEAEs with bapineuzumab treatment", "chunk": 5}
{"article": "PMC4866415.txt", "subject": "Intracranial hemorrhage", "relationship": "HIGHER_INCIDENCE_IN", "object": "Placebo group compared to bapineuzumab groups", "chunk": 5}
{"article": "PMC4866415.txt", "subject": "Seizure/convulsions", "relationship": "HIGHER_INCIDENCE_IN", "object": "Placebo group compared to bapineuzumab groups", "chunk": 5}
{"article": "PMC4866415.txt", "subject": "Amyloid beta", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-positive patient", "chunk": 6}
{"article": "PMC4866415.txt", "subject": "Amyloid beta", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Inclusion criterion for future antiamyloid therapy trials", "chunk": 6}
{"article": "PMC4866415.txt", "subject": "Amyloid beta", "relationship": "RELATED_PROGNOSIS", "object": "Progression of Alzheimer's disease", "chunk": 6}
{"article": "PMC4866415.txt", "subject": "p-tau (cerbral spinal fluid)", "relationship": "RELATED_PROGNOSIS", "object": "Progression of Alzheimer's disease", "chunk": 6}
{"article": "PMC4866415.txt", "subject": "A\u03b2x\u201340 levels in plasma", "relationship": "INDICATES_PRESENCE_OF", "object": "Peripheral target engagement", "chunk": 6}
{"article": "PMC4866415.txt", "subject": "ARIA-E", "relationship": "RELATED_TREATMENT", "object": "Bapineuzumab treatment", "chunk": 6}
{"article": "PMC4866415.txt", "subject": "ApoE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 7}
{"article": "PMC4866415.txt", "subject": "ApoE \u03b54", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Early-onset Alzheimer's Disease", "chunk": 7}
{"article": "PMC4870937.txt", "subject": "MicroRNA107 (Mir107)", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 1}
{"article": "PMC4870937.txt", "subject": "MicroRNA107 (Mir107)", "relationship": "TARGETS", "object": "beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1)", "chunk": 1}
{"article": "PMC4870937.txt", "subject": "MicroRNA107 (Mir107)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD pathology", "chunk": 1}
{"article": "PMC4870937.txt", "subject": "beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1)", "relationship": "USED_TO_DIAGNOSE", "object": "AD", "chunk": 1}
{"article": "PMC4870937.txt", "subject": "Mir107", "relationship": "RELATED_TO_TREATMENT", "object": "Target for analysis in plasma", "chunk": 2}
{"article": "PMC4870937.txt", "subject": "BACbche gene gene mRNA", "relationship": "RELATED_TO_TREATMENT", "object": "Target for analysis in plasma", "chunk": 2}
{"article": "PMC4870937.txt", "subject": "BACbche gene gene mRNA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Investigated as potential biomarker", "chunk": 2}
{"article": "PMC4870937.txt", "subject": "Mir107", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Investigated as potential biomarker", "chunk": 2}
{"article": "PMC4870937.txt", "subject": "Mir107", "relationship": "RELATED_PROGNOSIS", "object": "Associated with amild cognitive impairment", "chunk": 3}
{"article": "PMC4870937.txt", "subject": "BACbche gene gene mRNA", "relationship": "RELATED_PROGNOSIS", "object": "Associated with amild cognitive impairment", "chunk": 3}
{"article": "PMC4870937.txt", "subject": "Mir107", "relationship": "INDICATES_PRESENCE_OF", "object": "amild cognitive impairment", "chunk": 3}
{"article": "PMC4870937.txt", "subject": "BACbche gene gene mRNA", "relationship": "INDICATES_PRESENCE_OF", "object": "amild cognitive impairment", "chunk": 3}
{"article": "PMC4870937.txt", "subject": "Bacbche gene gene protein", "relationship": "NOT_RELATED", "object": "amild cognitive impairment", "chunk": 3}
{"article": "PMC4870937.txt", "subject": "precuneus", "relationship": "DIAGNOSTIC_OF", "object": "AD pathology", "chunk": 5}
{"article": "PMC4870937.txt", "subject": "Mir107", "relationship": "INDICATES_PRESENCE_OF", "object": "amild cognitive impairment", "chunk": 5}
{"article": "PMC4870937.txt", "subject": "BACbche gene gene mRNA", "relationship": "INDICATES_PRESENCE_OF", "object": "amild cognitive impairment", "chunk": 5}
{"article": "PMC4870937.txt", "subject": "Mir107", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Early biomarkers for AD", "chunk": 6}
{"article": "PMC4870937.txt", "subject": "Mir107", "relationship": "RELATED_PROGNOSIS", "object": "onset of AD", "chunk": 6}
{"article": "PMC4870937.txt", "subject": "Mir107", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "abnormal brain cortical anatomy including the decrease in CT of precuneus cortex and in SA of left superior frontal gyrus in amild cognitive impairment patients.", "chunk": 6}
{"article": "PMC4870937.txt", "subject": "BACbche gene gene mRNA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Early biomarkers for AD", "chunk": 6}
{"article": "PMC4870937.txt", "subject": "BACbche gene gene mRNA", "relationship": "RELATED_PROGNOSIS", "object": "onset of AD", "chunk": 6}
{"article": "PMC4870937.txt", "subject": "BACbche gene gene mRNA", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "abnormal brain cortical anatomy including the decrease in CT of precuneus cortex and in SA of left superior frontal gyrus in amild cognitive impairment patients.", "chunk": 6}
{"article": "PMC4875639.txt", "subject": "A\u03b21\u201340", "relationship": "RELATED_PROGNOSIS", "object": "disease risk or prognosis", "chunk": 1}
{"article": "PMC4875639.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_PROGNOSIS", "object": "disease risk or prognosis", "chunk": 1}
{"article": "PMC4875639.txt", "subject": "A\u03b2 peptides", "relationship": "DIAGNOSITC_OF", "object": "Evaluating disease risk or prognosis", "chunk": 1}
{"article": "PMC4875639.txt", "subject": "A\u03b2 peptides", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "monitoring therapeutic interventions", "chunk": 1}
{"article": "PMC4875639.txt", "subject": "A\u03b2 peptides", "relationship": "IS_TARGET_OF_TREATMENT", "object": "A\u03b2-lowering compounds", "chunk": 1}
{"article": "PMC4875639.txt", "subject": "A\u03b21\u201337", "relationship": "MEASURED", "object": "A\u03b2 species in cerebrospinal fluid", "chunk": 2}
{"article": "PMC4875639.txt", "subject": "A\u03b21\u201338", "relationship": "MEASURED", "object": "A\u03b2 species in cerebrospinal fluid", "chunk": 2}
{"article": "PMC4875639.txt", "subject": "A\u03b21\u201340", "relationship": "MEASURED", "object": "A\u03b2 species in cerebrospinal fluid", "chunk": 2}
{"article": "PMC4875639.txt", "subject": "A\u03b21\u201342", "relationship": "MEASURED", "object": "A\u03b2 species in cerebrospinal fluid", "chunk": 2}
{"article": "PMC4875639.txt", "subject": "A\u03b21\u201342", "relationship": "DIAGNOSTIC_THRESHOLD", "object": "cerebral cerebral cerebral cerebral spine fluid concentrations for AD versus normal controls", "chunk": 3}
{"article": "PMC4875639.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "pathologic", "chunk": 3}
{"article": "PMC4875639.txt", "subject": "A\u03b21\u201337", "relationship": "MEASURED", "object": "cerebral cerebral cerebral cerebral spinal fluid concentrations", "chunk": 3}
{"article": "PMC4875639.txt", "subject": "A\u03b21\u201338", "relationship": "MEASURED", "object": "cerebral cerebral cerebral cerebral spinal fluid concentrations", "chunk": 3}
{"article": "PMC4875639.txt", "subject": "A\u03b21\u201340", "relationship": "MEASURED", "object": "cerebral cerebral cerebral cerebral spinal fluid concentrations", "chunk": 3}
{"article": "PMC4875639.txt", "subject": "A\u03b21\u201342", "relationship": "MEASURED", "object": "cerebral cerebral cerebral cerebral spinal fluid concentrations", "chunk": 3}
{"article": "PMC4875639.txt", "subject": "T-tau", "relationship": "MEASURED", "object": "cerebral cerebral cerebral cerebral spinal fluid concentrations", "chunk": 3}
{"article": "PMC4875639.txt", "subject": "phosphotau181P", "relationship": "MEASURED", "object": "cerebral cerebral cerebral cerebral spinal fluid concentrations", "chunk": 3}
{"article": "PMC4875639.txt", "subject": "Apolipoprotein E (APOE)", "relationship": "RELATED_PROGNOSIS", "object": "probability of Alzheimer's disease", "chunk": 3}
{"article": "PMC4875639.txt", "subject": "APOE \u03b54 carrier", "relationship": "INDICATES_PRESENCE_OF", "object": "increased risk of Alzheimer's disease", "chunk": 3}
{"article": "PMC4875639.txt", "subject": "A\u03b21\u201340", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4875639.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4875639.txt", "subject": "T-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4875639.txt", "subject": "P-tau181P", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4875639.txt", "subject": "A\u03b2 levels", "relationship": "RELATED_PROGNOSIS", "object": "Drug effects on A\u03b2 levels", "chunk": 6}
{"article": "PMC4875639.txt", "subject": "A\u03b2 levels", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Assessing evidence of target engagement and pharmacological activity", "chunk": 6}
{"article": "PMC4875639.txt", "subject": "A\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "A\u03b2-targeting experimental drugs", "chunk": 6}
{"article": "PMC4875639.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Assessing evidence of target engagement and pharmacological activity of A\u03b2-targeting compounds", "chunk": 6}
{"article": "PMC4877513.txt", "subject": "liraglutide", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment for Alzheimer's disease based on its potential to prevent decline in cerebral glucose consumption and reduce A\u03b2 deposition.", "chunk": 1}
{"article": "PMC4877513.txt", "subject": "liraglutide", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of Alzheimer's disease based on the potential benefits observed in pre-clinical animal models and a study on deep brain stimulation patients with AD.", "chunk": 1}
{"article": "PMC4877513.txt", "subject": "liraglutide", "relationship": "RELATED_TREATMENT", "object": "A 26-week intervention aimed at examining the effects of liraglutide on cerebral glucose consumption, A\u03b2 deposition, and cognition in patients with Alzheimer's disease.", "chunk": 1}
{"article": "PMC4877513.txt", "subject": "GLP-1 analog treatment", "relationship": "PREVENTED_THE_DECLINE_OF", "object": "Cerebral glucose consumption in patients with Alzheimer's disease.", "chunk": 1}
{"article": "PMC4877513.txt", "subject": "[18F]FDG metabolism", "relationship": "RELATED_PROGNOSIS", "object": "A persistent increase in [18F]FDG metabolism was associated with improved clinical outcome and cortical circuitry compared to pharmacotherapy in patients with AD (Smith et al. 2012).", "chunk": 1}
{"article": "PMC4877513.txt", "subject": "A\u03b2 deposition", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease.", "chunk": 1}
{"article": "PMC4877513.txt", "subject": "[11C]PIB", "relationship": "RELATED_PROGNOSIS", "object": "Percentage changes of ligand binding potential in brain (BPND) between the baseline and the 6-month follow-up", "chunk": 3}
{"article": "PMC4877513.txt", "subject": "[18F]FDG", "relationship": "RELATED_PROGNOSIS", "object": "Percentage changes of ligand binding potential in brain (BPND) between the baseline and the 6-month follow-up", "chunk": 3}
{"article": "PMC4877513.txt", "subject": "[11C]PIB", "relationship": "RELATED_TREATMENT", "object": "Changes in cerebral glucose consumption and amyloid load", "chunk": 3}
{"article": "PMC4877513.txt", "subject": "[18F]FDG", "relationship": "RELATED_TREATMENT", "object": "Changes in cerebral glucose consumption and amyloid load", "chunk": 3}
{"article": "PMC4877513.txt", "subject": "[11C]PIB binding", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-beta pathology", "chunk": 4}
{"article": "PMC4877513.txt", "subject": "Cerebral Glucose Metabolism (CMRglc)", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4877513.txt", "subject": "[11C]PIB", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4877513.txt", "subject": "Neurodegeneration", "relationship": "RELATED_TREATMENT", "object": "Liraglutide", "chunk": 4}
{"article": "PMC4877513.txt", "subject": "Glutamatergic neurotransmission", "relationship": "RELATED_TREATMENT", "object": "Liraglutide", "chunk": 4}
{"article": "PMC4877513.txt", "subject": "Neuroinflammation", "relationship": "RELATED_TO", "object": "Liraglutide", "chunk": 4}
{"article": "PMC4877513.txt", "subject": "Liraglutide", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "No improvement in cognition", "chunk": 4}
{"article": "PMC4877513.txt", "subject": "A\u03b2 deposits", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid deposits in brain tissue", "chunk": 5}
{"article": "PMC4877513.txt", "subject": "[11C]PIB retention", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid deposits", "chunk": 5}
{"article": "PMC4877513.txt", "subject": "[11C]PIB binding", "relationship": "RELATED_PROGNOSIS", "object": "Disease progression", "chunk": 5}
{"article": "PMC4877513.txt", "subject": "hyperphosphorylated tau", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 5}
{"article": "PMC4877513.txt", "subject": "A\u03b2", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 5}
{"article": "PMC4877513.txt", "subject": "[18F]FDG", "relationship": "RELATED_PROGNOSIS", "object": "Disease progression and treatment effect", "chunk": 5}
{"article": "PMC4877513.txt", "subject": "CMRglc", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC4877513.txt", "subject": "Insulin signaling in brain of AD patients", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Diminished glucose metabolism", "chunk": 5}
{"article": "PMC4877513.txt", "subject": "Liraglutide", "relationship": "RELATED_TREATMENT", "object": "GLP-1 analog treatment", "chunk": 5}
{"article": "PMC4877513.txt", "subject": "Liraglutide", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Preventing decline of CMRglc", "chunk": 5}
{"article": "PMC4877513.txt", "subject": "Liraglutide", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Disease progression and disease duration", "chunk": 5}
{"article": "PMC4877513.txt", "subject": "Liraglutide", "relationship": "IS_TARGET_OF_TREATMENT", "object": "GLP-1 analog treatment", "chunk": 5}
{"article": "PMC4877513.txt", "subject": "CMRglc", "relationship": "MONITORED_DURING_TREATMENT", "object": "Liraglutide treatment", "chunk": 5}
{"article": "PMC4877513.txt", "subject": "GLUT1", "relationship": "RELATED_Treatment", "object": "Improving glucose uptake in AD", "chunk": 5}
{"article": "PMC4877513.txt", "subject": "HbA1c levels", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with liraglutide", "chunk": 6}
{"article": "PMC4877513.txt", "subject": "systolic blood pressure", "relationship": "RELATED_TREATMENT", "object": "26 weeks of liraglutide treatment", "chunk": 6}
{"article": "PMC4877513.txt", "subject": "CMRglc", "relationship": "INDICATES_PRESENCE_OF", "object": "disease progression", "chunk": 6}
{"article": "PMC4877813.txt", "subject": "PHQ-2", "relationship": "INDICATES_PRESENCE_OF", "object": "Major Depression", "chunk": 3}
{"article": "PMC4877813.txt", "subject": "GAD-2", "relationship": "INDICATES_PRESENCE_OF", "object": "Anxiety", "chunk": 3}
{"article": "PMC4877813.txt", "subject": "CBI", "relationship": "INDICATES_PRESENCE_OF", "object": "Fatigue", "chunk": 3}
{"article": "PMC4877813.txt", "subject": "GPS", "relationship": "INDICATES_PRESENCE_OF", "object": "Procrastination", "chunk": 3}
{"article": "PMC4877813.txt", "subject": "FLZ S", "relationship": "RELATED_TO", "object": "Life Satisfaction", "chunk": 3}
{"article": "PMC4879492.txt", "subject": "Event-related potentials (ERP)", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive deficits associated with early Alzheimer's disease", "chunk": 1}
{"article": "PMC4879492.txt", "subject": "Event-related potentials (ERP)", "relationship": "DIAGNOSTIC_OF", "object": " AD", "chunk": 1}
{"article": "PMC4879492.txt", "subject": "Event-related potentials", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": " cognitive response to cholinesterase inhibitors such as donepezil", "chunk": 1}
{"article": "PMC4879492.txt", "subject": "Event-related potentials", "relationship": "RELATED_PROGNOSIS", "object": "disease progression and subsequent conversion to dementia in individuals with mild cognitive impairment", "chunk": 1}
{"article": "PMC4879492.txt", "subject": "MMSE score", "relationship": "DIAGNOSTIC_OF", "object": "Early stages of Alzheimer's Disease", "chunk": 2}
{"article": "PMC4879492.txt", "subject": "CDR score", "relationship": "DIAGNOSTIC_OF", "object": "Early stages of Alzheimer's Disease", "chunk": 2}
{"article": "PMC4879492.txt", "subject": "Delayed recall of the Wechsler logical memory II subscale", "relationship": "DIAGNOSTIC_OF", "object": "Early stages of Alzheimer's Disease", "chunk": 2}
{"article": "PMC4879492.txt", "subject": "MMSE score", "relationship": "RELATED_TREATMENT", "object": "Inclusion criteria for the HC cohort", "chunk": 2}
{"article": "PMC4879492.txt", "subject": "CDR score", "relationship": "RELATED_TREATMENT", "object": "Inclusion criteria for the HC cohort", "chunk": 2}
{"article": "PMC4879492.txt", "subject": "Delayed recall of the Wechsler logical memory II subscale", "relationship": "RELATED_TREATMENT", "object": "Inclusion criteria for the HC cohort", "chunk": 2}
{"article": "PMC4879492.txt", "subject": "N100 amplitude", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower N100 amplitude found in subjects with mild AD", "chunk": 3}
{"article": "PMC4879492.txt", "subject": "P3b amplitude", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower P3b amplitude found in subjects with mild AD", "chunk": 3}
{"article": "PMC4879492.txt", "subject": "P3b latency", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Longer P3b latency found in subjects with mild AD", "chunk": 3}
{"article": "PMC4879492.txt", "subject": "N200 latency", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Longer N200 latency found in subjects with mild AD", "chunk": 3}
{"article": "PMC4879492.txt", "subject": "N200 peak", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "More negative N200 peak found in subjects with mild AD", "chunk": 3}
{"article": "PMC4879492.txt", "subject": "P50 latency", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Longer P50 latency found in subjects with mild AD", "chunk": 3}
{"article": "PMC4879492.txt", "subject": "N100 amplitude", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower N100 amplitude found in subjects with mild AD", "chunk": 3}
{"article": "PMC4879492.txt", "subject": "P3a amplitude", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Smaller P3a amplitude found in subjects with mild AD", "chunk": 3}
{"article": "PMC4879492.txt", "subject": "Slow wave latency", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Longer slow wave latency found in subjects with mild AD", "chunk": 3}
{"article": "PMC4879492.txt", "subject": "N100 average amplitude", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower N100 average amplitude found in subjects with mild AD", "chunk": 3}
{"article": "PMC4879492.txt", "subject": "Slow wave latency", "relationship": "RELATED_TO", "object": "Task difficulty", "chunk": 4}
{"article": "PMC4879492.txt", "subject": "Slow wave latency", "relationship": "RELATED_TO", "object": "Group differences: mild AD vs HC", "chunk": 4}
{"article": "PMC4879492.txt", "subject": "P3a amplitude", "relationship": "RELATED_TO", "object": "Attention and executive function", "chunk": 4}
{"article": "PMC4879492.txt", "subject": "P3a latency", "relationship": "RELATED_TO", "object": "Orientation to a nontarget deviant stimulus", "chunk": 4}
{"article": "PMC4879492.txt", "subject": "N100 amplitude", "relationship": "RELATED_TO", "object": "Attention and memory deficits", "chunk": 4}
{"article": "PMC4879492.txt", "subject": "N100 amplitude", "relationship": "RELATED_TO", "object": "Changes in regulatory inputs from prefrontal cortex and nucleus basalis", "chunk": 4}
{"article": "PMC4879492.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild Alzheimer's disease", "chunk": 5}
{"article": "PMC4879492.txt", "subject": "CDR", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild Alzheimer's disease", "chunk": 5}
{"article": "PMC4879492.txt", "subject": "Low scores on WMS-R logical memory (Immediate and Delayed recall)", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild Alzheimer's disease", "chunk": 5}
{"article": "PMC4879492.txt", "subject": "High scores on GDS", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild Alzheimer's disease", "chunk": 5}
{"article": "PMC4879492.txt", "subject": "Differences in ERP features", "relationship": "RELATED_PROGNOSIS", "object": "Mild Alzheimer's disease", "chunk": 5}
{"article": "PMC4879492.txt", "subject": "Low button press accuracy", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Diminished behavioral performance", "chunk": 5}
{"article": "PMC4879492.txt", "subject": "High false alarm rate", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Diminished behavioral performance", "chunk": 5}
{"article": "PMC4879492.txt", "subject": "High median reaction time", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Diminished behavioral performance", "chunk": 5}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer\u2019s disease (AD)", "chunk": 1}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "increased risk of future AD", "chunk": 1}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "development of new disease-modifying treatments", "chunk": 1}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "PREDICTS_SURVIVAL", "object": "reduced levels during the dementia stage of AD indicating that prominent changes in A\u03b2 metabolism occur later in the periphery compared to the brain", "chunk": 1}
{"article": "PMC4886210.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "reduction in patients with AD", "chunk": 1}
{"article": "PMC4886210.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "INIDICATES_PRESENCE_OF", "object": "amyloid burden as determined by amyloid PET", "chunk": 1}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "development of new disease-modifying treatments", "chunk": 1}
{"article": "PMC4886210.txt", "subject": "A\u03b242 and A\u03b240 levels", "relationship": "RELATED_PROGNOSIS", "object": "future AD risk", "chunk": 1}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (AD)", "chunk": 2}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (AD)", "chunk": 2}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease (AD) ", "chunk": 2}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease (AD)", "chunk": 2}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "USED_TO_DIAGNOSE", "object": "Distinguish individuals with a normal versus pathological cerebral spinal fluid signature", "chunk": 3}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "USED_TO_DIAGNOSE", "object": "Distinguish individuals with a normal versus pathological cerebral spinal fluid signature", "chunk": 3}
{"article": "PMC4886210.txt", "subject": "A\u03b242/A\u03b240 Ratio", "relationship": "USED_TO_DIAGNOSE", "object": "Distinguish individuals with a normal versus pathological cerebral spinal fluid signature", "chunk": 3}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "High composite [18F]flutemetamol SUVR was associated with lower plasma A\u03b242", "chunk": 3}
{"article": "PMC4886210.txt", "subject": "A\u03b242/A\u03b240 Ratio", "relationship": "RELATED_PROGNOSIS", "object": "High composite [18F]flutemetamol SUVR was associated with lower A\u03b242/A\u03b240 ratio", "chunk": 3}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "mild cognitive impairment", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "SCD", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "APOE \u03b54 carrier status", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "RELATED_TO", "object": "APOE \u03b54 carrier status", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "RELATED_TO", "object": "APOE \u03b54 carrier status", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "RELATED_TO", "object": "pathological cerebral spinal fluid signature", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "subcortical WML load", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "RELATED_TO", "object": "subcortical WML load", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "RELATED_TO", "object": "cerebral cerebral cerebral cerebral spinal fluid A\u03b240 levels", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "CBMs", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "hypertension", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "RELATED_TO", "object": "hypertension", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "ischemic heart disease", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "RELATED_TO", "object": "ischemic heart disease", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "diabetes", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "RELATED_TO", "object": "diabetes", "chunk": 4}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid Plaque Burden", "chunk": 5}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "Cognitive Decline", "chunk": 5}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cerebral White Matter Lesions (WMLs)", "chunk": 5}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cerebral Microbleeds (CMBs)", "chunk": 5}
{"article": "PMC4886210.txt", "subject": "low plasma A\u03b242/A\u03b240 ratio", "relationship": "RELATED_TO", "object": "Greater Risk of Future AD", "chunk": 5}
{"article": "PMC4886210.txt", "subject": "decrease in plasma A\u03b242 levels", "relationship": "RELATED_TO", "object": "Cognitive Decline", "chunk": 5}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebrovascular Pathology", "chunk": 5}
{"article": "PMC4886210.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_TO", "object": "Amyloid Plaque Burden", "chunk": 5}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebrovascular Pathology", "chunk": 5}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Ischemic Heart Disease", "chunk": 5}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Vascular amyloid deposition in cerebral amyloid angiopathy", "chunk": 6}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Vascular amyloid deposition in cerebral amyloid angiopathy", "chunk": 6}
{"article": "PMC4886210.txt", "subject": " Increased A\u03b242 and A\u03b240 in plasma", "relationship": "ASSOCIATED_WITH", "object": "Hypertension, diabetes and ischemic heart disease", "chunk": 6}
{"article": "PMC4886210.txt", "subject": "high plasma A\u03b240", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased cardiovascular mortality in patients with coronary heart disease", "chunk": 6}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Dementia stages in Alzheimer\u2019s disease", "chunk": 6}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Dementia stages in Alzheimer\u2019s disease", "chunk": 6}
{"article": "PMC4886210.txt", "subject": "low plasma A\u03b242 and A\u03b242/A\u03b240 ratio", "relationship": "RELATED_TO", "object": "Amyloid deposition in the brain", "chunk": 6}
{"article": "PMC4886210.txt", "subject": "plasma A\u03b2 measures", "relationship": "POTENTIAL_TO_IMPROVE", "object": "The diagnostic performance of the plasma biomarker panels", "chunk": 6}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Plasma A\u03b242 levels lower in patients with Alzhiemer's disease", "chunk": 7}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Plasma A\u03b240 levels lower in patients with Alzhiemer's disease", "chunk": 7}
{"article": "PMC4886210.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Plasma A\u03b242/A\u03b240 ratio lower in patients with Alzhiemer's disease", "chunk": 7}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral spinal fluid A\u03b242 levels lower in patients with Alzhiemer's disease", "chunk": 7}
{"article": "PMC4886210.txt", "subject": "A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral spinal fluid A\u03b240 levels lower in patients with Alzhiemer's disease", "chunk": 7}
{"article": "PMC4886210.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral spinal fluid A\u03b242/A\u03b240 ratio lower in patients with Alzhiemer's disease", "chunk": 7}
{"article": "PMC4886210.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Plasma A\u03b242 levels are associated with amyloid PET SUVR.", "chunk": 7}
{"article": "PMC4886210.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "DIAGNOSITC_OF", "object": "Normal or Pathologic Cerebral Spinal Fluid Signature", "chunk": 8}
{"article": "PMC4886210.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Normal Cerebral Spinal Fluid Signature", "chunk": 8}
{"article": "PMC4886210.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Pathologic Cerebral Spinal Fluid Signature", "chunk": 8}
{"article": "PMC4886210.txt", "subject": "A\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Impairment of memory", "chunk": 1}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "IS_TARGET_OF_TREATMENT", "object": "A\u03b2 antibodies (solanezumab, crenezumab, and aducanumab)", "chunk": 1}
{"article": "PMC4888851.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4888851.txt", "subject": "A\u03b242 oligomers", "relationship": "INDICATES_PRESENCE_OF", "object": "AD neuropathology", "chunk": 2}
{"article": "PMC4888851.txt", "subject": "APP missense mutation", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Protection against AD and age-related cognitive decline", "chunk": 2}
{"article": "PMC4888851.txt", "subject": "A\u03b242/43 peptides", "relationship": "PREDICTS_SURVIVAL", "object": "Increased risk of AD", "chunk": 2}
{"article": "PMC4888851.txt", "subject": "A\u03b242 oligomers", "relationship": "RELATED_PROGNOSIS", "object": "Decrease in synapse density, inhibit LTP and enhance synaptic depression", "chunk": 2}
{"article": "PMC4888851.txt", "subject": "A\u03b242 oligomers", "relationship": "RELATED_PROGNOSIS", "object": "Impair memory", "chunk": 2}
{"article": "PMC4888851.txt", "subject": "Low cerebral spinal fluid A\u03b242", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 2}
{"article": "PMC4888851.txt", "subject": "Positive amyloid-PET scans", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 2}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "'Solanezumab', 'crenezumab', and 'aducanumab'", "chunk": 2}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Excess A\u03b2 aggregation", "chunk": 2}
{"article": "PMC4888851.txt", "subject": "APP mutations", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Therapeutic lowering of amyloid or its precursor protein", "chunk": 2}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Pathogenic presenilin mutations", "chunk": 3}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Amyloid hypothesis testing", "chunk": 3}
{"article": "PMC4888851.txt", "subject": "A\u03b243", "relationship": "INDICATES_PRESENCE_OF", "object": "Pathogenic presenilin mutations", "chunk": 3}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "IS_TARGET_OF_TREATMENT", "object": "A673T mutation", "chunk": 3}
{"article": "PMC4888851.txt", "subject": "APP", "relationship": "RELATED_TO_TREATMENT", "object": "Down's syndrome", "chunk": 3}
{"article": "PMC4888851.txt", "subject": "APP", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4888851.txt", "subject": "A673T", "relationship": "RELATED_PROGNOSIS", "object": "Protection against clinical AD", "chunk": 3}
{"article": "PMC4888851.txt", "subject": "A673T", "relationship": "RELATED_PROGNOSIS", "object": "Reduced risk of age-related cognitive decline", "chunk": 3}
{"article": "PMC4888851.txt", "subject": "SORL1", "relationship": "RELATED_TO_TREATMENT", "object": "therapeutic intervention", "chunk": 5}
{"article": "PMC4888851.txt", "subject": "PICALM", "relationship": "RELATED_TO_TREATMENT", "object": "therapeutic intervention", "chunk": 5}
{"article": "PMC4888851.txt", "subject": "PICALM", "relationship": "RELATED_TREATMENT", "object": "brain cholesterol metabolism", "chunk": 5}
{"article": "PMC4888851.txt", "subject": "A\u03b2", "relationship": "RELATED_TO_TREATMENT", "object": "therapeutic intervention", "chunk": 5}
{"article": "PMC4888851.txt", "subject": "ApoE4", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "plaque and vascular \u03b2\u2010amyloid deposits", "chunk": 5}
{"article": "PMC4888851.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "degenerative changes", "chunk": 5}
{"article": "PMC4888851.txt", "subject": "PICALM", "relationship": "RELATED_TREATMENT", "object": "A\u03b2 clearance pathways", "chunk": 5}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurofibrillary tangles and dystrophic neurites", "chunk": 5}
{"article": "PMC4888851.txt", "subject": "ApoE", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "AD risk", "chunk": 5}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "DIAGNOSTIC_OF", "object": "early-onset Alzheimer's Disease", "chunk": 5}
{"article": "PMC4888851.txt", "subject": "A\u03b2 oligomers", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild dementia", "chunk": 6}
{"article": "PMC4888851.txt", "subject": "A\u03b2 oligomers", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Alzheimer's disease", "chunk": 6}
{"article": "PMC4888851.txt", "subject": "A\u03b21\u201342 peptides", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Clinical symptoms of Alzheimer's disease", "chunk": 6}
{"article": "PMC4888851.txt", "subject": "p3E A\u03b2 peptide", "relationship": "CAN_BE_TARGET_FOR_THERAPY", "object": "A\u03b2 immunotherapy", "chunk": 6}
{"article": "PMC4888851.txt", "subject": "A\u03b243", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "\u03b2-secretase inhibitors", "chunk": 6}
{"article": "PMC4888851.txt", "subject": "N\u2010terminally extended A\u03b2 monomers", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Increase in levels by \u03b2-secretase inhibitors", "chunk": 6}
{"article": "PMC4888851.txt", "subject": "A\u03b7\u2010\u03b1", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "New pathway for A\u03b2 targeting", "chunk": 6}
{"article": "PMC4888851.txt", "subject": "cerebral spinal fluid A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "decrease in levels", "chunk": 8}
{"article": "PMC4888851.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "development of anti-amyloid therapies", "chunk": 8}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "IS_TARGET_OF_TREATMENT", "object": "semagacestat and aducanumab", "chunk": 8}
{"article": "PMC4888851.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC4888851.txt", "subject": "A\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "A\u03b2-lowering therapy", "chunk": 8}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "PREDICTED_BY", "object": "solanezumab", "chunk": 8}
{"article": "PMC4888851.txt", "subject": "Aducanumab", "relationship": "RELATED_PROGNOSIS", "object": "lowers PET amyloid levels and cognitive decline", "chunk": 8}
{"article": "PMC4888851.txt", "subject": "Cerebral spinal fluid tau", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "rise above the detection threshold", "chunk": 8}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "High risk for developing AD dementia", "chunk": 9}
{"article": "PMC4888851.txt", "subject": "A\u03b242", "relationship": "TARGETED_BY", "object": "\u03b2\u2013secretase inhibitors/modulators", "chunk": 9}
{"article": "PMC4888851.txt", "subject": "A\u03b242 monomers", "relationship": "LOWERED_BY", "object": "\u03b2\u2013secretase inhibitors/modulators", "chunk": 9}
{"article": "PMC4888851.txt", "subject": "A\u03b2", "relationship": "RELATED_TO", "object": "The other features of the AD syndrome", "chunk": 9}
{"article": "PMC4888851.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Amyloid therapeutic", "chunk": 9}
{"article": "PMC4888851.txt", "subject": "Amyloid", "relationship": "BOUND_AND_CLEARED", "object": "by antibodies", "chunk": 9}
{"article": "PMC4888851.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH", "object": "Dyshomeostasis", "chunk": 9}
{"article": "PMC4890804.txt", "subject": "TBI", "relationship": "INDICATES_PRESENCE_OF", "object": "Oxidative Stress", "chunk": 1}
{"article": "PMC4890804.txt", "subject": "Phenserine", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment for mTBI", "chunk": 1}
{"article": "PMC4890804.txt", "subject": "Thiobarbituric acid reactive substances (TBARS)", "relationship": "RELATED_PROGNOSIS", "object": "Marker of oxidative stress in mTBI", "chunk": 1}
{"article": "PMC4890804.txt", "subject": "Superoxide dismutase (SOD) 1 and 2", "relationship": "RELATED_TREATMENT", "object": "Increased by phenserine to mitigate oxidative stress", "chunk": 1}
{"article": "PMC4890804.txt", "subject": "Glutathione peroxidase (GPx)", "relationship": "RELATED_TREATMENT", "object": "Increased by phenserine to mitigate oxidative stress", "chunk": 1}
{"article": "PMC4890804.txt", "subject": "Blalock Alzheimer\u2019s Disease Up pathway", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "injury-induced regulations in this pathway observed in TBI", "chunk": 1}
{"article": "PMC4890804.txt", "subject": "Phenserine", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Potential for treatment of TBI based on its neuroprotective actions", "chunk": 1}
{"article": "PMC4890804.txt", "subject": "amyloid precursor protein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Phenserine", "chunk": 2}
{"article": "PMC4890804.txt", "subject": "alpha-synuclein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Phenserine", "chunk": 2}
{"article": "PMC4890804.txt", "subject": "acetylcholine (ACh)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Phenserine", "chunk": 2}
{"article": "PMC4890804.txt", "subject": "thiobarbituric acid reactive substances (TBARS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Oxidative stress", "chunk": 4}
{"article": "PMC4890804.txt", "subject": "superoxide dismutase (SOD)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Phenserine", "chunk": 4}
{"article": "PMC4890804.txt", "subject": "glutathione peroxidase (GPx)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Phenserine", "chunk": 4}
{"article": "PMC4890804.txt", "subject": "ACTB", "relationship": "MONITORED_DURING_TREATMENT", "object": "Gene array data to assess changes in expression", "chunk": 5}
{"article": "PMC4890804.txt", "subject": "ACTA1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Gene array data to assess changes in expression", "chunk": 5}
{"article": "PMC4890804.txt", "subject": "TUBA1b", "relationship": "MONITORED_DURING_TREATMENT", "object": "Gene array data to assess changes in expression", "chunk": 5}
{"article": "PMC4890804.txt", "subject": "TUBB4", "relationship": "MONITORED_DURING_TREATMENT", "object": "Gene array data to assess changes in expression", "chunk": 5}
{"article": "PMC4890804.txt", "subject": "TUBB5", "relationship": "MONITORED_DURING_TREATMENT", "object": "Gene array data to assess changes in expression", "chunk": 5}
{"article": "PMC4890804.txt", "subject": "TBARS", "relationship": "INDICATES_PRESENCE_OF", "object": "Lipid peroxidation", "chunk": 6}
{"article": "PMC4890804.txt", "subject": "TBARS", "relationship": "RELATED_PROGNOSIS", "object": "Elevated levels at 14 days post mTBI indicative of oxidative damage", "chunk": 6}
{"article": "PMC4890804.txt", "subject": "SOD", "relationship": "RELATED_TREATMENT", "object": "Elevated activity in both untreated and phenserine treated mTBI groups at day 5", "chunk": 6}
{"article": "PMC4890804.txt", "subject": "GPx", "relationship": "RELATED_TREATMENT", "object": "Elevated activity in both untreated and phenserine-treated mTBI groups at day 5", "chunk": 6}
{"article": "PMC4890804.txt", "subject": "SOD1", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Significantly reduced levels in untreated mTBI-challenged mice at 5 days, returned to control levels at 14 days", "chunk": 6}
{"article": "PMC4890804.txt", "subject": "SOD2", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Significantly reduced levels in untreated mTBI-challenged mice at 5 days, returned to control levels at 14 days", "chunk": 6}
{"article": "PMC4890804.txt", "subject": "GPx1", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Reduced protein level in untreated mTBI-challenged mice at day 5 compared to control shams and phenserine treated mTBI animals, elevated to control levels at day 14", "chunk": 6}
{"article": "PMC4890804.txt", "subject": "Cytochrome c oxidase subunit VIa polypeptide 2", "relationship": "RELATED_TO_TREATMENT", "object": "mTBI induced", "chunk": 7}
{"article": "PMC4890804.txt", "subject": "General transcription factor IIIC, polypeptide 1, alpha 220kD", "relationship": "RELATED_TO_TREATMENT", "object": "mTBI induced", "chunk": 7}
{"article": "PMC4890804.txt", "subject": "Adenosine deaminase, TRNA-Specific 2", "relationship": "RELATED_TO_TREATMENT", "object": "mTBI/PHEN induced", "chunk": 7}
{"article": "PMC4890804.txt", "subject": "FBJ murine osteosarcoma viral oncogene homolog", "relationship": "RELATED_TO_TREATMENT", "object": "PHEN only induced", "chunk": 7}
{"article": "PMC4890804.txt", "subject": "Rap guanine nucleotide exchange factor (GEF) 5", "relationship": "RELATED_TO_TREATMENT", "object": "PHEN only induced", "chunk": 7}
{"article": "PMC4890804.txt", "subject": "Blalock Alzheimer\u2019s Disease Up pathway", "relationship": "PRESENTED_WITH_NEGATIVE_Z_SCORE", "object": "mTBI vs. sham comparisons", "chunk": 8}
{"article": "PMC4890804.txt", "subject": "Blalock Alzheimer\u2019s Disease Up pathway", "relationship": "REVERSED", "object": "injury-induced gene expressions after treatment with PHEN", "chunk": 8}
{"article": "PMC4890804.txt", "subject": "Blalock Alzheimer\u2019s Disease Incipient Up", "relationship": "REGULATED", "object": "mTBI/PHEN vs. mTBI samples", "chunk": 8}
{"article": "PMC4890804.txt", "subject": "Blalock Alzheimer\u2019s Disease Incipient Down", "relationship": "REGULATED", "object": "mTBI/PHEN vs. mTBI samples", "chunk": 8}
{"article": "PMC4890804.txt", "subject": "Blalock Alzheimer\u2019s Disease Down", "relationship": "REGULATED", "object": "mTBI/PHEN vs. mTBI samples", "chunk": 8}
{"article": "PMC4890804.txt", "subject": "Biocarta Parkin Pathway", "relationship": "UP_REGULATED", "object": "mTBI vs. sham and PHEN vs. sham comparisons", "chunk": 8}
{"article": "PMC4890804.txt", "subject": "cholinergic system function", "relationship": "ASSOCIATED_WITH", "object": "Alzheimer\u2019s disease", "chunk": 9}
{"article": "PMC4890804.txt", "subject": "choline acetyltransferase (ChAT)", "relationship": "RELATED_TREATMENT", "object": "Phenserine treatment", "chunk": 9}
{"article": "PMC4890804.txt", "subject": "vesicular acetylcholine transporter (vAChT)", "relationship": "RELATED_TREATMENT", "object": "Phenserine treatment", "chunk": 9}
{"article": "PMC4890804.txt", "subject": "muscarinic and nicotinic ACh receptors", "relationship": "RELATED_TREATMENT", "object": "Phenserine treatment", "chunk": 9}
{"article": "PMC4890804.txt", "subject": "AChE activity", "relationship": "RELATED_TREATMENT", "object": "Phenserine treatment", "chunk": 9}
{"article": "PMC4890804.txt", "subject": "AChE", "relationship": "RELATED_TREATMENT", "object": "Phenserine treatment", "chunk": 9}
{"article": "PMC4890804.txt", "subject": "cholinergic neurons", "relationship": "RELATED_TREATMENT", "object": "Phenserine treatment", "chunk": 9}
{"article": "PMC4890804.txt", "subject": "Fos", "relationship": "ASSOCIATED_WITH", "object": "Alzheimer\u2019s disease", "chunk": 9}
{"article": "PMC4890804.txt", "subject": "Arc", "relationship": "ASSOCIATED_WITH", "object": "Alzheimer\u2019s disease", "chunk": 9}
{"article": "PMC4890804.txt", "subject": "Blalock Alzheimer's Disease Up", "relationship": "RELATED_TREATMENT", "object": "Phenserine treatment", "chunk": 9}
{"article": "PMC4890804.txt", "subject": "TBARS", "relationship": "INDICATES_PRESENCE_OF", "object": "Oxidative stress, particularly lipid peroxidation", "chunk": 10}
{"article": "PMC4890804.txt", "subject": "SOD1", "relationship": "RELATED_TREATMENT", "object": "Augmentation of antioxidant mechanisms, particularly endogenous pathways", "chunk": 10}
{"article": "PMC4890804.txt", "subject": "SOD2", "relationship": "RELATED_TREATMENT", "object": "Augmentation of antioxidant mechanisms, particularly endogenous pathways", "chunk": 10}
{"article": "PMC4890804.txt", "subject": "GPx", "relationship": "RELATED_TREATMENT", "object": "Augmentation of antioxidant mechanisms, particularly endogenous pathways", "chunk": 10}
{"article": "PMC4890804.txt", "subject": "Amyloid precursor protein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Lowering synthesis", "chunk": 10}
{"article": "PMC4890804.txt", "subject": "Alpha-synuclein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Lowering synthesis", "chunk": 10}
{"article": "PMC4899632.txt", "subject": "HTT aggregates", "relationship": "RESOLVED_TO", "object": "Human donor cells engraftment", "chunk": 3}
{"article": "PMC4899632.txt", "subject": "Q73 mHtt glia", "relationship": "INDICATES_PRESENCE_OF", "object": "Cytoplasmic Htt aggregates", "chunk": 3}
{"article": "PMC4899632.txt", "subject": "Q23-transduced controls", "relationship": "NOT_ASSOCIATED_WITH_ ", "object": "Aggregate formation", "chunk": 3}
{"article": "PMC4899632.txt", "subject": "neurons", "relationship": "RESPONDED_TO", "object": "Engraftment with 73Q mHtt glia", "chunk": 3}
{"article": "PMC4899632.txt", "subject": "Interstitial K+", "relationship": "RELATED_TO", "object": "hyperexcitability and increased membrane resistance of R6/2 striatal neurons", "chunk": 5}
{"article": "PMC4899632.txt", "subject": "Interstitial K+", "relationship": "RELATED_TO", "object": "decreased release probability", "chunk": 5}
{"article": "PMC4899632.txt", "subject": "Interstitial K+", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "disease-associated reduction", "chunk": 5}
{"article": "PMC4899632.txt", "subject": "Interstitial K+", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "reduction in K+ afforded by glial chimerization", "chunk": 5}
{"article": "PMC4899632.txt", "subject": "CAG repeat expansion", "relationship": "RELATED_TO", "object": "Transgenic R6/2 mice", "chunk": 7}
{"article": "PMC4899632.txt", "subject": "hGPC", "relationship": "RELATED_TREATMENT", "object": "Improvement of motor and cognitive behaviour", "chunk": 11}
{"article": "PMC4899632.txt", "subject": "hGPC", "relationship": "RELATED_TREATMENT", "object": "Acquisition in R6/2 mice during the initial training phase", "chunk": 11}
{"article": "PMC4899632.txt", "subject": "hGPC", "relationship": "RELATED_TREATMENT", "object": "Improved performance during retraining", "chunk": 11}
{"article": "PMC4899632.txt", "subject": "hGPC", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Decision to engraft hGPCs", "chunk": 11}
{"article": "PMC4899632.txt", "subject": "hGPC", "relationship": "RELATED_PROGNOSIS", "object": "Partially restores striatal function", "chunk": 11}
{"article": "PMC4899632.txt", "subject": "hGPC", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Engraftment was performed", "chunk": 11}
{"article": "PMC4899632.txt", "subject": "CD44 hGPCs", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Engraftment of CD44-sorted hGPC", "chunk": 11}
{"article": "PMC4899632.txt", "subject": "CD44-sorted hGPCs", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Transplantation into R6/2 mice", "chunk": 11}
{"article": "PMC4899632.txt", "subject": "CD44-engrafted R6/2s", "relationship": "RESPONDED_TO", "object": "Treatment with CD44-sorted hGPCs", "chunk": 11}
{"article": "PMC4908397.txt", "subject": "Ki-67", "relationship": "INDICATES_PRESENCE_OF", "object": "Proliferating cells", "chunk": 2}
{"article": "PMC4908397.txt", "subject": "DCX", "relationship": "RELATED_TO", "object": "Newborn neurons", "chunk": 2}
{"article": "PMC4908397.txt", "subject": "GFAP", "relationship": "RELATED_TO", "object": "Astrocytic cells", "chunk": 2}
{"article": "PMC4908397.txt", "subject": "BDNF", "relationship": "RELATED_PROGNOSIS", "object": "Signaling pathway involved in neuroprotection and survival", "chunk": 3}
{"article": "PMC4908397.txt", "subject": "VEGF", "relationship": "RELATED_PROGNOSIS", "object": "Signaling pathway involved in neuroprotection and survival", "chunk": 3}
{"article": "PMC4908397.txt", "subject": "NGF", "relationship": "RELATED_PROGNOSIS", "object": "Signaling pathway involved in neuroprotection and survival", "chunk": 3}
{"article": "PMC4908397.txt", "subject": "IGF-1", "relationship": "RELATED_PROGNOSIS", "object": "Signaling pathway involved in neuroprotection and survival", "chunk": 3}
{"article": "PMC4908397.txt", "subject": "cystatin-C", "relationship": "RELATED_TREATMENT", "object": "Potential therapeutic target in neurodegenerative diseases", "chunk": 3}
{"article": "PMC4908397.txt", "subject": "glia-derived nexin", "relationship": "RELATED_TREATMENT", "object": "Potential therapeutic target in neurodegenerative diseases", "chunk": 3}
{"article": "PMC4908397.txt", "subject": "galectin-1", "relationship": "RELATED_TREATMENT", "object": "Potential therapeutic target in neurodegenerative diseases", "chunk": 3}
{"article": "PMC4908397.txt", "subject": "pigment epithelium-derived factor", "relationship": "RELATED_TREATMENT", "object": "Potential therapeutic target in neurodegenerative diseases", "chunk": 3}
{"article": "PMC4908397.txt", "subject": "Ezrin", "relationship": "RELATED_TREATMENT", "object": "Potential therapeutic target in neurodegenerative diseases", "chunk": 3}
{"article": "PMC4908397.txt", "subject": "Radixin", "relationship": "RELATED_TREATMENT", "object": "Potential therapeutic target in neurodegenerative diseases", "chunk": 3}
{"article": "PMC4908397.txt", "subject": "Beta-1,4-galactosyltransferase", "relationship": "RELATED_TREATMENT", "object": "Potential therapeutic target in neurodegenerative diseases", "chunk": 3}
{"article": "PMC4908397.txt", "subject": "connective tissue growth factor", "relationship": "RELATED_TREATMENT", "object": "Potential therapeutic target in neurodegenerative diseases", "chunk": 3}
{"article": "PMC4908397.txt", "subject": "miR-16", "relationship": "RELATED_TREATMENT", "object": "Potential therapeutic target in neurodegenerative diseases", "chunk": 3}
{"article": "PMC4908397.txt", "subject": "NOTCH1", "relationship": "RELATED_TREATMENT", "object": "Potential therapeutic target in neurodegenerative diseases", "chunk": 3}
{"article": "PMC4908397.txt", "subject": "PEDF", "relationship": "RELATED_TREATMENT", "object": "Modulation of neurogenesis", "chunk": 4}
{"article": "PMC4908397.txt", "subject": "Gal-1", "relationship": "RELATED_TREATMENT", "object": "Modulation of neurogenesis", "chunk": 4}
{"article": "PMC4908397.txt", "subject": "BDNF", "relationship": "RELATED_TREATMENT", "object": "Modulation of neuronal survival and differentiation", "chunk": 4}
{"article": "PMC4908397.txt", "subject": "VEGF", "relationship": "RELATED_TREATMENT", "object": "Regulation of progenitor cell proliferation and neuronal differentiation", "chunk": 4}
{"article": "PMC4908397.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Enhancement of neurogenesis, survival and neuronal/glial maturation", "chunk": 4}
{"article": "PMC4908397.txt", "subject": "IGF-1", "relationship": "RELATED_TREATMENT", "object": "Enhancement of neuronal differentiation and hippocampal neurogenesis", "chunk": 4}
{"article": "PMC4908397.txt", "subject": "miR-16", "relationship": "RELATED_TREATMENT", "object": "Neurogenesis and neuronal differentiation", "chunk": 4}
{"article": "PMC4908397.txt", "subject": "Ki-67", "relationship": "INDICATES_PRESENCE_OF", "object": "Proliferating cells", "chunk": 8}
{"article": "PMC4908397.txt", "subject": "Ki-67", "relationship": "RELATED_PROGNOSIS", "object": "Increased number of proliferating cells in the DG.", "chunk": 8}
{"article": "PMC4908397.txt", "subject": "DCX", "relationship": "INDICATES_PRESENCE_OF", "object": "Newborn neurons", "chunk": 8}
{"article": "PMC4908397.txt", "subject": "GFAP", "relationship": "RELATED_PROGNOSIS", "object": "Increased number within astrocytes", "chunk": 8}
{"article": "PMC4908397.txt", "subject": "cystatin C", "relationship": "RELATED_PROGNOSIS", "object": "Upregulated in the dynamic hBM-MSCs secretome", "chunk": 8}
{"article": "PMC4908397.txt", "subject": "glia-derived nexin", "relationship": "RELATED_PROGNOSIS", "object": "Upregulated in the dynamic hBM-MSCs secretome", "chunk": 8}
{"article": "PMC4908397.txt", "subject": "galectin-1", "relationship": "RELATED_PROGNOSIS", "object": "Upregulated in the dynamic hBM-MSCs secretome", "chunk": 8}
{"article": "PMC4908397.txt", "subject": "pigment epithelium-derived factor", "relationship": "RELATED_PROGNOSIS", "object": "Upregulated in the dynamic hBM-MSCs secretome", "chunk": 8}
{"article": "PMC4908397.txt", "subject": "brain-derived neurotrophic factor", "relationship": "RELATED_PROGNOSIS", "object": "Upregulated in the dynamic hBM-MSCs secretome", "chunk": 8}
{"article": "PMC4908397.txt", "subject": "vascular endothelial growth factor", "relationship": "RELATED_PROGNOSIS", "object": "Upregulated in the dynamic hBM-MSCs secretome", "chunk": 8}
{"article": "PMC4908397.txt", "subject": "nerve growth factor", "relationship": "RELATED_PROGNOSIS", "object": "Upregulated in the dynamic hBM-MSCs secretome", "chunk": 8}
{"article": "PMC4908397.txt", "subject": "insulin growth factor 1", "relationship": "RELATED_PROGNOSIS", "object": "Upregulated in the dynamic hBM-MSCs secretome", "chunk": 8}
{"article": "PMC4908397.txt", "subject": "miR-16", "relationship": "RELATED_PROGNOSIS", "object": "Upregulated in the dynamic hBM-MSCs secretome", "chunk": 8}
{"article": "PMC4918115.txt", "subject": "ApoE \u03b54", "relationship": "RELATED_TO_TREATMENT", "object": "The 3002 study evaluated ApoE \u03b54 allele noncarriers and the 3003 study evaluated ApoE \u03b54 allele carriers.", "chunk": 2}
{"article": "PMC4918115.txt", "subject": "ARI", "relationship": "INDICATES_PRESENCE_OF", "object": "ARIA-E were a primary safety finding in these studies in patients treated with bapineuzumab", "chunk": 2}
{"article": "PMC4918115.txt", "subject": "bapineuzumab", "relationship": "RELATED_TREATMENT", "object": "The 3002 study evaluated ApoE \u03b54 allele noncarriers and the 3003 study evaluated ApoE \u03b54 allele carriers.", "chunk": 2}
{"article": "PMC4918115.txt", "subject": "diagnosis of probable Alzheimer\u2019s Disease", "relationship": "DIAGNOSITC_OF", "object": "Patients met the inclusion criteria for AD in the parent studies (3000 and 3001) if they had: a diagnosis of probable AD according to the National Institute of Neurological and Communicative Disorders and Stroke\u2013Alzheimer\u2019s Disease and Related Disorders Association criteria", "chunk": 2}
{"article": "PMC4918115.txt", "subject": "Rosen Modified Hachinski Ischemic Score", "relationship": "RELATED_PROGNOSIS", "object": "Patients met the inclusion criteria for AD in the parent studies (3000 and 3001) if they had: a diagnosis of probable AD according to the National Institute of Neurological and Communicative Disorders and Stroke\u2013Alzheimer\u2019s Disease and Related Disorders Association criteria; Rosen Modified Hachinski Ischemic Score\u2009\u2264\u20094", "chunk": 2}
{"article": "PMC4918115.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "RELATES_TO_TREATMENT", "object": "All patients were assigned to bapineuzumab 0.5\u00a0mg/kg whether they received bapineuzumab or placebo in the parent study.", "chunk": 2}
{"article": "PMC4918115.txt", "subject": "Mini-Mental State Examination (MMSE) score ", "relationship": "DIAGNOSITC_OF", "object": " Patients met the inclusion criteria for AD in the parent studies (3000 and 3001) if they had: a diagnosis of probable AD according to the National Institute of Neurological and Communicative Disorders and Stroke\u2013Alzheimer\u2019s Disease and Related Disorders Association criteria; Rosen Modified Hachinski Ischemic Score\u2009\u2264\u20094; Mini-Mental State Examination (MMSE) score of 16\u201326, inclusive", "chunk": 2}
{"article": "PMC4918115.txt", "subject": "brain MRI scan", "relationship": "DIAGNOSITC_OF", "object": "Patients met the inclusion criteria for AD in the parent studies (3000 and 3001) if they had: a diagnosis of probable AD according to the National Institute of Neurological and Communicative Disorders and Stroke\u2013Alzheimer\u2019s Disease and Related Disorders Association criteria; Rosen Modified Hachinski Ischemic Score\u2009\u2264\u20094; Mini-Mental State Examination (MMSE) score of 16\u201326, inclusive; and a screening brain MRI scan consistent with the diagnosis of AD", "chunk": 2}
{"article": "PMC4918115.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid", "relationship": "ASSESSED_IN", "object": "subset of patients", "chunk": 3}
{"article": "PMC4918115.txt", "subject": "phosphorylated tau (p-tau)", "relationship": "ASSESSED_IN", "object": "subset of patients", "chunk": 3}
{"article": "PMC4918115.txt", "subject": "[11C]-Pittsburgh Compound B positron emission tomography (PiB-PET)", "relationship": "ASSESSED_IN", "object": "subset of patients", "chunk": 3}
{"article": "PMC4918115.txt", "subject": "AD biomarkers", "relationship": "ASSESSED", "object": "a subset of patients", "chunk": 3}
{"article": "PMC4918115.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Lower baseline MMSE scores were observed at the beginning of the extension study compared with baseline MMSE in the parent study", "chunk": 4}
{"article": "PMC4918115.txt", "subject": "ApoE \u03b54 allele count", "relationship": "INDICATES_PRESENCE_OF", "object": "ApoE \u03b54 carrier status", "chunk": 4}
{"article": "PMC4918115.txt", "subject": "AChEI", "relationship": "RELATED_TREATMENT", "object": "Most patients were using cholinesterase inhibitors and/or memantine", "chunk": 4}
{"article": "PMC4918115.txt", "subject": "memantine", "relationship": "RELATED_TREATMENT", "object": "Most patients were using cholinesterase inhibitors and/or memantine", "chunk": 4}
{"article": "PMC4918115.txt", "subject": "ApoE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "risk of AEs", "chunk": 5}
{"article": "PMC4918115.txt", "subject": "ApoE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Higher incidence of TEAEs", "chunk": 5}
{"article": "PMC4918115.txt", "subject": "ApoE \u03b54", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Study inclusion criteria", "chunk": 5}
{"article": "PMC4918115.txt", "subject": "ARIA-E", "relationship": "DIAGNOSITC_OF", "object": "Vasogenic cerebral edema", "chunk": 5}
{"article": "PMC4918115.txt", "subject": "ARIA-E", "relationship": "RELATED_PROGNOSIS", "object": "Potential risk, especially in  ApoE \u03b54 carriers", "chunk": 5}
{"article": "PMC4918115.txt", "subject": "ApoE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Increased risk of death", "chunk": 5}
{"article": "PMC4918115.txt", "subject": "ARIA-E", "relationship": "INDICATES_PRESENCE_OF", "object": "Adverse Event", "chunk": 6}
{"article": "PMC4918115.txt", "subject": "ARIA-E", "relationship": "related_treatment", "object": "Bapineuzumab Treatment", "chunk": 6}
{"article": "PMC4918115.txt", "subject": "Intracranial hemorrhage", "relationship": "INDICATES_PRESENCE_OF", "object": "Adverse Event", "chunk": 6}
{"article": "PMC4918115.txt", "subject": "seizure/convulsion", "relationship": "INDICATES_PRESENCE_OF", "object": "Adverse Event", "chunk": 6}
{"article": "PMC4918115.txt", "subject": "DVT/PE", "relationship": "INDICATES_PRESENCE_OF", "object": "Adverse Event", "chunk": 6}
{"article": "PMC4918115.txt", "subject": "ADAS-Cog/11", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease progression", "chunk": 6}
{"article": "PMC4918115.txt", "subject": "DAD", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease progression", "chunk": 6}
{"article": "PMC4918115.txt", "subject": "NPI", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease progression", "chunk": 6}
{"article": "PMC4918115.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease progression", "chunk": 6}
{"article": "PMC4918115.txt", "subject": "p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "neurodegeneration", "chunk": 7}
{"article": "PMC4918115.txt", "subject": "ApoE \u03b54", "relationship": "ASSOCIATED_WITH", "object": "reduced cerebral cerebral cerebral cerebral spinal fluid p-tau concentrations", "chunk": 7}
{"article": "PMC4918115.txt", "subject": "ApoE \u03b54", "relationship": "ASSOCIATED_WITH", "object": "decrease in amyloid accumulation based on PiB-PET findings", "chunk": 7}
{"article": "PMC4918115.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC4918115.txt", "subject": "PiB-PET", "relationship": "MONITORED_DURING_TREATMENT", "object": " Bapineuzumab", "chunk": 8}
{"article": "PMC4918115.txt", "subject": "vMRI", "relationship": "MONITORED_DURING_TREATMENT", "object": " Bapineuzumab", "chunk": 8}
{"article": "PMC4918115.txt", "subject": "ADAS-Cog/11", "relationship": "RELATED_PROGNOSIS", "object": "AD progression", "chunk": 8}
{"article": "PMC4918115.txt", "subject": "DAD", "relationship": "RELATED_PROGNOSIS", "object": "AD progression", "chunk": 8}
{"article": "PMC4918115.txt", "subject": "ApoE \u03b54", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Bapineuzumab treatment", "chunk": 8}
{"article": "PMC4922661.txt", "subject": "albuminemia", "relationship": "PREDICTED_\u2206BM", "object": "in women with AD", "chunk": 1}
{"article": "PMC4922661.txt", "subject": "cortisolism", "relationship": "PREDICTED_\u2206BM", "object": "in men with AD", "chunk": 1}
{"article": "PMC4922661.txt", "subject": "cortisolism", "relationship": "RELATED_TO_WEIGHT_LOSS", "object": "May affect", "chunk": 1}
{"article": "PMC4922661.txt", "subject": "albumin plasma levels", "relationship": "INDICATES_PRESENCE_OF", "object": "increased oxidative stress", "chunk": 1}
{"article": "PMC4922661.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Dementia progression and severity", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "Neuro-Psychiatric Inventory (NPI)", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Behavioral disorders", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "Clinical Dementia Rating (CDR)", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Dementia progression and severity", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "Blood Glucose", "relationship": "MONITORED_DURING_TREATMENT", "object": "Standard institutionalized diet", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "Red Blood Cells", "relationship": "MONITORED_DURING_TREATMENT", "object": "Standard institutionalized diet", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "Hemoglobin", "relationship": "MONITORED_DURING_TREATMENT", "object": "Standard institutionalized diet", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "High-Density Lipoprotein (HDL)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Standard institutionalized diet", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "Low-Density Lipoprotein (LDL)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Standard institutionalized diet", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "Creatinine", "relationship": "MONITORED_DURING_TREATMENT", "object": "Standard institutionalized diet", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "Azotemia", "relationship": "MONITORED_DURING_TREATMENT", "object": "Standard institutionalized diet", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "Hepatic Function", "relationship": "MONITORED_DURING_TREATMENT", "object": "Standard institutionalized diet", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "White Blood Cell Count (WBC)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Standard institutionalized diet", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "Neutrophils", "relationship": "MONITORED_DURING_TREATMENT", "object": "Standard institutionalized diet", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "Eosinophils", "relationship": "MONITORED_DURING_TREATMENT", "object": "Standard institutionalized diet", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "Basophils", "relationship": "MONITORED_DURING_TREATMENT", "object": "Standard institutionalized diet", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "Lymphocytes", "relationship": "MONITORED_DURING_TREATMENT", "object": "Standard institutionalized diet", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "Albumin (ALB)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Standard institutionalized diet", "chunk": 2}
{"article": "PMC4922661.txt", "subject": "cortisol", "relationship": "RELATED_PROGNOSIS", "object": "Patients with AD demonstrated chronic inflammatory state", "chunk": 3}
{"article": "PMC4922661.txt", "subject": "cortisol", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "COR levels were significantly higher in the AD group", "chunk": 3}
{"article": "PMC4922661.txt", "subject": "WBC", "relationship": "RELATED_PROGNOSIS", "object": "Patients with AD demonstrated chronic inflammatory state", "chunk": 3}
{"article": "PMC4922661.txt", "subject": "Neutrophil", "relationship": "RELATED_PROGNOSIS", "object": "Patients with AD demonstrated chronic inflammatory state", "chunk": 3}
{"article": "PMC4922661.txt", "subject": "ALB", "relationship": "RELATED_PROGNOSIS", "object": "AD patients demonstrated lower plasma levels compared to CTRL", "chunk": 3}
{"article": "PMC4922661.txt", "subject": "WBC", "relationship": "INDICATES_PRESENCE_OF", "object": "Elevated WBC count in AD patients", "chunk": 4}
{"article": "PMC4922661.txt", "subject": "NMED", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Disease status", "chunk": 4}
{"article": "PMC4922661.txt", "subject": "Albumin", "relationship": "RELATED_PROGNOSIS", "object": "Lowered Albumin levels in AD patients", "chunk": 4}
{"article": "PMC4922661.txt", "subject": "Retinol", "relationship": "RELATED_PROGNOSIS", "object": "Retinol levels were unaffected in AD patients", "chunk": 4}
{"article": "PMC4922661.txt", "subject": "Systolic BP", "relationship": "RELATED_PROGNOSIS", "object": "Elevated Systolic BP in AD patients", "chunk": 4}
{"article": "PMC4922661.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline indicated by lower MMSE score in AD patients", "chunk": 4}
{"article": "PMC4922661.txt", "subject": "NMED", "relationship": "RELATED_PROGNOSIS", "object": "changes in body mass (\u2206BM)", "chunk": 5}
{"article": "PMC4922661.txt", "subject": "ALB", "relationship": "RELATED_PROGNOSIS", "object": "changes in body mass (\u2206BM)", "chunk": 5}
{"article": "PMC4922661.txt", "subject": "NPI", "relationship": "RELATED_PROGNOSIS", "object": "changes in body mass (\u2206BM)", "chunk": 5}
{"article": "PMC4922661.txt", "subject": "COR", "relationship": "RELATED_PROGNOSIS", "object": "changes in body mass (\u2206BM) in women with AD", "chunk": 5}
{"article": "PMC4922661.txt", "subject": "COR", "relationship": "RELATED_PROGNOSIS", "object": "changes in body mass (\u2206BM) in men with AD", "chunk": 5}
{"article": "PMC4922661.txt", "subject": "ALB", "relationship": "RELATED_PROGNOSIS", "object": "Involuntary WL in the present group of W with AD", "chunk": 6}
{"article": "PMC4922661.txt", "subject": "NMED", "relationship": "RELATED_PROGNOSIS", "object": "Involuntary WL in the present group of W with AD", "chunk": 6}
{"article": "PMC4922661.txt", "subject": "COR", "relationship": "RELATED_PROGNOSIS", "object": "Involuntary WL in patients with AD", "chunk": 6}
{"article": "PMC4922661.txt", "subject": "COR", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "WL treatment selection", "chunk": 6}
{"article": "PMC4922661.txt", "subject": "COR", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treatment for WL ", "chunk": 6}
{"article": "PMC4922661.txt", "subject": "COR", "relationship": "RELATED_Treatment", "object": "WL in patients with AD", "chunk": 6}
{"article": "PMC4922661.txt", "subject": "retinol", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Adquate energy intake", "chunk": 7}
{"article": "PMC4922661.txt", "subject": "albumin", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "prediction of possible reduction of BM", "chunk": 7}
{"article": "PMC4922661.txt", "subject": "cortisol", "relationship": "RELATED_PROGNOSIS", "object": "exacerbation of behavioral disorders", "chunk": 7}
{"article": "PMC4922661.txt", "subject": "cortisol levels", "relationship": "RELATED_TO", "object": "changes in body mass (BM) over 12 months", "chunk": 8}
{"article": "PMC4922661.txt", "subject": "cortisol levels", "relationship": "PREDICTS", "object": "patients at risk of unintentional weight loss (WL)", "chunk": 8}
{"article": "PMC4922661.txt", "subject": "ALB", "relationship": "RELATED_TO", "object": "changes in body mass (BM) in women (W) with Alzheimer's Disease (AD)", "chunk": 8}
{"article": "PMC4922661.txt", "subject": "number of medications taken", "relationship": "RELATED_TO", "object": "changes in body mass (BM) in women (W) with Alzheimer's Disease (AD)", "chunk": 8}
{"article": "PMC4922661.txt", "subject": "cortisol levels", "relationship": "MAINLY_ASSOCIATED_WITH", "object": "WL in men (M) with Alzheimer's Disease (AD)", "chunk": 8}
{"article": "PMC4922661.txt", "subject": "hypoalbuminemia", "relationship": "RELATED_TO", "object": "BM changes in women (W) with Alzheimer's Disease (AD)", "chunk": 8}
{"article": "PMC4922661.txt", "subject": "hypercortisolism", "relationship": "RELATED_TO", "object": "BM changes in both women (W) and men (M) with Alzheimer's Disease (AD)", "chunk": 8}
{"article": "PMC4928349.txt", "subject": "APOE \u025b4 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4928349.txt", "subject": "APOE \u025b4 allele", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Reduced risk of developing Alzheimer's disease", "chunk": 1}
{"article": "PMC4928349.txt", "subject": "APOE \u025b4 allele", "relationship": "RELATED_PROGNOSIS", "object": "Development of AD symptoms earlier", "chunk": 1}
{"article": "PMC4928349.txt", "subject": "APOE \u025b4 allele", "relationship": "USED_TO_DIAGNOSE", "object": "Late-onset Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4928349.txt", "subject": "DHA", "relationship": "RELATED_TREATMENT", "object": "DHA supplementation trials", "chunk": 1}
{"article": "PMC4928349.txt", "subject": "DHA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Determining effective treatment for Alzheimer's disease", "chunk": 1}
{"article": "PMC4928349.txt", "subject": "cerebral spinal fluid A\u03b242 levels", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 1}
{"article": "PMC4928349.txt", "subject": "cerebral spinal fluid A\u03b242 levels", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4928349.txt", "subject": "low cerebral spinal fluid A\u03b242 levels", "relationship": "PREDICT", "object": "developing Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4928349.txt", "subject": "APOE \u025b4", "relationship": "RELATED_PROGNOSIS", "object": "Reduced delivery of DHA to the brain", "chunk": 2}
{"article": "PMC4928349.txt", "subject": "APOE \u025b4", "relationship": "RELATED_TREATMENT", "object": "DHA supplementation trial", "chunk": 2}
{"article": "PMC4928349.txt", "subject": "cerebral  spinal fluid A\u03b242 levels", "relationship": "RELATED_TREATMENT", "object": "Limit delivery of DHA to the brain", "chunk": 2}
{"article": "PMC4928349.txt", "subject": "DHA", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebral spinal fluid levels", "chunk": 2}
{"article": "PMC4928349.txt", "subject": "DHA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Determining the dose of DHA based on plasma levels", "chunk": 2}
{"article": "PMC4928349.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": " Probable Alzheimer's disease", "chunk": 2}
{"article": "PMC4928349.txt", "subject": "A\u03b242", "relationship": "DIAGNOSTIC_OF", "object": "Assess amyloid-beta levels in cerebral spinal fluid", "chunk": 3}
{"article": "PMC4928349.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Baseline A\u03b242 levels related to DHA ratios", "chunk": 3}
{"article": "PMC4928349.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "DHA treatment effect analyzed in relation to A\u03b242 levels", "chunk": 3}
{"article": "PMC4928349.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Study divided into tertiles based on A\u03b242 levels", "chunk": 3}
{"article": "PMC4928349.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower baseline cerebral spinal fluid to plasma DHA", "chunk": 4}
{"article": "PMC4928349.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "18-month change in cerebral spinal fluid DHA", "chunk": 4}
{"article": "PMC4928349.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Ratio of cerebral spinal fluid to plasma DHA", "chunk": 4}
{"article": "PMC4928349.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Change in the 18-month change in DHA", "chunk": 4}
{"article": "PMC4928349.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower increase in the cerebral spinal fluid-to-plasma DHA ratio", "chunk": 4}
{"article": "PMC4928349.txt", "subject": "DHA", "relationship": "RELATED_TREATMENT", "object": "18 months DHA supplementation", "chunk": 4}
{"article": "PMC4928349.txt", "subject": "DHA", "relationship": "IS_TARGET_OF_TREATMENT", "object": "DHA supplementation", "chunk": 4}
{"article": "PMC4928349.txt", "subject": "DHA", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma phospholipid DHA", "chunk": 4}
{"article": "PMC4928349.txt", "subject": "DHA", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebral spinal fluid DHA", "chunk": 4}
{"article": "PMC4928349.txt", "subject": "DHA", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Response to DHA supplementation", "chunk": 4}
{"article": "PMC4928349.txt", "subject": "APOE \u025b4", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "DHA treatment effect on cerebral spinal fluid DHA", "chunk": 4}
{"article": "PMC4928349.txt", "subject": "APOE \u025b4 allele", "relationship": "IS_RELATED_TO", "object": "diminished response to DHA supplementation", "chunk": 6}
{"article": "PMC4928349.txt", "subject": "cerebral spinal fluid A\u03b242 levels", "relationship": "ASSOCIATED_WITH", "object": "lower cerebral spinal fluid-to-plasma DHA ratio", "chunk": 6}
{"article": "PMC4928349.txt", "subject": "APOE \u03b54 allele", "relationship": "IS_BASIS_FOR", "object": "hypothesized defect in DHA brain delivery years before the onset of neurodegeneration", "chunk": 6}
{"article": "PMC4928349.txt", "subject": "DHA intervention", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "reduces variation resulting from potential confounders with baseline measurements", "chunk": 6}
{"article": "PMC4928349.txt", "subject": "DHA", "relationship": "IS_TARGET_OF_TREATMENT", "object": "DHA supplementation", "chunk": 6}
{"article": "PMC4928349.txt", "subject": "nonsterified DHA", "relationship": "PREDICTED_BY", "object": "decreased in cerebral spinal fluid in mild cognitive impairment and AD", "chunk": 6}
{"article": "PMC4928349.txt", "subject": "total DHA", "relationship": "PREDICTED_BY", "object": "decreased in cerebral spinal fluid in mild cognitive impairment and AD", "chunk": 6}
{"article": "PMC4928349.txt", "subject": "APOE \u03b54 allele", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "lack of efficacy of DHA in participants with established AD", "chunk": 6}
{"article": "PMC4928349.txt", "subject": "DHA", "relationship": "RELATED_PROGNOSIS", "object": "reduction in brain DHA consumption through liberation from cerebral spinal fluid and brain phospholipids ", "chunk": 6}
{"article": "PMC4928807.txt", "subject": "neuron loss in the substantia nigra", "relationship": "INDICATES_PRESENCE_OF", "object": "Parkinson\u2019s disease", "chunk": 1}
{"article": "PMC4928807.txt", "subject": "dopamine depletion in the motor region of the striatum", "relationship": "INDICATES_PRESENCE_OF", "object": "Parkinson\u2019s disease", "chunk": 1}
{"article": "PMC4928807.txt", "subject": "\u03b1-synuclein deposits accumulated in neurites (Lewy neurites)", "relationship": "INDICATES_PRESENCE_OF", "object": "PD", "chunk": 1}
{"article": "PMC4928807.txt", "subject": "\u03b1-synuclein deposits accumulated in neuronal somata (Lewy bodies)", "relationship": "INDICATES_PRESENCE_OF", "object": "PD", "chunk": 1}
{"article": "PMC4928807.txt", "subject": "FA", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Reduced FA has been found in PD patients in WM structures", "chunk": 2}
{"article": "PMC4928807.txt", "subject": "MD", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased MD and reduced FA in the superior longitudinal fasciculus (SLF), the genu of the corpus callosum (CC), and in the cingulum (CG)", "chunk": 2}
{"article": "PMC4928807.txt", "subject": "FA", "relationship": "INDICATES_PRESENCE_OF", "object": "A meta-analysis of FA changes in the substantia nigra has questioned the stability and validity of this measure as a PD biomarker", "chunk": 2}
{"article": "PMC4928807.txt", "subject": "MD", "relationship": "INDICATES_PRESENCE_OF", "object": "Elevated mean kurtosis (MK) in the putamen and in the substantia nigra in PD", "chunk": 2}
{"article": "PMC4928807.txt", "subject": "FA", "relationship": "RELATED_PROGNOSIS", "object": "FA and negatively correlated with MD in relevant WM tracts, consistent with the expectation that FA decreases and MD increases with increased levels of neurodegeneration and neurocognitive dysfunction.", "chunk": 2}
{"article": "PMC4928807.txt", "subject": "MK", "relationship": "RELATED_PROGNOSIS", "object": "elevated mean kurtosis (MK) in the putamen and in the substantia nigra in PD", "chunk": 2}
{"article": "PMC4928807.txt", "subject": "NDI", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "To obtain the neurite density index (fic) and the partial fraction of free water (fiso)", "chunk": 2}
{"article": "PMC4928807.txt", "subject": "fiso", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "To obtain the neurite density index (fic) and the partial fraction of free water (fiso)", "chunk": 2}
{"article": "PMC4928807.txt", "subject": "FA", "relationship": "RELATED_PROGNOSIS", "object": "Changes in FA and MD", "chunk": 2}
{"article": "PMC4928807.txt", "subject": "MD", "relationship": "RELATED_PROGNOSIS", "object": "Changes in FA and MD", "chunk": 2}
{"article": "PMC4928807.txt", "subject": "MK", "relationship": "RELATED_PROGNOSIS", "object": "Decreased MK in the putamen is associated with Parkinson's disease", "chunk": 5}
{"article": "PMC4928807.txt", "subject": "MD", "relationship": "RELATED_PROGNOSIS", "object": "Increased MD in the putamen and thalamus is associated with Parkinson's disease", "chunk": 5}
{"article": "PMC4928807.txt", "subject": "FA", "relationship": "RELATED_PROGNOSIS", "object": "Decreased FA in the putamen and thalamus is associated with Parkinson's disease", "chunk": 5}
{"article": "PMC4928807.txt", "subject": "FA", "relationship": "RELATED_PROGNOSIS", "object": "DTI measures of FA in white matter tracts are related to the prognosis in Parkinson's disease", "chunk": 6}
{"article": "PMC4928807.txt", "subject": "MK", "relationship": "RELATED_PROGNOSIS", "object": "DTI measures of MK in white matter tracts are related to the prognosis in Parkinson's disease", "chunk": 6}
{"article": "PMC4928807.txt", "subject": "MD", "relationship": "RELATED_PROGNOSIS", "object": "DTI measures of MD in white matter tracts are related to the prognosis in Parkinson's disease", "chunk": 6}
{"article": "PMC4928807.txt", "subject": "NDI fiso", "relationship": "INDICATES_PRESENCE_OF", "object": "Worsening of motor function", "chunk": 7}
{"article": "PMC4928807.txt", "subject": "NDI fiso", "relationship": "INDICATES_PRESENCE_OF", "object": "Worsening of cognitive function", "chunk": 7}
{"article": "PMC4928807.txt", "subject": "MD", "relationship": "INDICATES_PRESENCE_OF", "object": "Worsening motor function", "chunk": 7}
{"article": "PMC4928807.txt", "subject": "MK", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Reduced memory performance", "chunk": 7}
{"article": "PMC4928807.txt", "subject": "MD", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Impaired cognitive speed and attention", "chunk": 7}
{"article": "PMC4928807.txt", "subject": "MD", "relationship": "RELATED_PROGNOSIS", "object": "More severe motor and cognitive symptomatology", "chunk": 7}
{"article": "PMC4928807.txt", "subject": "MD", "relationship": "RELATED_TREATMENT", "object": "Monitor during treatment", "chunk": 7}
{"article": "PMC4928807.txt", "subject": "FA", "relationship": "RELATED_PROGNOSIS", "object": "Microstructural damage", "chunk": 7}
{"article": "PMC4928807.txt", "subject": "MD putamen", "relationship": "INDICATES_PRESENCE_OF", "object": "PD", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "FA putamen", "relationship": "PREDICTED_SURVIVAL", "object": "Worsening of motor speed, balance", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "MK putamen", "relationship": "INDICATES_PRESENCE_OF", "object": "PD", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "MD thalamus", "relationship": "INDICATES_PRESENCE_OF", "object": "PD", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "FA thalamus", "relationship": "INDICATES_PRESENCE_OF", "object": "PD", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "MD SLF", "relationship": "INDICATES_PRESENCE_OF", "object": "PD", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "fiso SLF", "relationship": "INDICATES_PRESENCE_OF", "object": "PD", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "fic CST", "relationship": "INDICATES_PRESENCE_OF", "object": "PD", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "MD putamen", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Worsening of motor speed, balance", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "FA putamen", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Worsening of motor speed, balance", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "MK putamen", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Worsening of motor speed, balance", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "MD putamen", "relationship": "RELATED_PROGNOSIS", "object": "Improving cognitive function", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "MD thalamus", "relationship": "RELATED_PROGNOSIS", "object": "Worsening of motor speed, balance, cognitive function", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "FA thalamus", "relationship": "RELATED_PROGNOSIS", "object": "Worsening of motor speed, balance, cognitive function", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "MD SLF", "relationship": "RELATED_PROGNOSIS", "object": "Worsening of motor speed, balance, cognitive function", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "fiso SLF", "relationship": "RELATED_PROGNOSIS", "object": "Worsening of motor speed, balance, cognitive function", "chunk": 8}
{"article": "PMC4928807.txt", "subject": "Mean diffusivity (MD)", "relationship": "RELATED_TO", "object": "Signal-to-noise ratio (SNR)", "chunk": 10}
{"article": "PMC4928807.txt", "subject": "Mean diffusivity (MD)", "relationship": "INDICATES_PRESENCE_OF", "object": "Parkinson disease", "chunk": 10}
{"article": "PMC4928807.txt", "subject": "Mean diffusivity (MD)", "relationship": "INDICATES_PRESENCE_OF", "object": "Progressive supranuclear palsy", "chunk": 10}
{"article": "PMC4928807.txt", "subject": "Mean diffusivity (MD)", "relationship": "INDICATES_PRESENCE_OF", "object": "Multiple system atrophy", "chunk": 10}
{"article": "PMC4936020.txt", "subject": "nerve growth factor (NGF)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "A potential therapy for Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4936020.txt", "subject": "ngf", "relationship": "RELATED_PROGNOSIS", "object": "Reduces cognitive deficits in animal models", "chunk": 1}
{"article": "PMC4936020.txt", "subject": "need for ", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Targeted delivery of NGF to the brain", "chunk": 1}
{"article": "PMC4936020.txt", "subject": "cholinesterase inhibitors (ChEIs)", "relationship": "RELATED_TREATMENT", "object": "Development of", "chunk": 1}
{"article": "PMC4936020.txt", "subject": "neurofilament light chain (NFL)", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4936020.txt", "subject": "neurofilament light chain (NFL)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Of NGF-ECB", "chunk": 1}
{"article": "PMC4936020.txt", "subject": "glial fibrillary acidic protein (GFAP)", "relationship": "RELATED_PROGNOSIS", "object": "Remained stable", "chunk": 1}
{"article": "PMC4936020.txt", "subject": "cholinergic dysfunction", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment", "chunk": 1}
{"article": "PMC4936020.txt", "subject": "NGF", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": " Patients with stable treatment with ChEIs for at least 3 months before enrolment as well as during the study.", "chunk": 2}
{"article": "PMC4936020.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "treatment of  AD was a second-generation NGF-ECB implant", "chunk": 2}
{"article": "PMC4936020.txt", "subject": "NGF", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Delivery of NGF via CERE-110", "chunk": 2}
{"article": "PMC4936020.txt", "subject": "NGF", "relationship": "IS_TARGET_OF_TREATMENT", "object": " Patients with AD who were receiving NGF infusion directly into the striatum", "chunk": 2}
{"article": "PMC4936020.txt", "subject": "amyloid-beta peptide 1\u201342 (A\u03b21\u201342)", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral spinal fluid", "chunk": 3}
{"article": "PMC4936020.txt", "subject": "total tau (t-tau)", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral spinal fluid", "chunk": 3}
{"article": "PMC4936020.txt", "subject": "tau protein, phosphorylate (p-tau)", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral spinal fluid", "chunk": 3}
{"article": "PMC4936020.txt", "subject": "neurofilament light chain protein (NFL)", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral spinal fluid", "chunk": 3}
{"article": "PMC4936020.txt", "subject": "glial fibrillary acidic protein (GFAP)", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral spinal fluid", "chunk": 3}
{"article": "PMC4936020.txt", "subject": "acetylcholinesterase (AChE)", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral spinal fluid", "chunk": 3}
{"article": "PMC4936020.txt", "subject": "protein levels of AChE", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral spinal fluid", "chunk": 3}
{"article": "PMC4936020.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Levels of A\u03b2 did not change significantly.", "chunk": 4}
{"article": "PMC4936020.txt", "subject": "t-tau", "relationship": "RELATED_PROGNOSIS", "object": "Levels of t-tau did not change significantly.", "chunk": 4}
{"article": "PMC4936020.txt", "subject": "p-tau", "relationship": "RELATED_PROGNOSIS", "object": "Levels of p-tau did not change significantly.", "chunk": 4}
{"article": "PMC4936020.txt", "subject": "NFL", "relationship": "RELATED_PROGNOSIS", "object": "levels of NFL were increased in all patients at 3\u00a0months but had decreased at the 6-month time point.", "chunk": 4}
{"article": "PMC4936020.txt", "subject": "GFAP", "relationship": "RELATED_PROGNOSIS", "object": "This change in NFL levels was not paralleled by an increase in cerebral cerebral cerebral cerebral spinal fluid GFAP ", "chunk": 4}
{"article": "PMC4936020.txt", "subject": "ChAT", "relationship": "RELATED_PROGNOSIS", "object": "ChAT and AChE activities were increased in two of the four patients at 6\u00a0months compared with baseline. These increased activities coincided with a lesser decline in MMSE compared with the other two patients.", "chunk": 4}
{"article": "PMC4936020.txt", "subject": "AChE", "relationship": "RELATED_PROGNOSIS", "object": "ChAT and AChE activities were increased in two of the four patients at 6\u00a0months compared with baseline. These increased activities coincided with a lesser decline in MMSE compared with the other two patients.", "chunk": 4}
{"article": "PMC4936020.txt", "subject": "A\u03b21\u201342", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4936020.txt", "subject": "t-tau", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4936020.txt", "subject": "p-tau", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4936020.txt", "subject": "NFL", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4936020.txt", "subject": "GFAP", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4936020.txt", "subject": "ChAT activity", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4936020.txt", "subject": "AChE activity", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4936020.txt", "subject": "11C-nicotinic binding", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4936020.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4936020.txt", "subject": "A\u03b2\u03b2", "relationship": "RELATED_TO", "object": "Cerebral cerebral cerebral cerebral spinal fluid AD biomarkers", "chunk": 6}
{"article": "PMC4936020.txt", "subject": "tau protein", "relationship": "RELATED_TO", "object": "Cerebral cerebral cerebral cerebral spinal fluid AD biomarkers", "chunk": 6}
{"article": "PMC4936020.txt", "subject": "NFL", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Markers of acute tissue damage", "chunk": 6}
{"article": "PMC4956742.txt", "subject": "amyloid-\u03b2 (A\u03b2) peptides", "relationship": "RELATED_PROGNOSIS", "object": "cognitive decline", "chunk": 1}
{"article": "PMC4956742.txt", "subject": "Neurofibrillary tangles", "relationship": "RELATED_PROGNOSIS", "object": "progressive cognitive decline", "chunk": 1}
{"article": "PMC4956742.txt", "subject": "A\u03b2 plaque deposition", "relationship": "RESPONDED_TO", "object": "prolonged shifts in gut microbial composition and diversity", "chunk": 1}
{"article": "PMC4956742.txt", "subject": "A\u03b2 plaque deposition", "relationship": "ASSOCIATED_WITH", "object": "amyloidosis", "chunk": 1}
{"article": "PMC4956742.txt", "subject": "Microglial phagocytosis and clearance of A\u03b2", "relationship": "RELATED_TREATMENT", "object": "GWAS studies have identified numerous genetic risk factors for late-onset AD", "chunk": 1}
{"article": "PMC4956742.txt", "subject": "type-1 interferon responses", "relationship": "INDICATES_PRESENCE_OF", "object": "deleterious signs of aging", "chunk": 1}
{"article": "PMC4956742.txt", "subject": "type-1 interferon signaling", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 1}
{"article": "PMC4956742.txt", "subject": "A\u03b21-40", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloidosis", "chunk": 2}
{"article": "PMC4956742.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloidosis", "chunk": 2}
{"article": "PMC4956742.txt", "subject": "A\u03b21-40", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4956742.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4956742.txt", "subject": "A\u03b2 plaque burden", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4956742.txt", "subject": "A\u03b21-42 levels", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4956742.txt", "subject": "Iba1 positive microglial cells", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4956742.txt", "subject": "CCL11", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Age-associated deficits in hippocampal neurogenesis", "chunk": 4}
{"article": "PMC4956742.txt", "subject": "CCL11", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Potential microbiome-based therapies for humans at risk or in the early stages of AD", "chunk": 4}
{"article": "PMC4956742.txt", "subject": "CCL11", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Treatment with microbiome-based therapies", "chunk": 4}
{"article": "PMC4956742.txt", "subject": "amyloid plaque", "relationship": "MONITORED_DURING_TREATMENT", "object": "plaque burden percentage", "chunk": 5}
{"article": "PMC4956742.txt", "subject": "amyloid plaque", "relationship": "MONITORED_DURING_TREATMENT", "object": "plaque size", "chunk": 5}
{"article": "PMC4956742.txt", "subject": "A\u03b238/40/42", "relationship": "WAS_DETECTED", "object": "Levels were quantified using Meso Scale A\u03b238/40/42-triplex kits", "chunk": 6}
{"article": "PMC4956742.txt", "subject": "A\u03b2 plaque deposition", "relationship": "RELATED_PROGNOSIS", "object": "Altered in ABX-treated male APPSWE/PS1\u0394E9 mice", "chunk": 7}
{"article": "PMC4956742.txt", "subject": "3D6+ve area", "relationship": "RELATED_PROGNOSIS", "object": "Averaged from 4 sections/mouse (240\u2009\u03bcm apart) and expressed relative to total cortical and hippocampal area.", "chunk": 7}
{"article": "PMC4956742.txt", "subject": "A\u03b21-40", "relationship": "RELATED_PROGNOSIS", "object": "Levels in combined cortical and hippocampal tissue of vehicle control and ABX-treated male 6 month old APPSWE/PS1\u0394E9 mice using anti-A\u03b2 mAb 4G8", "chunk": 7}
{"article": "PMC4956742.txt", "subject": "A\u03b21-42", "relationship": "RELATED_PROGNOSIS", "object": "Levels in combined cortical and hippocampal tissue of vehicle control and ABX-treated male 6 month old APPSWE/PS1\u0394E9 mice using anti-A\u03b2 mAb 4G8", "chunk": 7}
{"article": "PMC4956742.txt", "subject": "A\u03b21-40:A\u03b21-42 ratio", "relationship": "RELATED_PROGNOSIS", "object": "From the TBS-soluble MSD Mesoscale\u00ae data in vehicle control and ABX-treated male 6 month old APPSWE/PS1\u0394E9 mice", "chunk": 7}
{"article": "PMC4956742.txt", "subject": "IBA-1+ve A\u03b2 plaque-localized microglia", "relationship": "RELATED_PROGNOSIS", "object": "Visualization of plaque-localized microglial number in vehicle control and ABX-treated male 6 month old APPSWE/PS1\u0394E9 mice", "chunk": 7}
{"article": "PMC4956742.txt", "subject": "plaque-localized IBA-1+ve microglial number", "relationship": "RELATED_PROGNOSIS", "object": "Expressed relative to 3D6+ve A\u03b2 plaque area in vehicle control and ABX-treated male 6 month old APPSWE/PS1\u0394E9 mice", "chunk": 7}
{"article": "PMC4956742.txt", "subject": "GFAP+ve A\u03b2 plaque-localized astrocytes", "relationship": "RELATED_PROGNOSIS", "object": "Visualization of plaque-localized astrocyte number in vehicle control and ABX-treated male 6 month old APPSWE/PS1\u0394E9 mice", "chunk": 7}
{"article": "PMC4956742.txt", "subject": "plaque-localized GFAP+ve astrocyte number", "relationship": "RELATED_PROGNOSIS", "object": "Expressed relative to 3D6+ve A\u03b2 plaque area in vehicle control and ABX-treated male 6 month old APPSWE/PS1\u0394E9 mice", "chunk": 7}
{"article": "PMC4961391.txt", "subject": "p-Tau181", "relationship": "DIAGNOSTIC_OF", "object": "Early-onset AD", "chunk": 2}
{"article": "PMC4961391.txt", "subject": "Tau and p-Tau181", "relationship": "RELATED_PROGNOSIS", "object": "Diagnostic marker for early detection", "chunk": 2}
{"article": "PMC4961391.txt", "subject": "Tau and p-Tau181", "relationship": "RELATED_TREATMENT", "object": "Measurement of these proteins in serum", "chunk": 2}
{"article": "PMC4961391.txt", "subject": "Tau and p-Tau181", "relationship": "RELATED_TREATMENT", "object": "Validation experiments using western blot", "chunk": 2}
{"article": "PMC4961391.txt", "subject": "Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4961391.txt", "subject": "p-Tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4961391.txt", "subject": "Tau", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4961391.txt", "subject": "p-Tau181", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4961391.txt", "subject": "Tau", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4961391.txt", "subject": "p-Tau181", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4961391.txt", "subject": "Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 4}
{"article": "PMC4961391.txt", "subject": "Tau", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "High mortality rate", "chunk": 4}
{"article": "PMC4961391.txt", "subject": "Tau", "relationship": "RELATED_PROGNOSIS", "object": "Progression of AD", "chunk": 4}
{"article": "PMC4961391.txt", "subject": "p-Tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 4}
{"article": "PMC4961391.txt", "subject": "p-Tau181", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Faster progression of mild cognitive impairment to AD", "chunk": 4}
{"article": "PMC4961391.txt", "subject": "p-Tau181", "relationship": "RELATED_PROGNOSIS", "object": "Rapid cognitive decline in AD", "chunk": 4}
{"article": "PMC4961391.txt", "subject": "Tau", "relationship": "RELATED_TREATMENT", "object": "Blood based biomarkers", "chunk": 4}
{"article": "PMC4962090.txt", "subject": "glucose uptake", "relationship": "INDICATES_PRESENCE_OF", "object": "Solid tumors", "chunk": 1}
{"article": "PMC4962090.txt", "subject": "CEST imaging", "relationship": "DID_NOT_DETECT", "object": "glucose uptake", "chunk": 1}
{"article": "PMC4962090.txt", "subject": "glucoCEST signal enhancement", "relationship": "ASSOCIATED_WITH", "object": "Tumors having a higher rate than normal muscle", "chunk": 1}
{"article": "PMC4962090.txt", "subject": "Glucose uptake", "relationship": "INDICATES_PRESENCE_OF", "object": "Tumor", "chunk": 3}
{"article": "PMC4962090.txt", "subject": "CEST signal intensities", "relationship": "ASSOCIATED_WITH", "object": "Tumors having significantly higher CEST signal intensities", "chunk": 3}
{"article": "PMC4979550.txt", "subject": "insulin resistance", "relationship": "RELATED_TO", "object": "NEURODEGENERATION", "chunk": 1}
{"article": "PMC4979550.txt", "subject": "insulin deficiency", "relationship": "RELATED_TO", "object": "neurodegeneration", "chunk": 1}
{"article": "PMC4979550.txt", "subject": "T3D-959", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Potential disease modification in AD", "chunk": 1}
{"article": "PMC4979550.txt", "subject": "insulin", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Targeting neuro-metabolic dysfunction through T3D-959 agonism", "chunk": 1}
{"article": "PMC4979550.txt", "subject": "T3D-959", "relationship": "RELATED_TREATMENT", "object": "Preserving spatial learning and memory and preventing cellular and molecular indices of neurodegeneration in an established experimental model of sporadic AD", "chunk": 2}
{"article": "PMC4979550.txt", "subject": "T3D-959", "relationship": "RELATED_TREATMENT", "object": "Treating or reducing severity of neurodegeneration in structural targets of brain insulin resistance in AD.", "chunk": 2}
{"article": "PMC4979550.txt", "subject": "T3D-959", "relationship": "RELATED_TREATMENT", "object": "Preventing white matter atrophy in rats", "chunk": 2}
{"article": "PMC4979550.txt", "subject": "STZ", "relationship": "CAUSES", "object": "Amyloid-\u03b2 deposition", "chunk": 3}
{"article": "PMC4979550.txt", "subject": "STZ", "relationship": "CAUSES", "object": "pTau accumulation", "chunk": 3}
{"article": "PMC4979550.txt", "subject": "STZ", "relationship": "CAUSES", "object": "Cortical-limbic pathway degeneration", "chunk": 3}
{"article": "PMC4979550.txt", "subject": "STZ", "relationship": "CAUSES", "object": "Deficits in spatial learning and memory", "chunk": 3}
{"article": "PMC4979550.txt", "subject": "STZ", "relationship": "CAUSES", "object": "Neuro-inflammation", "chunk": 3}
{"article": "PMC4979550.txt", "subject": "STZ", "relationship": "CAUSES", "object": "Oxidative stress", "chunk": 3}
{"article": "PMC4979550.txt", "subject": "T3D-959", "relationship": "INCREASED", "object": "Molecular layer thickness", "chunk": 3}
{"article": "PMC4979550.txt", "subject": "T3D-959", "relationship": "REDUCES", "object": "Neuronal loss and necrosis in the Purkinje layer", "chunk": 3}
{"article": "PMC4979550.txt", "subject": "T3D-959", "relationship": "EXPANDED", "object": "White matter core thickness", "chunk": 3}
{"article": "PMC4979550.txt", "subject": "T3D-959", "relationship": "RESTORES", "object": "Granule cell layer thickness (cellularity and thickness uniformity)", "chunk": 3}
{"article": "PMC4979550.txt", "subject": "T3D-959", "relationship": "PREVENTED", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC4979550.txt", "subject": "T3D-959", "relationship": "PREVENTED", "object": "Neurodegeneration", "chunk": 3}
{"article": "PMC4983010.txt", "subject": "Vitamin E", "relationship": "RELATED_TREATMENT", "object": "Prevention of Alzheimer\u2019s Disease", "chunk": 2}
{"article": "PMC4983010.txt", "subject": "Selenium", "relationship": "RELATED_TREATMENT", "object": "Prevention of Alzheimer\u2019s Disease", "chunk": 2}
{"article": "PMC4983010.txt", "subject": "Memory Impairment Screen (MIS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Memory issues", "chunk": 3}
{"article": "PMC4983010.txt", "subject": "Memory Impairment Screen (MIS)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Medical work-up for treatable causes of memory loss", "chunk": 3}
{"article": "PMC4983010.txt", "subject": "Memory Impairment Screen (MIS)", "relationship": "RELATED_TREATMENT", "object": "Medical work-up", "chunk": 3}
{"article": "PMC4983010.txt", "subject": "Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD) battery", "relationship": "RELATED_PROGNOSIS", "object": "Cognition and memory problems", "chunk": 3}
{"article": "PMC4983010.txt", "subject": "CERAD", "relationship": "RELATED_TO", "object": "Consortium to establish a Registry for Alzheimer\u2019s Disease", "chunk": 7}
{"article": "PMC4983010.txt", "subject": "PREADVISE", "relationship": "RELATED_PROGNOSIS", "object": "Prevention of Alzheimer\u2019s Disease with Vitamin E and Selenium", "chunk": 7}
{"article": "PMC4983010.txt", "subject": "AD", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC4987494.txt", "subject": "high-density lipoprotein cholesterol", "relationship": "RELATED_PROGNOSIS", "object": "Statistically significant higher number of questions per day", "chunk": 1}
{"article": "PMC4987494.txt", "subject": "body mass index (BMI)", "relationship": "RELATED_PROGNOSIS", "object": "Statistically better performance in attaining their recommended daily goals", "chunk": 1}
{"article": "PMC4987494.txt", "subject": "stress", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Reported efforts were correlated with systolic blood pressure category changes", "chunk": 1}
{"article": "PMC4987494.txt", "subject": "BMI", "relationship": "RELATED_PROGNOSIS", "object": "Increased BMI is associated with a higher risk of late-life AD", "chunk": 2}
{"article": "PMC4987494.txt", "subject": "hypertension", "relationship": "RELATED_PROGNOSIS", "object": "Hypertension is linked with higher late-life AD risk", "chunk": 2}
{"article": "PMC4987494.txt", "subject": "serum cholesterol levels", "relationship": "RELATED_PROGNOSIS", "object": "Elevated serum cholesterol levels are associated with a greater risk of late-life AD", "chunk": 2}
{"article": "PMC4987494.txt", "subject": "physical activity during leisure time", "relationship": "RELATED_PROGNOSIS", "object": "Lack of physical activity during leisure time is linked to a higher risk of late-life AD", "chunk": 2}
{"article": "PMC4987494.txt", "subject": "Alzheimer's", "relationship": "RELATED_TREATMENT", "object": "risk and prevention strategies", "chunk": 4}
{"article": "PMC4987494.txt", "subject": "Alzheimer's", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "cognitive decline", "chunk": 4}
{"article": "PMC4987494.txt", "subject": "BMI", "relationship": "RELATED_TREATMENT", "object": "reduction in BMI and blood pressure observed in those who used the app more than 7 times per week", "chunk": 8}
{"article": "PMC4987494.txt", "subject": "Systolic blood pressure (SBP)", "relationship": "RELATED_TREATMENT", "object": "reduction in BMI and blood pressure observed in those who used the app more than 7 times per week", "chunk": 8}
{"article": "PMC4987494.txt", "subject": "Blood carotenoids", "relationship": "RELATED_PROGNOSIS", "object": "weak negative relationship between daily log completion and blood carotenoids", "chunk": 8}
{"article": "PMC4987494.txt", "subject": "Resting heart rate", "relationship": "RELATED_PROGNOSIS", "object": "weak negative relationship between daily log completion and resting heart rate", "chunk": 8}
{"article": "PMC4987494.txt", "subject": "Total cholesterol", "relationship": "RELATED_PROGNOSIS", "object": "positive correlation found between average questions per day and total cholesterol levels", "chunk": 8}
{"article": "PMC4987494.txt", "subject": "Triglycerides", "relationship": "RELATED_PROGNOSIS", "object": "weak positive correlation found between the number of logs completed and triglycerides", "chunk": 8}
{"article": "PMC4987494.txt", "subject": "Serum glucose", "relationship": "RELATED_PROGNOSIS", "object": "weak negative correlation found between the number of logs completed and serum glucose levels", "chunk": 8}
{"article": "PMC4987494.txt", "subject": "Insulin levels", "relationship": "RELATED_PROGNOSIS", "object": "negative weak correlation found between the number of logs completed and blood insulin levels", "chunk": 8}
{"article": "PMC4987494.txt", "subject": "High-density lipoprotein (HDL) cholesterol levels", "relationship": "INDICATES_PRESENCE_OF", "object": "Participants who improved their HDL cholesterol levels answered a statistically significant higher number of questions per day", "chunk": 8}
{"article": "PMC4987494.txt", "subject": "BMI", "relationship": "RELATED_PROGNOSIS", "object": "Negative Correlation: % of recommended goals achieved", "chunk": 9}
{"article": "PMC4987494.txt", "subject": "BMI", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increase in BMI", "chunk": 9}
{"article": "PMC4987494.txt", "subject": "BMI", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "BMI Reduction", "chunk": 9}
{"article": "PMC4987494.txt", "subject": "HDL cholesterol", "relationship": "MONITORED_DURING_TREATMENT", "object": "Changes in HDL Cholesterol during intervention", "chunk": 9}
{"article": "PMC4987494.txt", "subject": "NikeFuel points", "relationship": "RELATED_TO_TREATMENT", "object": "Higher NikeFuel points are linked to improved HDL cholesterol levels", "chunk": 9}
{"article": "PMC4987494.txt", "subject": "Stress Reduction Efforts", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Participant's stress reduction effort rating can influence the SBP category change", "chunk": 9}
{"article": "PMC4987494.txt", "subject": "BMI", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Desirable lowering of BMI observed", "chunk": 10}
{"article": "PMC4987494.txt", "subject": "HDL and low-density lipoprotein cholesterol levels", "relationship": "RELATED_TREATMENT", "object": "Improvements observed", "chunk": 10}
{"article": "PMC4987494.txt", "subject": "SBP", "relationship": "RELATED_TREATMENT", "object": "Lowering of SBP observed", "chunk": 10}
{"article": "PMC4987494.txt", "subject": "resting heart rate", "relationship": "RELATED_TREATMENT", "object": "Lowering of resting heart rate observed", "chunk": 10}
{"article": "PMC4987494.txt", "subject": "perceived stress levels", "relationship": "RELATED_TREATMENT", "object": "Improvements observed", "chunk": 10}
{"article": "PMC4991069.txt", "subject": "IL-1\u03b2", "relationship": "RELATED_TO_TREATMENT", "object": "reduced levels in saliva", "chunk": 1}
{"article": "PMC4991069.txt", "subject": "IL-8", "relationship": "RELATED_TO_TREATMENT", "object": "reduced levels in saliva", "chunk": 1}
{"article": "PMC4991069.txt", "subject": "MCP-1", "relationship": "RELATED_TO_TREATMENT", "object": "reduced levels in saliva", "chunk": 1}
{"article": "PMC4991069.txt", "subject": "pro-inflammatory biomarkers", "relationship": "RELATED_PROGNOSIS", "object": "implicated in several diseases", "chunk": 1}
{"article": "PMC4991069.txt", "subject": "IL-1\u03b2", "relationship": "RELATED_TO_TREATMENT", "object": "lowered levels in YB group", "chunk": 2}
{"article": "PMC4991069.txt", "subject": "IL-1\u03b2", "relationship": "RELATED_TO_TREATMENT", "object": "reduced levels even after a brief practice/learning period", "chunk": 2}
{"article": "PMC4991069.txt", "subject": "IL-8", "relationship": "RELATED_TO_TREATMENT", "object": "showed significant differences between groups and changed significantly over time", "chunk": 2}
{"article": "PMC4991069.txt", "subject": "MCP-1", "relationship": "RELATED_TO_TREATMENT", "object": "showed significant differences between groups and changed significantly over time", "chunk": 2}
{"article": "PMC4991069.txt", "subject": "IL-1\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "stress and inflammation in various diseases, including Alzheimer's disease", "chunk": 3}
{"article": "PMC4991069.txt", "subject": "IL-1\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "higher levels are deleterious as shown in several diseases including cancer", "chunk": 3}
{"article": "PMC4991069.txt", "subject": "IL-1\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Canakinumab for treating autoinflammatory syndromes", "chunk": 3}
{"article": "PMC4991069.txt", "subject": "IL-8", "relationship": "INDICATES_PRESENCE_OF", "object": "inflammatory processes during various stress conditions involving oxidative stress", "chunk": 3}
{"article": "PMC4991069.txt", "subject": "IL-8", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "poor prognosis of breast cancer and in psychosomatic disorders", "chunk": 3}
{"article": "PMC4991069.txt", "subject": "MCP-1", "relationship": "INDICATES_PRESENCE_OF", "object": "inflammatory processes, along with IL-1\u03b2 and IL-8", "chunk": 3}
{"article": "PMC4991069.txt", "subject": "IL-1\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "higher levels are deleterious", "chunk": 3}
{"article": "PMC4991069.txt", "subject": "IL-8", "relationship": "RELATED_PROGNOSIS", "object": "assocated with poor prognosis of breast cancer and in psychosomatic disorders", "chunk": 3}
{"article": "PMC4991069.txt", "subject": "MCP-1", "relationship": "RELATED_PROGNOSIS", "object": "change in salivary expression of MCP-1 is significant in response to YB practice", "chunk": 3}
{"article": "PMC4991069.txt", "subject": "MCP-1", "relationship": "INDICATES_PRESENCE_OF", "object": "chronic pathological conditions", "chunk": 4}
{"article": "PMC4991069.txt", "subject": "MCP-1", "relationship": "RELATED_PROGNOSIS", "object": "severity of pathogenesis including Alzheimer\u2019s disease", "chunk": 4}
{"article": "PMC4991069.txt", "subject": "MCP-1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "severity of pathogenesis including Alzheimer\u2019s disease", "chunk": 4}
{"article": "PMC4991069.txt", "subject": "MCP-1", "relationship": "DIAGNOSTIC_OF", "object": "coronarys heart disease and post-traumatic stress disorder (PTSD)", "chunk": 4}
{"article": "PMC4991069.txt", "subject": "IL-1\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Monitoring salivary levels over time during Yogic Breathing practice", "chunk": 5}
{"article": "PMC4991069.txt", "subject": "IL-8", "relationship": "MONITORED_DURING_TREATMENT", "object": "Monitoring salivary levels over time during Yogic Breathing practice", "chunk": 5}
{"article": "PMC4991069.txt", "subject": "MCP-1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Monitoring salivary levels over time during Yogic Breathing practice", "chunk": 5}
{"article": "PMC4992501.txt", "subject": "Alzheimer\u2019s disease", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Home care needs will increase for those with complex cognitive and/or physical impairments, such as Alzheimer\u2019s disease, or at end of life", "chunk": 4}
{"article": "PMC546007.txt", "subject": "APOE-\u03b54", "relationship": "RELATED_TO_RISK", "object": "Alzheimer's Disease risk", "chunk": 1}
{"article": "PMC546007.txt", "subject": "APOE-\u03b54 carrier", "relationship": "RELATED_PROGNOSIS", "object": "Increased risk of developing AD", "chunk": 2}
{"article": "PMC546007.txt", "subject": "APOE-\u03b54 carrier", "relationship": "INDICATES_PRESENCE_OF", "object": "Higher likelihood of being diagnosed with AD", "chunk": 2}
{"article": "PMC546007.txt", "subject": "NSAIDs use", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Reduced risk of AD", "chunk": 2}
{"article": "PMC546007.txt", "subject": "NSAIDs use", "relationship": "RELATED_TO_TREATMENT", "object": "Potential preventive strategy for AD", "chunk": 2}
{"article": "PMC546007.txt", "subject": "APOE-\u03b54 carrier", "relationship": "INDICATES_PRESENCE_OF", "object": "Greater benefit from NSAID use as a potential preventive strategy for AD", "chunk": 2}
{"article": "PMC546007.txt", "subject": "APOE-\u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased vulnerability to AD", "chunk": 3}
{"article": "PMC546007.txt", "subject": "APOE-\u03b54", "relationship": "RELATED_RISK", "object": "AD risk", "chunk": 3}
{"article": "PMC546007.txt", "subject": "APOE-\u03b54", "relationship": "RELATED_TREATMENT", "object": "Modification of NSAID use effect", "chunk": 3}
{"article": "PMC546007.txt", "subject": "APOE-\u03b54", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Determining effectiveness of NSAIDs", "chunk": 3}
{"article": "PMC8000213.txt", "subject": "BP", "relationship": "RELATED_TO", "object": "hypertension intervention, including MBSR effects", "chunk": 2}
{"article": "PMC8000213.txt", "subject": "SBP", "relationship": "RELATED_TREATMENT", "object": "Reduced by MBSR in a clinical trial.", "chunk": 7}
{"article": "PMC8000213.txt", "subject": "DBP", "relationship": "RELATED_TREATMENT", "object": "Reduced by MBSR in a clinical trial.", "chunk": 7}
{"article": "PMC8000213.txt", "subject": "Systolic BP", "relationship": "RELATED_TREATMENT", "object": "Lowered by MBSR compared to social support control in a clinical trial.", "chunk": 7}
{"article": "PMC8000213.txt", "subject": "Diastolic BP", "relationship": "RELATED_TREATMENT", "object": "Lowered by MBSR compared to social support control in a clinical trial.", "chunk": 7}
{"article": "PMC8005243.txt", "subject": "A\u03b2 deposition", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC8005243.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_PROGNOSIS", "object": "Progression to AD dementia", "chunk": 1}
{"article": "PMC8005243.txt", "subject": "A\u03b2 accumulation", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Progression to AD dementia", "chunk": 1}
{"article": "PMC8005243.txt", "subject": "18F-florbetaben PET", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "To evaluate A\u03b2 accumulation and progression in Alzheimer's Disease ", "chunk": 2}
{"article": "PMC8005243.txt", "subject": "18F-florbetaben PET", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "To determine treatment eligibility for anti-A\u03b2 therapies", "chunk": 2}
{"article": "PMC8005243.txt", "subject": "18F-florbetaben PET SUVR abnormality", "relationship": "DIAGNOSITC_OF", "object": "A\u03b2 accumulation and established A\u03b2 pathology", "chunk": 2}
{"article": "PMC8005243.txt", "subject": "18F-florbetaben PET SUVR abnormality cutoffs", "relationship": "RELATED_PROGNOSIS", "object": "Predicting A\u03b2 accumulation and progression", "chunk": 2}
{"article": "PMC8005243.txt", "subject": "A\u03b2 amyloid-beta", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "To determine the effectiveness of drug treatments.", "chunk": 3}
{"article": "PMC8005243.txt", "subject": "SUVRearly", "relationship": "DIAGNOSTIC_OF", "object": "Early amyloid deposition", "chunk": 4}
{"article": "PMC8005243.txt", "subject": "SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Progression of A\u03b2 accumulation", "chunk": 4}
{"article": "PMC8005243.txt", "subject": "SUVRearly", "relationship": "INDICATES_PRESENCE_OF", "object": "Early A\u03b2 deposition", "chunk": 4}
{"article": "PMC8005243.txt", "subject": "SUVRestab", "relationship": "INDICATES_PRESENCE_OF", "object": "Established A\u03b2 pathology", "chunk": 4}
{"article": "PMC8005243.txt", "subject": "\u0394SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Progression on the AD continuum", "chunk": 4}
{"article": "PMC8005243.txt", "subject": "SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Progression of A\u03b2 accumulation", "chunk": 4}
{"article": "PMC8005243.txt", "subject": "SUVR (half-maximal carrying capacity)", "relationship": "RELATED_PROGNOSIS", "object": "Time of earliest amyloid signal", "chunk": 4}
{"article": "PMC8005243.txt", "subject": "A\u03b2dep", "relationship": "RELATED_PROGNOSIS", "object": "A\u03b2 accumulated based on annual amount", "chunk": 4}
{"article": "PMC8005243.txt", "subject": "A\u03b2-negative subjects", "relationship": "INDICATES_PRESENCE_OF", "object": "Not having accumulated A\u03b2", "chunk": 4}
{"article": "PMC8005243.txt", "subject": "A\u03b2-positive subjects", "relationship": "INDICATES_PRESENCE_OF", "object": "Having accumulated A\u03b2", "chunk": 4}
{"article": "PMC8005243.txt", "subject": "Subjects in the 'gray zone'", "relationship": "INDICATES_PRESENCE_OF", "object": "Initial stages of A\u03b2 accumulation", "chunk": 4}
{"article": "PMC8005243.txt", "subject": "SUVR", "relationship": "INDICATES_PRESENCE_OF", "object": "Early A\u03b2 (amyloid-beta) pathology", "chunk": 5}
{"article": "PMC8005243.txt", "subject": "SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Rate of amyloid accumulation", "chunk": 5}
{"article": "PMC8005243.txt", "subject": "SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Progression of A\u03b2 deposition", "chunk": 5}
{"article": "PMC8005243.txt", "subject": "CL", "relationship": "INDICATES_PRESENCE_OF", "object": "Established A\u03b2 pathology", "chunk": 5}
{"article": "PMC8005243.txt", "subject": "CL", "relationship": "RELATED_PROGNOSIS", "object": "Rate of amyloid accumulation", "chunk": 5}
{"article": "PMC8005243.txt", "subject": "SUVR (t=T50)", "relationship": "USED_TO_DIAGNOSE", "object": "Earliest amyloid accumulation (when compared against the \u0394SUVR)", "chunk": 5}
{"article": "PMC8005243.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_PROGNOSIS", "object": "Progression to AD dementia", "chunk": 6}
{"article": "PMC8005243.txt", "subject": "SUVR in the \u201cgray zone\u201d or with established A\u03b2 deposition", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased rate of amyloid accumulation", "chunk": 6}
{"article": "PMC8005243.txt", "subject": "A\u03b2-negative subjects", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "No accumulation of amyloid", "chunk": 6}
{"article": "PMC8005243.txt", "subject": "SUVR above SUVRestab", "relationship": "PREDICTS_SURVIVAL", "object": "Progression to AD dementia after 4 years", "chunk": 6}
{"article": "PMC8005243.txt", "subject": "Established A\u03b2 pathology", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Progression to AD dementia", "chunk": 6}
{"article": "PMC8005243.txt", "subject": "Amyloid load (18F-florbetaben)", "relationship": "RELATED_TO", "object": "Tau deposition ([18F] flortaucipir)", "chunk": 6}
{"article": "PMC8005243.txt", "subject": "A\u03b2-negative subjects And subjects in the gray zone", "relationship": "INDICATES_PRESENCE_OF", "object": "Rarely observed tau deposition", "chunk": 6}
{"article": "PMC8005243.txt", "subject": "18F-flortaucipir SUVR", "relationship": "INDICATES_PRESENCE_OF", "object": "Early A\u03b2 pathology", "chunk": 7}
{"article": "PMC8005243.txt", "subject": "18F-flortaucipir SUVRs", "relationship": "RELATED_PROGNOSIS", "object": "Early amyloid accumulation", "chunk": 7}
{"article": "PMC8005243.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH", "object": "Pre-AD dementia levels of A\u03b2 burden", "chunk": 7}
{"article": "PMC8005243.txt", "subject": "A\u03b2 load", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline", "chunk": 8}
{"article": "PMC8019776.txt", "subject": "Self-Compassion Scale (SCS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Levels of self-compassion", "chunk": 6}
{"article": "PMC8019776.txt", "subject": "Mindfulness (SCS subscale)", "relationship": "RELATED_TO", "object": "Overall well-being", "chunk": 6}
{"article": "PMC8019776.txt", "subject": "Self-compassion", "relationship": "RELATED_TREATMENT", "object": "The Serene group reported significantly greater improvements in self-compassion than the waitlist control group", "chunk": 7}
{"article": "PMC8019776.txt", "subject": "Self-compassion", "relationship": "RELATED_TREATMENT", "object": "intervention", "chunk": 7}
{"article": "PMC8028241.txt", "subject": "Glucose metabolism in the right middle temporal gyrus", "relationship": "INDICATES_PRESENCE_OF", "object": "Subjective cognitive decline (SCD)", "chunk": 1}
{"article": "PMC8028241.txt", "subject": "Glucose metabolism in the right middle temporal gyrus", "relationship": "RELATED_PROGNOSIS", "object": "Patient cognitive decline along the continuum: SCD to AD", "chunk": 1}
{"article": "PMC8028241.txt", "subject": "Amyloid deposition", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Correlated with lower glucose metabolism in the right middle temporal gyrus", "chunk": 1}
{"article": "PMC8028241.txt", "subject": "Glucose metabolism", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 2}
{"article": "PMC8028241.txt", "subject": "[18F]fluoro-2-deoxyglucose (FDG)", "relationship": "RELATED_TO", "object": "Positron emission tomography (PET) imaging technique", "chunk": 2}
{"article": "PMC8028241.txt", "subject": "Hypometabolism", "relationship": "CHARACTERIZED_BY", "object": "PET imaging in several brain regions", "chunk": 2}
{"article": "PMC8028241.txt", "subject": "Posterior cingulate cortex (PCC)", "relationship": "ASSOCIATED_WITH", "object": "Glucose metabolic hypometabolism - specifically in SCD", "chunk": 2}
{"article": "PMC8028241.txt", "subject": "Phosphorylated tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Targeting amyloid plaques", "chunk": 2}
{"article": "PMC8028241.txt", "subject": "RMTG blood glucose", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "RMTG is the only brain area that had significant differences in each subset of the 10 repeated two-fold cross-validations", "chunk": 4}
{"article": "PMC8028241.txt", "subject": "RMTG", "relationship": "DIAGNOSITC_OF", "object": "SCD", "chunk": 4}
{"article": "PMC8028241.txt", "subject": "RMTG", "relationship": "DIAGNOSITC_OF", "object": "SCD (subjective cognitive decline)", "chunk": 5}
{"article": "PMC8028241.txt", "subject": "RMTG", "relationship": "INDICATES_PRESENCE_OF", "object": "SCD (subjective cognitive decline)", "chunk": 5}
{"article": "PMC8028241.txt", "subject": "RMTG", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Decline", "chunk": 5}
{"article": "PMC8028241.txt", "subject": "RMTG", "relationship": "RELATED_PROGNOSIS", "object": "Deterioration of cognition", "chunk": 5}
{"article": "PMC8028241.txt", "subject": "RMTG", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive continuum", "chunk": 5}
{"article": "PMC8028241.txt", "subject": "RMTG metabolism", "relationship": "DIAGNOSITC_OF", "object": "Subjective Cognitive Decline (SCD)", "chunk": 6}
{"article": "PMC8028241.txt", "subject": "RMTG metabolism", "relationship": "INDICATES_PRESENCE_OF", "object": "Limited changes in the brain metabolism", "chunk": 6}
{"article": "PMC8028241.txt", "subject": "RMTG metabolism", "relationship": "RELATED_PROGNOSIS", "object": "Deterioration of cognition", "chunk": 6}
{"article": "PMC8028241.txt", "subject": "RMTG metabolism", "relationship": "ASSSOCIATED_WITH_POOR_OUTCOME", "object": "Decreased metabolic levels", "chunk": 6}
{"article": "PMC8028241.txt", "subject": "RMTG metabolism", "relationship": "DIAGNOSITC_OF", "object": "SCD", "chunk": 7}
{"article": "PMC8028241.txt", "subject": "RMTG metabolism", "relationship": "INDICATES_PRESENCE_OF", "object": "SCD", "chunk": 7}
{"article": "PMC8028241.txt", "subject": "RMTG metabolism", "relationship": "RELATED_PROGNOSIS", "object": "Future deterioration of cognitive function", "chunk": 7}
{"article": "PMC8028241.txt", "subject": "RMTG metabolism", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive deterioration", "chunk": 7}
{"article": "PMC8028241.txt", "subject": "RMTG metabolism", "relationship": "RELATED_TREATMENT", "object": "Identifying suitable treatment for SCD", "chunk": 7}
{"article": "PMC8028241.txt", "subject": "RMTG metabolism", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Specifying the type of treatment based on the RMTG metabolism levels", "chunk": 7}
{"article": "PMC8028241.txt", "subject": "RMTG metabolism", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Individualized therapy for SCD patients", "chunk": 7}
{"article": "PMC8028241.txt", "subject": "RMTG metabolism", "relationship": "MONITORED_DURING_TREATMENT", "object": "SCD treatment", "chunk": 7}
{"article": "PMC8028241.txt", "subject": "RMTG metabolism", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Treatment response for SCD", "chunk": 7}
{"article": "PMC8028241.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "ROI-based brain regions of interest with significant differences between Subjective Cognitive Decline (SCD) and Normal control (NC)", "chunk": 8}
{"article": "PMC8028241.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "AUCs of the ROC curves", "chunk": 8}
{"article": "PMC8028241.txt", "subject": "APOE", "relationship": "RELATED_PROGNOSIS", "object": "ROI-based brain regions of interest with significant differences between Subjective Cognitive Decline (SCD) and Normal control (NC)", "chunk": 8}
{"article": "PMC8028241.txt", "subject": "APOE", "relationship": "RELATED_PROGNOSIS", "object": "AUCs of the ROC curves", "chunk": 8}
{"article": "PMC8028783.txt", "subject": "anosognosia", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC8028783.txt", "subject": "MMSE", "relationship": "RELATED_TO", "object": "Caregiver's awareness", "chunk": 4}
{"article": "PMC8028783.txt", "subject": "CDR", "relationship": "RELATED_PROGNOSIS", "object": "High CDR scores (CDR \u22652) are associated with low patient awareness.", "chunk": 5}
{"article": "PMC8028783.txt", "subject": "CDR", "relationship": "RELATED_PROGNOSIS", "object": "Caregivers\u2019 awareness was high if the patient\u2019s CDR global was greater than 2.", "chunk": 5}
{"article": "PMC8028783.txt", "subject": "CAS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Factors associated with a high CAS score include caregiver age, education level, employment status , relationship to patient, and cohabitation status and may help guide treatment selection.", "chunk": 5}
{"article": "PMC8028783.txt", "subject": "ZBI", "relationship": "RELATED_TREATMENT_SELECTION", "object": "A high ZBI score may indicate the need for treatments or support to assist with the caregiver's well-being.", "chunk": 5}
{"article": "PMC8028783.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "Used to assess cognitive function; low MMSE scores, indicate dementia.", "chunk": 5}
{"article": "PMC8028783.txt", "subject": "CDR", "relationship": "INDICATES_PRESENCE_OF", "object": "High CDR scores are an indicator of dementia severity.", "chunk": 5}
{"article": "PMC8028783.txt", "subject": "ZBI", "relationship": "INDICATES_PRESENCE_OF", "object": "A high ZBI score suggests a greater level of caregiver burden.", "chunk": 5}
{"article": "PMC8028783.txt", "subject": "CAS", "relationship": "INDICATES_PRESENCE_OF", "object": "A high CAS score suggests increased caregiving activity.", "chunk": 5}
{"article": "PMC8028783.txt", "subject": "MMSE", "relationship": "INDIATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 6}
{"article": "PMC8043748.txt", "subject": "amyloid-\u03b2 (A\u03b2)", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC8043748.txt", "subject": "gut microbiome", "relationship": "RELATED_TO", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC8043748.txt", "subject": "microbiome-derived short chain fatty acids (SCFA)", "relationship": "ASSOCIATED_WITH", "object": "reduced A\u03b2 pathology", "chunk": 1}
{"article": "PMC8043748.txt", "subject": "microbiome-derived short chain fatty acids (SCFA)", "relationship": "ASSOCIATED_WITH", "object": "increased A\u03b2 deposition", "chunk": 1}
{"article": "PMC8043748.txt", "subject": "germ-free(GF) animals", "relationship": "INDICATES_PRESENCE_OF", "object": "reduced A\u03b2 pathology", "chunk": 1}
{"article": "PMC8043748.txt", "subject": "A\u03b2 plaque", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 2}
{"article": "PMC8043748.txt", "subject": "SCFA", "relationship": "RELATED_PROGNOSIS", "object": "A\u03b2 pathology", "chunk": 2}
{"article": "PMC8043748.txt", "subject": "SCFA", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "A\u03b2 pathology", "chunk": 2}
{"article": "PMC8043748.txt", "subject": "SCFA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatments targeting A\u03b2 plaque deposition", "chunk": 2}
{"article": "PMC8043748.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased A\u03b2 plaque load upon SCFA administration", "chunk": 3}
{"article": "PMC8043748.txt", "subject": "A\u03b2 level", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Significantly increased in SCFA group", "chunk": 3}
{"article": "PMC8043748.txt", "subject": "A\u03b2", "relationship": "RELATED_TO", "object": "A\u03b2 deposition and clearance", "chunk": 3}
{"article": "PMC8043748.txt", "subject": "SCFA", "relationship": "RELATED_PROGNOSIS", "object": "Mildly increase amyloidogenic processing", "chunk": 3}
{"article": "PMC8043748.txt", "subject": "SCFA", "relationship": "RELATED_PROGNOSIS", "object": "Triggered alterations in A\u03b2 deposition and clearance", "chunk": 3}
{"article": "PMC8043748.txt", "subject": "A\u03b2 aggregation", "relationship": "ASSOCIATED_WITH_SCFA", "object": "Not directly modified by SCFA", "chunk": 3}
{"article": "PMC8043748.txt", "subject": "Microglia", "relationship": "RELATED_TO", "object": "A\u03b2 pathology ", "chunk": 3}
{"article": "PMC8043748.txt", "subject": "SCFA-supplemented GF APPPS1 mice", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased microglial activation", "chunk": 3}
{"article": "PMC8043748.txt", "subject": "Microglial phenotypes", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Circularity index (CI), indicating a more amoeboid shape", "chunk": 3}
{"article": "PMC8043748.txt", "subject": "Trem2 mRNA", "relationship": "MONITORED_DURING_TREATMENT", "object": "To assess microglial activation in SPF mice", "chunk": 3}
{"article": "PMC8043748.txt", "subject": "Trem2", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial activation", "chunk": 4}
{"article": "PMC8043748.txt", "subject": "ApoE", "relationship": "RELATED_TREATMENT", "object": "A biological pathway that was affected by SCFA", "chunk": 4}
{"article": "PMC8043748.txt", "subject": "ApoE", "relationship": "IS_TARGET_OF_TREATMENT", "object": "SCFA treatment", "chunk": 4}
{"article": "PMC8043748.txt", "subject": "ApoE", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Up regulation of ApoE", "chunk": 4}
{"article": "PMC8043748.txt", "subject": "Myd88", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial activation", "chunk": 4}
{"article": "PMC8043748.txt", "subject": "Tyrobp", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial activation", "chunk": 4}
{"article": "PMC8043748.txt", "subject": "Tlr7", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial activation", "chunk": 4}
{"article": "PMC8043748.txt", "subject": "ApoE-TREM2 pathway", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Up regulation by SCFA", "chunk": 4}
{"article": "PMC8043748.txt", "subject": "SCFA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "ApoE expression level used to assess its impact", "chunk": 4}
{"article": "PMC8043748.txt", "subject": "ApoE", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 plaque deposition in the brain", "chunk": 5}
{"article": "PMC8043748.txt", "subject": "SCFA", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Accelerated A\u03b2 deposition", "chunk": 5}
{"article": "PMC8043748.txt", "subject": "A\u03b240", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "In vitro amyloid aggregation assay", "chunk": 8}
{"article": "PMC8043748.txt", "subject": "Methoxy-X04", "relationship": "RELATED_TREATMENT", "object": "Histological analysis (using", "chunk": 8}
{"article": "PMC8043748.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid plaques", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "A\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Study of SCFA effects on amyloid aggregation", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "Treatment with SCFA mixture", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "Control treatment with saline solution", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "A\u03b2", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose amyloid disease", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Aggregation patterns potentially influence disease progression", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "3552", "relationship": "USED_TO_DIAGNOSE", "object": "Identify \u03b2-amyloid plaques", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "3552", "relationship": "INDICATES_PRESENCE_OF", "object": "\u03b2-amyloid pathology", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "APOE", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Determine appropriate therapeutic strategies", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "C83", "relationship": "RELATED_PROGNOSIS", "object": "Potential marker for Alzheimer's pathogenesis", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "C99", "relationship": "RELATED_PROGNOSIS", "object": "Potential marker for Alzheimer's pathogenesis", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "CD68", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial activation in response to A\u03b2", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "Iba1", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial cells", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "Iba1", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target for therapeutic intervention aiming to modulate microglial activity", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "P2Y12", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Selection of therapies for various neurological conditions", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "ApoE", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk for Alzheimer's disease", "chunk": 9}
{"article": "PMC8043748.txt", "subject": "SCFAs", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased A\u03b2 plaque load", "chunk": 12}
{"article": "PMC8043748.txt", "subject": "SCFAs", "relationship": "RELATED_PROGNOSIS", "object": "AD progression", "chunk": 12}
{"article": "PMC8043748.txt", "subject": "SCFAs", "relationship": "RELATED_TREATMENT", "object": "Treatment with SCFA in drinking water", "chunk": 12}
{"article": "PMC8043748.txt", "subject": "SCFAs", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Understanding  of the effect of SCFAs on microglia", "chunk": 12}
{"article": "PMC8043748.txt", "subject": "ApoE", "relationship": "RELATED_TREATMENT", "object": "Up regulation of ApoE", "chunk": 12}
{"article": "PMC8043748.txt", "subject": "Microglia", "relationship": "RELATED_TREATMENT", "object": "Activation of microglia", "chunk": 12}
{"article": "PMC8043748.txt", "subject": "SCFA treated microglia", "relationship": "MONITORED_DURING_TREATMENT", "object": "mRNA transcription of  Casp1, Fcrls, Gadd45, Il6ra, and others", "chunk": 12}
{"article": "PMC8043748.txt", "subject": "SCFA treated microglia", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Modulation of the NF-\u03baB pathway and NF-\u03baB-regulated secretory functions of microglia", "chunk": 12}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "DIAGNOSITC_OF", "object": "Incipient Alzheimer\u2019s disease pathology", "chunk": 1}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease (AD) pathophysiology", "chunk": 1}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "RELATED_PROGNOSIS", "object": "Clinical\u00a0stages of AD\u00a0and neuropathology", "chunk": 1}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "PREDICT_SUPERVIVAL", "object": "AD pathology", "chunk": 1}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Clinical trials to identify vulnerable populations", "chunk": 1}
{"article": "PMC8043944.txt", "subject": "amyloid-\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 3}
{"article": "PMC8043944.txt", "subject": "tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 3}
{"article": "PMC8043944.txt", "subject": "p-tau181", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's disease", "chunk": 3}
{"article": "PMC8043944.txt", "subject": "total tau", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's disease", "chunk": 3}
{"article": "PMC8043944.txt", "subject": "p-tau217", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's disease", "chunk": 3}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's disease", "chunk": 3}
{"article": "PMC8043944.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's disease", "chunk": 3}
{"article": "PMC8043944.txt", "subject": "CDR score \u2265 0.5", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's disease", "chunk": 3}
{"article": "PMC8043944.txt", "subject": "p-tau blood measurements", "relationship": "MONITORED_DURING_TREATMENT", "object": "Alzheimer's disease", "chunk": 3}
{"article": "PMC8043944.txt", "subject": "A\u03b2 PET negative", "relationship": "EXCLUDED_FROM", "object": "Alzheimer's disease diagnosis", "chunk": 3}
{"article": "PMC8043944.txt", "subject": "Braak staging for Neurofibrillary tangles", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's disease", "chunk": 3}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "RELATED_PROGNOSIS", "object": "Longitudinal changes in MMSE score", "chunk": 4}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "RELATED_PROGNOSIS", "object": "Hippocampal volume", "chunk": 4}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "A\u03b2 PET load", "chunk": 4}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "RELATED_TREATMENT", "object": "Treatment decisions", "chunk": 4}
{"article": "PMC8043944.txt", "subject": "tau PET SUVR", "relationship": "DIAGNOSITC_OF", "object": "Braak stages of Neurofibrillary tangles pathology", "chunk": 4}
{"article": "PMC8043944.txt", "subject": "A\u03b2 PET SUVR", "relationship": "DIAGNOSITC_OF", "object": "A\u03b2-positive", "chunk": 4}
{"article": "PMC8043944.txt", "subject": "A\u03b2 PET", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment for Alzheimer's Disease", "chunk": 4}
{"article": "PMC8043944.txt", "subject": "plasma p-tau231 concentration", "relationship": "INDICATES_PRESENCE_OF", "object": "AD dementia", "chunk": 5}
{"article": "PMC8043944.txt", "subject": "plasma p-tau231 concentration", "relationship": "RELATED_TO_DIAGNOSIS", "object": "AD dementia", "chunk": 5}
{"article": "PMC8043944.txt", "subject": "plasma p-tau231 concentration", "relationship": "RELATED_PROGNOSIS", "object": "Preclinical phase of the disease", "chunk": 5}
{"article": "PMC8043944.txt", "subject": "plasma p-tau231 concentration", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Mild cognitive impairment  A\u03b2-positive", "chunk": 5}
{"article": "PMC8043944.txt", "subject": "plasma p-tau231 concentration", "relationship": "correlated_WITH", "object": "plasma p-tau181", "chunk": 5}
{"article": "PMC8043944.txt", "subject": "plasma p-tau231 concentration", "relationship": "correlated_WITH", "object": "plasma NfL", "chunk": 5}
{"article": "PMC8043944.txt", "subject": "plasma p-tau231 concentration", "relationship": "PREDICTS_SURVIVAL", "object": "Higher accuracy in  discriminating between AD dementia and non-AD neurodegenerative", "chunk": 5}
{"article": "PMC8043944.txt", "subject": "APOE \u03b54", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Early-onset Alzheimer's Disease", "chunk": 5}
{"article": "PMC8043944.txt", "subject": "Braak score", "relationship": "RELATED_TO_DIAGNOSIS", "object": "AD", "chunk": 5}
{"article": "PMC8043944.txt", "subject": "A\u03b2- status", "relationship": "RELATED_TO_DIAGNOSIS", "object": "AD", "chunk": 5}
{"article": "PMC8043944.txt", "subject": "Plasma p\u2212 tau231", "relationship": "INDICATES_PRESENCE_OF", "object": "Hippocampal volume decrease", "chunk": 7}
{"article": "PMC8043944.txt", "subject": "Plasma p\u2212 tau231", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline (MMSE worsening)", "chunk": 7}
{"article": "PMC8043944.txt", "subject": "Plasma p\u2212 tau231 ", "relationship": "DIAGNOSTIC_OF", "object": "AD (Alzheimer's Disease)", "chunk": 7}
{"article": "PMC8043944.txt", "subject": "Plasma p\u2212 tau231", "relationship": "RELATED_PROGNOSIS", "object": "Early tau deposition", "chunk": 7}
{"article": "PMC8043944.txt", "subject": "Plasma p\u2212 tau231", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Identifying A\u03b2 positivity", "chunk": 7}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "DIAGNOSITC_OF", "object": "AD in a primary care setting", "chunk": 9}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 9}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "RELATED_PROGNOSIS", "object": "emerging AD pathology", "chunk": 9}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "LEVELS_REFLECT_RESPONSE", "object": " A\u03b2 deposition", "chunk": 9}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "clinical trials targeting vulnerable populations", "chunk": 9}
{"article": "PMC8043944.txt", "subject": "p-tau231", "relationship": "MONITORED_DURING_TREATMENT", "object": " treatment", "chunk": 9}
{"article": "PMC8043944.txt", "subject": "A\u03b2 PET Centloids", "relationship": "RELATED_TREATMENT", "object": "disease stage", "chunk": 9}
{"article": "PMC8043944.txt", "subject": "p-tau181", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Treatment", "chunk": 9}
{"article": "PMC8043944.txt", "subject": "p-tau217", "relationship": "RELATED_TREATMENT", "object": " A\u03b2 PET", "chunk": 9}
{"article": "PMC8043944.txt", "subject": "A\u03b2 PET", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "disease stage", "chunk": 9}
{"article": "PMC8043944.txt", "subject": "Plasma p-tau231", "relationship": "RESPONSED_TO", "object": "subtle A\u03b2 deposition ", "chunk": 9}
{"article": "PMC8048550.txt", "subject": "mevidalen", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Adverse Events", "chunk": 3}
{"article": "PMC8048550.txt", "subject": "mevidalen", "relationship": "MONITORED_DURING_TREATMENT", "object": "Safety assessment", "chunk": 3}
{"article": "PMC8048550.txt", "subject": "mevidalen", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Therapeutic response", "chunk": 3}
{"article": "PMC8048550.txt", "subject": "pulse rate (PR)", "relationship": "RELATED_TO", "object": "dose-related increases", "chunk": 5}
{"article": "PMC8048550.txt", "subject": "systolic blood pressure (SBP)", "relationship": "RELATED_TO", "object": "dose-related increases", "chunk": 5}
{"article": "PMC8048550.txt", "subject": "diastolic blood pressure (DBP)", "relationship": "RELATED_TO", "object": "dose-related increases", "chunk": 5}
{"article": "PMC8048550.txt", "subject": "mevidalen", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "selecting subjects for developing neuropsychiatric disorders", "chunk": 5}
{"article": "PMC8049572.txt", "subject": "Alzheimer\u2019s disease", "relationship": "INDICATES_PRESENCE_OF", "object": "Degeneration of nerve cells ", "chunk": 1}
{"article": "PMC8049572.txt", "subject": "Alzheimer\u2019s disease", "relationship": "RELATED_PROGNOSIS", "object": "Deterioration of cognitive and functional abilities", "chunk": 1}
{"article": "PMC8049572.txt", "subject": "Alzheimer\u2019s disease", "relationship": "DIAGNOSTIC_OF", "object": "Neuropsychiatry and behavioral symptoms", "chunk": 1}
{"article": "PMC8049572.txt", "subject": "Alzheimer\u2019s disease", "relationship": "RELATED_PROGNOSIS", "object": "Deterioration of cognitive and functional abilities", "chunk": 1}
{"article": "PMC8049572.txt", "subject": "Alzheimer\u2019s disease", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Huge economic impact", "chunk": 1}
{"article": "PMC8049572.txt", "subject": "Alzheimer\u2019s disease", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Non-pharmacological interventions combined with pharmacotherapies", "chunk": 1}
{"article": "PMC8049572.txt", "subject": "Alzheimer\u2019s disease", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Cognitive Stimulation", "chunk": 1}
{"article": "PMC8049572.txt", "subject": "APOE4", "relationship": "RELATED_TO", "object": "Genetic factors", "chunk": 5}
{"article": "PMC8049572.txt", "subject": "Alzheimer disease", "relationship": "RELATED_TREATMENT", "object": "non-pharmacological interventions", "chunk": 7}
{"article": "PMC8049572.txt", "subject": "Mild cognitive impairment", "relationship": "RELATED_TREATMENT", "object": "non-pharmacological interventions", "chunk": 7}
{"article": "PMC8049572.txt", "subject": "Alzheimer disease", "relationship": "RELATED_TREATMENT", "object": "computer-based cognitive intervention", "chunk": 7}
{"article": "PMC8049572.txt", "subject": "Mild cognitive impairment", "relationship": "RELATED_TREATMENT", "object": "computer-based cognitive intervention", "chunk": 7}
{"article": "PMC8053280.txt", "subject": "amyloid \u03b2 protein (A\u03b2)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Lecanemab therapy targets soluble A\u03b2 aggregates, suggesting it could be effective for early-stage AD.", "chunk": 1}
{"article": "PMC8053280.txt", "subject": "A\u03b2 protofibrils", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Lecanemab is an antibody designed to reduce A\u03b2 protofibrils.", "chunk": 1}
{"article": "PMC8053280.txt", "subject": "Neurofilament light", "relationship": "RELATED_PROGNOSIS", "object": "A biomarker with changes being measured to evaluate the outcomes of lecanemab treatment.", "chunk": 1}
{"article": "PMC8053280.txt", "subject": "Neurogranin", "relationship": "RELATED_PROGNOSIS", "object": "A biomarker with changes being measured to evaluate the outcomes of lecanemab treatment.", "chunk": 1}
{"article": "PMC8053280.txt", "subject": "p-tau", "relationship": "RELATED_PROGNOSIS", "object": "A biomarker with changes being measured to evaluate the outcomes of lecanemab treatment.", "chunk": 1}
{"article": "PMC8053280.txt", "subject": "Alzheimer\u2019s Disease Composite Score (ADCOMS)", "relationship": "RELATED_TREATMENT", "object": "Used to assess treatment effectiveness", "chunk": 2}
{"article": "PMC8053280.txt", "subject": "ED90", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Represents the simplest dose achieving \u226590% of maximum treatment effect", "chunk": 2}
{"article": "PMC8053280.txt", "subject": "A\u03b21\u201342", "relationship": "DIAGNOSITC_OF", "object": "Amyloid Positive", "chunk": 3}
{"article": "PMC8053280.txt", "subject": "A\u03b21\u201342", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal Fluid", "chunk": 3}
{"article": "PMC8053280.txt", "subject": "p-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal Fluid", "chunk": 3}
{"article": "PMC8053280.txt", "subject": "t-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal Fluid", "chunk": 3}
{"article": "PMC8053280.txt", "subject": "Neurogranin", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Exploratory Biomarker", "chunk": 3}
{"article": "PMC8053280.txt", "subject": "Neurofilament light chain [NfL]", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Exploratory Biomarker", "chunk": 3}
{"article": "PMC8053280.txt", "subject": "10mg/kg biweekly", "relationship": "RELATED_PROGNOSIS", "object": "64% probability of being better than placebo with 25% less decline on ADCOMS at 12 months", "chunk": 5}
{"article": "PMC8053280.txt", "subject": "10mg/kg biweekly", "relationship": "RELATED_PROGNOSIS", "object": "76% probability of being better than placebo by 25% less decline on ADCOMS", "chunk": 5}
{"article": "PMC8053280.txt", "subject": "10mg/kg biweekly", "relationship": "RELATED_PROGNOSIS", "object": "97.6% and 97.7% probability of being superior to placebo by any magnitude at both 12 and 18 months, respectively", "chunk": 5}
{"article": "PMC8053280.txt", "subject": "apoe4", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "discontinuation of subjects who were apoe4 carriers and who were on 10mg/kg lecanemab biweekly for less than 6 months", "chunk": 5}
{"article": "PMC8053280.txt", "subject": "florbetapir", "relationship": "RELATED_TREATMENT", "object": "dose-dependent reductions in amyloid PET SUVr values were observed using florbetapir as the imaging agent", "chunk": 5}
{"article": "PMC8053280.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC8053280.txt", "subject": "p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC8053280.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC8053280.txt", "subject": "t-tau", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC8053280.txt", "subject": "apOE4 ", "relationship": "RELATED_PROGNOSIS", "object": "Participants with apoe4 were found to have a higher incidence of ARIA-H.", "chunk": 7}
{"article": "PMC8053280.txt", "subject": "apoe4 ", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk of ARIA-H", "chunk": 7}
{"article": "PMC8053280.txt", "subject": "ARIA-E", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Lecanemab treatment was associated with a higher incidence of ARIA-E in apoe4 carriers.", "chunk": 7}
{"article": "PMC8053280.txt", "subject": "ARIA-E", "relationship": "RELATED_TO", "object": "Amyloid-related imaging abnormalities-edema (ARIA-E) occurred concurrently with ARIA-H, or after the onset of ARIA\u2013E in certain subjects.", "chunk": 7}
{"article": "PMC8053280.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid plaques", "chunk": 8}
{"article": "PMC8053280.txt", "subject": "A\u03b21\u201342", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Decrease in monomers in cerebrospinal fluid due to sequestration into amyloid plaques", "chunk": 8}
{"article": "PMC8053280.txt", "subject": "p-tau", "relationship": "RELATED_TREATMENT", "object": "Lecanemab-mediated effects", "chunk": 8}
{"article": "PMC8053280.txt", "subject": "p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD-related changes", "chunk": 8}
{"article": "PMC8053280.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_TREATMENT", "object": "Lecanemab treatment", "chunk": 8}
{"article": "PMC8053280.txt", "subject": "A\u03b21\u201342", "relationship": "MONITORED_DURING_TREATMENT", "object": "Lecanemab treatment", "chunk": 8}
{"article": "PMC8053280.txt", "subject": "t-tau", "relationship": "RELATED_TREATMENT", "object": "Lecanemab treatment", "chunk": 8}
{"article": "PMC8053280.txt", "subject": "Neurogranin", "relationship": "RELATES_TO_TREATMENT", "object": "Post hoc analysis of cerebrospinal fluid", "chunk": 8}
{"article": "PMC8053280.txt", "subject": "NfL", "relationship": "RELATES_TO_TREATMENT", "object": "Post hoc analysis of cerebrospinal fluid", "chunk": 8}
{"article": "PMC8053280.txt", "subject": "apoe4", "relationship": "RELATED_TREATMENT", "object": "Full 10\u2009mg/kg biweekly dose is implemented in apoe4 carriers", "chunk": 9}
{"article": "PMC8053280.txt", "subject": "apoe4", "relationship": "ASSOCIATED_WITH", "object": "ARIA-E is dose- and apoe4-status (apoe4+\u2009>\u2009apoe4-) dependent", "chunk": 9}
{"article": "PMC8053280.txt", "subject": "apoe4", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Full 10\u2009mg/kg biweekly dose is implemented in apoe4 carriers in the open label extension", "chunk": 9}
{"article": "PMC8053280.txt", "subject": "apoe4", "relationship": "RELATED_TREATMENT", "object": "dose,  and apoe4-status", "chunk": 9}
{"article": "PMC8060832.txt", "subject": "female gender", "relationship": "RELATED_PROGNOSIS", "object": "higher risk for Alzheimer disease", "chunk": 1}
{"article": "PMC8060832.txt", "subject": "age", "relationship": "RELATED_PROGNOSIS", "object": "major risk factor for Alzheimer disease", "chunk": 1}
{"article": "PMC8060832.txt", "subject": "female gender", "relationship": "RELATED_PROGNOSIS", "object": "two-thirds of older adults with AD are women", "chunk": 1}
{"article": "PMC8060832.txt", "subject": "N-Methyl-D-aspartate receptor (NMDAR)", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia manifestations, including cognitive and behavioral domains", "chunk": 2}
{"article": "PMC8060832.txt", "subject": "NMDAR overactivation", "relationship": "ASSOCIATED_WITH", "object": "Neurotoxicity", "chunk": 2}
{"article": "PMC8060832.txt", "subject": "NMDAR hypofunction", "relationship": "ASSOCIATED_WITH", "object": "Neurodegeneration", "chunk": 2}
{"article": "PMC8060832.txt", "subject": "Sodium benzoate", "relationship": "RELATED_TREATMENT", "object": "Treatment of dementia via NMDAR enhancement", "chunk": 2}
{"article": "PMC8060832.txt", "subject": "Sodium benzoate", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of dementia with behavioral and psychological symptoms", "chunk": 2}
{"article": "PMC8060832.txt", "subject": "D-amino acids oxidase (DAAO)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Inhibition using sodium benzoate", "chunk": 2}
{"article": "PMC8060832.txt", "subject": "Follicle-stimulating hormone (FSH)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Measured at baseline and end point of benzoate or placebo treatment", "chunk": 2}
{"article": "PMC8060832.txt", "subject": "Estradiol", "relationship": "MONITORED_DURING_TREATMENT", "object": "Measured at baseline and end point of benzoate or placebo treatment", "chunk": 2}
{"article": "PMC8060832.txt", "subject": "ADAS-cog", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive Improvement", "chunk": 3}
{"article": "PMC8060832.txt", "subject": "ADAS-cog", "relationship": "USED_TO_DIAGNOSE", "object": "Cognitive decline", "chunk": 3}
{"article": "PMC8060832.txt", "subject": "ADAS-cog", "relationship": "MONITORED_DURING_TREATMENT", "object": "Benzoate treatment", "chunk": 3}
{"article": "PMC8060832.txt", "subject": "ADAS-cog", "relationship": "RESPONSED_TO", "object": "Benzoate treatment in women", "chunk": 3}
{"article": "PMC8060832.txt", "subject": "sodium benzoate", "relationship": "RELATED_TREATMENT", "object": "treatment of dementia", "chunk": 4}
{"article": "PMC8060832.txt", "subject": "sodium benzoate", "relationship": "INDICATED_PRESENCE_OF", "object": "antipsychotic properties", "chunk": 4}
{"article": "PMC8060832.txt", "subject": "sodium benzoate", "relationship": "RELATED_TREATMENT", "object": "treatment of schizophrenia", "chunk": 4}
{"article": "PMC8060832.txt", "subject": "sodium benzoate", "relationship": "RELATED_TREATMENT", "object": "treatment of early psychosis", "chunk": 4}
{"article": "PMC8060832.txt", "subject": "sodium benzoate", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treatment of dementia", "chunk": 4}
{"article": "PMC8060832.txt", "subject": "sodium benzoate", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "treatment of dementia", "chunk": 4}
{"article": "PMC8060832.txt", "subject": "sodium benzoate", "relationship": "DIAGNOSTIC_OF", "object": "none", "chunk": 4}
{"article": "PMC8060832.txt", "subject": "sodium benzoate", "relationship": "USED_TO_DIAGNOSE", "object": "none", "chunk": 4}
{"article": "PMC8061233.txt", "subject": "Alzheimer\u2019s disease", "relationship": "DIAGNOSITC_OF", "object": "decreased execution of instrumental activities of daily living (IADLs)", "chunk": 1}
{"article": "PMC8061233.txt", "subject": "Alzheimer\u2019s disease", "relationship": "DIAGNOSITC_OF", "object": "loss of recent memory", "chunk": 1}
{"article": "PMC8061233.txt", "subject": "Alzheimer\u2019s disease", "relationship": "DIAGNOSITC_OF", "object": "spatial and temporal disorientation", "chunk": 1}
{"article": "PMC8061233.txt", "subject": "Alzheimer\u2019s disease", "relationship": "INDICATES_PRESENCE_OF", "object": "atrophic disease due to diffuse cortical atrophy", "chunk": 1}
{"article": "PMC8061233.txt", "subject": "Alzheimer\u2019s disease", "relationship": "INDICATES_PRESENCE_OF", "object": "intense synaptic loss", "chunk": 1}
{"article": "PMC8061233.txt", "subject": "Alzheimer\u2019s disease", "relationship": "INDICATES_PRESENCE_OF", "object": "degeneration of the central nervous system", "chunk": 1}
{"article": "PMC8061233.txt", "subject": "Alzheimer\u2019s disease", "relationship": "INDICATES_PRESENCE_OF", "object": "senile plaques", "chunk": 1}
{"article": "PMC8061233.txt", "subject": "Alzheimer\u2019s disease", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurofibrillary tangles", "chunk": 1}
{"article": "PMC8061233.txt", "subject": "ADAS-Cog", "relationship": "MONITORED_DURING_TREATMENT", "object": "tDCS treatment", "chunk": 2}
{"article": "PMC8061233.txt", "subject": "Word Recall task", "relationship": "MONITORED_DURING_TREATMENT", "object": "tDCS treatment", "chunk": 2}
{"article": "PMC8061233.txt", "subject": "Stroop test", "relationship": "MONITORED_DURING_TREATMENT", "object": "tDCS treatment", "chunk": 2}
{"article": "PMC8066440.txt", "subject": "rs4970944", "relationship": "RELATED_TO_DIAGNOSIS", "object": "ALS age of onset", "chunk": 3}
{"article": "PMC8066440.txt", "subject": "rs4970944", "relationship": "PREDICTS_SURVIVAL", "object": "ALS age of onset", "chunk": 3}
{"article": "PMC8066440.txt", "subject": "rs4970944", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treatments for ALS", "chunk": 3}
{"article": "PMC8074126.txt", "subject": "APOE", "relationship": "RELATED_PROGNOSIS", "object": "risk of progression to mild cognitive impairment  or dementia", "chunk": 1}
{"article": "PMC8074126.txt", "subject": "PER2 C111G polymorphism", "relationship": "DIAGNOSTIC_OF", "object": "Subjective cognitive decline", "chunk": 1}
{"article": "PMC8074126.txt", "subject": "PER2 C111G polymorphism", "relationship": "INDICATES_PRESENCE_OF", "object": "deterioration of cognitive function in mild cognitive impairment", "chunk": 1}
{"article": "PMC8074126.txt", "subject": "APOE \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease risk", "chunk": 2}
{"article": "PMC8074126.txt", "subject": "APOE \u03b54+ ", "relationship": "DIAGNOSTIC_OF", "object": "Early-onset Alzheimer's Disease", "chunk": 2}
{"article": "PMC8074126.txt", "subject": "Apolipoprotein E (APOE)", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline", "chunk": 2}
{"article": "PMC8074126.txt", "subject": "PER2 C111G polymorphism", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Neuropsychological interventions", "chunk": 2}
{"article": "PMC8074126.txt", "subject": "PER2 C111G polymorphism", "relationship": "RELATED_TREATMENT", "object": "Neuropsychological treatment", "chunk": 2}
{"article": "PMC8074126.txt", "subject": "APOE \u03b54+", "relationship": "RELATED_TO", "object": "G carriers vs. G non-carriers", "chunk": 4}
{"article": "PMC8076882.txt", "subject": "Alzheimer's disease", "relationship": "INDICATES_PRESENCE_OF", "object": "disturbed sleep", "chunk": 1}
{"article": "PMC8076882.txt", "subject": "Alzheimer's disease", "relationship": "RELATED_TO", "object": "increases in self-reported fatigue", "chunk": 1}
{"article": "PMC8076882.txt", "subject": "Alzheimer's disease", "relationship": "RELATED_TO", "object": "difficulties with activities of daily living (ADLs)", "chunk": 1}
{"article": "PMC8076882.txt", "subject": "Alzheimer's disease", "relationship": "RELATED_TO", "object": "depression", "chunk": 1}
{"article": "PMC8076882.txt", "subject": "Alzheimer's disease", "relationship": "RELATED_TO", "object": "fall risk", "chunk": 1}
{"article": "PMC8076882.txt", "subject": "Alzheimer's disease", "relationship": "RELATED_TO", "object": "decreases in memory", "chunk": 1}
{"article": "PMC8076882.txt", "subject": "Alzheimer's disease", "relationship": "RELATED_TO", "object": "decreases in mobility", "chunk": 1}
{"article": "PMC8076882.txt", "subject": "Alzheimer's disease", "relationship": "RELATED_TO", "object": "morbidity", "chunk": 1}
{"article": "PMC8076882.txt", "subject": "Alzheimer's disease", "relationship": "RELATED_TO", "object": "rates of survival", "chunk": 1}
{"article": "PMC8076882.txt", "subject": "STOP-Bang screening tool", "relationship": "USED_TO_DIAGNOSE", "object": "Residents with high risk of obstructive sleep apnea", "chunk": 4}
{"article": "PMC8076882.txt", "subject": "MDS Brief Interview for Mental Status (BIMS) score", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased likelihood of capacity to consent", "chunk": 4}
{"article": "PMC8076882.txt", "subject": "sedating medications", "relationship": "MONITORED_DURING_TREATMENT", "object": "Inter-resident sleep variability", "chunk": 5}
{"article": "PMC8076882.txt", "subject": "doses of any sedating medications", "relationship": "MONITORED_DURING_TREATMENT", "object": "Inter-resident sleep variability", "chunk": 5}
{"article": "PMC8076882.txt", "subject": "incidents of delirium", "relationship": "MONITORED_DURING_TREATMENT", "object": "Inter-resident sleep variability", "chunk": 5}
{"article": "PMC8076882.txt", "subject": "any urinary tract infections", "relationship": "MONITORED_DURING_TREATMENT", "object": "Inter-resident sleep variability", "chunk": 5}
{"article": "PMC8076882.txt", "subject": "trouble falling or staying asleep or sleeping too much", "relationship": "INDICATES_PRESENCE_OF", "object": "Sleep Problems", "chunk": 5}
{"article": "PMC8076882.txt", "subject": "pain", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Sleep Problems", "chunk": 5}
{"article": "PMC8088704.txt", "subject": "A\u03b242/40 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "brain amyloid plaques", "chunk": 1}
{"article": "PMC8088704.txt", "subject": "Plasma A\u03b242/40 ratio", "relationship": "DIAGNOSTIC_OF", "object": "Brain amyloid positivity", "chunk": 1}
{"article": "PMC8088704.txt", "subject": "A\u03b242/40", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment for Alzheimer's Disease", "chunk": 1}
{"article": "PMC8088704.txt", "subject": "plasma A\u03b242/40 ratio", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC8088704.txt", "subject": "ApoE proteotype", "relationship": "RELATED_TREATMENT", "object": "Treatment for Alzheimer's Disease", "chunk": 1}
{"article": "PMC8088704.txt", "subject": "plasma A\u03b242/40 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "brain amyloid plaques", "chunk": 2}
{"article": "PMC8088704.txt", "subject": "plasma A\u03b242/40 ratio", "relationship": "DIAGNOSTIC_OF", "object": "brain amyloid plaques", "chunk": 2}
{"article": "PMC8088704.txt", "subject": "C2N Plasma A\u03b242/40", "relationship": "RELATED_PROGNOSIS", "object": "Amyloid positivity", "chunk": 2}
{"article": "PMC8088704.txt", "subject": "A\u03b240", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma A\u03b240 concentration by comparing each sample\u2019s 14N/15N ratio to their respective calibration curves", "chunk": 3}
{"article": "PMC8088704.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma A\u03b242 concentration by comparing each sample\u2019s 14N/15N ratio to their respective calibration curves", "chunk": 3}
{"article": "PMC8088704.txt", "subject": "A\u03b242/40 ratio", "relationship": "MONITORED_DURING_TREATMENT", "object": "Quality control plasma samples with known A\u03b242 and A\u03b240 concentrations and A\u03b242/40 ratios", "chunk": 3}
{"article": "PMC8088704.txt", "subject": "A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "For the targeted analytes, precursor and product ions were detected using parallel reaction monitoring (PRM). Precursor ions were filtered by quadrupole isolation of 1.6\u2009m/z and detected within the orbitrap at a mass resolution of 30,000. Automatic gain control (AGC) targets for A\u03b240 and A\u03b242 were set at 1.0e5 and 5.0e5, respectively.", "chunk": 3}
{"article": "PMC8088704.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "For the targeted analytes, precursor and product ions were detected using parallel reaction monitoring (PRM). Precursor ions were filtered by quadrupole isolation of 1.6\u2009m/z and detected within the orbitrap at a mass resolution of 30,000. Automatic gain control (AGC) targets for A\u03b240 and A\u03b242 were set at 1.0e5 and 5.0e5, respectively.", "chunk": 3}
{"article": "PMC8088704.txt", "subject": "ApoE", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "ApoE proteotyping for each of the six ApoE genotypes (\u03b52/2, \u03b52/3, \u03b52/4, \u03b53/3, \u03b53/4, \u03b54/4) used a combination of the presence or absence of the four targeted ApoE isoform-specific tryptic peptides.", "chunk": 3}
{"article": "PMC8088704.txt", "subject": "A\u03b242/40 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Brain amyloid positivity", "chunk": 4}
{"article": "PMC8088704.txt", "subject": "A\u03b242/40 ratio", "relationship": "RELATED_PROGNOSIS", "object": " Amyloid positivity", "chunk": 4}
{"article": "PMC8088704.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Brain amyloid positivity", "chunk": 4}
{"article": "PMC8088704.txt", "subject": "A\u03b242", "relationship": "RELATED_TO_DIAGNOSIS", "object": " Amyloid positivity", "chunk": 4}
{"article": "PMC8088704.txt", "subject": "A\u03b240", "relationship": "RELATED_TO_DIAGNOSIS", "object": " Amyloid positivity", "chunk": 4}
{"article": "PMC8088704.txt", "subject": "A\u03b242/40 ratio", "relationship": "RELATED_PROGNOSIS", "object": "Plasma A\u03b242/40 ratio accurately identifies brain amyloid status.", "chunk": 1}
{"article": "PMC8088704.txt", "subject": "A\u03b242/40 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "brain amyloid positivity", "chunk": 1}
{"article": "PMC8088704.txt", "subject": "A\u03b242/40 ratio", "relationship": "USED_TO_DIAGNOSE", "object": "blood-based diagnostic test", "chunk": 1}
{"article": "PMC8088704.txt", "subject": "ApoE proteotype", "relationship": "USED_TO_DIAGNOSE", "object": "blood-based diagnostic test", "chunk": 1}
{"article": "PMC8088704.txt", "subject": "plasma A\u03b242/40 concentration ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "brain amyloid plaques", "chunk": 2}
{"article": "PMC8088704.txt", "subject": "low plasma A\u03b242/40 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "brain amyloid plaques", "chunk": 2}
{"article": "PMC8088704.txt", "subject": "plasma A\u03b242/40 concentration ratio", "relationship": "RELATED_TO", "object": "presence or absence of brain amyloidosis", "chunk": 2}
{"article": "PMC8088704.txt", "subject": "A\u03b240", "relationship": "PREDICTED_SURVIVAL", "object": "Quantification of A\u03b240 and A\u03b242 peptide levels with LC-MS/MS was used for the assessment", "chunk": 3}
{"article": "PMC8088704.txt", "subject": "A\u03b242", "relationship": "PREDICTED_SURVIVAL", "object": "Quantification of A\u03b240 and A\u03b242 peptide levels with LC-MS/MS was used for the assessment", "chunk": 3}
{"article": "PMC8088704.txt", "subject": "plasma A\u03b242/40 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid positivity", "chunk": 4}
{"article": "PMC8088704.txt", "subject": "plasma A\u03b242/40 ratio", "relationship": "RELATED_PROGNOSIS", "object": "Amyloid positivity", "chunk": 4}
{"article": "PMC8088704.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Amyloid positivity", "chunk": 4}
{"article": "PMC8088704.txt", "subject": "A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Amyloid positivity", "chunk": 4}
{"article": "PMC8088704.txt", "subject": "ApoE proteotype", "relationship": "RELATED_PROGNOSIS", "object": "Amyloid positivity", "chunk": 4}
{"article": "PMC8088704.txt", "subject": "A\u03b242/40 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Brain amyloid", "chunk": 5}
{"article": "PMC8088704.txt", "subject": "A\u03b242/40 ratio", "relationship": "RELATED_PROGNOSIS", "object": "Amyloid positivity", "chunk": 5}
{"article": "PMC8088704.txt", "subject": "A\u03b242/40 ratio", "relationship": "USED_TO_DIAGNOSE", "object": "Brain amyloid status", "chunk": 5}
{"article": "PMC8088704.txt", "subject": "A\u03b242/40 ratio", "relationship": "RELATED_TREATMENT", "object": "Predicting Amyloid positivity", "chunk": 5}
{"article": "PMC8088704.txt", "subject": "A\u03b242", "relationship": "DIAGNOSITC_OF", "object": "Diagnose: Early-onset Alzheimer's Disease", "chunk": 5}
{"article": "PMC8088704.txt", "subject": "ApoE  isoform-specific peptides", "relationship": "RELATED_TREATMENT", "object": "Predict brain amyloid status", "chunk": 5}
{"article": "PMC8088704.txt", "subject": "ApoE genotype", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease and brain amyloidosis", "chunk": 5}
{"article": "PMC8088704.txt", "subject": "Age", "relationship": "RELATED_PROGNOSIS", "object": "Risk for Alzheimer\u2019s disease and brain amyloidosis", "chunk": 5}
{"article": "PMC8088704.txt", "subject": "plasma A\u03b242/40 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "amyloid pathology", "chunk": 6}
{"article": "PMC8088704.txt", "subject": "plasma A\u03b242/40 ratio", "relationship": "RELATED_PROGNOSIS", "object": "risk of converting to amyloid PET positive", "chunk": 6}
{"article": "PMC8088704.txt", "subject": "plasma A\u03b242/40 ratio", "relationship": "DIAGNOSTIC_OF", "object": "brain amyloid status", "chunk": 6}
{"article": "PMC8088704.txt", "subject": "plasma A\u03b242/40 ratio", "relationship": "RELATED_TREATMENT", "object": "model for identifying amyloid positivity", "chunk": 6}
{"article": "PMC8088704.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "plasma A\u03b242, A\u03b240, ApoE analytical platforms", "chunk": 8}
{"article": "PMC8088704.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "plasma A\u03b242, A\u03b240, ApoE analytical platforms", "chunk": 8}
{"article": "PMC8088704.txt", "subject": "ApoE", "relationship": "RELATED_TREATMENT", "object": "plasma A\u03b242, A\u03b240, ApoE analytical platforms", "chunk": 8}
{"article": "PMC8088704.txt", "subject": "A\u03b242", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "amyloid probability prediction models", "chunk": 8}
{"article": "PMC8110716.txt", "subject": "Episodic, lexico-semantic, executive functioning and visuospatial deficits", "relationship": "INDICATES_PRESENCE_OF", "object": "Slower speech rate and slower turn-taking in conversational settings", "chunk": 1}
{"article": "PMC8110716.txt", "subject": "Speech characteristics", "relationship": "RELATED_TO", "object": "Volume reductions in frontal, temporal and cerebellar areas ", "chunk": 1}
{"article": "PMC8110716.txt", "subject": "Slower speech rate", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment and Alzheimer's Disease", "chunk": 2}
{"article": "PMC8110716.txt", "subject": "Higher number of silent pauses", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment and Alzheimer's Disease", "chunk": 2}
{"article": "PMC8110716.txt", "subject": "Longer pauses", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment and Alzheimer's Disease", "chunk": 2}
{"article": "PMC8110716.txt", "subject": "Shorter interpausal units", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment and Alzheimer's Disease", "chunk": 2}
{"article": "PMC8110716.txt", "subject": "Longer pauses between clauses", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Speech planning difficulties", "chunk": 2}
{"article": "PMC8110716.txt", "subject": "mild cognitive impairment", "relationship": "RELATED_TO", "object": "conversation speech timing characteristics", "chunk": 3}
{"article": "PMC8110716.txt", "subject": "AD", "relationship": "RELATED_TO", "object": "conversation speech timing characteristics", "chunk": 3}
{"article": "PMC8110716.txt", "subject": "mild cognitive impairment", "relationship": "RELATED_TO", "object": "atrophy of the medial temporal lobe", "chunk": 3}
{"article": "PMC8110716.txt", "subject": "AD", "relationship": "RELATED_TO", "object": "atrophy of the medial temporal lobe", "chunk": 3}
{"article": "PMC8110716.txt", "subject": "mild cognitive impairment", "relationship": "ASSOCIATED_WITH", "object": "volume reductions in [the fusiform gyrus, posterior cingulate/precuneus, superior temporal, inferior parietal, and orbito-frontal cortices]", "chunk": 3}
{"article": "PMC8110716.txt", "subject": "AD", "relationship": "ASSOCIATED_WITH", "object": "volume reductions in [the fusiform gyrus, posterior cingulate/precuneus, superior temporal, inferior parietal, and orbito-frontal cortices]", "chunk": 3}
{"article": "PMC8110716.txt", "subject": "Number of pauses", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Mild cognitive impairment and AD", "chunk": 6}
{"article": "PMC8110716.txt", "subject": "Gap/transition overlap ratio", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Mild cognitive impairment and AD", "chunk": 6}
{"article": "PMC8110716.txt", "subject": "Duration of pauses", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Mild cognitive impairment and AD", "chunk": 6}
{"article": "PMC8110716.txt", "subject": "Duration of transitions", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Mild cognitive impairment and AD", "chunk": 6}
{"article": "PMC8110716.txt", "subject": "Interpausal units", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Mild cognitive impairment and AD", "chunk": 6}
{"article": "PMC8110716.txt", "subject": "Speech rate", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Mild cognitive impairment and AD", "chunk": 6}
{"article": "PMC8110716.txt", "subject": "RBANS.T", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "MOCA.T", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "Memory", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "Language", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "WM/Attention", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "Visuoconstructional/EF", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "Orientation", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "Total gray matter (cm3)", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "N pauses", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "Gap/overlap ratio", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "Pause duration", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "Gap duration", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "Turn duration", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "IPU duration", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "Tov duration", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "Speech rate", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC8110716.txt", "subject": "Speech rate", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC8110716.txt", "subject": "Interpausal unit duration", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC8110716.txt", "subject": "Transition overlaps", "relationship": "RELATED_TO", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC8110716.txt", "subject": "Speech Rate", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower Memory scores in the Describe-Trial", "chunk": 9}
{"article": "PMC8110716.txt", "subject": "Speech Rate", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower Visuoconstructional/Executive function scores in the Match-Trial", "chunk": 9}
{"article": "PMC8110716.txt", "subject": "Turn Duration", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower Working Memory/Attention scores across the three trials", "chunk": 9}
{"article": "PMC8110716.txt", "subject": "Turn Duration", "relationship": "RELATED_PROGNOSIS", "object": "Lower Working Memory/Attention scores", "chunk": 9}
{"article": "PMC8110716.txt", "subject": "Turn Duration", "relationship": "RELATED_PROGNOSIS", "object": "Lower Memory scores", "chunk": 9}
{"article": "PMC8110716.txt", "subject": "Interpausal Unit Duration", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower Memory scores", "chunk": 9}
{"article": "PMC8110716.txt", "subject": "Interpausal Unit Duration", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower Working Memory/Attention scores", "chunk": 9}
{"article": "PMC8110716.txt", "subject": "Interpausal Unit Duration", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower Orientation scores", "chunk": 9}
{"article": "PMC8110716.txt", "subject": "Gap/Transition Overlap Ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower Language scores in the Match-Trial", "chunk": 9}
{"article": "PMC8110716.txt", "subject": "Slower speech rate", "relationship": "RELATED_TREATMENT", "object": "Volume of L MTG and R MTG", "chunk": 9}
{"article": "PMC8110716.txt", "subject": "Slower speech rate", "relationship": "RELATED_TREATMENT", "object": "Volume of R STG", "chunk": 9}
{"article": "PMC8110716.txt", "subject": "speech changes", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive deficits", "chunk": 11}
{"article": "PMC8110716.txt", "subject": "speech changes", "relationship": "INDICATES_PRESENCE_OF", "object": "Underlying structural changes", "chunk": 11}
{"article": "PMC8110716.txt", "subject": "Speech-based approaches", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Assessment and monitoring of cognitive deficits", "chunk": 11}
{"article": "PMC8110716.txt", "subject": "Speech-based approaches", "relationship": "RELATED_TREATMENT", "object": "Cognitive deficits", "chunk": 11}
{"article": "PMC8127192.txt", "subject": "Sleep Disorder Inventory (SDI)", "relationship": "INDICATES_PRESENCE_OF", "object": "clinically significant sleep disruption (score of 5 or more)", "chunk": 3}
{"article": "PMC8127192.txt", "subject": "SDI", "relationship": "INDICATES_PRESENCE_OF", "object": "Less disrupted sleep", "chunk": 6}
{"article": "PMC8127192.txt", "subject": "SDI", "relationship": "RELATED_PROGNOSIS", "object": "Better sleep", "chunk": 6}
{"article": "PMC8127192.txt", "subject": "Sleep Disorder Inventory (SDI)", "relationship": "RELATED_PROGNOSIS", "object": "SDI score had significant positive correlations with the total number of medications and number of psychotropic medications", "chunk": 7}
{"article": "PMC8127192.txt", "subject": "Sleep Disorder Inventory (SDI)", "relationship": "RELATED_PROGNOSIS", "object": "These differences were significant at week 16 and 24 in the mixed linear model", "chunk": 7}
{"article": "PMC8127192.txt", "subject": "Sleep Disorder Inventory (SDI)", "relationship": "RELATED_TREATMENT", "object": "Compared to the control group, the intervention group fared better from baseline to week 16 and from baseline to week 24, as measured by the proxy-rated Sleep Disorder Inventory (SDI)", "chunk": 7}
{"article": "PMC8154928.txt", "subject": "Alzheimer\u2019s disease", "relationship": "DIAGNOSITC_OF", "object": "Dementia", "chunk": 1}
{"article": "PMC8154928.txt", "subject": "Alzheimer\u2019s disease", "relationship": "CAUSES", "object": "Dementia", "chunk": 1}
{"article": "PMC8154928.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 2}
{"article": "PMC8154928.txt", "subject": "HRV", "relationship": "INDICATES_PRESENCE_OF", "object": "ANS activity", "chunk": 3}
{"article": "PMC8154928.txt", "subject": "HRV", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "optimal HRV is critical to health and well-being", "chunk": 3}
{"article": "PMC8154928.txt", "subject": "HRV", "relationship": "RELATED_TREATMENT", "object": "fNIRS, EEG and HRV", "chunk": 3}
{"article": "PMC8154928.txt", "subject": "HRV", "relationship": "MONITORED_DURING_TREATMENT", "object": "task-related neurophysiological changes", "chunk": 3}
{"article": "PMC8154928.txt", "subject": "D2", "relationship": "RELATED_TREATMENT", "object": "mental workload", "chunk": 3}
{"article": "PMC8154928.txt", "subject": "RMSSD", "relationship": "RELATED_PROGNOSIS", "object": "vagally mediated HRV", "chunk": 3}
{"article": "PMC8154928.txt", "subject": "pNN50", "relationship": "RELATED_PROGNOSIS", "object": "vagally mediated HRV", "chunk": 3}
{"article": "PMC8154928.txt", "subject": "HF", "relationship": "RELATED_PROGNOSIS", "object": "vagally mediated HRV", "chunk": 3}
{"article": "PMC8154928.txt", "subject": "Verbal fluency", "relationship": "RELATED_TREATMENT", "object": "Worsens with the development of AD", "chunk": 5}
{"article": "PMC8154928.txt", "subject": "RMSSD", "relationship": "RELATED_TREATMENT", "object": "HRV with RMSSD, pNN50, HF (absolute and nu) will be measured using electrocardiography (ECG)", "chunk": 7}
{"article": "PMC8154928.txt", "subject": "pNN50", "relationship": "RELATED_TREATMENT", "object": "HRV with RMSSD, pNN50, HF (absolute and nu) will be measured using electrocardiography (ECG)", "chunk": 7}
{"article": "PMC8154928.txt", "subject": "HF", "relationship": "RELATED_TREATMENT", "object": "HRV with RMSSD, pNN50, HF (absolute and nu) will be measured using electrocardiography (ECG)", "chunk": 7}
{"article": "PMC8154928.txt", "subject": "SD1", "relationship": "RELATED_TREATMENT", "object": "Non-linear ECG parameters (SD1, SD2, ApEn, SampEn, DFA, D2, RPA, MSE) will also be measured", "chunk": 7}
{"article": "PMC8154928.txt", "subject": "SD2", "relationship": "RELATED_TREATMENT", "object": "Non-linear ECG parameters (SD1, SD2, ApEn, SampEn, DFA, D2, RPA, MSE) will also be measured", "chunk": 7}
{"article": "PMC8154928.txt", "subject": "ApEn", "relationship": "RELATED_TREATMENT", "object": "Non-linear ECG parameters (SD1, SD2, ApEn, SampEn, DFA, D2, RPA, MSE) will also be measured", "chunk": 7}
{"article": "PMC8154928.txt", "subject": "SampEn", "relationship": "RELATED_TREATMENT", "object": "Non-linear ECG parameters (SD1, SD2, ApEn, SampEn, DFA, D2, RPA, MSE) will also be measured", "chunk": 7}
{"article": "PMC8154928.txt", "subject": "DFA", "relationship": "RELATED_TREATMENT", "object": "Non-linear ECG parameters (SD1, SD2, ApEn, SampEn, DFA, D2, RPA, MSE) will also be measured", "chunk": 7}
{"article": "PMC8154928.txt", "subject": "D2", "relationship": "RELATED_TREATMENT", "object": "Non-linear ECG parameters (SD1, SD2, ApEn, SampEn, DFA, D2, RPA, MSE) will also be measured", "chunk": 7}
{"article": "PMC8154928.txt", "subject": "RPA", "relationship": "RELATED_TREATMENT", "object": "Non-linear ECG parameters (SD1, SD2, ApEn, SampEn, DFA, D2, RPA, MSE) will also be measured", "chunk": 7}
{"article": "PMC8154928.txt", "subject": "MSE", "relationship": "RELATED_TREATMENT", "object": "Non-linear ECG parameters (SD1, SD2, ApEn, SampEn, DFA, D2, RPA, MSE) will also be measured", "chunk": 7}
{"article": "PMC8154928.txt", "subject": "neurophysiological signals", "relationship": "ARE_INDICATED_PRESENCE_OF", "object": "preclinical AD stages", "chunk": 8}
{"article": "PMC8154928.txt", "subject": "neurophysiological signals", "relationship": "RELATED_TO", "object": "changes in cognitive performance", "chunk": 8}
{"article": "PMC8154928.txt", "subject": "neurophysiological biomarkers", "relationship": "USED_TO_DIAGNOSE", "object": "mild cognitive impairment", "chunk": 8}
{"article": "PMC8157623.txt", "subject": "p38\u03b1 kinase", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Synaptic dysfunction in AD", "chunk": 1}
{"article": "PMC8157623.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Pathological amyloid-beta formation", "chunk": 1}
{"article": "PMC8157623.txt", "subject": "p38\u03b1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Amyloid-beta (A\u03b2) production and tau pathology, Inflammation, and tau-induced synaptic dysfunction", "chunk": 1}
{"article": "PMC8157623.txt", "subject": "p38\u03b1 kinase inhibitors", "relationship": "RESPONDED_TO", "object": "Spatial learning deficits in animal models", "chunk": 1}
{"article": "PMC8157623.txt", "subject": "neurogranin", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal fluid levels during neflamapimod treatment", "chunk": 1}
{"article": "PMC8157623.txt", "subject": "p-tau181", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal fluid levels during neflamapimod treatment", "chunk": 1}
{"article": "PMC8157623.txt", "subject": "T-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal fluid levels during neflamapimod treatment", "chunk": 1}
{"article": "PMC8157623.txt", "subject": "T-tau", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Significantly reduced cerebrospinal fluid levels with neflamapimod treatment compared to placebo", "chunk": 1}
{"article": "PMC8157623.txt", "subject": "p-tau181", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Significantly reduced cerebrospinal fluid levels with neflamapimod treatment compared to placebo", "chunk": 1}
{"article": "PMC8157623.txt", "subject": "neurogranin", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Decreased cerebrospinal fluid levels with neflamapimod treatment compared to placebo (trend)", "chunk": 1}
{"article": "PMC8157623.txt", "subject": "p38\u03b1", "relationship": "RELATED_PROGNOSIS", "object": "Memory formation", "chunk": 1}
{"article": "PMC8157623.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Cerebral spinal fluid A\u03b242 < 1000 pg/mL is an eligibility criterion", "chunk": 2}
{"article": "PMC8157623.txt", "subject": "p-tau181/A\u03b242 ratio", "relationship": "RELATED_TREATMENT", "object": "Cerebral spinal fluid p-tau181/A\u03b242 ratio >0.024 is an eligibility criterion", "chunk": 2}
{"article": "PMC8157623.txt", "subject": "T-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebral spinal fluid levels are determined", "chunk": 2}
{"article": "PMC8157623.txt", "subject": "p-tau181", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebral spinal fluid levels are determined", "chunk": 2}
{"article": "PMC8157623.txt", "subject": "A\u03b240", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebral spinal fluid levels are determined", "chunk": 2}
{"article": "PMC8157623.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebral spinal fluid levels are determined", "chunk": 2}
{"article": "PMC8157623.txt", "subject": "neurogranin", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebral spinal fluid levels are determined", "chunk": 2}
{"article": "PMC8157623.txt", "subject": "NfL", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebral spinal fluid levels are determined", "chunk": 2}
{"article": "PMC8157623.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid T-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC8157623.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid p-tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC8157623.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid T-tau", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC8157623.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid p-tau181", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC8157623.txt", "subject": "T-tau", "relationship": "RELATED_TREATMENT", "object": "Plasma trough dependent effect", "chunk": 4}
{"article": "PMC8157623.txt", "subject": "p-tau181", "relationship": "RELATED_TREATMENT", "object": "Plasma trough dependent effect", "chunk": 4}
{"article": "PMC8157623.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Plasma trough dependent effect", "chunk": 4}
{"article": "PMC8157623.txt", "subject": "T-tau", "relationship": "PREDICTED_SURVIVAL", "object": "improvement with neflamapimod treatment", "chunk": 4}
{"article": "PMC8157623.txt", "subject": "p-tau181", "relationship": "PREDICTED_SURVIVAL", "object": "improvement with neflamapimod treatment", "chunk": 4}
{"article": "PMC8157623.txt", "subject": "A\u03b242", "relationship": "PREDICTED_SURVIVAL", "object": "improvement with neflamapimod treatment", "chunk": 4}
{"article": "PMC8157623.txt", "subject": "neurogranin", "relationship": "PREDICTED_SURVIVAL", "object": "  trend towards improvement with neflamapimod treatment", "chunk": 4}
{"article": "PMC8157623.txt", "subject": "T-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC8157623.txt", "subject": "p-tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC8157623.txt", "subject": "p-tau (pS202)", "relationship": "INDICATES_PRESENCE_OF", "object": "synaptic dysfunction", "chunk": 5}
{"article": "PMC8157623.txt", "subject": "p-tau", "relationship": "RELATED_PROGNOSIS", "object": "synaptic dysfunction", "chunk": 5}
{"article": "PMC8157623.txt", "subject": "tau", "relationship": "RELATED_PROGNOSIS", "object": "synaptic dysfunction", "chunk": 5}
{"article": "PMC8157623.txt", "subject": "neurogranin", "relationship": "RELATED_PROGNOSIS", "object": "synaptic dysfunction", "chunk": 5}
{"article": "PMC8157623.txt", "subject": "neflamapimod", "relationship": "RELATED_TREATMENT", "object": "p38\u03b1 inhibition", "chunk": 5}
{"article": "PMC8157623.txt", "subject": "neflamapimod", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "plasma drug concentration levels", "chunk": 5}
{"article": "PMC8157623.txt", "subject": "neflamapimod", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treatment of Alzheimer's Disease", "chunk": 5}
{"article": "PMC8157623.txt", "subject": "PK\u2013PD analysis", "relationship": "INDICATES_PRESENCE_OF", "object": "relationship between outcomes and PK parameters", "chunk": 6}
{"article": "PMC8157623.txt", "subject": "Ctrough \u2265 75th percentile", "relationship": "RELATED_PROGNOSIS", "object": "Improvement from baseline of 0.45 Z-score on the primary endpoint", "chunk": 6}
{"article": "PMC8157623.txt", "subject": "125-mg BID dose", "relationship": "RELATED_TREATMENT", "object": "greater improvement in WMS scores", "chunk": 6}
{"article": "PMC8157623.txt", "subject": "plasma drug levels resulting from 125-mg BID", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "greater improvement in WMS scores", "chunk": 6}
{"article": "PMC8157623.txt", "subject": "40 mg BID dose", "relationship": "RELATED_TREATMENT", "object": "improvement seen", "chunk": 6}
{"article": "PMC8157623.txt", "subject": "neflamapimod", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "determining whether such relationships between biomarker and clinical effects exist for neflamapimod in AD", "chunk": 6}
{"article": "PMC8157623.txt", "subject": "plasma drug concentration\u2013effect relationships", "relationship": "GUIDES_TREATMENT_SELECTION", "object": " therapeutically active dose range is at least 50% higher than 40-mg BID", "chunk": 6}
{"article": "PMC8157623.txt", "subject": " Ctrough \u22654 ng/mL", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "low incidence of liver enzyme elevation is expected", "chunk": 6}
{"article": "PMC8157623.txt", "subject": "plasma drug concentrations are half that in the brain", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "minimize such toxicities, while maintaining robust pharmacological effects in the brain", "chunk": 6}
{"article": "PMC8157623.txt", "subject": "drug is 95% protein-bound in whole blood", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "minimize such toxicities, while maintaining robust pharmacological effects in the brain", "chunk": 6}
{"article": "PMC8157623.txt", "subject": "cerebral  cerebral  cerebral  cerebral spinal fluid biomarker results", "relationship": "MONITORED_DURING_TREATMENT", "object": "pharmacological activity was demonstrated", "chunk": 6}
{"article": "PMC8157623.txt", "subject": "neflamapimod plasma levels", "relationship": "RELATED_PROGNOSIS", "object": "Subjects with higher levels showed less episodic memory decline", "chunk": 7}
{"article": "PMC8157623.txt", "subject": "cerebral spinal fluid protein markers of synaptic dysfunction", "relationship": "RELATED_TREATMENT", "object": "TREATMENT: neflamapimod decreased these markers relative to placebo", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "APOE e4 allele", "relationship": "RELATED_TREATMENT", "object": "Individuals with at least one APOE e4 allele copy are at greater risk of developing AD", "chunk": 2}
{"article": "PMC8201462.txt", "subject": "APOE e4 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "increased risk of developing AD", "chunk": 2}
{"article": "PMC8201462.txt", "subject": "High levels of physical activity", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "better performance on specific cognitive tasks", "chunk": 2}
{"article": "PMC8201462.txt", "subject": "Brain-derived neurotrophic factor (BDNF)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "improve overall neural health by increasing brain vascularization, neurogenesis, and synaptic efficiency in the hippocampus", "chunk": 2}
{"article": "PMC8201462.txt", "subject": "Brain-derived neurotrophic factor (BDNF)", "relationship": "INDICATES_PRESENCE_OF", "object": "prevent memory loss and cognitive decline with aging", "chunk": 2}
{"article": "PMC8201462.txt", "subject": "Clinical dementia Rating Scale", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline", "chunk": 4}
{"article": "PMC8201462.txt", "subject": "Telephone Interview for Cognitive Status (TICS-modified; score \u2264 20", "relationship": "INDICATES_PRESENCE_OF", "object": "Suspected dementia", "chunk": 4}
{"article": "PMC8201462.txt", "subject": "History of hypertension", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "ADRD", "chunk": 4}
{"article": "PMC8201462.txt", "subject": "Diabetes mellitus", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "ADRD", "chunk": 4}
{"article": "PMC8201462.txt", "subject": "Obesity (body mass index (BMI) < 40\u2009kg/m2)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "ADRD", "chunk": 4}
{"article": "PMC8201462.txt", "subject": "Elevated cholesterol", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "ADRD", "chunk": 4}
{"article": "PMC8201462.txt", "subject": "Current smoking", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "ADRD", "chunk": 4}
{"article": "PMC8201462.txt", "subject": "Coronary artery disease without recent (<\u20095\u2009years) symptoms", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "ADRD", "chunk": 4}
{"article": "PMC8201462.txt", "subject": "Family history of ADRD", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Risk of ADRD", "chunk": 4}
{"article": "PMC8201462.txt", "subject": "Brain Injury Screening Questionnaire (BISQ)", "relationship": "INDICATES_PRESENCE_OF", "object": "Lifetime history of traumatic brain injury", "chunk": 4}
{"article": "PMC8201462.txt", "subject": "Montreal Cognitive Assessment (MoCA)", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive functioning", "chunk": 4}
{"article": "PMC8201462.txt", "subject": "Memory Assessment Clinic questionnaire (MAC-Q)", "relationship": "RELATED_PROGNOSIS", "object": "Subjective memory complaints", "chunk": 4}
{"article": "PMC8201462.txt", "subject": "Physical Activity Readiness Questionnaire (PAR-Q+)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Safety of exercise program participation", "chunk": 4}
{"article": "PMC8201462.txt", "subject": "Blood work", "relationship": "MONITORED_DURING_TREATMENT", "object": "6-month aerobic training programme", "chunk": 5}
{"article": "PMC8201462.txt", "subject": "Estradiol", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood biomarkers analysis", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "Progesterone", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood biomarkers analysis", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "Testosterone", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood biomarkers analysis", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "Sex hormone-binding globulin", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood biomarkers analysis", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "Albumin", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood biomarkers analysis", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "Cholesterol", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood biomarkers analysis", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "Low-density lipoprotein", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood biomarkers analysis", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "High-density lipoprotein", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood biomarkers analysis", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "Triglycerides", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood biomarkers analysis", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "Thyroid-stimulating hormone", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood biomarkers analysis", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "Creatinine", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood biomarkers analysis", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "Alanine aminotransferase", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood biomarkers analysis", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "Bilirubin", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood biomarkers analysis", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "High-sensitivity C-reactive protein", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood biomarkers analysis", "chunk": 7}
{"article": "PMC8201462.txt", "subject": "hsCRP", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammation", "chunk": 8}
{"article": "PMC8201462.txt", "subject": "hsCRP", "relationship": "MONITORED_DURING_TREATMENT", "object": "Intervention", "chunk": 8}
{"article": "PMC8211849.txt", "subject": "apoe4", "relationship": "DIAGNOSTIC_OF", "object": "Sporadic, Late-onset Alzheimer's dementia", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Modified neurovascular coupling", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Leaky blood-brain barrier", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Angiopathy", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Disrupted nutrient transport", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "Increased vascular risk", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "apoe4", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Altered and generally lower resting CBF", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "Potential preferential benefit from regular exercise", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "apoe4", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Exercise interventions", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "apoe4", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Acute exercise intervention", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "restisting CBF", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Decreasing with age", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "Exercise", "relationship": "RELATED_PROGNOSIS", "object": "Improved cerebrovascular reserve", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "Exercise", "relationship": "RELATED_TREATMENT", "object": "Age-related cognitive decline", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "Exercise", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Cognitive decline in APOE e4 carriers", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "exercise", "relationship": "IST_A_MEANS_OF", "object": "Cumulavite effect on cognitive function", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "CBF", "relationship": "RELATED_PROGNOSIS", "object": "Sedentary lifestyle", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "CBF", "relationship": "RELATED_PROGNOSIS", "object": "Older adults", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "CBF regulation", "relationship": "RELATED_TREATMENT", "object": "Acute exercise intervention", "chunk": 1}
{"article": "PMC8211849.txt", "subject": "VEGF", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Neurogenesis and treatment response to exercise", "chunk": 2}
{"article": "PMC8211849.txt", "subject": "BDNF", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Understanding brain health and cognitive decline", "chunk": 2}
{"article": "PMC8211849.txt", "subject": "VEGF", "relationship": "IS_TARGET_OF_TREATMENT", "object": "In studies related to understanding the effects of exercise on brain health", "chunk": 2}
{"article": "PMC8211849.txt", "subject": "IGF1", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Understanding brain health and cognitive decline", "chunk": 2}
{"article": "PMC8211849.txt", "subject": "BDNF", "relationship": "RELATED_TO_TREATMENT", "object": "Exercise-induced changes in cerebral hemodynamics", "chunk": 2}
{"article": "PMC8211849.txt", "subject": "VEGF", "relationship": "RELATED_TO_TREATMENT", "object": "Exercise-induced neurogenesis and benefits to brain health", "chunk": 2}
{"article": "PMC8211849.txt", "subject": "IGF1", "relationship": "RELATED_TO_TREATMENT", "object": "Exercise-induced effects on brain health and cognition", "chunk": 2}
{"article": "PMC8211849.txt", "subject": "apoe4", "relationship": "RELATED_TREATMENT", "object": "Enrollment considerations for the study.", "chunk": 3}
{"article": "PMC8211849.txt", "subject": "apoe4", "relationship": "RELATED_TREATMENT", "object": "Matching of participants based on genotype group.", "chunk": 3}
{"article": "PMC8211849.txt", "subject": "apoe4", "relationship": "RELATED_TREATMENT", "object": "Genotyping is performed to determine apoe4 status.", "chunk": 3}
{"article": "PMC8211849.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "May provide a basis to assess perfusion differences related to genotype", "chunk": 4}
{"article": "PMC8211849.txt", "subject": "CBF", "relationship": "RELATED_PROGNOSIS", "object": "CBF rebound following exercise", "chunk": 5}
{"article": "PMC8211849.txt", "subject": "BDNF", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Optimization of pre- and post- processing techniques revealed higher BDNF levels in plasma", "chunk": 5}
{"article": "PMC8211849.txt", "subject": "apoe4", "relationship": "RELATED_TO", "object": "Alzheimer\u2019s disease", "chunk": 6}
{"article": "PMC8211849.txt", "subject": "BDNF", "relationship": "RELATED_TO", "object": "Brain health", "chunk": 6}
{"article": "PMC8211849.txt", "subject": "VEGF", "relationship": "RELATED_TO", "object": "Brain health", "chunk": 6}
{"article": "PMC8211849.txt", "subject": "IGF1", "relationship": "RELATED_TO", "object": "Brain health", "chunk": 6}
{"article": "PMC8225898.txt", "subject": "intraindividual variability", "relationship": "RELATED_TO", "object": "detection of abnormal cognition", "chunk": 1}
{"article": "PMC8225898.txt", "subject": "high intraindividual variability", "relationship": "CAUSES", "object": "inaccuracy of cross-sectional assessments in predicting future cognitive performance and risk of cognitive decline", "chunk": 1}
{"article": "PMC8225898.txt", "subject": "conventional neuropsychological assessments", "relationship": " ASSOCIATED_WITH", "object": "high intraindividual variability", "chunk": 1}
{"article": "PMC8225898.txt", "subject": "digital neuro signature", "relationship": "RELATED_TO", "object": "capturing longitudinal individual-level change", "chunk": 1}
{"article": "PMC8225898.txt", "subject": "digital neuro signature", "relationship": "RELATED_TO", "object": "lower intraindividual variability", "chunk": 1}
{"article": "PMC8225898.txt", "subject": "digital neuro signature (DNS)", "relationship": "IS_MORE_SENSITIVE_THAN", "object": "conventional neuropsychological assessments", "chunk": 1}
{"article": "PMC8225898.txt", "subject": "DNS-intraindividual variability", "relationship": "PREDICTS", "object": "conversion from mild cognitive impairment  to Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC8225898.txt", "subject": "IIV", "relationship": "INDICATES_PRESENCE_OF", "object": "cognitive decline", "chunk": 2}
{"article": "PMC8225898.txt", "subject": "IIV", "relationship": "RELATED_TO", "object": "prodromal stages of AD", "chunk": 2}
{"article": "PMC8225898.txt", "subject": "apoe4 allele", "relationship": "RELATED_TO", "object": "amnestic mild cognitive impairment", "chunk": 2}
{"article": "PMC8225898.txt", "subject": "High levels of IIV in reaction time", "relationship": "PREDICTS", "object": "impending cognitive decline", "chunk": 2}
{"article": "PMC8225898.txt", "subject": "High levels of IIV in reaction time", "relationship": "ASSOCIATED_WITH", "object": "increased mortality risk", "chunk": 2}
{"article": "PMC8225898.txt", "subject": "Reaction time variability", "relationship": "RELATED_TO", "object": "Impending cognitive decline", "chunk": 2}
{"article": "PMC8225898.txt", "subject": "Accuracy-based IIV observations", "relationship": "USEFUL_FOR", "object": "differentiating between patients with AD, Parkinson\u2019s disease, and healthy controls", "chunk": 2}
{"article": "PMC8225898.txt", "subject": "Altoida Digital Neuro Signature (DNS)", "relationship": "PREDICTS", "object": "risk of developing mild cognitive impairment due to AD", "chunk": 2}
{"article": "PMC8225898.txt", "subject": "Altoida Digital Neuro Signature (DNS)", "relationship": "IS_RELATED_TO", "object": "cognitive decline", "chunk": 2}
{"article": "PMC8225898.txt", "subject": "Altoida DNS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Identifying markers of disease trajectory trends for treatment selection", "chunk": 4}
{"article": "PMC8225898.txt", "subject": "Altoida DNS", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Provides information for therapy choices due to its prediction of AD conversion", "chunk": 4}
{"article": "PMC8225898.txt", "subject": "IIV", "relationship": "PREDICTS_SURVIVAL", "object": "Predicts the transition from MCI to AD", "chunk": 4}
{"article": "PMC8225898.txt", "subject": "Altoida DNS", "relationship": "RELATED_TREATMENT", "object": "Used for monitoring disease progression in cognitive aging and for  patient monitoring in clinical trials", "chunk": 4}
{"article": "PMC8225898.txt", "subject": "Altoida DNS", "relationship": "RELATED_TREATMENT", "object": "Useful for lifestyle interventions to delay conversion from MCI to AD", "chunk": 4}
{"article": "PMC8225898.txt", "subject": "ApoE genotype", "relationship": "DIAGNOSITC_OF", "object": "Mild cognitive impairment", "chunk": 5}
{"article": "PMC8225898.txt", "subject": "cerebral spinal fluid", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer\u2019s dementia", "chunk": 5}
{"article": "PMC8225898.txt", "subject": "brain MRI", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer\u2019s dementia", "chunk": 5}
{"article": "PMC8225898.txt", "subject": "\u03b2-amyloid", "relationship": "DIAGNOSTIC_OF", "object": "Mild Cognitive Impairment and Dementia due to AD (aMCI and AD)", "chunk": 6}
{"article": "PMC8225898.txt", "subject": "p-tau", "relationship": "DIAGNOSTIC_OF", "object": "Mild Cognitive Impairment and Dementia due to AD (aMCI and AD)", "chunk": 6}
{"article": "PMC8225898.txt", "subject": "total tau protein", "relationship": "DIAGNOSTIC_OF", "object": "Mild Cognitive Impairment and Dementia due to AD (aMCI and AD)", "chunk": 6}
{"article": "PMC8225898.txt", "subject": "\u03b2-amyloid and p-tau and total tau protein cerebral spinal fluid levels", "relationship": "RELATED_TO", "object": "classification in diagnostic clusters of mild cognitive impairment and dementia due to AD (aMCI and AD), or mild cognitive impairment and dementia not associated with AD (naMCI and nADD)", "chunk": 6}
{"article": "PMC8225898.txt", "subject": "IIV", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "the IIV is a highly sensitive predictor of disease onset and conversion to AD", "chunk": 7}
{"article": "PMC8225898.txt", "subject": "IIV", "relationship": "RELATED_PROGNOSIS", "object": "The IIV is a highly sensitive predictor of disease onset and conversion to AD", "chunk": 7}
{"article": "PMC8246599.txt", "subject": "thiamine", "relationship": "INDICATES_PRESENCE_OF", "object": "Interference with energy metabolism, neuronal functioning, and cognitive development", "chunk": 1}
{"article": "PMC8246599.txt", "subject": "thiamine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment for thiamine deficiency", "chunk": 1}
{"article": "PMC8246599.txt", "subject": "thiamine", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment in infancy", "chunk": 1}
{"article": "PMC8246599.txt", "subject": "Whole blood thiamine diphosphate (ThDP) concentrations", "relationship": "RELATED_PROGNOSIS", "object": "Impact of longer-term maternal intake of various doses of oral thiamine on maternal and infant thiamine biomarkers", "chunk": 2}
{"article": "PMC8246599.txt", "subject": "Erythrocyte transketolase activity coefficients (ETKac)", "relationship": "RELATED_PROGNOSIS", "object": "Impact of longer-term maternal intake of various doses of oral thiamine on maternal and infant thiamine biomarkers", "chunk": 2}
{"article": "PMC8246599.txt", "subject": "Human milk total thiamine concentrations", "relationship": "RELATED_PROGNOSIS", "object": "Impact of longer-term maternal intake of various doses of oral thiamine on maternal and infant thiamine biomarkers", "chunk": 2}
{"article": "PMC8246599.txt", "subject": "ThDP", "relationship": "RELATED_TREATMENT", "object": "treatment with thiamine", "chunk": 5}
{"article": "PMC8246599.txt", "subject": "ThDP", "relationship": "RELATED_PROGNOSIS", "object": "Whole blood ThDP concentrations are calculated.", "chunk": 5}
{"article": "PMC8246599.txt", "subject": "ETKac", "relationship": "RELATED_TREATMENT", "object": "treatment with thiamine", "chunk": 5}
{"article": "PMC8246599.txt", "subject": "ETKac", "relationship": "RELATED_PROGNOSIS", "object": "Erythrocyte transketolase activity coefficient at 2 wk is calculated.", "chunk": 5}
{"article": "PMC8246599.txt", "subject": "Human milk total thiamine concentrations", "relationship": "RELATED_TREATMENT", "object": "treatment with thiamine", "chunk": 5}
{"article": "PMC8246599.txt", "subject": "ThDP concentrations", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Thiamine supplementation", "chunk": 6}
{"article": "PMC8246599.txt", "subject": "ThDP concentrations", "relationship": "MONITORED_DURING_TREATMENT", "object": "Infant thiamine status", "chunk": 6}
{"article": "PMC8246599.txt", "subject": "ETKac ratios", "relationship": "DICAGATONS_OF", "object": "Thiamine status", "chunk": 6}
{"article": "PMC8246599.txt", "subject": "ETKac ratios", "relationship": "RELATED_PROGNOSIS", "object": "Thiamine status", "chunk": 6}
{"article": "PMC8246599.txt", "subject": "ETKac", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Assessment of basal transketolase activity alone could be a better indicator of thiamine status among infants", "chunk": 7}
{"article": "PMC8246599.txt", "subject": "ThDP", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "ThDP concentrations are used to assess thiamine status", "chunk": 7}
{"article": "PMC8246599.txt", "subject": "ThDP", "relationship": "USED_TO_DIAGNOSE", "object": "Comparing ThDP levels to whole blood values can help diagnose deficiency", "chunk": 7}
{"article": "PMC8246599.txt", "subject": "ThDP", "relationship": "RELATED_PROGNOSIS", "object": "Higher ThDP levels in infants suggest better thiamine status", "chunk": 7}
{"article": "PMC8246599.txt", "subject": "ThDP", "relationship": "MONITORED_DURING_TREATMENT", "object": "ThDP levels are monitored during thiamine supplementation to assess efficacy", "chunk": 7}
{"article": "PMC8246599.txt", "subject": "ETKac", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measurement of ETKac, even though less common, is a good indicator of thiamine status", "chunk": 7}
{"article": "PMC8258160.txt", "subject": "microglia", "relationship": "RELATED_TO", "object": "neuroinflammation and neurodegenerative pathology", "chunk": 1}
{"article": "PMC8258160.txt", "subject": "Age-related changes", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "chronic neuroinflammation and thus dementia", "chunk": 1}
{"article": "PMC8258160.txt", "subject": "T cells and B cells", "relationship": "ASSOCIATED_WITH", "object": "chronic neuroinflammation", "chunk": 1}
{"article": "PMC8258160.txt", "subject": "Amyloid plaques and Neurofibrillary tangles", "relationship": "RELATED_PROGNOSIS", "object": "cognitive decline and dementia", "chunk": 1}
{"article": "PMC8258160.txt", "subject": "Vascular contribution to cognitive impairment", "relationship": "RELATED_PROGNOSIS", "object": "dementia", "chunk": 1}
{"article": "PMC8258160.txt", "subject": "IL-1", "relationship": "INDICATES_PRESENCE_OF", "object": "AD patients' brains", "chunk": 2}
{"article": "PMC8258160.txt", "subject": "IL-1\u03b2", "relationship": "ASSOCIATED_WITH", "object": "Higher circulating cytokine amounts in individuals with AD", "chunk": 2}
{"article": "PMC8258160.txt", "subject": "IL-6", "relationship": "ASSOCIATED_WITH", "object": "Higher circulating cytokine amounts in individuals with AD", "chunk": 2}
{"article": "PMC8258160.txt", "subject": "IL-18", "relationship": "ASSOCIATED_WITH", "object": "Higher circulating cytokine amounts in individuals with AD", "chunk": 2}
{"article": "PMC8258160.txt", "subject": "TNF\u03b1", "relationship": "ASSOCIATED_WITH", "object": "Higher circulating cytokine amounts in individuals with AD", "chunk": 2}
{"article": "PMC8258160.txt", "subject": "granulocytes-to-lymphocyte ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk for developing all-cause dementia", "chunk": 5}
{"article": "PMC8258160.txt", "subject": "platelets-to-lymphocyte", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower indicators of adaptive immunity", "chunk": 5}
{"article": "PMC8258160.txt", "subject": "lymphocyte number", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Decrease in lymphocyte number", "chunk": 5}
{"article": "PMC8258160.txt", "subject": "neutrophile number", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increase in neutrophil number", "chunk": 5}
{"article": "PMC8258160.txt", "subject": "neutrophil-to-lymphocyte ratios", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased neutrophil-to-lymphocyte ratios", "chunk": 5}
{"article": "PMC8258160.txt", "subject": "granulocytes", "relationship": "RELATED_PROGNOSIS", "object": "Exacerbation of normal age-related changes in immune balance", "chunk": 5}
{"article": "PMC8258160.txt", "subject": "lymphocytes", "relationship": "RELATED_PROGNOSIS", "object": "Declined number of adaptive immune cells", "chunk": 5}
{"article": "PMC8258160.txt", "subject": "CD4", "relationship": "INDICATES_PRESENCE_OF", "object": "Severe dementia", "chunk": 6}
{"article": "PMC8258160.txt", "subject": "CD8", "relationship": "INDICATES_PRESENCE_OF", "object": "Severe dementia", "chunk": 6}
{"article": "PMC8258160.txt", "subject": "CD4", "relationship": "RELATED_TREATMENT", "object": "B cell suppression", "chunk": 6}
{"article": "PMC8258160.txt", "subject": "CD8", "relationship": "RELATED_TREATMENT", "object": "B cell suppression", "chunk": 6}
{"article": "PMC8258160.txt", "subject": "CD8+ TEMRA", "relationship": "INDICATES_PRESENCE_OF", "object": "Worse cognitive function", "chunk": 6}
{"article": "PMC8258160.txt", "subject": "CD8+ TEMRA", "relationship": "RELATED_TREATMENT", "object": "Clonal expansion in CSF ", "chunk": 6}
{"article": "PMC8258160.txt", "subject": "IL-1", "relationship": "RELATED_PROGNOSIS", "object": "Higher levels correlated with higher levels of immune cell activation.", "chunk": 7}
{"article": "PMC8258160.txt", "subject": "IL-6", "relationship": "RELATED_PROGNOSIS", "object": "Higher levels correlated with higher levels of immune cell activation.", "chunk": 7}
{"article": "PMC8258160.txt", "subject": "IL-1\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Decreased levels found in Down's syndrome individuals, compared to age-matched controls.", "chunk": 7}
{"article": "PMC8258160.txt", "subject": "IL-4", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Decreased levels observed in AD patients compared to controls, potentially contributing to an increased pro-inflammatory state.", "chunk": 7}
{"article": "PMC8258160.txt", "subject": "IFN\u03b3", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Elevated production found in AD patient CD8 T cells compared to age-matched controls, possibly contributing to inflammation.", "chunk": 7}
{"article": "PMC8258160.txt", "subject": "TNF\u03b1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Elevated production found in AD patient CD8 T cells compared to age-matched controls, potentially contributing to inflammation.", "chunk": 7}
{"article": "PMC8258160.txt", "subject": "IgG+IgD\u2013CD27\u2013 B cells", "relationship": "DIAGNOSITC_OF", "object": "Increased levels in peripheral blood of patients with moderate to severe AD compared to those with mild AD or no cognitive impairment.", "chunk": 7}
{"article": "PMC8258160.txt", "subject": "B1 cells", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-beta clearance in people and mice", "chunk": 8}
{"article": "PMC8258160.txt", "subject": "B1 cells", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-beta plaque formation", "chunk": 8}
{"article": "PMC8258160.txt", "subject": "IgM", "relationship": "INDICATOR_PRESENCE_OF", "object": "Amyloid-beta clearance in people and mice", "chunk": 8}
{"article": "PMC8258160.txt", "subject": "memory T cells", "relationship": "RELATED_PROGNOSIS", "object": "Decline in cognitive function in AD", "chunk": 8}
{"article": "PMC8258160.txt", "subject": "TEMRA T cells", "relationship": "RELATED_PROGNOSIS", "object": "Decline in cognitive function in AD", "chunk": 8}
{"article": "PMC8258160.txt", "subject": "Th17s", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive dysfunction", "chunk": 9}
{"article": "PMC8258160.txt", "subject": "Th17-cytokines (IL-17, IL-22)", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive dysfunction", "chunk": 9}
{"article": "PMC8258160.txt", "subject": "blockade of immune checkpoints, such as PD-1", "relationship": "RELATED_TREATMENT", "object": "Improved outcomes in multiple AD-relevant animal models", "chunk": 9}
{"article": "PMC8258160.txt", "subject": "IL-7", "relationship": "RELATED_TREATMENT", "object": "Replenish the depleted immune system", "chunk": 9}
{"article": "PMC8258160.txt", "subject": "checkpoint inhibitors like PD-1", "relationship": "RELATED_TREATMENT", "object": "Replenish the depleted immune system", "chunk": 9}
{"article": "PMC8266337.txt", "subject": "Streptococcus", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "neural damage, cerebral microbleeds, and cognitive impairment", "chunk": 2}
{"article": "PMC8266337.txt", "subject": "Lachnospiraceae", "relationship": "RELATED_PROGNOSIS", "object": "worse clinical profile, including higher frequencies of cognitive impairment", "chunk": 2}
{"article": "PMC8266337.txt", "subject": "Lachnospiraceae", "relationship": "RELATED_PROGNOSIS", "object": "good cognition behaviors independent of clinical variables", "chunk": 2}
{"article": "PMC8266337.txt", "subject": "Pseudoflavonifractor", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "weight loss of obese patients", "chunk": 2}
{"article": "PMC8266337.txt", "subject": "Pseudoflavonifractor", "relationship": "RELATED_TREATMENT", "object": "producing short-chain fatty acids", "chunk": 2}
{"article": "PMC8266337.txt", "subject": "Lachnospiraceae", "relationship": "ASSOCIATED_WITH_LEARNING", "object": "functions of the hosts", "chunk": 3}
{"article": "PMC8266337.txt", "subject": "Streptococcus", "relationship": "ASSOCIATED_WITH_LEARNING", "object": "and memory functions of the hosts", "chunk": 3}
{"article": "PMC8280160.txt", "subject": "plasma p-tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease pathology", "chunk": 1}
{"article": "PMC8280160.txt", "subject": "plasma p-tau181", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnostic tool for Alzheimer's disease in Down syndrome", "chunk": 1}
{"article": "PMC8280160.txt", "subject": "plasma p-tau181", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Detection of Alzheimer's disease in Down syndrome", "chunk": 1}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "DIAGNOSITC_OF", "object": "Differentiate AD from other neurodegenerative disorders", "chunk": 2}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "RELATED_PROGNOSIS", "object": "Prodromal AD and AD dementia stage", "chunk": 2}
{"article": "PMC8280160.txt", "subject": "plasma p-tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "Early stage of AD in DS", "chunk": 2}
{"article": "PMC8280160.txt", "subject": "plasma p-tau181 levels", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased AD severity", "chunk": 2}
{"article": "PMC8280160.txt", "subject": "cerebral p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Early stage of AD in DS", "chunk": 2}
{"article": "PMC8280160.txt", "subject": "NfL", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebrospinal fluid", "chunk": 2}
{"article": "PMC8280160.txt", "subject": "NfL", "relationship": "INDICATES_PRESENCE_OF", "object": "AD progression in DS", "chunk": 2}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "DIAGNOSITC_OF", "object": "AD in DS", "chunk": 3}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "RELATED_TO", "object": "plasma NfL concentration", "chunk": 3}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "RELATED_TO", "object": "cerebral spinal fluid ratio A\u03b21-42/1-40", "chunk": 3}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "RELATED_TO", "object": "cerebral spinal fluid concentration of total tau", "chunk": 3}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "RELATED_TO", "object": "cerebral spinal fluid concentration of p-tau181", "chunk": 3}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "RELATED_TO", "object": "cerebral spinal fluid concentration of NfL", "chunk": 3}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "RELATED_TO", "object": "atropny measured by MRI", "chunk": 3}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "RELATED_TO", "object": "lower brain metabolism in temporoparietal regions measured by FDG-PET", "chunk": 3}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "Central tau pathology", "chunk": 3}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "DIAGNOSITC_OF", "object": "Diagnose: Early-onset Alzheimer's Disease", "chunk": 4}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid \u03b2 PET positivity", "chunk": 4}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "RELATED_PROGNOSIS", "object": "Disease progression", "chunk": 4}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "MONITORED_DURING_TREATMENT", "object": "Trials with anti-tau compounds", "chunk": 4}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "AD in DS", "chunk": 5}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "RELATED_PROGNOSIS", "object": "Hallmarks of AD observed in other biomarker modalities", "chunk": 5}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "ClinicalTrials in DS", "chunk": 5}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "MONITORED_DURING_TREATMENT", "object": "Drug effects on tau pathology", "chunk": 5}
{"article": "PMC8280160.txt", "subject": "NfL", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "ClinicalTrials in DS", "chunk": 5}
{"article": "PMC8280160.txt", "subject": "NfL", "relationship": "MONITORED_DURING_TREATMENT", "object": "Drug effects on tau pathology", "chunk": 5}
{"article": "PMC8280160.txt", "subject": "A\u03b211-42", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Alzheimer's Disease", "chunk": 6}
{"article": "PMC8280160.txt", "subject": "A\u03b21-40", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Alzheimer's Disease", "chunk": 6}
{"article": "PMC8280160.txt", "subject": "p-tau181", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Alzheimer's Disease", "chunk": 6}
{"article": "PMC8280160.txt", "subject": "total tau", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Alzheimer's Disease", "chunk": 6}
{"article": "PMC8280160.txt", "subject": "NfL", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Alzheimer's Disease", "chunk": 6}
{"article": "PMC8280160.txt", "subject": "plasma p-tau181", "relationship": "RELATED_PROGNOSIS", "object": "Prognosis in individuals with Down's Syndrome", "chunk": 6}
{"article": "PMC8280160.txt", "subject": "Markers of synaptopathy", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosing and treating neurodegenerative disorders", "chunk": 7}
{"article": "PMC8281974.txt", "subject": "EEG", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "development of potential digital biomarkers for neuropsychiatric and neurodegenerative disorders", "chunk": 1}
{"article": "PMC8281974.txt", "subject": "EEG", "relationship": "DIAGNOSITC_OF", "object": "diseases such as schizophrenia, depression and Alzheimer's disease", "chunk": 1}
{"article": "PMC8281974.txt", "subject": "EEG", "relationship": "RELATED_TREATMENT", "object": "allows for more frequent sampling and detection of subtle daily fluctuations, at minimal disruption to the patient", "chunk": 1}
{"article": "PMC8281974.txt", "subject": "EEG", "relationship": "MONITORED_DURING_TREATMENT", "object": "therapeutic response", "chunk": 1}
{"article": "PMC8281974.txt", "subject": "MoCA score", "relationship": "INDICATES_PRESENCE_OF", "object": "Healthy adults", "chunk": 4}
{"article": "PMC8281974.txt", "subject": "System Usability Scale (SUS)", "relationship": "RELATED_TO", "object": "Usability of the system", "chunk": 4}
{"article": "PMC8281974.txt", "subject": "P300", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Decline", "chunk": 7}
{"article": "PMC8281974.txt", "subject": "P300", "relationship": "RELATED_PROGNOSIS", "object": "Ageing", "chunk": 7}
{"article": "PMC8281974.txt", "subject": "ERN", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive Control", "chunk": 7}
{"article": "PMC8281974.txt", "subject": "EEG", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Determining Treatment Approaches in Neuropsychiatric Disorders", "chunk": 8}
{"article": "PMC8281974.txt", "subject": "EEG", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measurement of Treatment Response in Psychiatry", "chunk": 8}
{"article": "PMC8281974.txt", "subject": "EEG", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Personalized Medicine Interventions", "chunk": 8}
{"article": "PMC8287201.txt", "subject": "Default Mode Network (DMN)", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 2}
{"article": "PMC8287201.txt", "subject": "Fronto-Parietal Network (FPN)", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 2}
{"article": "PMC8287201.txt", "subject": "DLPFC node of the FPN", "relationship": "RELATED_TO", "object": "rTMS studies in AD", "chunk": 2}
{"article": "PMC8287201.txt", "subject": "IPL node of the DMN", "relationship": "RELATED_TO", "object": "rTMS studies in AD", "chunk": 2}
{"article": "PMC8287201.txt", "subject": "IPL", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Tailored network-based rTMS protocols", "chunk": 6}
{"article": "PMC8287201.txt", "subject": "DMN", "relationship": "RELATED_PROGNOSIS", "object": "Pathological aging and healthy aging", "chunk": 6}
{"article": "PMC8287201.txt", "subject": "FPN", "relationship": "RELATED_PROGNOSIS", "object": "Pathological aging and healthy aging", "chunk": 6}
{"article": "PMC8287201.txt", "subject": "BA9", "relationship": "RELATED_PROGNOSIS", "object": "Pathological aging", "chunk": 6}
{"article": "PMC8287201.txt", "subject": "BA46", "relationship": "RELATED_PROGNOSIS", "object": "Pathological aging", "chunk": 6}
{"article": "PMC8294388.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "A\u03b2 is a target of treatment in the PIONEER and SUSTAIN trials.", "chunk": 2}
{"article": "PMC8294388.txt", "subject": "tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Tau is a target of treatment in the PIONEER and SUSTAIN trials.", "chunk": 2}
{"article": "PMC8294388.txt", "subject": "semaglutide", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of type 2 Diabetes Mellitus", "chunk": 7}
{"article": "PMC8294388.txt", "subject": "semaglutide", "relationship": "DOES_NOT_PREDICT", "object": "Pancreatitis incidence", "chunk": 7}
{"article": "PMC8294388.txt", "subject": "semaglutide", "relationship": "DOES_NOT_PREDICT", "object": "Pancreatic Cancer incidence", "chunk": 7}
{"article": "PMC8294388.txt", "subject": "semaglutide", "relationship": "RELATED_PROGNOSIS", "object": "weight loss", "chunk": 7}
{"article": "PMC8294388.txt", "subject": "semaglutide", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Prevention or treatment of gastrointestinal disturbances", "chunk": 7}
{"article": "PMC8294388.txt", "subject": "semaglutide", "relationship": "MONITORED_DURING_TREATMENT", "object": "pancreatic lipase levels", "chunk": 7}
{"article": "PMC8294388.txt", "subject": "semaglutide", "relationship": "MONITORED_DURING_TREATMENT", "object": "pancreatic amylase levels", "chunk": 7}
{"article": "PMC8294388.txt", "subject": "Serum calcitonin", "relationship": "MONITORED_DURING_TREATMENT", "object": "SUSTAIN trials", "chunk": 8}
{"article": "PMC8294388.txt", "subject": "Serum calcitonin", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Treatment response", "chunk": 8}
{"article": "PMC8294388.txt", "subject": "semaglutide", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "DRP complications", "chunk": 9}
{"article": "PMC8294388.txt", "subject": "semaglutide", "relationship": "RELATED_TREATMENT", "object": "acute kidney injury", "chunk": 9}
{"article": "PMC8294388.txt", "subject": "semaglutide", "relationship": "INDContinued_BY_DIETH", "object": "renal outcomes", "chunk": 9}
{"article": "PMC8302739.txt", "subject": "APOE-\u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "Earlier age at onset of Alzheimer's disease", "chunk": 1}
{"article": "PMC8302739.txt", "subject": "APOE-\u03b54 allele", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Associated with earlier age at onset", "chunk": 1}
{"article": "PMC8302739.txt", "subject": "APOE-\u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk for Alzheimer's disease", "chunk": 1}
{"article": "PMC8302739.txt", "subject": "APOE \u03b52", "relationship": "RELATED_TO_TREATMENT", "object": "Used as an adjustment factor in PRS models alongside SNP selection", "chunk": 2}
{"article": "PMC8302739.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TO_TREATMENT", "object": "Used as an adjustment factor in PRS models alongside SNP selection", "chunk": 2}
{"article": "PMC8302739.txt", "subject": "APOE(\u03b52\u2009+\u2009\u03b54)", "relationship": "INDICATES_PRESENCE_OF", "object": "Higher AD risk", "chunk": 2}
{"article": "PMC8302739.txt", "subject": "APOE(\u03b52\u2009+\u2009\u03b54)", "relationship": "USED_TO_DIAGNOSE", "object": "Used to identify patients at high risk for AD", "chunk": 2}
{"article": "PMC8302739.txt", "subject": "APOE-\u03b54", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Informed by the simulation results, we explored the APOE-\u03b54 allele frequencies in the case-control dataset with age", "chunk": 3}
{"article": "PMC8302739.txt", "subject": "APOE-\u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Clearly, APOE and ORS will serve as better predictors of AD risk at younger ages.", "chunk": 3}
{"article": "PMC8302739.txt", "subject": "APOE-\u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "The \u03b54 allele frequency in this data set decreases with age", "chunk": 3}
{"article": "PMC8302739.txt", "subject": "APOE-\u03b54", "relationship": "DIAGNOSTIC_OF", "object": "the allele frequencies in cases and controls as 0.356 and 0.142, respectively", "chunk": 3}
{"article": "PMC8302739.txt", "subject": "APOE(\u03b52\u2009+\u2009\u03b54)", "relationship": "RELATED_TREATMENT", "object": "The best prediction accuracy (AUC\u2009=\u200974.1%) and the highest variance explained (R2\u2009=\u20090.24) is achieved by the PRS.AD model where PRS.no.APOE is combined with APOE(\u03b52\u2009+\u2009\u03b54)", "chunk": 3}
{"article": "PMC8302739.txt", "subject": "APOE", "relationship": "RELATED_PROGNOSIS", "object": "modelled separately and subsequently added to PRS.no.APOE", "chunk": 4}
{"article": "PMC8302739.txt", "subject": "APOE", "relationship": "RELATED_PROGNOSIS", "object": "both prediction metrics (AUC, R2) are better", "chunk": 4}
{"article": "PMC8302739.txt", "subject": "APOE", "relationship": "RELATED_PROGNOSIS", "object": "PRS.AD  using each method.", "chunk": 4}
{"article": "PMC8302739.txt", "subject": "APOE", "relationship": "RELATED_TREATMENT", "object": "PRS.AD model using each method.", "chunk": 4}
{"article": "PMC8302739.txt", "subject": "APOE-\u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk for Alzheimer's disease", "chunk": 5}
{"article": "PMC8302739.txt", "subject": "APOE-\u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Lower burden of common AD risk alleles", "chunk": 5}
{"article": "PMC8302739.txt", "subject": "PRS.no.APOE", "relationship": "USED_TO_DIAGNOSE", "object": "Predict the likelihood of Alzheimer's disease", "chunk": 5}
{"article": "PMC8302739.txt", "subject": "APOE-\u03b54", "relationship": "RELATED_PROGNOSIS", "object": "survival by altering the age at onset of AD", "chunk": 6}
{"article": "PMC8302739.txt", "subject": "APOE-\u03b54", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Hyperlipidaemia, atherosclerosis, cardiovascular disease ", "chunk": 6}
{"article": "PMC8302739.txt", "subject": "APOE-\u03b54", "relationship": "PREDICTED_SURVIVAL", "object": "age at onset of AD", "chunk": 6}
{"article": "PMC8302739.txt", "subject": "APOE genotype", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Prediction accuracy", "chunk": 6}
{"article": "PMC8302739.txt", "subject": "APOE", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC8302739.txt", "subject": "APOE \u03b52", "relationship": "RELATED_TREATMENT", "object": "Indicates a specific APOE allele effect", "chunk": 7}
{"article": "PMC8302739.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "Indicates a specific APOE allele effect", "chunk": 7}
{"article": "PMC8302739.txt", "subject": "APOE-\u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 8}
{"article": "PMC8305709.txt", "subject": "MMSE", "relationship": "RELATED_TO", "object": "The cognitive assessment of people with dementia", "chunk": 1}
{"article": "PMC8305709.txt", "subject": "CASI", "relationship": "RELATED_TO", "object": "The assessment of general cognitive function", "chunk": 1}
{"article": "PMC8305709.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "Cognitive impairment", "chunk": 1}
{"article": "PMC8305709.txt", "subject": "CASI", "relationship": "DIAGNOSITC_OF", "object": "Cognitive impairment", "chunk": 1}
{"article": "PMC8305709.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 2}
{"article": "PMC8305709.txt", "subject": "CDR", "relationship": "RELATED_PROGNOSIS", "object": "Severity of dementia", "chunk": 2}
{"article": "PMC8305709.txt", "subject": "CDR Score 0", "relationship": "RELATED_PROGNOSIS", "object": "Healthy", "chunk": 2}
{"article": "PMC8305709.txt", "subject": "CDR Score 0.5", "relationship": "RELATED_PROGNOSIS", "object": "Questionable Dementia", "chunk": 2}
{"article": "PMC8305709.txt", "subject": "CDR Score 1", "relationship": "RELATED_PROGNOSIS", "object": "Mild Dementia", "chunk": 2}
{"article": "PMC8305709.txt", "subject": "CDR Score 2", "relationship": "RELATED_PROGNOSIS", "object": "Moderate Dementia", "chunk": 2}
{"article": "PMC8305709.txt", "subject": "CDR Score 3", "relationship": "RELATED_PROGNOSIS", "object": "Severe Dementia", "chunk": 2}
{"article": "PMC8314554.txt", "subject": "A\u03b242/40", "relationship": "DIAGNOSITC_OF", "object": "Low Burden of A\u03b2 Pathology", "chunk": 1}
{"article": "PMC8314554.txt", "subject": "A\u03b242/40", "relationship": "INDICATES_PRESENCE_OF", "object": "Low Burden of A\u03b2 Pathology", "chunk": 1}
{"article": "PMC8314554.txt", "subject": "A\u03b242/40", "relationship": "USED_TO_DIAGNOSE", "object": "Low Burden of A\u03b2 Pathology", "chunk": 1}
{"article": "PMC8314554.txt", "subject": "p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Low Burden of A\u03b2 Pathology", "chunk": 1}
{"article": "PMC8314554.txt", "subject": "t-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Low Burden of A\u03b2 Pathology", "chunk": 1}
{"article": "PMC8314554.txt", "subject": "NfL", "relationship": "INDICATES_PRESENCE_OF", "object": "Low Burden of A\u03b2 Pathology", "chunk": 1}
{"article": "PMC8314554.txt", "subject": "neurogranin", "relationship": "INDICATES_PRESENCE_OF", "object": "Low Burden of A\u03b2 Pathology", "chunk": 1}
{"article": "PMC8314554.txt", "subject": "amyloid-\u03b2 (A\u03b2)", "relationship": "DIAGNOSITC_OF", "object": "Early-onset Alzheimer's disease", "chunk": 2}
{"article": "PMC8314554.txt", "subject": "amyloid-\u03b2 (A\u03b2)", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's continuum", "chunk": 2}
{"article": "PMC8314554.txt", "subject": "A\u03b2 PET", "relationship": "RELATED_PROGNOSIS", "object": "cognitive decline and tau deposition", "chunk": 2}
{"article": "PMC8314554.txt", "subject": "subthreshold A\u03b2 PET levels", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 downstream pathophysiological changes", "chunk": 2}
{"article": "PMC8314554.txt", "subject": "subthreshold A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "cognitive decline", "chunk": 2}
{"article": "PMC8314554.txt", "subject": "A\u03b242/40 ratio", "relationship": "DIAGNOSITC_OF", "object": "A\u03b2-negative status", "chunk": 2}
{"article": "PMC8314554.txt", "subject": "p-tau", "relationship": "DIAGNOSITC_OF", "object": "tau-positive", "chunk": 2}
{"article": "PMC8314554.txt", "subject": "A\u03b242", "relationship": "IS_TARGET_OF_TREATMENT", "object": "A\u03b2-lowering interventions", "chunk": 2}
{"article": "PMC8314554.txt", "subject": "cerebral spinal fluid biomarkers", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Identification of individuals with a low burden of A\u03b2 pathology", "chunk": 2}
{"article": "PMC8314554.txt", "subject": "A\u03b2 PET", "relationship": "INDICATES_PRESENCE_OF", "object": "subtle A\u03b2 pathology", "chunk": 2}
{"article": "PMC8314554.txt", "subject": "cerebral spinal fluid biomarkers and PET A\u03b2", "relationship": "RELATED_TREATMENT", "object": "Identification of individuals with a low burden of A\u03b2 pathology", "chunk": 2}
{"article": "PMC8314554.txt", "subject": "A\u03b242/A\u03b240", "relationship": "DIAGNOSITC_OF", "object": " A\u03b2 pathology", "chunk": 3}
{"article": "PMC8314554.txt", "subject": "CL", "relationship": "RELATED_PROGNOSIS", "object": "A\u03b2 pathology", "chunk": 3}
{"article": "PMC8314554.txt", "subject": "A\u03b2 PET", "relationship": "RELATED_PROGNOSIS", "object": "A\u03b2 pathology", "chunk": 3}
{"article": "PMC8314554.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid A\u03b242/A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 pathology", "chunk": 3}
{"article": "PMC8314554.txt", "subject": "CL values", "relationship": "RELATED_PROGNOSIS", "object": "A\u03b2 pathology", "chunk": 3}
{"article": "PMC8314554.txt", "subject": "A\u03b2 PET visual read", "relationship": "RELATED_PROGNOSIS", "object": "A\u03b2 pathology", "chunk": 3}
{"article": "PMC8314554.txt", "subject": "A\u03b2- ", "relationship": "RELATED_PROGNOSIS", "object": "participants were younger than those in  A\u03b2+ group", "chunk": 4}
{"article": "PMC8314554.txt", "subject": "A\u03b2+ ", "relationship": "RELATED_PROGNOSIS", "object": "participants were older than those in A\u03b2- group", "chunk": 4}
{"article": "PMC8314554.txt", "subject": "A\u03b2+ ", "relationship": "RELATED_PROGNOSIS", "object": "participants were older than those in low burden group", "chunk": 4}
{"article": "PMC8314554.txt", "subject": "low burden group (definition 3)", "relationship": "RELATED_PROGNOSIS", "object": "participants were significantly older than the A\u03b2- group participants", "chunk": 4}
{"article": "PMC8314554.txt", "subject": "low burden group (definitions 1 and 2)", "relationship": "RELATED_PROGNOSIS", "object": "mean age did not differ from that of the A\u03b2- group", "chunk": 4}
{"article": "PMC8314554.txt", "subject": "low burden group (definitions 1 and 2)", "relationship": "INDICATES_PRESENCE_OF", "object": "higher prevalence of APOE-\u03b54 carriers than the A\u03b2- group", "chunk": 4}
{"article": "PMC8314554.txt", "subject": "definition 3 low burden group", "relationship": "RELATED_TREATMENT", "object": "all the individuals in its low burden group (n = 18) had also abnormal cerebral cerebral cerebral cerebral spinal fluid A\u03b242/40 levels", "chunk": 4}
{"article": "PMC8314554.txt", "subject": "p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's-related pathophysiological processes", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "t-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's-related pathophysiological processes", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "Neurogranin", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's-related pathophysiological processes", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "NfL", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's-related pathophysiological processes", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "p-tau", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "High levels", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "t-tau", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "High levels", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "Neurogranin", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "High levels", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "NfL", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "High levels", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "sTREM2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "High levels", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "YKL40", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "High levels", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "GFAP", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "High levels", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "sTREM2", "relationship": "RELATED_PROGNOSIS", "object": "Low burden group", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "YKL40", "relationship": "RELATED_PROGNOSIS", "object": "Low burden group", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "GFAP", "relationship": "RELATED_PROGNOSIS", "object": "Low burden group", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "p-tau", "relationship": "RELATED_TO", "object": "Cerebral spinal fluid", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "t-tau", "relationship": "RELATED_TO", "object": "Cerebral spinal fluid", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "Neurogranin", "relationship": "RELATED_TO", "object": "Cerebral spinal fluid", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "NfL", "relationship": "RELATED_TO", "object": "Cerebral spinal fluid", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "sTREM2", "relationship": "RELATED_TO", "object": "Cerebral spinal fluid", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "YKL40", "relationship": "RELATED_TO", "object": "Cerebral spinal fluid", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "GFAP", "relationship": "RELATED_TO", "object": "Cerebral spinal fluid", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "IL6", "relationship": "RELATED_TO", "object": "Cerebral spinal fluid", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "S100B", "relationship": "RELATED_TO", "object": "Cerebral spinal fluid", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "\u03b1-synuclein", "relationship": "RELATED_TO", "object": "Cerebral spinal fluid", "chunk": 5}
{"article": "PMC8314554.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid p-tau", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s continuum", "chunk": 6}
{"article": "PMC8314554.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid t-tau", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s continuum", "chunk": 6}
{"article": "PMC8314554.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid neurogranin", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s continuum", "chunk": 6}
{"article": "PMC8314554.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid NfL", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s continuum", "chunk": 6}
{"article": "PMC8314554.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s Disease", "chunk": 6}
{"article": "PMC8314554.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid t-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s Disease", "chunk": 6}
{"article": "PMC8314554.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid NfL", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s Disease", "chunk": 6}
{"article": "PMC8314554.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid neurogranin", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s Disease", "chunk": 6}
{"article": "PMC8314554.txt", "subject": "YKL40", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s Disease", "chunk": 6}
{"article": "PMC8314554.txt", "subject": "GFAP", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s Disease", "chunk": 6}
{"article": "PMC8314554.txt", "subject": "p-tau", "relationship": "INDIACATES_PRESENCE_OF", "object": "Low A\u03b2 pathology burden", "chunk": 7}
{"article": "PMC8314554.txt", "subject": "t-tau", "relationship": "INDIACATES_PRESENCE_OF", "object": "Low A\u03b2 pathology burden", "chunk": 7}
{"article": "PMC8314554.txt", "subject": "Neurogranin", "relationship": "RELATED_PROGNOSIS", "object": "Predict later-stage tau pathology or cognitive decline", "chunk": 7}
{"article": "PMC8314554.txt", "subject": "NfL", "relationship": "RELATED_PROGNOSIS", "object": "Predict later-stage tau pathology or cognitive decline", "chunk": 7}
{"article": "PMC8314554.txt", "subject": "A\u03b242/40", "relationship": "INDICATES_PRESENCE_OF", "object": "Very early stage of Alzheimer\u2019s continuum", "chunk": 7}
{"article": "PMC8314554.txt", "subject": "APOE-\u03b54", "relationship": "RELATED_TREATMENT", "object": "Prevalence may be affected by age and prevalence of APOE-\u03b54", "chunk": 7}
{"article": "PMC8314554.txt", "subject": "A\u03b2 pathology", "relationship": "INDICATES_PRESENCE_OF", "object": "Incipient stage of Alzheimer's Disease", "chunk": 8}
{"article": "PMC8314554.txt", "subject": "A\u03b2 pathology", "relationship": "RELATED_PROGNOSIS", "object": "Progression to symptomatic stages of Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC8314554.txt", "subject": "A\u03b2 PET", "relationship": "PREDICTOR_OF", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC8314554.txt", "subject": "A\u03b2 pathology", "relationship": "RELATED_TO", "object": "Structural and functional changes in the brain", "chunk": 8}
{"article": "PMC8314554.txt", "subject": "Subtle A\u03b2 changes", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Early prevention or intervention trials for Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC8316394.txt", "subject": "EFEs", "relationship": "INDICATES_PRESENCE_OF", "object": "Emotional states", "chunk": 2}
{"article": "PMC8316394.txt", "subject": "EFEs", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Assessing the impact of social context on a patient's socio-emotional engagement", "chunk": 2}
{"article": "PMC8316394.txt", "subject": "EFEs", "relationship": "MONITORED_DURING_TREATMENT", "object": "Musical activities", "chunk": 2}
{"article": "PMC8316394.txt", "subject": "EFEs+ and EFEs\u2212", "relationship": "RESPONDED_TO", "object": "Social context", "chunk": 2}
{"article": "PMC8316394.txt", "subject": "MMSE score", "relationship": "DIAGNOSITC_OF", "object": "Severity of Cognitive Impairment", "chunk": 3}
{"article": "PMC8316394.txt", "subject": "ADL score", "relationship": "RELATED_PROGNOSIS", "object": "Personal independence", "chunk": 3}
{"article": "PMC8317398.txt", "subject": "Bright light treatment (BLT)", "relationship": "RELATED_TREATMENT", "object": "BPSD", "chunk": 1}
{"article": "PMC8317398.txt", "subject": "Bright light treatment (BLT)", "relationship": "RELATED_TREATMENT", "object": "depression", "chunk": 1}
{"article": "PMC8317398.txt", "subject": "Bright light treatment (BLT)", "relationship": "RELATED_TREATMENT", "object": "agitation", "chunk": 1}
{"article": "PMC8317398.txt", "subject": "Bright light treatment (BLT)", "relationship": "RELATED_TREATMENT", "object": "sleep problems", "chunk": 1}
{"article": "PMC8317398.txt", "subject": "Bright light treatment (BLT)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Nursing home patients with dementia", "chunk": 1}
{"article": "PMC8317398.txt", "subject": "NPI-NH total", "relationship": "RELATED_TREATMENT", "object": "total score used  in multilevel regression models", "chunk": 4}
{"article": "PMC8317398.txt", "subject": "NPI-NH Affective symptoms", "relationship": "RELATED_TREATMENT", "object": "range: 0\u201324. part of multilevel regression models", "chunk": 4}
{"article": "PMC8317398.txt", "subject": "NPI-NH Psychosis", "relationship": "RELATED_TREATMENT", "object": "range: 0\u201324. part of multilevel regression models", "chunk": 4}
{"article": "PMC8317398.txt", "subject": "NPI-NH Agitation", "relationship": "RELATED_TREATMENT", "object": "range: 0\u201324. part of multilevel regression models", "chunk": 4}
{"article": "PMC8317398.txt", "subject": "NPI-NH total", "relationship": "MONITORED_DURING_TREATMENT", "object": "Multilevel regression models", "chunk": 4}
{"article": "PMC8317398.txt", "subject": "WASO", "relationship": "MONITORED_DURING_TREATMENT", "object": "Actigraphs worn on dominant wrist", "chunk": 4}
{"article": "PMC8317398.txt", "subject": "Estimated light exposure time", "relationship": "RELATED_TO", "object": "Intervention condition", "chunk": 4}
{"article": "PMC8317398.txt", "subject": "FAST score", "relationship": "RELATED_TO", "object": "Dementia severity", "chunk": 4}
{"article": "PMC8317398.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Severe cognitive impairment", "chunk": 5}
{"article": "PMC8317398.txt", "subject": "MMSE", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Diagnosis of dementia", "chunk": 5}
{"article": "PMC8317398.txt", "subject": "MMSE score below 26", "relationship": "DIAGNOSITC_OF", "object": "Dementia", "chunk": 5}
{"article": "PMC8317398.txt", "subject": "CSDD total", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression", "chunk": 6}
{"article": "PMC8317398.txt", "subject": "CSDD total", "relationship": "RELATED_PROGNOSIS", "object": "Change in depression symptoms over time", "chunk": 6}
{"article": "PMC8317398.txt", "subject": "NPI-NH total", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuropsychiatric symptoms", "chunk": 6}
{"article": "PMC8317398.txt", "subject": "NPI-NH Agitation", "relationship": "INDICATES_PRESENCE_OF", "object": "Agitation", "chunk": 6}
{"article": "PMC8317398.txt", "subject": "NPI-NH Affective symptoms", "relationship": "INDICATES_PRESENCE_OF", "object": "Affective symptoms", "chunk": 6}
{"article": "PMC8317398.txt", "subject": "NPI-NH Psychosis", "relationship": "INDICATES_PRESENCE_OF", "object": "Psychosis", "chunk": 6}
{"article": "PMC8317398.txt", "subject": "FAST", "relationship": "RELATED_TO", "object": "Dementia Severity", "chunk": 7}
{"article": "PMC8317398.txt", "subject": "Cornell Scale for Depression in dementia (CSDD)", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression", "chunk": 8}
{"article": "PMC8317398.txt", "subject": "CSDD Mood-related signs", "relationship": "RELATED_PROGNOSIS", "object": "Affective symptoms", "chunk": 8}
{"article": "PMC8317398.txt", "subject": "NPI-NH Affective symptoms", "relationship": "RELATED_PROGNOSIS", "object": "Affective symptoms", "chunk": 8}
{"article": "PMC8317398.txt", "subject": "NPI-NH total", "relationship": "RELATED_TREATMENT", "object": "-BPSD improvement from BLT ", "chunk": 8}
{"article": "PMC8317398.txt", "subject": "NPI-NH Affective symptoms", "relationship": "MONITORED_DURING_TREATMENT", "object": "Intervention", "chunk": 9}
{"article": "PMC8317398.txt", "subject": "NPI-NH  Behavioral disturbance", "relationship": "MONITORED_DURING_TREATMENT", "object": "Intervention", "chunk": 9}
{"article": "PMC8317398.txt", "subject": "CSDD Mood-related signs", "relationship": "MONITORED_DURING_TREATMENT", "object": "Intervention", "chunk": 9}
{"article": "PMC8317398.txt", "subject": "CSDD Behavioral disturbance", "relationship": "MONITORED_DURING_TREATMENT", "object": "Intervention", "chunk": 9}
{"article": "PMC8317398.txt", "subject": "SDI", "relationship": "MONITORED_DURING_TREATMENT", "object": "Intervention", "chunk": 9}
{"article": "PMC8317398.txt", "subject": "Meatonin production", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Future studies on BLT", "chunk": 9}
{"article": "PMC8317398.txt", "subject": "Circadian rhythms", "relationship": "RELATED_TREATMENT", "object": "BLT", "chunk": 9}
{"article": "PMC8325256.txt", "subject": "Levetiracetam", "relationship": "RELATED_TREATMENT", "object": "Treatment for seizures", "chunk": 2}
{"article": "PMC8325256.txt", "subject": "Levetiracetam", "relationship": "RELATED_TREATMENT", "object": "Treatment for Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC8325256.txt", "subject": "Levetiracetam", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment for seizures and Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC8325256.txt", "subject": "synaptic vesicle protein 2A (SV2A)", "relationship": "INDICATES_PRESENCE_OF", "object": "Associated with late-onset AD", "chunk": 2}
{"article": "PMC8325256.txt", "subject": "apoe4", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk of Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC8325256.txt", "subject": "amyloid precursor protein (APP)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased levels linked to Alzheimer\u2019s disease progression", "chunk": 2}
{"article": "PMC8325256.txt", "subject": "levetiracetam", "relationship": "INDIVIDUALS_WITH_AD_AND_SEIZURES", "object": "levetiracetam has been associated with improvements in attention and verbal fluency as well as better seizure control", "chunk": 3}
{"article": "PMC8325256.txt", "subject": "levetiracetam", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Its lack of drug-drug interactions and favourable cognitive profile makes levetiracetam a preferred medication in older people with epilepsy.", "chunk": 3}
{"article": "PMC8325256.txt", "subject": "levetiracetam", "relationship": "RELATED_TREATMENT", "object": "Levetiracetam is effective at controlling seizures and is well-tolerated in people with epilepsy and AD", "chunk": 3}
{"article": "PMC8325256.txt", "subject": "levetiracetam", "relationship": "IS_TARGET_OF_TREATMENT", "object": "To determine if the anti-seizure medication levetiracetam offers benefit to cognition in patients with AD who have not experienced an overt seizure", "chunk": 3}
{"article": "PMC8325256.txt", "subject": "EEG", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Determine who may benefit from levetiracetam and similarly who may experience side effects.", "chunk": 7}
{"article": "PMC8325256.txt", "subject": "ADAS-Cog", "relationship": "PREDICTS_SURVIVAL", "object": "Changes in standardized effect of 0.7 in this method, the trial is powered to detect a standardized effect of 0.7 in a specific and sensitive test of hippocampal function that has already been tested in people with AD.", "chunk": 7}
{"article": "PMC8325256.txt", "subject": "levetiracetam", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treatment for AD", "chunk": 10}
{"article": "PMC8325256.txt", "subject": "levetiracetam", "relationship": "RELATED_TREATMENT", "object": "seizure disorder", "chunk": 10}
{"article": "PMC8325256.txt", "subject": "levetiracetam", "relationship": "IS_TARGET_OF_TREATMENT", "object": "ILiAD trial", "chunk": 10}
{"article": "PMC8333062.txt", "subject": "PU-H71", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Epichaperome inhibitors", "chunk": 2}
{"article": "PMC8333062.txt", "subject": "HSP90", "relationship": "RELATED_TREATMENT", "object": "PU-H71 has affinity for the N-terminal domain pocket of HSP90", "chunk": 2}
{"article": "PMC8333062.txt", "subject": "PU-H71", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Discovery platform for BBB-permeable epichaperome probes", "chunk": 2}
{"article": "PMC8333062.txt", "subject": "PU-HZ151", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Epichaperome-mediated interactome dysfunctions", "chunk": 2}
{"article": "PMC8333062.txt", "subject": "PU-HZ151", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Imaging", "chunk": 5}
{"article": "PMC8333062.txt", "subject": "PU-HZ151", "relationship": "IS_TARGET_OF_TREATMENT", "object": " Epichaperome", "chunk": 5}
{"article": "PMC8333062.txt", "subject": "PU-HZ151", "relationship": "RELATED_TREATMENT", "object": "rapid clearance from systemic circulation", "chunk": 5}
{"article": "PMC8333062.txt", "subject": "PU-HZ151", "relationship": "RESPONDED_TO", "object": "rapid clearance from plasma, which initiates a body-wide dilution state", "chunk": 5}
{"article": "PMC8333062.txt", "subject": "PU-HZ151", "relationship": "MONITORED_DURING_TREATMENT", "object": "time-dependent concentration", "chunk": 5}
{"article": "PMC8333062.txt", "subject": "PU-HZ151", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "distribution state, dilution state, clearance phase, slow terminal clearance phase", "chunk": 5}
{"article": "PMC8333062.txt", "subject": "epichaperome", "relationship": "RELATED_PROGNOSIS", "object": "Epichaperome levels predict sensitivity to agents that induce epichaperome disassembly", "chunk": 7}
{"article": "PMC8333062.txt", "subject": "epichaperome", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "GBMs with higher epichaperome levels are more vulnerable to epichaperome probes", "chunk": 7}
{"article": "PMC8333062.txt", "subject": "PU-HZ151", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Epichaperome", "chunk": 9}
{"article": "PMC8333062.txt", "subject": "PU-HZ151", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment for GBM", "chunk": 9}
{"article": "PMC8333062.txt", "subject": "PU-HZ151", "relationship": "RESPONDED_TO", "object": "Epichaperome", "chunk": 9}
{"article": "PMC8333062.txt", "subject": "PU-HZ151", "relationship": "IS_TARGET_OF_TREATMENT", "object": "GSCs", "chunk": 9}
{"article": "PMC8336239.txt", "subject": "HPA axis activity", "relationship": "RELATED_PROGNOSIS", "object": "Flattening of HPA axis activity or a persistent rise in evening HPA activity in PLWD is associated with SWD", "chunk": 1}
{"article": "PMC8336239.txt", "subject": "cortisol", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Salivary measures of cortisol and melatonin are collected to assess potential intervention mechanisms", "chunk": 1}
{"article": "PMC8336239.txt", "subject": "melatonin", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Salivary measures of cortisol and melatonin are collected to assess potential intervention mechanisms", "chunk": 1}
{"article": "PMC8336239.txt", "subject": "Salivary cortisol", "relationship": "INDICATES_PRESENCE_OF", "object": "Diurnal stress across the day", "chunk": 5}
{"article": "PMC8336239.txt", "subject": "Salivary melatonin", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuroendocrine activity", "chunk": 5}
{"article": "PMC8336239.txt", "subject": "Clinical dementia Rating (CDR)", "relationship": "DIAGNOSITC_OF", "object": "Cognitive impairment", "chunk": 5}
{"article": "PMC8336239.txt", "subject": "cortisol (salivary)", "relationship": "RELATED_TREATMENT", "object": "Timed activity intervention may impact", "chunk": 6}
{"article": "PMC8336239.txt", "subject": "cortisol (salivary)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Intervention effects", "chunk": 6}
{"article": "PMC8336239.txt", "subject": "cortisol (salivary)", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Measure potential influence on SWD symptoms", "chunk": 6}
{"article": "PMC8336239.txt", "subject": "salivary cortisol", "relationship": "INDICATES_PRESENCE_OF", "object": "Mediating effect of HPA axis activity on SWD symptoms", "chunk": 6}
{"article": "PMC8345445.txt", "subject": "Alzheimer Disease", "relationship": "INDICATES_PRESENCE_OF", "object": "Apathy", "chunk": 1}
{"article": "PMC8345445.txt", "subject": "Alzheimer Disease", "relationship": "RELATED_PROGNOSIS", "object": "Global functional impairment", "chunk": 1}
{"article": "PMC8345445.txt", "subject": "Alzheimer Disease", "relationship": "RELATED_PROGNOSIS", "object": "Loss of autonomy in activities of daily living", "chunk": 1}
{"article": "PMC8345445.txt", "subject": "motor activity", "relationship": "INDICATES_PRESENCE_OF", "object": "apathy", "chunk": 2}
{"article": "PMC8345445.txt", "subject": "mean motor activity", "relationship": "CORRELATED_NEGATIVELY_WITH", "object": "apathy scores on neuropsychiatric assessment scales", "chunk": 2}
{"article": "PMC8345445.txt", "subject": "daytime mean motor activity", "relationship": "LOWER_IN", "object": "individuals with apathy", "chunk": 2}
{"article": "PMC8345445.txt", "subject": "wake time after sleep onset", "relationship": "HIGHER_IN", "object": "individuals with apathy", "chunk": 2}
{"article": "PMC8345445.txt", "subject": "total time in bed during the night", "relationship": "HIGHER_IN", "object": "individuals with apathy", "chunk": 2}
{"article": "PMC8345445.txt", "subject": "early afternoon motor activity", "relationship": "DECLINE_IN", "object": "individuals with apathy", "chunk": 2}
{"article": "PMC8345445.txt", "subject": "wake and bed time", "relationship": "EARLIER", "object": "individuals with apathy", "chunk": 2}
{"article": "PMC8345445.txt", "subject": "level of motor activity between 9:00 a.m. and 12:00 p.m. and also between 18:00 p.m. and 21:00 p.m.", "relationship": "LOWER_IN", "object": "individuals with dementia and apathy", "chunk": 2}
{"article": "PMC8345445.txt", "subject": "motor activity", "relationship": "ASSOCIATED_WITH", "object": "lower activity in the afternoon of their caregivers", "chunk": 2}
{"article": "PMC8345445.txt", "subject": "daytime locomotor activity", "relationship": "INDICATES_PRESENCE_OF", "object": "apathy mechanism of auto-activation deficits", "chunk": 3}
{"article": "PMC8345445.txt", "subject": "intensity of daytime activity", "relationship": "RELATED_PROGNOSIS", "object": "apathy", "chunk": 3}
{"article": "PMC8345445.txt", "subject": "quality of sleep", "relationship": "RELATED_PROGNOSIS", "object": "apathy", "chunk": 3}
{"article": "PMC8345445.txt", "subject": "quality of sleep", "relationship": "RELATED_TO", "object": "apathy", "chunk": 3}
{"article": "PMC8345445.txt", "subject": "lack of emotional arousal", "relationship": "INDICATES_PRESENCE_OF", "object": "apathy", "chunk": 3}
{"article": "PMC8345445.txt", "subject": "amplified potencial amplitude during unpleasant picture viewing", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "apathy", "chunk": 3}
{"article": "PMC8345445.txt", "subject": "skin conductance", "relationship": "USED_TO_DIAGNOSE", "object": "quality of sleep", "chunk": 3}
{"article": "PMC8345445.txt", "subject": "heart rate", "relationship": "USED_TO_DIAGNOSE", "object": "quality of sleep", "chunk": 3}
{"article": "PMC8345445.txt", "subject": "variability of skin conductance", "relationship": "RELATED_TO", "object": "emotional arousal", "chunk": 3}
{"article": "PMC8345445.txt", "subject": "variability of heart rate", "relationship": "RELATED_TO", "object": "emotional arousal", "chunk": 3}
{"article": "PMC8345445.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment when score is below 10", "chunk": 4}
{"article": "PMC8345445.txt", "subject": "MMSE", "relationship": "USED_TO_DIAGNOSE", "object": "general cognitive efficiency", "chunk": 10}
{"article": "PMC8345445.txt", "subject": "MADRS", "relationship": "USED_TO_DIAGNOSE", "object": "depression symptoms", "chunk": 10}
{"article": "PMC8345445.txt", "subject": "CDR", "relationship": "INDICATES_PRESENCE_OF", "object": "severity of dementia symptoms", "chunk": 10}
{"article": "PMC8345445.txt", "subject": "AS", "relationship": "INDICATES_PRESENCE_OF", "object": "apathy", "chunk": 10}
{"article": "PMC8345445.txt", "subject": "DAS", "relationship": "INDICATES_PRESENCE_OF", "object": "apathy", "chunk": 10}
{"article": "PMC8345445.txt", "subject": "ESS", "relationship": "INDICATES_PRESENCE_OF", "object": "sleepiness", "chunk": 10}
{"article": "PMC8351379.txt", "subject": "cholesterol", "relationship": "INDICATES_PRESENCE_OF", "object": "myelin sheaths", "chunk": 1}
{"article": "PMC8351379.txt", "subject": "cholesterol", "relationship": "INDICATES_PRESENCE_OF", "object": "cell membranes of neurons and astrocytes", "chunk": 1}
{"article": "PMC8351379.txt", "subject": "simvastatin", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "prevention of cardiovascular and cerebrovascular disease", "chunk": 1}
{"article": "PMC8351379.txt", "subject": "statins", "relationship": "USED_TO_DIAGNOSE", "object": "hypercholesterolemia", "chunk": 1}
{"article": "PMC8351379.txt", "subject": "simvastatin", "relationship": "PREDICTS_SURVIVAL", "object": " WM integrity", "chunk": 1}
{"article": "PMC8351379.txt", "subject": "beta amyloid", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease dementia", "chunk": 2}
{"article": "PMC8351379.txt", "subject": "APOE-\u025b4", "relationship": "RELATED_TREATMENT", "object": "Simvastatin treatment evaluated for effects on WM microstructure in conjunction with APOE-\u025b4 genotype", "chunk": 3}
{"article": "PMC8351379.txt", "subject": "Fractional anisotropy (FA)", "relationship": "RELATED_PROGNOSIS", "object": "Simvastatin treatment at 18 months resulted in a lower decrease in FA compared to placebo.", "chunk": 4}
{"article": "PMC8351379.txt", "subject": "Radial diffusivity (RD)", "relationship": "RELATED_PROGNOSIS", "object": "Simvastatin treatment at 18 months resulted in a lower increase in RD compared to placebo.", "chunk": 4}
{"article": "PMC8351379.txt", "subject": "FA", "relationship": "MONITORED_DURING_TREATMENT", "object": "Change in FA from baseline at 18 months was different between treatment groups.", "chunk": 4}
{"article": "PMC8351379.txt", "subject": "RD", "relationship": "MONITORED_DURING_TREATMENT", "object": "Change in RD from baseline at 18 months was different between treatment groups.", "chunk": 4}
{"article": "PMC8351379.txt", "subject": "MD", "relationship": "MONITORED_DURING_TREATMENT", "object": "Change in MD from baseline at 18 months was not different between treatment groups.", "chunk": 4}
{"article": "PMC8351379.txt", "subject": "AD", "relationship": "MONITORED_DURING_TREATMENT", "object": "Change in AD from baseline at 18 months was not different between treatment groups.", "chunk": 4}
{"article": "PMC8351379.txt", "subject": "Total WM volume", "relationship": "RELATED_TREATMENT", "object": "Simvastatin group showed significantly different percent change in total WM volume at 12 and 18 months compared to placebo group.", "chunk": 4}
{"article": "PMC8351379.txt", "subject": "serum total cholesterol", "relationship": "RELATED_PROGNOSIS", "object": "Mediated 28%, 32%, and 29% of the total effect for FA, MD, and RD, respectively.", "chunk": 5}
{"article": "PMC8351379.txt", "subject": "serum total cholesterol", "relationship": "RELATED_TREATMENT", "object": "Lowering circulating cholesterol levels", "chunk": 5}
{"article": "PMC8351379.txt", "subject": "serum total cholesterol", "relationship": "MONITORED_DURING_TREATMENT", "object": "Change in serum total cholesterol levels", "chunk": 5}
{"article": "PMC8351379.txt", "subject": "WMH lesion volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Small vessel cerebrovascular disease", "chunk": 6}
{"article": "PMC8351379.txt", "subject": "WMH lesion volume", "relationship": "RELATED_TREATMENT", "object": "Simvastatin treatment did not appear to affect", "chunk": 6}
{"article": "PMC8351379.txt", "subject": "Peripheral cholesterol levels", "relationship": "RELATED_TREATMENT", "object": "Lowering contributed to a portion of the effect of simvastatin on preserving WM integrity", "chunk": 6}
{"article": "PMC8351379.txt", "subject": "RD", "relationship": "RELATED_TREATMENT", "object": "Simvastatin treatment", "chunk": 6}
{"article": "PMC8351379.txt", "subject": "Brain cholesterol homeostasis", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Simvastatin treatment", "chunk": 6}
{"article": "PMC8351379.txt", "subject": "Brain cholesterol synthesis", "relationship": "RELATED_TREATMENT", "object": "Statin treatment", "chunk": 6}
{"article": "PMC8351379.txt", "subject": "Brain cholesterol efflux", "relationship": "RELATED_TREATMENT", "object": "Statin treatment", "chunk": 6}
{"article": "PMC8351379.txt", "subject": "Neuroinflammation and oxidative stress", "relationship": "RELATED_TREATMENT", "object": "Statins", "chunk": 6}
{"article": "PMC8351379.txt", "subject": "cholesterol recycling", "relationship": "RELATED_TREATMENT", "object": "Simvastatin treatment", "chunk": 6}
{"article": "PMC8351379.txt", "subject": "WM integrity", "relationship": "RELATED_TREATMENT", "object": "Simvastatin treatment", "chunk": 6}
{"article": "PMC8364310.txt", "subject": "Tau pathology", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer\u2019s disease (AD)", "chunk": 1}
{"article": "PMC8364310.txt", "subject": "Tau pathology", "relationship": "RELATED_PROGNOSIS", "object": "AD severity", "chunk": 1}
{"article": "PMC8364310.txt", "subject": "Tau pathology", "relationship": "RELATED_PROGNOSIS", "object": "Episodic memory decline", "chunk": 1}
{"article": "PMC8364310.txt", "subject": "ta u deposition", "relationship": "RELATED_TREATMENT", "object": " assessed with  [18F]Flortaucipir tau PET ", "chunk": 2}
{"article": "PMC8364310.txt", "subject": "amyloid-\u03b2", "relationship": "RELATED_TREATMENT", "object": "assessed with amyloid PET imaging ", "chunk": 2}
{"article": "PMC8364310.txt", "subject": "[18F]Flortaucipir", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "for assessing tau deposition ", "chunk": 2}
{"article": "PMC8364310.txt", "subject": "SUVR", "relationship": "DIAGNOSITC_OF", "object": "Amyloid-\u03b2 positive", "chunk": 3}
{"article": "PMC8364310.txt", "subject": "SUVR", "relationship": "DIAGNOSITC_OF", "object": "Tau positivity", "chunk": 3}
{"article": "PMC8364310.txt", "subject": "[18F]Florbetapir", "relationship": "USED_TO_DIAGNOSE", "object": "Amyloid-\u03b2 positive", "chunk": 3}
{"article": "PMC8364310.txt", "subject": "[18F]Florbetaben", "relationship": "USED_TO_DIAGNOSE", "object": "Amyloid-\u03b2 positive", "chunk": 3}
{"article": "PMC8364310.txt", "subject": "SUVR > 1.23", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau positivity", "chunk": 3}
{"article": "PMC8364310.txt", "subject": "SUVR for [18F]Florbetapir higher than 1.1", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-\u03b2 positive", "chunk": 3}
{"article": "PMC8364310.txt", "subject": "SUVR for [18F]Florbetaben higher than 1.2", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-\u03b2 positive", "chunk": 3}
{"article": "PMC8364310.txt", "subject": "ICVF", "relationship": "RELATED_PROGNOSIS", "object": "Axonal density", "chunk": 3}
{"article": "PMC8364310.txt", "subject": "OD", "relationship": "RELATED_PROGNOSIS", "object": "Degree of fanning in axonal orientations", "chunk": 3}
{"article": "PMC8364310.txt", "subject": "FA", "relationship": "RELATED_PROGNOSIS", "object": "Coherence of microstructure water diffusion", "chunk": 3}
{"article": "PMC8364310.txt", "subject": "MD", "relationship": "RELATED_PROGNOSIS", "object": "Magnitude of overall water diffusion", "chunk": 3}
{"article": "PMC8364310.txt", "subject": "DA", "relationship": "RELATED_PROGNOSIS", "object": "Water diffusion along principal direction", "chunk": 3}
{"article": "PMC8364310.txt", "subject": "DR", "relationship": "RELATED_PROGNOSIS", "object": "Water diffusion perpendicular to principal direction", "chunk": 3}
{"article": "PMC8364310.txt", "subject": "tau+ prevalence", "relationship": "RELATED_PROGNOSIS", "object": "Higher tau+ prevalence  in  the  basal ganglia  and  medial temporal regions", "chunk": 5}
{"article": "PMC8364310.txt", "subject": "tau+ prevalence", "relationship": "RELATED_PROGNOSIS", "object": "higher tau+ prevalence compared to the CN and SCD groups", "chunk": 5}
{"article": "PMC8364310.txt", "subject": "tau levels", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "higher tau levels were associated with increased MD", "chunk": 5}
{"article": "PMC8364310.txt", "subject": "MD", "relationship": "MONITORED_DURING_TREATMENT", "object": "MD was monitored during the assessment of the tau-MD association patterns", "chunk": 5}
{"article": "PMC8364310.txt", "subject": "tau-PET signal", "relationship": "INDICATES_PRESENCE_OF", "object": "WM pathology", "chunk": 6}
{"article": "PMC8364310.txt", "subject": "WM integrity", "relationship": "RELATED_PROGNOSIS", "object": "Tau related WM degeneration", "chunk": 6}
{"article": "PMC8364310.txt", "subject": "WM alterations", "relationship": "RELATED_PROGNOSIS", "object": "AD pathophysiological cascade", "chunk": 6}
{"article": "PMC8364310.txt", "subject": "mean and radial water diffusivity", "relationship": "ASSOCIATED_WITH", "object": "tau-related WM degeneration", "chunk": 6}
{"article": "PMC8364310.txt", "subject": "decreased axonal density", "relationship": "ASSOCIATED_WITH", "object": "tau-related WM degeneration", "chunk": 6}
{"article": "PMC8364310.txt", "subject": "tau and Da", "relationship": "RELATED_TO", "object": "Early pathways connecting the medial temporal lobe and parahippocampal or inferior parietal lobe", "chunk": 6}
{"article": "PMC8364310.txt", "subject": "amyloid positive participants", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau-WM association pattern", "chunk": 6}
{"article": "PMC8364310.txt", "subject": "WM integrity", "relationship": "RELATED_TO", "object": "Cognitive function", "chunk": 6}
{"article": "PMC8364310.txt", "subject": "amyloid-\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Genetic origins ", "chunk": 6}
{"article": "PMC8364310.txt", "subject": "tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Genetic origins", "chunk": 6}
{"article": "PMC8364310.txt", "subject": "Neurofibrillary tangles", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Increase the sensitivity of the tau-PET signal", "chunk": 7}
{"article": "PMC8364310.txt", "subject": "Neurofibrillary tangles", "relationship": "ASSOCIATED_WITH", "object": "aggregates of hyperphosphorylated tau protein", "chunk": 7}
{"article": "PMC8364310.txt", "subject": "tau protein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "To test the robustness of our findings", "chunk": 7}
{"article": "PMC8364310.txt", "subject": "WM degeneration", "relationship": "RELATED_TREATMENT", "object": "partial volume correction", "chunk": 7}
{"article": "PMC8364310.txt", "subject": "tau-PET signal", "relationship": "RELATED_TO", "object": "Diffusion metrics like FA, MD, Da, Dr", "chunk": 8}
{"article": "PMC8364310.txt", "subject": "tau-PET signal", "relationship": "RELATED_TO", "object": "Intracellular volume fraction (ICVF)", "chunk": 8}
{"article": "PMC8381483.txt", "subject": "pyroglutamate-A-beta (pGluAB42)", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC8381483.txt", "subject": "pGluAB42", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Synaptotoxicity, neuroinflammation, and neurodegeneration", "chunk": 1}
{"article": "PMC8381483.txt", "subject": "pGluAB42", "relationship": "RELATED_PROGNOSIS", "object": "Development of Alzheimer's disease", "chunk": 1}
{"article": "PMC8381483.txt", "subject": "varoglutamstat", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of Alzheimer's disease", "chunk": 1}
{"article": "PMC8381483.txt", "subject": "varoglutamstat", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Reduction of pGluAB42 levels", "chunk": 1}
{"article": "PMC8381483.txt", "subject": "varoglutamstat", "relationship": "USED_TO_DIAGNOSE", "object": "Safety and tolerability of treatment", "chunk": 1}
{"article": "PMC8381483.txt", "subject": "glutaminyl cyclase (QC)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Varoglutamstat", "chunk": 1}
{"article": "PMC8381483.txt", "subject": "pGluAB42", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Varoglutamstat", "chunk": 1}
{"article": "PMC8381483.txt", "subject": "pGluAB42", "relationship": "MONITORED_DURING_TREATMENT", "object": "Varoglutamstat", "chunk": 1}
{"article": "PMC8381483.txt", "subject": "pGluAB42", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "QC-inhibition", "chunk": 1}
{"article": "PMC8381483.txt", "subject": "pGluAB42", "relationship": "RELATED_TREATMENT", "object": "Donanemab", "chunk": 1}
{"article": "PMC8381483.txt", "subject": "pGluAB42", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Varoglutamstat", "chunk": 1}
{"article": "PMC8381483.txt", "subject": "A\u03b242 concentration", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC8381483.txt", "subject": "p-tau", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC8381483.txt", "subject": "p-tau/A\u03b242 ratio", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC8381483.txt", "subject": "Amyloid positron-emission tomography (PET) evidence", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC8381483.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC8381483.txt", "subject": "p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC8381483.txt", "subject": "p-tau/A\u03b242 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC8381483.txt", "subject": "AB42", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC8381483.txt", "subject": "pGluAB42", "relationship": "RELATED_TREATMENT", "object": "varoglutamstat inhibits QC activity and reduces the level of", "chunk": 5}
{"article": "PMC8381483.txt", "subject": "pGluAB42", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurotoxic effects", "chunk": 5}
{"article": "PMC8381483.txt", "subject": "YKL-40", "relationship": "DIAGNOSITC_OF", "object": "Neuroinflammation in AD", "chunk": 5}
{"article": "PMC8381483.txt", "subject": "YKL-40", "relationship": "INDICATES_PRESENCE_OF", "object": "Decrease by approximately 5% from baseline levels within 12 weeks using varoglutamstat", "chunk": 5}
{"article": "PMC8381483.txt", "subject": "neurogranin", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduction by approximately 4% when using varoglutamstat", "chunk": 5}
{"article": "PMC8381483.txt", "subject": "biochemical biomarkers", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "serve as an inclusion criterion, minimizing the risk of including non-AD patients into the trial and also function as outcome measures on week 48/and or end of treatment", "chunk": 5}
{"article": "PMC8381483.txt", "subject": "QC-inhibition", "relationship": "MONITORED_DURING_TREATMENT", "object": "Long-term treatment effect (safety and efficacy)", "chunk": 6}
{"article": "PMC8381483.txt", "subject": "QC-inhibition", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "varoglutamstat treatment", "chunk": 6}
{"article": "PMC8381483.txt", "subject": "varoglutamstat", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Development of new biomarker-based diagnostics", "chunk": 6}
{"article": "PMC8386362.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer disease", "chunk": 1}
{"article": "PMC8386362.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TO", "object": "Change in cognitive function", "chunk": 1}
{"article": "PMC8386362.txt", "subject": "ADAS-Cog score", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment response to rTMS", "chunk": 2}
{"article": "PMC8386362.txt", "subject": "ADAS-Cog score", "relationship": "RELATED_TREATMENT", "object": "Responding to rTMS treatment", "chunk": 2}
{"article": "PMC8386362.txt", "subject": "ADAS-Cog score", "relationship": "INDICATES_PRESENCE_OF", "object": "Improvement in cognitive function", "chunk": 2}
{"article": "PMC8386362.txt", "subject": "ADCS-ADL", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment response to rTMS", "chunk": 2}
{"article": "PMC8386362.txt", "subject": "ADCS-ADL", "relationship": "RELATED_TREATMENT", "object": "Responding to rTMS treatment", "chunk": 2}
{"article": "PMC8386362.txt", "subject": "NPI-Q", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment response to rTMS", "chunk": 2}
{"article": "PMC8386362.txt", "subject": "NPI-Q", "relationship": "RELATED_TREATMENT", "object": "Responding to rTMS treatment", "chunk": 2}
{"article": "PMC8386362.txt", "subject": "ADAS-Cog score", "relationship": "RELATED_PROGNOSIS", "object": "Predicting treatment response to rTMS", "chunk": 2}
{"article": "PMC8406802.txt", "subject": "IL-6", "relationship": "INDICATES_PRESENCE_OF", "object": "Hyperinflammatory response in COVID-19 patients", "chunk": 1}
{"article": "PMC8406802.txt", "subject": "C-reactive protein", "relationship": "INDICATES_PRESENCE_OF", "object": "COVID-19 inflammation", "chunk": 1}
{"article": "PMC8406802.txt", "subject": "IL-10", "relationship": "RELATED_PROGNOSIS", "object": "Improved inflammatory outcomes in chronic inflammatory diseases", "chunk": 1}
{"article": "PMC8406802.txt", "subject": "IL-6", "relationship": "INDICATES_PRESENCE_OF", "object": "COVID-19 inflammation", "chunk": 2}
{"article": "PMC8406802.txt", "subject": "CRP", "relationship": "INDICATES_PRESENCE_OF", "object": "COVID-19 inflammation", "chunk": 2}
{"article": "PMC8406802.txt", "subject": "D-dimer", "relationship": "INDICATES_PRESENCE_OF", "object": "COVID-19 inflammation", "chunk": 2}
{"article": "PMC8406802.txt", "subject": "IL-6", "relationship": "MONITORED_DURING_TREATMENT", "object": "inflammatory blood markers", "chunk": 2}
{"article": "PMC8406802.txt", "subject": "CRP", "relationship": "MONITORED_DURING_TREATMENT", "object": "inflammatory blood markers", "chunk": 2}
{"article": "PMC8406802.txt", "subject": "D-dimer", "relationship": "MONITORED_DURING_TREATMENT", "object": "inflammatory blood markers", "chunk": 2}
{"article": "PMC8406802.txt", "subject": "IL-18", "relationship": "MONITORED_DURING_TREATMENT", "object": "inflammatory blood markers", "chunk": 2}
{"article": "PMC8406802.txt", "subject": "IL-6", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "worse outcome in COVID-19", "chunk": 5}
{"article": "PMC8406802.txt", "subject": "CRP", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "worse outcome in COVID-19", "chunk": 5}
{"article": "PMC8406802.txt", "subject": "IL-6", "relationship": "MONITORED_DURING_TREATMENT", "object": "Monitored as a biomarker during treatment with Foralumab", "chunk": 6}
{"article": "PMC8406802.txt", "subject": "CRP", "relationship": "MONITORED_DURING_TREATMENT", "object": "Monitored as a biomarker during treatment with Foralumab", "chunk": 6}
{"article": "PMC8416781.txt", "subject": "amyloid beta peptides peptides (A\u03b2)", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 1}
{"article": "PMC8416781.txt", "subject": "neurofilament light chain (NfL)", "relationship": "RELATED_PROGNOSIS", "object": "diagnosis and disease monitoring", "chunk": 1}
{"article": "PMC8416781.txt", "subject": "phosphorylated tau (p\u2010tau; T)", "relationship": "RELATED_PROGNOSIS", "object": "diagnosis and disease monitoring", "chunk": 1}
{"article": "PMC8416781.txt", "subject": "amyloid beta peptides (A\u03b2)", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (AD) - amyloid plaques in the brain parenchyma", "chunk": 2}
{"article": "PMC8416781.txt", "subject": "amyloid angiopathy", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (AD) - amyloid beta peptides in cerebral blood vessels", "chunk": 2}
{"article": "PMC8416781.txt", "subject": "Neurofibrillary tangles", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (AD) - composed of hyperphosphorylated tau", "chunk": 2}
{"article": "PMC8416781.txt", "subject": "phosphorylated tau (p\u2010tau)", "relationship": "RELATED_TO", "object": "Alzheimer's Disease (AD) - used as a biomarker for tau pathology in cerebral spinal fluid (CSF) and PET imaging", "chunk": 2}
{"article": "PMC8416781.txt", "subject": "A\u03b21\u201042", "relationship": "RELATED_TO", "object": "Alzheimer's Disease (AD) - used as a biomarker for amyloid pathology in CSF and PET imaging", "chunk": 2}
{"article": "PMC8416781.txt", "subject": "A\u03b21\u201042", "relationship": "ASSOCIATED_WITH", "object": "Alzheimer's Disease (AD) - decreased levels of A\u03b21\u201042 indicate A\u03b2 pathology", "chunk": 2}
{"article": "PMC8416781.txt", "subject": "A\u03b21\u201042/A\u03b21\u201040 ratio (A\u03b21\u201042/1\u201040)", "relationship": "RELATED_TO", "object": "Alzheimer's Disease (AD) - decreased ratio indicates A\u03b2 pathology", "chunk": 2}
{"article": "PMC8416781.txt", "subject": "tau PET tracer uptake", "relationship": "RELATED_TO", "object": "Alzheimer's Disease (AD) - used as a biomarker for tau pathology in PET imaging", "chunk": 2}
{"article": "PMC8416781.txt", "subject": "t\u2010tau", "relationship": "RELATED_TO", "object": "Alzheimer's Disease (AD) - used as a biomarker for neurodegeneration in CSF", "chunk": 2}
{"article": "PMC8416781.txt", "subject": "NfL", "relationship": "RELATED_TO", "object": "Alzheimer's Disease (AD) - used as a biomarker for neurodegeneration in CSF", "chunk": 2}
{"article": "PMC8416781.txt", "subject": "[18F]\u2010fluorodeoxyglucose (FDG)\u2013PET", "relationship": "RELATED_TO", "object": "Alzheimer's Disease (AD) - measures glucose metabolism in the brain, which is decreased in AD", "chunk": 2}
{"article": "PMC8416781.txt", "subject": "grey matter atrophy on structural MRI", "relationship": "RELATED_TO", "object": "Alzheimer's Disease (AD) - measures loss of grey matter in the brain, which is characteristic of AD", "chunk": 2}
{"article": "PMC8416781.txt", "subject": "A\u03b21\u201042", "relationship": "RELATED_PROGNOSIS", "object": "a better biomarker for AD", "chunk": 3}
{"article": "PMC8416781.txt", "subject": "A\u03b21\u201042", "relationship": "DIAGNOSTIC_OF", "object": "diagnosing patients with probable AD dementia", "chunk": 3}
{"article": "PMC8416781.txt", "subject": "A\u03b21\u201042", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "decrease in AD", "chunk": 3}
{"article": "PMC8416781.txt", "subject": "A\u03b21\u201042/1\u201040", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "improve the reliability of results compared to using cerebral cerebral cerebral cerebral spinal fluid A\u03b21\u201042 alone", "chunk": 3}
{"article": "PMC8416781.txt", "subject": "A\u03b21\u201042/1\u201040", "relationship": "RELATED_TREATMENT", "object": "significantly improved diagnostic accuracy", "chunk": 3}
{"article": "PMC8416781.txt", "subject": "A\u03b21\u201042/1\u201040", "relationship": "RELATED_TREATMENT", "object": "improved diagnostic accuracy when comparing patients with AD to either controls or those with non\u2010AD dementia", "chunk": 3}
{"article": "PMC8416781.txt", "subject": "A\u03b21\u201042/1\u201040", "relationship": "RELATED_TREATMENT", "object": "improved the ability to differentiate AD from non\u2010AD dementia", "chunk": 3}
{"article": "PMC8416781.txt", "subject": "A\u03b21-42/1-40", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 pathology in AD", "chunk": 4}
{"article": "PMC8416781.txt", "subject": "A\u03b21-40", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD patients compared with controls and patients with either mild cognitive impairment or subjective cognitive decline.", "chunk": 4}
{"article": "PMC8416781.txt", "subject": "A\u03b21-42", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD patients compared with controls and patients with either mild cognitive impairment or subjective cognitive decline.", "chunk": 4}
{"article": "PMC8416781.txt", "subject": "A\u03b21-42/1-40", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "lower in patients with mild cognitive impairment compared with both SCD and controls.", "chunk": 4}
{"article": "PMC8416781.txt", "subject": "A\u03b21-42/1-40", "relationship": "RELATED_PROGNOSIS", "object": "longitudinal change in grey matter volume", "chunk": 4}
{"article": "PMC8416781.txt", "subject": "Plasma A\u03b21-42/1-40", "relationship": "PREDICTS_SURVIVAL", "object": "amyloid PET positivity and negativity", "chunk": 4}
{"article": "PMC8416781.txt", "subject": "A\u03b21-42", "relationship": "RELATED_PROGNOSIS", "object": "cerebral spinal fluid A\u03b2", "chunk": 4}
{"article": "PMC8416781.txt", "subject": "Plasma A\u03b21-42", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "A\u03b2+ individuals", "chunk": 4}
{"article": "PMC8416781.txt", "subject": "A\u03b21-42", "relationship": "PREDICT_MORTALITY", "object": "cerebral A\u03b2 deposition", "chunk": 4}
{"article": "PMC8416781.txt", "subject": "A\u03b21\u201043", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC8416781.txt", "subject": "A\u03b21\u201043", "relationship": "RELATED_TO", "object": "Early\u2010onset AD and Late\u2010onset AD", "chunk": 6}
{"article": "PMC8416781.txt", "subject": "A\u03b21\u201043", "relationship": "RELATED_TO", "object": "Differentiating between different groups of AD patients", "chunk": 6}
{"article": "PMC8416781.txt", "subject": "p\u2010tau", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 6}
{"article": "PMC8416781.txt", "subject": "p\u2010tau", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline in preclinical cases of AD", "chunk": 6}
{"article": "PMC8416781.txt", "subject": "p\u2010tau181", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 6}
{"article": "PMC8416781.txt", "subject": "p\u2010tau181", "relationship": "RELATED_TO", "object": "Differentiating AD from controls and other tauopathies and neurodegenerative disorderssss", "chunk": 6}
{"article": "PMC8416781.txt", "subject": "p\u2010tau217", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 6}
{"article": "PMC8416781.txt", "subject": "p\u2010tau217", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline", "chunk": 6}
{"article": "PMC8416781.txt", "subject": "p\u2010tau217", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Clinical practice", "chunk": 6}
{"article": "PMC8416781.txt", "subject": "p\u2010tau217", "relationship": "RELATED_PROGNOSIS", "object": "predict future progression to AD dementia", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau217", "relationship": "RELATED_PROGNOSIS", "object": "increases minimally in individuals diagnosed with AD but who are amyloid PET-negative", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau217", "relationship": "INDICATES_PRESENCE_OF", "object": "increased A\u03b2 pathology", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau217", "relationship": "RELATED_TREATMENT", "object": "employed as a treatment response measure in therapeutic clinical trials", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau217", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "patient recruitment into clinical trials", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau217", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "patient recruitment into clinical trials", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau181", "relationship": "DIAGNOSITC_OF", "object": "Diagnose: Early-onset Alzheimer's Disease", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau181", "relationship": "RELATED_PROGNOSIS", "object": "predict future progression to AD dementia", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau181", "relationship": "RELATED_PROGNOSIS", "object": "increases more prominently in individuals with decreased cerebral cerebral cerebral cerebral spinal fluid A\u03b2 prior to amyloid PET positivity", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau181", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "a rate of tau degradation", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau181", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "increases  in  synchrony with A\u03b2 pathology changes", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau181", "relationship": "IS_TARGET_OF_TREATMENT", "object": "treatment response measure", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau231", "relationship": "RELATED_PROGNOSIS", "object": "identify AD with 85% sensitivity and 97% specificity", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau231", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau231", "relationship": "RELATED_TREATMENT", "object": "treatment response measure", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau231", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "patient recruitment into clinical trials", "chunk": 7}
{"article": "PMC8416781.txt", "subject": "p\u2010tau217", "relationship": "INDICATES_PRESENCE_OF", "object": "Early AD pathology", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "p\u2010tau231", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "p\u2010tau231", "relationship": "RELATED_PROGNOSIS", "object": "Progression to AD dementia ", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "t\u2010tau", "relationship": "DIAGNOSTIC_OF", "object": "Neuronal or axonal injury", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "t\u2010tau", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "elevated", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "t\u2010tau", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "reduced ", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "t\u2010tau", "relationship": "INDICATES_PRESENCE_OF", "object": "neurodegeneration", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "plasma t\u2010tau", "relationship": "RELATED_PROGNOSIS", "object": "Risk-stratification for progression to AD dementia", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "NfL", "relationship": "INDICATES_PRESENCE_OF", "object": "white matter lesions", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "NfL", "relationship": "INDICATES_PRESENCE_OF", "object": "subcortical brain damage", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "NfL", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "treatment for Neuronal death and axonal loss", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "NfL", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment for Neuronal death and axonal loss", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "NfL", "relationship": "PREDICTS_SURVIVAL", "object": "progression from mild cognitive impairment to AD", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "NfL", "relationship": "PREDICTS_MORTALITY", "object": " progression from mild cognitive impairment to AD", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "plasma NfL", "relationship": "RELATED_TREATMENT", "object": "treatment for Neuronal death and axonal loss", "chunk": 8}
{"article": "PMC8416781.txt", "subject": "NfL", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurodegeneration", "chunk": 9}
{"article": "PMC8416781.txt", "subject": "NfL", "relationship": "USED_TO_DIAGNOSE", "object": "Neurodegeneration", "chunk": 9}
{"article": "PMC8416781.txt", "subject": "NfL", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment efficacy", "chunk": 9}
{"article": "PMC8416781.txt", "subject": "NfL", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Treatment efficacy", "chunk": 9}
{"article": "PMC8416781.txt", "subject": "t\u2010tau", "relationship": "RELATED_TO", "object": "A\u03b2 pathology changes", "chunk": 9}
{"article": "PMC8416781.txt", "subject": "NfL", "relationship": "RELATED_TO", "object": "A\u03b2 pathology changes", "chunk": 9}
{"article": "PMC8416781.txt", "subject": "p\u2010tau181", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Diagnosis and differential diagnosis", "chunk": 9}
{"article": "PMC8416781.txt", "subject": "p\u2010tau181", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment efficacy", "chunk": 9}
{"article": "PMC8416781.txt", "subject": "plasma A\u03b2", "relationship": "USED_TO_DIAGNOSE", "object": "Early or pre\u2010symptomatic AD", "chunk": 9}
{"article": "PMC8416781.txt", "subject": "plasma p\u2010tau217 and p\u2010tau231", "relationship": "PREDICT", "object": "Differentiation between AD and non-AD neurodegenerative dementia", "chunk": 9}
{"article": "PMC8436545.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Diagnose: Alzheimer's disease (with or without cerebrovascular component)", "chunk": 1}
{"article": "PMC8436545.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive function", "chunk": 3}
{"article": "PMC8436545.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "Subgroup analyses for the effect of the intervention", "chunk": 3}
{"article": "PMC8436545.txt", "subject": "NPI", "relationship": "DIAGNOSITC_OF", "object": "Behavioral and psychological symptoms of dementia (BPSD)", "chunk": 3}
{"article": "PMC8436545.txt", "subject": "ZBI", "relationship": "DIAGNOSITC_OF", "object": "Caregiver burden", "chunk": 3}
{"article": "PMC8436545.txt", "subject": "ZBI", "relationship": "RELATED_PROGNOSIS", "object": "The effect of the intervention", "chunk": 3}
{"article": "PMC8436545.txt", "subject": "Logsdon QOL-AD", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Inclusion of participants in statistical analyses", "chunk": 3}
{"article": "PMC8436545.txt", "subject": "ZBI scores", "relationship": "INDICATES_PRESENCE_OF", "object": "Significant effect of the intervention on the caregiver-reported QOL at 6 and 12\u2009months", "chunk": 7}
{"article": "PMC8436545.txt", "subject": "ZBI scores", "relationship": "INDICATES_PRESENCE_OF", "object": "Significant effect of the intervention on the caregiver-reported QOL at 2\u2009months in the subgroups with ZBI scores between 20 and 40 and \u2264 20.", "chunk": 7}
{"article": "PMC8436545.txt", "subject": "ZBI scores > 40", "relationship": "RELATED_PROGNOSIS", "object": "Significant effect of the intervention on the caregiver-reported QOL at 6 and 12\u2009months", "chunk": 7}
{"article": "PMC8436545.txt", "subject": "ZBI scores \u2264 20", "relationship": "RELATED_PROGNOSIS", "object": "Significant effect of the intervention on the caregiver-reported QOL at 6 and 12\u2009months", "chunk": 7}
{"article": "PMC8436545.txt", "subject": "ZBI scores between 20 and 40", "relationship": "RELATED_PROGNOSIS", "object": "Significant effect of the intervention on the caregiver-reported QOL at 2\u2009months", "chunk": 7}
{"article": "PMC8436545.txt", "subject": "ZBI scores \u2264 20", "relationship": "RELATED_PROGNOSIS", "object": "Significant effect of the intervention on the caregiver-reported QOL at 2\u2009months", "chunk": 7}
{"article": "PMC8436545.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "QOL", "chunk": 8}
{"article": "PMC8436545.txt", "subject": "ZBI score", "relationship": "RELATED_PROGNOSIS", "object": "QOL", "chunk": 8}
{"article": "PMC8439008.txt", "subject": "Amyloid-beta (A\u03b2)", "relationship": "RELATED_TO", "object": "Core pathological features of AD", "chunk": 1}
{"article": "PMC8439008.txt", "subject": "Tau", "relationship": "RELATED_TO", "object": "Core pathological features of AD", "chunk": 1}
{"article": "PMC8439008.txt", "subject": "A\u03b2 level", "relationship": "REDUCED_BY", "object": "soluble intracellular adhesion molecule-1 (sICAM-1) and AgRP secreted by human umbilical cord blood\u2013derived MSCs", "chunk": 2}
{"article": "PMC8439008.txt", "subject": "A\u03b2 neurotoxicity", "relationship": "PROTECTED_AGAINST", "object": "hUCB-MSC\u2013derived galectin-3", "chunk": 2}
{"article": "PMC8439008.txt", "subject": "Endogenous adult neurogenesis and synaptic activity", "relationship": "ENHANCED_BY", "object": "secretion of GDF-15 and Activin A", "chunk": 2}
{"article": "PMC8439008.txt", "subject": "11C-Pittsburgh compound B (PiB) PET or 18F-Florbetaben PET", "relationship": "ASSESSED_FOR", "object": "significant amyloid burden", "chunk": 2}
{"article": "PMC8439008.txt", "subject": "atropy on structural brain MRI or hypometabolism on FDG PET", "relationship": "ASSESSED_FOR", "object": "neuronal degeneration", "chunk": 2}
{"article": "PMC8439008.txt", "subject": "APOE genotype", "relationship": "RELATED_PROGNOSIS", "object": "Diagnose: Alzheimer's Disease", "chunk": 4}
{"article": "PMC8439008.txt", "subject": "amyloid PET", "relationship": "RELATED_PROGNOSIS", "object": "Diagnose: Alzheimer's Disease", "chunk": 4}
{"article": "PMC8439008.txt", "subject": "Galactine-3", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC8439008.txt", "subject": "sICAM-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC8439008.txt", "subject": "progranulin", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC8439008.txt", "subject": "GDF-15", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC8439008.txt", "subject": "Decorin", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC8439008.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC8439008.txt", "subject": "total-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC8439008.txt", "subject": "phosphorylated-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC8439008.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC8439008.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC8439008.txt", "subject": "S-IADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC8439008.txt", "subject": "NPI", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC8439008.txt", "subject": "total tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal fluid samples collected 1 day and 4 weeks after hUCB-MSC injections", "chunk": 7}
{"article": "PMC8439008.txt", "subject": "phosphorylated tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal fluid samples collected 1 day and 4 weeks after hUCB-MSC injections", "chunk": 7}
{"article": "PMC8439008.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal fluid samples collected 1 day and 4 weeks after hUCB-MSC injections", "chunk": 7}
{"article": "PMC8439008.txt", "subject": "Galactin-3", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels noted a day following MSC transplantation and dropped dramatically within 4 weeks", "chunk": 7}
{"article": "PMC8439008.txt", "subject": "sICAM-1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels noted a day following MSC transplantation and dropped dramatically within 4 weeks", "chunk": 7}
{"article": "PMC8439008.txt", "subject": "progranulin", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels noted a day following MSC transplantation and dropped dramatically within 4 weeks", "chunk": 7}
{"article": "PMC8439008.txt", "subject": "GDF-15", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels noted a day following MSC transplantation and dropped dramatically within 4 weeks", "chunk": 7}
{"article": "PMC8451777.txt", "subject": "ThDP", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Thiamine status assessment", "chunk": 1}
{"article": "PMC8451777.txt", "subject": "ETKAC", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Thiamine status assessment", "chunk": 1}
{"article": "PMC8451777.txt", "subject": "Erythrocyte transketolase (ETK)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Assessing thiamine status", "chunk": 1}
{"article": "PMC8451777.txt", "subject": "Erythrocyte ThDP", "relationship": "RELATED_PROGNOSIS", "object": "Long-term thiamine status", "chunk": 1}
{"article": "PMC8451777.txt", "subject": "ETKAC", "relationship": "INDICATES_PRESENCE_OF", "object": "Thiamine Deficiency", "chunk": 2}
{"article": "PMC8451777.txt", "subject": "ETKAC", "relationship": "RELATED_PROGNOSIS", "object": "Risk of Thiamine Deficiency", "chunk": 2}
{"article": "PMC8451777.txt", "subject": "ETKAC", "relationship": "RELATED_PROGNOSIS", "object": "Low risk of Clinical Deficiency", "chunk": 2}
{"article": "PMC8451777.txt", "subject": "ETKAC", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Beriberi", "chunk": 2}
{"article": "PMC8451800.txt", "subject": "serum thiamine", "relationship": "DIAGNOSITC_OF", "object": "Wernicke\u2013Korsakoff syndrome", "chunk": 2}
{"article": "PMC8451800.txt", "subject": "serum thiamine", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "low thiamine levels (<7 nmol/L)", "chunk": 2}
{"article": "PMC8451800.txt", "subject": "whole blood thiamine", "relationship": "INDICATES_PRESENCE_OF", "object": "Thiamine deficiency", "chunk": 4}
{"article": "PMC8451800.txt", "subject": "total thiamine in whole blood", "relationship": "RELATED_PROGNOSIS", "object": "Beriberi neuropathy", "chunk": 4}
{"article": "PMC8451800.txt", "subject": "serum thiamine level", "relationship": "INDICATES_PRESENCE_OF", "object": "Wernicke encephalopathy", "chunk": 4}
{"article": "PMC8451800.txt", "subject": "low levels of thiamine", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Heart failure", "chunk": 4}
{"article": "PMC8451800.txt", "subject": "plasma thiamine level", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Thiamine supplementation", "chunk": 4}
{"article": "PMC8453354.txt", "subject": "amyloid-\u03b2 42/40 Assays", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer Disease", "chunk": 1}
{"article": "PMC8453354.txt", "subject": "amyloid-beta", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Plasma amyloid-beta test licensed to C2N Diagnostics", "chunk": 2}
{"article": "PMC8453354.txt", "subject": "[18F]flutemetamol injection", "relationship": "MONITORED_DURING_TREATMENT", "object": "Study of the biomarker", "chunk": 2}
{"article": "PMC8453354.txt", "subject": "4NPE", "relationship": "USED_TO_DIAGNOSE", "object": "This study", "chunk": 2}
{"article": "PMC8453354.txt", "subject": "plasma A\u03b242/40", "relationship": "DETECTED_Abnormal_Cerebral_Cerebral_Cerebral_Cerebral_Spinal_Fluid_A\u03b2", "object": "using 8 different A\u03b2 assays", "chunk": 3}
{"article": "PMC8453354.txt", "subject": "plasma A\u03b242/40", "relationship": "USED_TO_DETECT", "object": "Abnormalities in brain A\u03b2 status", "chunk": 3}
{"article": "PMC8453354.txt", "subject": "IP-MS-WashU A\u03b242/40", "relationship": "INDICATES_PRESENCE_OF", "object": "abnormal cerebral cerebral cerebral cerebral spinal fluid A\u03b242/40", "chunk": 3}
{"article": "PMC8453354.txt", "subject": "A\u03b242/40 quantified using ultrasensitive Simoa immunoassay", "relationship": "RELATED_PROGNOSIS", "object": "detect abnormal cerebral cerebral cerebral cerebral spinal fluid A\u03b2 or A\u03b2-positron emission tomography (PET) status with moderate accuracy", "chunk": 3}
{"article": "PMC8453354.txt", "subject": "A\u03b242/40", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal cerebral spinal fluid A\u03b242/40", "chunk": 4}
{"article": "PMC8453354.txt", "subject": "A\u03b242", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Low plasma levels associated with A\u03b2 positivity", "chunk": 4}
{"article": "PMC8453354.txt", "subject": "A\u03b240", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "No differences in levels between A\u03b2-positive and A\u03b2-negative individuals", "chunk": 4}
{"article": "PMC8453354.txt", "subject": "A\u03b242/40", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Used to determine participation in A\u03b2-related studies", "chunk": 4}
{"article": "PMC8453354.txt", "subject": "Plasma A\u03b242/40", "relationship": "RELATED_PROGNOSIS", "object": "Prediction of abnormal cerebral cerebral cerebral cerebral spinal fluid A\u03b242/40 status", "chunk": 5}
{"article": "PMC8453354.txt", "subject": "IP-MS-WashU A\u03b242/40", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal cerebral cerebral cerebral cerebral spinal fluid A\u03b242/40", "chunk": 5}
{"article": "PMC8453354.txt", "subject": "plasma IP-MS-WashU A\u03b242/40", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment selection for individuals with possible Alzheimer's Disease", "chunk": 5}
{"article": "PMC8453354.txt", "subject": "p-tau217", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC8453354.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid A\u03b242/40", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC8453354.txt", "subject": "A\u03b2-PET", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC8453354.txt", "subject": "IP-MS-WashU A\u03b242/40", "relationship": "RELATED_TREATMENT", "object": "Abnormally elevated levels suggest further investigation into patient status using potentially guided therapeutic interventions", "chunk": 5}
{"article": "PMC8453354.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid A\u03b242/40 relative to plasma A\u03b242/40", "relationship": "RELATED_PROGNOSIS", "object": "Assessing the relationship between these biomarkers can provide information regarding the disease progression in patients with Alzheimer's", "chunk": 5}
{"article": "PMC8453354.txt", "subject": "IP-MS-WashU A\u03b242/40", "relationship": "RELATED_TO", "object": "Identification of individuals with early Alzheimer's Disease", "chunk": 6}
{"article": "PMC8453354.txt", "subject": "IP-MS-Shim A\u03b242/40", "relationship": "RELATED_TO", "object": "Identification of individuals with early Alzheimer's Disease", "chunk": 6}
{"article": "PMC8453354.txt", "subject": "Plasma A\u03b242/40", "relationship": "RELATED_TO", "object": "Determinining cerebral spinal fluid A\u03b242/40", "chunk": 6}
{"article": "PMC8453354.txt", "subject": "Plasma A\u03b242/40", "relationship": "RELATED_TO", "object": "Determining A\u03b2-PET status", "chunk": 6}
{"article": "PMC8453354.txt", "subject": "A\u03b242/40 IP-MS-WashU", "relationship": "RELATED_TO", "object": "Identification of individuals with Alzheimer's disease", "chunk": 6}
{"article": "PMC8453354.txt", "subject": "IP-MS-Shim composite biomarker score", "relationship": "RELATED_TO", "object": "Identification of abnormal A\u03b2-PET", "chunk": 6}
{"article": "PMC8453354.txt", "subject": "A\u03b242/40 IP-MS-WashU", "relationship": "RELATED_TO", "object": "Better performance than other plasma assays", "chunk": 6}
{"article": "PMC8453354.txt", "subject": "A\u03b242/40", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal brain A\u03b2 status in AD", "chunk": 7}
{"article": "PMC8453354.txt", "subject": "A\u03b242/40", "relationship": "RELATED_PROGNOSIS", "object": "Abnormal cerebral cerebral cerebral cerebral spinal fluid A\u03b242 and A\u03b240EI status", "chunk": 7}
{"article": "PMC8453354.txt", "subject": "A\u03b242/40", "relationship": "RELATED_TREATMENT", "object": "Could inform the future clinical use of blood tests for A\u03b2 pathology in AD", "chunk": 7}
{"article": "PMC8470960.txt", "subject": "Alzheimer\u2019s disease", "relationship": "associated_with", "object": "IF clinical studies have shown benefits for epilepsy, Alzheimer\u2019s disease, and multiple sclerosis on disease symptoms and progress.", "chunk": 1}
{"article": "PMC8470960.txt", "subject": "BDNF", "relationship": "RELATED_PROGNOSIS", "object": "Promotion of mitochondrial biogenesis, synaptic plasticity and cellular stress resistance in animal models", "chunk": 2}
{"article": "PMC8470960.txt", "subject": "BDNF", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "The upregulation of BDNF is associated with the promotion of mitochondrial biogenesis, synaptic plasticity and cellular stress resistance in animal models", "chunk": 2}
{"article": "PMC8470960.txt", "subject": "AMPK", "relationship": "RELATED_TREATMENT", "object": "Activation of AMPK and CaKMII kinases", "chunk": 2}
{"article": "PMC8470960.txt", "subject": "CaKMII", "relationship": "RELATED_TREATMENT", "object": "Activation of AMPK and CaKMII kinases", "chunk": 2}
{"article": "PMC8470960.txt", "subject": "CREB", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Their downstream transcription factors (CREB and PGC1\u03b1) enables these kinases to inhibit anabolic processes, thus inhibiting cell growth and protein biosynthesis", "chunk": 2}
{"article": "PMC8470960.txt", "subject": "mTOR", "relationship": "RELATED_TREATMENT", "object": "Inhibition of the mTOR pathway leads to an improvement in antioxidant defenses, DNA repair, and stimulation of BDNF", "chunk": 2}
{"article": "PMC8470960.txt", "subject": "Autophagy", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Autophagy is also responsible for the body\u2019s ability to cope with oxidative stress (the accumulation of harmful free radicals) which deteriorates by age and during the progress of neurodegenerative disorders", "chunk": 2}
{"article": "PMC8470960.txt", "subject": "Insulin sensitivity", "relationship": "RELATED_PROGNOSIS", "object": "IF leads to decreased levels of circulating insulin in the blood, which enhances the sensitivity of insulin receptors and upregulates the insulin/IGF-1 signaling (IIS) pathway, leading to enhanced uptake and utilization of glucose by neurons", "chunk": 2}
{"article": "PMC8470960.txt", "subject": "IIS", "relationship": "RELATED_PROGNOSIS", "object": "Upregulated IIS activity also decreases the activity of the mTOR pathway and is associated with enhancement of neuroplasticity and protection against oxidative stress", "chunk": 2}
{"article": "PMC8470960.txt", "subject": "Insulin", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Glucose metabolism rates decay with age and are associated with Alzheimer\u2019s disease, even before the onset of the disease", "chunk": 3}
{"article": "PMC8470960.txt", "subject": "TRF (time-restricted feeding)", "relationship": "RELATED_TREATMENT", "object": "TRF decreases both post-meal and mean 24 h insulin levels, leading to an overall increased insulin sensitivity", "chunk": 3}
{"article": "PMC8470960.txt", "subject": "TRF (time-restricted feeding)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "TRF leads to optimal rhythms of behavior, physiology, and metabolism and ensures that anabolic and catabolic types of mechanisms are regulated in harmony with someone\u2019s activity and rest cycle", "chunk": 3}
{"article": "PMC8470960.txt", "subject": "Gut microbiota", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The gut microbiota is involved in the pathogenesis of various central nervous system disorders in humans like Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC8470960.txt", "subject": "A\u03b2 plaques", "relationship": "RELATED_PROGNOSIS", "object": "reduction of A\u03b2 plaques and slow down cognitive decline", "chunk": 4}
{"article": "PMC8470960.txt", "subject": "A\u03b2 plaques", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 4}
{"article": "PMC8470960.txt", "subject": "APP", "relationship": "RELATED_PROGNOSIS", "object": "reduce amyloid precursor protein (APP), the precursor of A\u03b2", "chunk": 4}
{"article": "PMC8470960.txt", "subject": "BDNF", "relationship": "RELATED_PROGNOSIS", "object": "enhanced in mice practicing a FMD and was therefore speculated to have a role in the FMD-mediated neuroprotection", "chunk": 4}
{"article": "PMC8470960.txt", "subject": "BDNF", "relationship": "INDICATES_PRESENCE_OF", "object": "survival of dopaminergic neurons", "chunk": 4}
{"article": "PMC8470960.txt", "subject": "BHB", "relationship": "RELATED_TREATMENT", "object": "injected BHB (a ketone after approximately 12 to 16 h of fasting has led to improved cognitive functioning", "chunk": 4}
{"article": "PMC8470960.txt", "subject": "glucose metabolism rates", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "reduction in glucose metabolism rates with age, which can be present long before the onset of AD and is associated with A\u03b2 plaque density", "chunk": 4}
{"article": "PMC8470960.txt", "subject": "gut microbiota", "relationship": "RELATED_TREATMENT", "object": "reshaped the composition of the gut microbiota", "chunk": 4}
{"article": "PMC8470960.txt", "subject": "Blood glucose levels", "relationship": "INDICATES_PRESENCE_OF", "object": "Epilepsy (in animal models)", "chunk": 5}
{"article": "PMC8470960.txt", "subject": "mTOR signaling", "relationship": "INDICATES_PRESENCE_OF", "object": "Epilepsy (in animal models)", "chunk": 5}
{"article": "PMC8470960.txt", "subject": "Inflammatory markers", "relationship": "INDICATES_PRESENCE_OF", "object": "Epilepsy (in animal models)", "chunk": 5}
{"article": "PMC8470960.txt", "subject": "AMPK signaling", "relationship": "INDICATES_PRESENCE_OF", "object": "Epilepsy (in animal models)", "chunk": 5}
{"article": "PMC8470960.txt", "subject": "Autophagy", "relationship": "INDICATES_PRESENCE_OF", "object": "Epilepsy (in animal models)", "chunk": 5}
{"article": "PMC8470960.txt", "subject": "Ketones", "relationship": "RELATED_PROGNOSIS", "object": "Ischemic stroke", "chunk": 5}
{"article": "PMC8470960.txt", "subject": "Reactive oxygen species (ROS)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Ischemic stroke", "chunk": 5}
{"article": "PMC8470960.txt", "subject": "Fasting", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Ischemic stroke (potential treatment)", "chunk": 5}
{"article": "PMC8470960.txt", "subject": "BDNF", "relationship": "INDICATES_PRESENCE_OF", "object": "Mood disorders (potential biomarker)", "chunk": 5}
{"article": "PMC8470960.txt", "subject": "A\u03b2", "relationship": "RELATED_TO", "object": "Pathology in Alzheimer's Disease", "chunk": 6}
{"article": "PMC8470960.txt", "subject": "tau", "relationship": "RELATED_TO", "object": "Pathology in Alzheimer's Disease", "chunk": 6}
{"article": "PMC8470960.txt", "subject": "C-reactive protein serum levels", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Ischemic stroke", "chunk": 7}
{"article": "PMC8470960.txt", "subject": "insulin sensitivity", "relationship": "RELATED_PROGNOSIS", "object": "Neurological disease prevention", "chunk": 7}
{"article": "PMC8470960.txt", "subject": "APP levels", "relationship": "INDICATES_PRESENCE_OF", "object": "Protective of developing AD", "chunk": 7}
{"article": "PMC8470960.txt", "subject": "mTOR pathway activity", "relationship": "INDICATES_PRESENCE_OF", "object": "Protective of developing AD", "chunk": 7}
{"article": "PMC8470960.txt", "subject": "IGF-1", "relationship": "RELATED_PROGNOSIS", "object": "When IGF-1 was reduced it led to an enhancement of neuroplasticity", "chunk": 8}
{"article": "PMC8470960.txt", "subject": "LC3A", "relationship": "INDICATES_PRESENCE_OF", "object": "Autophagy", "chunk": 8}
{"article": "PMC8470960.txt", "subject": "PER1", "relationship": "INDICATES_PRESENCE_OF", "object": "Circadian clock", "chunk": 8}
{"article": "PMC8470960.txt", "subject": "CRY1", "relationship": "INDICATES_PRESENCE_OF", "object": "Circadian clock", "chunk": 8}
{"article": "PMC8470960.txt", "subject": "CRY2", "relationship": "INDICATES_PRESENCE_OF", "object": "Circadian clock", "chunk": 8}
{"article": "PMC8470960.txt", "subject": "BMAL1", "relationship": "INDICATES_PRESENCE_OF", "object": "Circadian clock", "chunk": 8}
{"article": "PMC8470960.txt", "subject": "SIRT1", "relationship": "INDICATES_PRESENCE_OF", "object": "Insulin sensitivity", "chunk": 8}
{"article": "PMC8470960.txt", "subject": "methionine", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Low levels are associated with longevity", "chunk": 8}
{"article": "PMC8470960.txt", "subject": "polyunsaturated free fatty acids", "relationship": "RELATED_TREATMENT", "object": "Increased levels observed during fasting", "chunk": 8}
{"article": "PMC8470960.txt", "subject": "alpha-tocopherol", "relationship": "RELATED_TREATMENT", "object": "Increased levels observed during fasting", "chunk": 8}
{"article": "PMC8470960.txt", "subject": "amino acids", "relationship": "RELATED_TREATMENT", "object": "Decreased levels observed during fasting", "chunk": 8}
{"article": "PMC8470960.txt", "subject": "GLP-1", "relationship": "ASSOCIATED_WITH_IMPROVED_OUTCOME", "object": "cognitive functioning, for instance in AD", "chunk": 9}
{"article": "PMC8470960.txt", "subject": "ketones", "relationship": "INDICATES_PRESENCE_OF", "object": "Improved cognitive functioning", "chunk": 10}
{"article": "PMC8470960.txt", "subject": "ketones", "relationship": "RELATED_TREATMENT", "object": "Injected ketones", "chunk": 10}
{"article": "PMC8470960.txt", "subject": "BDNF", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Promote mitochondrial biogenesis, synaptic plasticity, and cellular stress resistance", "chunk": 10}
{"article": "PMC8470960.txt", "subject": "IF", "relationship": "RELATED_PROGNOSIS", "object": "Protective effect on developing neurological disorders", "chunk": 10}
{"article": "PMC8480485.txt", "subject": "\u03b2-amyloid (A\u03b2)", "relationship": "INDICATES_PRESENCE_OF", "object": "AD-typical \u03b2-amyloid (A\u03b2) and tau pathology", "chunk": 1}
{"article": "PMC8480485.txt", "subject": "tau pathology", "relationship": "INDICATES_PRESENCE_OF", "object": "AD-typical \u03b2-amyloid (A\u03b2) and tau pathology", "chunk": 1}
{"article": "PMC8480485.txt", "subject": "p-tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 2}
{"article": "PMC8480485.txt", "subject": "p-tau181", "relationship": "CORRELATES_WITH", "object": "cerebral spinal fluid measures of p-tau181", "chunk": 2}
{"article": "PMC8480485.txt", "subject": "p-tau181", "relationship": "CORRELATES_WITH", "object": "PET measures of A\u03b2 and tau pathology", "chunk": 2}
{"article": "PMC8480485.txt", "subject": "p-tau181", "relationship": "DISTINGUISH_BETWEEN", "object": "AD and other neurodegenerative disorders", "chunk": 2}
{"article": "PMC8480485.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 2}
{"article": "PMC8480485.txt", "subject": "A\u03b2", "relationship": "RELATED_TO", "object": "PET measures of A\u03b2 and tau pathology", "chunk": 2}
{"article": "PMC8480485.txt", "subject": "tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 2}
{"article": "PMC8480485.txt", "subject": "tau", "relationship": "RELATED_TO", "object": "PET measures of A\u03b2 and tau pathology", "chunk": 2}
{"article": "PMC8480485.txt", "subject": "neurofilament light (NfL)", "relationship": "RELATED_TO", "object": "preliminary analysis", "chunk": 2}
{"article": "PMC8480485.txt", "subject": "A\u03b21-42", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment assessment", "chunk": 3}
{"article": "PMC8480485.txt", "subject": "t-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment assessment", "chunk": 3}
{"article": "PMC8480485.txt", "subject": "p-tau181", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment assessment", "chunk": 3}
{"article": "PMC8480485.txt", "subject": "A\u03b21-42", "relationship": "levels_reflect_response", "object": "treatment response", "chunk": 3}
{"article": "PMC8480485.txt", "subject": "t-tau", "relationship": "levels_reflect_response", "object": "treatment response", "chunk": 3}
{"article": "PMC8480485.txt", "subject": "p-tau181", "relationship": "levels_reflect_response", "object": "treatment response", "chunk": 3}
{"article": "PMC8480485.txt", "subject": "A\u03b21-42", "relationship": "RELATED_PROGNOSIS", "object": "High A\u03b21-42 levels associated with Alzheimer's disease neuropathology", "chunk": 4}
{"article": "PMC8480485.txt", "subject": "t-tau", "relationship": "RELATED_PROGNOSIS", "object": "Higher t-tau levels correlated with Alzheimer's disease neuropathology", "chunk": 4}
{"article": "PMC8480485.txt", "subject": "p-tau181", "relationship": "RELATED_PROGNOSIS", "object": "Increased p-tau181 levels associated with Alzheimer's disease neuropathology", "chunk": 4}
{"article": "PMC8480485.txt", "subject": "t-tau/A\u03b21-42 ratio", "relationship": "RELATED_PROGNOSIS", "object": "Higher t-tau/A\u03b21-42 ratios associated with Alzheimer's disease neuropathology", "chunk": 4}
{"article": "PMC8480485.txt", "subject": "p-tau181/A\u03b21-42 ratio", "relationship": "RELATED_PROGNOSIS", "object": "Higher p-tau181/A\u03b21-42 ratios associated with Alzheimer's disease neuropathology", "chunk": 4}
{"article": "PMC8480485.txt", "subject": "p-tau181", "relationship": "DIAGNOSITC_OF", "object": "Distinguishing pathologically confirmed Alzheimer's disease from amyloid-negative controls", "chunk": 4}
{"article": "PMC8480485.txt", "subject": "NfL", "relationship": "DIAGNOSITC_OF", "object": "Differentiating pathologically confirmed Alzheimer's disease from amyloid-negative controls", "chunk": 4}
{"article": "PMC8480485.txt", "subject": "A\u03b21-42 levels", "relationship": "INDICATES_PRESENCE_OF", "object": "High and low degrees of Thal phase (A) and diffuse plaque scores (D)", "chunk": 5}
{"article": "PMC8480485.txt", "subject": "p-tau181 levels", "relationship": "INDICATES_PRESENCE_OF", "object": "High and low degrees of Braak stage (B) and neuritic plaque scores (C)", "chunk": 5}
{"article": "PMC8480485.txt", "subject": "t-tau cutoff", "relationship": "INDICATES_PRESENCE_OF", "object": "High degrees of Braak stage (B) and neuritic plaques (C)", "chunk": 5}
{"article": "PMC8480485.txt", "subject": "t-tau/A\u03b21-42 ratio", "relationship": "indicated_presence_of", "object": "High and low degrees of pathology", "chunk": 5}
{"article": "PMC8480485.txt", "subject": "p-tau181/A\u03b21-42 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "High and low degrees of pathology", "chunk": 5}
{"article": "PMC8480485.txt", "subject": "A\u03b21-42 levels", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Presence of Cerebral amyloid angiopathy (CAA)", "chunk": 5}
{"article": "PMC8480485.txt", "subject": "t-tau/A\u03b21-42 ratio", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Presence of Cerebral amyloid angiopathy (CAA)", "chunk": 5}
{"article": "PMC8480485.txt", "subject": "p-tau181/A\u03b21-42 ratio", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Presence of Cerebral amyloid angiopathy (CAA)", "chunk": 5}
{"article": "PMC8480485.txt", "subject": "plasma p-tau181", "relationship": "RELATED_PROGNOSIS", "object": "Braak stage (B) and neuritic plaque scores (C)", "chunk": 5}
{"article": "PMC8480485.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "AD dementia", "chunk": 6}
{"article": "PMC8480485.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TO", "object": "Cerbral cerebral cerebral cerebral spinal fluid A\u03b21-42 levels", "chunk": 6}
{"article": "PMC8480485.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TO", "object": "Thal phase and diffuse plaques", "chunk": 6}
{"article": "PMC8480485.txt", "subject": "p-tau181", "relationship": "RELATED_TO", "object": "Braak stage and neuritic plaques", "chunk": 6}
{"article": "PMC8480485.txt", "subject": "A\u03b21-42", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "CAA pathology", "chunk": 6}
{"article": "PMC8480485.txt", "subject": "A\u03b21-42", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "In vivo assessment of A\u03b2 plaque pathology", "chunk": 6}
{"article": "PMC8480485.txt", "subject": "A\u03b21-42", "relationship": "MONITORED_DURING_TREATMENT", "object": "Assessing clinical progression using Elecsys platform", "chunk": 6}
{"article": "PMC8480485.txt", "subject": "t-tau", "relationship": "RELATED_TREATMENT", "object": "Clinical progression", "chunk": 6}
{"article": "PMC8480485.txt", "subject": "p-tau181", "relationship": "RELATED_TREATMENT", "object": "Clinical progression", "chunk": 6}
{"article": "PMC8480485.txt", "subject": "A\u03b21-42", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Detecting A\u03b2 positivity", "chunk": 6}
{"article": "PMC8480485.txt", "subject": "A\u03b21-42", "relationship": "DIAGNOSTIC_OF", "object": "Pathologic confirmation of AD", "chunk": 7}
{"article": "PMC8480485.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TO", "object": "Average cerebral spinal fluid A\u03b21-42 levels", "chunk": 7}
{"article": "PMC8480485.txt", "subject": "p-tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "AD neuropathology", "chunk": 7}
{"article": "PMC8480485.txt", "subject": "p-tau181", "relationship": "RELATED_PROGNOSIS", "object": "Braak tau stage or neuritic plaque scores", "chunk": 7}
{"article": "PMC8480485.txt", "subject": "p-tau181", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Differential diagnosis of dementia", "chunk": 7}
{"article": "PMC8480485.txt", "subject": "A\u03b2 markers (plasma)", "relationship": "RELATED_PROGNOSIS", "object": "Neuropathologic measures", "chunk": 7}
{"article": "PMC8480485.txt", "subject": "p-tau181 (cerebral spinal fluid)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Cerebral spinal fluid biomarkers", "chunk": 7}
{"article": "PMC8480485.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis of Alzheimer's Disease", "chunk": 8}
{"article": "PMC8480485.txt", "subject": "t-tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis of Alzheimer's Disease", "chunk": 8}
{"article": "PMC8480485.txt", "subject": "p-tau181", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis of Alzheimer's Disease", "chunk": 8}
{"article": "PMC8480485.txt", "subject": "NfL", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis of Alzheimer's Disease", "chunk": 8}
{"article": "PMC8481830.txt", "subject": "Mitochondrial 18 kDa translocator protein (TSPO)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "PET imaging of neuroinflammation in Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC8481830.txt", "subject": "TSPO (18 kDa translocator protein)", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuroinflammation", "chunk": 1}
{"article": "PMC8481830.txt", "subject": "TREM2", "relationship": "RELATED_TO", "object": "A\u03b2-laden microglia", "chunk": 1}
{"article": "PMC8481830.txt", "subject": "Apolipoprotein E (ApoE)", "relationship": "RELATED_TO", "object": "A\u03b2-laden microglia", "chunk": 1}
{"article": "PMC8481830.txt", "subject": "Tumor necrosis factor alpha (TNF\u03b1)", "relationship": "DIAGNOSITC_OF", "object": "AD  and mild cognitive impairment", "chunk": 1}
{"article": "PMC8481830.txt", "subject": "Interleukin-6 (IL-6)", "relationship": "DIAGNOSITC_OF", "object": "AD and mild cognitive impairment ", "chunk": 1}
{"article": "PMC8481830.txt", "subject": "IL-10", "relationship": "DIAGNOSITC_OF", "object": "AD and mild cognitive impairment", "chunk": 1}
{"article": "PMC8481830.txt", "subject": "TSPO", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 2}
{"article": "PMC8481830.txt", "subject": "TSPO", "relationship": "RELATED_TREATMENT", "object": "Homologous blocker treatment", "chunk": 2}
{"article": "PMC8481830.txt", "subject": "[11C]GW2580", "relationship": "RELATED_PROGNOSIS", "object": "Tau lesion-associated microglial TSPO", "chunk": 2}
{"article": "PMC8481830.txt", "subject": "[18F]FEBMP", "relationship": "RELATED_PROGNOSIS", "object": "Tau lesion-associated microglial TSPO", "chunk": 2}
{"article": "PMC8481830.txt", "subject": "[11C]PK11195", "relationship": "RELATED_PROGNOSIS", "object": "Tau lesion-associated microglial TSPO", "chunk": 2}
{"article": "PMC8481830.txt", "subject": "[18F]FEBMP", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Tau lesion-associated microglial TSPO", "chunk": 2}
{"article": "PMC8481830.txt", "subject": "[11C]PK11195", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 accumulation", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "[11C]PK11195", "relationship": "RELATED_PROGNOSIS", "object": "functional network connectivity, grey matters atrophy, and cognitive decline", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "[11C]PK11195", "relationship": "RELATED_PROGNOSIS", "object": "cognitive impairments", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "[11C]PBR28", "relationship": "RELATED_PROGNOSIS", "object": "amyloid load and memory impairment", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "[11C]PBR28", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "too high", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "[11C]PBR28", "relationship": "INDICATES_PRESENCE_OF", "object": "microglial activation", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "[11C]PBR28", "relationship": "RELATED_TREATMENT", "object": "treatment selection", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "[18F]DPA-714", "relationship": "RELATED_TREATMENT", "object": "treatment selection", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "[18F]DPA-714", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "progression in AD", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "[18F]florbetaben", "relationship": "DIAGNOSITC_OF", "object": "amyloid load", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "[18F]flortaucipir", "relationship": "DIAGNOSITC_OF", "object": "tau accumulation", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "[11C]ER176", "relationship": "RELATED_PROGNOSIS", "object": "microglial activation", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "[18F]GE-180", "relationship": "RELATED_PROGNOSIS", "object": "amyloidosis, tauopathy rodent models", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "[18F]GE-180", "relationship": "DIAGNOSITC_OF", "object": "microglial activation", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "[18F]GE-180", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 load", "chunk": 3}
{"article": "PMC8481830.txt", "subject": "TSPO", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Imaging biomarkers for neuroinflammation", "chunk": 4}
{"article": "PMC8481830.txt", "subject": "Colony-Stimulating Factor 1 Receptor", "relationship": "DIAGNOSITC_OF", "object": "Microglia activation", "chunk": 4}
{"article": "PMC8481830.txt", "subject": "Colony-Stimulating Factor 1 Receptor", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammation in the brain", "chunk": 4}
{"article": "PMC8481830.txt", "subject": "[11C]CPPC", "relationship": "MONITORED_DURING_TREATMENT", "object": "Acute inflammation induced by LPS injection", "chunk": 4}
{"article": "PMC8481830.txt", "subject": "[11C]GW2580", "relationship": "MONITORED_DURING_TREATMENT", "object": "Chronic inflammation", "chunk": 4}
{"article": "PMC8481830.txt", "subject": "COX-1", "relationship": "RELATED_PROGNOSIS", "object": "Neuro\u708e\u75c7 in neurodegenerative disorders including AD.", "chunk": 4}
{"article": "PMC8481830.txt", "subject": "COX-2", "relationship": "RELATED_PROGNOSIS", "object": "Neuro\u708e\u75c7 in neurodegenerative disorders including AD.", "chunk": 4}
{"article": "PMC8481830.txt", "subject": "[11C]KTP-Me", "relationship": "INDICATES_PRESENCE_OF", "object": "Acute inflammation in AD patients", "chunk": 4}
{"article": "PMC8481830.txt", "subject": "[11C]KTP-Me", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Imaging tools to detect AD", "chunk": 4}
{"article": "PMC8481830.txt", "subject": "CB2R", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's disease", "chunk": 4}
{"article": "PMC8481830.txt", "subject": "P2X7 receptor", "relationship": "RELATED_TREATMENT", "object": "Inflammation as a treatment target", "chunk": 4}
{"article": "PMC8481830.txt", "subject": "P2Y12 receptor", "relationship": "RELATED_TREATMENT", "object": "Neuroinflammation} ", "chunk": 4}
{"article": "PMC8481830.txt", "subject": "deprenyl", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Astrocytosis imaging", "chunk": 5}
{"article": "PMC8481830.txt", "subject": "[11C]SMBT-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s Disease", "chunk": 5}
{"article": "PMC8481830.txt", "subject": "[11C]BU99008", "relationship": "RELATED_PROGNOSIS", "object": "Amyloid-beta load", "chunk": 5}
{"article": "PMC8481830.txt", "subject": "[11C]BU99008", "relationship": "PREDICTED_SURVIVAL", "object": "Progression of Alzheimer\u2019s Disease", "chunk": 5}
{"article": "PMC8481830.txt", "subject": "[11C]BU99008", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Assessment of AD continuum", "chunk": 5}
{"article": "PMC8481830.txt", "subject": "[11C]BU99008", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Therapeutic interventions for AD", "chunk": 5}
{"article": "PMC8481830.txt", "subject": "[18F]FBAT", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Neuroinflammation imaging", "chunk": 6}
{"article": "PMC8481830.txt", "subject": "[18F]ROStrace", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Neuroinflammation imaging", "chunk": 6}
{"article": "PMC8481830.txt", "subject": "[18F]ox-ROStrace", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Neuroinflammation imaging", "chunk": 6}
{"article": "PMC8481830.txt", "subject": "[18F]dihydromethidine", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Neuroinflammation imaging", "chunk": 6}
{"article": "PMC8481830.txt", "subject": "[11C]Ascorbic", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Neuroinflammation imaging", "chunk": 6}
{"article": "PMC8481830.txt", "subject": "[62Cu]ATSM", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Neuroinflammation imaging", "chunk": 6}
{"article": "PMC8481830.txt", "subject": "[11C]dehydroascorbic acid", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Neuroinflammation imaging", "chunk": 6}
{"article": "PMC8481830.txt", "subject": "[64Cu]TREM1-mAb", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Neuroinflammation imaging", "chunk": 6}
{"article": "PMC8481830.txt", "subject": "[18F]BR-351", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Neuroinflammation imaging", "chunk": 6}
{"article": "PMC8481830.txt", "subject": "[18F]BR-420", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Neuroinflammation imaging", "chunk": 6}
{"article": "PMC8481830.txt", "subject": "[11C]acetate", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Neuroinflammation imaging", "chunk": 6}
{"article": "PMC8481830.txt", "subject": "[\u00b9\u2078F]FEBU", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Neuroinflammation imaging", "chunk": 6}
{"article": "PMC8481830.txt", "subject": "[18F]2B-SRF101", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Neuroinflammation imaging", "chunk": 6}
{"article": "PMC8496617.txt", "subject": "Antipsychotic medications", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increase the risk of death in people with dementia", "chunk": 1}
{"article": "PMC8496617.txt", "subject": "Music & MemorySM (M&M)", "relationship": "RELATED_TREATMENT", "object": "a personalized music program in which the music a resident liked as a young adult is loaded onto a personal music device and administered by NH staff to address agitation", "chunk": 1}
{"article": "PMC8496617.txt", "subject": "Music & MemorySM (M&M)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The need for non-pharmaceutical approaches for managing behaviors in residents with dementia has resulted in widespread adoption of M&M ahead of effectiveness evidence.", "chunk": 1}
{"article": "PMC8496617.txt", "subject": "Minimum Data Set Agitated and Reactive Behavior Scale (MDS-ARBS)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Behavioral interventions for agitated residents in NH settings", "chunk": 3}
{"article": "PMC8500065.txt", "subject": "amyloid-\u03b2 (A\u03b2) oligomers", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD-related pathological proteins associated with cognitive dysfunction.", "chunk": 1}
{"article": "PMC8500065.txt", "subject": "hyperphosphorylated tau", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD-related pathological proteins associated with cognitive dysfunction.", "chunk": 1}
{"article": "PMC8500065.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Determining the initial MMSE score is used to determine patients' eligibility for the study based on their cognitive function", "chunk": 2}
{"article": "PMC8500065.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "INDICATES_PRESENCE_OF", "object": "Scores range between 0 and 30, with higher scores suggesting better cognitive performance.", "chunk": 2}
{"article": "PMC8500065.txt", "subject": "Alzheimer\u2019s Disease Cooperative Study \u2013 Activities of Daily Living (ADCS-ADL)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Patients' initial ADCS-ADL scores are assessed to understand their functional capacity to participate in the study.", "chunk": 2}
{"article": "PMC8500065.txt", "subject": "Alzheimer\u2019s Disease Cooperative Study \u2013 Activities of Daily Living (ADCS-ADL)", "relationship": "INDICATES_PRESENCE_OF", "object": "Scores range between 0 and 78, with higher scores indicating better functioning.", "chunk": 2}
{"article": "PMC8502814.txt", "subject": "high glycemic diet", "relationship": "RELATED_TO", "object": "brain amyloid accumulation", "chunk": 1}
{"article": "PMC8502814.txt", "subject": "high glycemic diet", "relationship": "RELATED_TO", "object": "precuneal amyloid accumulation", "chunk": 1}
{"article": "PMC8502814.txt", "subject": "high glycemic diet", "relationship": "RELATED_TO", "object": "higher amyloid accumulation in the lateral temporal lobe", "chunk": 1}
{"article": "PMC8502814.txt", "subject": "high glycemic diet", "relationship": "RELATED_TO", "object": "posterior cingulate gyrus amyloid accumulation", "chunk": 1}
{"article": "PMC8502814.txt", "subject": "sugar", "relationship": "RELATED_TO", "object": "precuneal amyloid accumulation", "chunk": 1}
{"article": "PMC8502814.txt", "subject": "total carbohydrate", "relationship": "RELATED_TO", "object": "precuneal amyloid accumulation", "chunk": 1}
{"article": "PMC8502814.txt", "subject": "sugar", "relationship": "RELATED_TO", "object": "posterior cingulate gyrus amyloid accumulation", "chunk": 1}
{"article": "PMC8502814.txt", "subject": "total carbohydrate", "relationship": "RELATED_TO", "object": "posterior cingulate gyrus amyloid accumulation", "chunk": 1}
{"article": "PMC8502814.txt", "subject": "APOE4", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Eligibility for the APEx trial", "chunk": 2}
{"article": "PMC8502814.txt", "subject": "APOE4", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose individuals for APOE4 carrier status", "chunk": 2}
{"article": "PMC8502814.txt", "subject": "amyloid PET", "relationship": "INDICATES_PRESENCE_OF", "object": "Elevated or sub-threshold cerebral amyloid", "chunk": 2}
{"article": "PMC8502814.txt", "subject": "amyloid PET", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Determining eligibility for the APEx trial", "chunk": 2}
{"article": "PMC8502814.txt", "subject": "SUVR", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid accumulation", "chunk": 3}
{"article": "PMC8502814.txt", "subject": "SUVR", "relationship": "RELATED_TO", "object": "High glycemic diet pattern", "chunk": 3}
{"article": "PMC8502814.txt", "subject": "APOE4 status", "relationship": "USED_TO_ADJUST", "object": "Statistical models", "chunk": 3}
{"article": "PMC8502814.txt", "subject": "Elevated amyloid status", "relationship": "INDICATES_PRESENCE_OF", "object": "Higher SUVR change scores (indicator of more aggregated amyloid)", "chunk": 4}
{"article": "PMC8502814.txt", "subject": "Elevated amyloid status", "relationship": "RELATED_PROGNOSIS", "object": "Higher amyloid SUVR values in the inferior medial frontal gyrus", "chunk": 4}
{"article": "PMC8502814.txt", "subject": "Elevated amyloid status", "relationship": "RELATED_PROGNOSIS", "object": "Higher amyloid SUVR values in the lateral temporal lobe", "chunk": 4}
{"article": "PMC8502814.txt", "subject": "Elevated amyloid status", "relationship": "RELATED_PROGNOSIS", "object": "Higher amyloid SUVR values in the precuneus", "chunk": 4}
{"article": "PMC8502814.txt", "subject": "HGDiet pattern score", "relationship": "RELATED_PROGNOSIS", "object": "Amyloid accumulation over 1 year in the precuneus and cuneus", "chunk": 5}
{"article": "PMC8502814.txt", "subject": "HGDiet pattern score", "relationship": "RELATED_PROGNOSIS", "object": "Amyloid accumulation in the precuneus (inverted U shape)", "chunk": 5}
{"article": "PMC8502814.txt", "subject": "HGDiet pattern score", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Higher Amyloid accumulation", "chunk": 5}
{"article": "PMC8502814.txt", "subject": "Sugar (g)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Amyloid accumulation in the posterior cingulate gyrus and precuneus", "chunk": 5}
{"article": "PMC8502814.txt", "subject": "Carbohydrate (g)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Amyloid accumulation in the posterior cingulate gyrus and precuneus", "chunk": 5}
{"article": "PMC8502814.txt", "subject": "HGDiet pattern score", "relationship": "RELATED_PROGNOSIS", "object": "Amyloid accumulation in the lateral temporal lobe, posterior cingulate gyrus, and precuneus", "chunk": 5}
{"article": "PMC8502814.txt", "subject": "HGDiet pattern score", "relationship": "RELATED_PROGNOSIS", "object": "Global amyloid", "chunk": 5}
{"article": "PMC8502814.txt", "subject": "HGDiet pattern score", "relationship": "RELATED_PROGNOSIS", "object": "Change in cerebral amyloid burden", "chunk": 5}
{"article": "PMC8502814.txt", "subject": "High Glycemic Diet Pattern", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased amyloid burden", "chunk": 6}
{"article": "PMC8502814.txt", "subject": "High Glycemic Diet Pattern", "relationship": "RELATED_PROGNOSIS", "object": "1-year change in amyloid levels", "chunk": 6}
{"article": "PMC8502814.txt", "subject": "High Glycemic Diet Pattern", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid accumulation", "chunk": 6}
{"article": "PMC8507171.txt", "subject": "APOE", "relationship": "RELATED_TO_RISK", "object": "Alzheimer\u2019s disease risk", "chunk": 1}
{"article": "PMC8507171.txt", "subject": "Alzheimer\u2019s disease biomarkers", "relationship": "INDICATES_PRESENCE_OF", "object": "Biologically defined disease", "chunk": 1}
{"article": "PMC8507171.txt", "subject": "APOE-\u03b54", "relationship": "IS_RELATED_TO", "object": "moderate-penetrance genes, causing a significant but limited increase in Alzheimer\u2019s risk", "chunk": 2}
{"article": "PMC8507171.txt", "subject": "APOE-\u03b54", "relationship": "IS_RELATED_TO", "object": "familiarisation of risk communication in cancer genetics", "chunk": 2}
{"article": "PMC8507171.txt", "subject": "amyloid PET", "relationship": "USED_TO_DIAGNOSE", "object": "mild cognitive impairment", "chunk": 3}
{"article": "PMC8507171.txt", "subject": "amyloid PET", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid Pathology", "chunk": 3}
{"article": "PMC8507171.txt", "subject": "APOE", "relationship": "PREDICTING TREATMENT", "object": "Alzheimer\u2019s Disease Progression", "chunk": 3}
{"article": "PMC8507171.txt", "subject": "APOE-\u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s Disease Risk", "chunk": 3}
{"article": "PMC8507171.txt", "subject": "APOE-\u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s Disease Progression", "chunk": 3}
{"article": "PMC8507171.txt", "subject": "APOE", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Diagnosis: Alzheimer\u2019s Disease", "chunk": 4}
{"article": "PMC8507171.txt", "subject": "amyloid PET", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Diagnosis: Alzheimer\u2019s Disease", "chunk": 4}
{"article": "PMC8507171.txt", "subject": "APOE", "relationship": "RELATED_TO", "object": "Risk for Developing AD and/or Dementia", "chunk": 5}
{"article": "PMC8507171.txt", "subject": "Biomarker testing", "relationship": "IS_BASIS_FOR", "object": "Decision-making about pursuing biomarker testing for AD and/or knowing their dementia risk", "chunk": 5}
{"article": "PMC8507171.txt", "subject": "Biomarkers", "relationship": "Predicts", "object": "Disease severity", "chunk": 5}
{"article": "PMC8518196.txt", "subject": "Social support", "relationship": "RESULTS_IN", "object": "Improved health outcomes for caregivers and people with dementia", "chunk": 1}
{"article": "PMC8518196.txt", "subject": "Social support", "relationship": "PREDICTOR_OF", "object": "Reduced risk for premature mortality", "chunk": 1}
{"article": "PMC8518196.txt", "subject": "Geriatric Depression Scale scores", "relationship": "RELATED_PROGNOSIS", "object": "changes in the primary outcomes over time", "chunk": 5}
{"article": "PMC8518196.txt", "subject": "MoCA score", "relationship": "RELATED_TREATMENT", "object": "increases power", "chunk": 5}
{"article": "PMC8518196.txt", "subject": "Geriatric Depression Scale scores", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "clinical group", "chunk": 5}
{"article": "PMC8518196.txt", "subject": "relationship characteristics", "relationship": "INDICATES_PRESENCE_OF", "object": "Impact on dementia outcomes for both the caregiver and the PWD", "chunk": 6}
{"article": "PMC8518196.txt", "subject": "relationship quality", "relationship": "RELATED_PROGNOSIS", "object": "Impact on both the caregiver and the care-recipient", "chunk": 6}
{"article": "PMC8524126.txt", "subject": "working memory deficit", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment after aSAH", "chunk": 1}
{"article": "PMC8524126.txt", "subject": "working memory deficit", "relationship": "RELATED_TO", "object": "Neural alterations of aSAH patients", "chunk": 1}
{"article": "PMC8524126.txt", "subject": "working memory deficit", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Patients' daily life", "chunk": 1}
{"article": "PMC8524126.txt", "subject": "working memory deficit", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Improvement of current rehabilitation", "chunk": 1}
{"article": "PMC8524126.txt", "subject": "Head CT of Fisher grade", "relationship": "INDICATES_PRESENCE_OF", "object": "Severity of aSAH", "chunk": 2}
{"article": "PMC8524356.txt", "subject": "GFAP", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer Disease Continuum", "chunk": 1}
{"article": "PMC8524356.txt", "subject": "plasma GFAP", "relationship": "RELATED_TO_DIAGNOSIS_OF", "object": "Alzheimer disease (AD)", "chunk": 2}
{"article": "PMC8524356.txt", "subject": "GFAP", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 pathology", "chunk": 2}
{"article": "PMC8524356.txt", "subject": "plasma GFAP", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosing Alzheimer disease (AD)", "chunk": 2}
{"article": "PMC8524356.txt", "subject": "plasma GFAP", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "AD", "chunk": 2}
{"article": "PMC8524356.txt", "subject": "GFAP", "relationship": "INDICATES_PRESENCE_OF", "object": "reactive astrogliosis", "chunk": 3}
{"article": "PMC8524356.txt", "subject": "GFAP Levels", "relationship": "RELATED_PROGNOSIS", "object": "stages of the AD continuum", "chunk": 3}
{"article": "PMC8524356.txt", "subject": "Plasma GFAP", "relationship": "RELATED_TREATMENT", "object": "detect and track reactive astrogliosis and A\u03b2 pathology", "chunk": 3}
{"article": "PMC8524356.txt", "subject": "Plasma GFAP", "relationship": "IS_TARGET_OF_TREATMENT", "object": "evaluating", "chunk": 3}
{"article": "PMC8524356.txt", "subject": "GFAP", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer disease pathology", "chunk": 3}
{"article": "PMC8524356.txt", "subject": "Plasma GFAP Levels", "relationship": "RELATED_TREATMENT", "object": "screening large populations of cognitively unimpaired individuals", "chunk": 3}
{"article": "PMC8524356.txt", "subject": "GFAP", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC8524356.txt", "subject": "GFAP", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC8524356.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC8524356.txt", "subject": "A\u03b242/40", "relationship": "RELATED_PROGNOSIS", "object": "Higher levels in CSF are associated with a more advanced stage of Alzheimer\u2019s", "chunk": 5}
{"article": "PMC8524356.txt", "subject": "p-tau181", "relationship": "RELATED_PROGNOSIS", "object": "Higher levels in CSF are associated with a more advanced stage of Alzheimer\u2019s", "chunk": 5}
{"article": "PMC8524356.txt", "subject": "t-tau", "relationship": "RELATED_PROGNOSIS", "object": "Higher levels in CSF are associated with a more advanced stage of Alzheimer\u2019s", "chunk": 5}
{"article": "PMC8524356.txt", "subject": "NfL", "relationship": "RELATED_PROGNOSIS", "object": "Higher levels in CSF are associated with a more advanced stage of Alzheimer\u2019s", "chunk": 5}
{"article": "PMC8524356.txt", "subject": "GFAP", "relationship": "RELATED_PROGNOSIS", "object": "Higher levels in CSF are associated with a more advanced stage of Alzheimer\u2019s", "chunk": 5}
{"article": "PMC8524356.txt", "subject": "plasma GFAP", "relationship": "RELATED_PROGNOSIS", "object": "Higher levels are associated with a more advanced stage of Alzheimer\u2019s", "chunk": 5}
{"article": "PMC8524356.txt", "subject": "amyloid-\u03b2 (A\u03b2)", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer disease continuum groups", "chunk": 6}
{"article": "PMC8524356.txt", "subject": "A\u03b2\u2013", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease (AD) continuum groups", "chunk": 6}
{"article": "PMC8524356.txt", "subject": "A\u03b242/40", "relationship": "MONITORED_DURING_TREATMENT", "object": "study the AD continuum", "chunk": 6}
{"article": "PMC8524356.txt", "subject": "A\u03b2 PET", "relationship": "MONITORED_DURING_TREATMENT", "object": "study the AD continuum", "chunk": 6}
{"article": "PMC8524356.txt", "subject": "GFAP", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Alzheimer disease continuum groups", "chunk": 6}
{"article": "PMC8524356.txt", "subject": "plasma GFAP levels", "relationship": "RELATED_PROGNOSIS", "object": "A\u03b2 pathology", "chunk": 6}
{"article": "PMC8524356.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid GFAP levels", "relationship": "RELATED_PROGNOSIS", "object": "A\u03b2 pathology", "chunk": 6}
{"article": "PMC8524356.txt", "subject": "plasma GFAP levels", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "A\u03b2 pathology", "chunk": 6}
{"article": "PMC8524356.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid GFAP levels", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "A\u03b2 pathology", "chunk": 6}
{"article": "PMC8524356.txt", "subject": "plasma GFAP", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 pathology", "chunk": 7}
{"article": "PMC8524356.txt", "subject": "plasma GFAP", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "A\u03b2 pathology", "chunk": 7}
{"article": "PMC8524356.txt", "subject": "plasma GFAP", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Discriminate A\u03b2 status", "chunk": 7}
{"article": "PMC8524356.txt", "subject": "plasma GFAP", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Discriminate A\u03b2 status", "chunk": 7}
{"article": "PMC8524356.txt", "subject": "cerebral GFAP", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 pathology", "chunk": 7}
{"article": "PMC8524356.txt", "subject": "cerebral GFAP", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "A\u03b2 pathology", "chunk": 7}
{"article": "PMC8524356.txt", "subject": "p-tau181", "relationship": "RELATED_TO_IMPAIRMENT", "object": "Diagnosis: Mild cognitive impairment", "chunk": 7}
{"article": "PMC8524356.txt", "subject": "p-tau181", "relationship": "RELATED_TO_IMPAIRMENT", "object": "A\u03b2 pathology", "chunk": 7}
{"article": "PMC8524356.txt", "subject": "NfL", "relationship": "RELATED_TO_IMPAIRMENT", "object": "A\u03b2 pathology", "chunk": 7}
{"article": "PMC8524356.txt", "subject": "GFAP levels", "relationship": "ASSOCITAED_WITH_POOR_OUTCOME", "object": "No increase. Indicates plasma GFAP levels appear to be a superior biomarker                                                                    tracking A\u03b2 pathology than its cerebral spinal fluid counterpart.", "chunk": 8}
{"article": "PMC8524356.txt", "subject": "GFAP levels", "relationship": "RELATED_TREATMENT", "object": "Previous studies showed that plasma and serum GFAP levels are higher in those with symptomatic AD,9,24,25,26,27 results that are in line with those reported for cerebral spinal fluid GFAP levels.24,28,29,30,31 However, less is known about plasma GFAP levels among individuals along the whole AD continuum and, particularly, in those with preclinical AD.", "chunk": 8}
{"article": "PMC8524356.txt", "subject": "plasma GFAP levels", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 pathology", "chunk": 9}
{"article": "PMC8524356.txt", "subject": "plasma GFAP levels", "relationship": "RELATED_PROGNOSIS", "object": "A\u03b2 pathology in preclinical AD", "chunk": 9}
{"article": "PMC8524356.txt", "subject": "plasma GFAP levels", "relationship": "RELATED_PROGNOSIS", "object": "advanced clinical diagnosis (CU+ less than mild cognitive impairment +, which was less than AD dementia)", "chunk": 9}
{"article": "PMC8524356.txt", "subject": "plasma GFAP levels", "relationship": "RELATED_PROGNOSIS", "object": "tau pathology", "chunk": 9}
{"article": "PMC8524356.txt", "subject": "plasma GFAP levels", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "preclinical stages of A\u03b2 pathology", "chunk": 9}
{"article": "PMC8524356.txt", "subject": "plasma GFAP levels", "relationship": "INDICATES_PRESENCE_OF", "object": "reactive astrocytes", "chunk": 9}
{"article": "PMC8524356.txt", "subject": "plasma GFAP levels", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treatment for Alzheimer's Disease", "chunk": 9}
{"article": "PMC8524356.txt", "subject": "plasma GFAP levels", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment for Alzheimer's Disease ", "chunk": 9}
{"article": "PMC8524356.txt", "subject": "plasma GFAP levels", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "response to treatment for Alzheimer's Disease", "chunk": 9}
{"article": "PMC8524356.txt", "subject": "GFAP", "relationship": "IS_TARGET_OF_TREATMENT", "object": "treatment for neurodegenerative diseases ", "chunk": 9}
{"article": "PMC8524356.txt", "subject": "GFAP", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 pathology", "chunk": 10}
{"article": "PMC8524356.txt", "subject": "GFAP", "relationship": "DIAGONISTIC_OF", "object": "AD, particularly in its preclinical stage", "chunk": 10}
{"article": "PMC8524356.txt", "subject": "GFAP", "relationship": "RELATED_PROGNOSIS", "object": "disease progression", "chunk": 10}
{"article": "PMC8524356.txt", "subject": "GFAP", "relationship": "RELATED_TREATMENT", "object": "screening for A\u03b2+ individuals", "chunk": 10}
{"article": "PMC8530186.txt", "subject": "hippocampal volume", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Aerobic exercise as a potential disease-modifying treatment for AD", "chunk": 1}
{"article": "PMC8530186.txt", "subject": "hippocampal volume", "relationship": "RELATED_PROGNOSIS", "object": "positive correlation between 6-month changes in hippocampal volume and ADAS-Cog", "chunk": 1}
{"article": "PMC8530186.txt", "subject": "hippocampal volume", "relationship": "MONITORED_DURING_TREATMENT", "object": "Intervention period", "chunk": 1}
{"article": "PMC8530186.txt", "subject": "temporal meta-ROI cortical thickness", "relationship": "ASSSOCIATED_WITH_POOR_OUTCOME", "object": "Declines in these parameters over time but the effect sizes ... are likely to be very small", "chunk": 1}
{"article": "PMC8530186.txt", "subject": "WMH volume", "relationship": "RELATED_PROGNOSIS", "object": "Aerobic exercise is effective on slowing down WMH progression", "chunk": 1}
{"article": "PMC8530186.txt", "subject": "amyloid-beta", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Drugs targeting AD neuropathology ... [recently promising drug trials ... ] did not affect AD pathology", "chunk": 1}
{"article": "PMC8530186.txt", "subject": "tau", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Drugs targeting AD neuropathology ... [recently promising drug trials ... ] did not affect AD pathology", "chunk": 1}
{"article": "PMC8530186.txt", "subject": "amyloid-beta", "relationship": "INDICATES_PRESENCE_OF", "object": "AD neuropathology", "chunk": 1}
{"article": "PMC8530186.txt", "subject": "tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD neuropathology", "chunk": 1}
{"article": "PMC8530186.txt", "subject": "p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathological processes", "chunk": 1}
{"article": "PMC8530186.txt", "subject": "BDNF", "relationship": "ISM_BASIS_FOR_THERAPY_CHOICE", "object": "Aerobic exercise ... stimulate[s] the production and function", "chunk": 1}
{"article": "PMC8530186.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH", "object": "higher cerebral cerebral cerebral cerebral spinal fluid A\u03b242", "chunk": 2}
{"article": "PMC8530186.txt", "subject": "total tau", "relationship": "ASSOCIATED_WITH", "object": "lower cerebral cerebral cerebral cerebral spinal fluid total tau", "chunk": 2}
{"article": "PMC8530186.txt", "subject": "p-tau", "relationship": "ASSOCIATED_WITH", "object": "lower cerebral cerebral cerebral cerebral spinal fluid p-tau", "chunk": 2}
{"article": "PMC8530186.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH", "object": "lower levels of plasma A\u03b2", "chunk": 2}
{"article": "PMC8530186.txt", "subject": "Positron Emission Tomography-qualified A\u03b2", "relationship": "ASSOCIATED_WITH", "object": "lower levels of  Positron Emission Tomography-qualified A\u03b2", "chunk": 2}
{"article": "PMC8530186.txt", "subject": "PET-quantified tau", "relationship": "ASSOCIATED_WITH", "object": "lower PET-quantified tau", "chunk": 2}
{"article": "PMC8530186.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Higher cerebral cerebral cerebral cerebral spinal fluid A\u03b242", "chunk": 2}
{"article": "PMC8530186.txt", "subject": "total tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower cerebral cerebral cerebral cerebral spinal fluid total tau", "chunk": 2}
{"article": "PMC8530186.txt", "subject": "p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower cerebral cerebral cerebral cerebral spinal fluid p-tau", "chunk": 2}
{"article": "PMC8530186.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower levels of plasma A\u03b2", "chunk": 2}
{"article": "PMC8530186.txt", "subject": "Positron Emission Tomography-qualified A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower Positron Emission Tomography-qualified A\u03b2", "chunk": 2}
{"article": "PMC8530186.txt", "subject": "PET-quantified tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower PET-quantified tau", "chunk": 2}
{"article": "PMC8530186.txt", "subject": "Hippocampal volume", "relationship": "RELATED_PROGNOSIS", "object": "Change in ADAS-Cog score at 6 months", "chunk": 4}
{"article": "PMC8530186.txt", "subject": "Hippocampal volume", "relationship": "RELATED_PROGNOSIS", "object": "Change in ADAS-Cog score at 12 months", "chunk": 4}
{"article": "PMC8530186.txt", "subject": "Temporal meta-ROI cortical thickness", "relationship": "RELATED_PROGNOSIS", "object": "Change in ADAS-Cog score at 6 months", "chunk": 4}
{"article": "PMC8530186.txt", "subject": "Temporal meta-ROI cortical thickness", "relationship": "RELATED_PROGNOSIS", "object": "Change in ADAS-Cog score at 12 months", "chunk": 4}
{"article": "PMC8530186.txt", "subject": "WMH volume", "relationship": "RELATED_PROGNOSIS", "object": "Change in ADAS-Cog score at 6 months", "chunk": 4}
{"article": "PMC8530186.txt", "subject": "WMH volume", "relationship": "RELATED_PROGNOSIS", "object": "Change in ADAS-Cog score at 12 months", "chunk": 4}
{"article": "PMC8530186.txt", "subject": "BDNF", "relationship": "INDICATES_PRESENCE_OF", "object": "Disease-modifying potential of aerobic exercise for AD", "chunk": 5}
{"article": "PMC8530186.txt", "subject": "Amyloid plaques", "relationship": "INDICATES_PRESENCE_OF", "object": "Disease-modifying potential of aerobic exercise for AD", "chunk": 5}
{"article": "PMC8530186.txt", "subject": "Neurofibrillary tangles", "relationship": "INDICATES_PRESENCE_OF", "object": "Disease-modifying potential of aerobic exercise for AD", "chunk": 5}
{"article": "PMC8530186.txt", "subject": "Hippocampal volume", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline during the intervention period", "chunk": 5}
{"article": "PMC8530186.txt", "subject": "Temporal meta-ROI cortical thickness", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline during the intervention period", "chunk": 5}
{"article": "PMC8530186.txt", "subject": "WMH volume", "relationship": "RELATED_PROGNOSIS", "object": "WMH progression on the effects of aerobic exercise", "chunk": 5}
{"article": "PMC8530186.txt", "subject": "Hippocampal atrophy", "relationship": "RELATED_PROGNOSIS", "object": "Intervention effects and potential biological mechanism mediating them", "chunk": 5}
{"article": "PMC8530186.txt", "subject": "Temporal meta-ROI cortical thickness", "relationship": "RELATED_PROGNOSIS", "object": "Intervention effects and potential biological mechanism mediating them", "chunk": 5}
{"article": "PMC8530186.txt", "subject": "WMH volume", "relationship": "RELATED_PROGNOSIS", "object": "Effects of aerobic exercise on WMH progression", "chunk": 5}
{"article": "PMC8530186.txt", "subject": "NFQ", "relationship": "INDICATES_PRESENCE_OF", "object": "Functional connectivity", "chunk": 5}
{"article": "PMC8530186.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Global cognition and cognitive decline", "chunk": 5}
{"article": "PMC8549374.txt", "subject": "undisagnosed dementia", "relationship": "PREDICT-SURVIVAL", "object": "Early detection of dementia may improve patient care and quality of life", "chunk": 1}
{"article": "PMC8549374.txt", "subject": "diagnosed dementia", "relationship": "RELATED_TREATMENT", "object": "maximize time for planning and support for people with dementia and caregivers", "chunk": 1}
{"article": "PMC8549374.txt", "subject": "eletronic health records", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "help identify individuals at risk of having undiagnosed dementia for outreach and assessment", "chunk": 1}
{"article": "PMC8549374.txt", "subject": "Early Detection of Dementia", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": " To maximize time for planning and support for people with dementia and caregivers", "chunk": 1}
{"article": "PMC8549374.txt", "subject": "elevated risk for undiagnosed dementia", "relationship": "INDICATES_PRESENCE_OF", "object": "Concern about  psychological harm", "chunk": 5}
{"article": "PMC8549374.txt", "subject": "elevated risk for undiagnosed dementia", "relationship": "RELATED_TREATMENT", "object": "Would want to hear so that there could be more evaluation to determine whether dementia is truly present", "chunk": 5}
{"article": "PMC8549374.txt", "subject": "blood-based biomarkers", "relationship": "INDICATES_PRESENCE_OF", "object": "early-stage Alzheimer\u2019s", "chunk": 7}
{"article": "PMC8564955.txt", "subject": "physical inactivity", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": " 40% of all cases of major and minor NCDs", "chunk": 1}
{"article": "PMC8564955.txt", "subject": "physical activity", "relationship": "RELATED_PROGNOSIS", "object": "counteracting/managing disease-related factors and associated symptoms of major NCD", "chunk": 1}
{"article": "PMC8564955.txt", "subject": "MMSE (Mini-Mental State Examination)", "relationship": "RELATED_PROGNOSIS", "object": "Indicator of cognitive function in people with NCD", "chunk": 2}
{"article": "PMC8564955.txt", "subject": "SPPB", "relationship": "RELATED_PROGNOSIS", "object": "associated with disability and all-cause mortality", "chunk": 5}
{"article": "PMC8564955.txt", "subject": "SPPB", "relationship": "RELATED_PROGNOSIS", "object": "associated with disability and all-cause mortality", "chunk": 5}
{"article": "PMC8564955.txt", "subject": "SPPB", "relationship": "INDICATES_PRESENCE_OF", "object": "frailty status, physical disability, and dependency", "chunk": 5}
{"article": "PMC8564955.txt", "subject": "TUG", "relationship": "PREDICTS_SURVIVAL", "object": "predicted fall risks and nursing home admission", "chunk": 5}
{"article": "PMC8564955.txt", "subject": "TUG", "relationship": "RELATED_PROGNOSIS", "object": "impaired mobility (TUG >\u200910\u2009s) was associated with a higher risk of subsequent functional dependency occurrence (e.g., institutionalization or admission to a long-term care facility)", "chunk": 5}
{"article": "PMC8564955.txt", "subject": "BI", "relationship": "RELATED_TREATMENT", "object": "improve their physical health and psychosocial well-being", "chunk": 5}
{"article": "PMC8564955.txt", "subject": "gait speed", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurological dysfunction", "chunk": 6}
{"article": "PMC8564955.txt", "subject": "gait speed", "relationship": "RELATED_PROGNOSIS", "object": "ADL and/or instrumental ADL decline", "chunk": 6}
{"article": "PMC8564955.txt", "subject": "gait speed", "relationship": "RELATED_PROGNOSIS", "object": "Worsening of ADL", "chunk": 6}
{"article": "PMC8564955.txt", "subject": "SPPB", "relationship": "RELATED_PROGNOSIS", "object": "ADL and/or instrumental ADL decline", "chunk": 6}
{"article": "PMC8564955.txt", "subject": "BI", "relationship": "RELATED_PROGNOSIS", "object": "Functional independence", "chunk": 6}
{"article": "PMC8564955.txt", "subject": "cognitive performance", "relationship": "INDICATES_PRESENCE_OF", "object": "Functional decline", "chunk": 6}
{"article": "PMC8564955.txt", "subject": "processing speed", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Instrumental ADL", "chunk": 6}
{"article": "PMC8564955.txt", "subject": "attention", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Instrumental ADL", "chunk": 6}
{"article": "PMC8570037.txt", "subject": "Amyloid-beta (A\u03b2)", "relationship": "RELATED_PROGNOSIS", "object": "AD progression", "chunk": 1}
{"article": "PMC8570037.txt", "subject": "Amyloid-beta (A\u03b2) deposition", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC8570037.txt", "subject": "Amyloid-beta (A\u03b2) plaques", "relationship": "RELATED_PROGNOSIS", "object": "Clinical improvement ", "chunk": 1}
{"article": "PMC8570037.txt", "subject": "Amyloid-beta (A\u03b2)", "relationship": "RELATED_TREATMENT", "object": "Removal with FUS-mediated BBB opening", "chunk": 1}
{"article": "PMC8570037.txt", "subject": "Amyloid-beta (A\u03b2) burden", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive function", "chunk": 1}
{"article": "PMC8570037.txt", "subject": "18F-Florbetaben (FBB)", "relationship": "MONITORED_DURING_TREATMENT", "object": "BBB opening efficacy", "chunk": 1}
{"article": "PMC8570037.txt", "subject": "18F-Florbetaben (FBB) PET", "relationship": "INDICATES_PRESENCE_OF", "object": "Significant cerebral A\u03b2 deposition", "chunk": 2}
{"article": "PMC8570037.txt", "subject": "18F-fluorodeoxyglucose PET scans", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuronal injury relevant for AD", "chunk": 2}
{"article": "PMC8570037.txt", "subject": "FBB PET", "relationship": "USED_TO_DIAGNOSE", "object": "Reduce A\u03b2 deposition", "chunk": 2}
{"article": "PMC8570037.txt", "subject": "FBB PET", "relationship": "RELATED_PROGNOSIS", "object": "Reduction of A\u03b2 deposition", "chunk": 2}
{"article": "PMC8570037.txt", "subject": "K-MMSE", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Dementia severity", "chunk": 3}
{"article": "PMC8570037.txt", "subject": "CDR-SOB", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Dementia severity", "chunk": 3}
{"article": "PMC8570037.txt", "subject": "FBB global SUVR", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-\u03b2 deposition", "chunk": 3}
{"article": "PMC8570037.txt", "subject": "18F-Florbetaben uptake", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC8570037.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC8570037.txt", "subject": "A\u03b2", "relationship": "RELATED_TO", "object": "Cognitive Decline", "chunk": 5}
{"article": "PMC8570037.txt", "subject": "BBB opening", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "AD treatment", "chunk": 5}
{"article": "PMC8570037.txt", "subject": "MRgFUS", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "A\u03b2 reduction in the frontal lobe", "chunk": 5}
{"article": "PMC8570037.txt", "subject": "18F-Florbetaben", "relationship": "MONITORED_DURING_TREATMENT", "object": "Individual longitudinal changes in 18F-Florbetaben uptake after treatment", "chunk": 6}
{"article": "PMC8570037.txt", "subject": "18F-Florbetaben", "relationship": "RELATED_TO", "object": "Decreased FBB SUVR", "chunk": 6}
{"article": "PMC8570037.txt", "subject": "FBB SUVR", "relationship": "RELATED_TO", "object": "Temporary improvement in related symptoms", "chunk": 6}
{"article": "PMC8570373.txt", "subject": "Brain atrophy rates", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurodegeneration", "chunk": 2}
{"article": "PMC8570373.txt", "subject": "Brain atrophy rates", "relationship": "RELATED_TREATMENT", "object": "Assessment of treatment response", "chunk": 2}
{"article": "PMC8570373.txt", "subject": "Brain atrophy rates", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Development of interventions to reduce post-stroke secondary degeneration and vascular cognitive impairment", "chunk": 2}
{"article": "PMC8570373.txt", "subject": "brain volume loss", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Interventions to reduce post-stroke secondary degeneration and vascular cognitive impairment", "chunk": 2}
{"article": "PMC8570373.txt", "subject": "APOE \u03b54 carriers", "relationship": "DIAGNOSITC_OF", "object": "Early-onset Alzheimer's Disease", "chunk": 2}
{"article": "PMC8570373.txt", "subject": "cerebral spinal fluid and blood biomarkers", "relationship": "RELATED_PROGNOSIS", "object": "Neurodegeneration", "chunk": 2}
{"article": "PMC8570373.txt", "subject": "Stroke Status", "relationship": "ASSOCIATED_WITH", "object": "Lesion volume", "chunk": 3}
{"article": "PMC8570373.txt", "subject": "CogState Detection Task", "relationship": "RELATED_TREATMENT", "object": "Attention", "chunk": 3}
{"article": "PMC8570373.txt", "subject": "CogState Identification Task", "relationship": "RELATED_TREATMENT", "object": "Attention", "chunk": 3}
{"article": "PMC8570373.txt", "subject": "CogState One-Back Task", "relationship": "RELATED_TREATMENT", "object": "Attention", "chunk": 3}
{"article": "PMC8570373.txt", "subject": "Trail-Making Test (Part A)", "relationship": "RELATED_TREATMENT", "object": "Attention", "chunk": 3}
{"article": "PMC8570373.txt", "subject": "Digit Symbol Task", "relationship": "RELATED_TREATMENT", "object": "Attention", "chunk": 3}
{"article": "PMC8570373.txt", "subject": "Rey-Osterrieth Complex Figure Task", "relationship": "RELATED_TREATMENT", "object": "Visuospatial Function", "chunk": 3}
{"article": "PMC8570373.txt", "subject": "Clock Drawing Test", "relationship": "RELATED_TREATMENT", "object": "Executive Function", "chunk": 3}
{"article": "PMC8570373.txt", "subject": "Boston Naming Test", "relationship": "RELATED_TREATMENT", "object": "Language", "chunk": 3}
{"article": "PMC8570373.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 4}
{"article": "PMC8570373.txt", "subject": "Total Brain Volume (TBV)", "relationship": "RELATED_PROGNOSIS", "object": "Greater TBV loss over 3 years was significantly greater in stroke patients compared to controls and in stroke patients who were cognitively impaired at 3 months compared to those without cognitive impairment.", "chunk": 6}
{"article": "PMC8570373.txt", "subject": "Hippocampal Volume (HV)", "relationship": "RELATED_PROGNOSIS", "object": "Hippocampal atrophy rates were greater in 3 months after stroke than the ensuing 9 months", "chunk": 6}
{"article": "PMC8570373.txt", "subject": "Vascular risk factors", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitively impaired stroke participants at 3 months had larger stroke lesion volumes, more vascular risk factors...", "chunk": 6}
{"article": "PMC8570373.txt", "subject": "White matter lesions (WMH)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "...our stroke participants are already at high risk of greater WMH burden due to their vascular risk factors, and we demonstrated that they have greater WMH volume than control participants.", "chunk": 6}
{"article": "PMC8570373.txt", "subject": "TBV", "relationship": "RELATED_TO", "object": "cognitive impairment at 3 months", "chunk": 7}
{"article": "PMC8581408.txt", "subject": "amyloid-\u03b2", "relationship": "CLEARED_BY", "object": "FUS-mediated blood-brain barrier disruption", "chunk": 1}
{"article": "PMC8581408.txt", "subject": "hyperphosphorylated tau", "relationship": "CLEARED_BY", "object": "FUS-mediated blood-brain barrier disruption", "chunk": 1}
{"article": "PMC8581408.txt", "subject": "sterile inflammation", "relationship": "SECONDARY_EFFECT", "object": "FUS-mediated blood-brain barrier disruption", "chunk": 1}
{"article": "PMC8581408.txt", "subject": "neurogenesis", "relationship": "SECONDARY_EFFECT", "object": "FUS-mediated blood-brain barrier disruption", "chunk": 1}
{"article": "PMC8581408.txt", "subject": "CE", "relationship": "RELATED_TREATMENT", "object": "A blood-brain barrier opening", "chunk": 2}
{"article": "PMC8581408.txt", "subject": "MBA", "relationship": "RELATED_TREATMENT", "object": "A blood-brain barrier opening", "chunk": 2}
{"article": "PMC8581408.txt", "subject": "CE", "relationship": "PREDICTS_GENE_EXPRESSION", "object": "Gene expression 6 or 24 h after treatment", "chunk": 2}
{"article": "PMC8581408.txt", "subject": "MBA", "relationship": "PREDICTS_GENE_EXPRESSION", "object": "Gene expression 6 or 24 h after treatment", "chunk": 2}
{"article": "PMC8581408.txt", "subject": "CE", "relationship": "INDICATES_PRESENCE_OF", "object": "increased BBB permeability", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "CE", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Monitor FUS BBBD treatment", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "MBA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Monitor FUS BBBD treatment", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "CE", "relationship": "PREDICTS_GENE_EXPRESSION", "object": "BBBD-driven transcriptional changes", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "MBA", "relationship": "PREDICTS_GENE_EXPRESSION", "object": "BBBD-driven transcriptional changes", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "Nfkb2", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "A consequence of CE or MBA", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "Tnf", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "A consequence of CE or MBA", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "Tlr2", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "A consequence of CE or MBA", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "Ccl12", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "A consequence of CE or MBA", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "Cd14", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "A consequence of CE or MBA", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "Il1a", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "A consequence of CE or MBA", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "Il1b", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "A consequence of CE or MBA", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "Cd44", "relationship": "INDICATES_PRESENCE_OF", "object": "Lymphocyte activation", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "Gbp2", "relationship": "INDICATES_PRESENCE_OF", "object": "Adaptive immunity response", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "Gpb3", "relationship": "INDICATES_PRESENCE_OF", "object": "Adaptive immunity response", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "Gbp6", "relationship": "INDICATES_PRESENCE_OF", "object": "Adaptive immunity response", "chunk": 4}
{"article": "PMC8581408.txt", "subject": "Icam1", "relationship": "INDICATES_PRESENCE_OF", "object": "inflamed BBB endothelium", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Sele", "relationship": "INDICATES_PRESENCE_OF", "object": "inflamed BBB endothelium", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Cav1", "relationship": "RELATED_PROGNOSIS", "object": "Transcellular transport across the BBB", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Emp1", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "assembly of the BBB", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Apold1", "relationship": "RELATED_TREATMENT", "object": "regulation of endothelial cell signaling and blood-brain barrier integrity", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Cldn5", "relationship": "RELATED_TREATMENT", "object": "tight junctions", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Cdh5", "relationship": "RELATED_TREATMENT", "object": "tight junctions", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Flt1", "relationship": "RELATED_TREATMENT", "object": "VEGF signaling", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Dlg4", "relationship": "RELATED_TREATMENT", "object": "VEGF signaling", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Hey1", "relationship": "RELATED_TREATMENT", "object": "VEGF signaling", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Itga5", "relationship": "RELATED_TREATMENT", "object": "basement membrane interaction", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Adamts1", "relationship": "RELATED_TREATMENT", "object": "basement membrane interaction", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Lgals3", "relationship": "RELATED_TREATMENT", "object": "basement membrane interaction", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Vcl", "relationship": "RELATED_TREATMENT", "object": "basement membrane interaction", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "JAM-1", "relationship": "RELATED_TREATMENT", "object": "tight junction", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "ZO-1", "relationship": "RELATED_TREATMENT", "object": "tight junction", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "A2m", "relationship": "RELATED_TREATMENT", "object": "clearance and degradation of amyloid-\u03b2", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Maff", "relationship": "RELATED_TREATMENT", "object": "Neurogenesis", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "Per1", "relationship": "RELATED_TREATMENT", "object": "memory related signaling", "chunk": 5}
{"article": "PMC8581408.txt", "subject": "CE", "relationship": "RELATED_TREATMENT", "object": "Predict enrichment of gene associated with actin filament organization.", "chunk": 6}
{"article": "PMC8581408.txt", "subject": "MBA", "relationship": "RELATED_TREATMENT", "object": "Predict enrichment of gene associated with actin filament organization.", "chunk": 6}
{"article": "PMC8581408.txt", "subject": "CE", "relationship": "RELATED_TREATMENT", "object": "Predict enrichment of geneset's associated with neurogenesis and amyloid-beta clearance.", "chunk": 6}
{"article": "PMC8581408.txt", "subject": "MBA", "relationship": "RELATED_TREATMENT", "object": "Predict enrichment of geneset's associated with neurogenesis and amyloid-beta clearance.", "chunk": 6}
{"article": "PMC8581408.txt", "subject": "CE", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Predict enrichment of genes associated with actin filament organization.", "chunk": 6}
{"article": "PMC8581408.txt", "subject": "MBA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Predict enrichment of genes associated with actin filament organization.", "chunk": 6}
{"article": "PMC8582661.txt", "subject": "rhythmic auditory stimulation", "relationship": "INDICATES_PRESENCE_OF", "object": "improvements in gait parameters", "chunk": 2}
{"article": "PMC8582661.txt", "subject": "rhythmic auditory stimulation", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "reduction in falls", "chunk": 2}
{"article": "PMC8582661.txt", "subject": "music", "relationship": "RELATED_PROGNOSIS", "object": "improvement in gait 'on' and 'off' dopaminergic states", "chunk": 2}
{"article": "PMC8582661.txt", "subject": "singing", "relationship": "RELATED_TREATMENT", "object": "improvement of gait in older adults and people with PD", "chunk": 2}
{"article": "PMC8582661.txt", "subject": "Group singing exercises", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Voice quality, articulatory control, and speech intelligibility", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Singing familiar melodies and improvised melodic continuations", "relationship": "RELATED_TO", "object": "Expressive linguistic prosody in PD", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Choral singing", "relationship": "RELATED_TO", "object": "Speech treatment for some people with PD", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Therapeutic singing", "relationship": "RELATED_TO", "object": "Addressing oropharyngeal dysphagia", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Group vocal strengthening activities", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Maintaining vocal skills and delaying vocal deterioration in PD", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "ParkinSong", "relationship": "RELATED_TO", "object": "Increasing respiratory volume and function in people with mild to moderately severe PD", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Group music therapy", "relationship": "RELATED_TO", "object": "Improving the psychosocial well-being of PD patients", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Group singing", "relationship": "RELATED_TO", "object": "Emotional ventilation, psychological stability, change in self-perception, increased free time, change in lifestyle, positive attitudes towards music, and active interactions among group members", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Performing special physiotherapy exercises with music therapy", "relationship": "RELATED_TO", "object": "Improving the quality of life, work capacity, and disability of patients", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Music therapy", "relationship": "RELATED_TO", "object": "Increased motivation, self-confidence, improved motor and gait control, mood regulation, improved focus, and the opportunity for emotional expression and support", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Group music intervention", "relationship": "RELATED_TO", "object": "Increasing the mood, alertness, and quality of life in PD patients", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Music therapy", "relationship": "RELATED_TO", "object": "Improving mood, depressive syndromes, and quality of life in neurological patients", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Singing therapy", "relationship": "RELATED_TO", "object": "Improving vocal function and decreasing symptoms of depression", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Music therapy", "relationship": "RELATED_TO", "object": "Improving depression in PD patients", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Music therapy", "relationship": "RELATED_TO", "object": "Has direct effects on motor, memory, and cognitive skills", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Intensive piano training", "relationship": "RELATED_TO", "object": "Serving as an effective cognitive and psychosocial intervention", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Music training", "relationship": "RELATED_TO", "object": "Improving cognitive outcomes", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Group singing", "relationship": "RELATED_TO", "object": "Positive effects on physical, mood, cognitive functioning, social connection,\"fluid\" effects, and sense of self", "chunk": 7}
{"article": "PMC8582661.txt", "subject": "Active music therapy", "relationship": "RELATED_TO", "object": "Having a beneficial effect on frontal function and cognition", "chunk": 7}
{"article": "PMC8615475.txt", "subject": "TSG-6", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Treatment of  TSG-6  alleviates liver fibrosis", "chunk": 4}
{"article": "PMC8615475.txt", "subject": "TSG-6", "relationship": "RELATED_TREATMENT", "object": "Treatment of liver fibrosis", "chunk": 4}
{"article": "PMC8615475.txt", "subject": "TSG-6", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Patients whose HSC are activated", "chunk": 4}
{"article": "PMC8615475.txt", "subject": "MFGE8", "relationship": "RELATED_TREATMENT", "object": "Treatment of hepatic fibrosis", "chunk": 4}
{"article": "PMC8615475.txt", "subject": "MFGE8", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "MFGE8 downregulates the expression of TGF \u03b2 receptor TGF\u03b2R1", "chunk": 4}
{"article": "PMC8615475.txt", "subject": "miR-122", "relationship": "IS_RELATED_TO_TREATMENT", "object": "Inhibition of HSC proliferation", "chunk": 5}
{"article": "PMC8615475.txt", "subject": "miR-181-5p", "relationship": "IS_RELATED_TO_TREATMENT", "object": "Inhibition of HSC activation", "chunk": 5}
{"article": "PMC8615475.txt", "subject": "insulin growth factor like-1", "relationship": "IS_RELATED_TO_TREATMENT", "object": "Anti-fibrotic effects by inactivating the HSCs and reducing the production of pro-inflammatory cytokines in macrophages", "chunk": 5}
{"article": "PMC8615475.txt", "subject": "MELD", "relationship": "RELATED_PROGNOSIS", "object": "Used as a score to monitor liver disease progression", "chunk": 7}
{"article": "PMC8615475.txt", "subject": "Child-Pugh score", "relationship": "RELATED_PROGNOSIS", "object": "Used as a score to monitor liver disease severity", "chunk": 7}
{"article": "PMC8615475.txt", "subject": "serum albumin", "relationship": "DIAGNOSITC_OF", "object": "Low levels can diagnose liver cirrhosis", "chunk": 7}
{"article": "PMC8615475.txt", "subject": "total bilirubin", "relationship": "DIAGNOSITC_OF", "object": "High levels can indicate liver disease", "chunk": 7}
{"article": "PMC8615475.txt", "subject": "ALT", "relationship": "DIAGNOSITC_OF", "object": "Elevated levels often accompany liver damage", "chunk": 7}
{"article": "PMC8615475.txt", "subject": "MELD Na score", "relationship": "RELATED_PROGNOSIS", "object": "Used to assess survival probability in liver failure", "chunk": 7}
{"article": "PMC8615475.txt", "subject": "collagen accumulation", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "High levels are characteristic of liver fibrosis", "chunk": 7}
{"article": "PMC8615475.txt", "subject": "IL-17", "relationship": "RELATED_TREATMENT", "object": "Decreasing IL-17 levels is associated with therapeutic effects of MSCs", "chunk": 7}
{"article": "PMC8615475.txt", "subject": "IL-10", "relationship": "RELATED_TREATMENT", "object": "Increasing IL-10 levels  is associated with therapeutic effects of MSCs", "chunk": 7}
{"article": "PMC8615475.txt", "subject": "IDO", "relationship": "RELATED_TREATMENT", "object": "Increasing IDO level  is associated with therapeutic effects of MSCs", "chunk": 7}
{"article": "PMC8615475.txt", "subject": "Treg/Th17 cells balance", "relationship": "RELATED_TREATMENT", "object": "MSCs were shown to ameliorate the imbalance of Treg/Th17 cells", "chunk": 7}
{"article": "PMC8615710.txt", "subject": "LvPPA", "relationship": "INDICATES_PRESENCE_OF", "object": "Impaired word retrieval in spontaneous speech and naming", "chunk": 1}
{"article": "PMC8615710.txt", "subject": "LvPPA", "relationship": "INDICATES_PRESENCE_OF", "object": "Impaired repetition of phrases and sentences", "chunk": 1}
{"article": "PMC8615710.txt", "subject": "LvPPA", "relationship": "RELATED_TO", "object": "Left temporoparietal atrophy", "chunk": 1}
{"article": "PMC8615710.txt", "subject": "LvPPA", "relationship": "RELATED_TO", "object": "Alzheimer\u2019s pathology", "chunk": 1}
{"article": "PMC8615710.txt", "subject": "svPPA", "relationship": "INDICATES_PRESENCE_OF", "object": "Left greater than right atrophy in the anterior temporal lobes", "chunk": 1}
{"article": "PMC8615710.txt", "subject": "svPPA", "relationship": "INDICATES_PRESENCE_OF", "object": "Impaired confrontation naming", "chunk": 1}
{"article": "PMC8615710.txt", "subject": "svPPA", "relationship": "INDICATES_PRESENCE_OF", "object": "Impaired single-word comprehension", "chunk": 1}
{"article": "PMC8615710.txt", "subject": "left and right temporal variants of FTD", "relationship": "RELATED_TO", "object": "TDP-43 proteinopathy", "chunk": 1}
{"article": "PMC8615710.txt", "subject": "Anomia", "relationship": "RELATED_PROGNOSIS", "object": "Neurodegenerative disorderssss", "chunk": 1}
{"article": "PMC8615710.txt", "subject": "APOE4", "relationship": "DIAGNOSITC_OF", "object": "Early-onset Alzheimer's Disease", "chunk": 1}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 tau PET", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Predictive biomarker for cognitive decline in Alzheimer\u2019s disease.", "chunk": 1}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 tau PET", "relationship": "USED_TO_DIAGNOSE", "object": "Tau pathology in Alzheimer's Disease", "chunk": 1}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 tau PET", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "stratification or inclusion/exclusion criteria in AD clinical trials", "chunk": 1}
{"article": "PMC8638526.txt", "subject": "Neurofibrillary tangles (comprised of hyperphosphorylated tau protein)", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurofibrillary tangles pathology", "chunk": 2}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "future comparisons between studies using different tau PET tracers", "chunk": 2}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1", "relationship": "RELATED_PROGNOSIS", "object": "cognitive progression", "chunk": 2}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1", "relationship": "RELATED_PROGNOSIS", "object": "clinically meaningful longitudinal cognitive change", "chunk": 2}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Disease severity", "chunk": 3}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 SUVR", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC8638526.txt", "subject": "[18F]florbetapir SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Disease severity", "chunk": 3}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Temporal ROI", "chunk": 3}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Braak ROI", "chunk": 3}
{"article": "PMC8638526.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Moderate Alzheimer's Disease", "chunk": 3}
{"article": "PMC8638526.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC8638526.txt", "subject": "CDR-SB", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC8638526.txt", "subject": "ADAS-Cog13", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC8638526.txt", "subject": "RBANS Total Index", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 WCG SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC8638526.txt", "subject": "[18F]florbetapir cortical SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Disease severity", "chunk": 3}
{"article": "PMC8638526.txt", "subject": "Cortical Volume (cm3)", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Annualized cognitive change, specifically decline on MMSE, CDR-SB, and ADAS-Cog13", "chunk": 4}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 SUVR", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Greater cognitive decline", "chunk": 4}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 SUVR", "relationship": "RELATED_TO", "object": "WCG, temporal, Braak I/II, Braak III/IV, and Braak V/VI ROIs", "chunk": 4}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 SUVR", "relationship": "PREDICTS_SURVIVAL", "object": "Age of Onset of Alzheimer's Disease", "chunk": 4}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 SUVR", "relationship": "INDICATES_PRESENCE_OF", "object": "steeper cognitive declines in AD", "chunk": 5}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 SUVR", "relationship": "RELATED_PROGNOSIS", "object": "cognitive decline in AD", "chunk": 5}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 tau PET", "relationship": "IS_PREDICTION_OF", "object": "declining cognitive function in AD", "chunk": 5}
{"article": "PMC8638526.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline", "chunk": 7}
{"article": "PMC8638526.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Annualized change scores calculated via estimated slopes", "chunk": 7}
{"article": "PMC8638526.txt", "subject": "CDR-SB", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline", "chunk": 7}
{"article": "PMC8638526.txt", "subject": "ADAS-Cog13", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline", "chunk": 7}
{"article": "PMC8638526.txt", "subject": "ADAS-Cog13", "relationship": "RELATED_PROGNOSIS", "object": "Annualized change scores calculated via estimated slopes", "chunk": 7}
{"article": "PMC8638526.txt", "subject": "RBANS", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline", "chunk": 7}
{"article": "PMC8638526.txt", "subject": "RBANS", "relationship": "RELATED_PROGNOSIS", "object": "Annualized change scores calculated via estimated slopes", "chunk": 7}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline", "chunk": 7}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 SUVR", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Determining cut points for distinguishing between decliners and non-decliners", "chunk": 7}
{"article": "PMC8638526.txt", "subject": "[18F]GTP1 SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Odds ratios for participants experiencing cognitive decline", "chunk": 7}
{"article": "PMC8645072.txt", "subject": "transcranial direct current stimulation (tDCS)", "relationship": "RELATED_TO", "object": "improvement of cognitive symptoms", "chunk": 1}
{"article": "PMC8645072.txt", "subject": "Exercise", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "tDCS to improve cognition", "chunk": 1}
{"article": "PMC8645072.txt", "subject": "BDNF", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "tDCS has been shown to enhance its secretion, which can improve neuronal survival and plasticity", "chunk": 2}
{"article": "PMC8645072.txt", "subject": "VEGF", "relationship": "RELATED_TO_THERAPY_CHOICE", "object": "tDCS-induced cognitive improvement", "chunk": 3}
{"article": "PMC8645072.txt", "subject": "ANGP-2", "relationship": "RELATED_TO_THERAPY_CHOICE", "object": "tDCS-induced cognitive improvement", "chunk": 3}
{"article": "PMC8645072.txt", "subject": "BDNF", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function", "chunk": 3}
{"article": "PMC8645072.txt", "subject": "endostatin", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD pathology", "chunk": 3}
{"article": "PMC8645072.txt", "subject": "BDNF", "relationship": "RELATED_TREATMENT", "object": "Exercise and tDCS outcomes", "chunk": 4}
{"article": "PMC8645072.txt", "subject": "VEGF", "relationship": "RELATED_TREATMENT", "object": "Exercise and tDCS outcomes", "chunk": 4}
{"article": "PMC8645072.txt", "subject": "ANGP-2", "relationship": "RELATED_TREATMENT", "object": "Exercise and tDCS outcomes", "chunk": 4}
{"article": "PMC8645072.txt", "subject": "endostatin", "relationship": "RELATED_TREATMENT", "object": "Exercise and tDCS outcomes", "chunk": 4}
{"article": "PMC8645072.txt", "subject": "MMSE", "relationship": "USED_TO_DIAGNOSE", "object": "Mild to moderate AD", "chunk": 5}
{"article": "PMC8645072.txt", "subject": "MoCA", "relationship": "RELATED_TREATMENT", "object": "Exercise-primed tDCS", "chunk": 5}
{"article": "PMC8645072.txt", "subject": "MoCA", "relationship": "RELATED_TO_TREATMENT", "object": "Treatment effectiveness assessment", "chunk": 5}
{"article": "PMC8645072.txt", "subject": "MoCA", "relationship": "MONITORED_DURING_TREATMENT", "object": "Exercise-primed tDCS", "chunk": 5}
{"article": "PMC8645072.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TREATMENT", "object": "Exercise-primed tDCS", "chunk": 5}
{"article": "PMC8645072.txt", "subject": "NPI", "relationship": "RELATED_TREATMENT", "object": "Exercise-primed tDCS", "chunk": 5}
{"article": "PMC8645072.txt", "subject": "BDNF", "relationship": "RELATED_TREATMENT", "object": "Exercise-primed tDCS", "chunk": 5}
{"article": "PMC8645072.txt", "subject": "VEGF", "relationship": "RELATED_TREATMENT", "object": "Exercise-primed tDCS", "chunk": 5}
{"article": "PMC8645072.txt", "subject": "ANGP-2", "relationship": "RELATED_TREATMENT", "object": "Exercise-primed tDCS", "chunk": 5}
{"article": "PMC8645072.txt", "subject": "endostatin", "relationship": "RELATED_TREATMENT", "object": "Exercise-primed tDCS", "chunk": 5}
{"article": "PMC8690894.txt", "subject": "gamma band oscillatory brain activity", "relationship": "RELATED_PROGNOSIS", "object": "Increased blood flow and increase in blood oxygenation", "chunk": 1}
{"article": "PMC8690894.txt", "subject": "gamma band oscillatory brain activity", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Identifying potential interventions to modulate brain perfusion and potentially reverse or mitigate cognitive decline in AD patients", "chunk": 1}
{"article": "PMC8690894.txt", "subject": "CBF reduction", "relationship": "RELATED_PROGNOSIS", "object": "Disease progression starting from the prodromal stage", "chunk": 1}
{"article": "PMC8690894.txt", "subject": "CBF reduction", "relationship": "RELATED_PROGNOSIS", "object": "Patient conversion to AD", "chunk": 1}
{"article": "PMC8690894.txt", "subject": "CBF reduction", "relationship": "INDICATES_PRESENCE_OF", "object": "language impairment in AD patients", "chunk": 1}
{"article": "PMC8690894.txt", "subject": "Perfusion changes", "relationship": "RELATED_PROGNOSIS", "object": "Positive correlation with changes in episodic memory and spectral power changes in the gamma band", "chunk": 1}
{"article": "PMC8690894.txt", "subject": "\u03b3 activity", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "mice model of AD", "chunk": 2}
{"article": "PMC8690894.txt", "subject": "Decreased \u03b3 activity", "relationship": "LINKED_TO", "object": "PV+ inhibitory interneuron pathology", "chunk": 2}
{"article": "PMC8690894.txt", "subject": "A\u03b2 and p-tau depositions", "relationship": "REDUCED_BY", "object": "exogenously-induced increase of gamma oscillations", "chunk": 2}
{"article": "PMC8690894.txt", "subject": "gamma activity", "relationship": "IMPAIRED_IN", "object": "AD mouse models and AD patients", "chunk": 2}
{"article": "PMC8690894.txt", "subject": "gamma activity", "relationship": "APPLICATION_DIRECTS", "object": "tACS", "chunk": 2}
{"article": "PMC8690894.txt", "subject": "gamma oscillations", "relationship": "ENHANCEMENT_OF", "object": "tACS", "chunk": 2}
{"article": "PMC8690894.txt", "subject": "gamma activity", "relationship": "RESTORATION_OF", "object": "physiological activity of PV interneurons", "chunk": 2}
{"article": "PMC8690894.txt", "subject": "40Hz gamma stimulation", "relationship": "TARGETED_BY", "object": "tACS", "chunk": 2}
{"article": "PMC8690894.txt", "subject": "A\u03b2 load", "relationship": "RELATED_TREATMENT", "object": "Personalized stimulation tACS according to individual A\u03b2 accumulation maps", "chunk": 3}
{"article": "PMC8690894.txt", "subject": "A\u03b2 load", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Placement and intensity of tACS stimulation", "chunk": 3}
{"article": "PMC8690894.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive decline in AD patients", "chunk": 3}
{"article": "PMC8690894.txt", "subject": "Tau protein", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive decline in AD patients", "chunk": 3}
{"article": "PMC8690894.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TREATMENT", "object": "tACS was targeted to areas of A\u03b2", "chunk": 4}
{"article": "PMC8690894.txt", "subject": "A\u03b2 deposition", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "tACS was targeted based on PET defined areas of A\u03b2 deposition", "chunk": 4}
{"article": "PMC8690894.txt", "subject": "A\u03b2 distribution", "relationship": "RELATED_TREATMENT", "object": "tACS stimulation was targeted to areas of A\u03b2", "chunk": 4}
{"article": "PMC8690894.txt", "subject": "tau protein", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "deposition of tau protein commonly involves the bilateral temporal lobes when patients are symptomatic", "chunk": 4}
{"article": "PMC8690894.txt", "subject": "CBF", "relationship": "INDICATES_PRESENCE_OF", "object": "Hypoperfusion in AD patients", "chunk": 6}
{"article": "PMC8690894.txt", "subject": "CBF", "relationship": "RELATED_PROGNOSIS", "object": "Increased CBF in the right temporal lobe after tACS intervention", "chunk": 6}
{"article": "PMC8690894.txt", "subject": "CBF increase in the right temporal lobe", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved memory performance scores", "chunk": 6}
{"article": "PMC8690894.txt", "subject": "narrow gamma spectral power", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "tACS intervention targeting", "chunk": 6}
{"article": "PMC8690894.txt", "subject": "CBF increase in the right anterior temporal lobe", "relationship": "RELATED_TREATMENT", "object": "narrow gamma spectral power increase", "chunk": 6}
{"article": "PMC8690894.txt", "subject": "CBF", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Treating conditions characterized by hypoperfusion", "chunk": 7}
{"article": "PMC8690894.txt", "subject": "CBF", "relationship": "MONITORED_DURING_TREATMENT", "object": "Monitoring CBF changes during tACS treatment", "chunk": 7}
{"article": "PMC8690894.txt", "subject": "CBF", "relationship": "RELATED_TREATMENT", "object": "Increases in CBF observed in response to gamma tACS", "chunk": 7}
{"article": "PMC8690894.txt", "subject": "2", "relationship": "RELATED_PROGNOSIS", "object": "Recent studies reporting an increase in CBF in AD patients during drug treatment (e.g., donepezil)", "chunk": 7}
{"article": "PMC8690894.txt", "subject": "tau pathology", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Hypoperfusion in the entorhinal cortex", "chunk": 7}
{"article": "PMC8690894.txt", "subject": "gamma activity", "relationship": "INDICATES_PRESENCE_OF", "object": "Memory impairments in AD mouse models", "chunk": 8}
{"article": "PMC8690894.txt", "subject": "gamma oscillations", "relationship": "RELATED_TO", "object": "Memory processes", "chunk": 8}
{"article": "PMC8690894.txt", "subject": "gamma oscillations", "relationship": "RELATED_TO", "object": "Phase reciprocal relationship with theta oscillations", "chunk": 8}
{"article": "PMC8690894.txt", "subject": "gamma oscillations", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Transcranial alternating current stimulation (tACS)", "chunk": 8}
{"article": "PMC8690894.txt", "subject": "gamma oscillatory activity", "relationship": "MONITORED_DURING_TREATMENT", "object": "tACS treatment", "chunk": 8}
{"article": "PMC8690894.txt", "subject": "Gamma spectral power", "relationship": "RESPONDED_TO", "object": "tACS treatment", "chunk": 8}
{"article": "PMC8733254.txt", "subject": "A\u03b2", "relationship": "DIAGNOSTIC_OF", "object": "Early-stage Alzheimer's Disease", "chunk": 1}
{"article": "PMC8733254.txt", "subject": "cerebral spinal fluid (CSF) testing", "relationship": "DIAGNOSTIC_OF", "object": "A\u03b2 deposition in the brain", "chunk": 1}
{"article": "PMC8733254.txt", "subject": "amyloid-\u03b2 (A\u03b2)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment with aducanumab", "chunk": 1}
{"article": "PMC8733254.txt", "subject": "plasma A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 burden in the brain", "chunk": 1}
{"article": "PMC8733254.txt", "subject": "phosphorylated-Tau (p-Tau)", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau in the brain and cerebral spinal fluid", "chunk": 1}
{"article": "PMC8733254.txt", "subject": "hippocampus volume", "relationship": "PREDICT", "object": "cognitive impairment", "chunk": 2}
{"article": "PMC8733254.txt", "subject": "subcortical changes (CSVD)", "relationship": "PREDICT", "object": "cognitive impairment", "chunk": 2}
{"article": "PMC8733254.txt", "subject": "apolipoprotein E (ApoE) genotype", "relationship": "RELATED_PROGNOSIS", "object": "progression from mild cognitive impairment to dementia", "chunk": 2}
{"article": "PMC8733254.txt", "subject": "biomedical biomarkers", "relationship": "USED_TO_DIAGNOSE", "object": "early detection and diagnosis of cognitive impairment", "chunk": 2}
{"article": "PMC8733254.txt", "subject": "clinical, biomedical, and imaging markers", "relationship": "PREDICT", "object": "the development process of cognitive impairment", "chunk": 2}
{"article": "PMC8733254.txt", "subject": "MRI", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "diagnosis of cognitive impairment", "chunk": 2}
{"article": "PMC8733254.txt", "subject": "ApoE", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Alzheimer's Disease", "chunk": 3}
{"article": "PMC8733254.txt", "subject": "A\u03b2 peptide", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "A\u03b2 PET ([18F] florbetapir (AV-45))", "chunk": 3}
{"article": "PMC8733254.txt", "subject": "p-Tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "tau PET ([18F] AV1451or [18F] PI-2620)", "chunk": 3}
{"article": "PMC8733254.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "A\u03b2 PET ([18F] florbetapir (AV-45))", "chunk": 3}
{"article": "PMC8733254.txt", "subject": "A\u03b240/A\u03b242", "relationship": "PREDICTS_SURVIVAL", "object": "Brain Amyloid-\u03b2 burden determined by A\u03b2-PET imaging", "chunk": 4}
{"article": "PMC8733254.txt", "subject": "P-tau181", "relationship": "PREDICTS_SURVIVAL", "object": "Cerebral spinal fluid P-tau181 and the imaging parameter in tau PET", "chunk": 4}
{"article": "PMC8733254.txt", "subject": "A\u03b240/A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Brain Amyloid-\u03b2 burden determined by A\u03b2-PET imaging", "chunk": 4}
{"article": "PMC8733254.txt", "subject": "P-tau181", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral spinal fluid P-tau181 and the imaging parameter in tau PET", "chunk": 4}
{"article": "PMC8733254.txt", "subject": "imaging markers (lacunes, WMHs, and CMBs)", "relationship": "INDICATES_PRESENCE_OF", "object": "cognitive impairment", "chunk": 5}
{"article": "PMC8733254.txt", "subject": "brain atrophy", "relationship": "INDICATES_PRESENCE_OF", "object": "cognitive impairment", "chunk": 5}
{"article": "PMC8733254.txt", "subject": "decreased cortical thickness of the cortex in specific regions related to cognition decline", "relationship": "INDICATES_PRESENCE_OF", "object": "cognitive impairment", "chunk": 5}
{"article": "PMC8733254.txt", "subject": "plasma biomarkers", "relationship": "DIAGNOSTIC_OF", "object": "cognitive impairment", "chunk": 5}
{"article": "PMC8733254.txt", "subject": "imaging parameters", "relationship": "PREDICTS_SURVIVAL", "object": "cognitive impairment", "chunk": 5}
{"article": "PMC8733254.txt", "subject": "plasma biomarkers and imaging parameters", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "treatment of cognitive impairment", "chunk": 5}
{"article": "PMC8754244.txt", "subject": "SGLT2 inhibitors", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Patients with type 2 diabetes", "chunk": 6}
{"article": "PMC8754244.txt", "subject": "ACEIs/ARBs", "relationship": "RELATED_TREATMENT", "object": "Management of diabetic nephropathy", "chunk": 6}
{"article": "PMC8754244.txt", "subject": "SGLT2 inhibitors", "relationship": "RELATED_TREATMENT", "object": "Management of type 2 diabetes", "chunk": 6}
{"article": "PMC8754244.txt", "subject": "RAAS inhibitors", "relationship": "RELATED_TREATMENT", "object": "Management of type 2 diabetes", "chunk": 6}
{"article": "PMC8760674.txt", "subject": "cortical thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "Improvements in memory and verbal functions", "chunk": 2}
{"article": "PMC8760674.txt", "subject": "functional connectivity", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved memory and verbal functions", "chunk": 2}
{"article": "PMC8760674.txt", "subject": "dendritic spines", "relationship": "PREDICTED_BY", "object": "Ongoing functional up-regulation via NIBS", "chunk": 2}
{"article": "PMC8760674.txt", "subject": "synapse density", "relationship": "PREDICTED_BY", "object": "Ongoing functional up-regulation via NIBS", "chunk": 2}
{"article": "PMC8760674.txt", "subject": "interneural connections", "relationship": "PREDICTED_BY", "object": "Ongoing functional up-regulation via NIBS", "chunk": 2}
{"article": "PMC8760674.txt", "subject": "FA (fractional anisotropy)", "relationship": "INDICATES_PRESENCE_OF", "object": "Better white matter integrity", "chunk": 4}
{"article": "PMC8760674.txt", "subject": "MD (mean diffusivity)", "relationship": "RELATED_TREATMENT", "object": "Treatment related changes", "chunk": 4}
{"article": "PMC8760674.txt", "subject": "AD (axial diffusivity)", "relationship": "RELATED_TREATMENT", "object": "Treatment related changes", "chunk": 4}
{"article": "PMC8760674.txt", "subject": "RD (radial diffusivity)", "relationship": "RELATED_TREATMENT", "object": "Treatment related changes", "chunk": 4}
{"article": "PMC8760674.txt", "subject": "Axial diffusivity (AD)", "relationship": "RELATED_PROGNOSIS", "object": "Improved axonal status in the stimulated sensorimotor network", "chunk": 5}
{"article": "PMC8760674.txt", "subject": "AD", "relationship": "INDICATES_PRESENCE_OF", "object": "Improved axonal status", "chunk": 5}
{"article": "PMC8760674.txt", "subject": "Axial Diffusivity (AD)", "relationship": "RELATED_TREATMENT", "object": "Improvement observed after transcranial pulsed stimulation (TPS)", "chunk": 6}
{"article": "PMC8760674.txt", "subject": "Axial Diffusivity (AD)", "relationship": "RELATED_TREATMENT", "object": "Decreased in left primary motor and left primary somatosensory ROIs after verum TPS stimulation", "chunk": 6}
{"article": "PMC8760674.txt", "subject": "Global Efficiency", "relationship": "RELATED_TREATMENT", "object": "Increased in the sensorimotor network of the stimulated left hemisphere after verum TPS stimulation", "chunk": 6}
{"article": "PMC8760674.txt", "subject": "Global Efficiency", "relationship": "RELATED_TREATMENT", "object": "Increased one week after the last TPS stimulation compared to sham stimulation", "chunk": 6}
{"article": "PMC8761354.txt", "subject": "cognitive impairment", "relationship": "RELATED_PROGNOSIS", "object": "Dement=64.1%,SD 11.8", "chunk": 4}
{"article": "PMC8761354.txt", "subject": "Activities of Daily Living score", "relationship": "RELATED_PROGNOSIS", "object": "16.7,SD 1.7; range 7\u201328; higher scores indicate worse function", "chunk": 4}
{"article": "PMC8761354.txt", "subject": "Composite adhesion score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Implementation fidelity to an ePCT intervention for improving care for residents with Alzheimer's disease", "chunk": 6}
{"article": "PMC8763605.txt", "subject": "Alzheimer\u2019s disease and related dementias (ADRDs)", "relationship": "RELATED_PROGNOSIS", "object": "Increasing direct and indirect dementia-related costs are expected in the foreseeable future.", "chunk": 1}
{"article": "PMC8763605.txt", "subject": "Alzheimer\u2019s disease and related dementias (ADRDs)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Added to this cost is the time value of caregiving provided by family/friends to persons living with dementia.", "chunk": 1}
{"article": "PMC8789895.txt", "subject": "cerebral spinal fluid IFN-\u03b3", "relationship": "MONITORED_DURING_TREATMENT", "object": "Insulin treatment", "chunk": 2}
{"article": "PMC8789895.txt", "subject": "cerebral spinal fluid IFN-\u03b3", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Increased over the course of the trial", "chunk": 2}
{"article": "PMC8789895.txt", "subject": "cerebral spinal fluid eotaxin", "relationship": "MONITORED_DURING_TREATMENT", "object": "Insulin treatment", "chunk": 2}
{"article": "PMC8789895.txt", "subject": "cerebral spinal fluid eotaxin", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Increased in the insulin-treated group to a greater degree than in the placebo group", "chunk": 2}
{"article": "PMC8789895.txt", "subject": "cerebral spinal fluid IL-6", "relationship": "MONITORED_DURING_TREATMENT", "object": "Insulin treatment", "chunk": 2}
{"article": "PMC8789895.txt", "subject": "cerebral spinal fluid IL-6", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Decreased in the insulin-treated group and remained stable in the placebo group", "chunk": 2}
{"article": "PMC8789895.txt", "subject": "cerebral spinal fluid MDC", "relationship": "MONITORED_DURING_TREATMENT", "object": "Insulin treatment", "chunk": 2}
{"article": "PMC8789895.txt", "subject": "cerebral spinal fluid MDC", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Trending interaction: increased in the placebo group and decreased slightly in the insulin group", "chunk": 2}
{"article": "PMC8789895.txt", "subject": "cerebral spinal fluid IL-2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Insulin treatment", "chunk": 2}
{"article": "PMC8789895.txt", "subject": "cerebral spinal fluid IL-2", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Trending interaction: increased more in the insulin group than in the placebo group", "chunk": 2}
{"article": "PMC8789895.txt", "subject": "eotaxin-3", "relationship": "INDICATES_PRESENCE_OF", "object": "Negative correlation with changes in A\u03b242, A\u03b240, T-tau, and P-tau", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "MIP-1\u03b1", "relationship": "INDICATES_PRESENCE_OF", "object": "Negative correlation with changes in T-tau", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "TNF-\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Negative correlation with changes in A\u03b242/T-tau ratio", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "IL-1\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Negative correlation with changes in A\u03b242, A\u03b240, T-tau, and P-tau", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "IL-8", "relationship": "INDICATES_PRESENCE_OF", "object": "Negative correlation with changes in A\u03b242, A\u03b240, and P-tau", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "MCP-1", "relationship": "RELATED_PROGNOSIS", "object": "Positive correlation with changes in A\u03b242/40 ratio", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "IL-12/IL-23p40", "relationship": "RELATED_PROGNOSIS", "object": "Positive correlation with both A\u03b242 and A\u03b240", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "IL-15", "relationship": "RELATED_PROGNOSIS", "object": "Positive correlation with A\u03b242", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "IL-5", "relationship": "RELATED_PROGNOSIS", "object": "Positive correlation with A\u03b2 40, T-tau, and P-tau", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "IL-2", "relationship": "RELATED_PROGNOSIS", "object": "Positive correlation with A\u03b242 and A\u03b240", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "eotaxin", "relationship": "RELATED_PROGNOSIS", "object": "Positive correlation with change in ADL", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "IL-16", "relationship": "RELATED_PROGNOSIS", "object": "Positive correlation with change in ADL", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "IL-13", "relationship": "RELATED_PROGNOSIS", "object": "Positive correlation with change in ADL score", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "IFN-\u03b3", "relationship": "RELATED_PROGNOSIS", "object": "Positive correlation with change in global WMHV", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "MIP-1alpha", "relationship": "RELATED_PROGNOSIS", "object": "Positive correlation with changes in deep WMHV", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "IL-8", "relationship": "RELATED_PROGNOSIS", "object": "Positive correlation with change in temporal-parietal GMV meta-ROI", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "MDC", "relationship": "RELATED_PROGNOSIS", "object": "Negative correlation with ADAS-Cog change", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "IL-12/IL-23p40", "relationship": "RELATED_PROGNOSIS", "object": "Negative correlation with ADAS-Cog", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "MIP-1alpha", "relationship": "RELATED_PROGNOSIS", "object": "Negative correlation with CDR-SOB", "chunk": 3}
{"article": "PMC8789895.txt", "subject": "PIGF", "relationship": "RELATED_PROGNOSIS", "object": "Changes in PIGF correlated with A\u03b242/T-tau ratio", "chunk": 4}
{"article": "PMC8789895.txt", "subject": "Tie-2", "relationship": "RELATED_PROGNOSIS", "object": "Changes in Tie-2 correlated with A\u03b242/40 ratio", "chunk": 4}
{"article": "PMC8789895.txt", "subject": "SAA", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Negative correlations observed between change in SAA and change in three cerebral spinal fluid markers: A\u03b242, T-tau, and P-tau", "chunk": 4}
{"article": "PMC8789895.txt", "subject": "VEGF-D", "relationship": "RELATED_PROGNOSIS", "object": "Changes in VEGF-D correlated with A\u03b242 changes", "chunk": 4}
{"article": "PMC8789895.txt", "subject": "VCAM-1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Negative correlation observed between change in VCAM-1 and global WMHV", "chunk": 4}
{"article": "PMC8789895.txt", "subject": "IFN-\u03b3", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Higher levels of IFN-\u03b3 were associated with slower AD progression", "chunk": 4}
{"article": "PMC8789895.txt", "subject": "eotaxin", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Higher levels of eotaxin were associated with slower cognitive decline in AD", "chunk": 4}
{"article": "PMC8789895.txt", "subject": "IL-2", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "IL-2", "relationship": "RELATED_TO", "object": "Improved spine density, synaptic plasticity, and memory", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "IL-2", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Potential treatment for AD", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "IL-6", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD progression", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "IL-1\u03b2", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "IL-1\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Insulin treatment", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "IL-8", "relationship": "MONITORED_DURING_TREATMENT", "object": "Insulin treatment", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "IL-8", "relationship": "RELATED_TO", "object": "Reduced A\u03b242, A\u03b240, and P-tau", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "Eotaxin-3", "relationship": "MONITORED_DURING_TREATMENT", "object": "Insulin treatment", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "Eotaxin-3", "relationship": "RELATED_TO", "object": "Less loss of hippocampal gray matter volume", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "SAA", "relationship": "RELATED_TREATMENT", "object": "Insulin treatment", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "VEGF", "relationship": "RELATED_TREATMENT", "object": "Insulin treatment", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "VEGF", "relationship": "PREDICTS_OUTCOME", "object": "Better performance on a memory composite score", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "Tie-2", "relationship": "RELATED_TO", "object": "A\u03b242/40 ratio", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "PlGF", "relationship": "RELATED_TO", "object": "A\u03b242/T-tau ratio", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "MDC", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Management of inflammation", "chunk": 5}
{"article": "PMC8789895.txt", "subject": "PlGF", "relationship": "INDICATES_PRESENCE_OF", "object": "increased concentrations in cerebral spinal fluid in adults with AD or other neurodegenerative disorders", "chunk": 6}
{"article": "PMC8789895.txt", "subject": "Tie2", "relationship": "INDICATES_PRESENCE_OF", "object": "lower levels in AD", "chunk": 6}
{"article": "PMC8789895.txt", "subject": "PlGF", "relationship": "RELATED_TREATMENT", "object": "insulin-induced modulation could improve BBB function and thereby aid in the clearance of A\u03b2", "chunk": 6}
{"article": "PMC8789895.txt", "subject": "Tie2", "relationship": "RELATED_TREATMENT", "object": "insulin-induced modulation could improve BBB function and thereby aid in the clearance of A\u03b2", "chunk": 6}
{"article": "PMC8789895.txt", "subject": "PlGF and Tie-2", "relationship": "MONITORED_DURING_TREATMENT", "object": "changes in response to intranasal insulin treatment", "chunk": 6}
{"article": "PMC8789895.txt", "subject": "PlGF and Tie-2", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Changes in PlGF and Tie-2 levels could reflect the impact of insulin treatment on BBB function", "chunk": 6}
{"article": "PMC8795741.txt", "subject": "ADAS-Cog", "relationship": "USED_TO_DIAGNOSE", "object": "Cognition in older adults.", "chunk": 2}
{"article": "PMC8795741.txt", "subject": "MoCA-P", "relationship": "USED_TO_DIAGNOSE", "object": "Cognition in older adults.", "chunk": 2}
{"article": "PMC8795741.txt", "subject": "BNT", "relationship": "USED_TO_DIAGNOSE", "object": "Cognition in older adults.", "chunk": 2}
{"article": "PMC8795741.txt", "subject": "mild cognitive impairment", "relationship": "DIAGNOSITC_OF", "object": "Potential Participant Criteria", "chunk": 3}
{"article": "PMC8795741.txt", "subject": "early-stage AD", "relationship": "DIAGNOSITC_OF", "object": "Potential Participant Criteria", "chunk": 3}
{"article": "PMC8795741.txt", "subject": "mixed AD/vascular dementia", "relationship": "DIAGNOSITC_OF", "object": "Potential Participant Criteria", "chunk": 3}
{"article": "PMC8795741.txt", "subject": "depression", "relationship": "INDICATES_PRESENCE_OF", "object": "Data Assessment During Study", "chunk": 3}
{"article": "PMC8795741.txt", "subject": "other psychiatric symptoms", "relationship": "INDICATES_PRESENCE_OF", "object": "Data Assessment During Study", "chunk": 3}
{"article": "PMC8795741.txt", "subject": "Global efficiency", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased global efficiency after dance intervention", "chunk": 5}
{"article": "PMC8795741.txt", "subject": "Scaled inclusivity", "relationship": "RELATED_TO", "object": "Changes in network metrics", "chunk": 5}
{"article": "PMC8795741.txt", "subject": "Path length", "relationship": "RELATED_TO", "object": "Changes in network metrics", "chunk": 5}
{"article": "PMC8795741.txt", "subject": "Clustering", "relationship": "RELATED_TO", "object": "Changes in network metrics", "chunk": 5}
{"article": "PMC8795741.txt", "subject": "Modularity (Q)", "relationship": "RELATED_TO", "object": "Changes in network metrics", "chunk": 5}
{"article": "PMC8795741.txt", "subject": "FAB score", "relationship": "RELATED_TREATMENT", "object": "A one point increase is estimated to decrease fall risk", "chunk": 6}
{"article": "PMC8795741.txt", "subject": "FAB score", "relationship": "RELATED_TREATMENT", "object": "decrease fall risk", "chunk": 6}
{"article": "PMC8795741.txt", "subject": "NPID+A", "relationship": "RELATED_TREATMENT", "object": "Considered in full trial (changing the valence and effect size)", "chunk": 6}
{"article": "PMC8795741.txt", "subject": "QoL-AD", "relationship": "PREDICTED_SURVIVAL", "object": "Modest correlation observed between change in QoL and changes in balance measured with the FAB", "chunk": 6}
{"article": "PMC8795741.txt", "subject": "QoL-AD", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Better QoL correlated with improved NPI depression and apathy", "chunk": 6}
{"article": "PMC8795741.txt", "subject": "QoL-AD", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Better QoL correlated with decreased GDS scores", "chunk": 6}
{"article": "PMC8795741.txt", "subject": "SMN SI", "relationship": "RELATED_PROGNOSIS", "object": "Change in FAB (functional ambulation battery) score", "chunk": 7}
{"article": "PMC8795741.txt", "subject": "Eglob", "relationship": "RELATED_PROGNOSIS", "object": "Changes on NPID+A (Neuropsychiatric Inventory plus Activities of Daily Living)", "chunk": 7}
{"article": "PMC8795741.txt", "subject": "Giant Component Size", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Sparsity threshold for brain imaging networks", "chunk": 7}
{"article": "PMC8797052.txt", "subject": "monaco and di-CQAs", "relationship": "ARE_FOUND_IN", "object": "Centella asiatica", "chunk": 2}
{"article": "PMC8797052.txt", "subject": "monaco and di-CQAs", "relationship": "PROTECT", "object": "neuroblastoma cells from beta amyloid (A\u03b2) toxicity", "chunk": 2}
{"article": "PMC8797052.txt", "subject": "Centella asiatica", "relationship": "ARE_IMPORTANT_FOR", "object": "rejuvenating effects, boosts memory, prevents cognitive deficits, and improves brain function", "chunk": 2}
{"article": "PMC8797052.txt", "subject": "Centella asiatica", "relationship": "IS_RELATED_TO_REDUCED", "object": "cognitive decline", "chunk": 2}
{"article": "PMC8797052.txt", "subject": "TT", "relationship": "MONITORED_DURING_TREATMENT", "object": "Intermediates in the manufacturing process", "chunk": 4}
{"article": "PMC8797052.txt", "subject": "CAW", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Intermediates in the manufacturing process were evaluated for CAW", "chunk": 4}
{"article": "PMC8797052.txt", "subject": "CQAs", "relationship": "MONITORED_DURING_TREATMENT", "object": "Intermediates in the manufacturing process", "chunk": 4}
{"article": "PMC8797052.txt", "subject": "CAW", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "the final formulated product", "chunk": 5}
{"article": "PMC8797052.txt", "subject": "CAW", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Investigational New Drug (IND) status", "chunk": 5}
{"article": "PMC8797052.txt", "subject": "CAW", "relationship": "RELATED_TREATMENT", "object": "an in vivo bioassay to confirm biological activity", "chunk": 5}
{"article": "PMC8797052.txt", "subject": "TTs and CQAs", "relationship": "RELATED_PROGNOSIS", "object": "stability studies", "chunk": 5}
{"article": "PMC8808989.txt", "subject": "A\u03b2 seeds", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 1}
{"article": "PMC8808989.txt", "subject": "A\u03b2 seeds", "relationship": "RELATED_TO", "object": "The polymerization property of \u03b2-amyloid (A\u03b2)", "chunk": 1}
{"article": "PMC8808989.txt", "subject": "A\u03b2 seeds", "relationship": "IS_BASIS_FOR", "object": "The biochemical diagnosis of AD", "chunk": 1}
{"article": "PMC8808989.txt", "subject": "Plasma A\u03b2 seeding activity", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Diagnosis of AD", "chunk": 1}
{"article": "PMC8808989.txt", "subject": "Plasma A\u03b2 seeding activity", "relationship": "RELATED_PROGNOSIS", "object": "cognitive performance", "chunk": 1}
{"article": "PMC8808989.txt", "subject": "Plasma A\u03b2 seeding activity", "relationship": "RELATED_PROGNOSIS", "object": "conventional biomarkers (cerebral cerebral cerebral cerebral spinal fluid A\u03b242/40, cerebral cerebral cerebral cerebral spinal fluid T-tau/A\u03b242, cerebral cerebral cerebral cerebral spinal fluid P-tau/A\u03b242)", "chunk": 1}
{"article": "PMC8808989.txt", "subject": "Plasma A\u03b2 seeding activity", "relationship": "PREDICTED_BY", "object": "AD-seeds protein analyzer (a novel instrument)", "chunk": 1}
{"article": "PMC8808989.txt", "subject": "A\u03b2 seeding activity", "relationship": "RESPONDED_TO", "object": "measurement using an AD-seeds protein analyzer", "chunk": 1}
{"article": "PMC8808989.txt", "subject": "A\u03b2 seeds", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD pathology", "chunk": 1}
{"article": "PMC8808989.txt", "subject": "A\u03b242", "relationship": "MEASURED_BY", "object": "A\u03b2 seeding activity in plasma samples", "chunk": 2}
{"article": "PMC8808989.txt", "subject": "P-tau181", "relationship": "MEASURED_BY", "object": "conventional biomarkers of AD", "chunk": 2}
{"article": "PMC8808989.txt", "subject": "T-Tau", "relationship": "RELATED_TO", "object": "conventional biomarkers of AD", "chunk": 2}
{"article": "PMC8808989.txt", "subject": "A\u03b242", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Diagnosing AD", "chunk": 3}
{"article": "PMC8808989.txt", "subject": "A\u03b240", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Diagnosing AD", "chunk": 3}
{"article": "PMC8808989.txt", "subject": "A\u03b2 seeding activity", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 3}
{"article": "PMC8808989.txt", "subject": "A\u03b2 seeding activity", "relationship": "MONITORED_DURING_TREATMENT", "object": "Clinical trials evaluating AD treatment efficacy", "chunk": 3}
{"article": "PMC8808989.txt", "subject": "Plasma A\u03b2 seeding activity", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Diagnostic evaluation for AD differentiation from NC or NADD", "chunk": 3}
{"article": "PMC8808989.txt", "subject": "A\u03b2 seeding activity", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "A\u03b2 aggregation in AD patients", "chunk": 3}
{"article": "PMC8808989.txt", "subject": "Plasma A\u03b2 seeding activity", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function in AD patients", "chunk": 3}
{"article": "PMC8808989.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Decreased levels linked to cognitive decline", "chunk": 3}
{"article": "PMC8808989.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Decreased levels linked to cognitive decline", "chunk": 3}
{"article": "PMC8808989.txt", "subject": "T-tau", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Elevated levels indicate disease progression", "chunk": 3}
{"article": "PMC8808989.txt", "subject": "P-tau", "relationship": "RELATED_PROGNOSIS", "object": "Disease progression and severity", "chunk": 3}
{"article": "PMC8808989.txt", "subject": "APOE \u03b54 status", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC8808989.txt", "subject": "plasma A\u03b2 seeding activity", "relationship": "DIAGNOSTIC_OF", "object": "AD", "chunk": 4}
{"article": "PMC8808989.txt", "subject": "A\u03b2 seeding activity", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 4}
{"article": "PMC8808989.txt", "subject": "plasma A\u03b2 seeding activity", "relationship": "RELATED_PROGNOSIS", "object": "General cognitive level", "chunk": 4}
{"article": "PMC8808989.txt", "subject": "plasma A\u03b2 seeding activity", "relationship": "INDICATES_PRESENCE_OF", "object": "amyloid deposition", "chunk": 4}
{"article": "PMC8808989.txt", "subject": "plasma A\u03b2 seeding activity", "relationship": "RELATED_TREATMENT", "object": "Monitoring disease progression", "chunk": 4}
{"article": "PMC8808989.txt", "subject": "A\u03b2 seeding activity", "relationship": "MONITORED_DURING_TREATMENT", "object": "AD", "chunk": 4}
{"article": "PMC8808989.txt", "subject": "A\u03b2 oligomerization tendency", "relationship": "RELATED_PROGNOSIS", "object": "cognitive function", "chunk": 4}
{"article": "PMC8808989.txt", "subject": "levels of A\u03b2 oligomerization", "relationship": "PREDICT_SURVIVAL", "object": "AD", "chunk": 4}
{"article": "PMC8808989.txt", "subject": "plasma A\u03b2 seeding activity", "relationship": "RESPONDED_TO", "object": "A\u03b2 seeds", "chunk": 4}
{"article": "PMC8810394.txt", "subject": "High Body-Mass Index (BMI)", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 4}
{"article": "PMC8810394.txt", "subject": "High Fasting Plasma Glucose", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 4}
{"article": "PMC8810394.txt", "subject": "Smoking", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 4}
{"article": "PMC8810394.txt", "subject": "Low Physical Activity", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Dementia Prevalence", "chunk": 4}
{"article": "PMC8810394.txt", "subject": "High Systolic Blood Pressure", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Dementia Prevalence", "chunk": 4}
{"article": "PMC8810394.txt", "subject": "Low Education", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Dementia Prevalence", "chunk": 4}
{"article": "PMC8810394.txt", "subject": "Alcohol Use", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Dementia Prevalence", "chunk": 4}
{"article": "PMC8810394.txt", "subject": "Air Pollution", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Dementia Prevalence", "chunk": 4}
{"article": "PMC8810394.txt", "subject": "BMI", "relationship": "RELATED_PROGNOSIS", "object": "Increases in BMI were associated with increased dementia prevalence in most regions  ", "chunk": 7}
{"article": "PMC8810394.txt", "subject": "Fasting Plasma Glucose", "relationship": "RELATED_PROGNOSIS", "object": "Increases in fasting plasma glucose were associated with increased dementia prevalence in most regions", "chunk": 7}
{"article": "PMC8810394.txt", "subject": "Smoking", "relationship": "RELATED_PROGNOSIS", "object": "Increases in smoking had less clear trends associated with dementia prevalence", "chunk": 7}
{"article": "PMC8810394.txt", "subject": "Educational Attainment", "relationship": "RELATED_PROGNOSIS", "object": "Increases in average educational attainment were associated with a decrease in  dementia prevalence ", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "A\u03b2 deposition", "relationship": "INDICATES_PRESENCE_OF", "object": "Preclinical Alzheimer's Disease", "chunk": 2}
{"article": "PMC8843023.txt", "subject": "Plasma A\u03b242/40 ratio", "relationship": "RELATED_TO", "object": "Brain A\u03b2 positivity in preclinical AD individuals", "chunk": 2}
{"article": "PMC8843023.txt", "subject": "Plasma A\u03b240 and A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Conflicting results regarding correlation with AD pathology", "chunk": 2}
{"article": "PMC8843023.txt", "subject": "Plasma A\u03b2", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Potential diagnostic tool for routine clinical work", "chunk": 2}
{"article": "PMC8843023.txt", "subject": "Gut microbiota", "relationship": "ASSOCIATED_WITH", "object": "AD pathology", "chunk": 2}
{"article": "PMC8843023.txt", "subject": "Gut microbiota alterations", "relationship": "RELATED_PROGNOSIS", "object": "Investigating their role in preclinical AD", "chunk": 2}
{"article": "PMC8843023.txt", "subject": "Gut microbiota", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Potential hallmarks", "chunk": 2}
{"article": "PMC8843023.txt", "subject": "Gut microbiota", "relationship": "RELATED_TO", "object": "Brain function such as memory and learning", "chunk": 2}
{"article": "PMC8843023.txt", "subject": "A\u03b2 deposition", "relationship": "INDICATES_PRESENCE_OF", "object": "Preclinical Alzheimer's Disease", "chunk": 2}
{"article": "PMC8843023.txt", "subject": "A\u03b240", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma A\u03b240, A\u03b242, and their ratio (A\u03b242/A\u03b240) indexes were used for the subsequent analysis.", "chunk": 3}
{"article": "PMC8843023.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma A\u03b240, A\u03b242, and their ratio (A\u03b242/A\u03b240) indexes were used for the subsequent analysis.", "chunk": 3}
{"article": "PMC8843023.txt", "subject": "A\u03b242/A\u03b240", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma A\u03b240, A\u03b242, and their ratio (A\u03b242/A\u03b240) indexes were used for the subsequent analysis.", "chunk": 3}
{"article": "PMC8843023.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Plasma A\u03b240, A\u03b242, and their ratio (A\u03b242/A\u03b240) indexes were used for the subsequent analysis.", "chunk": 3}
{"article": "PMC8843023.txt", "subject": "A\u03b242", "relationship": "RELATED_TO_ALZHEIMERS_DISEASE", "object": "Significantly reduced in plasma of CN+ group compared to CN-", "chunk": 4}
{"article": "PMC8843023.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_TO_ALZHEIMERS_DISEASE", "object": "Significantly reduced in plasma of CN+ group compared to CN-", "chunk": 4}
{"article": "PMC8843023.txt", "subject": "Global standard uptake value rate (SUVR)", "relationship": "DIAGNOSTIC_INDICATOR", "object": "Positive A\u03b2 burden defined as SUVR above or equal to 1.18", "chunk": 4}
{"article": "PMC8843023.txt", "subject": "Plasma A\u03b242 levels", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower levels in CN+ group compared to CN-", "chunk": 4}
{"article": "PMC8843023.txt", "subject": "Plasma A\u03b242/A\u03b240 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower ratio in CN+ group compared to CN-", "chunk": 4}
{"article": "PMC8843023.txt", "subject": "ASV_19", "relationship": "RELATED_TO_ALZHEIMERS_DISEASE", "object": "Significantly lower abundance in CN+ group", "chunk": 4}
{"article": "PMC8843023.txt", "subject": "ASV_9", "relationship": "RELATED_TO_ALZHEIMERS_DISEASE", "object": "Significantly lower abundance in CN+ group", "chunk": 4}
{"article": "PMC8843023.txt", "subject": "Bacteroidetes", "relationship": "INDICATES_PRESENCE_OF", "object": "CN+ group", "chunk": 5}
{"article": "PMC8843023.txt", "subject": "Bacteroidia", "relationship": "INDICATES_PRESENCE_OF", "object": "CN+ group", "chunk": 5}
{"article": "PMC8843023.txt", "subject": "Bacteroidales", "relationship": "INDICATES_PRESENCE_OF", "object": "CN+ group", "chunk": 5}
{"article": "PMC8843023.txt", "subject": "Firmicutes", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "CN+ group", "chunk": 5}
{"article": "PMC8843023.txt", "subject": "Clostridia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "CN+ group", "chunk": 5}
{"article": "PMC8843023.txt", "subject": "Deltaproteobacteria", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "CN+ group", "chunk": 5}
{"article": "PMC8843023.txt", "subject": "Clostridiales", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "CN+ group", "chunk": 5}
{"article": "PMC8843023.txt", "subject": "Desulfovibrionales", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "CN+ group", "chunk": 5}
{"article": "PMC8843023.txt", "subject": "Lachnospiraceae", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "CN+ group", "chunk": 5}
{"article": "PMC8843023.txt", "subject": "Desulfovibrionaceae", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "CN+ group", "chunk": 5}
{"article": "PMC8843023.txt", "subject": "Ruminococcaceae", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "CN+ group", "chunk": 5}
{"article": "PMC8843023.txt", "subject": "Bilophila", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "CN+ group", "chunk": 5}
{"article": "PMC8843023.txt", "subject": "Faecalibacterium", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "CN+ group", "chunk": 5}
{"article": "PMC8843023.txt", "subject": "A\u03b242/A\u03b240", "relationship": "NEGATIVE_CORRELATED_WITH", "object": "global brain SUVR", "chunk": 6}
{"article": "PMC8843023.txt", "subject": "A\u03b242", "relationship": "NEGATIVE_CORRELATED_WITH", "object": "global brain SUVR", "chunk": 6}
{"article": "PMC8843023.txt", "subject": "Family Desulfovibrionaceae", "relationship": "NEGATIVE_CORRELATED_WITH", "object": "global brain SUVR", "chunk": 6}
{"article": "PMC8843023.txt", "subject": "Genus Bilophila", "relationship": "NEGATIVE_CORRELATED_WITH", "object": "global brain SUVR", "chunk": 6}
{"article": "PMC8843023.txt", "subject": "Genus Faecalibacterium", "relationship": "NEGATIVE_CORRELATED_WITH", "object": "global brain SUVR", "chunk": 6}
{"article": "PMC8843023.txt", "subject": "A\u03b242", "relationship": "RELATED_TO_TREATMENT", "object": "plasma A\u03b242 and A\u03b242/A\u03b240 may serve as a minimally invasive and cost-effective index for screening preclinical AD", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "brain amyloidosis", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_TO_TREATMENT", "object": "plasma A\u03b242 and A\u03b242/A\u03b240 may serve as a minimally invasive and cost-effective index for screening preclinical AD", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "A\u03b242/A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "brain amyloidosis", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "A\u03b242/A\u03b240 ratio may be more predictive of brain A\u03b2 pathological changes than A\u03b242 and A\u03b240", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "A\u03b242/A\u03b240", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The combination of plasma A\u03b2 markers, altered gut microbiota, and clinical cognition showed the potential of distinguishing CN+  from CN\u2212", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "A\u03b240", "relationship": "RELATED_TO_TREATMENT", "object": "plasma A\u03b242 and A\u03b242/A\u03b240 may serve as a minimally invasive and cost-effective index for screening preclinical AD", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "family Desulfovibrionaceae", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "the global brain, A\u03b2 burden was negatively associated with the plasma A\u03b242/A\u03b240, family Desulfovibrionaceae,", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "genus Bilophila", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "the global brain, A\u03b2 burden was negatively associated with the plasma A\u03b242/A\u03b240, family Desulfovibrionaceae,", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "genus Faecalibacterium", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "the global brain, A\u03b2 burden was negatively associated with the plasma A\u03b242/A\u03b240, family Desulfovibrionaceae,", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "phylum Firmicutes", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "change of the gut microbial profiling occurred in the preclinical AD", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "family Ruminococcaceae", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "change of the gut microbial profiling occurred in the preclinical AD", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "family Lachnospiraceae", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "change of the gut microbial profiling occurred in the preclinical AD", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "class Clostridia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "change of the gut microbial profiling occurred in the preclinical AD", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "order Clostridiales", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "change of the gut microbial profiling occurred in the preclinical AD", "chunk": 7}
{"article": "PMC8843023.txt", "subject": "Bacteroidetes", "relationship": "RELATED_PROGNOSIS", "object": "AD pathology", "chunk": 8}
{"article": "PMC8843023.txt", "subject": "Bacteroidetes", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased translocation of LPS to systemic circulation", "chunk": 8}
{"article": "PMC8843023.txt", "subject": "Bacteroidetes", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased systemic inflammation and release of pro-inflammatory cytokines", "chunk": 8}
{"article": "PMC8843023.txt", "subject": "Deltaproteobacteria", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Biomarker of gut microbial alteration in AD", "chunk": 8}
{"article": "PMC8843023.txt", "subject": "Deltaproteobacteria", "relationship": "INDICATES_PRESENCE_OF", "object": "Low abundance in preclinical AD patients", "chunk": 8}
{"article": "PMC8843023.txt", "subject": "LPS", "relationship": "RELATED_TREATMENT", "object": "Can exacerbate AD pathology through inflammation", "chunk": 8}
{"article": "PMC8843023.txt", "subject": "LPS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Monitoring its levels in systemic circulation may guide treatment strategies", "chunk": 8}
{"article": "PMC8843023.txt", "subject": "A\u03b242/A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "preclinical AD", "chunk": 9}
{"article": "PMC8843023.txt", "subject": "gut microbiota", "relationship": "RELATED_TREATMENT", "object": "therapeutic strategies of AD-related cognitive decline", "chunk": 9}
{"article": "PMC8843023.txt", "subject": "gut microbiota", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "therapeutic strategies of AD-related cognitive decline", "chunk": 9}
{"article": "PMC8843023.txt", "subject": "gut microbiota", "relationship": "MONITORED_DURING_TREATMENT", "object": "therapeutic strategies of AD-related cognitive decline", "chunk": 9}
{"article": "PMC8843023.txt", "subject": "gut microbiota", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "therapeutic strategies of AD-related cognitive decline", "chunk": 9}
{"article": "PMC8843023.txt", "subject": "A\u03b242/A\u03b240", "relationship": "USED_TO_DIAGNOSE", "object": "preclinical AD", "chunk": 9}
{"article": "PMC8843023.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "preclinical AD", "chunk": 9}
{"article": "PMC8857690.txt", "subject": "apoe4", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Risk for developing AD", "chunk": 1}
{"article": "PMC8857690.txt", "subject": "Lifestyle behaviors", "relationship": "RELATED_TREATMENT", "object": "Interventions to reduce the risk for developing dementia", "chunk": 1}
{"article": "PMC8857690.txt", "subject": "overweight and obesity", "relationship": "RELATED_TO_ALZHEIMER", "object": "Risk Factors for AD", "chunk": 1}
{"article": "PMC8857690.txt", "subject": "physical inactivity", "relationship": "RELATED_TO_ALZHEIMER", "object": "Risk Factors for AD", "chunk": 1}
{"article": "PMC8857690.txt", "subject": "stress", "relationship": "RELATED_TO_ALZHEIMER", "object": "Risk Factors for AD", "chunk": 1}
{"article": "PMC8857690.txt", "subject": "chronic inflammation", "relationship": "RELATED_TO_ALZHEIMER", "object": "Risk Factors for AD", "chunk": 1}
{"article": "PMC8857690.txt", "subject": "dietary habits", "relationship": "RELATED_TO_ALZHEIMER", "object": "Risk Factors for AD", "chunk": 1}
{"article": "PMC8857690.txt", "subject": "sleep", "relationship": "RELATED_TO_ALZHEIMER", "object": "Risk Factors for AD", "chunk": 1}
{"article": "PMC8857690.txt", "subject": "blood glucose and lipid levels", "relationship": "RELATED_TO_ALZHEIMER", "object": "Risk Factors for AD", "chunk": 1}
{"article": "PMC8857690.txt", "subject": "low cognitive activity", "relationship": "RELATED_TO_ZHEIMER", "object": "Risk Factors for AD", "chunk": 1}
{"article": "PMC8857690.txt", "subject": "low social engagement", "relationship": "RELATED_TO_ALZHEIMER", "object": "Risk Factors for AD", "chunk": 1}
{"article": "PMC8857690.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "As a biomarker for Alzheimer's disease risk.", "chunk": 3}
{"article": "PMC8857690.txt", "subject": "brain-derived neurotrophic factor", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Can be a target for therapeutic interventions aimed at reducing Alzheimer's disease risk.", "chunk": 3}
{"article": "PMC8857690.txt", "subject": "high-sensitivity C-reactive protein", "relationship": "INDICATES_PRESENCE_OF", "object": "Chronic inflammation, a risk factor for Alzheimer's disease.", "chunk": 3}
{"article": "PMC8857690.txt", "subject": "interleukin-6", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammation, a risk factor for Alzheimer's disease.", "chunk": 3}
{"article": "PMC8857690.txt", "subject": "High-sensitivity C-reactive protein", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Blood Biomarker", "chunk": 5}
{"article": "PMC8857690.txt", "subject": "Interleukin-6", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Blood Biomarker", "chunk": 5}
{"article": "PMC8857690.txt", "subject": "Brain-derived neurotrophic factor", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Blood Biomarker", "chunk": 5}
{"article": "PMC8857690.txt", "subject": "Cholesterol (total, HDL, and LDL)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Blood Biomarker", "chunk": 5}
{"article": "PMC8857690.txt", "subject": "Triglycerides", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Blood Biomarker", "chunk": 5}
{"article": "PMC8857690.txt", "subject": "Blood glucose levels", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Blood Biomarker", "chunk": 5}
{"article": "PMC8857690.txt", "subject": "APOE status", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Blood Biomarker", "chunk": 5}
{"article": "PMC8857690.txt", "subject": "ANU-ADRI score", "relationship": "RELATED_PROGNOSIS", "object": "8% increase in the risk for developing mild cognitive impairment   or dementia, mediated by brain volume", "chunk": 6}
{"article": "PMC8857690.txt", "subject": "ANU-ADRI score", "relationship": "RELATED_PROGNOSIS", "object": "1-point increase is associated with an 8% increase in the risk for developing mild cognitive impairment   or dementia", "chunk": 6}
{"article": "PMC8857690.txt", "subject": "MIND diet", "relationship": "RELATED_PROGNOSIS", "object": "Better brain health and reduced dementia risk", "chunk": 7}
{"article": "PMC8857690.txt", "subject": "MIND diet", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduction in the rate of developing AD in the top tertile of MIND diet scores by 53%", "chunk": 7}
{"article": "PMC8857690.txt", "subject": "MIND diet", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduction in the rate of developing AD in the middle tertile of MIND diet scores by 35%", "chunk": 7}
{"article": "PMC8857690.txt", "subject": "Australian National University-Alzheimer Disease Risk Index (ANU-ADRI)", "relationship": "DIAGNOSTIC_OF", "object": "Dementia risk", "chunk": 7}
{"article": "PMC8857690.txt", "subject": "Higher cardiorespiratory fitness and physical activity participation", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Cognitive performance", "chunk": 7}
{"article": "PMC8857690.txt", "subject": "Acute exercise", "relationship": "PREDICTS_SURVIVAL", "object": "Improved performance in many cognitive paradigms, especially executive function and reaction time", "chunk": 7}
{"article": "PMC8857690.txt", "subject": "Sleep disturbances", "relationship": "RELATED_TO_RISK_OF_CONDITION", "object": "Future cognitive decline", "chunk": 7}
{"article": "PMC8857690.txt", "subject": "Chronic stress", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cardiovascular disease and cognitive dysfunction.", "chunk": 7}
{"article": "PMC8857690.txt", "subject": "Stress hormones", "relationship": "RELATED_PROGNOSIS", "object": "Decrease in glutamate receptor function in the prefrontal cortex, leading to potential impairment in executive function.", "chunk": 7}
{"article": "PMC8857690.txt", "subject": "Habitual physical inactivity", "relationship": "RELATED_PROGNOSIS", "object": "Type 2 diabetes, cardiovascular disease, and hypertension. ", "chunk": 7}
{"article": "PMC8857690.txt", "subject": "APOE", "relationship": "RELATED_PROGNOSIS", "object": "risk of AD", "chunk": 8}
{"article": "PMC8857690.txt", "subject": "ANU-ADRI", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "AD risk reduction", "chunk": 8}
{"article": "PMC8866346.txt", "subject": "amyloid peptides", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 1}
{"article": "PMC8866346.txt", "subject": "tau protein", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 1}
{"article": "PMC8866346.txt", "subject": "Plasma A\u03b21\u201342/A\u03b21\u201340 ratio", "relationship": "RELATED_PROGNOSIS", "object": "different cerebral cerebral cerebral cerebral spinal fluid profile and in particular of the nonpathological (A\u2212/T\u2212/N\u2212) profile", "chunk": 1}
{"article": "PMC8866346.txt", "subject": "phosphorylated tau (p-tau(181))", "relationship": "RELATED_PROGNOSIS", "object": "different cerebral cerebral cerebral cerebral spinal fluid profile and in particular of the nonpathological (A\u2212/T\u2212/N\u2212) profile", "chunk": 1}
{"article": "PMC8866346.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_TREATMENT", "object": "Plasma levels of A\u03b21\u201342 and A\u03b21\u201340 were measured using \u2018Neurology 3-Plex A\u2019 (Q3, both cohorts) and \u2018Neurology 4-plex E Advantage kit\u2019 (Q4, Montpellier cohort) in the Simoa platform (Quanterix) and an IP-MS approach from Shimadzu (Nakamura et al. 2018) (both cohorts) implemented in Montpellier\u2019s laboratory and slightly modified from the original protocol (Alcolea et al. 2021).", "chunk": 2}
{"article": "PMC8866346.txt", "subject": "A\u03b21\u201340", "relationship": "RELATED_TREATMENT", "object": "Plasma levels of A\u03b21\u201342 and A\u03b21\u201340 were measured using \u2018Neurology 3-Plex A\u2019 (Q3, both cohorts) and \u2018Neurology 4-plex E Advantage kit\u2019 (Q4, Montpellier cohort) in the Simoa platform (Quanterix) and an IP-MS approach from Shimadzu (Nakamura et al. 2018) (both cohorts) implemented in Montpellier\u2019s laboratory and slightly modified from the original protocol (Alcolea et al. 2021).", "chunk": 2}
{"article": "PMC8866346.txt", "subject": "A\u03b21\u201342/A\u03b21\u201340 ratio (A)", "relationship": "DIAGNOSITC_OF", "object": "a nonpathological cerebral cerebral cerebral cerebral spinal fluid profile corresponding the (A\u2212/T\u2212/N\u2212) situation is defined as having a value of the A\u03b21\u201342/A\u03b21\u201340 ratio (A) above the cutoff and values of tau (N) and p-tau(181) (T) below the pathological cutoffs.", "chunk": 2}
{"article": "PMC8866346.txt", "subject": "tau (N)", "relationship": "DIAGNOSITC_OF", "object": "a nonpathological cerebral cerebral cerebral cerebral spinal fluid profile corresponding the (A\u2212/T\u2212/N\u2212) situation is defined as having a value of the A\u03b21\u201342/A\u03b21\u201340 ratio (A) above the cutoff and values of tau (N) and p-tau(181) (T) below the pathological cutoffs.", "chunk": 2}
{"article": "PMC8866346.txt", "subject": "p-tau(181) (T)", "relationship": "DIAGNOSITC_OF", "object": "a nonpathological cerebral cerebral cerebral cerebral spinal fluid profile corresponding the (A\u2212/T\u2212/N\u2212) situation is defined as having a value of the A\u03b21\u201342/A\u03b21\u201340 ratio (A) above the cutoff and values of tau (N) and p-tau(181) (T) below the pathological cutoffs.", "chunk": 2}
{"article": "PMC8866346.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Thus, the objective here is to evaluate the performance of blood biomarkers in detecting a \u2018nonpathological\u2019 (A\u2212/T\u2212/N\u2212) cerebral cerebral cerebral cerebral spinal fluid profile, rather than a specific pathological profile as seen in AD or brain injury.", "chunk": 2}
{"article": "PMC8866346.txt", "subject": "A\u03b21\u201340", "relationship": "INDICATES_PRESENCE_OF", "object": "Thus, the objective here is to evaluate the performance of blood biomarkers in detecting a \u2018nonpathological\u2019 (A\u2212/T\u2212/N\u2212) cerebral cerebral cerebral cerebral spinal fluid profile, rather than a specific pathological profile as seen in AD or brain injury.", "chunk": 2}
{"article": "PMC8866346.txt", "subject": "A\u03b21\u201342/A\u03b21\u201340", "relationship": "INDICATES_PRESENCE_OF", "object": "pathological cerebral cerebral cerebral cerebral spinal fluid profile", "chunk": 3}
{"article": "PMC8866346.txt", "subject": "p-tau(181)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "pathological cerebral cerebral cerebral cerebral spinal fluid profile", "chunk": 3}
{"article": "PMC8866346.txt", "subject": "p-tau(181)", "relationship": "DIAGNOSITC_OF", "object": "pathological cerebral cerebral cerebral cerebral spinal fluid profile", "chunk": 3}
{"article": "PMC8866346.txt", "subject": "A\u03b21\u201342/A\u03b21\u201340", "relationship": "RELATED_PROGNOSIS", "object": "detection of nonpathological amyloid and tau cerebral cerebral cerebral cerebral spinal fluid profiles", "chunk": 3}
{"article": "PMC8866346.txt", "subject": "p-tau(181)", "relationship": "RELATED_PROGNOSIS", "object": "detection of nonpathological amyloid and tau cerebral cerebral cerebral cerebral spinal fluid profiles", "chunk": 3}
{"article": "PMC8866346.txt", "subject": "p-tau(181)", "relationship": "RELATED_PROGNOSIS", "object": "detection of amyloid (A+) cerebral cerebral cerebral cerebral spinal fluid profiles", "chunk": 3}
{"article": "PMC8866346.txt", "subject": "p-tau(181)", "relationship": "RELATED_PROGNOSIS", "object": "detection of tau-neurodegeneration (T+/N+) cerebral cerebral cerebral cerebral spinal fluid profiles", "chunk": 3}
{"article": "PMC8866346.txt", "subject": "A\u03b21\u201342/A\u03b21\u201340", "relationship": "RELATED_PROGNOSIS", "object": "detection of amyloid (A+) cerebral cerebral cerebral cerebral spinal fluid profiles", "chunk": 3}
{"article": "PMC8866346.txt", "subject": "p-tau(181)", "relationship": "PREDICTS_SURVIVAL", "object": "If p-tau(181) levels (or the A\u03b21\u201342/A\u03b21\u201340 ratio) are elevated, it indicates a higher probability of a pathological cerebral cerebral cerebral cerebral spinal fluid profile, which can guide decisions about further diagnostic testing and treatment.", "chunk": 3}
{"article": "PMC8866346.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease (AD)", "chunk": 4}
{"article": "PMC8866346.txt", "subject": "p-tau(181)", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid profile in cerebral spinal fluid", "chunk": 4}
{"article": "PMC8866346.txt", "subject": "p-tau(181)", "relationship": "RELATED_PROGNOSIS", "object": "Detection of nonpathological cerebral spinal fluid profiles", "chunk": 4}
{"article": "PMC8866346.txt", "subject": "p-tau(217)", "relationship": "RELATED_PROGNOSIS", "object": "Better diagnostic performance for Alzheimer's Disease", "chunk": 4}
{"article": "PMC8866346.txt", "subject": "p-tau(231)", "relationship": "RELATED_PROGNOSIS", "object": "Better diagnostic performance for Alzheimer's Disease", "chunk": 4}
{"article": "PMC8866346.txt", "subject": "A\u03b21\u201342/A\u03b21\u201340 ratio", "relationship": "PREDICTS_SURVIVAL", "object": "Alzheimer's disease (AD) discrimination from non-AD", "chunk": 4}
{"article": "PMC8866346.txt", "subject": "Blood amyloid and tau biomarkers", "relationship": "RELATED_TREATMENT", "object": "Determining the need for lumbar puncture (LP)", "chunk": 4}
{"article": "PMC8866346.txt", "subject": "Blood amyloid and tau biomarkers", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Decision to add other diagnostic tests (e.g., imaging)", "chunk": 4}
{"article": "PMC8868383.txt", "subject": "\u03b2-amyloid (A\u03b2) plaques", "relationship": "RELATED_TO", "object": "AD pathogenesis", "chunk": 1}
{"article": "PMC8868383.txt", "subject": "Neurofibrillary tangles", "relationship": "RELATED_TO", "object": "AD pathogenesis", "chunk": 1}
{"article": "PMC8868383.txt", "subject": "Mitochondrial dysfunction", "relationship": "RELATED_TO", "object": "AD Pathogenesis", "chunk": 1}
{"article": "PMC8868383.txt", "subject": "Oxidative stress", "relationship": "RELATED_TO", "object": "AD Pathogenesis", "chunk": 1}
{"article": "PMC8868383.txt", "subject": "tau protein", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurofibrillary tangles", "chunk": 1}
{"article": "PMC8868383.txt", "subject": "A\u03b2 plaques", "relationship": "CAUSES", "object": "Disruption of synaptic communication", "chunk": 1}
{"article": "PMC8868383.txt", "subject": "NRF2", "relationship": "MODULATES", "object": "Mitochondrial function and biogenesis", "chunk": 1}
{"article": "PMC8868383.txt", "subject": "NRF2", "relationship": "REGULATES", "object": "Expression of antioxidant response genes", "chunk": 1}
{"article": "PMC8868383.txt", "subject": "cholinesterase inhibitors", "relationship": "USED_TO_DIAGNOSE", "object": "Treatment of AD", "chunk": 1}
{"article": "PMC8868383.txt", "subject": "N-methyl-d-aspartate (NMDA) receptor antagonists", "relationship": "USED_TO_DIAGNOSE", "object": "Treatment of AD", "chunk": 1}
{"article": "PMC8868383.txt", "subject": "aducanumab", "relationship": "USED_TO_DIAGNOSE", "object": "Treatment of AD", "chunk": 1}
{"article": "PMC8868383.txt", "subject": "Centella asiatica", "relationship": "RELATED_TREATMENT", "object": "Cognitive decline and Alzheimer's Disease", "chunk": 2}
{"article": "PMC8868383.txt", "subject": "Asiatic acid", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Pharmacokinetic studies", "chunk": 2}
{"article": "PMC8868383.txt", "subject": "Caffeoylquinic acids (CQAs)", "relationship": "RELATED_TREATMENT", "object": "Cognitive decline and Alzheimer's Disease treatment", "chunk": 2}
{"article": "PMC8868383.txt", "subject": "Dihydroferulic acid", "relationship": "RELATED_TREATMENT", "object": "Cognitive decline and Alzheimer's Disease treatment", "chunk": 2}
{"article": "PMC8868383.txt", "subject": "Triterpenoid (TT) saponin glycosides", "relationship": "RELATED_TREATMENT", "object": "Neuroprotective and neurotropic effects", "chunk": 2}
{"article": "PMC8868383.txt", "subject": "asiatic acid", "relationship": "RELATED_TREATMENT", "object": "The pharmacokinetics of the TTs present in complex extracts.", "chunk": 8}
{"article": "PMC8868383.txt", "subject": "asiatic acid", "relationship": "MONITORED_DURING_TREATMENT", "object": "concentration-time profiles", "chunk": 8}
{"article": "PMC8868383.txt", "subject": "madecassic acid", "relationship": "MONITORED_DURING_TREATMENT", "object": "concentration-time profiles", "chunk": 8}
{"article": "PMC8868383.txt", "subject": "caffeoylquinic acids", "relationship": "RELATED_TREATMENT", "object": "The pharmacokinetics of the TTs present in complex extracts", "chunk": 8}
{"article": "PMC8868383.txt", "subject": "caffeoylquinic acids", "relationship": "MONITORED_DURING_TREATMENT", "object": "pharmacokinetic curves", "chunk": 8}
{"article": "PMC8868383.txt", "subject": "caffeoylquinic acids", "relationship": "RELATED_TREATMENT", "object": "dose-dependent absorption", "chunk": 8}
{"article": "PMC8868383.txt", "subject": "CAW", "relationship": "RELATED_PROGNOSIS", "object": "Increased antioxidant and mitochondrial activity", "chunk": 9}
{"article": "PMC8868383.txt", "subject": "NRF2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Activated NRF2  gene expression in Humans", "chunk": 9}
{"article": "PMC8868383.txt", "subject": "Blood urea nitrogen", "relationship": "RELATED_PROGNOSIS", "object": "Elevated levels associated with greater likelihood of cognitive decline", "chunk": 12}
{"article": "PMC8868383.txt", "subject": "CA", "relationship": "INDICATES_PRESENCE_OF", "object": "Psychiatric Events", "chunk": 13}
{"article": "PMC8868383.txt", "subject": "CA", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased urination", "chunk": 13}
{"article": "PMC8873004.txt", "subject": "valeric acid", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "worsened neuroinflammation, learning and memory in exercise mice with surgery", "chunk": 1}
{"article": "PMC8873004.txt", "subject": "valeric acid", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "a potential target for brain health", "chunk": 1}
{"article": "PMC8873004.txt", "subject": "valeric acid", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "exercise stabilizes gut microbiota in the presence of insult, such as surgery", "chunk": 1}
{"article": "PMC8873004.txt", "subject": "Valeric acid", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Mediating the effects of gut microbiota on learning and memory impairment after Surgery", "chunk": 2}
{"article": "PMC8873004.txt", "subject": "C3ar1", "relationship": "INDICATES_PRESENCE_OF", "object": "Surgery-induced neuroinflammation", "chunk": 3}
{"article": "PMC8873004.txt", "subject": "C3", "relationship": "INDICATES_PRESENCE_OF", "object": "Surgery-induced immune and inflammatory responses", "chunk": 3}
{"article": "PMC8873004.txt", "subject": "Iba-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Surgery-induced immune and inflammatory responses", "chunk": 3}
{"article": "PMC8873004.txt", "subject": "IL-6", "relationship": "INDICATES_PRESENCE_OF", "object": "Surgery-induced immune and inflammatory responses", "chunk": 3}
{"article": "PMC8873004.txt", "subject": "valeric acid", "relationship": "RELATED_TREATMENT", "object": "attenuation of surgery-induced learning and memory impairment", "chunk": 4}
{"article": "PMC8873004.txt", "subject": "valeric acid", "relationship": "RELATED_TREATMENT", "object": "altered by intraperitoneal injection", "chunk": 4}
{"article": "PMC8873004.txt", "subject": "valeric acid", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increased blood valeric acid was associated with decreased learning and memory", "chunk": 4}
{"article": "PMC8873004.txt", "subject": "C3ar1", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduced levels in the hippocampus after surgery", "chunk": 5}
{"article": "PMC8873004.txt", "subject": "C3", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduced levels in the hippocampus after surgery", "chunk": 5}
{"article": "PMC8873004.txt", "subject": "Iba-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduced levels in the hippocampus after surgery", "chunk": 5}
{"article": "PMC8873004.txt", "subject": "IL-1\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduced levels in the hippocampus after surgery", "chunk": 5}
{"article": "PMC8873004.txt", "subject": "IL-6", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduced levels in the hippocampus after surgery", "chunk": 5}
{"article": "PMC8873004.txt", "subject": "C3ar", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduced levels in the hippocampus after surgery", "chunk": 5}
{"article": "PMC8873004.txt", "subject": "exercise", "relationship": "RELATED_PROGNOSIS", "object": "better preservation of mental status after surgery in humans", "chunk": 6}
{"article": "PMC8873004.txt", "subject": "exercise", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "better preservation of mental status after surgery in humans", "chunk": 6}
{"article": "PMC8873004.txt", "subject": "exercise", "relationship": "RELATED_TREATMENT", "object": "attenuation of surgery-induced learning and memory impairment", "chunk": 6}
{"article": "PMC8873004.txt", "subject": "exercise", "relationship": "RELATED_TREATMENT", "object": "attenuation of neuroinflammatory responses to surgery", "chunk": 6}
{"article": "PMC8873004.txt", "subject": "exercise", "relationship": "RELATED_TREATMENT", "object": "attenuation of surgery-induced decrease of brain cell genesis and dendritic arborization", "chunk": 6}
{"article": "PMC8873004.txt", "subject": "surgery", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "learning and memory impairment", "chunk": 6}
{"article": "PMC8873004.txt", "subject": "surgery", "relationship": "DIAGNOSITC_OF", "object": "Postoperative Cognitive Decline (POCD)", "chunk": 6}
{"article": "PMC8873004.txt", "subject": "surgery", "relationship": "CAUSES", "object": "neuroinflammation", "chunk": 6}
{"article": "PMC8873004.txt", "subject": "surgery", "relationship": " CAUSES", "object": "decrease of brain cell genesis and dendritic arborization", "chunk": 6}
{"article": "PMC8873004.txt", "subject": "valeric acid", "relationship": "INDICATES_PRESENCE_OF", "object": "learning and memory dysfunction", "chunk": 7}
{"article": "PMC8873004.txt", "subject": "valeric acid", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "learning and memory", "chunk": 7}
{"article": "PMC8873004.txt", "subject": "valeric acid", "relationship": "REDUCED_BY", "object": "exercise", "chunk": 7}
{"article": "PMC8873004.txt", "subject": "valeric acid", "relationship": "ASSOCIATED_WITH", "object": "increased inflammatory responses", "chunk": 7}
{"article": "PMC8873004.txt", "subject": "valeric acid", "relationship": "ASSOCIATED_WITH", "object": "impaired brain cell genesis and dendritic arborization", "chunk": 7}
{"article": "PMC8873004.txt", "subject": "valeric acid", "relationship": "TARGET_OF_TREATMENT", "object": "C3 antagonist, SB290157", "chunk": 7}
{"article": "PMC8873004.txt", "subject": "C3", "relationship": "INDICATES_PRESENCE_OF", "object": "learning and memory dysfunction", "chunk": 7}
{"article": "PMC8873004.txt", "subject": "valeric acid", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Surgery-induced learning and memory dysfunction", "chunk": 8}
{"article": "PMC8873004.txt", "subject": "C3 Signaling", "relationship": "ACTIVATED_BY", "object": "increased valeric acid in the blood", "chunk": 8}
{"article": "PMC8873004.txt", "subject": "C3 Signaling", "relationship": "INHIBITS", "object": "beneficial effects, such as growth factor production and neuroinflammation reduction", "chunk": 8}
{"article": "PMC8873004.txt", "subject": "low intensity exercise", "relationship": "RELATED_TREATMENT", "object": "reduces postoperative cognitive dysfunction (POCD)", "chunk": 8}
{"article": "PMC8873004.txt", "subject": "C3", "relationship": "INDICATED_PRESENCE_OF", "object": "Hippocampal inflammation", "chunk": 13}
{"article": "PMC8873004.txt", "subject": "C3ar1", "relationship": "RELATED_TREATMENT", "object": "Potential therapeutic target for Alzheimer's disease", "chunk": 13}
{"article": "PMC8873004.txt", "subject": "GDNF", "relationship": "RELATED_TREATMENT", "object": "Potential neuroprotective therapy for Alzheimer's disease", "chunk": 13}
{"article": "PMC8873004.txt", "subject": "IL-1\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuroinflammation", "chunk": 13}
{"article": "PMC8873004.txt", "subject": "IL-6", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuroinflammation", "chunk": 13}
{"article": "PMC8873004.txt", "subject": "PSD95", "relationship": "RELATED_TREATMENT", "object": "Synaptic plasticity and function", "chunk": 13}
{"article": "PMC8873004.txt", "subject": "GFAP", "relationship": "INDICATES_PRESENCE_OF", "object": "Astrogliosis", "chunk": 13}
{"article": "PMC8873004.txt", "subject": "Iba-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial activation", "chunk": 13}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "INDICATES_PRESENCE_OF", "object": "AD dementia and cognitive decline", "chunk": 2}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "RELATED_PROGNOSIS", "object": "Longitudinal change in MMSE score", "chunk": 2}
{"article": "PMC8901176.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Longitudinal change in MMSE score", "chunk": 2}
{"article": "PMC8901176.txt", "subject": "P-tau", "relationship": "RELATED_PROGNOSIS", "object": "Longitudinal change in MMSE score", "chunk": 2}
{"article": "PMC8901176.txt", "subject": "A\u03b238/A\u03b240 ratio", "relationship": "USED_TO_DIAGNOSE", "object": "Probability of AD", "chunk": 2}
{"article": "PMC8901176.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "USED_TO_DIAGNOSE", "object": "Probability of AD", "chunk": 2}
{"article": "PMC8901176.txt", "subject": "P-tau/A\u03b242 ratio", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 2}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "INDICATES_PRESENCE_OF", "object": "AD-related outcomes", "chunk": 3}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "RELATED_PROGNOSIS", "object": "Conversion to AD dementia", "chunk": 3}
{"article": "PMC8901176.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "conversion to AD dementia", "chunk": 3}
{"article": "PMC8901176.txt", "subject": "P-tau", "relationship": "RELATED_PROGNOSIS", "object": "Conversion to AD dementia", "chunk": 3}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "ASSOCIATED_WITH", "object": "A\u03b242 in BioFINDER cohort", "chunk": 3}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "ASSOCIATED_WITH", "object": "A\u03b242 in ADNI cohort", "chunk": 3}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "ASSOCIATED_WITH", "object": "P-tau in BioFINDER cohort", "chunk": 3}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "ASSOCIATED_WITH", "object": "P-tau in ADNI cohort", "chunk": 3}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "RELATED_TREATMENT", "object": "AD-related outcomes", "chunk": 3}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "less decline in MMSE score over time", "chunk": 4}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "PREDICTED_SURVIVAL", "object": "lower risk of AD dementia", "chunk": 4}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "RELATED_TREATMENT", "object": "predictor", "chunk": 4}
{"article": "PMC8901176.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "predictor", "chunk": 4}
{"article": "PMC8901176.txt", "subject": "P-tau", "relationship": "RELATED_TREATMENT", "object": "predictor", "chunk": 4}
{"article": "PMC8901176.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Less decline in MMSE score", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Less decline in MMSE score", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "A\u03b240", "relationship": "PREDICT_SURVIVAL", "object": "Longer survival", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Conversion to AD dementia", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Conversion to AD dementia", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid A\u03b240", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment for Alzheimer's Disease", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "sAPP", "relationship": "RELATED_PROGNOSIS", "object": "Change in MMSE score", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "sAPP", "relationship": "RELATED_PROGNOSIS", "object": "Conversion to AD dementia", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "A\u03b238/A\u03b240 ratio", "relationship": "PREDICT_SURVIVAL", "object": "Longitudinal cognitive decline", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "RELATED_PROGNOSIS", "object": "Longitudinal cognitive decline", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Anti-amyloid therapies", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "P-tau", "relationship": "RELATED_TREATMENT", "object": "Anti-amyloid therapies", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "A\u03b242", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment for Alzheimer's Disease", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "P-tau", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment for Alzheimer's Disease", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "A\u03b238/A\u03b240 ratio", "relationship": "RELATED_PROGNOSIS", "object": "Potential protective mechanism from A\u03b238", "chunk": 5}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "RELATED_PROGNOSIS", "object": "lower risk of AD-related changes", "chunk": 6}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "RELATED_TREATMENT", "object": "GSMs", "chunk": 6}
{"article": "PMC8901176.txt", "subject": "A\u03b238", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "increasing", "chunk": 6}
{"article": "PMC8901176.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "brain A\u03b2 buildup", "chunk": 6}
{"article": "PMC8901176.txt", "subject": "tau", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's disease", "chunk": 6}
{"article": "PMC8901176.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "GSMs", "chunk": 6}
{"article": "PMC8901176.txt", "subject": "sAPP", "relationship": "RELATED_TREATMENT", "object": "GSMs", "chunk": 6}
{"article": "PMC8901176.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "GSMs", "chunk": 6}
{"article": "PMC8905724.txt", "subject": "Alzheimer\u2019s disease", "relationship": "DIAGNOSTIC_OF", "object": "indicated", "chunk": 1}
{"article": "PMC8905724.txt", "subject": "\u03b2-amyloid", "relationship": "INDICATES_PRESENCE_OF", "object": "AD is characterized by an accumulation of \u03b2-amyloid in plaques and", "chunk": 2}
{"article": "PMC8905724.txt", "subject": "\u03b2-amyloid", "relationship": "IS_TARGET_OF_TREATMENT", "object": "with aducanumab, a human monoclonal antibody that selectively binds to \u03b2-amyloid fibrils and soluble oligomers, provisionally approved by the Food and Drug Administration in the USA in 2021", "chunk": 2}
{"article": "PMC8905724.txt", "subject": "Aducanumab", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "the Food and Drug Administration in the USA in 2021", "chunk": 2}
{"article": "PMC8905724.txt", "subject": "\u03b2-amyloid", "relationship": "RELATED_TO", "object": "US-BBBD alone has been shown to reduce \u03b2-amyloid and tau pathologies", "chunk": 2}
{"article": "PMC8905724.txt", "subject": "\u03b2-amyloid", "relationship": "DIAGNOSITC_OF", "object": "The diagnosis was confirmed by the presence of cerebral cerebral cerebral cerebral spinal fluid levels of ptau/A\u03b21\u201342 > 0.11", "chunk": 2}
{"article": "PMC8905724.txt", "subject": "Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD is characterized by an accumulation of \u03b2-amyloid in plaques and Neurofibrillary tangles composed of tau in the brain", "chunk": 2}
{"article": "PMC8905724.txt", "subject": "Tau", "relationship": "IS_TARGET_OF_TREATMENT", "object": "with aducanumab, a human monoclonal antibody that selectively binds to \u03b2-amyloid fibrils and soluble oligomers, provisionally approved by the Food and Drug Administration in the USA in 2021", "chunk": 2}
{"article": "PMC8905724.txt", "subject": "Gd-DOTA", "relationship": "INDICATES_PRESENCE_OF", "object": "BBB disruption", "chunk": 3}
{"article": "PMC8905724.txt", "subject": "Glycoprotein 18F-florbetapir", "relationship": "USED_TO_DIAGNOSE", "object": "Amyloid positive regions", "chunk": 3}
{"article": "PMC8905724.txt", "subject": "Gilocorerobeutami", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Treatment for Alzheimer's disease", "chunk": 3}
{"article": "PMC8905724.txt", "subject": "18F-FDG", "relationship": "INDICATES_PRESENCE_OF", "object": "Glucose in the brain", "chunk": 3}
{"article": "PMC8905724.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "used to screen patients for inclusion in the trial", "chunk": 4}
{"article": "PMC8905724.txt", "subject": "amyloid burden", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC8905724.txt", "subject": "SUVRs", "relationship": "RELATED_TO", "object": "amyloid burden", "chunk": 5}
{"article": "PMC8905724.txt", "subject": "changes in amyloid PET", "relationship": "PREDICTED_BY", "object": "sonications", "chunk": 5}
{"article": "PMC8905724.txt", "subject": "decrease in regional glucose metabolism", "relationship": "ASSOCIATED_WITH", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC8905724.txt", "subject": "blunting or plateau of decline in glucose metabolism", "relationship": "RELATED_TO", "object": "treatment with sonications", "chunk": 5}
{"article": "PMC8905724.txt", "subject": "amyloid burden", "relationship": "RELATED_TO", "object": "decreased amyloid burden in tissue proximal to the implant", "chunk": 6}
{"article": "PMC8905724.txt", "subject": "Amyloid PET", "relationship": "REPORTS", "object": "resided in subjects having a positive baseline amyloid burden in the target region", "chunk": 6}
{"article": "PMC8905724.txt", "subject": "Gd-DOTA concentration maps", "relationship": "COMPUTED_FROM", "object": "MRI T1 maps", "chunk": 6}
{"article": "PMC8905724.txt", "subject": "BBB disruption", "relationship": "INDICATES_PRESENCE_OF", "object": "detectable ultrasound-mediated BBB disruption", "chunk": 6}
{"article": "PMC8905724.txt", "subject": "amyloid burden", "relationship": "RELATED_TO_TREATMENT", "object": "reduction of", "chunk": 7}
{"article": "PMC8905724.txt", "subject": "amyloid load", "relationship": "MONITORED_DURING_TREATMENT", "object": "The patient's amyloid load was monitored using PET imaging at M0, M4, and M8", "chunk": 7}
{"article": "PMC8905724.txt", "subject": "amyloid uptake", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "remained on average stable between M0 and M8", "chunk": 7}
{"article": "PMC8905724.txt", "subject": "FDG uptake", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "decreased on average between M0 and M8", "chunk": 7}
{"article": "PMC8905724.txt", "subject": "Gd-DOTA", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "presence of detectable BBB disruption", "chunk": 7}
{"article": "PMC8905724.txt", "subject": "SUVR", "relationship": "USED_TO_DIAGNOSE", "object": "regional amyloid and FDG PET tracers uptake", "chunk": 7}
{"article": "PMC8905724.txt", "subject": "APC", "relationship": "RELATED_PROGNOSIS", "object": "annualized percent change in PET uptake", "chunk": 7}
{"article": "PMC8905724.txt", "subject": "MMSE Score", "relationship": "RELATED_PROGNOSIS", "object": "measure of cognitive function in participants", "chunk": 7}
{"article": "PMC8918152.txt", "subject": "Apolipoprotein E (APOE) \u03b54 genotype", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk of Alzheimer\u2019s Disease", "chunk": 1}
{"article": "PMC8918152.txt", "subject": "Cognitive reserve", "relationship": "RELATED_PROGNOSIS", "object": "Progression from SCD to mild cognitive impairment and to AD", "chunk": 1}
{"article": "PMC8918152.txt", "subject": "APOE \u03b54 genotype", "relationship": "RELATED_PROGNOSIS", "object": "Risk of progression from SCD to mild cognitive impairment   and dementia", "chunk": 1}
{"article": "PMC8918152.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "APOE \u03b54 genotyping", "chunk": 2}
{"article": "PMC8918152.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s Disease risk", "chunk": 2}
{"article": "PMC8918152.txt", "subject": "APOE \u03b54", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer\u2019s Disease risk estimation", "chunk": 2}
{"article": "PMC8918152.txt", "subject": "APOE \u025b4", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC8918152.txt", "subject": "APOE \u025b4", "relationship": "RELATED_PROGNOSIS", "object": "A higher proportion in men is associated with possible poorer outcomes", "chunk": 3}
{"article": "PMC8918152.txt", "subject": "TIB", "relationship": "RELATED_PROGNOSIS", "object": "Age at onset of SCD", "chunk": 4}
{"article": "PMC8918152.txt", "subject": "TIB", "relationship": "RELATED_PROGNOSIS", "object": "Age at onset in men", "chunk": 4}
{"article": "PMC8918152.txt", "subject": "TIB", "relationship": "RELATED_TREATMENT", "object": "Predicts MAC-Q in men", "chunk": 4}
{"article": "PMC8918152.txt", "subject": "APOE \u025b4+", "relationship": "RELATED_PROGNOSIS", "object": "Age at onset", "chunk": 4}
{"article": "PMC8918152.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "MAC-Q in men", "chunk": 4}
{"article": "PMC8918152.txt", "subject": "HDRS", "relationship": "RELATED_PROGNOSIS", "object": "MAC-Q in men", "chunk": 4}
{"article": "PMC8918152.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduced or abolished neuroprotective effect of estrogen", "chunk": 5}
{"article": "PMC8918152.txt", "subject": "Estrogen", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Neuroprotective effect", "chunk": 5}
{"article": "PMC8918152.txt", "subject": "Sex hormones", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline and AD", "chunk": 5}
{"article": "PMC8918152.txt", "subject": "Education", "relationship": "PREDICTED_SURVIVAL", "object": "Age at onset of SCD", "chunk": 5}
{"article": "PMC8918152.txt", "subject": "Cognitive reserve", "relationship": "RELATED_TREATMENT", "object": "Severity of cognitive complaints", "chunk": 5}
{"article": "PMC8957010.txt", "subject": "Mini-Mental State Exam (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Initial assessment of cognitive impairment in patients with mild cognitive impairment", "chunk": 1}
{"article": "PMC8957010.txt", "subject": "Mini-Mental State Exam (MMSE)", "relationship": "RELATED_PROGNOSIS", "object": "Provides a baseline for tracking cognitive decline in patients with mild cognitive impairment", "chunk": 1}
{"article": "PMC8957010.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 2}
{"article": "PMC8957010.txt", "subject": "MMSE", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Algorithm adaptation and performance improvement", "chunk": 2}
{"article": "PMC8957010.txt", "subject": "Geriatric Depression Scale (GDS)", "relationship": "RELATED_PROGNOSIS", "object": "Inclusion/Exclusion criteria for the study", "chunk": 2}
{"article": "PMC8957010.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Performance on the MMSE may indicate cognitive ability and interaction with test completion in patients with mild cognitive impairment.", "chunk": 3}
{"article": "PMC8957010.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "Screening for cognitive impairment, particularly in the range of 20 to 28.", "chunk": 3}
{"article": "PMC8957010.txt", "subject": "TechPH", "relationship": "RELATED_PROGNOSIS", "object": "Scores on the TechPH might indicate technophilia, which did not show a significant correlation with test completion issues in this study population.", "chunk": 3}
{"article": "PMC8957010.txt", "subject": "MMSE", "relationship": "USED_TO_DIAGNOSE", "object": "Mild Cognitive Impairment", "chunk": 4}
{"article": "PMC8957010.txt", "subject": "GDS", "relationship": "USED_TO_DIAGNOSE", "object": "Geriatric Depression", "chunk": 4}
{"article": "PMC8961395.txt", "subject": "potentially inappropriate medications (PIMs)", "relationship": "ASSOCIATED_WITH_RISK", "object": "polypharmacy, adverse drug events, further cognitive deterioration and higher rates of hospitalization and mortality", "chunk": 2}
{"article": "PMC8961395.txt", "subject": "deprescribing", "relationship": "RELATED_TREATMENT", "object": "reduce the number of long-term medications prescribed and the percentage of individuals taking 1 or more PIMs", "chunk": 2}
{"article": "PMC8961395.txt", "subject": "deprescribing", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Optimize medications", "chunk": 2}
{"article": "PMC8961395.txt", "subject": "deprescribing", "relationship": "RELATED_TREATMENT", "object": "improve outcomes for individuals with multiple chronic conditions", "chunk": 2}
{"article": "PMC8961395.txt", "subject": "potentially inappropriate medication (PIM)", "relationship": "RELATED_TREATMENT", "object": "Interventions examined effects on the use of PIMs", "chunk": 4}
{"article": "PMC8961395.txt", "subject": "potentially inappropriate medication (PIM)", "relationship": "INDICATES_PRESENCE_OF", "object": "percentage of patients with \u22651 PIM", "chunk": 4}
{"article": "PMC8961395.txt", "subject": "PIMs (Potentially Inappropriate Medications)", "relationship": "RELATED_PROGNOSIS", "object": "Percentage of individuals taking PIMs is associated with the number of long-term medications prescribed.", "chunk": 5}
{"article": "PMC8961395.txt", "subject": "PIMs (Potentially Inappropriate Medications)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Higher percentage of individuals taking PIMs indicates a greater potential for risk in vulnerable populations of older adults.", "chunk": 5}
{"article": "PMC8961395.txt", "subject": "Long-term Medications", "relationship": "RELATED_TREATMENT", "object": "Deprescribing interventions aim to decrease the number of long-term medications prescribed to reduce the risk of PIMs and adverse outcomes.", "chunk": 5}
{"article": "PMC8961395.txt", "subject": "Deprescribing Interventions", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Interventions focus on patient, family, and clinician education and activation to guide deprescribing decisions for older adults with cognitive impairment.", "chunk": 5}
{"article": "PMC8961395.txt", "subject": "long-term medications", "relationship": "RELATED_PROGNOSIS", "object": "Higher levels associated with increased risk for adverse effects and greater risk for interventional targets", "chunk": 6}
{"article": "PMC8961395.txt", "subject": "PIMs (Potentially Inappropriate Medications)", "relationship": "RELATED_TREATMENT", "object": "Deprescribing PIMs is potentially beneficial regardless of total medication burden", "chunk": 6}
{"article": "PMC8961395.txt", "subject": "long-term medications", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Individuals taking more long-term medications are appropriate targets for deprescribing interventions", "chunk": 6}
{"article": "PMC8961395.txt", "subject": "number of long-term medications", "relationship": "MONITORED_DURING_TREATMENT", "object": " Reflects the direct effect of deprescribing intervention", "chunk": 6}
{"article": "PMC8961395.txt", "subject": "percent of individuals taking PIMs", "relationship": "MONITORED_DURING_TREATMENT", "object": "Reflects the direct effect of deprescribing intervention", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "INDICATES_PRESENCE_OF", "object": "Progression to Alzheimer's disease dementia", "chunk": 1}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "RELATED_PROGNOSIS", "object": "Risk of progression to AD dementia in mild cognitive impairment patients", "chunk": 1}
{"article": "PMC8966264.txt", "subject": "p-tau217 PLUS cognition", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Future prognostic algorithms for early AD", "chunk": 1}
{"article": "PMC8966264.txt", "subject": "amyloid-\u03b2 42/40", "relationship": "RELATED_TO", "object": "Alzheimer's disease related plasma biomarkers", "chunk": 1}
{"article": "PMC8966264.txt", "subject": "phosphorylated tau217 [p-tau217]", "relationship": "RELATED_TO", "object": "Alzheimer's disease related plasma biomarkers", "chunk": 1}
{"article": "PMC8966264.txt", "subject": "neurofilament light", "relationship": "RELATED_TO", "object": "Alzheimer's disease related plasma biomarkers", "chunk": 1}
{"article": "PMC8966264.txt", "subject": "glial fibrillary acidic protein", "relationship": "RELATED_TO", "object": "Alzheimer's disease related plasma biomarkers", "chunk": 1}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "INDICATES_PRESENCE_OF", "object": "Conversion to AD dementia", "chunk": 2}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "RELATED_PROGNOSIS", "object": "Conversion to AD dementia", "chunk": 2}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Developing prognostic algorithms", "chunk": 2}
{"article": "PMC8966264.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Identifying mild cognitive impairment patients likely to progress to AD dementia", "chunk": 2}
{"article": "PMC8966264.txt", "subject": "NfL", "relationship": "RELATED_TREATMENT", "object": "Identifying mild cognitive impairment patients likely to progress to AD dementia", "chunk": 2}
{"article": "PMC8966264.txt", "subject": "GFAP", "relationship": "RELATED_TREATMENT", "object": "Identifying mild cognitive impairment patients likely to progress to AD dementia", "chunk": 2}
{"article": "PMC8966264.txt", "subject": "APOE genotype", "relationship": "RELATED_TREATMENT", "object": "Identifying cognitive impairment patients likely to progress to AD dementia", "chunk": 2}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "INDICATES_PRESENCE_OF", "object": "AD dementia", "chunk": 3}
{"article": "PMC8966264.txt", "subject": "NfL", "relationship": "INDICATES_PRESENCE_OF", "object": "AD dementia", "chunk": 3}
{"article": "PMC8966264.txt", "subject": "GFAP", "relationship": "INDICATES_PRESENCE_OF", "object": "AD dementia", "chunk": 3}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Conversion to AD dementia", "chunk": 3}
{"article": "PMC8966264.txt", "subject": "NfL", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Conversion to AD dementia", "chunk": 3}
{"article": "PMC8966264.txt", "subject": "GFAP", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Conversion to AD dementia", "chunk": 3}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "predicts", "object": "Clinical progression to AD dementia in MCI patients", "chunk": 5}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "is most predictive", "object": "marker of clinical progression in patients with MCI", "chunk": 5}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "associated with", "object": "higher AUC when used alone compared to other plasma biomarkers", "chunk": 5}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "INDICATES_PRESENCE_OF", "object": "AD progression", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "best model predicting progression to AD dementia", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "RELATED_PROGNOSIS", "object": "conversion to AD dementia", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "parsimonious model with easily accessible markers predicting progression to AD dementia", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_TO", "object": "A\u03b2 pathology in earlier stages of the disease", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "GFAP", "relationship": "RELATED_TO", "object": "A\u03b2 pathology in earlier stages of the disease", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "GFAP", "relationship": "ASSOCIATED_WITH", "object": "A\u03b2 pathology", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "MONITORED_DURING_TREATMENT", "object": "AD progression", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "A\u03b242/A\u03b240", "relationship": "LESS_ACCURATE_THAN", "object": "Mass spectrometry-based A\u03b2 assays", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "A\u03b242/A\u03b240", "relationship": "NOT_ADDED_VALUE", "object": "Model fit or better discrimination when combined with plasma p-tau217", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "apoe4 genotype", "relationship": "USED_TO_DIAGNOSE", "object": "Early-onset Alzheimer's Disease", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "PREDICTING", "object": "A\u03b2-positive participants", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "RELATED_TO", "object": "clinical progression", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "GFAP", "relationship": "RELATIONSHIP_WITH", "object": "A\u03b2  rather than with p-tau", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "RELATED_TO", "object": "hippocampal volume", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "RELATED_TO", "object": "global cognitive score (mPACC)", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "RELATED_TO", "object": "apoe4 genotype", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "PREDICTING", "object": "conversion to AD dementia", "chunk": 6}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "RELATED_PROGNOSIS", "object": "Risk of conversion to AD dementia within 3 years", "chunk": 7}
{"article": "PMC8966264.txt", "subject": "plasma p-tau217", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved discrimination between those who progressed to AD dementia or not", "chunk": 7}
{"article": "PMC8966264.txt", "subject": "p-tau217", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Prediction of future decline in mild cognitive impairment patients", "chunk": 7}
{"article": "PMC8985764.txt", "subject": "digital activity data", "relationship": "RELATED_PROGNOSIS", "object": "understanding care needs as dementia advances", "chunk": 1}
{"article": "PMC8985764.txt", "subject": "digital activity data", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "tailored dementia care needs assessment", "chunk": 1}
{"article": "PMC8985764.txt", "subject": "cognitive testing", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "limited insight into unmet needs related to functional deficits or the care environment", "chunk": 1}
{"article": "PMC8985764.txt", "subject": "digital activity data", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "providing new objective insights into function, and routines", "chunk": 1}
{"article": "PMC8985764.txt", "subject": "care values", "relationship": "RELATED_TREATMENT", "object": "achieving person-centered care", "chunk": 1}
{"article": "PMC8985764.txt", "subject": "step count", "relationship": "RELATED_PROGNOSIS", "object": "activity patterns", "chunk": 3}
{"article": "PMC8985764.txt", "subject": "sleep duration", "relationship": "RELATED_PROGNOSIS", "object": "activity patterns", "chunk": 3}
{"article": "PMC8985764.txt", "subject": "medication-taking behavior", "relationship": "RELATED_PROGNOSIS", "object": "activity patterns", "chunk": 3}
{"article": "PMC8985764.txt", "subject": "daily weight", "relationship": "RELATED_PROGNOSIS", "object": "activity patterns", "chunk": 3}
{"article": "PMC8985764.txt", "subject": "bed exits at night", "relationship": "RELATED_PROGNOSIS", "object": "sleep metrics", "chunk": 3}
{"article": "PMC8985764.txt", "subject": "total sleep time", "relationship": "RELATED_PROGNOSIS", "object": "sleep metrics", "chunk": 3}
{"article": "PMC8985764.txt", "subject": "heart rate", "relationship": "RELATED_PROGNOSIS", "object": "physiologic data", "chunk": 3}
{"article": "PMC8985764.txt", "subject": "respirations", "relationship": "RELATED_PROGNOSIS", "object": "physiologic data", "chunk": 3}
